data_2lxc_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lxc _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.453 -0.282 0 N-CA-C 109.99 -0.374 . . . . 10.0 109.99 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -86.25 120.13 27.28 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.268 -0.424 . . . . 10.0 110.858 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.1 mp -125.72 120.08 29.7 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.881 -0.599 . . . . 10.0 109.844 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 15.6 m -99.54 112.97 25.1 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.968 0.413 . . . . 10.0 109.943 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 87' ' ' SER . 3.0 mm? -84.57 114.65 22.12 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.873 -0.603 . . . . 10.0 109.645 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -117.93 103.83 10.31 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.079 -0.51 . . . . 10.0 110.232 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.495 ' HG2' ' O ' ' A' ' 84' ' ' PRO . 15.9 tptm -92.17 121.8 34.04 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.806 -0.633 . . . . 10.0 109.348 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 75.6 mt -84.97 -57.78 4.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 O-C-N 123.631 0.582 . . . . 10.0 111.543 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -66.15 158.51 28.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.856 -0.611 . . . . 10.0 111.023 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.28 139.71 56.22 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 120.877 0.37 . . . . 10.0 111.188 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.495 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 7.3 Cg_exo -75.17 129.44 18.67 Favored 'Cis proline' 0 C--O 1.235 0.335 0 C-N-CA 123.297 -1.543 . . . . 10.0 110.708 -1.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.437 ' HE3' ' HB2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -92.08 158.99 15.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.191 0.519 . . . . 10.0 110.953 -179.179 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -173.23 167.9 4.77 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.396 -0.82 . . . . 10.0 109.879 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.538 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 46.4 m -146.61 97.66 2.95 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.275 -0.639 . . . . 10.0 109.275 178.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 38.0 pt -110.45 146.01 16.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.804 -0.634 . . . . 10.0 110.657 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -110.98 126.16 54.48 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.062 -0.718 . . . . 10.0 109.062 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 12.0 m80 -142.5 159.42 42.26 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.393 0.616 . . . . 10.0 111.976 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -105.75 126.76 52.54 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.044 -0.98 . . . . 10.0 109.922 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -117.89 167.65 11.22 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.935 -0.575 . . . . 10.0 110.587 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.561 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 1.7 m -89.72 153.73 47.81 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.144 -0.48 . . . . 10.0 110.463 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -60.52 -27.88 85.66 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.342 2.028 . . . . 10.0 112.329 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.6 m -103.97 17.93 23.07 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.002 -0.545 . . . . 10.0 110.678 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.561 ' HB2' ' O ' ' A' ' 93' ' ' SER . 0.3 OUTLIER -73.33 152.1 41.03 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.985 -0.552 . . . . 10.0 110.153 179.565 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.58 147.09 28.01 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.707 -0.679 . . . . 10.0 110.457 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 30.9 mm -62.3 -23.76 32.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.189 0.519 . . . . 10.0 110.511 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.2 -37.94 78.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.61 -0.723 . . . . 10.0 110.509 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -61.77 -40.02 93.69 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.457 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.582 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 45.9 mt -63.15 -47.49 92.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.974 -0.557 . . . . 10.0 109.65 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.569 ' HZ1' ' CG ' ' A' ' 128' ' ' ASP . 75.3 mttt -56.49 -47.36 79.43 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.448 -0.796 . . . . 10.0 110.962 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -61.35 -39.99 92.62 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.963 -0.562 . . . . 10.0 110.598 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 25.1 t60 -62.7 -38.54 90.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.476 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 101' ' ' ILE . 58.1 mt -65.43 -39.62 92.3 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.953 0.406 . . . . 10.0 110.671 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 43.2 mt -69.73 -39.7 78.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.103 0.478 . . . . 10.0 110.313 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.1 m -67.09 -20.33 65.79 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.893 -0.594 . . . . 10.0 111.305 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -98.8 14.6 28.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.633 -0.258 . . . . 10.0 111.242 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 58.11 35.12 24.86 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.121 -0.491 . . . . 10.0 111.166 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 8.6 mmtp -112.99 -13.34 13.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.547 -0.297 . . . . 10.0 111.335 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -135.06 155.81 50.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.394 -0.366 . . . . 10.0 110.762 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.1 m -94.46 -61.35 1.53 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.246 -0.434 . . . . 10.0 111.266 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -137.98 147.8 44.6 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.964 -0.384 . . . . 10.0 109.964 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 48.1 pt -60.43 -32.95 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.378 0.608 . . . . 10.0 110.843 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.4 m -58.59 -28.82 65.93 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.694 -1.139 . . . . 10.0 112.961 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.93 14.57 24.97 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.168 0.433 . . . . 10.0 112.168 -177.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 32.6 mt -115.87 135.44 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 113.288 0.847 . . . . 10.0 113.288 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 52.7 tttt -140.88 129.12 22.27 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 109.198 -0.667 . . . . 10.0 109.198 175.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -96.18 136.1 37.09 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.274 0.559 . . . . 10.0 111.342 -179.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.46 134.67 53.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.263 -0.88 . . . . 10.0 110.029 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.511 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 43.0 tp -127.49 96.63 4.61 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 107.429 -1.322 . . . . 10.0 107.429 177.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 21.7 tptp 36.43 59.39 0.98 Allowed 'General case' 0 N--CA 1.467 0.387 0 O-C-N 124.059 0.849 . . . . 10.0 111.457 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.27 -43.99 3.16 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 121.001 -0.619 . . . . 10.0 112.734 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.511 ' HB3' ' O ' ' A' ' 121' ' ' LEU . 26.9 tptt -59.73 126.87 29.3 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.916 -0.642 . . . . 10.0 109.765 178.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.0 m -94.15 140.72 16.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.688 0.625 . . . . 10.0 112.688 -178.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 7.2 mp -106.69 154.39 21.03 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.746 -0.661 . . . . 10.0 110.462 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -115.26 158.41 22.38 Favored 'General case' 0 C--O 1.226 -0.153 0 CA-C-O 120.677 0.275 . . . . 10.0 110.823 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.569 ' CG ' ' HZ1' ' A' ' 102' ' ' LYS . 1.2 m-20 -51.4 -55.01 20.93 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.827 1.047 . . . . 10.0 113.827 -178.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -94.02 19.35 9.23 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.756 0.312 . . . . 10.0 111.57 -177.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 12.8 tp -78.3 149.58 33.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.91 0.386 . . . . 10.0 111.088 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -108.9 150.28 27.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.768 -0.651 . . . . 10.0 110.031 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.509 HD11 ' O ' ' A' ' 93' ' ' SER . 64.3 mt -59.1 -28.18 66.27 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.211 0.449 . . . . 10.0 112.211 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.14 -12.55 59.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.118 0.485 . . . . 10.0 111.024 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -92.08 -49.86 5.99 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.131 -0.486 . . . . 10.0 110.839 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.3 pp -75.1 -25.93 58.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.017 -0.538 . . . . 10.0 111.274 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt 67.94 99.38 0.05 Allowed 'General case' 0 N--CA 1.465 0.313 0 O-C-N 124.062 0.851 . . . . 10.0 111.578 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.8 t -72.97 107.68 3.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.755 -0.461 . . . . 10.0 109.755 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.2 p -66.62 123.53 86.02 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.315 -0.402 . . . . 10.0 110.964 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -63.95 -24.0 67.66 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.731 2.288 . . . . 10.0 111.66 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -78.26 4.29 13.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.55 -0.75 . . . . 10.0 111.402 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -132.83 -72.61 0.51 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.758 -0.201 . . . . 10.0 110.991 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.0 m 60.33 14.94 5.02 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.321 0.581 . . . . 10.0 111.366 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.7 m -114.02 120.15 39.61 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.948 -0.569 . . . . 10.0 110.316 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 19.3 mm -110.22 119.71 59.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.964 -0.562 . . . . 10.0 109.737 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.6 m -83.19 123.91 30.02 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.345 -0.389 . . . . 10.0 110.32 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 13.4 t -97.52 124.95 50.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.135 -0.484 . . . . 10.0 111.942 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 13.7 mmt -117.94 118.37 31.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.53 -0.759 . . . . 10.0 109.494 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 35.4 mt -136.51 140.84 42.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 111.548 0.203 . . . . 10.0 111.548 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -106.68 120.13 49.31 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 108.264 -1.013 . . . . 10.0 108.264 178.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo . . . . . 0 N--CA 1.463 -0.281 0 C-N-CA 122.39 2.06 . . . . 10.0 113.264 -178.993 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.451 -0.423 0 N-CA-C 109.764 -0.458 . . . . 10.0 109.764 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . 0.474 ' H ' ' HG2' ' B' ' 5' ' ' LYS . 1.6 ptpp? -60.14 -43.36 95.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.329 -0.396 . . . . 10.0 111.501 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -59.04 -36.27 74.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.574 0.226 . . . . 10.0 110.972 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -64.66 -50.96 65.0 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.073 0.464 . . . . 10.0 109.88 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.537 ' O ' HD11 ' B' ' 12' ' ' ILE . 44.3 mm -61.51 -46.79 95.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.567 -0.742 . . . . 10.0 110.961 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.36 -47.77 75.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.9 0.381 . . . . 10.0 110.971 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.94 -32.11 73.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.986 -0.552 . . . . 10.0 110.694 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.3 mt -69.48 -38.06 77.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.362 -0.381 . . . . 10.0 110.399 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.537 HD11 ' O ' ' B' ' 8' ' ' ILE . 1.4 mp -63.46 -50.94 76.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.027 -0.533 . . . . 10.0 110.622 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.401 HG23 ' N ' ' B' ' 14' ' ' ASN . 12.3 m -67.83 -33.61 62.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.758 0.314 . . . . 10.0 110.722 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' ASN . . . . . 0.401 ' N ' HG23 ' B' ' 13' ' ' VAL . 65.8 t30 -67.38 -48.37 67.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.282 0.563 . . . . 10.0 110.074 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' TYR . . . . . 0.639 ' O ' HG12 ' B' ' 19' ' ' ILE . 15.9 t80 -60.56 -52.31 65.71 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.456 -0.793 . . . . 10.0 110.931 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -54.75 -46.76 74.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.27 -0.423 . . . . 10.0 111.64 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 27.3 m -59.55 -42.55 92.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.695 0.283 . . . . 10.0 111.279 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 23.6 p -72.44 -19.07 61.64 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 122.205 -0.309 . . . . 10.0 111.271 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.639 HG12 ' O ' ' B' ' 15' ' ' TYR . 31.5 mm -79.86 -39.8 20.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.996 0.427 . . . . 10.0 110.09 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 5.3 m -75.66 -22.79 16.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 121.503 0.668 . . . . 10.0 109.303 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -60.03 -48.99 79.44 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 114.616 -1.175 . . . . 10.0 110.862 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 3.5 mttp -102.08 6.73 41.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.809 -0.632 . . . . 10.0 110.797 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . 0.485 ' HZ1' ' CD ' ' B' ' 27' ' ' GLU . 26.9 mtpt 50.82 56.94 7.22 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.356 0.598 . . . . 10.0 110.589 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -90.6 33.68 0.91 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.425 -0.807 . . . . 10.0 110.973 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' ILE . . . . . 0.444 HG12 ' H ' ' B' ' 26' ' ' SER . 13.3 tt -168.44 168.63 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.218 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' SER . . . . . 0.444 ' H ' HG12 ' B' ' 25' ' ' ILE . 1.9 m -58.21 154.8 12.47 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.926 0.491 . . . . 10.0 112.105 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' GLU . . . . . 0.485 ' CD ' ' HZ1' ' B' ' 23' ' ' LYS . 52.6 mm-40 -52.12 -58.22 7.25 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.911 0.708 . . . . 10.0 112.911 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -70.56 -23.59 62.63 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.244 0.545 . . . . 10.0 109.68 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . 0.597 ' O ' ' HG ' ' B' ' 33' ' ' LEU . . . -63.96 -44.16 96.39 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 110.233 -1.147 . . . . 10.0 110.233 178.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.59 -40.69 95.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.168 0.509 . . . . 10.0 110.083 178.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -62.56 -43.22 99.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.465 -0.789 . . . . 10.0 110.051 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' SER . . . . . 0.497 ' O ' HG12 ' B' ' 35' ' ' VAL . 50.9 m -62.64 -42.49 99.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.428 -0.806 . . . . 10.0 110.393 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . 0.597 ' HG ' ' O ' ' B' ' 29' ' ' GLY . 82.2 mt -64.1 -38.91 92.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.35 -0.386 . . . . 10.0 110.341 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -65.77 -46.72 77.68 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.207 -0.451 . . . . 10.0 111.481 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . 0.497 HG12 ' O ' ' B' ' 32' ' ' SER . 9.9 p -67.8 -38.33 80.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 116.451 -0.341 . . . . 10.0 111.091 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.55 -39.9 88.76 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.204 -0.665 . . . . 10.0 109.204 178.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' MET . . . . . 0.597 ' SD ' ' HD2' ' B' ' 48' ' ' ARG . 0.7 OUTLIER -59.23 -45.14 91.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.362 -0.836 . . . . 10.0 110.142 178.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -61.09 -46.2 91.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.427 -0.806 . . . . 10.0 110.691 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 7.8 t -67.58 -38.39 83.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 10.0 111.01 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 55.9 mt -63.58 -39.02 83.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.878 0.37 . . . . 10.0 110.034 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.694 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 14.2 m -63.01 -38.49 91.38 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.52 -0.548 . . . . 10.0 109.52 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -69.78 -40.99 75.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.857 -0.61 . . . . 10.0 110.286 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.96 -39.45 81.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.48 -0.782 . . . . 10.0 111.975 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -94.89 -0.72 53.77 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.671 -0.24 . . . . 10.0 111.3 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.4 39.82 97.8 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-N 116.203 -0.453 . . . . 10.0 113.2 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.694 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 6.5 p90 -131.26 160.78 33.9 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.358 -0.608 . . . . 10.0 109.358 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -94.15 140.44 29.75 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.834 0.35 . . . . 10.0 110.61 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.597 ' HD2' ' SD ' ' B' ' 37' ' ' MET . 17.3 mtm180 -57.7 -29.68 64.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.899 -0.591 . . . . 10.0 111.664 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 30.4 mp0 -83.82 -0.42 51.05 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.594 -0.73 . . . . 10.0 112.894 -177.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.65 3.52 40.59 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 122.309 -0.245 . . . . 10.0 111.582 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.464 HG22 ' H ' ' B' ' 52' ' ' SER . 4.3 m -41.45 -59.75 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 113.215 0.82 . . . . 10.0 113.215 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' SER . . . . . 0.464 ' H ' HG22 ' B' ' 51' ' ' VAL . 0.1 OUTLIER -59.03 -20.96 58.04 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 113.103 0.779 . . . . 10.0 113.103 -179.527 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.88 -38.43 13.74 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.569 -0.824 . . . . 10.0 112.027 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 32.5 mt -86.25 -51.72 12.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 112.266 0.469 . . . . 10.0 112.266 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 83.5 mt -83.56 -67.31 0.8 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.18 0.515 . . . . 10.0 111.998 -178.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.03 -114.78 4.06 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 110.993 -0.843 . . . . 10.0 110.993 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 45.1 pttt -157.72 23.63 0.28 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.21 0.528 . . . . 10.0 110.381 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.61 35.53 0.41 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.757 -0.656 . . . . 10.0 111.391 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 . . . . . 0 N--CA 1.46 0.072 0 CA-C-N 116.292 -0.413 . . . . 10.0 110.653 -179.19 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.505 0 N-CA-C 109.773 -0.455 . . . . 10.0 109.773 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -98.78 138.52 35.81 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.489 -0.56 . . . . 10.0 109.489 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 5' ' ' LYS . . . . . 0.533 ' HB2' ' CE1' ' C' ' 44' ' ' PHE . 0.2 OUTLIER -60.64 -32.73 71.88 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.387 -0.37 . . . . 10.0 111.199 -179.233 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 6' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -59.75 -52.33 65.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.198 0.523 . . . . 10.0 110.288 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -55.62 -51.45 67.13 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.767 -0.651 . . . . 10.0 110.986 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 8' ' ' ILE . . . . . 0.655 ' O ' HG13 ' C' ' 12' ' ' ILE . 48.6 mm -57.18 -48.86 81.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.707 -0.679 . . . . 10.0 110.99 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.31 -44.98 72.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.044 0.45 . . . . 10.0 110.808 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.68 -33.78 76.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.752 -0.658 . . . . 10.0 110.877 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.58 -37.42 79.84 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.123 -0.325 . . . . 10.0 110.123 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 12' ' ' ILE . . . . . 0.655 HG13 ' O ' ' C' ' 8' ' ' ILE . 21.6 mt -64.01 -57.09 13.08 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.517 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 33.0 m -63.61 -26.2 40.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.682 -0.69 . . . . 10.0 111.506 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -75.73 -46.76 29.19 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.323 0.582 . . . . 10.0 109.603 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 15' ' ' TYR . . . . . 0.491 ' O ' HG12 ' C' ' 19' ' ' ILE . 46.9 t80 -64.07 -43.73 94.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.671 -0.695 . . . . 10.0 110.002 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -57.15 -42.67 81.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.982 -0.553 . . . . 10.0 110.292 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 67.0 m -57.95 -42.9 85.92 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.972 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.55 -20.68 58.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.541 -0.299 . . . . 10.0 111.647 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 19' ' ' ILE . . . . . 0.491 HG12 ' O ' ' C' ' 15' ' ' TYR . 19.7 mm -74.59 -40.45 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.181 0.515 . . . . 10.0 109.764 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 20' ' ' VAL . . . . . . . . . . . . . 17.8 m -82.14 -17.2 11.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.787 -0.642 . . . . 10.0 109.728 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -64.47 -59.61 4.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.369 -0.832 . . . . 10.0 110.163 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -87.73 -3.31 58.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.371 -0.377 . . . . 10.0 110.493 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 64.4 mttm 59.49 58.22 3.03 Favored 'General case' 0 C--N 1.334 -0.066 0 CA-C-N 115.747 -0.661 . . . . 10.0 109.954 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -86.23 9.84 16.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.469 -0.787 . . . . 10.0 110.935 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 15.2 tt -144.36 165.53 13.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.361 -0.607 . . . . 10.0 109.361 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.04 154.67 22.16 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 122.524 0.329 . . . . 10.0 111.243 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -56.3 -46.99 79.56 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.386 -0.37 . . . . 10.0 111.151 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 28' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -64.34 -35.2 80.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.229 0.538 . . . . 10.0 109.736 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 29' ' ' GLY . . . . . 0.561 ' O ' ' HG ' ' C' ' 33' ' ' LEU . . . -66.3 -39.97 94.52 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 110.918 -0.873 . . . . 10.0 110.918 178.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.14 -39.15 93.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.923 0.392 . . . . 10.0 110.27 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -62.81 -42.06 99.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.591 -0.731 . . . . 10.0 109.812 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 19.4 t -64.96 -43.76 91.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.365 -0.834 . . . . 10.0 110.763 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 33' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' C' ' 29' ' ' GLY . 64.2 mt -67.96 -27.73 66.85 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.336 -0.393 . . . . 10.0 110.933 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -73.04 -39.25 66.09 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 116.477 -0.328 . . . . 10.0 111.561 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 35' ' ' VAL . . . . . . . . . . . . . 10.2 p -75.17 -36.05 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 N-CA-C 109.535 -0.543 . . . . 10.0 109.535 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.96 -34.58 78.07 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.702 -0.681 . . . . 10.0 110.097 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 2.9 ttm -54.3 -53.48 53.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.54 -0.755 . . . . 10.0 110.986 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 38' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -69.92 -25.97 63.92 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 121.096 -0.242 . . . . 10.0 110.905 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 39' ' ' CYS . . . . . . . . . . . . . 1.1 t -66.47 -47.62 72.5 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.587 -0.523 . . . . 10.0 109.587 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 40' ' ' ILE . . . . . . . . . . . . . 11.4 mt -67.99 -37.86 78.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.688 -0.687 . . . . 10.0 109.835 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 41' ' ' SER . . . . . 0.6 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 35.4 m -63.25 -43.51 97.79 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.916 -0.584 . . . . 10.0 110.274 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -66.67 -39.76 88.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.789 -0.641 . . . . 10.0 110.47 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.82 -39.06 80.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.921 -0.581 . . . . 10.0 112.027 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 44' ' ' PHE . . . . . 0.533 ' CE1' ' HB2' ' C' ' 5' ' ' LYS . 65.2 m-85 -96.98 -3.33 41.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.68 -0.236 . . . . 10.0 111.59 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.68 39.53 97.62 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.212 -0.518 . . . . 10.0 113.446 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 46' ' ' PHE . . . . . 0.6 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 4.8 p90 -131.88 154.7 48.94 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.397 -0.594 . . . . 10.0 109.397 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -94.24 145.27 24.84 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.644 -0.422 . . . . 10.0 110.656 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 48' ' ' ARG . . . . . 0.401 ' O ' HG11 ' C' ' 51' ' ' VAL . 10.8 mtm-85 -63.27 -15.74 58.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.301 0.572 . . . . 10.0 110.233 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -80.16 -11.08 59.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.57 -0.741 . . . . 10.0 112.406 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -93.53 2.41 56.43 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.254 0.465 . . . . 10.0 112.254 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 51' ' ' VAL . . . . . 0.401 HG11 ' O ' ' C' ' 48' ' ' ARG . 12.1 m -47.58 -44.92 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 113.39 0.885 . . . . 10.0 113.39 -179.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.21 -44.7 92.26 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.821 0.674 . . . . 10.0 112.821 -179.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.2 -26.69 74.42 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.338 -0.934 . . . . 10.0 112.679 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 54' ' ' ILE . . . . . . . . . . . . . 67.3 mt -84.56 -63.44 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.947 0.403 . . . . 10.0 111.962 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 19.0 mt -70.82 -61.1 1.89 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.591 0.589 . . . . 10.0 112.591 -178.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 66.28 -130.0 31.94 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 111.04 -0.824 . . . . 10.0 111.04 -177.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 11.2 pttp -151.35 28.75 0.64 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.187 0.518 . . . . 10.0 110.35 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.55 30.82 0.78 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.013 -0.539 . . . . 10.0 111.121 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 . . . . . 0 C--O 1.232 0.151 0 CA-C-N 115.747 -0.661 . . . . 10.0 111.022 -179.925 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.0 p . . . . . 0 N--CA 1.452 -0.344 0 CA-C-O 121.191 0.52 . . . . 10.0 110.307 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -85.36 138.66 32.14 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.837 -0.62 . . . . 10.0 110.285 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.8 mp -127.97 125.22 39.06 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.964 -0.562 . . . . 10.0 109.929 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.4 HG23 ' HG2' ' A' ' 89' ' ' GLU . 3.0 m -93.45 106.84 18.77 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.015 -0.539 . . . . 10.0 110.417 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 87' ' ' SER . 3.4 mm? -80.73 110.53 16.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.958 -0.565 . . . . 10.0 110.089 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.414 ' HZ2' ' CG ' ' C' ' 31' ' ' ASP . 67.1 tttt -121.42 108.63 13.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.654 -0.703 . . . . 10.0 110.626 -179.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.1 tttm -106.15 125.69 51.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.245 -0.434 . . . . 10.0 110.959 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.454 HG22 ' OG ' ' C' ' 32' ' ' SER . 2.0 mp -83.91 -49.31 16.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 115.525 -0.761 . . . . 10.0 110.546 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -64.8 151.55 45.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.093 -0.503 . . . . 10.0 110.76 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.94 136.47 76.6 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.334 -0.393 . . . . 10.0 111.437 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -74.31 135.79 41.91 Favored 'Cis proline' 0 C--N 1.345 0.387 0 C-N-CA 123.73 -1.363 . . . . 10.0 111.682 -1.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -92.02 151.76 20.31 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.36 -0.382 . . . . 10.0 110.572 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.514 ' CZ ' ' HB3' ' A' ' 110' ' ' LYS . 33.8 p90 -171.18 165.73 7.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.124 -0.489 . . . . 10.0 111.193 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.441 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 51.1 m -148.41 103.57 3.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.547 -0.751 . . . . 10.0 109.591 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.5 pt -135.13 163.73 35.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.423 -0.353 . . . . 10.0 110.436 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.4 ' HG2' HG23 ' A' ' 77' ' ' THR . 5.2 mt-10 -114.8 148.72 38.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.712 0.291 . . . . 10.0 111.316 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 24.4 m80 -145.89 145.74 30.83 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.05 -0.722 . . . . 10.0 109.05 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -102.01 127.42 48.9 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.175 -0.676 . . . . 10.0 109.175 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -121.44 170.32 9.76 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.483 0.659 . . . . 10.0 111.618 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.0 145.76 33.74 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 115.172 -0.922 . . . . 10.0 109.16 178.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.12 -25.67 37.29 Favored 'Trans proline' 0 CA--C 1.527 0.156 0 C-N-CA 122.108 1.872 . . . . 10.0 112.523 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.89 17.06 8.28 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.823 0.344 . . . . 10.0 111.02 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -91.98 170.19 10.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.392 -0.367 . . . . 10.0 110.453 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.85 159.55 22.89 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.022 -0.536 . . . . 10.0 110.387 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.511 ' HB ' ' HA ' ' A' ' 128' ' ' ASP . 49.2 mm -66.8 -23.43 31.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.49 0.662 . . . . 10.0 109.835 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -57.96 -43.26 86.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.428 -0.806 . . . . 10.0 110.642 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -63.47 -33.9 76.59 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.16 -0.473 . . . . 10.0 111.275 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 47.7 mt -64.85 -44.75 96.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.3 -0.409 . . . . 10.0 110.184 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -54.76 -45.58 74.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.762 -0.653 . . . . 10.0 110.81 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -71.59 -33.09 68.74 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.701 -0.681 . . . . 10.0 110.425 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -64.62 -43.52 93.46 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.814 -0.63 . . . . 10.0 110.363 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 36.6 mt -60.53 -41.57 94.71 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.332 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 85.2 mt -62.35 -38.35 80.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.048 -0.523 . . . . 10.0 110.601 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.1 m -65.36 -26.82 68.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.074 -0.512 . . . . 10.0 111.547 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -98.83 12.92 34.24 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.936 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 59.94 24.5 13.62 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.69 -0.686 . . . . 10.0 111.558 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.514 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 41.6 mmtm -91.02 -16.85 27.25 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.475 0.655 . . . . 10.0 109.339 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -137.86 151.2 47.81 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.89 -1.05 . . . . 10.0 109.837 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.4 m -101.86 -46.73 4.81 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.812 -0.355 . . . . 10.0 111.643 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.488 ' O ' HG13 ' A' ' 117' ' ' ILE . 1.7 t-160 -134.72 127.92 31.95 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.789 -0.364 . . . . 10.0 111.498 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 11.2 tt -56.47 -41.85 73.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 115.746 -0.661 . . . . 10.0 111.572 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.43 -14.19 26.32 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.291 -0.868 . . . . 10.0 113.274 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -114.22 13.6 17.97 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.076 -0.39 . . . . 10.0 111.797 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 113' ' ' HIS . 62.0 mt -99.61 121.31 50.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.751 0.31 . . . . 10.0 111.038 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -126.11 117.96 24.26 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.473 -0.33 . . . . 10.0 110.248 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -94.4 138.27 32.55 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.235 0.541 . . . . 10.0 111.562 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -120.38 133.45 55.44 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.102 -1.073 . . . . 10.0 108.102 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 53.6 tp -115.96 96.53 5.63 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 106.009 -1.849 . . . . 10.0 106.009 178.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.9 tptm 43.8 64.9 1.13 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 114.648 -1.16 . . . . 10.0 110.628 -177.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.684 ' HA2' ' SG ' ' C' ' 39' ' ' CYS . . . 80.88 -47.87 3.62 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.556 -0.747 . . . . 10.0 113.859 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 39.5 tttp -67.38 120.76 14.41 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 109.419 -0.586 . . . . 10.0 109.419 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.1 p -66.06 139.42 21.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.356 0.598 . . . . 10.0 112.499 -178.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.3 tp -105.69 103.1 12.54 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.645 -0.707 . . . . 10.0 110.253 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -69.98 143.46 52.6 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.074 -0.966 . . . . 10.0 111.876 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.511 ' HA ' ' HB ' ' A' ' 98' ' ' ILE . 0.3 OUTLIER -61.57 -39.87 92.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.718 -0.674 . . . . 10.0 112.223 -179.561 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -73.88 -9.35 58.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.331 -0.395 . . . . 10.0 111.553 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 17.1 tp -76.85 142.01 40.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.251 -0.432 . . . . 10.0 110.356 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.418 ' HB2' ' HB2' ' A' ' 134' ' ' ASP . 41.2 m-85 -93.8 149.74 20.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.057 -0.52 . . . . 10.0 110.659 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 34.3 mt -59.32 -38.52 80.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.93 0.395 . . . . 10.0 111.21 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.24 -19.73 61.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.257 -0.429 . . . . 10.0 111.01 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.418 ' HB2' ' HB2' ' A' ' 131' ' ' PHE . 13.3 t0 -81.56 -40.37 23.18 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.738 -0.664 . . . . 10.0 111.108 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.3 pp -83.87 -26.36 29.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.508 -0.315 . . . . 10.0 111.317 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 96.0 mttt 63.07 99.18 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 O-C-N 123.659 0.599 . . . . 10.0 112.202 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.0 t -79.92 114.23 20.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.073 -0.512 . . . . 10.0 110.298 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.85 137.76 76.59 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.34 -0.391 . . . . 10.0 111.289 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -62.78 -16.99 57.0 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.818 2.345 . . . . 10.0 112.692 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -106.03 6.32 31.08 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.067 0.461 . . . . 10.0 110.924 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -140.34 71.28 1.37 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.753 -0.658 . . . . 10.0 109.536 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.4 t -99.27 11.81 38.0 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.654 -0.703 . . . . 10.0 110.17 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.35 95.58 5.76 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.127 0.489 . . . . 10.0 110.672 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 24.9 mm -92.37 104.4 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 N-CA-C 107.527 -1.286 . . . . 10.0 107.527 177.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.93 121.45 26.5 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.203 -0.453 . . . . 10.0 110.234 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 10.4 t -105.62 136.95 37.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.777 -0.647 . . . . 10.0 111.775 -178.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 25.1 mmt -136.0 120.78 18.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.126 -0.943 . . . . 10.0 108.643 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 11.8 mt -139.68 94.05 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.723 -0.391 . . . . 10.0 111.119 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -94.35 107.09 27.03 Favored Pre-proline 0 C--N 1.32 -0.706 0 N-CA-C 109.213 -0.662 . . . . 10.0 109.213 175.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 N--CA 1.462 -0.37 0 C-N-CA 122.508 2.139 . . . . 10.0 112.759 -178.184 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' SER . . . . . 0.476 ' O ' HG12 ' B' ' 8' ' ' ILE . 64.6 p . . . . . 0 N--CA 1.451 -0.425 0 CA-C-O 120.589 0.233 . . . . 10.0 110.717 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -54.34 -44.69 72.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.046 -0.525 . . . . 10.0 111.33 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -59.04 -47.19 86.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.408 -0.36 . . . . 10.0 111.487 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -59.86 -45.4 92.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.828 0.347 . . . . 10.0 110.511 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.476 HG12 ' O ' ' B' ' 4' ' ' SER . 37.2 mm -60.17 -49.62 83.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.739 -0.664 . . . . 10.0 110.505 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.4 -41.76 85.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.392 -0.367 . . . . 10.0 111.191 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.57 -38.09 89.81 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.207 0.527 . . . . 10.0 110.44 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 40.7 mt -66.1 -39.32 89.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.949 -0.569 . . . . 10.0 109.63 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 1.3 mp -56.8 -46.85 83.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.311 -0.858 . . . . 10.0 111.406 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 12.9 m -71.72 -29.78 35.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.579 -0.448 . . . . 10.0 111.731 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -73.88 -41.62 61.91 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.749 0.309 . . . . 10.0 111.288 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -69.38 -43.6 73.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.379 -0.373 . . . . 10.0 111.199 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 14.7 m-30 -61.43 -49.86 75.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.408 -0.36 . . . . 10.0 111.03 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 6.0 p -57.65 -45.26 85.74 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.929 0.344 . . . . 10.0 111.929 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' SER . . . . . 0.402 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 5.0 p -69.02 -21.25 64.13 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.036 0.384 . . . . 10.0 112.036 -179.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 22.5 mm -85.65 -43.58 16.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 120.689 -0.404 . . . . 10.0 110.676 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 26.9 m -73.54 -35.2 44.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.891 -0.324 . . . . 10.0 111.294 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -68.8 -38.28 79.82 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 120.487 -0.485 . . . . 10.0 110.235 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . 0.402 ' HG3' ' O ' ' B' ' 18' ' ' SER . 33.2 mtmt -75.12 -7.15 52.97 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.132 -0.322 . . . . 10.0 110.132 178.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 29.8 mmtm 57.63 41.33 25.69 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.808 -0.633 . . . . 10.0 110.375 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.453 ' O ' ' HE2' ' C' ' 5' ' ' LYS . 38.4 mt-10 -91.61 9.83 30.61 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.529 -0.759 . . . . 10.0 110.338 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 9.0 tp -141.99 150.18 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 N-CA-C 108.834 -0.802 . . . . 10.0 108.834 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 1.2 p -62.65 154.95 27.62 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.287 -0.264 . . . . 10.0 110.287 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -57.21 -32.56 66.62 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.672 0.273 . . . . 10.0 110.712 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -63.2 -46.64 86.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.419 0.628 . . . . 10.0 109.716 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . 0.525 ' O ' ' HG ' ' B' ' 33' ' ' LEU . . . -71.13 -40.72 61.37 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.542 -0.754 . . . . 10.0 111.384 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.73 -42.77 93.9 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.898 0.38 . . . . 10.0 111.069 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.404 ' O ' HG11 ' B' ' 35' ' ' VAL . 27.7 t0 -61.34 -44.19 97.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.619 -0.719 . . . . 10.0 110.214 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 13.4 m -65.52 -41.52 93.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.703 -0.68 . . . . 10.0 110.64 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' B' ' 29' ' ' GLY . 82.1 mt -66.08 -43.63 86.79 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.792 0.33 . . . . 10.0 111.296 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -60.3 -51.02 71.3 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 116.001 -0.545 . . . . 10.0 112.206 -178.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . 0.404 HG11 ' O ' ' B' ' 31' ' ' ASP . 7.1 p -66.64 -42.06 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 120.797 -0.361 . . . . 10.0 111.063 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.43 -35.0 77.88 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.947 0.403 . . . . 10.0 110.419 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' MET . . . . . . . . . . . . . 22.7 ttm -56.24 -51.12 69.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.578 -0.737 . . . . 10.0 111.033 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.97 -33.63 76.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.073 -0.512 . . . . 10.0 111.508 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 39.9 m -65.28 -42.95 92.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.015 0.436 . . . . 10.0 110.284 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 46.7 mt -67.27 -34.52 69.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.844 -0.617 . . . . 10.0 110.321 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.652 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 50.9 m -65.23 -40.51 94.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.061 -0.518 . . . . 10.0 110.74 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -72.72 -27.47 62.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 10.0 111.284 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.45 -39.37 81.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.981 -0.554 . . . . 10.0 111.54 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -97.13 -0.84 46.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.333 -0.394 . . . . 10.0 111.869 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.23 60.62 7.29 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.351 -0.452 . . . . 10.0 114.168 178.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.652 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 13.6 p90 -154.11 167.78 28.7 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.028 -0.36 . . . . 10.0 110.028 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -98.93 151.62 20.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.013 0.435 . . . . 10.0 110.379 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 3.9 mtm180 -71.34 -28.21 63.91 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.129 0.49 . . . . 10.0 110.632 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -84.51 7.34 20.24 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.054 -0.521 . . . . 10.0 112.257 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.13 4.38 48.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.513 0.197 . . . . 10.0 111.523 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.428 HG23 ' H ' ' B' ' 52' ' ' SER . 4.8 m -41.37 -57.39 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 113.425 0.898 . . . . 10.0 113.425 -179.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' SER . . . . . 0.428 ' H ' HG23 ' B' ' 51' ' ' VAL . 0.6 OUTLIER -53.72 -36.54 62.37 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.824 0.675 . . . . 10.0 112.824 -179.28 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.72 -42.25 32.35 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.934 -0.651 . . . . 10.0 113.353 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 24.8 mt -83.69 -45.64 18.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 112.253 0.464 . . . . 10.0 112.253 -178.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 81.0 mt -73.17 -64.27 1.01 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.949 0.404 . . . . 10.0 111.378 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.25 -151.05 48.11 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.912 -0.661 . . . . 10.0 112.403 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 10.0 tttt -100.08 6.92 44.96 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.073 0.463 . . . . 10.0 110.466 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.47 134.89 55.42 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.565 -0.743 . . . . 10.0 110.289 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 . . . . . 0 C--N 1.321 -0.655 0 CA-C-O 121.178 0.513 . . . . 10.0 110.648 -179.582 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.184 0 CA-C-O 120.857 0.361 . . . . 10.0 111.336 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 4' ' ' SER . . . . . 0.533 ' O ' HG12 ' C' ' 8' ' ' ILE . 0.7 OUTLIER -109.89 166.32 11.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.246 -0.434 . . . . 10.0 110.106 179.857 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 5' ' ' LYS . . . . . 0.481 ' HB2' ' CE1' ' C' ' 44' ' ' PHE . 10.3 ptpp? -51.86 -38.67 56.9 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 123.515 0.51 . . . . 10.0 111.863 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 6' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 -59.39 -54.59 44.93 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.381 -0.372 . . . . 10.0 111.494 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -60.91 -40.3 92.62 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.688 0.28 . . . . 10.0 110.34 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 8' ' ' ILE . . . . . 0.533 HG12 ' O ' ' C' ' 4' ' ' SER . 48.4 mm -60.0 -47.73 90.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.88 -0.6 . . . . 10.0 109.658 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.39 -44.82 76.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.966 -0.561 . . . . 10.0 111.203 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.82 -40.56 91.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.913 -0.585 . . . . 10.0 111.089 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 32.4 mt -61.36 -39.1 89.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.903 0.382 . . . . 10.0 110.26 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 12' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.17 -54.87 27.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.656 -0.702 . . . . 10.0 111.75 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 28.5 m -66.56 -26.04 36.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.262 0.467 . . . . 10.0 112.262 -178.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.24 -40.09 52.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.981 0.419 . . . . 10.0 110.433 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 15' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -72.6 -45.11 60.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.151 -0.477 . . . . 10.0 111.32 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -56.51 -49.67 74.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.371 -0.377 . . . . 10.0 110.846 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 10.0 p -58.48 -45.07 89.43 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.43 -0.35 . . . . 10.0 111.586 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 4.4 p -69.33 -22.24 63.78 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.805 -0.358 . . . . 10.0 111.845 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 19' ' ' ILE . . . . . . . . . . . . . 20.2 mm -79.34 -43.39 23.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 110.129 -0.322 . . . . 10.0 110.129 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 20' ' ' VAL . . . . . 0.415 HG11 ' HA ' ' C' ' 30' ' ' ALA . 4.2 m -73.99 -27.83 22.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.71 0.29 . . . . 10.0 110.385 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -69.84 -53.62 17.3 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.905 -0.406 . . . . 10.0 109.905 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 34.5 mtmt -70.67 -6.79 39.74 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.843 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm 61.48 47.03 6.96 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.251 0.548 . . . . 10.0 110.426 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -85.41 -3.93 59.0 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.827 -0.624 . . . . 10.0 110.422 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 11.2 tt -134.94 159.45 41.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.056 -0.52 . . . . 10.0 110.129 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -68.19 166.35 16.45 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.218 0.207 . . . . 10.0 111.272 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -53.74 -50.34 66.18 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.066 0.395 . . . . 10.0 112.066 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.76 -47.37 77.11 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.033 0.444 . . . . 10.0 110.48 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.09 -42.44 91.94 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.833 -0.699 . . . . 10.0 112.028 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . 0.415 ' HA ' HG11 ' C' ' 20' ' ' VAL . . . -57.35 -41.68 80.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.881 0.372 . . . . 10.0 110.963 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 31' ' ' ASP . . . . . 0.414 ' CG ' ' HZ2' ' A' ' 79' ' ' LYS . 9.0 t70 -68.07 -38.47 82.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.952 -0.567 . . . . 10.0 110.163 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 32' ' ' SER . . . . . 0.454 ' OG ' HG22 ' A' ' 81' ' ' ILE . 48.7 m -61.74 -29.37 70.07 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.455 -0.793 . . . . 10.0 109.938 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 33' ' ' LEU . . . . . 0.46 ' O ' ' HG3' ' C' ' 37' ' ' MET . 48.4 mt -77.76 -37.11 49.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.341 -0.39 . . . . 10.0 110.359 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -58.36 -53.63 56.13 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.06 -0.518 . . . . 10.0 110.369 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 35' ' ' VAL . . . . . . . . . . . . . 9.4 p -67.2 -38.58 81.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 115.361 -0.836 . . . . 10.0 110.681 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.94 -40.97 95.3 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 120.669 0.271 . . . . 10.0 111.257 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 37' ' ' MET . . . . . 0.46 ' HG3' ' O ' ' C' ' 33' ' ' LEU . 70.8 mtm -54.74 -47.14 74.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.426 -0.352 . . . . 10.0 110.593 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 38' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -69.41 -28.65 66.33 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 116.468 -0.333 . . . . 10.0 110.855 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 39' ' ' CYS . . . . . 0.684 ' SG ' ' HA2' ' A' ' 123' ' ' GLY . 91.8 m -61.25 -42.84 99.32 Favored 'General case' 0 CA--C 1.522 -0.115 0 N-CA-C 108.871 -0.789 . . . . 10.0 108.871 177.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 40' ' ' ILE . . . . . . . . . . . . . 1.4 mp -73.25 -46.11 51.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 114.84 -1.073 . . . . 10.0 110.704 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 41' ' ' SER . . . . . 0.614 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 9.2 m -60.98 -42.09 97.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.406 -0.361 . . . . 10.0 111.585 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -72.96 -29.28 62.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.412 -0.358 . . . . 10.0 110.506 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.6 -46.8 65.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.154 -0.476 . . . . 10.0 111.727 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 44' ' ' PHE . . . . . 0.481 ' CE1' ' HB2' ' C' ' 5' ' ' LYS . 93.4 m-85 -92.18 -7.03 49.49 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.089 0.403 . . . . 10.0 112.089 -178.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.36 60.86 5.18 Favored Glycine 0 C--O 1.227 -0.309 0 C-N-CA 121.244 -0.503 . . . . 10.0 113.889 178.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 46' ' ' PHE . . . . . 0.614 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 3.6 p90 -153.56 169.25 23.67 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 110.179 -0.304 . . . . 10.0 110.179 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 51.5 mp0 -99.23 144.08 28.76 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.803 0.335 . . . . 10.0 110.85 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.95 -28.36 69.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.214 0.53 . . . . 10.0 110.965 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -80.1 14.33 1.92 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.733 -0.667 . . . . 10.0 112.509 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -104.72 2.82 30.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.24 0.543 . . . . 10.0 110.753 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 1.7 m -49.44 -45.78 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 113.546 0.943 . . . . 10.0 113.546 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.63 -27.22 67.61 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.785 0.291 . . . . 10.0 111.785 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.91 -37.78 12.54 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.845 -0.693 . . . . 10.0 112.667 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 54' ' ' ILE . . . . . . . . . . . . . 40.0 mt -81.14 -56.35 6.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 O-C-N 122.697 -0.296 . . . . 10.0 111.253 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 26.5 mt -67.01 -41.24 87.0 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.229 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 58.08 -139.41 47.61 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.621 -0.718 . . . . 10.0 112.077 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 66.2 tttt -108.76 -6.34 15.93 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.074 0.464 . . . . 10.0 110.32 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 3.1 m -65.34 148.21 52.09 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.622 -0.717 . . . . 10.0 111.27 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.482 0 CA-C-O 121.068 0.461 . . . . 10.0 110.146 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.4 t . . . . . 0 CA--C 1.521 -0.146 0 CA-C-O 120.845 0.355 . . . . 10.0 111.475 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.456 ' CD2' ' HB3' ' A' ' 91' ' ' ASP . 4.8 m170 -91.53 126.3 36.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.075 -0.511 . . . . 10.0 110.629 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.6 mp -126.9 120.03 28.18 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.01 -0.541 . . . . 10.0 109.923 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.1 m -94.07 114.75 26.97 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.452 -0.573 . . . . 10.0 109.452 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.401 ' O ' ' HA ' ' A' ' 87' ' ' SER . 2.5 mm? -88.3 122.67 32.08 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.283 -0.417 . . . . 10.0 110.679 -178.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -122.95 104.58 9.33 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.969 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -92.11 120.57 32.84 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.909 -0.404 . . . . 10.0 109.909 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 20.8 mt -86.83 -59.46 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.573 -0.285 . . . . 10.0 111.649 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -57.0 158.12 5.21 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.75 0.309 . . . . 10.0 111.397 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.28 138.6 55.92 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.42 -0.355 . . . . 10.0 111.059 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -74.2 130.73 21.54 Favored 'Cis proline' 0 C--O 1.237 0.435 0 C-N-CA 123.039 -1.65 . . . . 10.0 111.87 -1.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.443 ' HZ2' ' CG ' ' C' ' 28' ' ' ASP . 0.0 OUTLIER -87.8 152.62 21.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.422 -0.353 . . . . 10.0 111.271 -179.277 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -177.52 170.75 2.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.736 -0.665 . . . . 10.0 110.03 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 15.2 m -151.17 133.42 15.32 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.123 -0.49 . . . . 10.0 109.696 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.1 pt -138.16 150.31 24.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.932 0.396 . . . . 10.0 111.383 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -113.58 120.4 40.82 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.359 -0.608 . . . . 10.0 109.359 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.39 167.39 23.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.014 0.435 . . . . 10.0 111.433 -178.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.456 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -121.4 131.57 54.25 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.848 -0.614 . . . . 10.0 110.905 179.101 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -118.74 168.8 10.39 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.727 -0.669 . . . . 10.0 109.85 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.605 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 7.4 t -80.89 146.95 60.74 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 116.545 -0.298 . . . . 10.0 110.398 -179.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.1 -22.62 70.47 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.245 1.963 . . . . 10.0 111.747 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 43.3 m -100.08 13.32 34.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.978 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.605 ' HB2' ' O ' ' A' ' 93' ' ' SER . 1.0 OUTLIER -80.52 163.11 23.97 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.528 -179.889 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.4 p -115.49 160.66 19.63 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.583 -0.735 . . . . 10.0 110.576 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 47.7 mm -65.28 -21.31 29.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.368 0.604 . . . . 10.0 109.438 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.28 -39.29 82.46 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.41 -0.814 . . . . 10.0 110.235 178.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -63.84 -40.24 96.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.103 -0.498 . . . . 10.0 110.316 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.515 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 54.1 mt -65.93 -48.6 81.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.841 -0.618 . . . . 10.0 109.499 178.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.451 ' HZ1' ' CG ' ' A' ' 128' ' ' ASP . 53.2 mttt -53.64 -48.01 69.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.322 -0.854 . . . . 10.0 111.151 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.477 ' OE1' ' HA ' ' A' ' 103' ' ' GLN . 11.4 mm-40 -59.8 -41.16 90.6 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.883 -0.599 . . . . 10.0 111.102 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.528 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 19.1 t60 -68.46 -33.75 74.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.29 -0.414 . . . . 10.0 110.539 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 101' ' ' ILE . 90.8 mt -62.55 -46.04 90.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.79 0.329 . . . . 10.0 110.989 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.6 mt -67.41 -32.35 56.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.124 0.488 . . . . 10.0 110.05 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.1 m -68.02 -15.49 63.62 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.511 -0.768 . . . . 10.0 112.159 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' A' ' 104' ' ' HIS . 17.5 mm-40 -95.1 6.88 47.83 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.628 -0.508 . . . . 10.0 109.628 178.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.447 ' HA ' ' OE1' ' A' ' 109' ' ' GLU . 3.4 mm-40 60.35 32.1 20.58 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.486 -0.779 . . . . 10.0 111.039 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -110.98 -5.64 14.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.111 -0.495 . . . . 10.0 110.795 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -135.57 148.69 49.17 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.81 -0.632 . . . . 10.0 109.952 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.498 ' OG ' ' HA ' ' A' ' 150' ' ' PRO . 0.6 OUTLIER -87.71 -59.18 2.32 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.948 0.404 . . . . 10.0 110.901 -179.81 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.488 ' O ' HG13 ' A' ' 117' ' ' ILE . 40.8 m80 -138.26 154.02 49.07 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.345 -0.389 . . . . 10.0 110.919 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.415 HG13 ' CD ' ' A' ' 102' ' ' LYS . 0.3 OUTLIER -63.34 -36.75 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 115.502 -0.772 . . . . 10.0 110.386 179.562 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.87 -24.0 34.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.821 -1.081 . . . . 10.0 112.463 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.19 0.16 31.32 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 121.182 -0.207 . . . . 10.0 111.397 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 113' ' ' HIS . 28.2 mt -90.75 119.91 38.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 120.266 -0.574 . . . . 10.0 109.534 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.42 ' HZ3' ' CG ' ' B' ' 31' ' ' ASP . 18.4 mmmt -118.1 112.15 19.82 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.114 0.483 . . . . 10.0 110.174 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' A' ' 126' ' ' LEU . 3.2 mm? -92.99 113.7 26.06 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.653 0.74 . . . . 10.0 110.995 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.445 HD13 ' HA ' ' A' ' 125' ' ' VAL . 4.5 mm? -110.75 140.43 45.16 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 107.406 -1.331 . . . . 10.0 107.406 178.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 17.9 tp -121.98 97.91 5.7 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.821 -0.807 . . . . 10.0 108.821 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? 46.82 58.27 4.86 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.612 0.72 . . . . 10.0 109.972 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.681 ' HA2' ' SG ' ' C' ' 39' ' ' CYS . . . 83.87 -44.41 3.31 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 114.6 -1.182 . . . . 10.0 114.154 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 22.9 tttp -59.64 140.03 56.73 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 120.696 0.284 . . . . 10.0 111.006 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.445 ' HA ' HD13 ' A' ' 120' ' ' LEU . 7.2 p -90.35 136.16 24.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 112.942 0.719 . . . . 10.0 112.942 -178.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.424 ' HB2' ' O ' ' A' ' 119' ' ' LEU . 6.0 mp -110.83 156.29 21.34 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 114.983 -1.008 . . . . 10.0 110.001 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -116.0 158.38 23.19 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.452 0.538 . . . . 10.0 112.452 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.451 ' CG ' ' HZ1' ' A' ' 102' ' ' LYS . 1.7 m-20 -52.81 -55.1 25.41 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 113.377 0.88 . . . . 10.0 113.377 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -91.26 14.13 15.28 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.242 0.46 . . . . 10.0 112.242 -178.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 9.4 tp -70.24 143.87 52.02 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.708 0.289 . . . . 10.0 110.428 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -98.85 146.84 25.54 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.72 -0.673 . . . . 10.0 110.18 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.505 HD11 ' O ' ' A' ' 93' ' ' SER . 13.0 mt -57.53 -39.09 75.84 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.414 -0.357 . . . . 10.0 111.183 178.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.4 p -73.17 -21.96 60.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.123 0.487 . . . . 10.0 111.198 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -82.25 -45.56 14.86 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 120.812 0.339 . . . . 10.0 110.519 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.2 pp -74.1 -21.97 59.68 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.352 -0.385 . . . . 10.0 110.846 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.6 mtmt 63.43 92.2 0.07 Allowed 'General case' 0 C--O 1.236 0.352 0 O-C-N 123.691 0.619 . . . . 10.0 110.785 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.0 t -66.07 101.5 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.6 -0.727 . . . . 10.0 110.38 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.52 119.66 48.88 Favored Pre-proline 0 N--CA 1.451 -0.415 0 CA-C-N 116.098 -0.501 . . . . 10.0 110.652 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -65.57 -11.46 30.59 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.773 2.315 . . . . 10.0 112.727 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -93.04 7.3 44.7 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.965 -0.561 . . . . 10.0 110.19 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -128.63 -75.02 0.56 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.518 -0.765 . . . . 10.0 110.14 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 38.6 m 57.66 13.27 1.89 Allowed 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.486 0.55 . . . . 10.0 112.486 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.9 m -121.46 121.75 38.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.619 0.247 . . . . 10.0 110.882 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 10.7 mm -102.85 126.12 57.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.714 -0.675 . . . . 10.0 109.666 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.43 107.15 17.92 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.887 -0.783 . . . . 10.0 108.887 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 21.7 t -87.34 126.08 41.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.663 -0.699 . . . . 10.0 110.209 -178.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 62.7 mtt -125.35 115.0 19.63 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.706 -1.134 . . . . 10.0 109.866 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.435 HG12 HG23 ' A' ' 117' ' ' ILE . 9.9 mt -138.96 146.11 26.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.35 -0.841 . . . . 10.0 110.674 -178.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.517 ' HD3' ' OD2' ' B' ' 38' ' ' ASP . 2.0 mmmm -125.94 115.51 24.24 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 109.37 -0.604 . . . . 10.0 109.37 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.498 ' HA ' ' OG ' ' A' ' 112' ' ' SER . 19.5 Cg_endo . . . . . 0 C--N 1.347 0.491 0 C-N-CA 122.425 2.084 . . . . 10.0 112.65 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 80.1 p . . . . . 0 N--CA 1.449 -0.507 0 N-CA-C 109.376 -0.601 . . . . 10.0 109.376 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -53.1 -40.54 64.22 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.85 0.315 . . . . 10.0 111.85 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -60.91 -47.25 87.27 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.668 -0.242 . . . . 10.0 110.838 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -58.84 -39.83 82.43 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.114 0.483 . . . . 10.0 110.075 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.504 ' O ' HD12 ' B' ' 12' ' ' ILE . 50.1 mm -64.52 -49.3 81.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.726 -0.67 . . . . 10.0 110.084 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.27 -36.65 78.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.193 0.52 . . . . 10.0 110.335 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.99 -32.77 74.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.534 -0.757 . . . . 10.0 110.221 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 28.1 mt -70.98 -34.96 71.91 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.421 -0.585 . . . . 10.0 109.421 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.504 HD12 ' O ' ' B' ' 8' ' ' ILE . 0.7 OUTLIER -59.37 -54.74 30.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.974 -0.557 . . . . 10.0 110.442 179.117 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 28.4 m -62.27 -33.51 59.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.33 -0.396 . . . . 10.0 111.117 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -68.72 -48.77 62.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.093 -0.503 . . . . 10.0 110.897 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' TYR . . . . . 0.466 ' O ' HG12 ' B' ' 19' ' ' ILE . 8.3 m-85 -70.94 -41.9 70.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.156 -0.474 . . . . 10.0 112.04 -178.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -55.92 -52.94 62.35 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 122.982 0.176 . . . . 10.0 111.45 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' SER . . . . . 0.492 ' O ' ' HB2' ' B' ' 21' ' ' GLU . 4.9 p -58.74 -46.85 86.48 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.448 -0.342 . . . . 10.0 111.357 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 28.8 p -65.45 -20.59 66.43 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.225 0.454 . . . . 10.0 112.225 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.466 HG12 ' O ' ' B' ' 15' ' ' TYR . 22.9 mm -84.93 -42.12 16.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.798 0.332 . . . . 10.0 111.221 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 34.5 m -77.43 -31.6 17.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.006 0.431 . . . . 10.0 111.311 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' B' ' 17' ' ' SER . 0.4 OUTLIER -71.64 -25.69 62.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.075 -0.511 . . . . 10.0 111.188 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -94.59 1.13 55.62 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.397 0.618 . . . . 10.0 109.578 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 14.7 mmtt 55.33 45.56 25.28 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 114.805 -1.089 . . . . 10.0 111.573 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -93.66 24.32 4.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.946 0.403 . . . . 10.0 111.223 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 16.8 tt -160.87 161.39 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 116.173 -0.467 . . . . 10.0 110.41 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.84 159.86 29.53 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.817 -0.629 . . . . 10.0 111.443 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -56.97 -41.86 79.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.65 -0.705 . . . . 10.0 111.412 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.33 -50.67 72.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.998 -0.547 . . . . 10.0 109.845 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . 0.495 ' O ' ' HG ' ' B' ' 33' ' ' LEU . . . -60.39 -41.08 98.37 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.622 -0.717 . . . . 10.0 111.677 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.25 -31.87 73.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.883 -0.158 . . . . 10.0 110.913 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.42 ' CG ' ' HZ3' ' A' ' 118' ' ' LYS . 17.4 t70 -71.5 -43.3 66.79 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.43 -0.582 . . . . 10.0 109.43 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' SER . . . . . 0.453 ' O ' HG12 ' B' ' 35' ' ' VAL . 4.1 m -62.54 -51.14 68.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.313 -0.858 . . . . 10.0 110.288 178.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' B' ' 29' ' ' GLY . 89.6 mt -59.12 -41.92 89.35 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.127 -0.488 . . . . 10.0 110.173 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -57.83 -49.61 76.09 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.752 -0.658 . . . . 10.0 111.106 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . 0.453 HG12 ' O ' ' B' ' 32' ' ' SER . 2.6 p -70.93 -33.81 53.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.738 -0.385 . . . . 10.0 111.691 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.23 -39.25 89.43 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 109.625 -0.509 . . . . 10.0 109.625 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' MET . . . . . . . . . . . . . 32.8 ttm -54.65 -45.6 73.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.305 -0.861 . . . . 10.0 109.574 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . 0.517 ' OD2' ' HD3' ' A' ' 149' ' ' LYS . 18.4 t70 -62.6 -53.73 50.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.118 -0.947 . . . . 10.0 110.886 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 59.8 m -52.09 -47.76 65.07 Favored 'General case' 0 N--CA 1.462 0.137 0 O-C-N 123.581 0.551 . . . . 10.0 111.529 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 59.7 mt -62.6 -44.83 99.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.02 -0.536 . . . . 10.0 110.69 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.547 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 49.0 m -61.28 -43.32 99.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.026 -0.534 . . . . 10.0 110.876 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -67.52 -42.39 82.87 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.679 -0.691 . . . . 10.0 111.243 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.2 -33.61 74.74 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.28 0.474 . . . . 10.0 112.28 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -90.38 -7.2 53.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.671 0.272 . . . . 10.0 111.062 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.84 46.74 90.96 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.201 -0.523 . . . . 10.0 112.864 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.547 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 3.7 p90 -144.34 154.71 43.31 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 122.569 -0.371 . . . . 10.0 110.474 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -92.93 147.08 23.14 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.404 -0.362 . . . . 10.0 110.408 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -27.34 68.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.548 -0.296 . . . . 10.0 111.483 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -72.68 -10.32 59.65 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.404 -0.362 . . . . 10.0 111.839 -179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.28 4.38 27.3 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.592 -0.276 . . . . 10.0 111.351 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.43 HG21 ' H ' ' B' ' 52' ' ' SER . 0.1 OUTLIER -42.77 -59.94 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 112.653 0.612 . . . . 10.0 112.653 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' SER . . . . . 0.43 ' H ' HG21 ' B' ' 51' ' ' VAL . 0.9 OUTLIER -60.89 -19.56 60.56 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.229 0.826 . . . . 10.0 113.229 -179.421 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.46 -38.5 12.35 Favored Glycine 0 C--O 1.235 0.203 0 C-N-CA 120.879 -0.677 . . . . 10.0 112.382 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 6.2 mt -86.63 -47.34 16.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.816 0.341 . . . . 10.0 111.23 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 53.4 mt -73.08 -57.88 3.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.306 0.574 . . . . 10.0 110.424 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.83 -144.7 48.56 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.327 -0.851 . . . . 10.0 112.569 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -91.67 -11.03 38.13 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.465 -0.367 . . . . 10.0 110.918 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.56 131.79 52.02 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.798 0.666 . . . . 10.0 112.798 -178.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 C--N 1.326 -0.45 0 N-CA-C 108.814 -0.81 . . . . 10.0 108.814 177.878 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.575 0.226 . . . . 10.0 111.047 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 4' ' ' SER . . . . . 0.515 ' O ' HG12 ' C' ' 8' ' ' ILE . 31.4 p -102.16 161.88 13.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.383 -0.371 . . . . 10.0 110.984 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -56.08 -39.34 71.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.294 -0.412 . . . . 10.0 111.498 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 6' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -61.2 -48.58 80.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.011 0.434 . . . . 10.0 110.911 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -63.49 -39.07 93.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.857 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 8' ' ' ILE . . . . . 0.539 ' O ' HD13 ' C' ' 12' ' ' ILE . 43.6 mm -60.89 -46.83 95.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.564 -0.532 . . . . 10.0 109.564 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 9' ' ' ALA . . . . . 0.405 ' HB2' ' CE1' ' C' ' 46' ' ' PHE . . . -60.04 -44.09 94.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.692 -0.686 . . . . 10.0 110.825 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.99 -41.93 98.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.94 -0.573 . . . . 10.0 111.224 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 16.6 mt -62.44 -41.72 98.93 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.463 0.649 . . . . 10.0 110.006 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 12' ' ' ILE . . . . . 0.539 HD13 ' O ' ' C' ' 8' ' ' ILE . 1.3 mp -59.22 -51.42 72.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.749 -1.114 . . . . 10.0 111.876 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 13' ' ' VAL . . . . . 0.51 ' N ' HG22 ' C' ' 12' ' ' ILE . 30.0 m -67.93 -24.95 31.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.028 0.442 . . . . 10.0 111.758 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -76.45 -42.56 43.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.749 0.309 . . . . 10.0 110.227 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 15' ' ' TYR . . . . . 0.448 ' O ' HG12 ' C' ' 19' ' ' ILE . 3.1 m-85 -73.32 -40.28 64.61 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.7 -0.4 . . . . 10.0 110.82 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -58.32 -49.48 77.03 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 109.998 -0.371 . . . . 10.0 109.998 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 35.4 p -62.05 -43.6 98.49 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.302 -0.408 . . . . 10.0 111.123 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 32.9 p -66.95 -24.45 66.07 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 111.69 0.256 . . . . 10.0 111.69 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 19' ' ' ILE . . . . . 0.448 HG12 ' O ' ' C' ' 15' ' ' TYR . 26.8 mm -80.6 -39.67 18.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 110.011 -0.366 . . . . 10.0 110.011 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 20' ' ' VAL . . . . . . . . . . . . . 19.5 m -77.43 -27.23 15.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.84 -0.344 . . . . 10.0 111.124 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -68.71 -50.33 51.66 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.846 -0.427 . . . . 10.0 109.846 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -71.92 -10.02 59.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.047 -0.524 . . . . 10.0 110.205 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm 58.95 42.31 19.66 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.506 0.67 . . . . 10.0 109.505 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -81.41 -6.28 58.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.232 -0.894 . . . . 10.0 110.729 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 18.1 tt -125.61 160.08 32.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.101 -0.5 . . . . 10.0 109.761 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -58.94 152.51 19.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.463 -0.335 . . . . 10.0 110.482 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -57.4 -34.49 68.94 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.81 0.338 . . . . 10.0 110.41 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 28' ' ' ASP . . . . . 0.443 ' CG ' ' HZ2' ' A' ' 85' ' ' LYS . 30.4 t70 -61.8 -50.77 71.0 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.51 -0.768 . . . . 10.0 109.983 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 29' ' ' GLY . . . . . 0.519 ' O ' ' HG ' ' C' ' 33' ' ' LEU . . . -67.33 -31.13 76.3 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.144 -0.934 . . . . 10.0 112.643 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.96 -46.66 88.7 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.557 0.218 . . . . 10.0 110.461 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -63.64 -37.81 88.74 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.529 -0.545 . . . . 10.0 109.529 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 14.0 m -57.61 -44.91 85.82 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.449 -0.796 . . . . 10.0 109.784 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 33' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' C' ' 29' ' ' GLY . 51.6 mt -70.25 -37.37 74.93 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.026 -0.534 . . . . 10.0 110.501 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -59.17 -55.83 29.96 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.048 -0.524 . . . . 10.0 111.429 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 35' ' ' VAL . . . . . . . . . . . . . 8.4 p -66.07 -41.77 90.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 115.961 -0.563 . . . . 10.0 111.117 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.55 -28.47 69.96 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.676 0.274 . . . . 10.0 111.032 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 9.0 mtm -59.98 -51.33 70.14 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.262 -0.426 . . . . 10.0 110.45 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 38' ' ' ASP . . . . . 0.612 ' CB ' ' HA3' ' A' ' 123' ' ' GLY . 1.2 m-20 -69.94 -27.47 64.78 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 109.639 -0.504 . . . . 10.0 109.639 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 39' ' ' CYS . . . . . 0.681 ' SG ' ' HA2' ' A' ' 123' ' ' GLY . 62.6 m -61.49 -50.25 73.46 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 109.297 -0.631 . . . . 10.0 109.297 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 40' ' ' ILE . . . . . . . . . . . . . 54.6 mt -67.2 -35.76 74.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.993 -1.003 . . . . 10.0 109.957 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 41' ' ' SER . . . . . 0.683 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 53.1 m -61.36 -51.81 67.27 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.713 -0.676 . . . . 10.0 110.536 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.82 -35.67 80.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.793 0.33 . . . . 10.0 110.867 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.66 -42.69 93.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.099 -0.5 . . . . 10.0 111.808 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 44' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -96.3 -2.48 45.79 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.869 0.366 . . . . 10.0 111.634 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.4 51.22 38.78 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.103 -0.57 . . . . 10.0 112.945 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 46' ' ' PHE . . . . . 0.683 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 4.3 p90 -144.48 157.58 44.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.055 0.455 . . . . 10.0 110.327 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -96.4 136.75 36.46 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.111 -0.495 . . . . 10.0 109.685 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 48' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -60.88 -13.97 19.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.757 -0.656 . . . . 10.0 112.111 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -84.03 -6.56 59.43 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.745 0.646 . . . . 10.0 112.745 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.53 4.55 27.57 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.134 0.42 . . . . 10.0 112.134 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 4.9 m -45.03 -54.4 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 113.548 0.944 . . . . 10.0 113.548 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 52' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.93 -30.88 68.19 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.775 0.658 . . . . 10.0 112.775 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.13 -49.81 5.77 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.426 -0.892 . . . . 10.0 112.912 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 54' ' ' ILE . . . . . . . . . . . . . 80.0 mt -69.67 -54.6 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-O 120.642 0.258 . . . . 10.0 111.328 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 70.0 mt -68.77 -52.76 26.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.433 -0.349 . . . . 10.0 111.009 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.38 -136.66 47.57 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.261 -0.495 . . . . 10.0 112.837 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 30.9 tttt -108.3 3.43 23.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.222 0.534 . . . . 10.0 110.094 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 9.1 t -73.62 138.15 44.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.966 -0.561 . . . . 10.0 110.555 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 . . . . . 0 C--N 1.321 -0.646 0 CA-C-N 115.585 -0.734 . . . . 10.0 109.721 178.49 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.1 t . . . . . 0 N--CA 1.455 -0.182 0 N-CA-C 110.352 -0.24 . . . . 10.0 110.352 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -87.57 129.29 35.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.57 0.224 . . . . 10.0 110.729 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.5 mp -127.87 129.17 46.46 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.126 0.489 . . . . 10.0 110.149 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.3 m -94.69 109.12 21.09 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.653 -0.703 . . . . 10.0 110.389 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -85.16 118.77 24.92 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.876 -0.787 . . . . 10.0 108.876 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.602 ' HZ1' ' CG ' ' C' ' 31' ' ' ASP . 14.2 ttpt -119.47 108.42 14.51 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.284 -0.416 . . . . 10.0 111.28 -178.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 84' ' ' PRO . 19.1 tptm -94.91 113.28 24.98 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 116.484 -0.326 . . . . 10.0 110.922 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.573 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 52.4 mt -80.49 -59.86 2.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 O-C-N 124.168 0.917 . . . . 10.0 111.542 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -63.13 160.31 15.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.787 0.327 . . . . 10.0 110.983 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.4 140.4 72.34 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 120.695 0.283 . . . . 10.0 111.401 -179.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.501 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 59.6 Cg_endo -76.9 140.61 66.02 Favored 'Cis proline' 0 C--N 1.343 0.266 0 C-N-CA 122.992 -1.67 . . . . 10.0 111.392 -1.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.573 ' HG2' ' O ' ' A' ' 81' ' ' ILE . 27.7 mtpp -82.91 145.1 29.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.436 -0.347 . . . . 10.0 110.965 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.413 ' CE2' ' HB3' ' A' ' 110' ' ' LYS . 34.1 p90 -165.73 156.08 13.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.714 0.292 . . . . 10.0 111.055 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.9 m -140.82 114.21 8.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.724 -0.671 . . . . 10.0 110.371 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 10.6 pt -134.87 149.02 29.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.558 -0.292 . . . . 10.0 110.816 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -117.16 116.62 27.65 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.384 -0.598 . . . . 10.0 109.384 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 25.7 t60 -130.3 146.31 51.88 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.412 -0.588 . . . . 10.0 109.412 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -99.11 139.66 34.43 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.201 0.524 . . . . 10.0 110.22 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -129.75 170.46 13.81 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.816 -0.629 . . . . 10.0 110.664 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.55 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 19.3 t -81.34 146.98 59.1 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 115.914 -0.585 . . . . 10.0 109.683 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -62.4 -18.02 60.73 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.126 1.884 . . . . 10.0 111.094 178.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.4 m -102.73 15.17 30.07 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.616 -0.72 . . . . 10.0 110.589 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.55 ' HB2' ' O ' ' A' ' 93' ' ' SER . 0.4 OUTLIER -83.5 167.88 17.0 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.043 0.449 . . . . 10.0 110.833 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.81 156.43 29.43 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.787 -0.642 . . . . 10.0 110.638 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 43.1 mm -63.3 -23.4 33.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.969 -0.559 . . . . 10.0 110.254 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.39 -40.58 65.14 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.355 -0.839 . . . . 10.0 110.873 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -64.02 -43.68 94.86 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 120.937 0.399 . . . . 10.0 110.864 -179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.535 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 44.6 mt -62.12 -47.57 92.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.87 -0.605 . . . . 10.0 109.568 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -54.44 -46.41 73.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.341 -0.845 . . . . 10.0 111.237 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.43 ' OE1' ' HA ' ' A' ' 103' ' ' GLN . 16.0 mm-40 -65.04 -34.47 78.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.161 -0.472 . . . . 10.0 110.881 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 48.0 t60 -62.91 -39.56 94.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.342 -0.39 . . . . 10.0 110.326 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 101' ' ' ILE . 17.3 mt -63.14 -41.11 99.24 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.187 -0.46 . . . . 10.0 110.139 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 14.6 mt -68.53 -39.42 80.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.302 -0.408 . . . . 10.0 109.929 178.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.4 m -65.05 -26.07 68.09 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.214 0.531 . . . . 10.0 111.285 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -88.06 2.76 51.14 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.315 -0.402 . . . . 10.0 110.806 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 62.95 25.36 15.02 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.336 0.588 . . . . 10.0 109.997 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.413 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 22.5 mmtp -99.18 -8.16 25.51 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.565 -0.743 . . . . 10.0 109.89 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -130.6 154.46 47.84 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.397 -0.819 . . . . 10.0 110.371 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.1 m -107.77 -33.28 7.31 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.021 -0.536 . . . . 10.0 111.516 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.437 ' O ' HG13 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -154.57 129.89 9.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.582 -0.281 . . . . 10.0 110.777 -178.306 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 9.3 tt -61.77 -38.84 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-O 120.937 0.398 . . . . 10.0 111.451 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.561 ' HB3' ' OE2' ' A' ' 116' ' ' GLU . 8.1 t -49.48 -38.27 29.38 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.12 -0.946 . . . . 10.0 112.461 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.561 ' OE2' ' HB3' ' A' ' 115' ' ' SER . 1.3 pm0 -94.73 11.6 30.79 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.176 0.436 . . . . 10.0 112.176 -178.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 113' ' ' HIS . 65.9 mt -95.6 119.98 44.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.992 -0.744 . . . . 10.0 108.992 178.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.501 ' HZ1' ' CG ' ' B' ' 31' ' ' ASP . 11.8 mmmt -126.22 120.37 29.86 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.777 -0.453 . . . . 10.0 109.777 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -95.79 127.24 41.65 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.132 0.491 . . . . 10.0 111.248 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -110.33 138.46 46.69 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.493 -0.776 . . . . 10.0 108.98 178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 25.3 tp -124.0 99.71 6.38 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.36 -0.607 . . . . 10.0 109.36 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 23.2 tptp 46.34 57.14 5.6 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 123.903 0.752 . . . . 10.0 110.416 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.557 ' HA3' ' CB ' ' C' ' 38' ' ' ASP . . . 81.48 -45.01 3.17 Favored Glycine 0 C--N 1.332 0.35 0 CA-C-N 115.567 -0.742 . . . . 10.0 113.097 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 40.1 tttp -62.61 133.16 54.49 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.807 -0.442 . . . . 10.0 109.807 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.3 p -83.03 141.03 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 113.341 0.867 . . . . 10.0 113.341 -177.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.5 mp -107.71 154.58 21.28 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.421 -0.808 . . . . 10.0 110.489 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 56.7 m-70 -111.9 154.61 24.95 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.781 0.324 . . . . 10.0 110.708 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -50.17 -54.04 23.54 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.727 1.01 . . . . 10.0 113.727 -178.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -96.51 18.69 13.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.921 0.391 . . . . 10.0 111.919 -177.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 12.0 tp -68.81 146.77 52.59 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.029 0.442 . . . . 10.0 111.048 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -99.7 143.62 29.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.779 -0.646 . . . . 10.0 110.082 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 49.7 mt -56.8 -28.99 62.25 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.255 0.347 . . . . 10.0 111.692 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.69 -22.37 56.73 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.988 0.423 . . . . 10.0 111.687 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -83.11 -49.13 9.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.532 -0.304 . . . . 10.0 110.588 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.6 pp -72.72 -25.24 61.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 10.0 111.06 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt 65.85 91.96 0.08 Allowed 'General case' 0 N--CA 1.463 0.216 0 O-C-N 123.884 0.74 . . . . 10.0 112.064 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.2 t -66.99 110.08 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.415 -0.587 . . . . 10.0 109.415 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -81.51 124.69 79.92 Favored Pre-proline 0 N--CA 1.447 -0.584 0 CA-C-N 115.95 -0.568 . . . . 10.0 111.156 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -64.92 -17.07 58.38 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.819 2.346 . . . . 10.0 111.967 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -79.72 0.12 31.85 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.914 -0.585 . . . . 10.0 110.789 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -136.48 -63.88 0.61 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.119 -0.492 . . . . 10.0 109.787 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 30.5 m 51.6 24.48 2.34 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.634 -0.712 . . . . 10.0 112.543 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 32.4 m -124.71 126.32 45.51 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.142 0.496 . . . . 10.0 111.094 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 24.3 mm -106.73 120.51 58.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.567 -0.742 . . . . 10.0 109.584 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.24 117.85 23.23 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.242 -0.435 . . . . 10.0 109.83 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 29.1 t -93.46 127.73 45.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.689 -0.687 . . . . 10.0 111.221 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' MET . . . . . 0.44 ' HE3' ' SG ' ' B' ' 39' ' ' CYS . 1.2 mpt? -124.65 117.26 23.88 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.47 -0.786 . . . . 10.0 109.247 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.432 HG21 HD12 ' A' ' 148' ' ' ILE . 10.2 mt -138.72 143.56 31.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.197 -0.456 . . . . 10.0 111.165 -177.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -109.8 114.56 56.45 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 108.846 -0.798 . . . . 10.0 108.846 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo . . . . . 0 CA--C 1.53 0.292 0 C-N-CA 122.447 2.098 . . . . 10.0 113.215 -178.792 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' SER . . . . . 0.466 ' O ' HG12 ' B' ' 8' ' ' ILE . 26.0 t . . . . . 0 CA--C 1.53 0.209 0 CA-C-O 120.529 0.204 . . . . 10.0 110.515 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 5.2 ptpp? -57.88 -44.17 86.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.284 -0.416 . . . . 10.0 110.664 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -58.11 -46.25 85.88 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.004 0.43 . . . . 10.0 110.549 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -62.29 -38.94 91.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.932 -0.577 . . . . 10.0 110.458 179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.492 HG13 ' CE2' ' C' ' 15' ' ' TYR . 38.7 mm -63.63 -45.8 96.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.992 -0.549 . . . . 10.0 109.99 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . 0.443 ' HA ' HD13 ' B' ' 12' ' ' ILE . . . -62.41 -36.72 83.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.736 -0.665 . . . . 10.0 110.994 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.36 -34.03 77.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.984 -0.553 . . . . 10.0 110.48 179.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 22.9 mt -67.02 -35.63 80.32 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.57 -0.53 . . . . 10.0 109.57 178.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.443 HD13 ' HA ' ' B' ' 9' ' ' ALA . 53.4 mt -59.91 -56.96 13.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.515 -0.766 . . . . 10.0 111.396 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.461 ' HB ' ' HG2' ' B' ' 48' ' ' ARG . 24.4 m -65.44 -31.95 56.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.432 -0.349 . . . . 10.0 111.613 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -65.26 -51.38 61.2 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.215 0.531 . . . . 10.0 110.179 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' TYR . . . . . 0.46 ' O ' HG12 ' B' ' 19' ' ' ILE . 16.5 m-85 -64.28 -44.97 90.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.974 -0.557 . . . . 10.0 111.338 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 9.3 m-30 -58.32 -50.37 73.87 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.559 0.207 . . . . 10.0 111.559 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 24.2 m -56.97 -38.5 73.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.933 0.397 . . . . 10.0 111.456 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 2.7 p -79.03 -20.11 49.79 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.293 -0.255 . . . . 10.0 111.256 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.46 HG12 ' O ' ' B' ' 15' ' ' TYR . 13.6 mm -76.72 -41.2 33.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 109.487 -0.56 . . . . 10.0 109.487 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 26.6 m -76.04 -27.78 18.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.937 -0.574 . . . . 10.0 110.369 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 tm-20 -65.22 -52.08 56.91 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.531 -0.544 . . . . 10.0 109.531 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 21.4 mmtm -79.89 -8.75 59.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.642 -0.708 . . . . 10.0 110.545 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 52.1 mttt 55.36 52.78 10.82 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.486 -0.779 . . . . 10.0 110.843 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.471 ' O ' ' HE2' ' C' ' 5' ' ' LYS . 87.7 mt-10 -89.35 26.64 1.61 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.249 -0.887 . . . . 10.0 110.105 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 13.7 tt -162.25 160.77 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.598 -0.728 . . . . 10.0 109.848 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.48 153.22 36.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.597 -0.274 . . . . 10.0 110.847 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -59.15 -44.44 92.09 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.379 0.511 . . . . 10.0 112.379 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.79 -47.48 82.45 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.089 0.471 . . . . 10.0 110.228 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . 0.436 ' O ' ' HG ' ' B' ' 33' ' ' LEU . . . -67.36 -34.54 85.41 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.791 -0.64 . . . . 10.0 111.901 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.9 -39.3 94.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.698 0.285 . . . . 10.0 111.02 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.501 ' CG ' ' HZ1' ' A' ' 118' ' ' LYS . 23.9 t70 -70.55 -30.43 67.15 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.751 -0.463 . . . . 10.0 109.751 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 2.0 m -62.23 -43.14 99.5 Favored 'General case' 0 C--N 1.334 -0.097 0 N-CA-C 109.126 -0.694 . . . . 10.0 109.126 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' B' ' 29' ' ' GLY . 26.7 mt -70.23 -36.4 74.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.751 -0.659 . . . . 10.0 109.851 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -54.82 -56.2 21.95 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.227 -0.897 . . . . 10.0 110.853 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 7.1 p -73.17 -34.32 44.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 115.947 -0.57 . . . . 10.0 111.397 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.09 -32.68 74.11 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.991 -0.374 . . . . 10.0 109.991 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' MET . . . . . . . . . . . . . 22.7 mtm -60.05 -44.12 94.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.414 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.27 -47.65 85.11 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.234 -0.439 . . . . 10.0 110.006 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' CYS . . . . . 0.44 ' SG ' ' HE3' ' A' ' 147' ' ' MET . 15.8 m -58.18 -43.44 87.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.789 -0.641 . . . . 10.0 110.817 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 96.5 mt -67.21 -48.65 77.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-O 120.742 0.305 . . . . 10.0 111.555 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.53 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 10.6 m -60.06 -46.4 89.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.361 -0.381 . . . . 10.0 110.895 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -67.41 -37.99 83.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.384 -0.371 . . . . 10.0 111.209 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.26 -42.36 99.13 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.877 0.325 . . . . 10.0 111.877 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -87.6 -7.87 56.96 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.889 0.329 . . . . 10.0 111.889 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.62 49.82 17.27 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.986 -0.626 . . . . 10.0 113.54 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.53 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 8.2 p90 -151.98 166.75 30.57 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.433 -0.58 . . . . 10.0 109.433 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -117.09 157.82 25.25 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.199 0.523 . . . . 10.0 110.554 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.461 ' HG2' ' HB ' ' B' ' 13' ' ' VAL . 0.6 OUTLIER -68.99 -22.94 64.06 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.473 -0.785 . . . . 10.0 111.597 -178.554 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -69.07 -8.57 46.39 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.179 0.807 . . . . 10.0 113.179 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -103.34 5.62 37.39 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.813 0.671 . . . . 10.0 112.813 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.525 HG22 ' H ' ' B' ' 52' ' ' SER . 2.6 m -40.69 -61.61 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 113.638 0.977 . . . . 10.0 113.638 -178.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' SER . . . . . 0.525 ' H ' HG22 ' B' ' 51' ' ' VAL . 1.0 OUTLIER -62.01 -23.14 66.25 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.991 0.737 . . . . 10.0 112.991 -178.696 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.66 -40.81 30.88 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.646 -0.788 . . . . 10.0 112.43 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 72.8 mt -81.34 -47.37 19.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.711 0.291 . . . . 10.0 111.226 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 67.0 mt -74.99 -67.99 0.59 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.742 0.306 . . . . 10.0 110.573 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 55.06 -106.13 0.49 Allowed Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.777 -0.647 . . . . 10.0 113.381 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 16.0 pttt -126.96 18.81 7.16 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.205 0.526 . . . . 10.0 110.211 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 13.1 m -76.68 -59.13 2.9 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.707 -0.678 . . . . 10.0 110.406 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 . . . . . 0 N--CA 1.447 -0.595 0 CA-C-N 116.359 -0.382 . . . . 10.0 110.051 -179.779 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.458 0 N-CA-C 110.27 -0.27 . . . . 10.0 110.27 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 4' ' ' SER . . . . . 0.46 ' O ' HG12 ' C' ' 8' ' ' ILE . 8.6 t -97.8 171.77 8.1 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.347 -0.612 . . . . 10.0 109.347 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 5' ' ' LYS . . . . . 0.471 ' HE2' ' O ' ' B' ' 24' ' ' GLU . 3.4 ptpp? -59.23 -37.97 78.85 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 121.407 -0.117 . . . . 10.0 110.903 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 6' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -58.27 -45.55 87.66 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.055 0.455 . . . . 10.0 110.725 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -69.99 -41.44 74.38 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.19 -0.459 . . . . 10.0 110.735 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 8' ' ' ILE . . . . . 0.46 HG12 ' O ' ' C' ' 4' ' ' SER . 40.1 mm -59.19 -44.89 92.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.825 -0.435 . . . . 10.0 109.825 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.41 -39.93 92.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.824 -0.625 . . . . 10.0 110.442 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.42 -43.03 99.58 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.816 -0.629 . . . . 10.0 110.41 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . 0.462 ' HG ' ' CD2' ' C' ' 55' ' ' LEU . 7.0 mt -61.04 -40.43 93.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.457 -0.338 . . . . 10.0 110.743 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 12' ' ' ILE . . . . . 0.458 HG13 ' O ' ' C' ' 8' ' ' ILE . 73.1 mt -65.2 -54.13 32.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.038 -0.528 . . . . 10.0 111.668 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 18.1 m -64.86 -27.47 42.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.899 0.38 . . . . 10.0 110.952 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -71.67 -47.08 56.65 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 120.986 0.422 . . . . 10.0 110.186 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 15' ' ' TYR . . . . . 0.492 ' CE2' HG13 ' B' ' 8' ' ' ILE . 3.2 m-85 -62.59 -42.66 99.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.829 -0.623 . . . . 10.0 110.598 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -59.18 -45.05 92.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.192 -0.458 . . . . 10.0 111.027 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 35.8 m -58.6 -39.7 81.15 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.119 -0.491 . . . . 10.0 111.692 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.71 -19.29 45.4 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.973 0.416 . . . . 10.0 111.139 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 19' ' ' ILE . . . . . 0.4 HG22 HD11 ' C' ' 19' ' ' ILE . 4.2 mm -75.87 -45.12 38.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.006 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 20' ' ' VAL . . . . . . . . . . . . . 27.3 m -75.44 -18.09 15.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 121.235 0.54 . . . . 10.0 110.676 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -70.91 -56.35 6.43 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.534 -0.757 . . . . 10.0 110.794 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 22' ' ' LYS . . . . . 0.489 ' HD2' ' OE2' ' C' ' 24' ' ' GLU . 45.5 mttm -81.22 -2.01 47.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.399 -0.818 . . . . 10.0 111.735 -178.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 87.7 mttt 55.58 49.23 16.98 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.475 0.655 . . . . 10.0 110.571 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . 0.489 ' OE2' ' HD2' ' C' ' 22' ' ' LYS . 46.3 mt-10 -82.47 -15.36 52.79 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.546 -0.752 . . . . 10.0 110.096 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 17.1 tt -114.2 161.14 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 115.608 -0.724 . . . . 10.0 109.829 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.31 154.08 39.29 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 123.288 0.368 . . . . 10.0 110.11 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -52.25 -44.5 64.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.95 0.405 . . . . 10.0 111.46 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 28' ' ' ASP . . . . . 0.448 ' CG ' ' HZ3' ' A' ' 85' ' ' LYS . 16.1 t0 -59.03 -45.07 91.65 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.882 -0.599 . . . . 10.0 110.646 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 29' ' ' GLY . . . . . 0.631 ' O ' ' HG ' ' C' ' 33' ' ' LEU . . . -68.12 -38.11 87.82 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.639 -0.709 . . . . 10.0 112.183 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.55 -43.31 84.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.047 0.451 . . . . 10.0 110.402 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 31' ' ' ASP . . . . . 0.602 ' CG ' ' HZ1' ' A' ' 79' ' ' LYS . 31.1 t70 -69.41 -37.59 77.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.904 -0.589 . . . . 10.0 110.347 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 24.3 m -64.23 -36.11 83.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.676 -0.693 . . . . 10.0 110.39 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 33' ' ' LEU . . . . . 0.631 ' HG ' ' O ' ' C' ' 29' ' ' GLY . 46.5 mt -73.05 -26.86 61.44 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.849 -0.426 . . . . 10.0 109.849 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 34' ' ' ASN . . . . . 0.476 ' HB3' ' O ' ' C' ' 31' ' ' ASP . 24.8 t30 -61.83 -56.6 17.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.917 -0.583 . . . . 10.0 110.303 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 35' ' ' VAL . . . . . 0.43 HG22 ' H ' ' A' ' 123' ' ' GLY . 6.3 p -66.64 -38.23 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 115.672 -0.695 . . . . 10.0 110.639 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . 0.475 ' O ' HG13 ' C' ' 40' ' ' ILE . . . -64.28 -32.57 74.22 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.389 -0.369 . . . . 10.0 110.995 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 14.0 mtm -59.29 -52.8 64.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.636 -0.256 . . . . 10.0 111.024 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 38' ' ' ASP . . . . . 0.557 ' CB ' ' HA3' ' A' ' 123' ' ' GLY . 28.1 m-20 -63.99 -26.55 68.62 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.462 -0.335 . . . . 10.0 110.597 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 39' ' ' CYS . . . . . 0.469 ' HB2' ' O ' ' C' ' 36' ' ' ALA . 62.7 m -60.23 -43.41 96.06 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 109.351 -0.611 . . . . 10.0 109.351 178.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 40' ' ' ILE . . . . . 0.475 HG13 ' O ' ' C' ' 36' ' ' ALA . 14.8 mt -69.03 -47.75 73.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.554 -0.748 . . . . 10.0 110.551 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 41' ' ' SER . . . . . 0.463 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 17.8 m -59.78 -43.18 94.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.916 -0.583 . . . . 10.0 111.712 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -68.59 -43.23 76.93 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.281 -0.418 . . . . 10.0 111.238 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.9 -44.86 75.98 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.355 0.502 . . . . 10.0 112.355 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 44' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -86.36 -7.31 58.56 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.95 0.352 . . . . 10.0 111.95 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.16 55.38 21.83 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.893 -0.67 . . . . 10.0 113.326 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 46' ' ' PHE . . . . . 0.463 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 4.7 p90 -153.98 177.7 10.75 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.896 -0.779 . . . . 10.0 108.896 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -125.27 150.87 46.67 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.263 0.554 . . . . 10.0 111.576 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 48' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -71.83 -27.63 63.04 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.499 -0.773 . . . . 10.0 110.954 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -72.15 2.8 5.27 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.006 -0.543 . . . . 10.0 111.246 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -108.96 0.88 20.3 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.436 0.532 . . . . 10.0 112.436 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 10.5 m -50.24 -43.21 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 114.379 1.252 . . . . 10.0 114.379 -177.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 52' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.77 -30.06 67.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.868 0.365 . . . . 10.0 111.174 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.91 -38.16 10.7 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.957 -0.64 . . . . 10.0 112.786 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 54' ' ' ILE . . . . . . . . . . . . . 37.3 mt -73.84 -62.68 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.853 0.359 . . . . 10.0 111.035 -179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 55' ' ' LEU . . . . . 0.462 ' CD2' ' HG ' ' C' ' 11' ' ' LEU . 68.9 mt -66.25 -54.97 18.66 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.628 -0.714 . . . . 10.0 110.71 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 52.67 -99.5 0.04 OUTLIER Glycine 0 CA--C 1.518 0.279 0 O-C-N 123.931 0.769 . . . . 10.0 112.457 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -138.89 21.09 2.65 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.187 -0.672 . . . . 10.0 109.187 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 18.4 m -78.69 -59.67 2.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.27 -0.877 . . . . 10.0 111.399 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 . . . . . 0 C--N 1.321 -0.636 0 N-CA-C 109.956 -0.387 . . . . 10.0 109.956 -179.901 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.8 p . . . . . 0 N--CA 1.453 -0.322 0 CA-C-O 120.807 0.336 . . . . 10.0 110.121 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -89.16 132.1 34.99 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.411 -0.359 . . . . 10.0 110.981 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -120.73 122.48 40.49 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.466 -0.938 . . . . 10.0 108.466 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.7 m -92.17 109.74 21.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.921 0.391 . . . . 10.0 110.346 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 87' ' ' SER . 2.3 mm? -81.67 110.65 17.21 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.239 -0.652 . . . . 10.0 109.239 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -120.52 107.11 12.47 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.316 -0.402 . . . . 10.0 111.059 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 46.5 tttm -96.74 120.57 37.31 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.587 -0.523 . . . . 10.0 109.587 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.447 HG21 ' OD2' ' C' ' 28' ' ' ASP . 18.1 mt -83.87 -36.21 11.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 O-C-N 123.863 0.727 . . . . 10.0 111.087 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.436 ' OE1' ' HA ' ' A' ' 147' ' ' MET . 19.7 mt-30 -65.42 149.17 50.46 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.993 -0.283 . . . . 10.0 110.394 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.91 134.05 78.49 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 116.437 -0.347 . . . . 10.0 111.041 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -80.07 142.14 60.91 Favored 'Cis proline' 0 C--O 1.236 0.4 0 C-N-CA 124.23 -1.154 . . . . 10.0 111.836 -1.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -80.36 158.13 26.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.029 -0.532 . . . . 10.0 111.585 -178.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -165.87 157.07 13.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.694 -0.685 . . . . 10.0 110.524 177.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.538 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 70.4 m -149.81 99.88 2.9 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.552 -0.536 . . . . 10.0 109.552 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.3 pt -121.03 155.32 24.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.039 -0.528 . . . . 10.0 110.761 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -114.91 119.33 36.18 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.554 -0.293 . . . . 10.0 110.546 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -118.11 156.05 29.34 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 110.059 -0.349 . . . . 10.0 110.059 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -107.89 110.99 22.89 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.098 -0.705 . . . . 10.0 109.098 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -117.56 151.55 36.92 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.788 0.328 . . . . 10.0 110.922 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.491 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 0.6 OUTLIER -66.93 134.01 93.95 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.072 -0.513 . . . . 10.0 110.626 179.682 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -52.46 -32.26 51.94 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.549 2.166 . . . . 10.0 112.853 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.4 m -97.52 20.27 12.03 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.042 -0.526 . . . . 10.0 111.529 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.491 ' HB2' ' O ' ' A' ' 93' ' ' SER . 0.6 OUTLIER -83.45 171.35 13.52 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.88 0.371 . . . . 10.0 110.896 -179.546 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.9 m -105.99 146.41 30.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.963 -0.562 . . . . 10.0 111.006 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.419 HG12 ' O ' ' A' ' 130' ' ' LEU . 39.2 mm -61.76 -29.52 46.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 121.31 0.576 . . . . 10.0 110.392 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.32 -42.78 78.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.591 -0.732 . . . . 10.0 110.942 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -64.6 -36.38 84.06 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 120.695 0.283 . . . . 10.0 110.981 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 59.2 mt -65.8 -48.27 82.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.267 -0.424 . . . . 10.0 109.886 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.482 ' HZ1' ' CG ' ' A' ' 128' ' ' ASP . 23.5 mtpt -60.15 -44.06 95.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.786 -0.643 . . . . 10.0 110.331 178.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -64.21 -33.46 75.85 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.776 -0.647 . . . . 10.0 110.227 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.413 ' O ' ' HG3' ' A' ' 108' ' ' GLU . 61.2 t60 -69.89 -37.7 76.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.822 -0.627 . . . . 10.0 110.398 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 60.8 mt -60.55 -39.97 89.85 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.115 0.483 . . . . 10.0 110.165 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 102' ' ' LYS . 12.2 mt -70.14 -38.5 75.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.996 -0.547 . . . . 10.0 109.905 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 48.9 m -66.02 -23.73 66.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.741 -0.663 . . . . 10.0 110.965 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 104' ' ' HIS . 47.2 mt-10 -96.75 7.05 47.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.154 -0.475 . . . . 10.0 110.202 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 58.13 32.09 21.56 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.452 -0.795 . . . . 10.0 111.683 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 6.3 mmpp? -100.39 -8.01 23.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.633 -0.712 . . . . 10.0 109.455 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.42 ' HA ' HD12 ' A' ' 148' ' ' ILE . . . -130.55 167.23 19.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.297 -0.865 . . . . 10.0 111.258 -179.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.8 t -101.1 -61.36 1.38 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.876 -0.602 . . . . 10.0 110.138 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.488 ' O ' HG13 ' A' ' 117' ' ' ILE . 20.2 m170 -139.59 143.76 37.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.351 -0.386 . . . . 10.0 110.335 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.412 HG13 ' HE2' ' A' ' 102' ' ' LYS . 3.9 tt -59.5 -42.91 89.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 121.317 0.58 . . . . 10.0 110.811 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.49 -15.03 33.87 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.084 -0.962 . . . . 10.0 112.304 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.448 ' CD ' ' HZ1' ' A' ' 149' ' ' LYS . 7.6 mm-40 -110.94 14.95 22.0 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.493 0.553 . . . . 10.0 112.493 -178.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 113' ' ' HIS . 71.1 mt -105.79 120.96 57.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-O 120.973 0.416 . . . . 10.0 110.725 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -121.9 114.07 20.5 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.961 -0.755 . . . . 10.0 108.961 178.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.452 ' O ' ' HB2' ' A' ' 126' ' ' LEU . 69.8 mt -100.37 131.37 46.33 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.746 0.784 . . . . 10.0 110.988 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.492 HD13 ' SG ' ' C' ' 39' ' ' CYS . 0.4 OUTLIER -118.06 144.29 45.73 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.914 -1.039 . . . . 10.0 108.753 179.187 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 27.6 tp -128.87 93.34 3.58 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 107.45 -1.315 . . . . 10.0 107.45 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.51 ' HG2' ' ND2' ' A' ' 141' ' ' ASN . 0.2 OUTLIER 35.29 69.33 0.17 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 113.903 -1.499 . . . . 10.0 112.498 -179.473 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.481 ' HA3' ' CB ' ' C' ' 38' ' ' ASP . . . 86.51 -45.28 3.43 Favored Glycine 0 CA--C 1.51 -0.256 0 C-N-CA 121.071 -0.585 . . . . 10.0 112.399 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -63.33 121.7 14.38 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.556 -0.535 . . . . 10.0 109.556 178.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.9 t -85.8 128.42 39.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 111.79 0.293 . . . . 10.0 111.79 -178.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 119' ' ' LEU . 5.3 mp -96.88 144.71 26.56 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.149 -0.315 . . . . 10.0 110.149 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -122.7 161.1 24.51 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.598 -0.441 . . . . 10.0 110.259 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.482 ' CG ' ' HZ1' ' A' ' 102' ' ' LYS . 0.9 OUTLIER -57.09 -34.19 68.06 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.224 0.824 . . . . 10.0 113.224 -178.842 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -96.93 8.35 44.63 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.985 0.365 . . . . 10.0 111.985 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.419 ' O ' HG12 ' A' ' 98' ' ' ILE . 1.1 mp -80.54 144.92 32.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.985 0.421 . . . . 10.0 110.65 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -107.68 148.67 29.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.769 -0.65 . . . . 10.0 109.362 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 51.0 mt -57.12 -39.18 74.61 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.106 0.409 . . . . 10.0 112.106 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.87 -18.52 58.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.749 0.309 . . . . 10.0 110.746 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -78.62 -49.33 13.42 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.811 -0.632 . . . . 10.0 110.623 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.431 HD21 ' HG ' ' A' ' 126' ' ' LEU . 1.2 pp -76.4 -26.49 55.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.283 -0.417 . . . . 10.0 111.159 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 10.8 mttp 60.84 100.52 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 O-C-N 123.634 0.584 . . . . 10.0 111.409 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.9 p -88.14 128.93 40.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.986 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.88 128.64 89.16 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.982 -0.554 . . . . 10.0 111.435 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -69.25 -9.69 26.97 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.479 2.119 . . . . 10.0 111.924 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -92.02 8.67 36.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.457 0.646 . . . . 10.0 109.484 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . 0.51 ' ND2' ' HG2' ' A' ' 122' ' ' LYS . 5.9 t-20 -134.61 -74.52 0.47 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.229 -0.896 . . . . 10.0 109.737 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.3 m 55.87 26.5 9.77 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.881 0.697 . . . . 10.0 112.881 178.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 19.4 m -121.0 124.24 44.38 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.009 0.433 . . . . 10.0 111.12 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 24.5 mm -103.19 125.77 57.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.82 -0.627 . . . . 10.0 110.115 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.19 106.44 14.09 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.355 -0.98 . . . . 10.0 108.355 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 30.0 t -89.35 122.27 40.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.668 -0.696 . . . . 10.0 111.816 -177.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' MET . . . . . 0.443 ' HG3' ' CG2' ' B' ' 35' ' ' VAL . 26.1 mmt -122.67 117.73 26.46 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.434 -0.803 . . . . 10.0 109.486 178.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.42 HD12 ' HA ' ' A' ' 111' ' ' ALA . 23.1 mt -135.45 138.26 48.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.798 -0.637 . . . . 10.0 110.233 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.448 ' HZ1' ' CD ' ' A' ' 116' ' ' GLU . 9.0 mtpt -103.83 115.02 64.1 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.928 -0.578 . . . . 10.0 110.903 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo . . . . . 0 N--CA 1.462 -0.34 0 C-N-CA 122.053 1.835 . . . . 10.0 111.503 179.248 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.449 -0.511 0 N-CA-C 110.09 -0.337 . . . . 10.0 110.09 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 7.1 ptpp? -57.2 -34.95 69.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.38 -0.373 . . . . 10.0 111.341 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -61.65 -44.17 97.47 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.239 -0.437 . . . . 10.0 110.64 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -56.99 -48.09 79.25 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.467 0.651 . . . . 10.0 109.571 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.609 ' O ' HG12 ' B' ' 12' ' ' ILE . 42.8 mm -63.4 -47.8 90.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.145 -0.934 . . . . 10.0 110.911 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.87 -41.26 70.62 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.983 0.421 . . . . 10.0 110.824 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.8 -31.4 70.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.904 -0.589 . . . . 10.0 110.554 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.36 -33.22 67.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.181 0.515 . . . . 10.0 109.676 179.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.609 HG12 ' O ' ' B' ' 8' ' ' ILE . 18.6 mm -66.08 -50.33 69.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.572 -0.74 . . . . 10.0 111.2 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 28.8 m -65.19 -32.18 57.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.804 0.335 . . . . 10.0 110.608 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -68.73 -48.92 62.59 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.244 -0.435 . . . . 10.0 109.954 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' TYR . . . . . 0.578 ' O ' HG12 ' B' ' 19' ' ' ILE . 5.5 t80 -59.54 -43.2 93.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.235 -0.439 . . . . 10.0 110.708 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 11.4 m-30 -56.82 -45.5 82.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.773 0.32 . . . . 10.0 110.315 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 74.2 m -58.54 -42.45 87.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.903 -0.59 . . . . 10.0 111.2 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 1.5 m -70.14 -21.72 63.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.377 -0.374 . . . . 10.0 111.501 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.578 HG12 ' O ' ' B' ' 15' ' ' TYR . 34.2 mm -87.27 -39.3 12.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.873 -0.331 . . . . 10.0 110.944 -178.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 30.3 m -73.33 -32.2 36.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.61 0.243 . . . . 10.0 110.469 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -65.1 -51.43 61.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.293 -0.412 . . . . 10.0 111.109 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -84.11 -4.6 58.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.329 -0.396 . . . . 10.0 111.492 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . 0.466 ' HZ1' ' CD ' ' B' ' 27' ' ' GLU . 53.0 mttm 57.03 47.44 17.51 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.49 0.662 . . . . 10.0 111.088 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.505 ' O ' ' HE2' ' C' ' 5' ' ' LYS . 80.9 mt-10 -89.31 30.01 1.03 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.702 -0.681 . . . . 10.0 110.348 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 13.3 tt -158.78 171.38 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.764 -0.828 . . . . 10.0 108.764 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.91 155.87 39.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.753 0.311 . . . . 10.0 110.368 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' GLU . . . . . 0.466 ' CD ' ' HZ1' ' B' ' 23' ' ' LYS . 16.1 mm-40 -59.96 -48.0 83.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.234 -0.439 . . . . 10.0 111.072 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.59 -39.17 93.7 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.197 -0.456 . . . . 10.0 109.875 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . 0.488 ' O ' ' HG ' ' B' ' 33' ' ' LEU . . . -66.71 -31.78 79.42 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.756 -0.656 . . . . 10.0 111.514 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.74 -38.07 89.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.648 0.261 . . . . 10.0 110.546 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -66.53 -36.52 82.88 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 108.713 -0.847 . . . . 10.0 108.713 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' SER . . . . . 0.629 ' HB3' ' SG ' ' C' ' 39' ' ' CYS . 2.4 m -64.79 -33.36 75.81 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.18 -0.918 . . . . 10.0 110.095 178.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' B' ' 29' ' ' GLY . 25.2 mt -73.35 -40.53 64.33 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.192 -0.458 . . . . 10.0 110.099 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 55.9 m-20 -62.75 -44.86 95.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.818 -0.628 . . . . 10.0 110.986 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . 0.443 ' CG2' ' HG3' ' A' ' 147' ' ' MET . 11.9 p -72.22 -37.53 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 116.331 -0.395 . . . . 10.0 110.564 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.7 -35.04 79.6 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 109.621 -0.511 . . . . 10.0 109.621 178.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' MET . . . . . . . . . . . . . 25.0 ttm -56.18 -51.62 67.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.388 -0.824 . . . . 10.0 110.028 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . 0.518 ' OD1' ' HD3' ' B' ' 48' ' ' ARG . 0.7 OUTLIER -69.09 -40.11 78.62 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.45 -0.795 . . . . 10.0 110.054 -179.905 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 4.5 t -52.64 -45.45 66.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.268 -0.878 . . . . 10.0 110.6 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 75.8 mt -74.42 -44.34 48.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.51 -0.768 . . . . 10.0 111.196 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.692 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 34.6 m -57.75 -43.74 85.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.85 0.357 . . . . 10.0 110.893 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -68.67 -41.73 78.85 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.955 -0.566 . . . . 10.0 110.849 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.29 -27.96 69.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.262 -0.426 . . . . 10.0 111.807 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -104.15 0.61 29.79 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.81 0.338 . . . . 10.0 111.479 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.08 46.68 84.47 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 116.052 -0.522 . . . . 10.0 113.718 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.692 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 9.2 p90 -135.51 154.91 51.24 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 117.176 0.488 . . . . 10.0 109.953 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -71.61 141.66 49.98 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.267 0.556 . . . . 10.0 112.044 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.518 ' HD3' ' OD1' ' B' ' 38' ' ' ASP . 0.1 OUTLIER -59.31 -42.47 91.47 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.066 -0.97 . . . . 10.0 110.257 179.409 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -88.69 5.23 44.18 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.084 0.772 . . . . 10.0 113.084 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.54 3.39 11.48 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.282 0.475 . . . . 10.0 112.282 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.441 HG22 ' H ' ' B' ' 52' ' ' SER . 13.0 m -43.91 -54.38 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 113.02 0.748 . . . . 10.0 113.02 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' SER . . . . . 0.441 ' H ' HG22 ' B' ' 51' ' ' VAL . 18.3 m -52.88 -35.94 58.49 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 113.213 0.82 . . . . 10.0 113.213 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.28 -33.79 55.99 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.128 -1.034 . . . . 10.0 112.349 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 22.7 mt -89.5 -59.5 2.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 113.759 1.022 . . . . 10.0 113.759 -178.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 60.2 mt -66.07 -67.89 0.41 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.402 0.89 . . . . 10.0 113.402 -177.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.52 -152.51 39.52 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.456 -0.878 . . . . 10.0 111.04 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.75 23.65 3.64 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.564 0.697 . . . . 10.0 109.674 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 1.4 m -86.94 40.42 0.91 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.972 -1.013 . . . . 10.0 111.416 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 . . . . . 0 CA--C 1.531 0.218 0 CA-C-N 115.955 -0.566 . . . . 10.0 111.586 179.919 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.231 0 N-CA-C 109.69 -0.485 . . . . 10.0 109.69 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -101.56 142.82 32.36 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.934 -0.395 . . . . 10.0 109.934 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 5' ' ' LYS . . . . . 0.505 ' HE2' ' O ' ' B' ' 24' ' ' GLU . 7.2 ptpp? -62.87 -37.08 85.45 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.32 0.489 . . . . 10.0 112.32 -178.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 6' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -62.08 -43.4 98.92 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.654 0.264 . . . . 10.0 110.29 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . 0.447 ' O ' HD21 ' C' ' 55' ' ' LEU . 69.9 mt-10 -64.02 -49.9 70.59 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.767 -0.651 . . . . 10.0 110.249 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 8' ' ' ILE . . . . . 0.59 ' O ' HG13 ' C' ' 12' ' ' ILE . 50.0 mm -61.64 -43.72 97.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.813 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.43 -45.36 76.77 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.249 -0.432 . . . . 10.0 111.121 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.84 -34.88 79.41 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.781 -0.645 . . . . 10.0 110.867 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 1.3 mt -65.36 -32.45 74.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.573 -0.285 . . . . 10.0 110.651 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 12' ' ' ILE . . . . . 0.59 HG13 ' O ' ' C' ' 8' ' ' ILE . 7.5 mt -67.71 -55.13 18.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.341 -0.391 . . . . 10.0 110.748 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 17.9 m -64.37 -30.86 51.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.812 -0.631 . . . . 10.0 111.311 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -70.39 -45.72 65.41 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.126 0.488 . . . . 10.0 109.716 178.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 15' ' ' TYR . . . . . 0.588 ' CE2' HG13 ' B' ' 8' ' ' ILE . 4.7 t80 -62.84 -46.99 85.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.863 -0.608 . . . . 10.0 110.454 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -56.11 -47.58 77.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.07 -0.514 . . . . 10.0 111.356 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 37.0 m -58.92 -41.25 86.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 10.0 111.584 -179.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 3.4 p -75.21 -20.84 59.06 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.297 0.481 . . . . 10.0 112.297 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 19' ' ' ILE . . . . . 0.486 HG12 ' O ' ' C' ' 15' ' ' TYR . 20.4 mm -84.06 -35.33 10.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.771 0.32 . . . . 10.0 110.666 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 20' ' ' VAL . . . . . . . . . . . . . 29.4 m -78.7 -28.12 14.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.866 -0.333 . . . . 10.0 110.385 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.1 -50.83 62.69 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.966 0.413 . . . . 10.0 110.221 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -85.8 1.69 48.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.241 -0.436 . . . . 10.0 110.064 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 63.7 mttm 48.03 53.54 11.45 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.105 -0.952 . . . . 10.0 111.989 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -85.09 13.73 5.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.468 . . . . 10.0 110.197 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 13.5 tt -138.82 167.6 20.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.744 -0.662 . . . . 10.0 109.823 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 8.2 p -66.22 160.42 24.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.524 0.202 . . . . 10.0 110.589 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -59.69 -41.99 91.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.919 0.39 . . . . 10.0 110.53 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 28' ' ' ASP . . . . . 0.447 ' OD2' HG21 ' A' ' 81' ' ' ILE . 31.0 t70 -68.84 -39.86 79.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.971 -0.558 . . . . 10.0 109.865 179.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 29' ' ' GLY . . . . . 0.528 ' O ' ' HG ' ' C' ' 33' ' ' LEU . . . -64.57 -35.66 92.2 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.927 -0.654 . . . . 10.0 111.627 178.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.4 -45.92 91.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.345 0.593 . . . . 10.0 110.113 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -60.9 -38.22 84.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.415 -0.811 . . . . 10.0 110.025 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 3.0 t -62.09 -34.37 76.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.358 -0.837 . . . . 10.0 110.593 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 33' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' C' ' 29' ' ' GLY . 50.1 mt -74.94 -29.58 60.98 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.17 -0.468 . . . . 10.0 110.475 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -71.61 -47.57 53.82 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.428 -0.351 . . . . 10.0 110.965 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 p -64.16 -40.73 90.08 Favored 'Isoleucine or valine' 0 C--N 1.343 0.304 0 CA-C-O 120.684 0.278 . . . . 10.0 110.449 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.6 -35.61 79.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.847 0.356 . . . . 10.0 110.32 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 40.5 ttm -53.34 -59.89 3.99 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.585 -0.734 . . . . 10.0 111.769 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 38' ' ' ASP . . . . . 0.481 ' CB ' ' HA3' ' A' ' 123' ' ' GLY . 4.1 m-20 -65.89 -33.77 76.59 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 121.028 -0.269 . . . . 10.0 111.504 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 39' ' ' CYS . . . . . 0.629 ' SG ' ' HB3' ' B' ' 32' ' ' SER . 0.5 OUTLIER -60.86 -47.89 84.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.107 0.48 . . . . 10.0 110.064 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 40' ' ' ILE . . . . . . . . . . . . . 59.8 mt -68.34 -44.52 83.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.526 -0.761 . . . . 10.0 110.956 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 41' ' ' SER . . . . . 0.559 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 40.4 m -59.52 -45.75 90.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.063 -0.517 . . . . 10.0 111.432 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 -69.32 -40.12 77.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.312 -0.404 . . . . 10.0 110.839 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.52 -44.43 93.15 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.989 -0.55 . . . . 10.0 112.256 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 44' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -89.1 -6.82 56.77 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.633 0.254 . . . . 10.0 111.521 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.9 58.0 7.26 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 114.397 0.519 . . . . 10.0 114.397 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 46' ' ' PHE . . . . . 0.559 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 13.2 p90 -153.24 154.02 33.83 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.46 -0.57 . . . . 10.0 109.46 178.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 47' ' ' GLU . . . . . 0.421 ' HA ' ' OE1' ' C' ' 47' ' ' GLU . 0.0 OUTLIER -80.54 144.18 32.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.861 0.362 . . . . 10.0 111.155 -179.805 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 48' ' ' ARG . . . . . 0.438 ' HD3' ' OD1' ' C' ' 38' ' ' ASP . 0.0 OUTLIER -61.03 -34.94 75.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.978 -0.555 . . . . 10.0 111.001 -179.42 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.42 3.16 37.38 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.079 0.4 . . . . 10.0 112.079 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.4 1.79 47.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.805 0.336 . . . . 10.0 111.242 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 5.9 m -49.72 -44.43 20.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 112.651 0.611 . . . . 10.0 112.651 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.7 -35.28 70.41 Favored 'General case' 0 C--O 1.225 -0.199 0 N-CA-C 112.461 0.541 . . . . 10.0 112.461 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.21 -28.22 58.56 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 119.712 -1.232 . . . . 10.0 112.642 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 54' ' ' ILE . . . . . . . . . . . . . 61.3 mt -89.05 -62.98 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 113.241 0.83 . . . . 10.0 113.241 -178.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 55' ' ' LEU . . . . . 0.447 HD21 ' O ' ' C' ' 7' ' ' GLU . 20.7 mt -74.81 -62.6 1.49 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.529 0.937 . . . . 10.0 113.529 -177.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.16 -119.79 6.89 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.216 -0.754 . . . . 10.0 111.216 -178.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -160.03 22.12 0.17 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.35 0.595 . . . . 10.0 110.086 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.52 44.87 1.14 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.587 -0.733 . . . . 10.0 111.617 -178.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 . . . . . 0 N--CA 1.463 0.204 0 CA-C-O 120.958 0.408 . . . . 10.0 110.785 -179.647 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.453 -0.308 0 CA-C-O 120.445 0.164 . . . . 10.0 110.68 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -91.16 124.78 35.64 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.957 -0.386 . . . . 10.0 109.957 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.6 mp -126.39 133.49 51.29 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.014 0.435 . . . . 10.0 110.861 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.413 HG22 ' HG2' ' A' ' 89' ' ' GLU . 8.8 m -102.97 117.08 33.8 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.246 -0.434 . . . . 10.0 110.701 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -85.68 107.78 17.72 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.12 0.486 . . . . 10.0 110.025 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.537 ' HZ3' ' CG ' ' C' ' 31' ' ' ASP . 15.3 tptm -106.41 98.93 8.54 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.536 -0.756 . . . . 10.0 110.457 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -99.27 114.09 26.73 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.404 -0.362 . . . . 10.0 110.308 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 57.5 mt -84.05 -57.86 4.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.823 -0.626 . . . . 10.0 111.124 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -61.96 158.94 15.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.883 -0.598 . . . . 10.0 112.066 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -77.94 138.76 61.35 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.924 -0.58 . . . . 10.0 112.318 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -76.33 130.66 21.97 Favored 'Cis proline' 0 C--O 1.235 0.334 0 C-N-CA 123.247 -1.564 . . . . 10.0 110.619 -1.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.49 153.26 22.58 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.253 0.549 . . . . 10.0 111.459 -178.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.438 ' CE1' ' HB3' ' A' ' 110' ' ' LYS . 47.6 p90 -168.15 160.01 11.42 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.173 -0.921 . . . . 10.0 109.416 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.0 m -143.09 98.77 3.33 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.863 -0.791 . . . . 10.0 108.863 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 24.1 pt -119.75 153.44 22.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.18 -0.464 . . . . 10.0 111.048 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.413 ' HG2' HG22 ' A' ' 77' ' ' THR . 43.3 mt-10 -115.62 127.6 55.33 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 109.246 -0.649 . . . . 10.0 109.246 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.54 157.0 44.77 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.065 0.46 . . . . 10.0 110.402 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -114.54 137.79 51.44 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.126 -0.488 . . . . 10.0 109.911 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -129.75 165.09 22.6 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.251 -0.431 . . . . 10.0 110.416 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.457 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 7.3 m -75.78 147.37 81.04 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.119 -0.492 . . . . 10.0 110.568 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.47 -22.57 59.75 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.864 2.376 . . . . 10.0 113.322 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.59 18.12 22.35 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.962 0.411 . . . . 10.0 110.791 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 93' ' ' SER . 0.3 OUTLIER -80.34 162.82 24.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.98 0.419 . . . . 10.0 110.83 179.872 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.6 m -109.38 150.77 27.56 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.976 -0.556 . . . . 10.0 111.506 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 37.8 mm -61.86 -22.05 27.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.272 0.558 . . . . 10.0 110.379 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.13 -38.45 68.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.281 -0.872 . . . . 10.0 110.418 178.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 73.3 mm-40 -62.09 -44.38 96.78 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.136 -0.484 . . . . 10.0 111.137 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.545 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 35.6 mt -63.7 -50.09 79.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.839 -0.619 . . . . 10.0 109.875 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -55.37 -44.55 76.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.626 -0.716 . . . . 10.0 110.854 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -63.73 -39.19 93.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 10.0 110.905 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -63.57 -39.81 95.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.131 -0.486 . . . . 10.0 110.918 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 101' ' ' ILE . 40.9 mt -62.13 -42.19 99.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.867 0.365 . . . . 10.0 110.478 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 48.8 mt -68.81 -44.24 82.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.439 -0.346 . . . . 10.0 110.563 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.5 m -61.07 -27.45 68.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.848 -0.615 . . . . 10.0 111.82 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -95.8 12.86 28.55 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 120.797 0.332 . . . . 10.0 111.145 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 59.76 34.43 21.96 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.696 -0.684 . . . . 10.0 111.925 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.438 ' HB3' ' CE1' ' A' ' 86' ' ' PHE . 17.5 mmtp -107.2 -7.17 16.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.324 0.583 . . . . 10.0 110.472 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -141.67 142.02 33.36 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.439 -0.8 . . . . 10.0 109.81 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.33 -41.84 17.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.728 0.299 . . . . 10.0 111.387 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -151.69 141.59 22.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.613 -0.267 . . . . 10.0 110.845 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.1 tt -62.21 -41.92 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 116.279 -0.419 . . . . 10.0 111.876 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.501 ' HB2' ' OE2' ' A' ' 116' ' ' GLU . 11.2 m -53.67 -17.93 2.61 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.922 0.712 . . . . 10.0 112.922 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.501 ' OE2' ' HB2' ' A' ' 115' ' ' SER . 0.9 OUTLIER -109.74 7.27 24.19 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 122.102 -0.374 . . . . 10.0 111.341 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.402 HG12 HG12 ' A' ' 148' ' ' ILE . 66.1 mt -93.48 120.68 43.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.635 -0.505 . . . . 10.0 109.635 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.9 mmmt -124.24 118.57 27.11 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.297 -0.41 . . . . 10.0 110.377 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.439 ' O ' ' HB2' ' A' ' 126' ' ' LEU . 3.9 mm? -95.52 110.73 22.76 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.397 -0.365 . . . . 10.0 110.757 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -101.26 107.36 18.71 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.491 -0.929 . . . . 10.0 108.491 177.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.0 tp -90.94 101.22 13.99 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.713 0.768 . . . . 10.0 109.278 178.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 13.5 tptp 52.33 56.34 7.85 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 113.957 -1.474 . . . . 10.0 109.142 -177.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.744 ' HA2' ' SG ' ' C' ' 39' ' ' CYS . . . 79.05 -43.56 2.48 Favored Glycine 0 C--O 1.228 -0.245 0 CA-C-N 114.581 -1.191 . . . . 10.0 112.509 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 22.0 tttp -58.07 119.65 7.17 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.001 -0.6 . . . . 10.0 111.351 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.4 p -72.34 136.38 25.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 113.562 0.949 . . . . 10.0 113.562 -177.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.439 ' HB2' ' O ' ' A' ' 119' ' ' LEU . 1.5 mp -102.31 156.83 17.33 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 114.901 -1.045 . . . . 10.0 109.332 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 62.6 m-70 -116.65 152.73 33.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.061 0.458 . . . . 10.0 110.822 -178.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -52.77 -52.23 57.47 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.575 0.954 . . . . 10.0 113.575 -178.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -89.42 11.05 20.37 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.002 0.371 . . . . 10.0 112.002 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.1 tp -74.03 146.58 43.63 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.905 0.383 . . . . 10.0 111.022 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -106.54 150.56 26.01 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.927 -0.578 . . . . 10.0 110.003 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.402 HD11 ' O ' ' A' ' 93' ' ' SER . 81.4 mt -58.22 -31.73 67.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.015 0.436 . . . . 10.0 111.282 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.1 -33.08 67.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.892 -0.595 . . . . 10.0 111.218 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -77.39 -44.9 27.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.277 -0.42 . . . . 10.0 111.29 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.5 pp -74.08 -25.76 59.99 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.8 -0.36 . . . . 10.0 111.1 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt 65.1 93.01 0.07 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.238 0.542 . . . . 10.0 111.758 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.8 t -71.68 112.24 6.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.975 -0.557 . . . . 10.0 110.06 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.12 125.05 84.29 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.515 -0.311 . . . . 10.0 110.916 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.1 -12.67 36.95 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.068 2.512 . . . . 10.0 112.633 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -82.8 -0.86 49.85 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.241 0.543 . . . . 10.0 110.367 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 55.1 m-20 -131.7 -71.32 0.56 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.629 -0.714 . . . . 10.0 109.271 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 31.9 m 58.16 17.75 4.79 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.491 -0.777 . . . . 10.0 111.649 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.22 124.22 47.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.22 -0.445 . . . . 10.0 110.689 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 4.5 mm -110.96 124.4 67.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.324 -0.621 . . . . 10.0 109.324 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.54 129.99 34.99 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.684 -0.488 . . . . 10.0 109.684 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 2.2 t -107.65 131.14 58.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.349 0.595 . . . . 10.0 111.252 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -129.72 125.31 35.63 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.201 -1.037 . . . . 10.0 108.201 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.402 HG12 HG12 ' A' ' 117' ' ' ILE . 47.6 mt -135.84 139.4 46.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 116.562 -0.29 . . . . 10.0 110.326 -178.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -101.69 113.72 65.78 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 109.053 -0.721 . . . . 10.0 109.053 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo . . . . . 0 C--O 1.233 0.249 0 C-N-CA 122.387 2.058 . . . . 10.0 112.863 -178.812 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' SER . . . . . 0.452 ' HG ' ' CD ' ' B' ' 7' ' ' GLU . 51.8 p . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 109.898 -0.408 . . . . 10.0 109.898 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . 0.445 ' HB2' ' CE1' ' B' ' 44' ' ' PHE . 7.8 ptpp? -57.81 -41.17 81.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.368 -0.378 . . . . 10.0 110.859 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -59.87 -50.46 73.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 10.0 111.811 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . 0.452 ' CD ' ' HG ' ' B' ' 4' ' ' SER . 3.5 mp0 -59.1 -42.37 90.32 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.705 0.288 . . . . 10.0 110.852 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.608 ' O ' HG13 ' B' ' 12' ' ' ILE . 47.8 mm -62.02 -47.5 92.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.77 -0.455 . . . . 10.0 109.77 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . 0.403 ' HB1' ' CE1' ' B' ' 46' ' ' PHE . . . -57.43 -41.99 81.5 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.75 -0.659 . . . . 10.0 111.053 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.03 -36.9 85.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.108 -0.496 . . . . 10.0 110.597 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 23.9 mt -69.64 -33.52 72.74 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.789 -0.448 . . . . 10.0 109.789 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.608 HG13 ' O ' ' B' ' 8' ' ' ILE . 86.1 mt -64.07 -57.0 13.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.984 -0.553 . . . . 10.0 111.025 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 29.4 m -59.41 -32.84 49.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.21 -0.45 . . . . 10.0 111.274 -178.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -72.19 -46.18 57.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.244 -0.434 . . . . 10.0 110.835 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' TYR . . . . . 0.53 ' O ' HG12 ' B' ' 19' ' ' ILE . 2.1 m-85 -68.89 -46.82 67.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.453 -0.34 . . . . 10.0 111.459 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -55.26 -52.15 64.34 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.683 0.278 . . . . 10.0 111.179 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' SER . . . . . 0.493 ' O ' ' HB2' ' B' ' 21' ' ' GLU . 18.8 p -59.53 -38.06 80.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.408 -0.36 . . . . 10.0 111.369 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 76.6 p -74.89 -20.72 59.6 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.073 0.397 . . . . 10.0 112.073 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.53 HG12 ' O ' ' B' ' 15' ' ' TYR . 25.9 mm -80.39 -42.48 21.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.165 0.507 . . . . 10.0 109.808 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 19.5 m -75.92 -27.78 18.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.775 -0.648 . . . . 10.0 110.433 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . 0.493 ' HB2' ' O ' ' B' ' 17' ' ' SER . 2.4 tp10 -70.06 -42.51 72.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.124 -0.489 . . . . 10.0 110.33 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 30.9 mtmt -78.36 -1.68 34.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 10.0 110.755 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 66.6 mmtt 55.73 38.84 30.61 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.745 -0.662 . . . . 10.0 110.847 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.564 ' O ' ' HE2' ' C' ' 5' ' ' LYS . 25.1 mt-10 -90.55 24.31 2.69 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.27 -0.423 . . . . 10.0 111.497 -178.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 17.6 tt -155.31 161.16 2.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.401 -0.363 . . . . 10.0 110.128 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.62 160.42 32.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.471 -0.332 . . . . 10.0 110.524 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -57.89 -46.25 85.2 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 111.738 0.273 . . . . 10.0 111.738 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -56.52 -42.08 77.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.846 0.355 . . . . 10.0 110.301 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.67 -42.67 61.9 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.021 -0.609 . . . . 10.0 111.912 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.85 -36.66 77.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.93 0.395 . . . . 10.0 110.526 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -71.82 -43.01 66.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.791 -0.64 . . . . 10.0 110.139 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 38.5 m -63.12 -38.64 91.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.69 -0.687 . . . . 10.0 110.282 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 92.7 mt -72.79 -39.27 66.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.255 -0.43 . . . . 10.0 110.316 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -61.33 -46.19 91.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.125 -0.489 . . . . 10.0 111.242 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 13.1 p -71.18 -34.62 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 116.516 -0.311 . . . . 10.0 110.342 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.12 -38.06 87.25 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.458 -0.571 . . . . 10.0 109.458 178.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' MET . . . . . . . . . . . . . 18.0 ttm -57.43 -44.46 84.69 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.688 -0.687 . . . . 10.0 110.01 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -60.88 -45.8 93.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.676 -0.693 . . . . 10.0 110.58 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 76.0 m -62.85 -40.99 99.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.0 -0.546 . . . . 10.0 110.384 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' ILE . . . . . 0.417 HD13 HG22 ' B' ' 12' ' ' ILE . 89.3 mt -65.32 -47.01 88.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.033 -0.53 . . . . 10.0 111.001 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.637 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 48.9 m -59.07 -42.3 90.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.86 0.362 . . . . 10.0 111.064 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -72.48 -39.46 67.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.247 -0.433 . . . . 10.0 111.232 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.59 -43.14 93.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.32 -0.4 . . . . 10.0 111.997 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' PHE . . . . . 0.445 ' CE1' ' HB2' ' B' ' 5' ' ' LYS . 58.0 m-85 -87.08 -4.28 59.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.679 -0.237 . . . . 10.0 111.377 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 62.46 52.22 50.66 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.238 -0.506 . . . . 10.0 113.023 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.637 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 4.7 p90 -146.58 164.46 32.55 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.241 -0.281 . . . . 10.0 110.241 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.99 148.87 21.86 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.436 -0.347 . . . . 10.0 110.496 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.424 ' H ' ' HG3' ' B' ' 48' ' ' ARG . 6.6 mtm180 -65.83 -32.92 74.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.317 0.579 . . . . 10.0 110.611 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -78.75 4.2 14.48 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.416 -0.811 . . . . 10.0 112.269 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.41 3.1 29.42 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.771 0.319 . . . . 10.0 110.386 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.44 HG23 ' H ' ' B' ' 52' ' ' SER . 0.8 OUTLIER -44.97 -64.01 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 115.54 -0.754 . . . . 10.0 112.804 -179.142 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' SER . . . . . 0.44 ' H ' HG23 ' B' ' 51' ' ' VAL . 0.2 OUTLIER -53.49 -30.01 39.05 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.688 0.625 . . . . 10.0 112.688 -179.901 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.14 -44.61 22.62 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.562 -0.828 . . . . 10.0 112.793 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 48.4 mt -82.58 -46.33 19.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 112.233 0.457 . . . . 10.0 112.233 -178.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 67.3 mt -73.16 -57.31 4.11 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.837 0.351 . . . . 10.0 111.071 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.72 -143.31 45.14 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.591 -0.814 . . . . 10.0 111.468 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 48.7 tttt -109.83 14.03 23.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.187 0.518 . . . . 10.0 110.213 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 5.1 m -79.34 138.54 37.74 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.842 -0.617 . . . . 10.0 110.408 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.323 -0.563 0 CA-C-O 121.049 0.452 . . . . 10.0 110.574 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.256 0 CA-C-O 120.835 0.35 . . . . 10.0 110.652 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 4' ' ' SER . . . . . . . . . . . . . 21.6 p -108.99 167.96 9.71 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.265 -0.425 . . . . 10.0 110.047 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 5' ' ' LYS . . . . . 0.564 ' HE2' ' O ' ' B' ' 24' ' ' GLU . 6.6 ptpp? -55.27 -42.28 73.33 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.445 0.535 . . . . 10.0 112.445 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 6' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -62.64 -38.79 91.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.497 -0.319 . . . . 10.0 111.788 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -76.22 -40.64 51.62 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.619 0.247 . . . . 10.0 110.866 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 8' ' ' ILE . . . . . 0.404 HG13 ' CE1' ' B' ' 15' ' ' TYR . 17.0 mm -60.93 -46.34 96.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.33 -0.395 . . . . 10.0 110.361 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.18 -41.67 97.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.108 -0.496 . . . . 10.0 110.072 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.84 -44.61 95.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.633 -0.712 . . . . 10.0 110.811 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.35 -37.95 89.24 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.041 -0.527 . . . . 10.0 110.934 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 12' ' ' ILE . . . . . . . . . . . . . 1.3 mp -68.23 -47.73 76.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.179 -0.464 . . . . 10.0 111.606 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 35.9 m -65.91 -25.16 35.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-O 121.136 0.493 . . . . 10.0 110.175 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.91 -41.91 50.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.925 -0.579 . . . . 10.0 109.778 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 15' ' ' TYR . . . . . 0.512 ' O ' HG12 ' C' ' 19' ' ' ILE . 0.5 OUTLIER -72.59 -37.44 68.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.567 -179.637 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -59.77 -47.84 84.06 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.373 -0.376 . . . . 10.0 110.787 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 17' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' C' ' 21' ' ' GLU . 2.6 p -61.48 -42.42 98.75 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.645 -0.252 . . . . 10.0 110.945 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 2.0 p -68.22 -25.51 65.24 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 111.865 0.32 . . . . 10.0 111.865 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 19' ' ' ILE . . . . . 0.512 HG12 ' O ' ' C' ' 15' ' ' TYR . 20.8 mm -78.65 -42.99 25.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 121.057 0.456 . . . . 10.0 110.448 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 20' ' ' VAL . . . . . . . . . . . . . 16.1 m -77.11 -23.69 14.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.869 0.366 . . . . 10.0 110.267 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' C' ' 17' ' ' SER . 5.0 tp10 -63.51 -51.2 66.53 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.341 -0.614 . . . . 10.0 109.341 178.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -77.01 -5.24 47.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.04 -0.982 . . . . 10.0 111.483 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm 58.03 42.93 21.82 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.317 0.579 . . . . 10.0 109.708 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . 0.44 ' O ' ' HE2' ' B' ' 5' ' ' LYS . 9.0 mt-10 -81.48 3.14 25.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.547 -0.751 . . . . 10.0 110.922 -178.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 18.2 tt -141.88 152.33 18.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 109.415 -0.587 . . . . 10.0 109.415 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.33 161.41 5.61 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 123.426 0.454 . . . . 10.0 111.844 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -54.27 -42.51 70.06 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.376 -0.374 . . . . 10.0 111.113 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.37 -49.9 71.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.774 -0.648 . . . . 10.0 110.493 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 29' ' ' GLY . . . . . 0.656 ' O ' ' HG ' ' C' ' 33' ' ' LEU . . . -68.64 -44.29 72.03 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.696 -0.684 . . . . 10.0 111.979 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.54 -45.67 81.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.87 0.367 . . . . 10.0 111.163 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 31' ' ' ASP . . . . . 0.537 ' CG ' ' HZ3' ' A' ' 79' ' ' LYS . 4.5 t70 -62.92 -44.81 95.08 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.969 -0.559 . . . . 10.0 110.076 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 53.5 m -60.59 -40.41 91.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.634 -0.712 . . . . 10.0 110.944 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 33' ' ' LEU . . . . . 0.656 ' HG ' ' O ' ' C' ' 29' ' ' GLY . 34.9 mt -67.16 -36.66 82.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.636 -0.256 . . . . 10.0 110.538 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -58.74 -57.76 11.59 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.083 -0.508 . . . . 10.0 111.013 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 35' ' ' VAL . . . . . . . . . . . . . 3.0 p -65.39 -38.53 82.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.394 -0.366 . . . . 10.0 111.194 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.48 -32.49 70.31 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.636 0.255 . . . . 10.0 110.918 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 49.1 mtm -60.92 -44.04 97.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.244 -0.435 . . . . 10.0 110.702 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 38' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -69.68 -30.96 68.74 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 109.819 -0.438 . . . . 10.0 109.819 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 39' ' ' CYS . . . . . 0.744 ' SG ' ' HA2' ' A' ' 123' ' ' GLY . 32.0 m -63.18 -48.22 79.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.28 0.562 . . . . 10.0 109.642 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 40' ' ' ILE . . . . . . . . . . . . . 66.4 mt -66.76 -45.68 87.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.21 -0.905 . . . . 10.0 110.776 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 41' ' ' SER . . . . . 0.513 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 27.9 m -62.31 -42.12 99.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.83 -0.623 . . . . 10.0 111.7 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -68.04 -39.99 82.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.869 0.366 . . . . 10.0 110.47 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.88 -49.21 78.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.777 -0.647 . . . . 10.0 111.967 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 44' ' ' PHE . . . . . 0.497 ' CE1' ' HB2' ' C' ' 5' ' ' LYS . 86.4 m-85 -88.17 -3.2 58.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.791 0.329 . . . . 10.0 111.477 -179.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.75 64.31 4.42 Favored Glycine 0 C--N 1.331 0.253 0 CA-C-N 116.116 -0.493 . . . . 10.0 113.781 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 46' ' ' PHE . . . . . 0.513 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 13.8 p90 -153.29 157.57 40.32 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.18 -0.304 . . . . 10.0 110.18 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 19.3 mp0 -83.98 137.92 33.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.4 -0.364 . . . . 10.0 110.614 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 48' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -65.78 -36.24 82.96 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.503 0.668 . . . . 10.0 110.229 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -79.95 15.0 1.57 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.114 -0.948 . . . . 10.0 111.782 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -104.15 1.05 30.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.968 0.413 . . . . 10.0 110.596 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 4.1 m -45.72 -42.06 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 113.053 0.76 . . . . 10.0 113.053 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 52' ' ' SER . . . . . . . . . . . . . 1.5 m -58.16 -28.53 64.81 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.325 0.491 . . . . 10.0 112.325 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.41 -28.25 27.95 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.66 -0.781 . . . . 10.0 112.408 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 54' ' ' ILE . . . . . . . . . . . . . 35.3 mt -85.21 -62.13 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.726 0.298 . . . . 10.0 110.913 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 47.5 mt -63.2 -44.31 95.71 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.777 -0.647 . . . . 10.0 110.854 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.34 -132.71 52.09 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.942 -0.647 . . . . 10.0 112.752 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 22.1 tttt -116.96 11.41 14.32 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.931 0.396 . . . . 10.0 110.237 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 2.0 m -78.19 136.81 37.89 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.798 -0.637 . . . . 10.0 110.984 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 59' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' C' ' 59' ' ' GLU . 1.1 pm0 . . . . . 0 N--CA 1.449 -0.51 0 CA-C-O 121.049 0.452 . . . . 10.0 109.879 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.9 t . . . . . 0 N--CA 1.45 -0.462 0 N-CA-C 109.609 -0.515 . . . . 10.0 109.609 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -87.41 125.31 34.19 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.836 0.35 . . . . 10.0 110.181 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 mp -120.94 122.29 39.86 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.679 -0.489 . . . . 10.0 109.679 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.7 m -101.01 113.93 27.39 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 110.089 -0.337 . . . . 10.0 110.089 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 87' ' ' SER . 2.8 mm? -88.41 117.73 27.54 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.183 -0.303 . . . . 10.0 110.183 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.402 ' HZ1' ' CG ' ' C' ' 31' ' ' ASP . 13.0 ttpt -114.63 99.19 7.35 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.923 -0.58 . . . . 10.0 109.714 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 85' ' ' LYS . 19.4 tptm -88.39 113.67 24.22 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.827 -0.624 . . . . 10.0 109.963 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 96.0 mt -81.46 -54.73 9.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.65 -0.704 . . . . 10.0 111.215 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -66.67 162.98 19.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.15 -0.477 . . . . 10.0 111.722 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.91 139.09 40.0 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.123 -0.49 . . . . 10.0 111.437 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -75.37 132.11 26.48 Favored 'Cis proline' 0 C--O 1.236 0.382 0 C-N-CA 123.047 -1.647 . . . . 10.0 110.378 -1.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -91.7 159.05 16.04 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.823 0.344 . . . . 10.0 111.458 -178.413 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -176.27 169.42 2.74 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.71 -0.677 . . . . 10.0 109.985 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 70.0 m -146.81 110.25 4.85 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.15 0.5 . . . . 10.0 110.184 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 33.8 pt -122.54 147.63 26.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.862 -0.608 . . . . 10.0 110.915 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -119.23 122.53 42.16 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.969 -0.56 . . . . 10.0 110.044 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -142.52 164.86 28.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.567 -0.288 . . . . 10.0 110.399 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.98 136.31 51.48 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.091 0.472 . . . . 10.0 110.565 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -126.81 170.2 12.43 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.741 -0.663 . . . . 10.0 109.684 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.568 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 5.3 m -92.31 148.27 36.2 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 109.862 -0.422 . . . . 10.0 109.862 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -51.8 -31.01 40.36 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.738 2.292 . . . . 10.0 112.683 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.75 10.84 19.45 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 112.295 0.48 . . . . 10.0 112.295 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.568 ' HB2' ' O ' ' A' ' 93' ' ' SER . 0.5 OUTLIER -81.03 152.72 27.78 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.746 -0.464 . . . . 10.0 109.746 179.111 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.17 154.39 21.26 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.156 -0.474 . . . . 10.0 110.068 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 39.3 mm -63.28 -21.87 29.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.53 0.681 . . . . 10.0 109.364 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.27 -44.04 75.24 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 114.756 -1.111 . . . . 10.0 110.474 178.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -62.79 -41.93 99.48 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.7 -0.682 . . . . 10.0 110.733 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.507 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 49.3 mt -60.64 -48.59 88.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.673 -0.694 . . . . 10.0 109.932 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -54.06 -43.79 70.56 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.219 -0.9 . . . . 10.0 111.609 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -62.78 -35.56 80.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.011 0.434 . . . . 10.0 110.589 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.565 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 36.1 t60 -66.08 -37.78 86.64 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.088 -0.505 . . . . 10.0 110.627 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 101' ' ' ILE . 11.3 mt -63.9 -40.12 95.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.208 0.528 . . . . 10.0 110.179 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 32.8 mt -69.97 -38.04 74.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.911 -0.586 . . . . 10.0 109.558 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 32.4 t -66.72 -22.28 66.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.396 -0.82 . . . . 10.0 111.076 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.565 ' HG2' ' O ' ' A' ' 104' ' ' HIS . 19.9 mm-40 -94.08 11.65 29.14 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 121.071 -0.252 . . . . 10.0 110.399 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 58.58 30.09 19.35 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.014 -0.539 . . . . 10.0 111.235 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.5 mmpp? -106.57 -5.67 18.58 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.127 -0.488 . . . . 10.0 110.513 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.419 ' HB3' HD12 ' A' ' 148' ' ' ILE . . . -135.54 154.44 51.38 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.711 -0.677 . . . . 10.0 109.946 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.7 m -107.81 -30.39 8.55 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.914 -0.315 . . . . 10.0 111.624 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.414 ' O ' HG13 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -152.75 136.83 16.41 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.22 -0.289 . . . . 10.0 110.22 -178.694 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.464 HG21 ' N ' ' A' ' 115' ' ' SER . 15.8 tt -65.77 -36.24 77.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.567 0.699 . . . . 10.0 109.983 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.528 ' HB2' ' OE2' ' A' ' 116' ' ' GLU . 0.7 OUTLIER -50.23 -34.98 24.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.278 -1.328 . . . . 10.0 113.232 179.398 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.528 ' OE2' ' HB2' ' A' ' 115' ' ' SER . 1.0 OUTLIER -99.08 12.01 37.34 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.402 0.519 . . . . 10.0 112.402 -178.707 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 113' ' ' HIS . 57.0 mt -93.71 121.07 44.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.64 -0.424 . . . . 10.0 110.5 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.452 ' HZ3' ' CG ' ' B' ' 31' ' ' ASP . 18.1 mmmt -121.79 114.4 21.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.297 -0.41 . . . . 10.0 110.464 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -91.4 128.23 37.15 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.976 0.417 . . . . 10.0 111.241 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 125' ' ' VAL . 2.8 mm? -116.01 137.43 52.12 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.982 -0.748 . . . . 10.0 108.982 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 16.5 tp -121.06 95.68 4.79 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.26 -1.015 . . . . 10.0 108.26 178.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.404 ' HD2' ' HA ' ' A' ' 122' ' ' LYS . 4.1 tptp 42.36 60.32 2.38 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.11 -0.95 . . . . 10.0 110.584 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.588 ' HA2' ' SG ' ' C' ' 39' ' ' CYS . . . 86.69 -46.05 3.52 Favored Glycine 0 C--N 1.331 0.299 0 CA-C-N 115.792 -0.64 . . . . 10.0 113.238 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.9 tttp -60.46 121.23 11.58 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 120.631 0.253 . . . . 10.0 110.554 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 120' ' ' LEU . 12.8 p -79.59 136.49 23.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.097 0.475 . . . . 10.0 111.458 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.2 mp -106.03 157.31 17.61 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.041 -0.527 . . . . 10.0 111.202 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -116.98 158.5 24.0 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 116.315 -0.402 . . . . 10.0 110.433 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.64 -48.25 82.39 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.491 -0.777 . . . . 10.0 112.143 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -82.97 5.52 21.76 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.93 -0.577 . . . . 10.0 111.162 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.0 tp -73.84 139.58 45.17 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.114 0.483 . . . . 10.0 111.447 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -102.82 148.8 25.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.382 -0.826 . . . . 10.0 109.641 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 60.4 mt -56.51 -39.11 72.75 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.991 0.367 . . . . 10.0 111.991 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.8 p -75.58 -19.19 59.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.821 0.343 . . . . 10.0 111.076 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -81.28 -42.5 20.55 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.253 -0.43 . . . . 10.0 111.255 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.2 pp -82.62 -22.51 34.71 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 121.084 -0.246 . . . . 10.0 110.876 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt 67.58 88.46 0.11 Allowed 'General case' 0 N--CA 1.463 0.218 0 O-C-N 123.723 0.639 . . . . 10.0 110.755 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 30.8 t -63.72 105.85 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.613 -0.721 . . . . 10.0 110.644 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.79 117.43 35.22 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.895 -0.593 . . . . 10.0 111.403 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -67.85 -11.75 33.11 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.822 2.348 . . . . 10.0 112.718 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -88.69 6.44 38.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.507 0.67 . . . . 10.0 110.014 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -134.97 -66.35 0.59 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.193 -0.912 . . . . 10.0 109.295 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.1 m 52.71 22.92 2.45 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.205 -0.907 . . . . 10.0 112.2 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 36.4 m -123.69 125.72 45.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.05 0.452 . . . . 10.0 110.188 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.27 117.59 55.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 108.292 -1.003 . . . . 10.0 108.292 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.37 126.6 31.38 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.318 -0.623 . . . . 10.0 109.318 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.2 t -99.7 130.75 48.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.89 -0.595 . . . . 10.0 112.095 -177.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' MET . . . . . 0.511 ' HE1' ' SG ' ' B' ' 39' ' ' CYS . 1.6 mpt? -122.64 117.71 26.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.089 -0.96 . . . . 10.0 109.257 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.419 HD12 ' HB3' ' A' ' 111' ' ' ALA . 21.1 mt -138.3 143.73 32.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.503 -0.317 . . . . 10.0 111.175 -177.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.505 ' HZ3' ' CG ' ' B' ' 38' ' ' ASP . 28.6 mmmt -112.2 117.98 46.72 Favored Pre-proline 0 N--CA 1.452 -0.371 0 CA-C-N 116.339 -0.391 . . . . 10.0 110.093 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo . . . . . 0 C--O 1.236 0.39 0 C-N-CA 122.535 2.157 . . . . 10.0 112.653 179.771 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 48.9 p . . . . . 0 N--CA 1.448 -0.565 0 CA-C-O 120.919 0.39 . . . . 10.0 111.008 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -59.38 -44.07 92.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.977 -0.556 . . . . 10.0 111.106 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -61.21 -47.89 84.02 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.317 -0.401 . . . . 10.0 111.133 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -57.29 -41.16 79.25 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.34 -0.391 . . . . 10.0 110.694 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.701 ' O ' HG13 ' B' ' 12' ' ' ILE . 26.0 mm -61.49 -48.43 88.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.787 -0.449 . . . . 10.0 109.787 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . 0.409 ' HA ' HD11 ' B' ' 12' ' ' ILE . . . -57.22 -43.37 82.76 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.965 -0.561 . . . . 10.0 111.264 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.8 -34.44 77.91 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.025 -0.534 . . . . 10.0 110.614 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 26.0 mt -71.78 -34.11 69.16 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.164 -0.471 . . . . 10.0 110.282 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.701 HG13 ' O ' ' B' ' 8' ' ' ILE . 21.4 mt -63.5 -52.48 57.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.229 -0.441 . . . . 10.0 110.571 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.41 HG12 ' HG3' ' B' ' 37' ' ' MET . 34.4 m -63.26 -30.51 49.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 116.358 -0.383 . . . . 10.0 111.06 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -68.85 -50.46 49.69 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.969 0.414 . . . . 10.0 110.793 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' TYR . . . . . 0.487 ' O ' HG12 ' B' ' 19' ' ' ILE . 1.7 m-85 -70.66 -36.22 73.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.885 -0.598 . . . . 10.0 111.669 -178.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -61.22 -54.63 41.77 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 121.191 -0.204 . . . . 10.0 111.547 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 12.4 p -60.37 -40.07 89.46 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.712 0.264 . . . . 10.0 111.712 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 4.8 p -70.69 -23.53 62.49 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 111.846 0.313 . . . . 10.0 111.846 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.487 HG12 ' O ' ' B' ' 15' ' ' TYR . 10.8 mm -79.95 -41.57 21.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 120.955 0.407 . . . . 10.0 109.934 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 10.6 m -77.77 -29.01 15.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.842 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . 0.452 ' HA ' ' OE1' ' B' ' 21' ' ' GLU . 3.8 tp10 -70.03 -43.88 70.39 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.616 -0.513 . . . . 10.0 109.616 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -71.32 -8.83 56.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.125 -0.488 . . . . 10.0 110.389 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm 60.36 46.35 10.1 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.692 -0.685 . . . . 10.0 110.131 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.465 ' O ' ' HE2' ' C' ' 5' ' ' LYS . 43.1 mt-10 -96.6 13.32 28.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.139 -0.937 . . . . 10.0 110.471 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 15.0 tt -148.64 154.44 10.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.659 -0.701 . . . . 10.0 109.759 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 1.8 p -67.86 162.73 23.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.485 -0.325 . . . . 10.0 110.926 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 41.5 mp0 -56.09 -46.79 78.92 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.422 -0.354 . . . . 10.0 111.945 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -57.54 -41.22 80.53 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.19 0.519 . . . . 10.0 110.255 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . 0.458 ' O ' ' HG ' ' B' ' 33' ' ' LEU . . . -71.29 -42.43 57.29 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.707 -0.678 . . . . 10.0 111.585 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.25 -44.76 95.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.754 -0.223 . . . . 10.0 111.239 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.452 ' CG ' ' HZ3' ' A' ' 118' ' ' LYS . 6.4 t0 -69.08 -33.26 73.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.833 0.349 . . . . 10.0 110.59 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 69.4 m -65.03 -42.04 94.69 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.593 -0.521 . . . . 10.0 109.593 178.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' B' ' 29' ' ' GLY . 79.1 mt -72.51 -31.18 65.14 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.438 -0.579 . . . . 10.0 109.438 178.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -62.38 -53.6 52.53 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.463 -0.789 . . . . 10.0 110.985 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 12.0 p -73.2 -33.73 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 116.363 -0.38 . . . . 10.0 110.654 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . 0.462 ' O ' HG13 ' B' ' 40' ' ' ILE . . . -62.53 -43.49 98.68 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.213 -0.662 . . . . 10.0 109.213 178.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' MET . . . . . 0.41 ' HG3' HG12 ' B' ' 13' ' ' VAL . 15.3 ttm -56.49 -41.6 76.91 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.089 -0.96 . . . . 10.0 110.316 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . 0.505 ' CG ' ' HZ3' ' A' ' 149' ' ' LYS . 27.3 t70 -62.15 -47.63 83.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.275 -0.875 . . . . 10.0 110.532 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' CYS . . . . . 0.511 ' SG ' ' HE1' ' A' ' 147' ' ' MET . 17.4 m -62.3 -46.89 86.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.937 -0.574 . . . . 10.0 110.82 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' ILE . . . . . 0.462 HG13 ' O ' ' B' ' 36' ' ' ALA . 58.3 mt -60.35 -38.44 77.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.171 -0.468 . . . . 10.0 110.757 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.604 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 0.1 OUTLIER -59.85 -47.37 86.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 10.0 110.99 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -77.69 -23.49 49.54 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.495 -0.321 . . . . 10.0 111.39 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.21 -39.35 92.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.443 -0.344 . . . . 10.0 111.124 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -100.92 2.57 40.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.197 -0.456 . . . . 10.0 111.093 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 62.2 55.67 26.51 Favored Glycine 0 CA--C 1.519 0.289 0 CA-C-N 115.859 -0.61 . . . . 10.0 113.599 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.604 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 6.6 p90 -149.37 160.78 43.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 117.079 0.44 . . . . 10.0 110.541 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.86 150.84 20.28 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.792 -0.448 . . . . 10.0 109.792 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.444 ' H ' ' HG3' ' B' ' 48' ' ' ARG . 1.4 mtm180 -63.8 -28.63 69.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.226 0.536 . . . . 10.0 110.73 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -78.31 7.86 5.85 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.787 -0.642 . . . . 10.0 111.691 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.32 2.89 55.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.013 0.435 . . . . 10.0 110.502 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.472 HG23 ' H ' ' B' ' 52' ' ' SER . 1.5 m -47.29 -64.02 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.248 -0.887 . . . . 10.0 112.792 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' SER . . . . . 0.472 ' H ' HG23 ' B' ' 51' ' ' VAL . 0.8 OUTLIER -56.33 -36.38 68.67 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.675 0.62 . . . . 10.0 112.675 -179.201 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.79 -44.99 60.23 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.818 -0.706 . . . . 10.0 112.906 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 57.8 mt -78.3 -50.44 19.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.856 0.36 . . . . 10.0 111.618 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 41.4 mt -71.18 -51.74 23.13 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.233 -0.44 . . . . 10.0 111.504 -178.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.94 -145.74 50.14 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.582 -0.818 . . . . 10.0 111.292 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 38.7 tttt -97.98 -8.98 26.89 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.005 0.431 . . . . 10.0 110.287 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.54 123.74 18.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.402 -0.817 . . . . 10.0 111.718 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 . . . . . 0 C--N 1.323 -0.564 0 CA-C-N 115.708 -0.678 . . . . 10.0 110.378 179.197 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 120.551 0.215 . . . . 10.0 110.592 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 4' ' ' SER . . . . . 0.533 ' O ' HG12 ' C' ' 8' ' ' ILE . 33.3 p -102.78 166.28 10.57 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.355 -0.384 . . . . 10.0 110.729 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 5' ' ' LYS . . . . . 0.465 ' HE2' ' O ' ' B' ' 24' ' ' GLU . 10.1 ptpp? -59.5 -39.56 84.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.246 -0.433 . . . . 10.0 110.916 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 6' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -60.87 -45.25 95.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 10.0 110.719 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -65.6 -37.36 86.4 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.304 -0.407 . . . . 10.0 110.588 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 8' ' ' ILE . . . . . 0.533 HG12 ' O ' ' C' ' 4' ' ' SER . 38.6 mm -64.85 -45.69 94.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 10.0 110.084 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.89 -45.9 85.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.918 -0.583 . . . . 10.0 110.222 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.33 -37.56 87.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.603 -0.726 . . . . 10.0 111.264 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 2.2 mt -68.33 -44.77 74.62 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.836 0.35 . . . . 10.0 110.977 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 12' ' ' ILE . . . . . . . . . . . . . 1.4 mp -63.03 -45.9 97.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.76 -0.654 . . . . 10.0 111.521 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 28.8 m -66.61 -27.76 41.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-O 120.919 0.39 . . . . 10.0 110.612 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.18 -44.03 54.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.029 -0.532 . . . . 10.0 110.358 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 15' ' ' TYR . . . . . 0.531 ' O ' HG12 ' C' ' 19' ' ' ILE . 1.1 m-85 -68.04 -37.15 81.01 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.482 -0.326 . . . . 10.0 110.298 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 5.9 m-30 -58.31 -51.33 70.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.397 -0.365 . . . . 10.0 110.657 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 1.5 p -62.44 -38.5 89.98 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.865 -0.607 . . . . 10.0 111.542 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 11.7 p -71.11 -21.33 62.23 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.743 0.306 . . . . 10.0 111.419 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 19' ' ' ILE . . . . . 0.531 HG12 ' O ' ' C' ' 15' ' ' TYR . 25.2 mm -85.71 -44.56 17.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 CA-C-O 120.941 0.4 . . . . 10.0 111.143 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 20' ' ' VAL . . . . . . . . . . . . . 35.5 m -72.66 -32.64 41.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.202 -0.454 . . . . 10.0 111.721 -177.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . 0.473 ' HA ' ' OE1' ' C' ' 21' ' ' GLU . 1.1 tp10 -78.6 -18.81 54.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.864 0.364 . . . . 10.0 111.098 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -95.19 -6.26 42.06 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.718 -0.475 . . . . 10.0 109.718 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm 59.11 50.81 7.66 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.355 -0.839 . . . . 10.0 110.916 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -98.62 4.2 47.99 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.541 -0.754 . . . . 10.0 111.27 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 19.9 tt -143.73 153.66 16.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.936 -0.394 . . . . 10.0 109.936 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.82 162.41 13.61 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.415 -0.357 . . . . 10.0 111.386 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -56.23 -40.74 74.59 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.182 -0.463 . . . . 10.0 111.585 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 28' ' ' ASP . . . . . 0.452 ' CG ' ' HZ3' ' A' ' 85' ' ' LYS . 0.5 OUTLIER -56.38 -48.07 77.61 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.385 0.612 . . . . 10.0 109.96 179.147 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 29' ' ' GLY . . . . . 0.585 ' O ' ' HG ' ' C' ' 33' ' ' LEU . . . -70.33 -38.31 70.85 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.314 -0.857 . . . . 10.0 112.224 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.17 -46.79 79.19 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.52 0.2 . . . . 10.0 111.273 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 31' ' ' ASP . . . . . 0.402 ' CG ' ' HZ1' ' A' ' 79' ' ' LYS . 17.1 t70 -66.7 -39.29 88.02 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.823 -0.436 . . . . 10.0 109.823 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 50.7 m -59.0 -39.17 81.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.7 -0.682 . . . . 10.0 110.218 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 33' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' C' ' 29' ' ' GLY . 52.1 mt -75.68 -27.78 58.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.013 -0.539 . . . . 10.0 110.179 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -71.08 -49.92 39.33 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 116.07 -0.513 . . . . 10.0 110.816 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 35' ' ' VAL . . . . . . . . . . . . . 8.9 p -67.01 -43.32 89.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-N 116.573 -0.285 . . . . 10.0 111.272 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' C' ' 39' ' ' CYS . . . -63.82 -30.99 72.02 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.886 0.374 . . . . 10.0 111.246 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 37' ' ' MET . . . . . 0.423 ' HB2' ' O ' ' C' ' 33' ' ' LEU . 26.7 ttm -59.01 -49.79 76.54 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.091 -0.504 . . . . 10.0 110.545 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 38' ' ' ASP . . . . . 0.542 ' CB ' ' HA3' ' A' ' 123' ' ' GLY . 15.2 m-20 -68.61 -26.15 65.22 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.968 -0.56 . . . . 10.0 110.623 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 39' ' ' CYS . . . . . 0.588 ' SG ' ' HA2' ' A' ' 123' ' ' GLY . 84.9 m -58.49 -46.35 86.84 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.515 0.674 . . . . 10.0 109.534 178.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 40' ' ' ILE . . . . . . . . . . . . . 6.6 mt -73.06 -39.73 57.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.244 -0.889 . . . . 10.0 110.346 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 41' ' ' SER . . . . . 0.528 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 19.7 m -60.45 -44.39 95.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.618 -0.719 . . . . 10.0 111.863 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -71.79 -41.07 68.77 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.896 -0.322 . . . . 10.0 110.772 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.75 -40.22 91.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.328 -0.396 . . . . 10.0 111.679 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 44' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -90.98 -10.73 41.28 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.52 -0.309 . . . . 10.0 111.166 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 66.22 47.85 68.94 Favored Glycine 0 CA--C 1.517 0.188 0 C-N-CA 121.238 -0.506 . . . . 10.0 112.711 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 46' ' ' PHE . . . . . 0.528 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 3.3 p90 -142.62 156.75 45.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.795 0.331 . . . . 10.0 110.6 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -89.01 142.33 27.73 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.085 -0.507 . . . . 10.0 110.133 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 48' ' ' ARG . . . . . 0.456 ' HD3' ' OD1' ' C' ' 38' ' ' ASP . 0.1 OUTLIER -61.41 -33.52 73.84 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.128 0.489 . . . . 10.0 111.202 -179.928 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -76.95 8.58 3.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.726 -0.67 . . . . 10.0 112.169 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.18 1.36 57.26 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.059 0.456 . . . . 10.0 110.684 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 51' ' ' VAL . . . . . 0.414 HG11 ' O ' ' C' ' 48' ' ' ARG . 5.9 m -46.53 -46.46 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 115.282 -0.872 . . . . 10.0 112.902 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.36 -35.12 64.91 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.499 0.555 . . . . 10.0 112.499 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.9 -34.79 23.52 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.547 -0.835 . . . . 10.0 113.248 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 54' ' ' ILE . . . . . . . . . . . . . 56.1 mt -80.84 -59.17 3.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.943 0.401 . . . . 10.0 111.175 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 36.1 mt -67.12 -49.51 64.64 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.246 -0.433 . . . . 10.0 111.078 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.13 -135.3 45.83 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.993 -0.622 . . . . 10.0 112.654 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 8.9 tttt -105.45 -5.67 20.12 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.122 0.487 . . . . 10.0 110.003 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.21 130.26 44.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.667 -0.697 . . . . 10.0 111.408 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 . . . . . 0 N--CA 1.449 -0.516 0 CA-C-O 120.992 0.425 . . . . 10.0 109.946 179.318 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.3 t . . . . . 0 N--CA 1.451 -0.408 0 N-CA-C 110.278 -0.267 . . . . 10.0 110.278 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -93.79 125.31 38.34 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.539 -0.464 . . . . 10.0 110.504 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.6 mp -127.93 139.85 52.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.812 -0.631 . . . . 10.0 110.744 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.2 m -102.43 115.36 30.41 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.136 -0.484 . . . . 10.0 110.146 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.418 ' O ' ' HA ' ' A' ' 87' ' ' SER . 2.2 mm? -85.91 110.45 19.44 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.795 -0.446 . . . . 10.0 109.795 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 51.4 tttt -108.9 102.56 11.56 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.215 -0.448 . . . . 10.0 111.267 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.524 ' HG2' ' O ' ' A' ' 84' ' ' PRO . 17.8 tptm -95.88 106.13 18.23 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.952 0.406 . . . . 10.0 110.097 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 91.9 mt -73.43 -55.94 11.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.512 -0.767 . . . . 10.0 111.548 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -70.19 164.54 24.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.405 -0.361 . . . . 10.0 110.88 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.471 ' HA ' ' C ' ' A' ' 84' ' ' PRO . . . -83.75 143.2 43.27 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 111.678 0.251 . . . . 10.0 111.678 -178.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.524 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 10.8 Cg_exo -69.14 128.37 11.81 Favored 'Cis proline' 0 C--N 1.347 0.495 0 C-N-CA 123.019 -1.659 . . . . 10.0 110.585 -1.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.44 ' N ' ' HA ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -86.77 148.08 25.57 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.418 -0.355 . . . . 10.0 111.204 -178.618 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -170.73 166.0 7.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.074 -0.512 . . . . 10.0 110.065 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 38.6 m -150.39 106.31 3.43 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.585 -0.524 . . . . 10.0 109.585 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 43.9 pt -126.86 158.88 37.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.314 -0.403 . . . . 10.0 111.058 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -121.39 139.82 52.94 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.506 -0.553 . . . . 10.0 109.506 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -149.61 165.01 33.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.883 0.373 . . . . 10.0 111.357 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -110.39 124.64 52.09 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.665 -0.698 . . . . 10.0 109.863 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -118.45 171.04 8.43 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.994 -0.548 . . . . 10.0 110.512 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.566 ' O ' HD11 ' A' ' 132' ' ' LEU . 1.5 m -80.15 144.87 59.39 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.424 -0.353 . . . . 10.0 110.368 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -59.04 -15.11 26.19 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.815 2.343 . . . . 10.0 112.332 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.0 t -119.21 19.98 12.72 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 116.244 -0.435 . . . . 10.0 110.434 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.477 ' HB2' ' O ' ' A' ' 93' ' ' SER . 0.3 OUTLIER -73.15 164.7 26.31 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.149 0.499 . . . . 10.0 111.182 -179.163 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.04 147.76 35.32 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.763 -0.653 . . . . 10.0 110.429 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 38.3 mm -58.83 -24.83 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 121.518 0.675 . . . . 10.0 110.49 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.39 -39.08 60.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.912 -1.04 . . . . 10.0 111.185 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 72.7 mm-40 -66.28 -39.9 89.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 10.0 110.978 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.644 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 18.0 mt -65.01 -51.05 71.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.171 -0.468 . . . . 10.0 109.956 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.462 ' HZ2' ' CG ' ' A' ' 128' ' ' ASP . 9.0 mttm -54.97 -50.46 68.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.496 -0.774 . . . . 10.0 111.759 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -62.49 -32.01 72.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.653 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 15.9 t60 -67.66 -39.17 84.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.048 -0.524 . . . . 10.0 109.999 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 101' ' ' ILE . 28.2 mt -59.71 -39.58 85.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.056 -0.52 . . . . 10.0 110.293 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 16.6 mt -72.91 -34.37 46.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 116.022 -0.536 . . . . 10.0 110.159 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.8 t -64.78 -22.79 67.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.794 -0.639 . . . . 10.0 111.128 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -100.09 7.28 44.76 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.828 -0.434 . . . . 10.0 109.828 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 60.21 31.62 20.56 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.687 -0.688 . . . . 10.0 111.172 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -101.56 -9.22 21.19 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.385 -0.598 . . . . 10.0 109.385 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.13 148.17 52.11 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.105 -0.952 . . . . 10.0 109.96 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.34 -55.74 3.19 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.806 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.562 ' O ' HG13 ' A' ' 117' ' ' ILE . 32.7 m170 -131.39 139.12 49.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.667 -0.242 . . . . 10.0 110.949 -179.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.41 HG21 ' H ' ' A' ' 115' ' ' SER . 4.5 tt -64.87 -44.34 96.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.362 0.601 . . . . 10.0 110.405 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.41 ' H ' HG21 ' A' ' 114' ' ' ILE . 16.3 t -52.31 -33.34 41.92 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.903 -1.044 . . . . 10.0 111.73 178.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -93.27 16.01 14.2 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.32 0.489 . . . . 10.0 112.32 -177.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.562 HG13 ' O ' ' A' ' 113' ' ' HIS . 55.2 mt -106.66 123.52 61.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.346 -0.388 . . . . 10.0 110.188 178.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -120.11 116.59 25.99 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.659 -0.497 . . . . 10.0 109.659 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.504 HD22 ' N ' ' A' ' 119' ' ' LEU . 3.5 mm? -94.34 123.48 37.77 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.739 0.304 . . . . 10.0 110.216 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.42 HD21 ' SD ' ' A' ' 147' ' ' MET . 2.8 mm? -109.21 141.1 41.96 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.193 -0.669 . . . . 10.0 109.193 179.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 24.7 tp -126.1 98.33 5.45 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.145 -1.057 . . . . 10.0 108.145 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 11.1 tptp 46.49 51.62 11.65 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.497 0.665 . . . . 10.0 110.246 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.623 ' HA3' ' CB ' ' C' ' 38' ' ' ASP . . . 89.72 -44.14 3.01 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.231 -0.895 . . . . 10.0 113.384 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.535 ' HZ2' ' CD ' ' C' ' 42' ' ' GLU . 0.4 OUTLIER -59.09 129.77 43.77 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.489 0.185 . . . . 10.0 110.88 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 8.8 p -82.61 139.29 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.136 0.493 . . . . 10.0 112.102 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 4.4 mp -112.46 154.37 25.95 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 115.654 -0.703 . . . . 10.0 111.055 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -117.16 159.48 22.54 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 121.763 -0.586 . . . . 10.0 112.208 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.462 ' CG ' ' HZ2' ' A' ' 102' ' ' LYS . 1.1 m-20 -56.38 -51.69 67.38 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.212 1.005 . . . . 10.0 112.229 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -83.18 6.94 17.6 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.3 -0.863 . . . . 10.0 112.194 -177.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.2 tp -79.77 148.69 31.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.928 0.394 . . . . 10.0 111.308 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -109.62 151.77 26.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.803 -0.635 . . . . 10.0 110.33 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.566 HD11 ' O ' ' A' ' 93' ' ' SER . 79.5 mt -59.09 -37.13 76.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 10.0 111.96 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.72 -17.53 60.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.086 0.47 . . . . 10.0 111.221 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -88.98 -40.06 13.29 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.176 -0.465 . . . . 10.0 110.958 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.0 pp -82.41 -26.44 32.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.612 -0.267 . . . . 10.0 111.301 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 26.2 mtmt 64.7 96.1 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 O-C-N 123.887 0.742 . . . . 10.0 111.131 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.8 t -71.83 121.03 21.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.86 -0.609 . . . . 10.0 110.632 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.76 119.73 65.75 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 10.0 110.723 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -58.72 -34.5 98.99 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.924 2.416 . . . . 10.0 113.531 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -84.41 15.84 3.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.019 0.438 . . . . 10.0 111.47 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -128.26 -74.14 0.58 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.977 -0.556 . . . . 10.0 109.853 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.2 m 58.58 9.89 1.24 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.792 -0.64 . . . . 10.0 112.639 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.8 m -109.24 123.82 49.87 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.321 0.582 . . . . 10.0 111.326 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 14.7 mm -107.61 119.23 56.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.479 -0.782 . . . . 10.0 109.984 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.4 124.53 30.75 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.856 0.36 . . . . 10.0 110.359 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.6 t -99.48 124.63 52.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.935 -0.575 . . . . 10.0 111.282 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' MET . . . . . 0.42 ' SD ' HD21 ' A' ' 120' ' ' LEU . 2.0 mpt? -122.67 121.69 37.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.884 -0.598 . . . . 10.0 110.633 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 22.0 mt -137.74 142.23 36.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.609 -0.269 . . . . 10.0 111.027 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.448 ' HD3' ' HD2' ' A' ' 150' ' ' PRO . 0.4 OUTLIER -125.99 107.86 25.08 Favored Pre-proline 0 N--CA 1.454 -0.274 0 N-CA-C 109.943 -0.391 . . . . 10.0 109.943 178.282 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.448 ' HD2' ' HD3' ' A' ' 149' ' ' LYS . 19.4 Cg_endo . . . . . 0 C--N 1.349 0.554 0 C-N-CA 122.889 2.393 . . . . 10.0 113.067 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.45 -0.432 0 N-CA-C 109.44 -0.578 . . . . 10.0 109.44 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -56.52 -46.56 80.53 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.248 -0.433 . . . . 10.0 111.438 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -56.64 -53.33 58.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.515 . . . . 10.0 112.033 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -57.24 -46.17 83.25 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.252 0.345 . . . . 10.0 110.814 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 17.2 mm -59.22 -45.9 92.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 10.0 110.41 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.64 -43.62 97.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.996 -0.547 . . . . 10.0 111.027 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.25 -36.11 82.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.035 -0.53 . . . . 10.0 110.616 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 17.7 mt -64.95 -36.25 83.79 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.343 0.592 . . . . 10.0 109.566 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.431 HG22 HD13 ' B' ' 40' ' ' ILE . 14.5 mt -61.42 -57.68 11.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.057 -0.974 . . . . 10.0 110.965 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 16.5 m -62.33 -25.98 39.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.989 0.423 . . . . 10.0 110.61 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -69.61 -51.53 34.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.777 -0.647 . . . . 10.0 110.657 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' TYR . . . . . 0.473 ' O ' HG12 ' B' ' 19' ' ' ILE . 2.3 m-85 -72.99 -39.67 65.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 10.0 111.844 -178.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -56.03 -50.85 69.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.67 0.271 . . . . 10.0 110.353 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 4.6 p -59.04 -46.32 88.52 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.654 -0.248 . . . . 10.0 111.338 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 6.7 p -65.06 -20.5 66.51 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.148 0.425 . . . . 10.0 112.148 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.473 HG12 ' O ' ' B' ' 15' ' ' TYR . 29.3 mm -85.05 -43.46 16.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 121.074 0.464 . . . . 10.0 110.349 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 35.2 m -75.97 -29.04 19.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.201 -0.454 . . . . 10.0 110.532 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . 0.522 ' HA ' ' OE1' ' B' ' 21' ' ' GLU . 1.8 tp10 -75.67 -34.79 60.48 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.269 -0.423 . . . . 10.0 110.766 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -81.86 -5.12 57.97 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.825 0.345 . . . . 10.0 110.446 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 34.0 mmtt 59.3 52.65 5.83 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.529 -0.759 . . . . 10.0 111.046 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -108.13 16.34 23.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.807 -0.633 . . . . 10.0 111.802 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -147.19 151.77 13.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 116.199 -0.455 . . . . 10.0 110.14 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 10.5 p -60.82 161.94 7.43 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.277 -0.419 . . . . 10.0 111.435 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -60.0 -49.68 76.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.074 0.464 . . . . 10.0 110.887 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.55 -42.97 93.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.427 -0.806 . . . . 10.0 110.003 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.13 -39.51 92.66 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.767 -0.73 . . . . 10.0 111.975 178.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.0 -44.55 97.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.875 0.369 . . . . 10.0 110.357 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -65.24 -35.59 81.51 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.374 -0.602 . . . . 10.0 109.374 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 47.9 m -60.95 -44.18 97.65 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 115.824 -0.625 . . . . 10.0 109.747 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 69.7 mt -72.11 -36.51 69.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.075 0.464 . . . . 10.0 110.044 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 12.7 t30 -60.02 -48.69 80.65 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.745 -0.662 . . . . 10.0 111.531 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 8.4 p -72.86 -35.61 49.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 120.85 0.357 . . . . 10.0 110.755 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.53 -39.36 93.62 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.534 -0.543 . . . . 10.0 109.534 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' MET . . . . . . . . . . . . . 24.1 ttm -57.79 -45.55 85.88 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.352 -0.84 . . . . 10.0 110.15 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -61.91 -42.13 98.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.562 -0.744 . . . . 10.0 110.801 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 59.3 m -63.43 -40.91 98.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.068 -0.514 . . . . 10.0 110.857 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' ILE . . . . . 0.431 HD13 HG22 ' B' ' 12' ' ' ILE . 55.0 mt -67.3 -40.35 84.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 110.144 -0.317 . . . . 10.0 110.144 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.638 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 9.7 m -63.1 -39.13 93.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.105 0.479 . . . . 10.0 110.081 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -70.86 -45.36 64.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.627 -0.715 . . . . 10.0 110.491 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.56 -48.66 78.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.539 -0.755 . . . . 10.0 112.547 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -83.42 -2.47 55.92 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.902 -0.319 . . . . 10.0 111.496 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 57.69 58.89 12.23 Favored Glycine 0 CA--C 1.518 0.236 0 CA-C-N 116.125 -0.489 . . . . 10.0 113.54 178.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.638 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 9.1 p90 -148.78 170.94 17.1 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.968 -0.382 . . . . 10.0 109.968 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -105.7 146.21 30.08 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.147 -0.316 . . . . 10.0 110.147 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 1.3 mtm180 -71.55 -26.87 62.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.278 0.561 . . . . 10.0 110.507 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -82.92 14.95 2.95 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.655 -0.702 . . . . 10.0 111.306 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -104.51 4.13 32.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.64 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -41.12 -63.52 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 114.011 1.115 . . . . 10.0 114.011 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 1.9 m -53.9 -31.86 51.46 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.578 0.584 . . . . 10.0 112.578 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.33 -41.68 30.15 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.986 -0.626 . . . . 10.0 113.352 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 19.6 mt -83.01 -43.54 18.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.999 0.428 . . . . 10.0 111.45 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 57.1 mt -71.52 -56.71 5.38 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.052 -0.522 . . . . 10.0 111.017 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.97 -150.38 45.9 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.692 -0.766 . . . . 10.0 111.298 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 32.8 tttt -103.8 2.5 32.9 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.357 0.599 . . . . 10.0 109.734 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.69 131.89 47.43 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.102 -0.954 . . . . 10.0 111.747 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.983 -0.553 . . . . 10.0 109.946 179.155 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.313 0 CA-C-O 120.823 0.344 . . . . 10.0 111.551 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 4' ' ' SER . . . . . 0.51 ' O ' HG12 ' C' ' 8' ' ' ILE . 23.0 p -98.3 163.68 12.62 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.339 -0.391 . . . . 10.0 110.213 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -57.76 -35.39 70.69 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 110.521 -0.178 . . . . 10.0 110.521 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 6' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -60.25 -49.67 76.7 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.219 0.533 . . . . 10.0 109.651 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -62.71 -42.32 99.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.365 -0.834 . . . . 10.0 110.817 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 8' ' ' ILE . . . . . 0.51 HG12 ' O ' ' C' ' 4' ' ' SER . 39.4 mm -59.15 -46.1 92.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.99 -0.55 . . . . 10.0 110.171 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.82 -43.66 94.4 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.086 -0.506 . . . . 10.0 110.554 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.91 -40.36 94.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.025 -0.534 . . . . 10.0 111.086 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 22.3 mt -65.15 -40.47 94.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.031 -0.531 . . . . 10.0 109.76 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 12' ' ' ILE . . . . . . . . . . . . . 1.2 mp -63.15 -47.86 90.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.187 -0.915 . . . . 10.0 111.869 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 34.1 m -71.09 -25.49 25.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.669 -0.412 . . . . 10.0 111.448 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -73.27 -40.59 64.46 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.063 0.459 . . . . 10.0 109.987 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 15' ' ' TYR . . . . . 0.533 ' O ' HG12 ' C' ' 19' ' ' ILE . 9.1 m-85 -71.74 -42.85 66.76 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.12 -0.491 . . . . 10.0 110.849 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -54.27 -49.48 69.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.737 0.304 . . . . 10.0 110.508 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 17' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' C' ' 21' ' ' GLU . 2.2 p -61.97 -41.66 98.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.139 -0.482 . . . . 10.0 111.4 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 3.6 p -69.36 -22.51 63.73 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 120.617 -0.433 . . . . 10.0 111.843 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 19' ' ' ILE . . . . . 0.533 HG12 ' O ' ' C' ' 15' ' ' TYR . 37.7 mm -80.83 -41.1 19.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 109.8 -0.444 . . . . 10.0 109.8 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 20' ' ' VAL . . . . . . . . . . . . . 16.8 m -77.85 -18.65 13.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.171 -0.677 . . . . 10.0 109.171 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' C' ' 17' ' ' SER . 4.1 tp10 -73.47 -50.67 20.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.551 -0.749 . . . . 10.0 110.734 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -84.07 1.09 45.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.368 -0.378 . . . . 10.0 111.782 -178.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 34.3 mmtt 55.79 46.83 21.6 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.162 0.506 . . . . 10.0 110.234 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -83.41 1.13 43.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.962 -0.563 . . . . 10.0 111.376 -178.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 16.0 tt -142.96 161.2 17.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.36 -0.607 . . . . 10.0 109.36 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 5.3 p -59.95 156.29 14.9 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.182 0.301 . . . . 10.0 110.607 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -60.76 -23.6 65.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.02 0.438 . . . . 10.0 110.337 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 28' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -68.39 -54.09 19.5 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.066 -0.716 . . . . 10.0 109.066 178.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 29' ' ' GLY . . . . . 0.407 ' O ' ' HG ' ' C' ' 33' ' ' LEU . . . -65.82 -33.05 84.74 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.318 -0.855 . . . . 10.0 110.984 178.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.72 -42.84 94.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.968 0.413 . . . . 10.0 110.441 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -68.02 -38.03 82.11 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.264 -0.643 . . . . 10.0 109.264 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 6.0 m -61.0 -43.48 98.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.407 -0.815 . . . . 10.0 110.046 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 33' ' ' LEU . . . . . 0.426 ' O ' ' HB2' ' C' ' 37' ' ' MET . 87.6 mt -71.05 -25.38 62.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.051 0.453 . . . . 10.0 110.373 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -72.25 -52.97 13.97 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.056 -0.52 . . . . 10.0 111.004 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 35' ' ' VAL . . . . . . . . . . . . . 7.6 p -69.21 -39.6 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 116.421 -0.354 . . . . 10.0 110.49 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . 0.532 ' O ' HD13 ' C' ' 40' ' ' ILE . . . -63.75 -32.25 73.69 Favored 'General case' 0 C--O 1.226 -0.163 0 CA-C-O 120.448 0.166 . . . . 10.0 110.661 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 37' ' ' MET . . . . . 0.426 ' HB2' ' O ' ' C' ' 33' ' ' LEU . 30.6 ttm -53.92 -52.44 60.59 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.178 0.513 . . . . 10.0 110.879 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 38' ' ' ASP . . . . . 0.623 ' CB ' ' HA3' ' A' ' 123' ' ' GLY . 1.7 m-20 -70.73 -26.44 63.39 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 116.176 -0.465 . . . . 10.0 111.124 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 39' ' ' CYS . . . . . 0.503 ' SG ' ' HA2' ' A' ' 123' ' ' GLY . 77.5 m -61.09 -42.24 98.15 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.773 -0.825 . . . . 10.0 108.773 177.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 40' ' ' ILE . . . . . 0.532 HD13 ' O ' ' C' ' 36' ' ' ALA . 1.4 mp -70.99 -40.74 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 115.097 -0.956 . . . . 10.0 109.891 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 41' ' ' SER . . . . . 0.629 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 13.4 m -60.18 -43.9 95.51 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.686 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 42' ' ' GLU . . . . . 0.535 ' CD ' ' HZ2' ' A' ' 124' ' ' LYS . 13.4 tt0 -72.2 -42.07 66.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.187 -0.461 . . . . 10.0 111.448 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.77 -48.46 75.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.286 -0.416 . . . . 10.0 111.626 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 44' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -88.96 -1.17 57.98 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.479 -0.328 . . . . 10.0 111.378 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 59.02 57.92 17.29 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.352 -0.451 . . . . 10.0 113.184 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 46' ' ' PHE . . . . . 0.629 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 4.3 p90 -145.65 156.36 43.6 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.989 0.395 . . . . 10.0 110.172 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 26.1 mp0 -81.84 128.04 33.62 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.488 -0.324 . . . . 10.0 110.302 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.5 -17.13 58.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.55 -0.295 . . . . 10.0 111.667 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -85.15 -2.53 58.13 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 122.321 0.249 . . . . 10.0 111.583 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.8 4.96 30.59 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.763 0.653 . . . . 10.0 112.763 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 3.6 m -42.98 -57.36 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 114.427 1.269 . . . . 10.0 114.427 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 52' ' ' SER . . . . . . . . . . . . . 1.2 m -61.31 -18.92 60.91 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.874 0.694 . . . . 10.0 112.874 -178.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.39 -48.59 4.99 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.809 -0.71 . . . . 10.0 112.953 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 54' ' ' ILE . . . . . . . . . . . . . 64.3 mt -74.66 -45.73 43.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.936 0.398 . . . . 10.0 110.311 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 45.7 mt -71.84 -47.82 50.45 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.178 0.513 . . . . 10.0 109.979 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 56.57 -137.0 48.83 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.373 -0.83 . . . . 10.0 112.371 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -111.6 24.07 13.19 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.954 -0.758 . . . . 10.0 108.954 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 6.8 m -91.7 139.92 30.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.181 -0.918 . . . . 10.0 111.006 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.324 -0.539 0 CA-C-N 116.165 -0.471 . . . . 10.0 109.84 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.6 t . . . . . 0 N--CA 1.457 -0.122 0 CA-C-O 120.594 0.235 . . . . 10.0 110.684 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -86.2 127.46 34.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.58 -0.282 . . . . 10.0 110.381 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.2 mp -127.29 129.76 48.3 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.449 -0.341 . . . . 10.0 110.5 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 20.5 m -101.32 114.18 27.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.866 -0.606 . . . . 10.0 110.402 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' A' ' 87' ' ' SER . 2.0 mm? -90.54 126.1 35.82 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.727 -0.472 . . . . 10.0 109.727 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.6 tttp -130.21 106.78 8.82 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.491 -0.322 . . . . 10.0 110.746 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' ' 82' ' ' GLN . 47.0 tttm -93.71 110.39 22.02 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.959 -0.385 . . . . 10.0 109.959 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.456 HG23 HD11 ' A' ' 81' ' ' ILE . 63.5 mt -74.92 -34.33 32.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 115.381 -0.827 . . . . 10.0 111.312 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.404 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 71.6 mt-30 -83.24 156.13 23.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.344 -0.389 . . . . 10.0 110.418 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.406 ' HA ' ' C ' ' A' ' 84' ' ' PRO . . . -78.54 138.93 58.8 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.458 -0.337 . . . . 10.0 111.421 -178.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.406 ' C ' ' HA ' ' A' ' 83' ' ' ALA . 17.0 Cg_exo -70.29 131.63 20.5 Favored 'Cis proline' 0 C--N 1.347 0.488 0 C-N-CA 123.613 -1.411 . . . . 10.0 112.137 -1.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -83.64 148.2 27.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.275 -0.42 . . . . 10.0 110.813 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -170.07 161.86 8.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.869 0.366 . . . . 10.0 110.915 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 39.8 m -146.8 108.09 4.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.715 -0.675 . . . . 10.0 109.72 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 41.7 pt -129.35 162.33 37.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.534 -0.303 . . . . 10.0 110.532 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -125.54 137.97 53.95 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.882 0.372 . . . . 10.0 110.563 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 46.1 t60 -149.72 151.25 33.34 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.771 -0.649 . . . . 10.0 109.491 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -99.49 132.03 45.1 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.047 0.451 . . . . 10.0 110.135 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -121.25 169.29 10.71 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.041 0.448 . . . . 10.0 111.283 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.501 ' O ' HD11 ' A' ' 132' ' ' LEU . 38.2 t -81.87 144.99 52.72 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.566 -0.743 . . . . 10.0 110.194 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.62 -14.52 31.6 Favored 'Trans proline' 0 CA--C 1.531 0.33 0 C-N-CA 122.55 2.167 . . . . 10.0 111.952 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -114.51 17.44 17.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.122 -0.49 . . . . 10.0 110.486 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 93' ' ' SER . 0.2 OUTLIER -77.04 161.19 28.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.36 -0.382 . . . . 10.0 110.591 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -111.41 151.29 28.68 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.032 -0.531 . . . . 10.0 111.129 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 19.0 mm -59.81 -29.48 43.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 120.973 0.416 . . . . 10.0 110.808 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.28 -35.86 65.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.788 -0.642 . . . . 10.0 110.638 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -62.46 -44.71 95.74 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.606 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.599 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 23.3 mt -65.12 -44.3 95.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.52 -0.548 . . . . 10.0 109.52 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.548 ' HZ2' ' CG ' ' A' ' 128' ' ' ASP . 56.1 mttt -54.46 -50.06 68.6 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.283 -0.871 . . . . 10.0 111.292 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -58.33 -40.34 81.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.941 -0.572 . . . . 10.0 111.233 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -64.07 -36.71 84.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 10.0 110.588 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.599 ' HG ' ' O ' ' A' ' 101' ' ' ILE . 44.4 mt -63.61 -38.66 91.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.969 0.414 . . . . 10.0 110.528 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 22.3 mt -72.95 -43.26 59.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.205 -0.452 . . . . 10.0 110.135 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.5 t -63.39 -21.47 66.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.758 -0.655 . . . . 10.0 111.718 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -95.23 13.27 26.06 Favored 'General case' 0 C--N 1.331 -0.197 0 O-C-N 122.341 -0.224 . . . . 10.0 111.018 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 61.6 27.99 17.32 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 123.462 0.476 . . . . 10.0 111.366 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.74 -22.7 13.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.877 0.37 . . . . 10.0 111.167 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -113.38 150.53 32.53 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.116 -0.493 . . . . 10.0 110.153 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.5 m -106.29 -18.21 14.06 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.352 -0.385 . . . . 10.0 111.579 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.469 ' HB3' ' CD ' ' A' ' 116' ' ' GLU . 0.2 OUTLIER -169.49 136.58 1.7 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.461 -0.57 . . . . 10.0 109.461 -178.5 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.544 HG13 ' HD3' ' A' ' 102' ' ' LYS . 0.8 OUTLIER -66.03 -39.83 85.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 121.191 0.519 . . . . 10.0 111.074 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.418 ' HB2' ' OE1' ' A' ' 116' ' ' GLU . 14.8 m -48.35 -44.13 34.12 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.86 -1.064 . . . . 10.0 113.209 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.469 ' CD ' ' HB3' ' A' ' 113' ' ' HIS . 0.7 OUTLIER -89.69 14.47 11.66 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.263 0.838 . . . . 10.0 113.263 -178.234 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 113' ' ' HIS . 51.5 mt -91.77 121.34 42.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.371 -0.532 . . . . 10.0 110.249 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.461 ' HZ1' ' CG ' ' B' ' 31' ' ' ASP . 9.5 mmmt -123.54 115.06 20.92 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.739 -0.467 . . . . 10.0 109.739 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -94.6 124.88 38.9 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.151 0.501 . . . . 10.0 110.856 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.85 139.51 44.85 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.538 -0.755 . . . . 10.0 109.98 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 31.9 tp -128.65 94.74 3.93 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.133 -1.432 . . . . 10.0 107.133 178.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 48.2 tttp 33.88 65.3 0.3 Allowed 'General case' 0 N--CA 1.464 0.274 0 O-C-N 124.261 0.976 . . . . 10.0 111.495 -177.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.479 ' HA3' ' CB ' ' C' ' 38' ' ' ASP . . . 87.41 -46.0 3.44 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.668 -0.696 . . . . 10.0 113.559 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.417 ' HE2' ' O ' ' A' ' 135' ' ' LEU . 43.1 tttp -63.04 121.23 13.06 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.683 -0.488 . . . . 10.0 109.683 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.0 p -84.11 133.84 28.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.354 0.597 . . . . 10.0 112.075 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.6 mp -100.49 152.34 20.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.647 -0.706 . . . . 10.0 110.083 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.462 ' H ' HD21 ' A' ' 130' ' ' LEU . 56.3 m-70 -120.93 157.44 29.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.621 0.248 . . . . 10.0 110.733 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.548 ' CG ' ' HZ2' ' A' ' 102' ' ' LYS . 1.0 OUTLIER -49.81 -47.32 51.45 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.628 0.973 . . . . 10.0 113.628 -178.902 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -92.29 12.96 20.7 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.412 0.523 . . . . 10.0 112.412 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.462 HD21 ' H ' ' A' ' 127' ' ' HIS . 3.2 tp -75.36 142.35 43.16 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.103 0.478 . . . . 10.0 111.37 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -104.7 149.27 25.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.562 -0.744 . . . . 10.0 109.614 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.501 HD11 ' O ' ' A' ' 93' ' ' SER . 35.2 mt -56.79 -33.07 66.29 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.787 0.292 . . . . 10.0 111.787 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.7 p -77.7 -14.27 59.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.051 0.453 . . . . 10.0 111.101 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -90.58 -40.71 11.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.267 -0.424 . . . . 10.0 110.841 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.417 ' O ' ' HE2' ' A' ' 124' ' ' LYS . 0.7 OUTLIER -83.86 -20.61 32.82 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 121.124 -0.23 . . . . 10.0 110.915 179.701 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 30.2 mtmt 64.41 91.55 0.08 Allowed 'General case' 0 C--O 1.234 0.266 0 O-C-N 123.756 0.66 . . . . 10.0 111.268 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 29.4 t -63.55 109.4 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.93 -0.577 . . . . 10.0 110.073 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.94 122.99 88.8 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.881 -0.6 . . . . 10.0 110.923 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -66.79 -17.9 52.52 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.652 2.234 . . . . 10.0 112.056 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -87.49 2.58 50.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.892 -0.594 . . . . 10.0 110.379 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -121.76 -73.08 0.66 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.572 -0.74 . . . . 10.0 109.593 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.2 m 59.78 8.52 1.37 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.506 -0.77 . . . . 10.0 112.75 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.7 m -122.56 131.47 53.85 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.879 0.371 . . . . 10.0 111.215 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 25.0 mm -112.97 122.61 67.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.772 -0.649 . . . . 10.0 109.923 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.18 121.01 26.51 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.411 -0.588 . . . . 10.0 109.411 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 12.6 t -97.62 127.22 50.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.177 0.513 . . . . 10.0 112.033 -178.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' MET . . . . . 0.546 ' HE1' ' SG ' ' B' ' 39' ' ' CYS . 2.1 mpt? -122.94 116.89 24.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.376 -0.829 . . . . 10.0 109.357 179.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 49.3 mt -138.1 143.13 33.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 110.012 -0.366 . . . . 10.0 110.012 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.402 ' HZ3' ' CG ' ' B' ' 38' ' ' ASP . 25.7 mmmt -97.81 110.07 53.83 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 108.834 -0.802 . . . . 10.0 108.834 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo . . . . . 0 N--CA 1.46 -0.471 0 C-N-CA 122.434 2.089 . . . . 10.0 113.063 -178.786 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.235 0.29 0 N-CA-C 109.429 -0.582 . . . . 10.0 109.429 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -59.94 -46.63 88.77 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.946 0.35 . . . . 10.0 111.946 -178.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -59.56 -46.27 89.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.673 0.273 . . . . 10.0 111.439 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -62.24 -46.62 88.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.34 -0.391 . . . . 10.0 111.167 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.718 ' O ' HG13 ' B' ' 12' ' ' ILE . 32.0 mm -62.94 -45.27 99.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 110.041 -0.355 . . . . 10.0 110.041 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.47 -45.2 73.1 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.388 -0.369 . . . . 10.0 110.752 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.09 -36.29 83.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.864 -0.607 . . . . 10.0 110.55 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.03 -38.02 87.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.275 -0.42 . . . . 10.0 110.653 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.718 HG13 ' O ' ' B' ' 8' ' ' ILE . 13.3 mt -63.35 -55.52 22.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.252 -0.431 . . . . 10.0 111.12 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 35.3 m -64.18 -32.35 57.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.034 -0.53 . . . . 10.0 111.253 -178.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -70.03 -40.91 74.9 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.586 -0.524 . . . . 10.0 109.586 178.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' TYR . . . . . 0.613 ' O ' HG12 ' B' ' 19' ' ' ILE . 21.3 t80 -64.91 -47.8 76.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.988 -0.551 . . . . 10.0 110.08 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 14.7 m-30 -58.04 -44.09 87.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 10.0 111.077 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 70.8 m -57.54 -40.82 79.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 10.0 110.609 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 10.9 m -74.41 -20.89 59.89 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.936 -0.575 . . . . 10.0 111.621 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.613 HG12 ' O ' ' B' ' 15' ' ' TYR . 29.4 mm -79.22 -42.26 23.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.608 0.242 . . . . 10.0 110.555 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 27.0 m -79.15 -21.27 12.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.144 0.497 . . . . 10.0 109.808 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -58.15 -42.61 86.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.172 -0.922 . . . . 10.0 110.67 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 4.4 mttp -109.59 0.56 19.18 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.755 -0.657 . . . . 10.0 109.962 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 33.2 mttt 54.7 52.13 12.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.214 -0.903 . . . . 10.0 110.706 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -82.94 35.16 0.47 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.299 -0.864 . . . . 10.0 110.44 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' ILE . . . . . 0.424 HG12 ' N ' ' B' ' 26' ' ' SER . 12.4 tt -163.68 164.8 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.592 -0.731 . . . . 10.0 109.374 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' SER . . . . . 0.424 ' N ' HG12 ' B' ' 25' ' ' ILE . 0.7 OUTLIER -62.73 160.2 14.77 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.728 0.411 . . . . 10.0 111.957 -179.855 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -55.94 -55.21 35.44 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.045 -0.525 . . . . 10.0 111.681 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.75 -42.64 89.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.006 0.431 . . . . 10.0 110.159 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . 0.517 ' O ' ' HG ' ' B' ' 33' ' ' LEU . . . -61.15 -42.77 99.89 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.698 -0.683 . . . . 10.0 112.26 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.37 -38.76 88.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.024 0.44 . . . . 10.0 110.437 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.461 ' CG ' ' HZ1' ' A' ' 118' ' ' LYS . 23.8 t70 -68.33 -35.84 78.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.707 -0.679 . . . . 10.0 109.875 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 14.6 m -65.85 -38.46 88.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.669 -0.696 . . . . 10.0 110.024 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' B' ' 29' ' ' GLY . 53.9 mt -70.63 -31.81 68.91 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.0 0.429 . . . . 10.0 109.903 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -61.38 -51.76 67.43 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.743 -0.662 . . . . 10.0 110.685 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 12.2 p -70.25 -32.77 51.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.902 -0.59 . . . . 10.0 110.831 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.6 -45.43 86.99 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 109.245 -0.65 . . . . 10.0 109.245 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' MET . . . . . . . . . . . . . 6.0 ttm -59.91 -37.98 80.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.707 -0.679 . . . . 10.0 109.636 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . 0.402 ' CG ' ' HZ3' ' A' ' 149' ' ' LYS . 19.7 t0 -66.78 -51.59 53.96 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.914 -1.039 . . . . 10.0 111.278 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' CYS . . . . . 0.546 ' SG ' ' HE1' ' A' ' 147' ' ' MET . 0.1 OUTLIER -66.66 -33.41 75.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.49 -0.323 . . . . 10.0 111.642 -179.526 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 50.6 mt -66.99 -46.27 85.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 110.133 -0.321 . . . . 10.0 110.133 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.52 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 28.7 m -59.4 -33.3 71.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.204 0.526 . . . . 10.0 109.982 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -74.38 -47.26 35.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.548 -0.751 . . . . 10.0 110.874 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.16 -37.5 85.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.088 -0.505 . . . . 10.0 112.258 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -94.0 -4.03 50.37 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 121.014 -0.274 . . . . 10.0 111.553 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.57 59.99 9.76 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 121.399 -0.429 . . . . 10.0 113.517 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.52 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 7.1 p90 -153.1 165.04 36.87 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.994 -0.372 . . . . 10.0 109.994 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -101.22 135.25 43.0 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.769 0.319 . . . . 10.0 111.382 -179.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.53 -20.45 64.66 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.101 -0.5 . . . . 10.0 111.623 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -83.17 -15.49 50.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.86 0.362 . . . . 10.0 111.303 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.6 3.54 47.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.365 -0.379 . . . . 10.0 111.748 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 2.6 m -47.24 -49.23 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 112.778 0.659 . . . . 10.0 112.778 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -50.61 -34.16 24.98 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 113.367 0.877 . . . . 10.0 113.367 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.63 -27.49 50.89 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.813 -0.708 . . . . 10.0 112.616 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 49.6 mt -87.02 -50.71 13.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.031 0.443 . . . . 10.0 111.976 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 69.1 mt -81.45 -67.4 0.78 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.106 -0.497 . . . . 10.0 112.228 -178.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.23 -129.06 8.81 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.567 -0.825 . . . . 10.0 111.044 -178.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -158.33 23.27 0.24 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.429 0.633 . . . . 10.0 110.012 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.1 32.88 0.89 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.507 -0.769 . . . . 10.0 111.466 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 . . . . . 0 N--CA 1.464 0.239 0 CA-C-N 115.713 -0.676 . . . . 10.0 111.978 179.856 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 110.021 -0.363 . . . . 10.0 110.021 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 4' ' ' SER . . . . . 0.517 ' O ' HG12 ' C' ' 8' ' ' ILE . 0.0 OUTLIER -89.42 137.79 32.02 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.386 -0.37 . . . . 10.0 110.719 -179.491 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 5' ' ' LYS . . . . . 0.431 ' HE3' HD11 ' B' ' 19' ' ' ILE . 49.5 mttp -63.77 -45.24 90.67 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.708 0.289 . . . . 10.0 110.486 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 6' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -54.47 -57.19 12.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.577 -0.738 . . . . 10.0 111.299 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . 0.531 ' HG3' ' O ' ' C' ' 54' ' ' ILE . 1.5 mp0 -61.61 -39.38 91.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.76 -0.654 . . . . 10.0 112.272 -179.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 8' ' ' ILE . . . . . 0.517 HG12 ' O ' ' C' ' 4' ' ' SER . 27.2 mm -66.7 -47.93 81.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.89 0.376 . . . . 10.0 110.247 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.48 -42.05 95.47 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.088 -0.505 . . . . 10.0 110.1 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.68 -40.46 92.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.621 -0.718 . . . . 10.0 110.926 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.5 -33.82 76.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.931 0.396 . . . . 10.0 110.392 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 12' ' ' ILE . . . . . 0.465 HG13 HG12 ' B' ' 12' ' ' ILE . 1.2 mp -70.89 -48.3 57.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.064 -0.516 . . . . 10.0 111.064 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 26.8 m -65.69 -28.03 43.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-O 121.218 0.532 . . . . 10.0 110.05 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -73.25 -39.77 65.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.66 -0.7 . . . . 10.0 109.382 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 15' ' ' TYR . . . . . 0.453 ' O ' HG12 ' C' ' 19' ' ' ILE . 32.7 t80 -68.89 -43.49 75.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 10.0 110.308 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 10.1 m-30 -55.63 -46.88 77.36 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.171 -0.468 . . . . 10.0 110.412 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 19.9 m -60.84 -43.89 97.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.868 -0.605 . . . . 10.0 111.364 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 12.7 m -67.67 -22.67 65.29 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.982 0.364 . . . . 10.0 111.982 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 19' ' ' ILE . . . . . 0.453 HG12 ' O ' ' C' ' 15' ' ' TYR . 29.5 mm -82.62 -39.7 16.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.589 0.233 . . . . 10.0 111.052 -179.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 20' ' ' VAL . . . . . . . . . . . . . 13.6 m -77.5 -23.69 14.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.289 0.566 . . . . 10.0 109.814 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -66.86 -48.08 69.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.122 -0.944 . . . . 10.0 111.018 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 33.7 mttp -91.12 -5.49 55.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.676 -0.238 . . . . 10.0 110.911 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 64.6 mttm 63.72 49.33 2.99 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.82 -0.627 . . . . 10.0 110.825 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -81.94 -5.44 58.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.894 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 12.7 tt -131.62 162.34 39.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.545 -0.539 . . . . 10.0 109.545 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.09 153.62 11.25 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 122.59 0.356 . . . . 10.0 111.156 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -58.4 -40.2 81.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.852 0.358 . . . . 10.0 110.858 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 28' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -67.12 -40.81 86.87 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.183 0.516 . . . . 10.0 109.697 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 29' ' ' GLY . . . . . 0.508 ' O ' ' HG ' ' C' ' 33' ' ' LEU . . . -65.16 -33.18 86.26 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.514 -0.766 . . . . 10.0 111.23 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.32 -39.63 95.08 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.815 -0.439 . . . . 10.0 109.815 178.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -63.17 -35.76 81.38 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.89 -0.596 . . . . 10.0 109.666 178.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 1.2 t -65.66 -43.83 88.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.494 -0.775 . . . . 10.0 109.81 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 33' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' C' ' 29' ' ' GLY . 43.5 mt -66.93 -34.52 77.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.074 0.464 . . . . 10.0 109.765 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -60.89 -50.43 73.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.388 -0.823 . . . . 10.0 110.94 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 35' ' ' VAL . . . . . 0.43 HG11 ' N ' ' C' ' 36' ' ' ALA . 12.2 p -71.86 -36.29 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 116.425 -0.352 . . . . 10.0 111.416 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . 0.43 ' N ' HG11 ' C' ' 35' ' ' VAL . . . -68.13 -33.34 74.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.875 0.369 . . . . 10.0 110.462 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 34.7 ttm -53.83 -59.96 3.94 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.643 -0.708 . . . . 10.0 111.036 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 38' ' ' ASP . . . . . 0.564 ' OD2' ' HD3' ' C' ' 48' ' ' ARG . 3.3 m-20 -67.03 -27.19 67.2 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.243 -0.435 . . . . 10.0 111.139 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 39' ' ' CYS . . . . . . . . . . . . . 1.1 t -65.04 -49.12 71.38 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.047 0.451 . . . . 10.0 110.48 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 40' ' ' ILE . . . . . . . . . . . . . 53.6 mt -66.94 -38.28 81.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.735 -0.666 . . . . 10.0 109.837 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 41' ' ' SER . . . . . 0.715 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 35.5 m -62.21 -47.22 85.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.546 -0.752 . . . . 10.0 110.716 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -65.1 -40.94 95.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.165 -0.471 . . . . 10.0 110.724 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.97 -43.92 91.42 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.519 0.562 . . . . 10.0 112.519 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 44' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -94.82 -2.47 50.8 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.969 0.359 . . . . 10.0 111.969 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.75 53.02 12.65 Favored Glycine 0 CA--C 1.52 0.387 0 N-CA-C 114.4 0.52 . . . . 10.0 114.4 178.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 46' ' ' PHE . . . . . 0.715 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 30.2 p90 -144.67 157.11 44.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 117.165 0.483 . . . . 10.0 110.473 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -83.18 146.15 28.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.528 -0.306 . . . . 10.0 110.298 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 48' ' ' ARG . . . . . 0.564 ' HD3' ' OD2' ' C' ' 38' ' ' ASP . 0.0 OUTLIER -61.91 -28.91 69.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.379 0.609 . . . . 10.0 110.578 179.619 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 49' ' ' GLU . . . . . 0.471 ' C ' ' H ' ' C' ' 51' ' ' VAL . 4.3 mp0 -84.91 18.88 2.28 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.437 -0.801 . . . . 10.0 112.393 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.1 8.26 0.22 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.941 0.896 . . . . 10.0 112.695 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 51' ' ' VAL . . . . . 0.471 ' H ' ' C ' ' C' ' 49' ' ' GLU . 3.5 m -34.67 -38.61 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 N-CA-C 117.708 2.484 . . . . 10.0 117.708 -176.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 52' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.17 -54.03 4.42 Favored 'General case' 0 C--O 1.217 -0.63 0 N-CA-C 118.653 2.834 . . . . 10.0 118.653 -175.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.11 -56.87 9.43 Favored Glycine 0 CA--C 1.494 -1.254 0 C-N-CA 119.869 -1.158 . . . . 10.0 115.799 -171.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 54' ' ' ILE . . . . . 0.531 ' O ' ' HG3' ' C' ' 7' ' ' GLU . 0.5 OUTLIER -82.0 -35.18 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 C-N-CA 119.847 -0.741 . . . . 10.0 110.561 -179.355 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.4 -75.38 0.33 Allowed 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 116.101 1.889 . . . . 10.0 116.101 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.36 -145.71 49.12 Favored Glycine 0 N--CA 1.471 1.014 0 C-N-CA 121.538 -0.363 . . . . 10.0 112.437 -177.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -150.44 22.46 0.82 Allowed 'General case' 0 C--O 1.233 0.186 0 N-CA-C 109.541 -0.541 . . . . 10.0 109.541 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.12 42.36 0.65 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.529 -0.76 . . . . 10.0 112.043 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 . . . . . 0 N--CA 1.467 0.38 0 CA-C-O 121.61 0.719 . . . . 10.0 111.613 -179.868 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 15.4 t . . . . . 0 N--CA 1.454 -0.227 0 N-CA-C 109.811 -0.44 . . . . 10.0 109.811 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -91.87 122.38 34.34 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.835 0.35 . . . . 10.0 110.569 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.1 mp -125.38 121.36 33.65 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.388 -0.369 . . . . 10.0 110.432 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.6 m -93.97 113.17 25.11 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 120.829 0.347 . . . . 10.0 110.202 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.549 ' O ' ' HA ' ' A' ' 87' ' ' SER . 2.6 mm? -84.94 119.33 25.25 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.948 -0.569 . . . . 10.0 109.771 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.526 ' HZ2' ' CG ' ' C' ' 31' ' ' ASP . 72.6 tttt -121.16 100.89 7.31 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.131 0.491 . . . . 10.0 110.921 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -87.13 114.86 24.1 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.579 -0.737 . . . . 10.0 110.757 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 16.0 mt -77.66 -66.41 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 O-C-N 123.915 0.759 . . . . 10.0 111.285 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -60.43 160.8 8.24 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.893 -0.594 . . . . 10.0 111.323 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.43 ' HA ' ' C ' ' A' ' 84' ' ' PRO . . . -86.02 143.13 36.95 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.225 -0.443 . . . . 10.0 111.134 -178.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.43 ' C ' ' HA ' ' A' ' 83' ' ' ALA . 43.7 Cg_endo -71.6 127.54 12.64 Favored 'Cis proline' 0 C--N 1.346 0.423 0 C-N-CA 123.068 -1.638 . . . . 10.0 111.202 -0.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.43 ' N ' ' HA ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -93.34 158.58 15.67 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.175 -0.466 . . . . 10.0 112.001 -178.627 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -178.96 172.4 1.3 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.318 -0.856 . . . . 10.0 109.316 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.549 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 66.4 m -152.95 110.34 3.53 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.899 0.381 . . . . 10.0 110.301 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.8 pt -119.15 158.82 20.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.875 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -114.81 113.9 24.84 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.085 -0.709 . . . . 10.0 109.085 179.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -129.51 147.88 51.36 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.175 0.512 . . . . 10.0 110.415 -178.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.91 130.65 53.82 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.862 -0.608 . . . . 10.0 109.368 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -121.39 171.6 8.65 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.09 0.472 . . . . 10.0 111.425 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.57 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 0.7 OUTLIER -80.02 151.2 72.92 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.732 -0.667 . . . . 10.0 110.977 -179.779 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -65.39 -16.73 55.59 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 122.311 2.007 . . . . 10.0 112.504 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.1 m -110.72 15.52 21.9 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.434 -0.58 . . . . 10.0 109.434 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.57 ' HB2' ' O ' ' A' ' 93' ' ' SER . 0.3 OUTLIER -75.38 161.81 28.93 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.699 -0.682 . . . . 10.0 110.806 -179.759 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.97 157.82 26.04 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.605 -0.725 . . . . 10.0 110.886 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.53 ' O ' ' HG3' ' A' ' 102' ' ' LYS . 41.2 mm -67.25 -22.29 28.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.343 -0.614 . . . . 10.0 109.343 178.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.42 -38.73 71.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.205 -0.907 . . . . 10.0 110.141 178.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -68.24 -40.61 81.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.035 -0.529 . . . . 10.0 110.996 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.522 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 51.7 mt -62.26 -47.26 93.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.796 -0.638 . . . . 10.0 109.588 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.53 ' HG3' ' O ' ' A' ' 98' ' ' ILE . 79.9 mttt -55.46 -44.4 76.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.927 -1.033 . . . . 10.0 111.436 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.484 ' OE1' ' HA ' ' A' ' 103' ' ' GLN . 10.0 mm-40 -62.26 -37.67 86.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.62 -0.264 . . . . 10.0 111.21 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -65.11 -39.77 93.61 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.906 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 101' ' ' ILE . 34.2 mt -63.03 -44.75 95.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.097 -0.501 . . . . 10.0 111.397 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 102' ' ' LYS . 12.6 mt -67.94 -42.21 85.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.121 -0.49 . . . . 10.0 111.404 -178.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 49.8 m -69.84 -9.89 56.44 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.013 0.375 . . . . 10.0 112.013 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -107.72 16.12 23.95 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 121.104 -0.238 . . . . 10.0 110.895 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 58.83 26.35 14.69 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.707 -0.679 . . . . 10.0 111.673 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.6 mmpp? -96.36 -16.48 21.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.369 0.604 . . . . 10.0 110.069 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -137.08 166.52 23.5 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.294 -0.866 . . . . 10.0 110.349 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.6 m -108.18 -49.46 3.19 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.766 0.317 . . . . 10.0 110.94 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.481 ' O ' HG13 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -136.87 139.01 41.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.138 -179.45 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.0 tt -64.07 -39.06 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.513 0.673 . . . . 10.0 109.865 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.0 m -52.39 -27.93 17.67 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.321 -1.309 . . . . 10.0 112.45 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.23 -4.56 38.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.71 0.291 . . . . 10.0 111.417 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 113' ' ' HIS . 59.1 mt -89.75 127.11 42.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.022 0.439 . . . . 10.0 110.945 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.62 128.83 20.99 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.544 -0.91 . . . . 10.0 108.544 177.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -91.24 136.69 32.92 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.387 0.613 . . . . 10.0 111.21 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.414 ' HB3' ' OG1' ' A' ' 145' ' ' THR . 3.7 tp -110.46 126.45 54.35 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.78 -1.1 . . . . 10.0 108.633 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 47.3 tp -113.76 93.04 4.19 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 106.624 -1.621 . . . . 10.0 106.624 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? 38.68 60.98 1.27 Allowed 'General case' 0 CA--C 1.539 0.546 0 O-C-N 123.944 0.778 . . . . 10.0 110.587 -177.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.496 ' HA3' ' CB ' ' C' ' 38' ' ' ASP . . . 87.95 -45.87 3.36 Favored Glycine 0 C--N 1.332 0.349 0 CA-C-N 115.544 -0.753 . . . . 10.0 113.999 -178.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.2 tttp -59.76 118.65 6.4 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 110.189 -0.3 . . . . 10.0 110.189 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.4 p -78.99 137.18 22.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.62 0.724 . . . . 10.0 112.205 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.8 mp -104.34 156.91 17.52 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 114.824 -1.08 . . . . 10.0 110.624 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.544 ' H ' HD21 ' A' ' 130' ' ' LEU . 35.8 m-70 -116.26 164.17 14.9 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.004 0.43 . . . . 10.0 112.005 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.418 ' CG ' ' HZ1' ' A' ' 102' ' ' LYS . 9.4 m-20 -55.15 -56.04 24.43 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 114.071 1.137 . . . . 10.0 114.071 -179.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -91.72 14.7 14.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.864 0.364 . . . . 10.0 111.322 -178.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.544 HD21 ' H ' ' A' ' 127' ' ' HIS . 15.1 tp -68.22 139.84 56.05 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.718 0.294 . . . . 10.0 110.501 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -97.4 145.24 26.36 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.261 -0.427 . . . . 10.0 110.484 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.492 HD11 ' O ' ' A' ' 93' ' ' SER . 10.7 mt -54.03 -38.75 65.5 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.747 0.647 . . . . 10.0 112.747 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.35 -17.14 56.92 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.817 0.303 . . . . 10.0 111.817 -179.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -79.13 -45.8 19.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.833 0.349 . . . . 10.0 110.278 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.7 pp -77.01 -23.7 52.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.875 -0.602 . . . . 10.0 110.81 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.2 mtmt 65.89 90.57 0.09 Allowed 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.618 0.574 . . . . 10.0 111.767 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.5 t -68.2 103.63 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.812 -0.631 . . . . 10.0 109.923 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.39 135.38 86.54 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.975 -0.557 . . . . 10.0 111.007 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -68.8 -22.23 37.14 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.224 1.95 . . . . 10.0 110.973 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -78.53 -3.55 44.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.306 -0.861 . . . . 10.0 110.485 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -122.69 -83.65 0.66 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.934 -0.575 . . . . 10.0 110.093 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.2 m 61.01 3.14 0.63 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.715 -0.675 . . . . 10.0 112.198 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.5 m -102.32 114.54 28.79 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-O 120.96 0.41 . . . . 10.0 110.044 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.408 HG22 HD12 ' A' ' 144' ' ' ILE . 1.4 mm -104.92 109.03 26.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 108.287 -1.005 . . . . 10.0 108.287 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.414 ' OG1' ' HB3' ' A' ' 120' ' ' LEU . 0.0 OUTLIER -79.6 122.03 26.0 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.653 -0.869 . . . . 10.0 108.653 -179.172 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.0 t -91.43 121.83 42.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.414 -0.812 . . . . 10.0 111.431 -177.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 81.5 mmm -115.56 113.96 24.31 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.008 -0.996 . . . . 10.0 109.732 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 11.3 mt -139.35 144.38 29.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.579 -0.737 . . . . 10.0 111.465 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -107.96 120.9 45.57 Favored Pre-proline 0 C--N 1.321 -0.656 0 N-CA-C 108.134 -1.062 . . . . 10.0 108.134 178.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo . . . . . 0 N--CA 1.462 -0.353 0 C-N-CA 122.332 2.022 . . . . 10.0 112.434 -179.109 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 109.985 -0.376 . . . . 10.0 109.985 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 4.4 ptpp? -60.35 -40.88 92.27 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.456 -0.338 . . . . 10.0 111.577 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -58.3 -43.13 87.94 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.858 0.361 . . . . 10.0 110.534 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -66.91 -46.19 75.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.03 -0.532 . . . . 10.0 111.424 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.539 ' O ' HD13 ' B' ' 12' ' ' ILE . 32.5 mm -65.0 -46.09 92.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.747 0.308 . . . . 10.0 110.532 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.76 -43.72 81.05 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.015 0.436 . . . . 10.0 110.622 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.59 -34.82 77.8 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.687 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.57 -35.73 77.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.911 0.386 . . . . 10.0 110.282 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.539 HD13 ' O ' ' B' ' 8' ' ' ILE . 1.6 mp -68.23 -50.55 56.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.775 -0.648 . . . . 10.0 111.138 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 31.4 m -63.92 -32.28 56.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 N-CA-C 109.694 -0.484 . . . . 10.0 109.694 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -64.18 -53.46 48.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.571 -0.741 . . . . 10.0 109.843 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' TYR . . . . . 0.593 ' O ' HG12 ' B' ' 19' ' ' ILE . 39.1 t80 -60.3 -48.16 82.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.766 -0.652 . . . . 10.0 111.217 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 10.1 m-30 -53.95 -47.74 70.97 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.813 0.34 . . . . 10.0 110.526 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 50.7 m -57.5 -36.45 71.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.18 -0.464 . . . . 10.0 111.247 178.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 1.2 m -74.84 -19.29 60.23 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.268 -0.423 . . . . 10.0 111.193 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.593 HG12 ' O ' ' B' ' 15' ' ' TYR . 35.8 mm -81.39 -43.01 20.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.392 -0.367 . . . . 10.0 111.549 -178.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 16.8 m -76.26 -25.89 16.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.232 0.539 . . . . 10.0 109.93 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -62.12 -43.92 97.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.264 -0.88 . . . . 10.0 111.344 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -102.61 4.33 38.24 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.894 -0.323 . . . . 10.0 110.433 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 54.0 mttm 52.07 54.85 10.11 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 115.454 -0.794 . . . . 10.0 110.675 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -88.82 25.54 1.75 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.34 -0.846 . . . . 10.0 110.8 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 15.9 tt -161.7 164.02 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.756 -0.656 . . . . 10.0 109.405 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 2.4 p -64.5 155.64 32.19 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.627 -0.26 . . . . 10.0 111.175 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -59.07 -42.31 90.06 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.927 0.394 . . . . 10.0 110.901 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -59.93 -41.37 91.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.789 -0.641 . . . . 10.0 109.948 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . 0.415 ' O ' ' HG ' ' B' ' 33' ' ' LEU . . . -73.09 -34.7 58.16 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.805 -0.712 . . . . 10.0 111.583 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.37 -42.76 99.23 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-O 120.822 0.344 . . . . 10.0 110.542 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -63.6 -41.14 98.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.233 0.54 . . . . 10.0 109.597 178.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 42.4 m -61.8 -46.38 89.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.243 -0.89 . . . . 10.0 110.923 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' B' ' 29' ' ' GLY . 68.5 mt -68.52 -30.27 69.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.381 -0.372 . . . . 10.0 110.938 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -65.63 -51.93 55.81 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.35 -0.386 . . . . 10.0 111.048 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 14.6 p -67.09 -33.92 66.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.916 -0.584 . . . . 10.0 110.538 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.79 -42.1 91.14 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.647 -0.501 . . . . 10.0 109.647 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' MET . . . . . 0.585 ' SD ' ' HD2' ' B' ' 48' ' ' ARG . 11.0 ttm -56.5 -53.02 62.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.259 -0.882 . . . . 10.0 110.354 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.66 -46.41 88.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 10.0 111.42 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 50.2 t -58.08 -44.68 87.68 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.513 -0.312 . . . . 10.0 111.749 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 87.5 mt -64.66 -39.0 84.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.269 0.557 . . . . 10.0 109.92 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.414 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 24.3 m -64.75 -40.32 95.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.597 -0.729 . . . . 10.0 110.442 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -75.82 -24.78 55.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.468 -0.333 . . . . 10.0 110.847 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.86 -33.38 66.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.052 -0.522 . . . . 10.0 111.09 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -102.36 -3.23 27.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.879 0.371 . . . . 10.0 111.241 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 66.48 59.65 7.03 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 114.466 0.547 . . . . 10.0 114.466 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.414 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 22.0 p90 -154.16 159.83 41.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 117.271 0.536 . . . . 10.0 110.335 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -86.52 144.06 27.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.879 0.371 . . . . 10.0 110.766 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.585 ' HD2' ' SD ' ' B' ' 37' ' ' MET . 3.1 mtm180 -64.88 -25.9 68.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.053 -0.522 . . . . 10.0 110.685 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 55.7 mp0 -85.07 -8.47 58.66 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.15 -0.477 . . . . 10.0 112.118 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.11 2.68 17.16 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 111.937 0.347 . . . . 10.0 111.937 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.442 HG11 ' O ' ' B' ' 48' ' ' ARG . 13.4 m -45.63 -53.16 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 113.06 0.763 . . . . 10.0 113.06 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 1.4 m -49.68 -41.59 43.5 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.321 0.86 . . . . 10.0 113.321 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.77 -29.55 65.15 Favored Glycine 0 C--O 1.23 -0.139 0 C-N-CA 120.686 -0.769 . . . . 10.0 112.456 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 25.5 mt -87.96 -51.0 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 112.902 0.705 . . . . 10.0 112.902 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 26.3 mt -82.29 -69.32 0.63 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.136 0.791 . . . . 10.0 113.136 -177.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.0 -132.91 11.44 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.618 -0.801 . . . . 10.0 111.701 -178.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -156.94 29.94 0.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.394 0.616 . . . . 10.0 109.942 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.03 30.48 1.61 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.39 -0.823 . . . . 10.0 111.361 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 . . . . . 0 C--O 1.235 0.324 0 CA-C-N 115.838 -0.619 . . . . 10.0 110.208 -178.903 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.427 0 N-CA-C 109.57 -0.53 . . . . 10.0 109.57 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 4' ' ' SER . . . . . 0.497 ' HB2' ' OE1' ' C' ' 7' ' ' GLU . 0.8 OUTLIER -96.98 154.2 17.45 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.727 0.298 . . . . 10.0 110.695 -178.016 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 5' ' ' LYS . . . . . 0.452 ' HB3' ' CE1' ' C' ' 44' ' ' PHE . 17.7 mttp -61.78 -40.99 97.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.083 -0.508 . . . . 10.0 111.757 -178.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 6' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -57.9 -57.94 10.56 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.459 0.474 . . . . 10.0 110.374 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . 0.497 ' OE1' ' HB2' ' C' ' 4' ' ' SER . 2.6 mp0 -55.79 -44.91 78.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.684 -0.689 . . . . 10.0 111.772 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 8' ' ' ILE . . . . . 0.641 ' O ' HG13 ' C' ' 12' ' ' ILE . 38.8 mm -62.58 -53.18 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 C-N-CA 121.233 -0.187 . . . . 10.0 110.604 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.99 -45.26 75.0 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.347 -0.388 . . . . 10.0 110.774 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.63 -35.0 79.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.797 -0.638 . . . . 10.0 110.942 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.6 -35.66 80.73 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.216 -0.447 . . . . 10.0 111.06 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 12' ' ' ILE . . . . . 0.641 HG13 ' O ' ' C' ' 8' ' ' ILE . 6.6 mt -69.87 -50.41 49.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.928 0.394 . . . . 10.0 111.265 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 16.4 m -68.11 -27.94 39.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 116.005 -0.543 . . . . 10.0 110.965 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -74.22 -43.06 58.62 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.256 -0.646 . . . . 10.0 109.256 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 15' ' ' TYR . . . . . 0.586 ' O ' HG12 ' C' ' 19' ' ' ILE . 13.1 t80 -64.28 -49.01 73.51 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.521 -0.763 . . . . 10.0 110.882 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 11.9 m-30 -55.75 -43.77 76.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.502 -0.317 . . . . 10.0 111.711 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 66.6 m -59.48 -40.61 87.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.569 -0.287 . . . . 10.0 111.522 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 1.3 m -76.25 -23.13 54.47 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.024 0.379 . . . . 10.0 112.024 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 19' ' ' ILE . . . . . 0.586 HG12 ' O ' ' C' ' 15' ' ' TYR . 29.2 mm -77.13 -38.48 27.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.067 0.461 . . . . 10.0 110.684 -178.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 20' ' ' VAL . . . . . . . . . . . . . 33.4 m -79.74 -20.12 12.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.377 0.608 . . . . 10.0 109.775 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -62.91 -51.63 66.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.973 -1.012 . . . . 10.0 110.838 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -92.7 -2.36 56.1 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.676 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 63.6 mttm 56.03 56.4 5.97 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.704 -0.68 . . . . 10.0 109.911 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -84.96 13.02 6.46 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.177 -0.92 . . . . 10.0 110.529 -179.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 15.9 tt -150.09 163.3 3.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.658 -0.867 . . . . 10.0 108.658 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 13.8 m -66.07 162.76 18.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.662 0.267 . . . . 10.0 110.639 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -60.82 -39.57 89.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.516 -0.311 . . . . 10.0 111.626 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 28' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -59.75 -47.84 84.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.018 0.437 . . . . 10.0 110.256 179.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 29' ' ' GLY . . . . . 0.526 ' O ' ' HG ' ' C' ' 33' ' ' LEU . . . -65.58 -41.36 96.14 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.855 -0.688 . . . . 10.0 111.587 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.5 -42.34 96.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.709 0.29 . . . . 10.0 111.36 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 31' ' ' ASP . . . . . 0.526 ' CG ' ' HZ2' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -63.9 -38.82 92.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.082 0.468 . . . . 10.0 110.319 179.424 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 6.3 m -62.46 -40.15 95.69 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.679 -0.691 . . . . 10.0 110.067 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 33' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' C' ' 29' ' ' GLY . 62.4 mt -72.2 -31.51 65.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.833 -0.621 . . . . 10.0 111.169 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -64.42 -53.77 43.18 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.256 -0.429 . . . . 10.0 111.717 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 35' ' ' VAL . . . . . 0.411 HG23 ' HG ' ' A' ' 120' ' ' LEU . 11.3 p -67.79 -35.06 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-O 120.888 0.375 . . . . 10.0 110.664 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.72 -29.2 66.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.794 0.331 . . . . 10.0 110.529 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 30.5 ttm -58.55 -50.94 71.97 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.006 -0.543 . . . . 10.0 110.514 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 38' ' ' ASP . . . . . 0.496 ' CB ' ' HA3' ' A' ' 123' ' ' GLY . 1.0 OUTLIER -69.71 -28.65 66.0 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 116.43 -0.35 . . . . 10.0 110.62 -179.721 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 39' ' ' CYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 123' ' ' GLY . 7.8 t -61.61 -50.25 73.33 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.423 -0.584 . . . . 10.0 109.423 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 40' ' ' ILE . . . . . . . . . . . . . 79.4 mt -60.57 -46.04 96.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.323 -0.853 . . . . 10.0 109.927 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 41' ' ' SER . . . . . 0.819 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 47.4 m -58.87 -38.18 78.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.55 -0.75 . . . . 10.0 111.366 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -70.71 -44.98 65.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.714 -0.675 . . . . 10.0 110.863 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.41 -37.44 72.74 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.819 0.674 . . . . 10.0 112.819 -178.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 44' ' ' PHE . . . . . 0.452 ' CE1' ' HB3' ' C' ' 5' ' ' LYS . 94.1 m-85 -97.9 2.35 49.08 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.179 -0.326 . . . . 10.0 111.633 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.74 57.93 16.39 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.314 -0.47 . . . . 10.0 113.518 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 46' ' ' PHE . . . . . 0.819 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 10.5 p90 -147.71 175.64 10.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 117.121 0.46 . . . . 10.0 110.404 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -100.97 136.19 41.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.642 -0.253 . . . . 10.0 110.355 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 48' ' ' ARG . . . . . . . . . . . . . 5.1 ptm180 -58.98 -37.47 76.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 10.0 111.293 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.61 18.58 3.86 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.752 1.019 . . . . 10.0 113.752 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.92 1.66 37.08 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.989 0.424 . . . . 10.0 111.421 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 27.2 m -45.22 -35.78 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 114.097 1.147 . . . . 10.0 114.097 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.98 -35.6 71.43 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.316 0.858 . . . . 10.0 113.316 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.55 -20.31 69.19 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 111.087 -0.805 . . . . 10.0 111.087 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 54' ' ' ILE . . . . . . . . . . . . . 50.5 mt -91.69 -65.38 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 114.35 1.241 . . . . 10.0 114.35 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 72.8 mt -78.43 -66.73 0.82 Allowed 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.222 -0.899 . . . . 10.0 112.984 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 75.39 -141.37 27.67 Favored Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 120.156 -1.021 . . . . 10.0 110.849 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 12.6 pttp -136.42 22.35 3.18 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.103 0.477 . . . . 10.0 110.546 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.44 19.09 1.31 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.747 -0.66 . . . . 10.0 111.337 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 . . . . . 0 N--CA 1.464 0.229 0 CA-C-N 115.623 -0.717 . . . . 10.0 111.039 -179.783 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 35.6 mtm . . . . . 0 N--CA 1.481 1.093 0 N-CA-C 109.826 -0.435 . . . . 10.0 109.826 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.2 t -101.54 133.38 45.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.99 -0.374 . . . . 10.0 109.99 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -86.25 120.13 27.28 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.268 -0.424 . . . . 10.0 110.858 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.1 mp -125.72 120.08 29.7 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.881 -0.599 . . . . 10.0 109.844 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 15.6 m -99.54 112.97 25.1 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.968 0.413 . . . . 10.0 109.943 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 87' ' ' SER . 3.0 mm? -84.57 114.65 22.12 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.873 -0.603 . . . . 10.0 109.645 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -117.93 103.83 10.31 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.079 -0.51 . . . . 10.0 110.232 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.495 ' HG2' ' O ' ' A' ' 84' ' ' PRO . 15.9 tptm -92.17 121.8 34.04 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.806 -0.633 . . . . 10.0 109.348 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 75.6 mt -84.97 -57.78 4.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 O-C-N 123.631 0.582 . . . . 10.0 111.543 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -66.15 158.51 28.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.856 -0.611 . . . . 10.0 111.023 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.28 139.71 56.22 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 120.877 0.37 . . . . 10.0 111.188 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.495 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 7.3 Cg_exo -75.17 129.44 18.67 Favored 'Cis proline' 0 C--O 1.235 0.335 0 C-N-CA 123.297 -1.543 . . . . 10.0 110.708 -1.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.437 ' HE3' ' HB2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -92.08 158.99 15.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.191 0.519 . . . . 10.0 110.953 -179.179 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -173.23 167.9 4.77 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.396 -0.82 . . . . 10.0 109.879 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.538 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 46.4 m -146.61 97.66 2.95 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.275 -0.639 . . . . 10.0 109.275 178.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 38.0 pt -110.45 146.01 16.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.804 -0.634 . . . . 10.0 110.657 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -110.98 126.16 54.48 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.062 -0.718 . . . . 10.0 109.062 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 12.0 m80 -142.5 159.42 42.26 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.393 0.616 . . . . 10.0 111.976 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -105.75 126.76 52.54 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.044 -0.98 . . . . 10.0 109.922 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -117.89 167.65 11.22 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.935 -0.575 . . . . 10.0 110.587 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.561 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 1.7 m -89.72 153.73 47.81 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.144 -0.48 . . . . 10.0 110.463 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -60.52 -27.88 85.66 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.342 2.028 . . . . 10.0 112.329 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.6 m -103.97 17.93 23.07 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.002 -0.545 . . . . 10.0 110.678 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.561 ' HB2' ' O ' ' A' ' 93' ' ' SER . 0.3 OUTLIER -73.33 152.1 41.03 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.985 -0.552 . . . . 10.0 110.153 179.565 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.58 147.09 28.01 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.707 -0.679 . . . . 10.0 110.457 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 30.9 mm -62.3 -23.76 32.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.189 0.519 . . . . 10.0 110.511 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.2 -37.94 78.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.61 -0.723 . . . . 10.0 110.509 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -61.77 -40.02 93.69 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.457 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.582 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 45.9 mt -63.15 -47.49 92.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.974 -0.557 . . . . 10.0 109.65 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.569 ' HZ1' ' CG ' ' A' ' 128' ' ' ASP . 75.3 mttt -56.49 -47.36 79.43 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.448 -0.796 . . . . 10.0 110.962 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -61.35 -39.99 92.62 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.963 -0.562 . . . . 10.0 110.598 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 25.1 t60 -62.7 -38.54 90.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.476 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 101' ' ' ILE . 58.1 mt -65.43 -39.62 92.3 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.953 0.406 . . . . 10.0 110.671 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 43.2 mt -69.73 -39.7 78.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.103 0.478 . . . . 10.0 110.313 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.1 m -67.09 -20.33 65.79 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.893 -0.594 . . . . 10.0 111.305 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -98.8 14.6 28.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.633 -0.258 . . . . 10.0 111.242 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 58.11 35.12 24.86 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.121 -0.491 . . . . 10.0 111.166 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 8.6 mmtp -112.99 -13.34 13.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.547 -0.297 . . . . 10.0 111.335 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -135.06 155.81 50.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.394 -0.366 . . . . 10.0 110.762 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.1 m -94.46 -61.35 1.53 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.246 -0.434 . . . . 10.0 111.266 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -137.98 147.8 44.6 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.964 -0.384 . . . . 10.0 109.964 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 48.1 pt -60.43 -32.95 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.378 0.608 . . . . 10.0 110.843 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.4 m -58.59 -28.82 65.93 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.694 -1.139 . . . . 10.0 112.961 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.93 14.57 24.97 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.168 0.433 . . . . 10.0 112.168 -177.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 32.6 mt -115.87 135.44 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 113.288 0.847 . . . . 10.0 113.288 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 52.7 tttt -140.88 129.12 22.27 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 109.198 -0.667 . . . . 10.0 109.198 175.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -96.18 136.1 37.09 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.274 0.559 . . . . 10.0 111.342 -179.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.46 134.67 53.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.263 -0.88 . . . . 10.0 110.029 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.511 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 43.0 tp -127.49 96.63 4.61 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 107.429 -1.322 . . . . 10.0 107.429 177.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 21.7 tptp 36.43 59.39 0.98 Allowed 'General case' 0 N--CA 1.467 0.387 0 O-C-N 124.059 0.849 . . . . 10.0 111.457 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.27 -43.99 3.16 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 121.001 -0.619 . . . . 10.0 112.734 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.511 ' HB3' ' O ' ' A' ' 121' ' ' LEU . 26.9 tptt -59.73 126.87 29.3 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.916 -0.642 . . . . 10.0 109.765 178.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.0 m -94.15 140.72 16.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.688 0.625 . . . . 10.0 112.688 -178.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 7.2 mp -106.69 154.39 21.03 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.746 -0.661 . . . . 10.0 110.462 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -115.26 158.41 22.38 Favored 'General case' 0 C--O 1.226 -0.153 0 CA-C-O 120.677 0.275 . . . . 10.0 110.823 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.569 ' CG ' ' HZ1' ' A' ' 102' ' ' LYS . 1.2 m-20 -51.4 -55.01 20.93 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.827 1.047 . . . . 10.0 113.827 -178.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -94.02 19.35 9.23 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.756 0.312 . . . . 10.0 111.57 -177.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 12.8 tp -78.3 149.58 33.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.91 0.386 . . . . 10.0 111.088 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -108.9 150.28 27.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.768 -0.651 . . . . 10.0 110.031 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.509 HD11 ' O ' ' A' ' 93' ' ' SER . 64.3 mt -59.1 -28.18 66.27 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.211 0.449 . . . . 10.0 112.211 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.14 -12.55 59.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.118 0.485 . . . . 10.0 111.024 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -92.08 -49.86 5.99 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.131 -0.486 . . . . 10.0 110.839 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.3 pp -75.1 -25.93 58.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.017 -0.538 . . . . 10.0 111.274 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt 67.94 99.38 0.05 Allowed 'General case' 0 N--CA 1.465 0.313 0 O-C-N 124.062 0.851 . . . . 10.0 111.578 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.8 t -72.97 107.68 3.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.755 -0.461 . . . . 10.0 109.755 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.2 p -66.62 123.53 86.02 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.315 -0.402 . . . . 10.0 110.964 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -63.95 -24.0 67.66 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.731 2.288 . . . . 10.0 111.66 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -78.26 4.29 13.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.55 -0.75 . . . . 10.0 111.402 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -132.83 -72.61 0.51 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.758 -0.201 . . . . 10.0 110.991 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.0 m 60.33 14.94 5.02 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.321 0.581 . . . . 10.0 111.366 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.7 m -114.02 120.15 39.61 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.948 -0.569 . . . . 10.0 110.316 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 19.3 mm -110.22 119.71 59.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.964 -0.562 . . . . 10.0 109.737 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.6 m -83.19 123.91 30.02 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.345 -0.389 . . . . 10.0 110.32 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 13.4 t -97.52 124.95 50.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.135 -0.484 . . . . 10.0 111.942 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 13.7 mmt -117.94 118.37 31.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.53 -0.759 . . . . 10.0 109.494 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 35.4 mt -136.51 140.84 42.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 111.548 0.203 . . . . 10.0 111.548 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -106.68 120.13 49.31 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 108.264 -1.013 . . . . 10.0 108.264 178.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.87 126.19 12.95 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.39 2.06 . . . . 10.0 113.264 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -95.97 -13.17 24.04 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.731 -0.668 . . . . 10.0 110.197 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 68.8 mt -88.44 125.22 34.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.59 -0.732 . . . . 10.0 109.802 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.288 -0.863 . . . . 10.0 110.81 -179.235 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' -1' ' ' SER . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.477 0.878 0 CA-C-O 120.793 0.33 . . . . 10.0 111.668 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 0' ' ' VAL . . . . . . . . . . . . . 1.1 t -83.08 14.02 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 112.556 0.576 . . . . 10.0 112.556 -177.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -56.4 106.78 0.31 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.054 0.454 . . . . 10.0 111.594 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.16 13.23 31.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.505 -0.77 . . . . 10.0 111.288 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -81.12 126.08 31.02 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.398 -0.365 . . . . 10.0 110.559 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 1.3 m -84.82 142.54 29.69 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.764 -0.458 . . . . 10.0 109.764 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . 0.474 ' H ' ' HG2' ' B' ' 5' ' ' LYS . 1.6 ptpp? -60.14 -43.36 95.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.329 -0.396 . . . . 10.0 111.501 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -59.04 -36.27 74.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.574 0.226 . . . . 10.0 110.972 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -64.66 -50.96 65.0 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.073 0.464 . . . . 10.0 109.88 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.537 ' O ' HD11 ' B' ' 12' ' ' ILE . 44.3 mm -61.51 -46.79 95.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.567 -0.742 . . . . 10.0 110.961 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.36 -47.77 75.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.9 0.381 . . . . 10.0 110.971 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.94 -32.11 73.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.986 -0.552 . . . . 10.0 110.694 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.3 mt -69.48 -38.06 77.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.362 -0.381 . . . . 10.0 110.399 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.537 HD11 ' O ' ' B' ' 8' ' ' ILE . 1.4 mp -63.46 -50.94 76.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.027 -0.533 . . . . 10.0 110.622 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.401 HG23 ' N ' ' B' ' 14' ' ' ASN . 12.3 m -67.83 -33.61 62.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.758 0.314 . . . . 10.0 110.722 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' ASN . . . . . 0.401 ' N ' HG23 ' B' ' 13' ' ' VAL . 65.8 t30 -67.38 -48.37 67.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.282 0.563 . . . . 10.0 110.074 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' TYR . . . . . 0.639 ' O ' HG12 ' B' ' 19' ' ' ILE . 15.9 t80 -60.56 -52.31 65.71 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.456 -0.793 . . . . 10.0 110.931 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -54.75 -46.76 74.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.27 -0.423 . . . . 10.0 111.64 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 27.3 m -59.55 -42.55 92.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.695 0.283 . . . . 10.0 111.279 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 23.6 p -72.44 -19.07 61.64 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 122.205 -0.309 . . . . 10.0 111.271 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.639 HG12 ' O ' ' B' ' 15' ' ' TYR . 31.5 mm -79.86 -39.8 20.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.996 0.427 . . . . 10.0 110.09 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 5.3 m -75.66 -22.79 16.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 121.503 0.668 . . . . 10.0 109.303 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -60.03 -48.99 79.44 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 114.616 -1.175 . . . . 10.0 110.862 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 3.5 mttp -102.08 6.73 41.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.809 -0.632 . . . . 10.0 110.797 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . 0.485 ' HZ1' ' CD ' ' B' ' 27' ' ' GLU . 26.9 mtpt 50.82 56.94 7.22 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.356 0.598 . . . . 10.0 110.589 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -90.6 33.68 0.91 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.425 -0.807 . . . . 10.0 110.973 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' ILE . . . . . 0.444 HG12 ' H ' ' B' ' 26' ' ' SER . 13.3 tt -168.44 168.63 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.218 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' SER . . . . . 0.444 ' H ' HG12 ' B' ' 25' ' ' ILE . 1.9 m -58.21 154.8 12.47 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.926 0.491 . . . . 10.0 112.105 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . 0.485 ' CD ' ' HZ1' ' B' ' 23' ' ' LYS . 52.6 mm-40 -52.12 -58.22 7.25 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.911 0.708 . . . . 10.0 112.911 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -70.56 -23.59 62.63 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.244 0.545 . . . . 10.0 109.68 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . 0.597 ' O ' ' HG ' ' B' ' 33' ' ' LEU . . . -63.96 -44.16 96.39 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 110.233 -1.147 . . . . 10.0 110.233 178.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.59 -40.69 95.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.168 0.509 . . . . 10.0 110.083 178.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -62.56 -43.22 99.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.465 -0.789 . . . . 10.0 110.051 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' SER . . . . . 0.497 ' O ' HG12 ' B' ' 35' ' ' VAL . 50.9 m -62.64 -42.49 99.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.428 -0.806 . . . . 10.0 110.393 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . 0.597 ' HG ' ' O ' ' B' ' 29' ' ' GLY . 82.2 mt -64.1 -38.91 92.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.35 -0.386 . . . . 10.0 110.341 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -65.77 -46.72 77.68 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.207 -0.451 . . . . 10.0 111.481 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.497 HG12 ' O ' ' B' ' 32' ' ' SER . 9.9 p -67.8 -38.33 80.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 116.451 -0.341 . . . . 10.0 111.091 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.55 -39.9 88.76 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.204 -0.665 . . . . 10.0 109.204 178.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' MET . . . . . 0.597 ' SD ' ' HD2' ' B' ' 48' ' ' ARG . 0.7 OUTLIER -59.23 -45.14 91.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.362 -0.836 . . . . 10.0 110.142 178.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -61.09 -46.2 91.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.427 -0.806 . . . . 10.0 110.691 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 7.8 t -67.58 -38.39 83.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 10.0 111.01 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 55.9 mt -63.58 -39.02 83.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.878 0.37 . . . . 10.0 110.034 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.694 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 14.2 m -63.01 -38.49 91.38 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.52 -0.548 . . . . 10.0 109.52 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -69.78 -40.99 75.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.857 -0.61 . . . . 10.0 110.286 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.96 -39.45 81.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.48 -0.782 . . . . 10.0 111.975 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -94.89 -0.72 53.77 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.671 -0.24 . . . . 10.0 111.3 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.4 39.82 97.8 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-N 116.203 -0.453 . . . . 10.0 113.2 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.694 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 6.5 p90 -131.26 160.78 33.9 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.358 -0.608 . . . . 10.0 109.358 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -94.15 140.44 29.75 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.834 0.35 . . . . 10.0 110.61 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.597 ' HD2' ' SD ' ' B' ' 37' ' ' MET . 17.3 mtm180 -57.7 -29.68 64.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.899 -0.591 . . . . 10.0 111.664 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 30.4 mp0 -83.82 -0.42 51.05 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.594 -0.73 . . . . 10.0 112.894 -177.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.65 3.52 40.59 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 122.309 -0.245 . . . . 10.0 111.582 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.464 HG22 ' H ' ' B' ' 52' ' ' SER . 4.3 m -41.45 -59.75 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 113.215 0.82 . . . . 10.0 113.215 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' SER . . . . . 0.464 ' H ' HG22 ' B' ' 51' ' ' VAL . 0.1 OUTLIER -59.03 -20.96 58.04 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 113.103 0.779 . . . . 10.0 113.103 -179.527 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.88 -38.43 13.74 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.569 -0.824 . . . . 10.0 112.027 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 32.5 mt -86.25 -51.72 12.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 112.266 0.469 . . . . 10.0 112.266 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 83.5 mt -83.56 -67.31 0.8 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.18 0.515 . . . . 10.0 111.998 -178.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . 0.447 ' HA2' ' HB3' ' C' ' 71' ' ' SER . . . 78.03 -114.78 4.06 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 110.993 -0.843 . . . . 10.0 110.993 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 45.1 pttt -157.72 23.63 0.28 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.21 0.528 . . . . 10.0 110.381 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.61 35.53 0.41 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.757 -0.656 . . . . 10.0 111.391 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 50.82 73.04 0.31 Allowed 'General case' 0 N--CA 1.46 0.072 0 CA-C-N 116.292 -0.413 . . . . 10.0 110.653 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.23 94.93 0.39 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.314 0.578 . . . . 10.0 111.119 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 7.5 mttt -95.31 90.37 5.81 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.677 -0.692 . . . . 10.0 109.77 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -71.42 78.32 0.58 Allowed Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.733 -0.667 . . . . 10.0 112.219 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -67.34 90.56 0.23 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.255 0.55 . . . . 10.0 110.906 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -139.73 91.77 2.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.686 -0.688 . . . . 10.0 109.849 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 81.1 mt -85.41 -23.53 27.88 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.952 -0.567 . . . . 10.0 110.589 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . 59.51 19.83 8.29 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.664 0.602 . . . . 10.0 110.876 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 59.43 41.34 19.57 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.262 -0.881 . . . . 10.0 111.156 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 59.3 mt -94.99 106.74 18.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.106 0.479 . . . . 10.0 110.972 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -112.78 10.49 19.2 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.768 -0.651 . . . . 10.0 109.529 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -100.74 41.67 1.16 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.387 -0.824 . . . . 10.0 109.399 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.52 -32.92 73.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.371 -0.831 . . . . 10.0 110.964 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.543 -0.741 . . . . 10.0 109.512 179.715 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' -1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.483 1.197 0 CA-C-O 120.593 0.235 . . . . 10.0 111.448 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 0' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -106.54 50.37 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-O 121.531 0.682 . . . . 10.0 109.595 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -68.96 96.32 0.77 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.975 -1.012 . . . . 10.0 110.632 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.42 61.2 5.52 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.481 -0.781 . . . . 10.0 110.996 -178.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -139.8 143.44 36.87 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.773 -0.455 . . . . 10.0 109.773 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -98.78 138.52 35.81 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.489 -0.56 . . . . 10.0 109.489 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . 0.533 ' HB2' ' CE1' ' C' ' 44' ' ' PHE . 0.2 OUTLIER -60.64 -32.73 71.88 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.387 -0.37 . . . . 10.0 111.199 -179.233 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 6' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -59.75 -52.33 65.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.198 0.523 . . . . 10.0 110.288 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -55.62 -51.45 67.13 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.767 -0.651 . . . . 10.0 110.986 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 8' ' ' ILE . . . . . 0.655 ' O ' HG13 ' C' ' 12' ' ' ILE . 48.6 mm -57.18 -48.86 81.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.707 -0.679 . . . . 10.0 110.99 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.31 -44.98 72.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.044 0.45 . . . . 10.0 110.808 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.68 -33.78 76.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.752 -0.658 . . . . 10.0 110.877 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.58 -37.42 79.84 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.123 -0.325 . . . . 10.0 110.123 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 12' ' ' ILE . . . . . 0.655 HG13 ' O ' ' C' ' 8' ' ' ILE . 21.6 mt -64.01 -57.09 13.08 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.517 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 33.0 m -63.61 -26.2 40.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.682 -0.69 . . . . 10.0 111.506 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -75.73 -46.76 29.19 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.323 0.582 . . . . 10.0 109.603 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 15' ' ' TYR . . . . . 0.491 ' O ' HG12 ' C' ' 19' ' ' ILE . 46.9 t80 -64.07 -43.73 94.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.671 -0.695 . . . . 10.0 110.002 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -57.15 -42.67 81.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.982 -0.553 . . . . 10.0 110.292 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 67.0 m -57.95 -42.9 85.92 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.972 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.55 -20.68 58.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.541 -0.299 . . . . 10.0 111.647 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 19' ' ' ILE . . . . . 0.491 HG12 ' O ' ' C' ' 15' ' ' TYR . 19.7 mm -74.59 -40.45 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.181 0.515 . . . . 10.0 109.764 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 20' ' ' VAL . . . . . . . . . . . . . 17.8 m -82.14 -17.2 11.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.787 -0.642 . . . . 10.0 109.728 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -64.47 -59.61 4.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.369 -0.832 . . . . 10.0 110.163 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -87.73 -3.31 58.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.371 -0.377 . . . . 10.0 110.493 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 64.4 mttm 59.49 58.22 3.03 Favored 'General case' 0 C--N 1.334 -0.066 0 CA-C-N 115.747 -0.661 . . . . 10.0 109.954 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -86.23 9.84 16.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.469 -0.787 . . . . 10.0 110.935 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 15.2 tt -144.36 165.53 13.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.361 -0.607 . . . . 10.0 109.361 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.04 154.67 22.16 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 122.524 0.329 . . . . 10.0 111.243 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -56.3 -46.99 79.56 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.386 -0.37 . . . . 10.0 111.151 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 28' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -64.34 -35.2 80.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.229 0.538 . . . . 10.0 109.736 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 29' ' ' GLY . . . . . 0.561 ' O ' ' HG ' ' C' ' 33' ' ' LEU . . . -66.3 -39.97 94.52 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 110.918 -0.873 . . . . 10.0 110.918 178.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.14 -39.15 93.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.923 0.392 . . . . 10.0 110.27 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -62.81 -42.06 99.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.591 -0.731 . . . . 10.0 109.812 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 19.4 t -64.96 -43.76 91.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.365 -0.834 . . . . 10.0 110.763 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 33' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' C' ' 29' ' ' GLY . 64.2 mt -67.96 -27.73 66.85 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.336 -0.393 . . . . 10.0 110.933 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -73.04 -39.25 66.09 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 116.477 -0.328 . . . . 10.0 111.561 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 35' ' ' VAL . . . . . . . . . . . . . 10.2 p -75.17 -36.05 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 N-CA-C 109.535 -0.543 . . . . 10.0 109.535 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.96 -34.58 78.07 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.702 -0.681 . . . . 10.0 110.097 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 2.9 ttm -54.3 -53.48 53.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.54 -0.755 . . . . 10.0 110.986 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 38' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -69.92 -25.97 63.92 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 121.096 -0.242 . . . . 10.0 110.905 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 39' ' ' CYS . . . . . . . . . . . . . 1.1 t -66.47 -47.62 72.5 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.587 -0.523 . . . . 10.0 109.587 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 40' ' ' ILE . . . . . . . . . . . . . 11.4 mt -67.99 -37.86 78.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.688 -0.687 . . . . 10.0 109.835 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 41' ' ' SER . . . . . 0.6 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 35.4 m -63.25 -43.51 97.79 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.916 -0.584 . . . . 10.0 110.274 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -66.67 -39.76 88.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.789 -0.641 . . . . 10.0 110.47 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.82 -39.06 80.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.921 -0.581 . . . . 10.0 112.027 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 44' ' ' PHE . . . . . 0.533 ' CE1' ' HB2' ' C' ' 5' ' ' LYS . 65.2 m-85 -96.98 -3.33 41.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.68 -0.236 . . . . 10.0 111.59 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.68 39.53 97.62 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.212 -0.518 . . . . 10.0 113.446 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 46' ' ' PHE . . . . . 0.6 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 4.8 p90 -131.88 154.7 48.94 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.397 -0.594 . . . . 10.0 109.397 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -94.24 145.27 24.84 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.644 -0.422 . . . . 10.0 110.656 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 48' ' ' ARG . . . . . 0.401 ' O ' HG11 ' C' ' 51' ' ' VAL . 10.8 mtm-85 -63.27 -15.74 58.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.301 0.572 . . . . 10.0 110.233 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -80.16 -11.08 59.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.57 -0.741 . . . . 10.0 112.406 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -93.53 2.41 56.43 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.254 0.465 . . . . 10.0 112.254 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 51' ' ' VAL . . . . . 0.401 HG11 ' O ' ' C' ' 48' ' ' ARG . 12.1 m -47.58 -44.92 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 113.39 0.885 . . . . 10.0 113.39 -179.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.21 -44.7 92.26 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.821 0.674 . . . . 10.0 112.821 -179.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.2 -26.69 74.42 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.338 -0.934 . . . . 10.0 112.679 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 54' ' ' ILE . . . . . . . . . . . . . 67.3 mt -84.56 -63.44 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.947 0.403 . . . . 10.0 111.962 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 19.0 mt -70.82 -61.1 1.89 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.591 0.589 . . . . 10.0 112.591 -178.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 66.28 -130.0 31.94 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 111.04 -0.824 . . . . 10.0 111.04 -177.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 11.2 pttp -151.35 28.75 0.64 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.187 0.518 . . . . 10.0 110.35 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.55 30.82 0.78 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.013 -0.539 . . . . 10.0 111.121 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 61.05 86.33 0.1 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.747 -0.661 . . . . 10.0 111.022 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 60' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -72.58 81.32 1.09 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.364 0.602 . . . . 10.0 110.707 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -83.39 71.36 10.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.616 -0.72 . . . . 10.0 110.277 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.81 74.04 2.03 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.756 -0.656 . . . . 10.0 112.369 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 63' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -66.74 100.31 0.69 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.909 0.385 . . . . 10.0 110.298 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 64' ' ' HIS . . . . . . . . . . . . . 17.0 t60 -133.4 85.73 2.23 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.183 -0.462 . . . . 10.0 109.872 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 74.1 mt -67.57 -31.03 70.82 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.687 -0.688 . . . . 10.0 111.327 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . 60.86 23.22 13.26 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.485 0.491 . . . . 10.0 110.715 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 63.63 35.84 11.3 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.243 -0.89 . . . . 10.0 111.743 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 68' ' ' ILE . . . . . . . . . . . . . 96.5 mt -83.49 109.01 16.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.086 0.47 . . . . 10.0 111.417 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.86 -5.63 10.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.018 -0.537 . . . . 10.0 109.99 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 70' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -92.16 44.71 1.18 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.345 0.593 . . . . 10.0 110.135 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 71' ' ' SER . . . . . 0.447 ' HB3' ' HA2' ' B' ' 56' ' ' GLY . 1.9 p -94.21 31.58 1.67 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.945 -0.571 . . . . 10.0 110.598 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.887 0 CA-C-N 115.864 -0.607 . . . . 10.0 109.532 -179.737 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 84.4 mmm . . . . . 0 N--CA 1.478 0.974 0 CA-C-O 120.553 0.216 . . . . 10.0 110.754 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.0 p -114.74 121.75 67.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.191 0.52 . . . . 10.0 110.307 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -85.36 138.66 32.14 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.837 -0.62 . . . . 10.0 110.285 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.8 mp -127.97 125.22 39.06 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.964 -0.562 . . . . 10.0 109.929 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.4 HG23 ' HG2' ' A' ' 89' ' ' GLU . 3.0 m -93.45 106.84 18.77 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.015 -0.539 . . . . 10.0 110.417 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 87' ' ' SER . 3.4 mm? -80.73 110.53 16.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.958 -0.565 . . . . 10.0 110.089 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.414 ' HZ2' ' CG ' ' C' ' 31' ' ' ASP . 67.1 tttt -121.42 108.63 13.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.654 -0.703 . . . . 10.0 110.626 -179.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.1 tttm -106.15 125.69 51.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.245 -0.434 . . . . 10.0 110.959 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.454 HG22 ' OG ' ' C' ' 32' ' ' SER . 2.0 mp -83.91 -49.31 16.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 115.525 -0.761 . . . . 10.0 110.546 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -64.8 151.55 45.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.093 -0.503 . . . . 10.0 110.76 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.94 136.47 76.6 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.334 -0.393 . . . . 10.0 111.437 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -74.31 135.79 41.91 Favored 'Cis proline' 0 C--N 1.345 0.387 0 C-N-CA 123.73 -1.363 . . . . 10.0 111.682 -1.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -92.02 151.76 20.31 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.36 -0.382 . . . . 10.0 110.572 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.514 ' CZ ' ' HB3' ' A' ' 110' ' ' LYS . 33.8 p90 -171.18 165.73 7.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.124 -0.489 . . . . 10.0 111.193 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.441 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 51.1 m -148.41 103.57 3.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.547 -0.751 . . . . 10.0 109.591 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.5 pt -135.13 163.73 35.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.423 -0.353 . . . . 10.0 110.436 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.4 ' HG2' HG23 ' A' ' 77' ' ' THR . 5.2 mt-10 -114.8 148.72 38.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.712 0.291 . . . . 10.0 111.316 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 24.4 m80 -145.89 145.74 30.83 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.05 -0.722 . . . . 10.0 109.05 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -102.01 127.42 48.9 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.175 -0.676 . . . . 10.0 109.175 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -121.44 170.32 9.76 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.483 0.659 . . . . 10.0 111.618 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.0 145.76 33.74 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 115.172 -0.922 . . . . 10.0 109.16 178.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.12 -25.67 37.29 Favored 'Trans proline' 0 CA--C 1.527 0.156 0 C-N-CA 122.108 1.872 . . . . 10.0 112.523 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.89 17.06 8.28 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.823 0.344 . . . . 10.0 111.02 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -91.98 170.19 10.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.392 -0.367 . . . . 10.0 110.453 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.85 159.55 22.89 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.022 -0.536 . . . . 10.0 110.387 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.511 ' HB ' ' HA ' ' A' ' 128' ' ' ASP . 49.2 mm -66.8 -23.43 31.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.49 0.662 . . . . 10.0 109.835 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -57.96 -43.26 86.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.428 -0.806 . . . . 10.0 110.642 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -63.47 -33.9 76.59 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.16 -0.473 . . . . 10.0 111.275 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 47.7 mt -64.85 -44.75 96.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.3 -0.409 . . . . 10.0 110.184 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -54.76 -45.58 74.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.762 -0.653 . . . . 10.0 110.81 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -71.59 -33.09 68.74 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.701 -0.681 . . . . 10.0 110.425 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -64.62 -43.52 93.46 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.814 -0.63 . . . . 10.0 110.363 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 36.6 mt -60.53 -41.57 94.71 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.332 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 85.2 mt -62.35 -38.35 80.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.048 -0.523 . . . . 10.0 110.601 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.1 m -65.36 -26.82 68.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.074 -0.512 . . . . 10.0 111.547 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -98.83 12.92 34.24 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.936 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 59.94 24.5 13.62 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.69 -0.686 . . . . 10.0 111.558 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.514 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 41.6 mmtm -91.02 -16.85 27.25 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.475 0.655 . . . . 10.0 109.339 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -137.86 151.2 47.81 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.89 -1.05 . . . . 10.0 109.837 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.4 m -101.86 -46.73 4.81 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.812 -0.355 . . . . 10.0 111.643 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.488 ' O ' HG13 ' A' ' 117' ' ' ILE . 1.7 t-160 -134.72 127.92 31.95 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.789 -0.364 . . . . 10.0 111.498 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 11.2 tt -56.47 -41.85 73.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 115.746 -0.661 . . . . 10.0 111.572 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.43 -14.19 26.32 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.291 -0.868 . . . . 10.0 113.274 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -114.22 13.6 17.97 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.076 -0.39 . . . . 10.0 111.797 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 113' ' ' HIS . 62.0 mt -99.61 121.31 50.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.751 0.31 . . . . 10.0 111.038 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -126.11 117.96 24.26 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.473 -0.33 . . . . 10.0 110.248 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -94.4 138.27 32.55 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.235 0.541 . . . . 10.0 111.562 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -120.38 133.45 55.44 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.102 -1.073 . . . . 10.0 108.102 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 53.6 tp -115.96 96.53 5.63 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 106.009 -1.849 . . . . 10.0 106.009 178.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.9 tptm 43.8 64.9 1.13 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 114.648 -1.16 . . . . 10.0 110.628 -177.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.684 ' HA2' ' SG ' ' C' ' 39' ' ' CYS . . . 80.88 -47.87 3.62 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.556 -0.747 . . . . 10.0 113.859 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 39.5 tttp -67.38 120.76 14.41 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 109.419 -0.586 . . . . 10.0 109.419 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.1 p -66.06 139.42 21.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.356 0.598 . . . . 10.0 112.499 -178.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.3 tp -105.69 103.1 12.54 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.645 -0.707 . . . . 10.0 110.253 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -69.98 143.46 52.6 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.074 -0.966 . . . . 10.0 111.876 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.511 ' HA ' ' HB ' ' A' ' 98' ' ' ILE . 0.3 OUTLIER -61.57 -39.87 92.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.718 -0.674 . . . . 10.0 112.223 -179.561 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -73.88 -9.35 58.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.331 -0.395 . . . . 10.0 111.553 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 17.1 tp -76.85 142.01 40.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.251 -0.432 . . . . 10.0 110.356 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.418 ' HB2' ' HB2' ' A' ' 134' ' ' ASP . 41.2 m-85 -93.8 149.74 20.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.057 -0.52 . . . . 10.0 110.659 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 34.3 mt -59.32 -38.52 80.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.93 0.395 . . . . 10.0 111.21 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.24 -19.73 61.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.257 -0.429 . . . . 10.0 111.01 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.418 ' HB2' ' HB2' ' A' ' 131' ' ' PHE . 13.3 t0 -81.56 -40.37 23.18 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.738 -0.664 . . . . 10.0 111.108 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.3 pp -83.87 -26.36 29.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.508 -0.315 . . . . 10.0 111.317 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 96.0 mttt 63.07 99.18 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 O-C-N 123.659 0.599 . . . . 10.0 112.202 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.0 t -79.92 114.23 20.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.073 -0.512 . . . . 10.0 110.298 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.85 137.76 76.59 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.34 -0.391 . . . . 10.0 111.289 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -62.78 -16.99 57.0 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.818 2.345 . . . . 10.0 112.692 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -106.03 6.32 31.08 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.067 0.461 . . . . 10.0 110.924 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -140.34 71.28 1.37 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.753 -0.658 . . . . 10.0 109.536 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.4 t -99.27 11.81 38.0 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.654 -0.703 . . . . 10.0 110.17 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.35 95.58 5.76 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.127 0.489 . . . . 10.0 110.672 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 24.9 mm -92.37 104.4 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 N-CA-C 107.527 -1.286 . . . . 10.0 107.527 177.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.93 121.45 26.5 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.203 -0.453 . . . . 10.0 110.234 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 10.4 t -105.62 136.95 37.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.777 -0.647 . . . . 10.0 111.775 -178.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 25.1 mmt -136.0 120.78 18.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.126 -0.943 . . . . 10.0 108.643 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 11.8 mt -139.68 94.05 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.723 -0.391 . . . . 10.0 111.119 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -94.35 107.09 27.03 Favored Pre-proline 0 C--N 1.32 -0.706 0 N-CA-C 109.213 -0.662 . . . . 10.0 109.213 175.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.96 147.23 43.23 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.508 2.139 . . . . 10.0 112.759 -178.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -83.9 101.98 12.06 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.536 -0.756 . . . . 10.0 110.174 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 46.3 mt -90.01 148.88 22.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.22 -0.446 . . . . 10.0 110.413 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.494 -0.765 . . . . 10.0 109.946 -179.72 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' -1' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.474 0.735 0 CA-C-O 120.47 0.176 . . . . 10.0 110.779 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 0' ' ' VAL . . . . . . . . . . . . . 3.6 m -135.86 -175.0 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.304 -0.628 . . . . 10.0 109.304 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . 0.474 ' CG ' ' HZ2' ' B' ' 61' ' ' LYS . 14.2 t0 -171.11 -79.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.002 0.429 . . . . 10.0 110.12 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 70.6 m -155.53 -31.72 0.1 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.144 -0.48 . . . . 10.0 110.382 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.39 134.51 57.07 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.222 -0.445 . . . . 10.0 110.588 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' SER . . . . . 0.476 ' O ' HG12 ' B' ' 8' ' ' ILE . 64.6 p -94.68 178.86 5.45 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.062 -0.517 . . . . 10.0 110.717 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -54.34 -44.69 72.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.046 -0.525 . . . . 10.0 111.33 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -59.04 -47.19 86.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.408 -0.36 . . . . 10.0 111.487 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -59.86 -45.4 92.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.828 0.347 . . . . 10.0 110.511 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.476 HG12 ' O ' ' B' ' 4' ' ' SER . 37.2 mm -60.17 -49.62 83.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.739 -0.664 . . . . 10.0 110.505 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.4 -41.76 85.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.392 -0.367 . . . . 10.0 111.191 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.57 -38.09 89.81 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.207 0.527 . . . . 10.0 110.44 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 40.7 mt -66.1 -39.32 89.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.949 -0.569 . . . . 10.0 109.63 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 1.3 mp -56.8 -46.85 83.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.311 -0.858 . . . . 10.0 111.406 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 12.9 m -71.72 -29.78 35.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.579 -0.448 . . . . 10.0 111.731 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -73.88 -41.62 61.91 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.749 0.309 . . . . 10.0 111.288 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -69.38 -43.6 73.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.379 -0.373 . . . . 10.0 111.199 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 14.7 m-30 -61.43 -49.86 75.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.408 -0.36 . . . . 10.0 111.03 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 6.0 p -57.65 -45.26 85.74 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.929 0.344 . . . . 10.0 111.929 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' SER . . . . . 0.402 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 5.0 p -69.02 -21.25 64.13 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.036 0.384 . . . . 10.0 112.036 -179.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 22.5 mm -85.65 -43.58 16.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 120.689 -0.404 . . . . 10.0 110.676 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 26.9 m -73.54 -35.2 44.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.891 -0.324 . . . . 10.0 111.294 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -68.8 -38.28 79.82 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 120.487 -0.485 . . . . 10.0 110.235 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . 0.402 ' HG3' ' O ' ' B' ' 18' ' ' SER . 33.2 mtmt -75.12 -7.15 52.97 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.132 -0.322 . . . . 10.0 110.132 178.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 29.8 mmtm 57.63 41.33 25.69 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.808 -0.633 . . . . 10.0 110.375 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.453 ' O ' ' HE2' ' C' ' 5' ' ' LYS . 38.4 mt-10 -91.61 9.83 30.61 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.529 -0.759 . . . . 10.0 110.338 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 9.0 tp -141.99 150.18 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 N-CA-C 108.834 -0.802 . . . . 10.0 108.834 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 1.2 p -62.65 154.95 27.62 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.287 -0.264 . . . . 10.0 110.287 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -57.21 -32.56 66.62 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.672 0.273 . . . . 10.0 110.712 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -63.2 -46.64 86.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.419 0.628 . . . . 10.0 109.716 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . 0.525 ' O ' ' HG ' ' B' ' 33' ' ' LEU . . . -71.13 -40.72 61.37 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.542 -0.754 . . . . 10.0 111.384 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.73 -42.77 93.9 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.898 0.38 . . . . 10.0 111.069 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.404 ' O ' HG11 ' B' ' 35' ' ' VAL . 27.7 t0 -61.34 -44.19 97.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.619 -0.719 . . . . 10.0 110.214 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 13.4 m -65.52 -41.52 93.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.703 -0.68 . . . . 10.0 110.64 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' B' ' 29' ' ' GLY . 82.1 mt -66.08 -43.63 86.79 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.792 0.33 . . . . 10.0 111.296 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -60.3 -51.02 71.3 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 116.001 -0.545 . . . . 10.0 112.206 -178.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.404 HG11 ' O ' ' B' ' 31' ' ' ASP . 7.1 p -66.64 -42.06 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 120.797 -0.361 . . . . 10.0 111.063 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.43 -35.0 77.88 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.947 0.403 . . . . 10.0 110.419 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' MET . . . . . . . . . . . . . 22.7 ttm -56.24 -51.12 69.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.578 -0.737 . . . . 10.0 111.033 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.97 -33.63 76.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.073 -0.512 . . . . 10.0 111.508 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 39.9 m -65.28 -42.95 92.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.015 0.436 . . . . 10.0 110.284 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 46.7 mt -67.27 -34.52 69.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.844 -0.617 . . . . 10.0 110.321 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.652 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 50.9 m -65.23 -40.51 94.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.061 -0.518 . . . . 10.0 110.74 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -72.72 -27.47 62.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 10.0 111.284 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.45 -39.37 81.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.981 -0.554 . . . . 10.0 111.54 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -97.13 -0.84 46.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.333 -0.394 . . . . 10.0 111.869 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.23 60.62 7.29 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.351 -0.452 . . . . 10.0 114.168 178.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.652 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 13.6 p90 -154.11 167.78 28.7 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.028 -0.36 . . . . 10.0 110.028 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -98.93 151.62 20.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.013 0.435 . . . . 10.0 110.379 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 3.9 mtm180 -71.34 -28.21 63.91 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.129 0.49 . . . . 10.0 110.632 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -84.51 7.34 20.24 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.054 -0.521 . . . . 10.0 112.257 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.13 4.38 48.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.513 0.197 . . . . 10.0 111.523 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.428 HG23 ' H ' ' B' ' 52' ' ' SER . 4.8 m -41.37 -57.39 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 113.425 0.898 . . . . 10.0 113.425 -179.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' SER . . . . . 0.428 ' H ' HG23 ' B' ' 51' ' ' VAL . 0.6 OUTLIER -53.72 -36.54 62.37 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.824 0.675 . . . . 10.0 112.824 -179.28 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.72 -42.25 32.35 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.934 -0.651 . . . . 10.0 113.353 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 24.8 mt -83.69 -45.64 18.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 112.253 0.464 . . . . 10.0 112.253 -178.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.419 HD23 ' CZ ' ' B' ' 60' ' ' PHE . 81.0 mt -73.17 -64.27 1.01 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.949 0.404 . . . . 10.0 111.378 -178.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.25 -151.05 48.11 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.912 -0.661 . . . . 10.0 112.403 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 10.0 tttt -100.08 6.92 44.96 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.073 0.463 . . . . 10.0 110.466 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.47 134.89 55.42 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.565 -0.743 . . . . 10.0 110.289 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -87.59 122.97 31.97 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.178 0.513 . . . . 10.0 110.648 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . 0.419 ' CZ ' HD23 ' B' ' 55' ' ' LEU . 64.4 m-85 -88.0 156.44 19.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.767 -0.651 . . . . 10.0 110.371 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . 0.474 ' HZ2' ' CG ' ' B' ' 1' ' ' ASP . 10.6 ptmm? -154.82 168.07 28.14 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.163 -0.472 . . . . 10.0 110.306 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -150.16 60.6 0.42 Allowed Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 111.455 -0.658 . . . . 10.0 111.455 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -79.52 127.89 32.7 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.769 -0.456 . . . . 10.0 109.769 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 46.0 p-80 -145.76 109.08 4.65 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.02 -0.537 . . . . 10.0 110.395 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -82.63 -13.05 57.16 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.453 0.644 . . . . 10.0 109.623 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -84.51 120.92 26.88 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.26 -0.882 . . . . 10.0 109.199 178.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.6 148.03 49.93 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.103 -0.499 . . . . 10.0 110.692 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 15.7 mt -81.57 83.69 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.294 -0.412 . . . . 10.0 109.901 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 97.4 mt 70.66 -67.8 0.23 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.142 -0.935 . . . . 10.0 111.039 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -148.88 -14.43 0.31 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.224 -0.444 . . . . 10.0 110.871 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 14.2 m 58.21 35.52 25.06 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 123.488 0.493 . . . . 10.0 111.013 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.696 -0.669 . . . . 10.0 110.667 -179.888 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' -1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.478 0.946 0 CA-C-O 120.901 0.381 . . . . 10.0 111.105 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 0' ' ' VAL . . . . . . . . . . . . . 13.5 m -128.54 168.31 22.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.978 -0.379 . . . . 10.0 109.978 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -135.39 -58.93 0.78 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.598 0.237 . . . . 10.0 111.289 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 48.2 m -157.01 -21.53 0.09 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.929 0.395 . . . . 10.0 110.785 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.31 145.8 55.43 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.972 -0.558 . . . . 10.0 111.336 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 4' ' ' SER . . . . . 0.533 ' O ' HG12 ' C' ' 8' ' ' ILE . 0.7 OUTLIER -109.89 166.32 11.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.246 -0.434 . . . . 10.0 110.106 179.857 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . 0.481 ' HB2' ' CE1' ' C' ' 44' ' ' PHE . 10.3 ptpp? -51.86 -38.67 56.9 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 123.515 0.51 . . . . 10.0 111.863 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 6' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 -59.39 -54.59 44.93 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.381 -0.372 . . . . 10.0 111.494 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -60.91 -40.3 92.62 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.688 0.28 . . . . 10.0 110.34 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 8' ' ' ILE . . . . . 0.533 HG12 ' O ' ' C' ' 4' ' ' SER . 48.4 mm -60.0 -47.73 90.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.88 -0.6 . . . . 10.0 109.658 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.39 -44.82 76.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.966 -0.561 . . . . 10.0 111.203 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.82 -40.56 91.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.913 -0.585 . . . . 10.0 111.089 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 32.4 mt -61.36 -39.1 89.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.903 0.382 . . . . 10.0 110.26 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 12' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.17 -54.87 27.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.656 -0.702 . . . . 10.0 111.75 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 28.5 m -66.56 -26.04 36.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.262 0.467 . . . . 10.0 112.262 -178.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.24 -40.09 52.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.981 0.419 . . . . 10.0 110.433 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 15' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -72.6 -45.11 60.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.151 -0.477 . . . . 10.0 111.32 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -56.51 -49.67 74.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.371 -0.377 . . . . 10.0 110.846 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 10.0 p -58.48 -45.07 89.43 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.43 -0.35 . . . . 10.0 111.586 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 4.4 p -69.33 -22.24 63.78 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.805 -0.358 . . . . 10.0 111.845 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 19' ' ' ILE . . . . . . . . . . . . . 20.2 mm -79.34 -43.39 23.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 110.129 -0.322 . . . . 10.0 110.129 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 20' ' ' VAL . . . . . 0.415 HG11 ' HA ' ' C' ' 30' ' ' ALA . 4.2 m -73.99 -27.83 22.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.71 0.29 . . . . 10.0 110.385 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -69.84 -53.62 17.3 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.905 -0.406 . . . . 10.0 109.905 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 34.5 mtmt -70.67 -6.79 39.74 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.843 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm 61.48 47.03 6.96 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.251 0.548 . . . . 10.0 110.426 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -85.41 -3.93 59.0 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.827 -0.624 . . . . 10.0 110.422 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 11.2 tt -134.94 159.45 41.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.056 -0.52 . . . . 10.0 110.129 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -68.19 166.35 16.45 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.218 0.207 . . . . 10.0 111.272 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -53.74 -50.34 66.18 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.066 0.395 . . . . 10.0 112.066 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.76 -47.37 77.11 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.033 0.444 . . . . 10.0 110.48 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.09 -42.44 91.94 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.833 -0.699 . . . . 10.0 112.028 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . 0.415 ' HA ' HG11 ' C' ' 20' ' ' VAL . . . -57.35 -41.68 80.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.881 0.372 . . . . 10.0 110.963 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 31' ' ' ASP . . . . . 0.414 ' CG ' ' HZ2' ' A' ' 79' ' ' LYS . 9.0 t70 -68.07 -38.47 82.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.952 -0.567 . . . . 10.0 110.163 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 32' ' ' SER . . . . . 0.454 ' OG ' HG22 ' A' ' 81' ' ' ILE . 48.7 m -61.74 -29.37 70.07 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.455 -0.793 . . . . 10.0 109.938 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 33' ' ' LEU . . . . . 0.46 ' O ' ' HG3' ' C' ' 37' ' ' MET . 48.4 mt -77.76 -37.11 49.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.341 -0.39 . . . . 10.0 110.359 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -58.36 -53.63 56.13 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.06 -0.518 . . . . 10.0 110.369 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 35' ' ' VAL . . . . . . . . . . . . . 9.4 p -67.2 -38.58 81.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 115.361 -0.836 . . . . 10.0 110.681 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.94 -40.97 95.3 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 120.669 0.271 . . . . 10.0 111.257 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 37' ' ' MET . . . . . 0.46 ' HG3' ' O ' ' C' ' 33' ' ' LEU . 70.8 mtm -54.74 -47.14 74.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.426 -0.352 . . . . 10.0 110.593 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 38' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -69.41 -28.65 66.33 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 116.468 -0.333 . . . . 10.0 110.855 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 39' ' ' CYS . . . . . 0.684 ' SG ' ' HA2' ' A' ' 123' ' ' GLY . 91.8 m -61.25 -42.84 99.32 Favored 'General case' 0 CA--C 1.522 -0.115 0 N-CA-C 108.871 -0.789 . . . . 10.0 108.871 177.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 40' ' ' ILE . . . . . . . . . . . . . 1.4 mp -73.25 -46.11 51.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 114.84 -1.073 . . . . 10.0 110.704 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 41' ' ' SER . . . . . 0.614 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 9.2 m -60.98 -42.09 97.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.406 -0.361 . . . . 10.0 111.585 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -72.96 -29.28 62.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.412 -0.358 . . . . 10.0 110.506 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.6 -46.8 65.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.154 -0.476 . . . . 10.0 111.727 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 44' ' ' PHE . . . . . 0.481 ' CE1' ' HB2' ' C' ' 5' ' ' LYS . 93.4 m-85 -92.18 -7.03 49.49 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.089 0.403 . . . . 10.0 112.089 -178.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.36 60.86 5.18 Favored Glycine 0 C--O 1.227 -0.309 0 C-N-CA 121.244 -0.503 . . . . 10.0 113.889 178.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 46' ' ' PHE . . . . . 0.614 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 3.6 p90 -153.56 169.25 23.67 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 110.179 -0.304 . . . . 10.0 110.179 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 51.5 mp0 -99.23 144.08 28.76 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.803 0.335 . . . . 10.0 110.85 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.95 -28.36 69.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.214 0.53 . . . . 10.0 110.965 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -80.1 14.33 1.92 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.733 -0.667 . . . . 10.0 112.509 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -104.72 2.82 30.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.24 0.543 . . . . 10.0 110.753 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 1.7 m -49.44 -45.78 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 113.546 0.943 . . . . 10.0 113.546 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.63 -27.22 67.61 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.785 0.291 . . . . 10.0 111.785 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.91 -37.78 12.54 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.845 -0.693 . . . . 10.0 112.667 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 54' ' ' ILE . . . . . . . . . . . . . 40.0 mt -81.14 -56.35 6.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 O-C-N 122.697 -0.296 . . . . 10.0 111.253 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 26.5 mt -67.01 -41.24 87.0 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.229 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 58.08 -139.41 47.61 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.621 -0.718 . . . . 10.0 112.077 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 66.2 tttt -108.76 -6.34 15.93 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.074 0.464 . . . . 10.0 110.32 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 3.1 m -65.34 148.21 52.09 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.622 -0.717 . . . . 10.0 111.27 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -97.01 134.39 40.44 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.068 0.461 . . . . 10.0 110.146 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 60' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -98.87 153.33 18.88 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.373 -0.376 . . . . 10.0 110.465 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 7.8 ptmm? -134.64 162.03 33.47 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.424 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -138.78 39.22 1.59 Allowed Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 111.381 -0.687 . . . . 10.0 111.381 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 63' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -60.98 145.03 52.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.784 0.326 . . . . 10.0 110.42 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 64' ' ' HIS . . . . . . . . . . . . . 42.2 p-80 -161.67 113.16 1.72 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.064 -0.516 . . . . 10.0 109.958 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . 0.538 ' N ' HD23 ' C' ' 65' ' ' LEU . 3.2 mm? -89.34 -20.64 23.79 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.927 -0.579 . . . . 10.0 109.825 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -76.92 147.57 36.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.47 -0.786 . . . . 10.0 110.056 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -79.33 149.03 31.87 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.994 0.426 . . . . 10.0 110.96 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 68' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' B' ' 52' ' ' SER . 0.1 OUTLIER -91.53 82.34 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.89 -0.596 . . . . 10.0 110.324 179.736 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 93.4 mt 69.53 -73.95 0.09 Allowed 'General case' 0 N--CA 1.465 0.279 0 O-C-N 124.068 0.855 . . . . 10.0 110.696 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 70' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -132.27 -21.95 2.28 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.818 -0.628 . . . . 10.0 110.95 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 71' ' ' SER . . . . . . . . . . . . . 15.2 m 60.42 30.59 19.91 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.954 -0.566 . . . . 10.0 111.335 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.869 0 CA-C-O 118.522 -0.751 . . . . 10.0 109.868 179.961 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 33.7 mtm . . . . . 0 N--CA 1.481 1.084 0 N-CA-C 110.321 -0.251 . . . . 10.0 110.321 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.4 t -95.58 139.36 19.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.845 0.355 . . . . 10.0 111.475 -178.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.456 ' CD2' ' HB3' ' A' ' 91' ' ' ASP . 4.8 m170 -91.53 126.3 36.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.075 -0.511 . . . . 10.0 110.629 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.6 mp -126.9 120.03 28.18 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.01 -0.541 . . . . 10.0 109.923 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.1 m -94.07 114.75 26.97 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.452 -0.573 . . . . 10.0 109.452 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.401 ' O ' ' HA ' ' A' ' 87' ' ' SER . 2.5 mm? -88.3 122.67 32.08 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.283 -0.417 . . . . 10.0 110.679 -178.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -122.95 104.58 9.33 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.969 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -92.11 120.57 32.84 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.909 -0.404 . . . . 10.0 109.909 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 20.8 mt -86.83 -59.46 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.573 -0.285 . . . . 10.0 111.649 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -57.0 158.12 5.21 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.75 0.309 . . . . 10.0 111.397 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.28 138.6 55.92 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.42 -0.355 . . . . 10.0 111.059 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -74.2 130.73 21.54 Favored 'Cis proline' 0 C--O 1.237 0.435 0 C-N-CA 123.039 -1.65 . . . . 10.0 111.87 -1.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.443 ' HZ2' ' CG ' ' C' ' 28' ' ' ASP . 0.0 OUTLIER -87.8 152.62 21.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.422 -0.353 . . . . 10.0 111.271 -179.277 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -177.52 170.75 2.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.736 -0.665 . . . . 10.0 110.03 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 15.2 m -151.17 133.42 15.32 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.123 -0.49 . . . . 10.0 109.696 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.1 pt -138.16 150.31 24.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.932 0.396 . . . . 10.0 111.383 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -113.58 120.4 40.82 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.359 -0.608 . . . . 10.0 109.359 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.39 167.39 23.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.014 0.435 . . . . 10.0 111.433 -178.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.456 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -121.4 131.57 54.25 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.848 -0.614 . . . . 10.0 110.905 179.101 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -118.74 168.8 10.39 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.727 -0.669 . . . . 10.0 109.85 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.605 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 7.4 t -80.89 146.95 60.74 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 116.545 -0.298 . . . . 10.0 110.398 -179.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.1 -22.62 70.47 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.245 1.963 . . . . 10.0 111.747 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 43.3 m -100.08 13.32 34.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.978 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.605 ' HB2' ' O ' ' A' ' 93' ' ' SER . 1.0 OUTLIER -80.52 163.11 23.97 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.528 -179.889 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.4 p -115.49 160.66 19.63 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.583 -0.735 . . . . 10.0 110.576 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 47.7 mm -65.28 -21.31 29.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.368 0.604 . . . . 10.0 109.438 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.28 -39.29 82.46 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.41 -0.814 . . . . 10.0 110.235 178.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -63.84 -40.24 96.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.103 -0.498 . . . . 10.0 110.316 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.515 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 54.1 mt -65.93 -48.6 81.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.841 -0.618 . . . . 10.0 109.499 178.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.451 ' HZ1' ' CG ' ' A' ' 128' ' ' ASP . 53.2 mttt -53.64 -48.01 69.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.322 -0.854 . . . . 10.0 111.151 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.477 ' OE1' ' HA ' ' A' ' 103' ' ' GLN . 11.4 mm-40 -59.8 -41.16 90.6 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.883 -0.599 . . . . 10.0 111.102 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.528 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 19.1 t60 -68.46 -33.75 74.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.29 -0.414 . . . . 10.0 110.539 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 101' ' ' ILE . 90.8 mt -62.55 -46.04 90.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.79 0.329 . . . . 10.0 110.989 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.6 mt -67.41 -32.35 56.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.124 0.488 . . . . 10.0 110.05 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.1 m -68.02 -15.49 63.62 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.511 -0.768 . . . . 10.0 112.159 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' A' ' 104' ' ' HIS . 17.5 mm-40 -95.1 6.88 47.83 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.628 -0.508 . . . . 10.0 109.628 178.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.447 ' HA ' ' OE1' ' A' ' 109' ' ' GLU . 3.4 mm-40 60.35 32.1 20.58 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.486 -0.779 . . . . 10.0 111.039 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -110.98 -5.64 14.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.111 -0.495 . . . . 10.0 110.795 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -135.57 148.69 49.17 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.81 -0.632 . . . . 10.0 109.952 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.498 ' OG ' ' HA ' ' A' ' 150' ' ' PRO . 0.6 OUTLIER -87.71 -59.18 2.32 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.948 0.404 . . . . 10.0 110.901 -179.81 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.488 ' O ' HG13 ' A' ' 117' ' ' ILE . 40.8 m80 -138.26 154.02 49.07 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.345 -0.389 . . . . 10.0 110.919 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.415 HG13 ' CD ' ' A' ' 102' ' ' LYS . 0.3 OUTLIER -63.34 -36.75 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 115.502 -0.772 . . . . 10.0 110.386 179.562 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.87 -24.0 34.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.821 -1.081 . . . . 10.0 112.463 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.431 ' HG3' ' OD1' ' A' ' 151' ' ' ASN . 0.3 OUTLIER -103.19 0.16 31.32 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 121.182 -0.207 . . . . 10.0 111.397 -179.117 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 113' ' ' HIS . 28.2 mt -90.75 119.91 38.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 120.266 -0.574 . . . . 10.0 109.534 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.42 ' HZ3' ' CG ' ' B' ' 31' ' ' ASP . 18.4 mmmt -118.1 112.15 19.82 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.114 0.483 . . . . 10.0 110.174 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' A' ' 126' ' ' LEU . 3.2 mm? -92.99 113.7 26.06 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.653 0.74 . . . . 10.0 110.995 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.445 HD13 ' HA ' ' A' ' 125' ' ' VAL . 4.5 mm? -110.75 140.43 45.16 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 107.406 -1.331 . . . . 10.0 107.406 178.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 17.9 tp -121.98 97.91 5.7 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.821 -0.807 . . . . 10.0 108.821 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? 46.82 58.27 4.86 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.612 0.72 . . . . 10.0 109.972 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.681 ' HA2' ' SG ' ' C' ' 39' ' ' CYS . . . 83.87 -44.41 3.31 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 114.6 -1.182 . . . . 10.0 114.154 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 22.9 tttp -59.64 140.03 56.73 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 120.696 0.284 . . . . 10.0 111.006 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.445 ' HA ' HD13 ' A' ' 120' ' ' LEU . 7.2 p -90.35 136.16 24.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 112.942 0.719 . . . . 10.0 112.942 -178.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.424 ' HB2' ' O ' ' A' ' 119' ' ' LEU . 6.0 mp -110.83 156.29 21.34 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 114.983 -1.008 . . . . 10.0 110.001 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -116.0 158.38 23.19 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.452 0.538 . . . . 10.0 112.452 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.451 ' CG ' ' HZ1' ' A' ' 102' ' ' LYS . 1.7 m-20 -52.81 -55.1 25.41 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 113.377 0.88 . . . . 10.0 113.377 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -91.26 14.13 15.28 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.242 0.46 . . . . 10.0 112.242 -178.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 9.4 tp -70.24 143.87 52.02 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.708 0.289 . . . . 10.0 110.428 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -98.85 146.84 25.54 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.72 -0.673 . . . . 10.0 110.18 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.505 HD11 ' O ' ' A' ' 93' ' ' SER . 13.0 mt -57.53 -39.09 75.84 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.414 -0.357 . . . . 10.0 111.183 178.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.4 p -73.17 -21.96 60.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.123 0.487 . . . . 10.0 111.198 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -82.25 -45.56 14.86 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 120.812 0.339 . . . . 10.0 110.519 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.2 pp -74.1 -21.97 59.68 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.352 -0.385 . . . . 10.0 110.846 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.6 mtmt 63.43 92.2 0.07 Allowed 'General case' 0 C--O 1.236 0.352 0 O-C-N 123.691 0.619 . . . . 10.0 110.785 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.0 t -66.07 101.5 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.6 -0.727 . . . . 10.0 110.38 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.52 119.66 48.88 Favored Pre-proline 0 N--CA 1.451 -0.415 0 CA-C-N 116.098 -0.501 . . . . 10.0 110.652 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -65.57 -11.46 30.59 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.773 2.315 . . . . 10.0 112.727 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -93.04 7.3 44.7 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.965 -0.561 . . . . 10.0 110.19 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -128.63 -75.02 0.56 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.518 -0.765 . . . . 10.0 110.14 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 38.6 m 57.66 13.27 1.89 Allowed 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.486 0.55 . . . . 10.0 112.486 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.9 m -121.46 121.75 38.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.619 0.247 . . . . 10.0 110.882 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 10.7 mm -102.85 126.12 57.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.714 -0.675 . . . . 10.0 109.666 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.43 107.15 17.92 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.887 -0.783 . . . . 10.0 108.887 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 21.7 t -87.34 126.08 41.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.663 -0.699 . . . . 10.0 110.209 -178.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 62.7 mtt -125.35 115.0 19.63 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.706 -1.134 . . . . 10.0 109.866 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.435 HG12 HG23 ' A' ' 117' ' ' ILE . 9.9 mt -138.96 146.11 26.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.35 -0.841 . . . . 10.0 110.674 -178.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.517 ' HD3' ' OD2' ' B' ' 38' ' ' ASP . 2.0 mmmm -125.94 115.51 24.24 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 109.37 -0.604 . . . . 10.0 109.37 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.498 ' HA ' ' OG ' ' A' ' 112' ' ' SER . 19.5 Cg_endo -61.82 117.47 4.3 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.425 2.084 . . . . 10.0 112.65 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.431 ' OD1' ' HG3' ' A' ' 116' ' ' GLU . 11.0 m120 -74.99 -38.23 61.67 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 108.954 -0.758 . . . . 10.0 108.954 178.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 69.3 mt -87.5 165.79 15.25 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.072 -0.967 . . . . 10.0 111.244 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.405 ' H ' ' HG3' ' A' ' 153' ' ' GLU . 11.8 mt-10 . . . . . 0 C--O 1.251 1.178 0 CA-C-N 115.606 -0.725 . . . . 10.0 110.698 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' -1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.482 1.175 0 CA-C-O 120.85 0.357 . . . . 10.0 110.709 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 0' ' ' VAL . . . . . . . . . . . . . 34.0 m -118.31 -162.57 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.975 -0.557 . . . . 10.0 109.968 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -156.96 -84.67 0.05 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.108 -0.33 . . . . 10.0 110.108 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 70.8 m -162.94 12.91 0.07 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 122.724 0.409 . . . . 10.0 110.378 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -97.87 151.28 20.4 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 122.292 -0.255 . . . . 10.0 110.599 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 80.1 p -86.82 157.11 19.64 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.376 -0.601 . . . . 10.0 109.376 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -53.1 -40.54 64.22 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.85 0.315 . . . . 10.0 111.85 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -60.91 -47.25 87.27 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.668 -0.242 . . . . 10.0 110.838 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -58.84 -39.83 82.43 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.114 0.483 . . . . 10.0 110.075 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.504 ' O ' HD12 ' B' ' 12' ' ' ILE . 50.1 mm -64.52 -49.3 81.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.726 -0.67 . . . . 10.0 110.084 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.27 -36.65 78.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.193 0.52 . . . . 10.0 110.335 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.99 -32.77 74.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.534 -0.757 . . . . 10.0 110.221 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 28.1 mt -70.98 -34.96 71.91 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.421 -0.585 . . . . 10.0 109.421 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.504 HD12 ' O ' ' B' ' 8' ' ' ILE . 0.7 OUTLIER -59.37 -54.74 30.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.974 -0.557 . . . . 10.0 110.442 179.117 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 28.4 m -62.27 -33.51 59.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.33 -0.396 . . . . 10.0 111.117 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -68.72 -48.77 62.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.093 -0.503 . . . . 10.0 110.897 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' TYR . . . . . 0.466 ' O ' HG12 ' B' ' 19' ' ' ILE . 8.3 m-85 -70.94 -41.9 70.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.156 -0.474 . . . . 10.0 112.04 -178.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -55.92 -52.94 62.35 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 122.982 0.176 . . . . 10.0 111.45 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' SER . . . . . 0.492 ' O ' ' HB2' ' B' ' 21' ' ' GLU . 4.9 p -58.74 -46.85 86.48 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.448 -0.342 . . . . 10.0 111.357 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 28.8 p -65.45 -20.59 66.43 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.225 0.454 . . . . 10.0 112.225 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.466 HG12 ' O ' ' B' ' 15' ' ' TYR . 22.9 mm -84.93 -42.12 16.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.798 0.332 . . . . 10.0 111.221 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 34.5 m -77.43 -31.6 17.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.006 0.431 . . . . 10.0 111.311 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' B' ' 17' ' ' SER . 0.4 OUTLIER -71.64 -25.69 62.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.075 -0.511 . . . . 10.0 111.188 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -94.59 1.13 55.62 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.397 0.618 . . . . 10.0 109.578 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 14.7 mmtt 55.33 45.56 25.28 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 114.805 -1.089 . . . . 10.0 111.573 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -93.66 24.32 4.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.946 0.403 . . . . 10.0 111.223 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 16.8 tt -160.87 161.39 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 116.173 -0.467 . . . . 10.0 110.41 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.84 159.86 29.53 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.817 -0.629 . . . . 10.0 111.443 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -56.97 -41.86 79.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.65 -0.705 . . . . 10.0 111.412 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.33 -50.67 72.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.998 -0.547 . . . . 10.0 109.845 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . 0.495 ' O ' ' HG ' ' B' ' 33' ' ' LEU . . . -60.39 -41.08 98.37 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.622 -0.717 . . . . 10.0 111.677 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.25 -31.87 73.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.883 -0.158 . . . . 10.0 110.913 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.42 ' CG ' ' HZ3' ' A' ' 118' ' ' LYS . 17.4 t70 -71.5 -43.3 66.79 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.43 -0.582 . . . . 10.0 109.43 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' SER . . . . . 0.453 ' O ' HG12 ' B' ' 35' ' ' VAL . 4.1 m -62.54 -51.14 68.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.313 -0.858 . . . . 10.0 110.288 178.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' B' ' 29' ' ' GLY . 89.6 mt -59.12 -41.92 89.35 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.127 -0.488 . . . . 10.0 110.173 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -57.83 -49.61 76.09 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.752 -0.658 . . . . 10.0 111.106 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.453 HG12 ' O ' ' B' ' 32' ' ' SER . 2.6 p -70.93 -33.81 53.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.738 -0.385 . . . . 10.0 111.691 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.23 -39.25 89.43 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 109.625 -0.509 . . . . 10.0 109.625 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' MET . . . . . . . . . . . . . 32.8 ttm -54.65 -45.6 73.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.305 -0.861 . . . . 10.0 109.574 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . 0.517 ' OD2' ' HD3' ' A' ' 149' ' ' LYS . 18.4 t70 -62.6 -53.73 50.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.118 -0.947 . . . . 10.0 110.886 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 59.8 m -52.09 -47.76 65.07 Favored 'General case' 0 N--CA 1.462 0.137 0 O-C-N 123.581 0.551 . . . . 10.0 111.529 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 59.7 mt -62.6 -44.83 99.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.02 -0.536 . . . . 10.0 110.69 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.547 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 49.0 m -61.28 -43.32 99.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.026 -0.534 . . . . 10.0 110.876 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -67.52 -42.39 82.87 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.679 -0.691 . . . . 10.0 111.243 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.2 -33.61 74.74 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.28 0.474 . . . . 10.0 112.28 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -90.38 -7.2 53.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.671 0.272 . . . . 10.0 111.062 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.84 46.74 90.96 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.201 -0.523 . . . . 10.0 112.864 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.547 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 3.7 p90 -144.34 154.71 43.31 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 122.569 -0.371 . . . . 10.0 110.474 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -92.93 147.08 23.14 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.404 -0.362 . . . . 10.0 110.408 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -27.34 68.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.548 -0.296 . . . . 10.0 111.483 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -72.68 -10.32 59.65 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.404 -0.362 . . . . 10.0 111.839 -179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.28 4.38 27.3 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.592 -0.276 . . . . 10.0 111.351 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.43 HG21 ' H ' ' B' ' 52' ' ' SER . 0.1 OUTLIER -42.77 -59.94 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 112.653 0.612 . . . . 10.0 112.653 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' SER . . . . . 0.43 ' H ' HG21 ' B' ' 51' ' ' VAL . 0.9 OUTLIER -60.89 -19.56 60.56 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.229 0.826 . . . . 10.0 113.229 -179.421 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.46 -38.5 12.35 Favored Glycine 0 C--O 1.235 0.203 0 C-N-CA 120.879 -0.677 . . . . 10.0 112.382 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 6.2 mt -86.63 -47.34 16.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.816 0.341 . . . . 10.0 111.23 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 53.4 mt -73.08 -57.88 3.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.306 0.574 . . . . 10.0 110.424 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.83 -144.7 48.56 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.327 -0.851 . . . . 10.0 112.569 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -91.67 -11.03 38.13 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.465 -0.367 . . . . 10.0 110.918 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.56 131.79 52.02 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.798 0.666 . . . . 10.0 112.798 -178.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -81.22 155.13 26.28 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.814 -0.81 . . . . 10.0 108.814 177.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -120.92 165.1 15.69 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 109.731 -0.47 . . . . 10.0 109.731 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? -157.03 160.95 39.47 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.046 0.45 . . . . 10.0 110.564 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -136.58 57.88 0.66 Allowed Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 115.54 -0.755 . . . . 10.0 111.631 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -78.28 130.38 36.15 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.765 -0.457 . . . . 10.0 109.765 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 48.7 p-80 -150.06 111.23 4.39 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.786 -0.643 . . . . 10.0 109.649 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.06 -8.51 58.65 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.447 -0.797 . . . . 10.0 110.487 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -86.24 126.86 34.59 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.527 -0.76 . . . . 10.0 110.306 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.83 126.16 27.61 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.834 -0.621 . . . . 10.0 110.367 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 19.9 mt -68.7 97.26 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.527 -0.306 . . . . 10.0 110.206 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 55.6 mt 63.8 -96.37 0.05 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.764 -0.653 . . . . 10.0 110.269 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -126.95 -1.45 6.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.627 0.251 . . . . 10.0 110.423 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 60.7 m 57.4 26.71 12.85 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.796 -0.638 . . . . 10.0 111.962 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.944 0 CA-C-O 118.422 -0.799 . . . . 10.0 111.206 179.952 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' -1' ' ' SER . . . . . . . . . . . . . 2.2 m . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 120.581 0.229 . . . . 10.0 110.465 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 0' ' ' VAL . . . . . . . . . . . . . 18.8 m -135.37 -179.97 3.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.2 -0.455 . . . . 10.0 110.631 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 1' ' ' ASP . . . . . 0.461 ' CG ' ' HZ1' ' C' ' 61' ' ' LYS . 6.6 t70 -150.09 -77.63 0.14 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.713 -0.847 . . . . 10.0 108.713 178.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 35.4 m -170.35 9.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.628 -0.715 . . . . 10.0 110.418 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -90.25 153.86 20.16 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.644 -0.253 . . . . 10.0 111.047 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 4' ' ' SER . . . . . 0.515 ' O ' HG12 ' C' ' 8' ' ' ILE . 31.4 p -102.16 161.88 13.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.383 -0.371 . . . . 10.0 110.984 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -56.08 -39.34 71.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.294 -0.412 . . . . 10.0 111.498 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 6' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -61.2 -48.58 80.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.011 0.434 . . . . 10.0 110.911 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -63.49 -39.07 93.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.857 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 8' ' ' ILE . . . . . 0.539 ' O ' HD13 ' C' ' 12' ' ' ILE . 43.6 mm -60.89 -46.83 95.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.564 -0.532 . . . . 10.0 109.564 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 9' ' ' ALA . . . . . 0.405 ' HB2' ' CE1' ' C' ' 46' ' ' PHE . . . -60.04 -44.09 94.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.692 -0.686 . . . . 10.0 110.825 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.99 -41.93 98.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.94 -0.573 . . . . 10.0 111.224 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 16.6 mt -62.44 -41.72 98.93 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.463 0.649 . . . . 10.0 110.006 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 12' ' ' ILE . . . . . 0.539 HD13 ' O ' ' C' ' 8' ' ' ILE . 1.3 mp -59.22 -51.42 72.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.749 -1.114 . . . . 10.0 111.876 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 13' ' ' VAL . . . . . 0.51 ' N ' HG22 ' C' ' 12' ' ' ILE . 30.0 m -67.93 -24.95 31.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.028 0.442 . . . . 10.0 111.758 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -76.45 -42.56 43.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.749 0.309 . . . . 10.0 110.227 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 15' ' ' TYR . . . . . 0.448 ' O ' HG12 ' C' ' 19' ' ' ILE . 3.1 m-85 -73.32 -40.28 64.61 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.7 -0.4 . . . . 10.0 110.82 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -58.32 -49.48 77.03 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 109.998 -0.371 . . . . 10.0 109.998 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 35.4 p -62.05 -43.6 98.49 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.302 -0.408 . . . . 10.0 111.123 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 32.9 p -66.95 -24.45 66.07 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 111.69 0.256 . . . . 10.0 111.69 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 19' ' ' ILE . . . . . 0.448 HG12 ' O ' ' C' ' 15' ' ' TYR . 26.8 mm -80.6 -39.67 18.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 110.011 -0.366 . . . . 10.0 110.011 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 20' ' ' VAL . . . . . . . . . . . . . 19.5 m -77.43 -27.23 15.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.84 -0.344 . . . . 10.0 111.124 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -68.71 -50.33 51.66 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.846 -0.427 . . . . 10.0 109.846 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -71.92 -10.02 59.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.047 -0.524 . . . . 10.0 110.205 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm 58.95 42.31 19.66 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.506 0.67 . . . . 10.0 109.505 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -81.41 -6.28 58.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.232 -0.894 . . . . 10.0 110.729 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 18.1 tt -125.61 160.08 32.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.101 -0.5 . . . . 10.0 109.761 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -58.94 152.51 19.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.463 -0.335 . . . . 10.0 110.482 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -57.4 -34.49 68.94 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.81 0.338 . . . . 10.0 110.41 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 28' ' ' ASP . . . . . 0.443 ' CG ' ' HZ2' ' A' ' 85' ' ' LYS . 30.4 t70 -61.8 -50.77 71.0 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.51 -0.768 . . . . 10.0 109.983 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 29' ' ' GLY . . . . . 0.519 ' O ' ' HG ' ' C' ' 33' ' ' LEU . . . -67.33 -31.13 76.3 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.144 -0.934 . . . . 10.0 112.643 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.96 -46.66 88.7 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.557 0.218 . . . . 10.0 110.461 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -63.64 -37.81 88.74 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.529 -0.545 . . . . 10.0 109.529 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 14.0 m -57.61 -44.91 85.82 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.449 -0.796 . . . . 10.0 109.784 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 33' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' C' ' 29' ' ' GLY . 51.6 mt -70.25 -37.37 74.93 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.026 -0.534 . . . . 10.0 110.501 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -59.17 -55.83 29.96 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.048 -0.524 . . . . 10.0 111.429 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 35' ' ' VAL . . . . . . . . . . . . . 8.4 p -66.07 -41.77 90.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 115.961 -0.563 . . . . 10.0 111.117 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.55 -28.47 69.96 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.676 0.274 . . . . 10.0 111.032 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 9.0 mtm -59.98 -51.33 70.14 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.262 -0.426 . . . . 10.0 110.45 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 38' ' ' ASP . . . . . 0.612 ' CB ' ' HA3' ' A' ' 123' ' ' GLY . 1.2 m-20 -69.94 -27.47 64.78 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 109.639 -0.504 . . . . 10.0 109.639 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 39' ' ' CYS . . . . . 0.681 ' SG ' ' HA2' ' A' ' 123' ' ' GLY . 62.6 m -61.49 -50.25 73.46 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 109.297 -0.631 . . . . 10.0 109.297 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 40' ' ' ILE . . . . . . . . . . . . . 54.6 mt -67.2 -35.76 74.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.993 -1.003 . . . . 10.0 109.957 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 41' ' ' SER . . . . . 0.683 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 53.1 m -61.36 -51.81 67.27 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.713 -0.676 . . . . 10.0 110.536 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.82 -35.67 80.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.793 0.33 . . . . 10.0 110.867 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.66 -42.69 93.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.099 -0.5 . . . . 10.0 111.808 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 44' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -96.3 -2.48 45.79 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.869 0.366 . . . . 10.0 111.634 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.4 51.22 38.78 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.103 -0.57 . . . . 10.0 112.945 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 46' ' ' PHE . . . . . 0.683 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 4.3 p90 -144.48 157.58 44.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.055 0.455 . . . . 10.0 110.327 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -96.4 136.75 36.46 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.111 -0.495 . . . . 10.0 109.685 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 48' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -60.88 -13.97 19.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.757 -0.656 . . . . 10.0 112.111 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -84.03 -6.56 59.43 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.745 0.646 . . . . 10.0 112.745 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.53 4.55 27.57 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.134 0.42 . . . . 10.0 112.134 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 4.9 m -45.03 -54.4 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 113.548 0.944 . . . . 10.0 113.548 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 52' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.93 -30.88 68.19 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.775 0.658 . . . . 10.0 112.775 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.13 -49.81 5.77 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.426 -0.892 . . . . 10.0 112.912 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 54' ' ' ILE . . . . . . . . . . . . . 80.0 mt -69.67 -54.6 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-O 120.642 0.258 . . . . 10.0 111.328 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 70.0 mt -68.77 -52.76 26.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.433 -0.349 . . . . 10.0 111.009 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.38 -136.66 47.57 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.261 -0.495 . . . . 10.0 112.837 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 30.9 tttt -108.3 3.43 23.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.222 0.534 . . . . 10.0 110.094 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 9.1 t -73.62 138.15 44.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.966 -0.561 . . . . 10.0 110.555 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -87.86 143.41 27.14 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.585 -0.734 . . . . 10.0 109.721 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 60' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -108.02 160.74 15.55 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.294 -0.632 . . . . 10.0 109.294 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 61' ' ' LYS . . . . . 0.461 ' HZ1' ' CG ' ' C' ' 1' ' ' ASP . 10.2 ptmm? -140.97 170.45 15.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.917 0.389 . . . . 10.0 111.34 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -151.18 54.98 0.47 Allowed Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.284 -0.871 . . . . 10.0 111.081 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 63' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -82.2 133.05 35.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.147 0.498 . . . . 10.0 110.68 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 64' ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -153.33 112.43 3.77 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.118 0.485 . . . . 10.0 110.366 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -76.21 -28.51 57.24 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.775 -0.648 . . . . 10.0 109.475 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.17 137.46 35.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.3 -0.864 . . . . 10.0 109.646 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.44 155.53 36.2 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.178 -0.465 . . . . 10.0 110.365 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 68' ' ' ILE . . . . . . . . . . . . . 34.3 mt -83.85 100.08 6.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.453 -0.573 . . . . 10.0 109.453 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 33.6 mt 68.36 -74.62 0.07 Allowed 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.75 0.656 . . . . 10.0 110.508 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 70' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -150.26 -26.48 0.24 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.818 -0.628 . . . . 10.0 110.054 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 71' ' ' SER . . . . . 0.402 ' HA ' ' CB ' ' B' ' 52' ' ' SER . 16.8 m 56.45 47.34 19.04 Favored 'General case' 0 C--N 1.335 -0.044 0 CA-C-N 115.439 -0.8 . . . . 10.0 110.922 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.133 0 CA-C-N 115.384 -0.825 . . . . 10.0 110.321 -179.613 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 74.4 mmm . . . . . 0 N--CA 1.485 1.317 0 N-CA-C 110.079 -0.341 . . . . 10.0 110.079 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.1 t -104.45 135.78 40.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.927 -0.579 . . . . 10.0 110.352 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -87.57 129.29 35.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.57 0.224 . . . . 10.0 110.729 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.5 mp -127.87 129.17 46.46 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.126 0.489 . . . . 10.0 110.149 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.3 m -94.69 109.12 21.09 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.653 -0.703 . . . . 10.0 110.389 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -85.16 118.77 24.92 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.876 -0.787 . . . . 10.0 108.876 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.602 ' HZ1' ' CG ' ' C' ' 31' ' ' ASP . 14.2 ttpt -119.47 108.42 14.51 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.284 -0.416 . . . . 10.0 111.28 -178.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 84' ' ' PRO . 19.1 tptm -94.91 113.28 24.98 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 116.484 -0.326 . . . . 10.0 110.922 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.573 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 52.4 mt -80.49 -59.86 2.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 O-C-N 124.168 0.917 . . . . 10.0 111.542 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -63.13 160.31 15.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.787 0.327 . . . . 10.0 110.983 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.4 140.4 72.34 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 120.695 0.283 . . . . 10.0 111.401 -179.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.501 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 59.6 Cg_endo -76.9 140.61 66.02 Favored 'Cis proline' 0 C--N 1.343 0.266 0 C-N-CA 122.992 -1.67 . . . . 10.0 111.392 -1.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.573 ' HG2' ' O ' ' A' ' 81' ' ' ILE . 27.7 mtpp -82.91 145.1 29.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.436 -0.347 . . . . 10.0 110.965 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.413 ' CE2' ' HB3' ' A' ' 110' ' ' LYS . 34.1 p90 -165.73 156.08 13.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.714 0.292 . . . . 10.0 111.055 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.9 m -140.82 114.21 8.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.724 -0.671 . . . . 10.0 110.371 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 10.6 pt -134.87 149.02 29.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.558 -0.292 . . . . 10.0 110.816 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -117.16 116.62 27.65 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.384 -0.598 . . . . 10.0 109.384 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 25.7 t60 -130.3 146.31 51.88 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.412 -0.588 . . . . 10.0 109.412 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -99.11 139.66 34.43 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.201 0.524 . . . . 10.0 110.22 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -129.75 170.46 13.81 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.816 -0.629 . . . . 10.0 110.664 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.55 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 19.3 t -81.34 146.98 59.1 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 115.914 -0.585 . . . . 10.0 109.683 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -62.4 -18.02 60.73 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.126 1.884 . . . . 10.0 111.094 178.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.4 m -102.73 15.17 30.07 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.616 -0.72 . . . . 10.0 110.589 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.55 ' HB2' ' O ' ' A' ' 93' ' ' SER . 0.4 OUTLIER -83.5 167.88 17.0 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.043 0.449 . . . . 10.0 110.833 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.81 156.43 29.43 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.787 -0.642 . . . . 10.0 110.638 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 43.1 mm -63.3 -23.4 33.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.969 -0.559 . . . . 10.0 110.254 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.39 -40.58 65.14 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.355 -0.839 . . . . 10.0 110.873 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -64.02 -43.68 94.86 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 120.937 0.399 . . . . 10.0 110.864 -179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.535 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 44.6 mt -62.12 -47.57 92.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.87 -0.605 . . . . 10.0 109.568 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -54.44 -46.41 73.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.341 -0.845 . . . . 10.0 111.237 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.43 ' OE1' ' HA ' ' A' ' 103' ' ' GLN . 16.0 mm-40 -65.04 -34.47 78.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.161 -0.472 . . . . 10.0 110.881 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 48.0 t60 -62.91 -39.56 94.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.342 -0.39 . . . . 10.0 110.326 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 101' ' ' ILE . 17.3 mt -63.14 -41.11 99.24 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.187 -0.46 . . . . 10.0 110.139 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 14.6 mt -68.53 -39.42 80.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.302 -0.408 . . . . 10.0 109.929 178.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.4 m -65.05 -26.07 68.09 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.214 0.531 . . . . 10.0 111.285 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -88.06 2.76 51.14 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.315 -0.402 . . . . 10.0 110.806 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 62.95 25.36 15.02 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.336 0.588 . . . . 10.0 109.997 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.413 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 22.5 mmtp -99.18 -8.16 25.51 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.565 -0.743 . . . . 10.0 109.89 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -130.6 154.46 47.84 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.397 -0.819 . . . . 10.0 110.371 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.1 m -107.77 -33.28 7.31 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.021 -0.536 . . . . 10.0 111.516 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.437 ' O ' HG13 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -154.57 129.89 9.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.582 -0.281 . . . . 10.0 110.777 -178.306 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 9.3 tt -61.77 -38.84 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-O 120.937 0.398 . . . . 10.0 111.451 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.561 ' HB3' ' OE2' ' A' ' 116' ' ' GLU . 8.1 t -49.48 -38.27 29.38 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.12 -0.946 . . . . 10.0 112.461 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.561 ' OE2' ' HB3' ' A' ' 115' ' ' SER . 1.3 pm0 -94.73 11.6 30.79 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.176 0.436 . . . . 10.0 112.176 -178.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 113' ' ' HIS . 65.9 mt -95.6 119.98 44.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.992 -0.744 . . . . 10.0 108.992 178.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.501 ' HZ1' ' CG ' ' B' ' 31' ' ' ASP . 11.8 mmmt -126.22 120.37 29.86 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.777 -0.453 . . . . 10.0 109.777 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -95.79 127.24 41.65 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.132 0.491 . . . . 10.0 111.248 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -110.33 138.46 46.69 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.493 -0.776 . . . . 10.0 108.98 178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 25.3 tp -124.0 99.71 6.38 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.36 -0.607 . . . . 10.0 109.36 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 23.2 tptp 46.34 57.14 5.6 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 123.903 0.752 . . . . 10.0 110.416 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.557 ' HA3' ' CB ' ' C' ' 38' ' ' ASP . . . 81.48 -45.01 3.17 Favored Glycine 0 C--N 1.332 0.35 0 CA-C-N 115.567 -0.742 . . . . 10.0 113.097 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 40.1 tttp -62.61 133.16 54.49 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.807 -0.442 . . . . 10.0 109.807 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.3 p -83.03 141.03 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 113.341 0.867 . . . . 10.0 113.341 -177.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.5 mp -107.71 154.58 21.28 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.421 -0.808 . . . . 10.0 110.489 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 56.7 m-70 -111.9 154.61 24.95 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.781 0.324 . . . . 10.0 110.708 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -50.17 -54.04 23.54 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.727 1.01 . . . . 10.0 113.727 -178.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -96.51 18.69 13.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.921 0.391 . . . . 10.0 111.919 -177.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 12.0 tp -68.81 146.77 52.59 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.029 0.442 . . . . 10.0 111.048 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -99.7 143.62 29.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.779 -0.646 . . . . 10.0 110.082 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 49.7 mt -56.8 -28.99 62.25 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.255 0.347 . . . . 10.0 111.692 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.69 -22.37 56.73 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.988 0.423 . . . . 10.0 111.687 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -83.11 -49.13 9.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.532 -0.304 . . . . 10.0 110.588 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.6 pp -72.72 -25.24 61.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 10.0 111.06 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt 65.85 91.96 0.08 Allowed 'General case' 0 N--CA 1.463 0.216 0 O-C-N 123.884 0.74 . . . . 10.0 112.064 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.2 t -66.99 110.08 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.415 -0.587 . . . . 10.0 109.415 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -81.51 124.69 79.92 Favored Pre-proline 0 N--CA 1.447 -0.584 0 CA-C-N 115.95 -0.568 . . . . 10.0 111.156 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -64.92 -17.07 58.38 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.819 2.346 . . . . 10.0 111.967 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -79.72 0.12 31.85 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.914 -0.585 . . . . 10.0 110.789 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -136.48 -63.88 0.61 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.119 -0.492 . . . . 10.0 109.787 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 30.5 m 51.6 24.48 2.34 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.634 -0.712 . . . . 10.0 112.543 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 32.4 m -124.71 126.32 45.51 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.142 0.496 . . . . 10.0 111.094 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 24.3 mm -106.73 120.51 58.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.567 -0.742 . . . . 10.0 109.584 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.24 117.85 23.23 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.242 -0.435 . . . . 10.0 109.83 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 29.1 t -93.46 127.73 45.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.689 -0.687 . . . . 10.0 111.221 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' MET . . . . . 0.44 ' HE3' ' SG ' ' B' ' 39' ' ' CYS . 1.2 mpt? -124.65 117.26 23.88 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.47 -0.786 . . . . 10.0 109.247 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.432 HG21 HD12 ' A' ' 148' ' ' ILE . 10.2 mt -138.72 143.56 31.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.197 -0.456 . . . . 10.0 111.165 -177.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -109.8 114.56 56.45 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 108.846 -0.798 . . . . 10.0 108.846 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -61.54 124.97 15.67 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.447 2.098 . . . . 10.0 113.215 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -95.05 -0.06 53.99 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.535 -0.543 . . . . 10.0 109.535 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 26.8 mt -79.94 110.21 15.1 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.409 -0.814 . . . . 10.0 110.63 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.49 -0.767 . . . . 10.0 110.152 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' -1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.477 0 N-CA-C 110.082 -0.34 . . . . 10.0 110.082 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 0' ' ' VAL . . . . . . . . . . . . . 16.6 m -139.36 150.14 22.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.337 -0.392 . . . . 10.0 110.077 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -156.99 -86.92 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.878 -0.601 . . . . 10.0 109.513 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' SER . . . . . 0.405 ' HB2' ' OE1' ' B' ' 59' ' ' GLU . 2.0 p -86.59 -43.14 12.91 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 121.078 0.466 . . . . 10.0 110.091 178.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -115.18 168.62 9.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.804 -0.634 . . . . 10.0 110.46 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' SER . . . . . 0.466 ' O ' HG12 ' B' ' 8' ' ' ILE . 26.0 t -87.25 168.36 13.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.387 -0.37 . . . . 10.0 110.515 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 5.2 ptpp? -57.88 -44.17 86.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.284 -0.416 . . . . 10.0 110.664 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -58.11 -46.25 85.88 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.004 0.43 . . . . 10.0 110.549 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -62.29 -38.94 91.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.932 -0.577 . . . . 10.0 110.458 179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.492 HG13 ' CE2' ' C' ' 15' ' ' TYR . 38.7 mm -63.63 -45.8 96.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.992 -0.549 . . . . 10.0 109.99 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.443 ' HA ' HD13 ' B' ' 12' ' ' ILE . . . -62.41 -36.72 83.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.736 -0.665 . . . . 10.0 110.994 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.36 -34.03 77.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.984 -0.553 . . . . 10.0 110.48 179.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 22.9 mt -67.02 -35.63 80.32 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.57 -0.53 . . . . 10.0 109.57 178.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.443 HD13 ' HA ' ' B' ' 9' ' ' ALA . 53.4 mt -59.91 -56.96 13.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.515 -0.766 . . . . 10.0 111.396 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.461 ' HB ' ' HG2' ' B' ' 48' ' ' ARG . 24.4 m -65.44 -31.95 56.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.432 -0.349 . . . . 10.0 111.613 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -65.26 -51.38 61.2 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.215 0.531 . . . . 10.0 110.179 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' TYR . . . . . 0.46 ' O ' HG12 ' B' ' 19' ' ' ILE . 16.5 m-85 -64.28 -44.97 90.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.974 -0.557 . . . . 10.0 111.338 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 9.3 m-30 -58.32 -50.37 73.87 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.559 0.207 . . . . 10.0 111.559 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 24.2 m -56.97 -38.5 73.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.933 0.397 . . . . 10.0 111.456 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 2.7 p -79.03 -20.11 49.79 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.293 -0.255 . . . . 10.0 111.256 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.46 HG12 ' O ' ' B' ' 15' ' ' TYR . 13.6 mm -76.72 -41.2 33.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 109.487 -0.56 . . . . 10.0 109.487 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 26.6 m -76.04 -27.78 18.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.937 -0.574 . . . . 10.0 110.369 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 tm-20 -65.22 -52.08 56.91 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.531 -0.544 . . . . 10.0 109.531 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 21.4 mmtm -79.89 -8.75 59.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.642 -0.708 . . . . 10.0 110.545 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 52.1 mttt 55.36 52.78 10.82 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.486 -0.779 . . . . 10.0 110.843 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.471 ' O ' ' HE2' ' C' ' 5' ' ' LYS . 87.7 mt-10 -89.35 26.64 1.61 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.249 -0.887 . . . . 10.0 110.105 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 13.7 tt -162.25 160.77 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.598 -0.728 . . . . 10.0 109.848 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.48 153.22 36.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.597 -0.274 . . . . 10.0 110.847 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -59.15 -44.44 92.09 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.379 0.511 . . . . 10.0 112.379 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.79 -47.48 82.45 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.089 0.471 . . . . 10.0 110.228 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . 0.436 ' O ' ' HG ' ' B' ' 33' ' ' LEU . . . -67.36 -34.54 85.41 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.791 -0.64 . . . . 10.0 111.901 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.9 -39.3 94.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.698 0.285 . . . . 10.0 111.02 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.501 ' CG ' ' HZ1' ' A' ' 118' ' ' LYS . 23.9 t70 -70.55 -30.43 67.15 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.751 -0.463 . . . . 10.0 109.751 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 2.0 m -62.23 -43.14 99.5 Favored 'General case' 0 C--N 1.334 -0.097 0 N-CA-C 109.126 -0.694 . . . . 10.0 109.126 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' B' ' 29' ' ' GLY . 26.7 mt -70.23 -36.4 74.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.751 -0.659 . . . . 10.0 109.851 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -54.82 -56.2 21.95 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.227 -0.897 . . . . 10.0 110.853 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 7.1 p -73.17 -34.32 44.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 115.947 -0.57 . . . . 10.0 111.397 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.09 -32.68 74.11 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.991 -0.374 . . . . 10.0 109.991 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' MET . . . . . . . . . . . . . 22.7 mtm -60.05 -44.12 94.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.414 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.27 -47.65 85.11 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.234 -0.439 . . . . 10.0 110.006 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' CYS . . . . . 0.44 ' SG ' ' HE3' ' A' ' 147' ' ' MET . 15.8 m -58.18 -43.44 87.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.789 -0.641 . . . . 10.0 110.817 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 96.5 mt -67.21 -48.65 77.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-O 120.742 0.305 . . . . 10.0 111.555 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.53 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 10.6 m -60.06 -46.4 89.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.361 -0.381 . . . . 10.0 110.895 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -67.41 -37.99 83.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.384 -0.371 . . . . 10.0 111.209 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.26 -42.36 99.13 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.877 0.325 . . . . 10.0 111.877 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -87.6 -7.87 56.96 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.889 0.329 . . . . 10.0 111.889 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.62 49.82 17.27 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.986 -0.626 . . . . 10.0 113.54 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.53 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 8.2 p90 -151.98 166.75 30.57 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.433 -0.58 . . . . 10.0 109.433 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -117.09 157.82 25.25 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.199 0.523 . . . . 10.0 110.554 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.461 ' HG2' ' HB ' ' B' ' 13' ' ' VAL . 0.6 OUTLIER -68.99 -22.94 64.06 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.473 -0.785 . . . . 10.0 111.597 -178.554 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -69.07 -8.57 46.39 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.179 0.807 . . . . 10.0 113.179 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -103.34 5.62 37.39 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.813 0.671 . . . . 10.0 112.813 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.525 HG22 ' H ' ' B' ' 52' ' ' SER . 2.6 m -40.69 -61.61 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 113.638 0.977 . . . . 10.0 113.638 -178.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' SER . . . . . 0.525 ' H ' HG22 ' B' ' 51' ' ' VAL . 1.0 OUTLIER -62.01 -23.14 66.25 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.991 0.737 . . . . 10.0 112.991 -178.696 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.66 -40.81 30.88 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.646 -0.788 . . . . 10.0 112.43 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 72.8 mt -81.34 -47.37 19.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.711 0.291 . . . . 10.0 111.226 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 67.0 mt -74.99 -67.99 0.59 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.742 0.306 . . . . 10.0 110.573 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . 0.514 ' HA2' ' HB3' ' C' ' 71' ' ' SER . . . 55.06 -106.13 0.49 Allowed Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.777 -0.647 . . . . 10.0 113.381 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 16.0 pttt -126.96 18.81 7.16 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.205 0.526 . . . . 10.0 110.211 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 13.1 m -76.68 -59.13 2.9 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.707 -0.678 . . . . 10.0 110.406 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . 0.405 ' OE1' ' HB2' ' B' ' 2' ' ' SER . 8.5 tt0 -152.61 146.8 25.49 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.359 -0.382 . . . . 10.0 110.051 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -166.54 -41.09 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.211 -0.45 . . . . 10.0 110.553 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -129.96 147.64 51.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.077 -0.51 . . . . 10.0 109.892 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . 0.492 ' CA ' ' HA2' ' C' ' 62' ' ' GLY . . . -127.14 -156.13 9.05 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.577 -0.82 . . . . 10.0 113.09 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -143.16 170.4 15.8 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.832 0.348 . . . . 10.0 110.646 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . 0.451 ' CD2' ' HA ' ' C' ' 58' ' ' SER . 6.7 m80 -71.31 101.64 2.4 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.631 -0.713 . . . . 10.0 110.297 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -121.85 131.01 53.81 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.935 -0.575 . . . . 10.0 110.303 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -89.38 54.16 2.85 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.356 0.598 . . . . 10.0 110.907 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.1 -24.29 35.25 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.813 -0.631 . . . . 10.0 110.726 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 5.3 mt -92.28 121.7 43.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.806 -0.634 . . . . 10.0 110.212 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 41.1 mt -97.22 -5.24 37.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.362 -0.381 . . . . 10.0 110.834 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -80.12 -22.31 42.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.156 0.503 . . . . 10.0 110.436 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.14 82.8 3.23 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.041 -0.527 . . . . 10.0 111.177 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.442 -0.79 . . . . 10.0 111.445 179.252 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' -1' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.475 0.797 0 CA-C-O 120.817 0.341 . . . . 10.0 110.858 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 0' ' ' VAL . . . . . 0.402 HG12 ' HA ' ' C' ' 4' ' ' SER . 2.2 m -137.68 70.26 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.391 0.615 . . . . 10.0 110.682 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 1' ' ' ASP . . . . . 0.41 ' HB3' ' H ' ' C' ' 2' ' ' SER . 0.4 OUTLIER -68.15 -90.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.527 -0.761 . . . . 10.0 111.343 -179.373 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 2' ' ' SER . . . . . 0.41 ' H ' ' HB3' ' C' ' 1' ' ' ASP . 3.3 p -83.84 -45.46 13.25 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.242 0.544 . . . . 10.0 110.604 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -104.66 172.88 6.56 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.388 -0.824 . . . . 10.0 110.27 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 4' ' ' SER . . . . . 0.46 ' O ' HG12 ' C' ' 8' ' ' ILE . 8.6 t -97.8 171.77 8.1 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.347 -0.612 . . . . 10.0 109.347 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . 0.471 ' HE2' ' O ' ' B' ' 24' ' ' GLU . 3.4 ptpp? -59.23 -37.97 78.85 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 121.407 -0.117 . . . . 10.0 110.903 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 6' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -58.27 -45.55 87.66 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.055 0.455 . . . . 10.0 110.725 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -69.99 -41.44 74.38 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.19 -0.459 . . . . 10.0 110.735 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 8' ' ' ILE . . . . . 0.46 HG12 ' O ' ' C' ' 4' ' ' SER . 40.1 mm -59.19 -44.89 92.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.825 -0.435 . . . . 10.0 109.825 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.41 -39.93 92.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.824 -0.625 . . . . 10.0 110.442 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.42 -43.03 99.58 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.816 -0.629 . . . . 10.0 110.41 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . 0.462 ' HG ' ' CD2' ' C' ' 55' ' ' LEU . 7.0 mt -61.04 -40.43 93.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.457 -0.338 . . . . 10.0 110.743 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 12' ' ' ILE . . . . . 0.458 HG13 ' O ' ' C' ' 8' ' ' ILE . 73.1 mt -65.2 -54.13 32.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.038 -0.528 . . . . 10.0 111.668 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 18.1 m -64.86 -27.47 42.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.899 0.38 . . . . 10.0 110.952 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -71.67 -47.08 56.65 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 120.986 0.422 . . . . 10.0 110.186 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 15' ' ' TYR . . . . . 0.492 ' CE2' HG13 ' B' ' 8' ' ' ILE . 3.2 m-85 -62.59 -42.66 99.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.829 -0.623 . . . . 10.0 110.598 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -59.18 -45.05 92.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.192 -0.458 . . . . 10.0 111.027 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 35.8 m -58.6 -39.7 81.15 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.119 -0.491 . . . . 10.0 111.692 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.71 -19.29 45.4 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.973 0.416 . . . . 10.0 111.139 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 19' ' ' ILE . . . . . 0.4 HG22 HD11 ' C' ' 19' ' ' ILE . 4.2 mm -75.87 -45.12 38.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.006 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 20' ' ' VAL . . . . . . . . . . . . . 27.3 m -75.44 -18.09 15.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 121.235 0.54 . . . . 10.0 110.676 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -70.91 -56.35 6.43 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.534 -0.757 . . . . 10.0 110.794 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 22' ' ' LYS . . . . . 0.489 ' HD2' ' OE2' ' C' ' 24' ' ' GLU . 45.5 mttm -81.22 -2.01 47.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.399 -0.818 . . . . 10.0 111.735 -178.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 87.7 mttt 55.58 49.23 16.98 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.475 0.655 . . . . 10.0 110.571 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . 0.489 ' OE2' ' HD2' ' C' ' 22' ' ' LYS . 46.3 mt-10 -82.47 -15.36 52.79 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.546 -0.752 . . . . 10.0 110.096 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 17.1 tt -114.2 161.14 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 115.608 -0.724 . . . . 10.0 109.829 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.31 154.08 39.29 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 123.288 0.368 . . . . 10.0 110.11 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -52.25 -44.5 64.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.95 0.405 . . . . 10.0 111.46 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 28' ' ' ASP . . . . . 0.448 ' CG ' ' HZ3' ' A' ' 85' ' ' LYS . 16.1 t0 -59.03 -45.07 91.65 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.882 -0.599 . . . . 10.0 110.646 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 29' ' ' GLY . . . . . 0.631 ' O ' ' HG ' ' C' ' 33' ' ' LEU . . . -68.12 -38.11 87.82 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.639 -0.709 . . . . 10.0 112.183 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.55 -43.31 84.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.047 0.451 . . . . 10.0 110.402 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 31' ' ' ASP . . . . . 0.602 ' CG ' ' HZ1' ' A' ' 79' ' ' LYS . 31.1 t70 -69.41 -37.59 77.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.904 -0.589 . . . . 10.0 110.347 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 24.3 m -64.23 -36.11 83.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.676 -0.693 . . . . 10.0 110.39 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 33' ' ' LEU . . . . . 0.631 ' HG ' ' O ' ' C' ' 29' ' ' GLY . 46.5 mt -73.05 -26.86 61.44 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.849 -0.426 . . . . 10.0 109.849 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 34' ' ' ASN . . . . . 0.476 ' HB3' ' O ' ' C' ' 31' ' ' ASP . 24.8 t30 -61.83 -56.6 17.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.917 -0.583 . . . . 10.0 110.303 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 35' ' ' VAL . . . . . 0.43 HG22 ' H ' ' A' ' 123' ' ' GLY . 6.3 p -66.64 -38.23 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 115.672 -0.695 . . . . 10.0 110.639 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . 0.475 ' O ' HG13 ' C' ' 40' ' ' ILE . . . -64.28 -32.57 74.22 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.389 -0.369 . . . . 10.0 110.995 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 14.0 mtm -59.29 -52.8 64.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.636 -0.256 . . . . 10.0 111.024 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 38' ' ' ASP . . . . . 0.557 ' CB ' ' HA3' ' A' ' 123' ' ' GLY . 28.1 m-20 -63.99 -26.55 68.62 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.462 -0.335 . . . . 10.0 110.597 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 39' ' ' CYS . . . . . 0.469 ' HB2' ' O ' ' C' ' 36' ' ' ALA . 62.7 m -60.23 -43.41 96.06 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 109.351 -0.611 . . . . 10.0 109.351 178.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 40' ' ' ILE . . . . . 0.475 HG13 ' O ' ' C' ' 36' ' ' ALA . 14.8 mt -69.03 -47.75 73.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.554 -0.748 . . . . 10.0 110.551 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 41' ' ' SER . . . . . 0.463 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 17.8 m -59.78 -43.18 94.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.916 -0.583 . . . . 10.0 111.712 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -68.59 -43.23 76.93 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.281 -0.418 . . . . 10.0 111.238 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.9 -44.86 75.98 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.355 0.502 . . . . 10.0 112.355 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 44' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -86.36 -7.31 58.56 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.95 0.352 . . . . 10.0 111.95 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.16 55.38 21.83 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.893 -0.67 . . . . 10.0 113.326 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 46' ' ' PHE . . . . . 0.463 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 4.7 p90 -153.98 177.7 10.75 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.896 -0.779 . . . . 10.0 108.896 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -125.27 150.87 46.67 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.263 0.554 . . . . 10.0 111.576 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 48' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -71.83 -27.63 63.04 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.499 -0.773 . . . . 10.0 110.954 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -72.15 2.8 5.27 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.006 -0.543 . . . . 10.0 111.246 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -108.96 0.88 20.3 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.436 0.532 . . . . 10.0 112.436 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 10.5 m -50.24 -43.21 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 114.379 1.252 . . . . 10.0 114.379 -177.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 52' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.77 -30.06 67.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.868 0.365 . . . . 10.0 111.174 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.91 -38.16 10.7 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.957 -0.64 . . . . 10.0 112.786 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 54' ' ' ILE . . . . . . . . . . . . . 37.3 mt -73.84 -62.68 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.853 0.359 . . . . 10.0 111.035 -179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 55' ' ' LEU . . . . . 0.462 ' CD2' ' HG ' ' C' ' 11' ' ' LEU . 68.9 mt -66.25 -54.97 18.66 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.628 -0.714 . . . . 10.0 110.71 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 52.67 -99.5 0.04 OUTLIER Glycine 0 CA--C 1.518 0.279 0 O-C-N 123.931 0.769 . . . . 10.0 112.457 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -138.89 21.09 2.65 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.187 -0.672 . . . . 10.0 109.187 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 58' ' ' SER . . . . . 0.451 ' HA ' ' CD2' ' B' ' 64' ' ' HIS . 18.4 m -78.69 -59.67 2.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.27 -0.877 . . . . 10.0 111.399 -179.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -139.28 136.74 35.22 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.956 -0.387 . . . . 10.0 109.956 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 60' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -168.72 -62.63 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.952 -0.567 . . . . 10.0 110.133 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp -87.74 119.89 28.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.915 -0.584 . . . . 10.0 109.86 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 62' ' ' GLY . . . . . 0.492 ' HA2' ' CA ' ' B' ' 62' ' ' GLY . . . -91.8 165.95 29.82 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.682 -0.771 . . . . 10.0 112.446 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 63' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -119.46 171.3 8.44 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.216 -0.661 . . . . 10.0 109.216 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 64' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -86.35 105.34 16.62 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.046 0.45 . . . . 10.0 110.519 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -107.84 -176.96 3.2 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.899 -0.591 . . . . 10.0 110.397 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.4 28.72 0.56 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.194 0.521 . . . . 10.0 109.953 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -67.91 -34.74 77.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.596 -0.729 . . . . 10.0 110.267 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 68' ' ' ILE . . . . . . . . . . . . . 25.7 mt -81.19 104.3 9.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.987 -0.551 . . . . 10.0 110.063 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 95.6 mt -94.97 -0.78 53.55 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.146 -0.479 . . . . 10.0 110.746 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 70' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -87.79 6.15 36.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.245 0.545 . . . . 10.0 110.532 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 71' ' ' SER . . . . . 0.514 ' HB3' ' HA2' ' B' ' 56' ' ' GLY . 36.3 m -108.87 47.49 0.91 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.12 -0.491 . . . . 10.0 111.022 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.003 0 CA-C-N 115.936 -0.574 . . . . 10.0 110.891 -179.87 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.417 ' HB2' ' OD2' ' A' ' 91' ' ' ASP . 29.8 mtt . . . . . 0 N--CA 1.479 0.994 0 N-CA-C 109.565 -0.531 . . . . 10.0 109.565 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.8 p -95.35 135.8 28.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.647 -0.421 . . . . 10.0 110.121 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -89.16 132.1 34.99 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.411 -0.359 . . . . 10.0 110.981 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -120.73 122.48 40.49 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.466 -0.938 . . . . 10.0 108.466 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.7 m -92.17 109.74 21.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.921 0.391 . . . . 10.0 110.346 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 87' ' ' SER . 2.3 mm? -81.67 110.65 17.21 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.239 -0.652 . . . . 10.0 109.239 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -120.52 107.11 12.47 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.316 -0.402 . . . . 10.0 111.059 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 46.5 tttm -96.74 120.57 37.31 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.587 -0.523 . . . . 10.0 109.587 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.447 HG21 ' OD2' ' C' ' 28' ' ' ASP . 18.1 mt -83.87 -36.21 11.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 O-C-N 123.863 0.727 . . . . 10.0 111.087 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.436 ' OE1' ' HA ' ' A' ' 147' ' ' MET . 19.7 mt-30 -65.42 149.17 50.46 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.993 -0.283 . . . . 10.0 110.394 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.91 134.05 78.49 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 116.437 -0.347 . . . . 10.0 111.041 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -80.07 142.14 60.91 Favored 'Cis proline' 0 C--O 1.236 0.4 0 C-N-CA 124.23 -1.154 . . . . 10.0 111.836 -1.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -80.36 158.13 26.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.029 -0.532 . . . . 10.0 111.585 -178.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -165.87 157.07 13.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.694 -0.685 . . . . 10.0 110.524 177.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.538 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 70.4 m -149.81 99.88 2.9 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.552 -0.536 . . . . 10.0 109.552 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.3 pt -121.03 155.32 24.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.039 -0.528 . . . . 10.0 110.761 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -114.91 119.33 36.18 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.554 -0.293 . . . . 10.0 110.546 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -118.11 156.05 29.34 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 110.059 -0.349 . . . . 10.0 110.059 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.417 ' OD2' ' HB2' ' A' ' 73' ' ' MET . 2.0 t70 -107.89 110.99 22.89 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.098 -0.705 . . . . 10.0 109.098 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -117.56 151.55 36.92 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.788 0.328 . . . . 10.0 110.922 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.491 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 0.6 OUTLIER -66.93 134.01 93.95 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.072 -0.513 . . . . 10.0 110.626 179.682 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -52.46 -32.26 51.94 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.549 2.166 . . . . 10.0 112.853 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.4 m -97.52 20.27 12.03 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.042 -0.526 . . . . 10.0 111.529 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.491 ' HB2' ' O ' ' A' ' 93' ' ' SER . 0.6 OUTLIER -83.45 171.35 13.52 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.88 0.371 . . . . 10.0 110.896 -179.546 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.9 m -105.99 146.41 30.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.963 -0.562 . . . . 10.0 111.006 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.419 HG12 ' O ' ' A' ' 130' ' ' LEU . 39.2 mm -61.76 -29.52 46.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 121.31 0.576 . . . . 10.0 110.392 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.32 -42.78 78.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.591 -0.732 . . . . 10.0 110.942 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -64.6 -36.38 84.06 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 120.695 0.283 . . . . 10.0 110.981 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 59.2 mt -65.8 -48.27 82.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.267 -0.424 . . . . 10.0 109.886 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.482 ' HZ1' ' CG ' ' A' ' 128' ' ' ASP . 23.5 mtpt -60.15 -44.06 95.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.786 -0.643 . . . . 10.0 110.331 178.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -64.21 -33.46 75.85 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.776 -0.647 . . . . 10.0 110.227 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.413 ' O ' ' HG3' ' A' ' 108' ' ' GLU . 61.2 t60 -69.89 -37.7 76.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.822 -0.627 . . . . 10.0 110.398 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 60.8 mt -60.55 -39.97 89.85 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.115 0.483 . . . . 10.0 110.165 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 102' ' ' LYS . 12.2 mt -70.14 -38.5 75.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.996 -0.547 . . . . 10.0 109.905 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 48.9 m -66.02 -23.73 66.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.741 -0.663 . . . . 10.0 110.965 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 104' ' ' HIS . 47.2 mt-10 -96.75 7.05 47.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.154 -0.475 . . . . 10.0 110.202 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 58.13 32.09 21.56 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.452 -0.795 . . . . 10.0 111.683 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 6.3 mmpp? -100.39 -8.01 23.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.633 -0.712 . . . . 10.0 109.455 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.42 ' HA ' HD12 ' A' ' 148' ' ' ILE . . . -130.55 167.23 19.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.297 -0.865 . . . . 10.0 111.258 -179.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.8 t -101.1 -61.36 1.38 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.876 -0.602 . . . . 10.0 110.138 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.488 ' O ' HG13 ' A' ' 117' ' ' ILE . 20.2 m170 -139.59 143.76 37.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.351 -0.386 . . . . 10.0 110.335 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.412 HG13 ' HE2' ' A' ' 102' ' ' LYS . 3.9 tt -59.5 -42.91 89.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 121.317 0.58 . . . . 10.0 110.811 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.49 -15.03 33.87 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.084 -0.962 . . . . 10.0 112.304 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.448 ' CD ' ' HZ1' ' A' ' 149' ' ' LYS . 7.6 mm-40 -110.94 14.95 22.0 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.493 0.553 . . . . 10.0 112.493 -178.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 113' ' ' HIS . 71.1 mt -105.79 120.96 57.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-O 120.973 0.416 . . . . 10.0 110.725 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -121.9 114.07 20.5 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.961 -0.755 . . . . 10.0 108.961 178.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.452 ' O ' ' HB2' ' A' ' 126' ' ' LEU . 69.8 mt -100.37 131.37 46.33 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.746 0.784 . . . . 10.0 110.988 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.492 HD13 ' SG ' ' C' ' 39' ' ' CYS . 0.4 OUTLIER -118.06 144.29 45.73 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.914 -1.039 . . . . 10.0 108.753 179.187 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 27.6 tp -128.87 93.34 3.58 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 107.45 -1.315 . . . . 10.0 107.45 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.51 ' HG2' ' ND2' ' A' ' 141' ' ' ASN . 0.2 OUTLIER 35.29 69.33 0.17 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 113.903 -1.499 . . . . 10.0 112.498 -179.473 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.481 ' HA3' ' CB ' ' C' ' 38' ' ' ASP . . . 86.51 -45.28 3.43 Favored Glycine 0 CA--C 1.51 -0.256 0 C-N-CA 121.071 -0.585 . . . . 10.0 112.399 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -63.33 121.7 14.38 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.556 -0.535 . . . . 10.0 109.556 178.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.9 t -85.8 128.42 39.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 111.79 0.293 . . . . 10.0 111.79 -178.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 119' ' ' LEU . 5.3 mp -96.88 144.71 26.56 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.149 -0.315 . . . . 10.0 110.149 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -122.7 161.1 24.51 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.598 -0.441 . . . . 10.0 110.259 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.482 ' CG ' ' HZ1' ' A' ' 102' ' ' LYS . 0.9 OUTLIER -57.09 -34.19 68.06 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.224 0.824 . . . . 10.0 113.224 -178.842 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -96.93 8.35 44.63 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.985 0.365 . . . . 10.0 111.985 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.419 ' O ' HG12 ' A' ' 98' ' ' ILE . 1.1 mp -80.54 144.92 32.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.985 0.421 . . . . 10.0 110.65 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -107.68 148.67 29.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.769 -0.65 . . . . 10.0 109.362 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 51.0 mt -57.12 -39.18 74.61 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.106 0.409 . . . . 10.0 112.106 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.87 -18.52 58.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.749 0.309 . . . . 10.0 110.746 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -78.62 -49.33 13.42 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.811 -0.632 . . . . 10.0 110.623 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.431 HD21 ' HG ' ' A' ' 126' ' ' LEU . 1.2 pp -76.4 -26.49 55.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.283 -0.417 . . . . 10.0 111.159 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 10.8 mttp 60.84 100.52 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 O-C-N 123.634 0.584 . . . . 10.0 111.409 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.9 p -88.14 128.93 40.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.986 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.88 128.64 89.16 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.982 -0.554 . . . . 10.0 111.435 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -69.25 -9.69 26.97 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.479 2.119 . . . . 10.0 111.924 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -92.02 8.67 36.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.457 0.646 . . . . 10.0 109.484 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.51 ' ND2' ' HG2' ' A' ' 122' ' ' LYS . 5.9 t-20 -134.61 -74.52 0.47 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.229 -0.896 . . . . 10.0 109.737 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.3 m 55.87 26.5 9.77 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.881 0.697 . . . . 10.0 112.881 178.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 19.4 m -121.0 124.24 44.38 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.009 0.433 . . . . 10.0 111.12 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 24.5 mm -103.19 125.77 57.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.82 -0.627 . . . . 10.0 110.115 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.19 106.44 14.09 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.355 -0.98 . . . . 10.0 108.355 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 30.0 t -89.35 122.27 40.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.668 -0.696 . . . . 10.0 111.816 -177.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' MET . . . . . 0.443 ' HG3' ' CG2' ' B' ' 35' ' ' VAL . 26.1 mmt -122.67 117.73 26.46 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.434 -0.803 . . . . 10.0 109.486 178.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.42 HD12 ' HA ' ' A' ' 111' ' ' ALA . 23.1 mt -135.45 138.26 48.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.798 -0.637 . . . . 10.0 110.233 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.448 ' HZ1' ' CD ' ' A' ' 116' ' ' GLU . 9.0 mtpt -103.83 115.02 64.1 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.928 -0.578 . . . . 10.0 110.903 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.43 108.59 1.62 Allowed 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.053 1.835 . . . . 10.0 111.503 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -78.57 61.51 2.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.235 0.54 . . . . 10.0 111.174 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 89.1 mt -94.31 -22.57 18.27 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.031 -0.532 . . . . 10.0 110.529 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.207 -0.901 . . . . 10.0 109.696 179.12 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' -1' ' ' SER . . . . . . . . . . . . . 6.7 p . . . . . 0 N--CA 1.478 0.936 0 CA-C-O 121.006 0.431 . . . . 10.0 110.827 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 0' ' ' VAL . . . . . . . . . . . . . 2.5 t -96.81 -0.01 10.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.0 0.429 . . . . 10.0 109.977 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -54.04 94.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.402 -0.817 . . . . 10.0 111.315 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.31 69.17 0.78 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.563 -0.744 . . . . 10.0 110.539 -178.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -144.92 148.53 33.97 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.039 -0.726 . . . . 10.0 109.039 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.34 134.38 34.36 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.594 -0.442 . . . . 10.0 110.09 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 7.1 ptpp? -57.2 -34.95 69.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.38 -0.373 . . . . 10.0 111.341 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -61.65 -44.17 97.47 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.239 -0.437 . . . . 10.0 110.64 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -56.99 -48.09 79.25 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.467 0.651 . . . . 10.0 109.571 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.609 ' O ' HG12 ' B' ' 12' ' ' ILE . 42.8 mm -63.4 -47.8 90.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.145 -0.934 . . . . 10.0 110.911 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.87 -41.26 70.62 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.983 0.421 . . . . 10.0 110.824 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.8 -31.4 70.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.904 -0.589 . . . . 10.0 110.554 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.36 -33.22 67.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.181 0.515 . . . . 10.0 109.676 179.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.609 HG12 ' O ' ' B' ' 8' ' ' ILE . 18.6 mm -66.08 -50.33 69.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.572 -0.74 . . . . 10.0 111.2 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 28.8 m -65.19 -32.18 57.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.804 0.335 . . . . 10.0 110.608 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -68.73 -48.92 62.59 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.244 -0.435 . . . . 10.0 109.954 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' TYR . . . . . 0.578 ' O ' HG12 ' B' ' 19' ' ' ILE . 5.5 t80 -59.54 -43.2 93.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.235 -0.439 . . . . 10.0 110.708 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 11.4 m-30 -56.82 -45.5 82.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.773 0.32 . . . . 10.0 110.315 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 74.2 m -58.54 -42.45 87.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.903 -0.59 . . . . 10.0 111.2 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 1.5 m -70.14 -21.72 63.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.377 -0.374 . . . . 10.0 111.501 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.578 HG12 ' O ' ' B' ' 15' ' ' TYR . 34.2 mm -87.27 -39.3 12.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.873 -0.331 . . . . 10.0 110.944 -178.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 30.3 m -73.33 -32.2 36.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.61 0.243 . . . . 10.0 110.469 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -65.1 -51.43 61.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.293 -0.412 . . . . 10.0 111.109 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -84.11 -4.6 58.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.329 -0.396 . . . . 10.0 111.492 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . 0.466 ' HZ1' ' CD ' ' B' ' 27' ' ' GLU . 53.0 mttm 57.03 47.44 17.51 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.49 0.662 . . . . 10.0 111.088 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.505 ' O ' ' HE2' ' C' ' 5' ' ' LYS . 80.9 mt-10 -89.31 30.01 1.03 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.702 -0.681 . . . . 10.0 110.348 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 13.3 tt -158.78 171.38 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.764 -0.828 . . . . 10.0 108.764 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.91 155.87 39.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.753 0.311 . . . . 10.0 110.368 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . 0.466 ' CD ' ' HZ1' ' B' ' 23' ' ' LYS . 16.1 mm-40 -59.96 -48.0 83.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.234 -0.439 . . . . 10.0 111.072 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.59 -39.17 93.7 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.197 -0.456 . . . . 10.0 109.875 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . 0.488 ' O ' ' HG ' ' B' ' 33' ' ' LEU . . . -66.71 -31.78 79.42 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.756 -0.656 . . . . 10.0 111.514 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.74 -38.07 89.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.648 0.261 . . . . 10.0 110.546 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -66.53 -36.52 82.88 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 108.713 -0.847 . . . . 10.0 108.713 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' SER . . . . . 0.629 ' HB3' ' SG ' ' C' ' 39' ' ' CYS . 2.4 m -64.79 -33.36 75.81 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.18 -0.918 . . . . 10.0 110.095 178.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' B' ' 29' ' ' GLY . 25.2 mt -73.35 -40.53 64.33 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.192 -0.458 . . . . 10.0 110.099 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 55.9 m-20 -62.75 -44.86 95.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.818 -0.628 . . . . 10.0 110.986 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.443 ' CG2' ' HG3' ' A' ' 147' ' ' MET . 11.9 p -72.22 -37.53 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 116.331 -0.395 . . . . 10.0 110.564 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.7 -35.04 79.6 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 109.621 -0.511 . . . . 10.0 109.621 178.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' MET . . . . . . . . . . . . . 25.0 ttm -56.18 -51.62 67.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.388 -0.824 . . . . 10.0 110.028 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . 0.518 ' OD1' ' HD3' ' B' ' 48' ' ' ARG . 0.7 OUTLIER -69.09 -40.11 78.62 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.45 -0.795 . . . . 10.0 110.054 -179.905 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 4.5 t -52.64 -45.45 66.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.268 -0.878 . . . . 10.0 110.6 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 75.8 mt -74.42 -44.34 48.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.51 -0.768 . . . . 10.0 111.196 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.692 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 34.6 m -57.75 -43.74 85.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.85 0.357 . . . . 10.0 110.893 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -68.67 -41.73 78.85 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.955 -0.566 . . . . 10.0 110.849 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.29 -27.96 69.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.262 -0.426 . . . . 10.0 111.807 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -104.15 0.61 29.79 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.81 0.338 . . . . 10.0 111.479 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.08 46.68 84.47 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 116.052 -0.522 . . . . 10.0 113.718 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.692 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 9.2 p90 -135.51 154.91 51.24 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 117.176 0.488 . . . . 10.0 109.953 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -71.61 141.66 49.98 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.267 0.556 . . . . 10.0 112.044 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.518 ' HD3' ' OD1' ' B' ' 38' ' ' ASP . 0.1 OUTLIER -59.31 -42.47 91.47 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.066 -0.97 . . . . 10.0 110.257 179.409 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -88.69 5.23 44.18 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.084 0.772 . . . . 10.0 113.084 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.54 3.39 11.48 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.282 0.475 . . . . 10.0 112.282 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.441 HG22 ' H ' ' B' ' 52' ' ' SER . 13.0 m -43.91 -54.38 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 113.02 0.748 . . . . 10.0 113.02 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' SER . . . . . 0.441 ' H ' HG22 ' B' ' 51' ' ' VAL . 18.3 m -52.88 -35.94 58.49 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 113.213 0.82 . . . . 10.0 113.213 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.28 -33.79 55.99 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.128 -1.034 . . . . 10.0 112.349 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 22.7 mt -89.5 -59.5 2.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 113.759 1.022 . . . . 10.0 113.759 -178.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 60.2 mt -66.07 -67.89 0.41 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.402 0.89 . . . . 10.0 113.402 -177.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . 0.599 ' HA2' ' OG ' ' C' ' 71' ' ' SER . . . 77.52 -152.51 39.52 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.456 -0.878 . . . . 10.0 111.04 -177.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.75 23.65 3.64 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.564 0.697 . . . . 10.0 109.674 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 1.4 m -86.94 40.42 0.91 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.972 -1.013 . . . . 10.0 111.416 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 54.51 82.51 0.09 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.955 -0.566 . . . . 10.0 111.586 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -73.96 78.69 1.67 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.123 0.487 . . . . 10.0 110.609 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -85.3 90.4 7.9 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.074 -0.512 . . . . 10.0 110.109 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -78.0 78.43 1.55 Allowed Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.477 -0.649 . . . . 10.0 111.477 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -69.3 93.62 0.65 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.314 0.578 . . . . 10.0 110.86 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 44.8 t60 -134.11 87.29 2.35 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.643 -0.708 . . . . 10.0 109.373 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 7.3 mt -78.15 -24.77 47.19 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.467 -0.788 . . . . 10.0 110.838 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . 57.33 19.26 4.91 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.156 -0.474 . . . . 10.0 111.004 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 57.07 37.93 28.89 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.478 -0.783 . . . . 10.0 111.391 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 93.7 mt -80.99 97.05 3.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.179 0.514 . . . . 10.0 110.341 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -104.4 26.41 8.98 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.041 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -126.83 54.95 1.58 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.951 -0.568 . . . . 10.0 109.902 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.87 0.41 35.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.748 -0.66 . . . . 10.0 111.247 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.553 -0.737 . . . . 10.0 110.987 -179.486 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' -1' ' ' SER . . . . . . . . . . . . . 9.2 p . . . . . 0 N--CA 1.478 0.958 0 CA-C-O 120.924 0.392 . . . . 10.0 110.197 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 0' ' ' VAL . . . . . . . . . . . . . 3.0 t -106.65 49.27 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.434 0.635 . . . . 10.0 109.573 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -71.65 96.29 1.56 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.722 -0.672 . . . . 10.0 109.273 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.35 62.45 7.43 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.744 -0.662 . . . . 10.0 111.987 -178.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -140.95 141.95 34.41 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.1 -0.5 . . . . 10.0 109.69 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -101.56 142.82 32.36 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.934 -0.395 . . . . 10.0 109.934 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . 0.505 ' HE2' ' O ' ' B' ' 24' ' ' GLU . 7.2 ptpp? -62.87 -37.08 85.45 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.32 0.489 . . . . 10.0 112.32 -178.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 6' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -62.08 -43.4 98.92 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.654 0.264 . . . . 10.0 110.29 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . 0.447 ' O ' HD21 ' C' ' 55' ' ' LEU . 69.9 mt-10 -64.02 -49.9 70.59 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.767 -0.651 . . . . 10.0 110.249 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 8' ' ' ILE . . . . . 0.59 ' O ' HG13 ' C' ' 12' ' ' ILE . 50.0 mm -61.64 -43.72 97.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.813 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.43 -45.36 76.77 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.249 -0.432 . . . . 10.0 111.121 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.84 -34.88 79.41 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.781 -0.645 . . . . 10.0 110.867 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 1.3 mt -65.36 -32.45 74.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.573 -0.285 . . . . 10.0 110.651 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 12' ' ' ILE . . . . . 0.59 HG13 ' O ' ' C' ' 8' ' ' ILE . 7.5 mt -67.71 -55.13 18.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.341 -0.391 . . . . 10.0 110.748 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 17.9 m -64.37 -30.86 51.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.812 -0.631 . . . . 10.0 111.311 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -70.39 -45.72 65.41 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.126 0.488 . . . . 10.0 109.716 178.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 15' ' ' TYR . . . . . 0.588 ' CE2' HG13 ' B' ' 8' ' ' ILE . 4.7 t80 -62.84 -46.99 85.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.863 -0.608 . . . . 10.0 110.454 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -56.11 -47.58 77.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.07 -0.514 . . . . 10.0 111.356 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 37.0 m -58.92 -41.25 86.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 10.0 111.584 -179.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 3.4 p -75.21 -20.84 59.06 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.297 0.481 . . . . 10.0 112.297 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 19' ' ' ILE . . . . . 0.486 HG12 ' O ' ' C' ' 15' ' ' TYR . 20.4 mm -84.06 -35.33 10.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.771 0.32 . . . . 10.0 110.666 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 20' ' ' VAL . . . . . . . . . . . . . 29.4 m -78.7 -28.12 14.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.866 -0.333 . . . . 10.0 110.385 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.1 -50.83 62.69 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.966 0.413 . . . . 10.0 110.221 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -85.8 1.69 48.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.241 -0.436 . . . . 10.0 110.064 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 63.7 mttm 48.03 53.54 11.45 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.105 -0.952 . . . . 10.0 111.989 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -85.09 13.73 5.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.468 . . . . 10.0 110.197 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 13.5 tt -138.82 167.6 20.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.744 -0.662 . . . . 10.0 109.823 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 8.2 p -66.22 160.42 24.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.524 0.202 . . . . 10.0 110.589 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -59.69 -41.99 91.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.919 0.39 . . . . 10.0 110.53 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 28' ' ' ASP . . . . . 0.447 ' OD2' HG21 ' A' ' 81' ' ' ILE . 31.0 t70 -68.84 -39.86 79.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.971 -0.558 . . . . 10.0 109.865 179.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 29' ' ' GLY . . . . . 0.528 ' O ' ' HG ' ' C' ' 33' ' ' LEU . . . -64.57 -35.66 92.2 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.927 -0.654 . . . . 10.0 111.627 178.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.4 -45.92 91.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.345 0.593 . . . . 10.0 110.113 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -60.9 -38.22 84.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.415 -0.811 . . . . 10.0 110.025 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 3.0 t -62.09 -34.37 76.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.358 -0.837 . . . . 10.0 110.593 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 33' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' C' ' 29' ' ' GLY . 50.1 mt -74.94 -29.58 60.98 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.17 -0.468 . . . . 10.0 110.475 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -71.61 -47.57 53.82 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.428 -0.351 . . . . 10.0 110.965 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 p -64.16 -40.73 90.08 Favored 'Isoleucine or valine' 0 C--N 1.343 0.304 0 CA-C-O 120.684 0.278 . . . . 10.0 110.449 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.6 -35.61 79.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.847 0.356 . . . . 10.0 110.32 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 40.5 ttm -53.34 -59.89 3.99 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.585 -0.734 . . . . 10.0 111.769 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 38' ' ' ASP . . . . . 0.481 ' CB ' ' HA3' ' A' ' 123' ' ' GLY . 4.1 m-20 -65.89 -33.77 76.59 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 121.028 -0.269 . . . . 10.0 111.504 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 39' ' ' CYS . . . . . 0.629 ' SG ' ' HB3' ' B' ' 32' ' ' SER . 0.5 OUTLIER -60.86 -47.89 84.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.107 0.48 . . . . 10.0 110.064 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 40' ' ' ILE . . . . . . . . . . . . . 59.8 mt -68.34 -44.52 83.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.526 -0.761 . . . . 10.0 110.956 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 41' ' ' SER . . . . . 0.559 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 40.4 m -59.52 -45.75 90.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.063 -0.517 . . . . 10.0 111.432 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 -69.32 -40.12 77.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.312 -0.404 . . . . 10.0 110.839 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.52 -44.43 93.15 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.989 -0.55 . . . . 10.0 112.256 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 44' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -89.1 -6.82 56.77 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.633 0.254 . . . . 10.0 111.521 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.9 58.0 7.26 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 114.397 0.519 . . . . 10.0 114.397 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 46' ' ' PHE . . . . . 0.559 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 13.2 p90 -153.24 154.02 33.83 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.46 -0.57 . . . . 10.0 109.46 178.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 47' ' ' GLU . . . . . 0.421 ' HA ' ' OE1' ' C' ' 47' ' ' GLU . 0.0 OUTLIER -80.54 144.18 32.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.861 0.362 . . . . 10.0 111.155 -179.805 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 48' ' ' ARG . . . . . 0.438 ' HD3' ' OD1' ' C' ' 38' ' ' ASP . 0.0 OUTLIER -61.03 -34.94 75.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.978 -0.555 . . . . 10.0 111.001 -179.42 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.42 3.16 37.38 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.079 0.4 . . . . 10.0 112.079 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.4 1.79 47.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.805 0.336 . . . . 10.0 111.242 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 5.9 m -49.72 -44.43 20.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 112.651 0.611 . . . . 10.0 112.651 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.7 -35.28 70.41 Favored 'General case' 0 C--O 1.225 -0.199 0 N-CA-C 112.461 0.541 . . . . 10.0 112.461 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.21 -28.22 58.56 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 119.712 -1.232 . . . . 10.0 112.642 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 54' ' ' ILE . . . . . . . . . . . . . 61.3 mt -89.05 -62.98 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 113.241 0.83 . . . . 10.0 113.241 -178.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 55' ' ' LEU . . . . . 0.447 HD21 ' O ' ' C' ' 7' ' ' GLU . 20.7 mt -74.81 -62.6 1.49 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.529 0.937 . . . . 10.0 113.529 -177.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.16 -119.79 6.89 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.216 -0.754 . . . . 10.0 111.216 -178.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -160.03 22.12 0.17 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.35 0.595 . . . . 10.0 110.086 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.52 44.87 1.14 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.587 -0.733 . . . . 10.0 111.617 -178.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 57.21 71.71 0.56 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.958 0.408 . . . . 10.0 110.785 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 60' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -74.66 80.44 2.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.237 0.541 . . . . 10.0 109.9 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -94.52 94.88 8.46 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.71 -0.677 . . . . 10.0 111.004 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.58 83.78 1.42 Allowed Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.127 -0.789 . . . . 10.0 111.127 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 63' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -72.67 81.98 1.13 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.229 0.538 . . . . 10.0 111.471 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 64' ' ' HIS . . . . . . . . . . . . . 65.5 t60 -115.78 73.51 0.85 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.812 -0.81 . . . . 10.0 108.812 178.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 2.2 mt -59.76 -33.43 71.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.442 -0.799 . . . . 10.0 111.439 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . 62.21 10.28 3.7 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 123.422 0.451 . . . . 10.0 110.846 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 59.59 37.02 22.78 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.636 -0.711 . . . . 10.0 110.486 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 68' ' ' ILE . . . . . . . . . . . . . 75.7 mt -76.2 106.97 6.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.977 -0.556 . . . . 10.0 110.994 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -114.32 11.4 17.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.862 -0.608 . . . . 10.0 109.789 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 70' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -95.04 23.04 5.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.494 -0.775 . . . . 10.0 111.231 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 71' ' ' SER . . . . . 0.599 ' OG ' ' HA2' ' B' ' 56' ' ' GLY . 6.8 m -107.34 31.83 5.11 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.109 -0.496 . . . . 10.0 110.756 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.442 -0.79 . . . . 10.0 110.853 -179.714 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 29.9 mtm . . . . . 0 N--CA 1.48 1.068 0 N-CA-C 109.702 -0.481 . . . . 10.0 109.702 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.7 t -90.18 124.75 42.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 121.089 -0.244 . . . . 10.0 110.68 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -91.16 124.78 35.64 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.957 -0.386 . . . . 10.0 109.957 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.6 mp -126.39 133.49 51.29 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.014 0.435 . . . . 10.0 110.861 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.413 HG22 ' HG2' ' A' ' 89' ' ' GLU . 8.8 m -102.97 117.08 33.8 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.246 -0.434 . . . . 10.0 110.701 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -85.68 107.78 17.72 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.12 0.486 . . . . 10.0 110.025 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.537 ' HZ3' ' CG ' ' C' ' 31' ' ' ASP . 15.3 tptm -106.41 98.93 8.54 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.536 -0.756 . . . . 10.0 110.457 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -99.27 114.09 26.73 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.404 -0.362 . . . . 10.0 110.308 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 57.5 mt -84.05 -57.86 4.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.823 -0.626 . . . . 10.0 111.124 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -61.96 158.94 15.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.883 -0.598 . . . . 10.0 112.066 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -77.94 138.76 61.35 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.924 -0.58 . . . . 10.0 112.318 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -76.33 130.66 21.97 Favored 'Cis proline' 0 C--O 1.235 0.334 0 C-N-CA 123.247 -1.564 . . . . 10.0 110.619 -1.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.49 153.26 22.58 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.253 0.549 . . . . 10.0 111.459 -178.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.438 ' CE1' ' HB3' ' A' ' 110' ' ' LYS . 47.6 p90 -168.15 160.01 11.42 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.173 -0.921 . . . . 10.0 109.416 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.0 m -143.09 98.77 3.33 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.863 -0.791 . . . . 10.0 108.863 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 24.1 pt -119.75 153.44 22.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.18 -0.464 . . . . 10.0 111.048 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.413 ' HG2' HG22 ' A' ' 77' ' ' THR . 43.3 mt-10 -115.62 127.6 55.33 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 109.246 -0.649 . . . . 10.0 109.246 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.54 157.0 44.77 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.065 0.46 . . . . 10.0 110.402 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -114.54 137.79 51.44 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.126 -0.488 . . . . 10.0 109.911 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -129.75 165.09 22.6 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.251 -0.431 . . . . 10.0 110.416 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.457 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 7.3 m -75.78 147.37 81.04 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.119 -0.492 . . . . 10.0 110.568 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.47 -22.57 59.75 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.864 2.376 . . . . 10.0 113.322 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.59 18.12 22.35 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.962 0.411 . . . . 10.0 110.791 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 93' ' ' SER . 0.3 OUTLIER -80.34 162.82 24.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.98 0.419 . . . . 10.0 110.83 179.872 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.6 m -109.38 150.77 27.56 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.976 -0.556 . . . . 10.0 111.506 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 37.8 mm -61.86 -22.05 27.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.272 0.558 . . . . 10.0 110.379 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.13 -38.45 68.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.281 -0.872 . . . . 10.0 110.418 178.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 73.3 mm-40 -62.09 -44.38 96.78 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.136 -0.484 . . . . 10.0 111.137 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.545 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 35.6 mt -63.7 -50.09 79.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.839 -0.619 . . . . 10.0 109.875 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -55.37 -44.55 76.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.626 -0.716 . . . . 10.0 110.854 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -63.73 -39.19 93.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 10.0 110.905 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -63.57 -39.81 95.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.131 -0.486 . . . . 10.0 110.918 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 101' ' ' ILE . 40.9 mt -62.13 -42.19 99.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.867 0.365 . . . . 10.0 110.478 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 48.8 mt -68.81 -44.24 82.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.439 -0.346 . . . . 10.0 110.563 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.5 m -61.07 -27.45 68.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.848 -0.615 . . . . 10.0 111.82 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -95.8 12.86 28.55 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 120.797 0.332 . . . . 10.0 111.145 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 59.76 34.43 21.96 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.696 -0.684 . . . . 10.0 111.925 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.438 ' HB3' ' CE1' ' A' ' 86' ' ' PHE . 17.5 mmtp -107.2 -7.17 16.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.324 0.583 . . . . 10.0 110.472 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -141.67 142.02 33.36 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.439 -0.8 . . . . 10.0 109.81 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.33 -41.84 17.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.728 0.299 . . . . 10.0 111.387 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -151.69 141.59 22.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.613 -0.267 . . . . 10.0 110.845 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.1 tt -62.21 -41.92 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 116.279 -0.419 . . . . 10.0 111.876 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.501 ' HB2' ' OE2' ' A' ' 116' ' ' GLU . 11.2 m -53.67 -17.93 2.61 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.922 0.712 . . . . 10.0 112.922 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.501 ' OE2' ' HB2' ' A' ' 115' ' ' SER . 0.9 OUTLIER -109.74 7.27 24.19 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 122.102 -0.374 . . . . 10.0 111.341 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.402 HG12 HG12 ' A' ' 148' ' ' ILE . 66.1 mt -93.48 120.68 43.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.635 -0.505 . . . . 10.0 109.635 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.9 mmmt -124.24 118.57 27.11 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.297 -0.41 . . . . 10.0 110.377 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.439 ' O ' ' HB2' ' A' ' 126' ' ' LEU . 3.9 mm? -95.52 110.73 22.76 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.397 -0.365 . . . . 10.0 110.757 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -101.26 107.36 18.71 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.491 -0.929 . . . . 10.0 108.491 177.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.0 tp -90.94 101.22 13.99 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.713 0.768 . . . . 10.0 109.278 178.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 13.5 tptp 52.33 56.34 7.85 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 113.957 -1.474 . . . . 10.0 109.142 -177.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.744 ' HA2' ' SG ' ' C' ' 39' ' ' CYS . . . 79.05 -43.56 2.48 Favored Glycine 0 C--O 1.228 -0.245 0 CA-C-N 114.581 -1.191 . . . . 10.0 112.509 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 22.0 tttp -58.07 119.65 7.17 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.001 -0.6 . . . . 10.0 111.351 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.4 p -72.34 136.38 25.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 113.562 0.949 . . . . 10.0 113.562 -177.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.439 ' HB2' ' O ' ' A' ' 119' ' ' LEU . 1.5 mp -102.31 156.83 17.33 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 114.901 -1.045 . . . . 10.0 109.332 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 62.6 m-70 -116.65 152.73 33.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.061 0.458 . . . . 10.0 110.822 -178.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -52.77 -52.23 57.47 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.575 0.954 . . . . 10.0 113.575 -178.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -89.42 11.05 20.37 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.002 0.371 . . . . 10.0 112.002 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.1 tp -74.03 146.58 43.63 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.905 0.383 . . . . 10.0 111.022 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -106.54 150.56 26.01 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.927 -0.578 . . . . 10.0 110.003 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.402 HD11 ' O ' ' A' ' 93' ' ' SER . 81.4 mt -58.22 -31.73 67.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.015 0.436 . . . . 10.0 111.282 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.1 -33.08 67.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.892 -0.595 . . . . 10.0 111.218 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -77.39 -44.9 27.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.277 -0.42 . . . . 10.0 111.29 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.5 pp -74.08 -25.76 59.99 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.8 -0.36 . . . . 10.0 111.1 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt 65.1 93.01 0.07 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.238 0.542 . . . . 10.0 111.758 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.8 t -71.68 112.24 6.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.975 -0.557 . . . . 10.0 110.06 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.12 125.05 84.29 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.515 -0.311 . . . . 10.0 110.916 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.1 -12.67 36.95 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.068 2.512 . . . . 10.0 112.633 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -82.8 -0.86 49.85 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.241 0.543 . . . . 10.0 110.367 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 55.1 m-20 -131.7 -71.32 0.56 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.629 -0.714 . . . . 10.0 109.271 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 31.9 m 58.16 17.75 4.79 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.491 -0.777 . . . . 10.0 111.649 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.22 124.22 47.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.22 -0.445 . . . . 10.0 110.689 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 4.5 mm -110.96 124.4 67.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.324 -0.621 . . . . 10.0 109.324 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.54 129.99 34.99 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.684 -0.488 . . . . 10.0 109.684 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 2.2 t -107.65 131.14 58.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.349 0.595 . . . . 10.0 111.252 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -129.72 125.31 35.63 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.201 -1.037 . . . . 10.0 108.201 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.402 HG12 HG12 ' A' ' 117' ' ' ILE . 47.6 mt -135.84 139.4 46.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 116.562 -0.29 . . . . 10.0 110.326 -178.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -101.69 113.72 65.78 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 109.053 -0.721 . . . . 10.0 109.053 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.44 118.28 5.47 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.387 2.058 . . . . 10.0 112.863 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -92.54 -3.17 55.51 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.723 -0.671 . . . . 10.0 109.469 178.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 98.1 mt -102.32 128.22 48.97 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.581 -0.736 . . . . 10.0 110.329 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.476 -0.773 . . . . 10.0 110.345 179.984 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' -1' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.476 0.87 0 CA-C-O 120.787 0.327 . . . . 10.0 110.895 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 0' ' ' VAL . . . . . . . . . . . . . 29.9 m -117.01 -168.15 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.054 -0.521 . . . . 10.0 110.491 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . 0.442 ' OD2' ' HG3' ' B' ' 61' ' ' LYS . 32.4 t70 -159.92 -81.45 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.651 -0.25 . . . . 10.0 110.505 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 15.6 t -161.59 26.36 0.12 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.375 0.607 . . . . 10.0 110.343 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -116.35 144.69 43.94 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.856 -0.611 . . . . 10.0 109.859 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' SER . . . . . 0.452 ' HG ' ' CD ' ' B' ' 7' ' ' GLU . 51.8 p -97.75 177.2 5.55 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.612 -0.435 . . . . 10.0 109.898 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . 0.445 ' HB2' ' CE1' ' B' ' 44' ' ' PHE . 7.8 ptpp? -57.81 -41.17 81.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.368 -0.378 . . . . 10.0 110.859 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -59.87 -50.46 73.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 10.0 111.811 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.452 ' CD ' ' HG ' ' B' ' 4' ' ' SER . 3.5 mp0 -59.1 -42.37 90.32 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.705 0.288 . . . . 10.0 110.852 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.608 ' O ' HG13 ' B' ' 12' ' ' ILE . 47.8 mm -62.02 -47.5 92.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.77 -0.455 . . . . 10.0 109.77 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.403 ' HB1' ' CE1' ' B' ' 46' ' ' PHE . . . -57.43 -41.99 81.5 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.75 -0.659 . . . . 10.0 111.053 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.03 -36.9 85.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.108 -0.496 . . . . 10.0 110.597 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 23.9 mt -69.64 -33.52 72.74 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.789 -0.448 . . . . 10.0 109.789 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.608 HG13 ' O ' ' B' ' 8' ' ' ILE . 86.1 mt -64.07 -57.0 13.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.984 -0.553 . . . . 10.0 111.025 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 29.4 m -59.41 -32.84 49.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.21 -0.45 . . . . 10.0 111.274 -178.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -72.19 -46.18 57.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.244 -0.434 . . . . 10.0 110.835 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' TYR . . . . . 0.53 ' O ' HG12 ' B' ' 19' ' ' ILE . 2.1 m-85 -68.89 -46.82 67.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.453 -0.34 . . . . 10.0 111.459 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -55.26 -52.15 64.34 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.683 0.278 . . . . 10.0 111.179 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' SER . . . . . 0.493 ' O ' ' HB2' ' B' ' 21' ' ' GLU . 18.8 p -59.53 -38.06 80.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.408 -0.36 . . . . 10.0 111.369 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 76.6 p -74.89 -20.72 59.6 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.073 0.397 . . . . 10.0 112.073 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.53 HG12 ' O ' ' B' ' 15' ' ' TYR . 25.9 mm -80.39 -42.48 21.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.165 0.507 . . . . 10.0 109.808 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 19.5 m -75.92 -27.78 18.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.775 -0.648 . . . . 10.0 110.433 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . 0.493 ' HB2' ' O ' ' B' ' 17' ' ' SER . 2.4 tp10 -70.06 -42.51 72.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.124 -0.489 . . . . 10.0 110.33 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 30.9 mtmt -78.36 -1.68 34.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 10.0 110.755 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 66.6 mmtt 55.73 38.84 30.61 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.745 -0.662 . . . . 10.0 110.847 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.564 ' O ' ' HE2' ' C' ' 5' ' ' LYS . 25.1 mt-10 -90.55 24.31 2.69 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.27 -0.423 . . . . 10.0 111.497 -178.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 17.6 tt -155.31 161.16 2.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.401 -0.363 . . . . 10.0 110.128 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.62 160.42 32.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.471 -0.332 . . . . 10.0 110.524 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -57.89 -46.25 85.2 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 111.738 0.273 . . . . 10.0 111.738 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -56.52 -42.08 77.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.846 0.355 . . . . 10.0 110.301 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.67 -42.67 61.9 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.021 -0.609 . . . . 10.0 111.912 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.85 -36.66 77.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.93 0.395 . . . . 10.0 110.526 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -71.82 -43.01 66.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.791 -0.64 . . . . 10.0 110.139 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 38.5 m -63.12 -38.64 91.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.69 -0.687 . . . . 10.0 110.282 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 92.7 mt -72.79 -39.27 66.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.255 -0.43 . . . . 10.0 110.316 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -61.33 -46.19 91.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.125 -0.489 . . . . 10.0 111.242 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 13.1 p -71.18 -34.62 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 116.516 -0.311 . . . . 10.0 110.342 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.12 -38.06 87.25 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.458 -0.571 . . . . 10.0 109.458 178.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' MET . . . . . . . . . . . . . 18.0 ttm -57.43 -44.46 84.69 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.688 -0.687 . . . . 10.0 110.01 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -60.88 -45.8 93.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.676 -0.693 . . . . 10.0 110.58 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 76.0 m -62.85 -40.99 99.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.0 -0.546 . . . . 10.0 110.384 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' ILE . . . . . 0.417 HD13 HG22 ' B' ' 12' ' ' ILE . 89.3 mt -65.32 -47.01 88.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.033 -0.53 . . . . 10.0 111.001 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.637 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 48.9 m -59.07 -42.3 90.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.86 0.362 . . . . 10.0 111.064 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -72.48 -39.46 67.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.247 -0.433 . . . . 10.0 111.232 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.59 -43.14 93.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.32 -0.4 . . . . 10.0 111.997 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' PHE . . . . . 0.445 ' CE1' ' HB2' ' B' ' 5' ' ' LYS . 58.0 m-85 -87.08 -4.28 59.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.679 -0.237 . . . . 10.0 111.377 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 62.46 52.22 50.66 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.238 -0.506 . . . . 10.0 113.023 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.637 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 4.7 p90 -146.58 164.46 32.55 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.241 -0.281 . . . . 10.0 110.241 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.99 148.87 21.86 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.436 -0.347 . . . . 10.0 110.496 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.424 ' H ' ' HG3' ' B' ' 48' ' ' ARG . 6.6 mtm180 -65.83 -32.92 74.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.317 0.579 . . . . 10.0 110.611 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -78.75 4.2 14.48 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.416 -0.811 . . . . 10.0 112.269 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.41 3.1 29.42 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.771 0.319 . . . . 10.0 110.386 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.44 HG23 ' H ' ' B' ' 52' ' ' SER . 0.8 OUTLIER -44.97 -64.01 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 115.54 -0.754 . . . . 10.0 112.804 -179.142 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' SER . . . . . 0.44 ' H ' HG23 ' B' ' 51' ' ' VAL . 0.2 OUTLIER -53.49 -30.01 39.05 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.688 0.625 . . . . 10.0 112.688 -179.901 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.14 -44.61 22.62 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.562 -0.828 . . . . 10.0 112.793 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 48.4 mt -82.58 -46.33 19.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 112.233 0.457 . . . . 10.0 112.233 -178.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 67.3 mt -73.16 -57.31 4.11 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.837 0.351 . . . . 10.0 111.071 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.72 -143.31 45.14 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.591 -0.814 . . . . 10.0 111.468 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 48.7 tttt -109.83 14.03 23.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.187 0.518 . . . . 10.0 110.213 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 5.1 m -79.34 138.54 37.74 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.842 -0.617 . . . . 10.0 110.408 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.51 145.3 26.85 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.049 0.452 . . . . 10.0 110.574 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -106.69 172.09 7.0 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.029 -0.532 . . . . 10.0 109.957 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . 0.442 ' HG3' ' OD2' ' B' ' 1' ' ' ASP . 6.3 ptmm? -163.47 172.68 14.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.85 0.357 . . . . 10.0 110.882 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -146.01 52.99 0.56 Allowed Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 110.86 -0.896 . . . . 10.0 110.86 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -73.25 125.81 28.65 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.097 0.475 . . . . 10.0 110.571 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 50.4 p-80 -148.04 113.2 5.53 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.78 -0.645 . . . . 10.0 110.456 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -82.58 -12.52 57.65 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.135 -0.691 . . . . 10.0 109.135 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -86.38 135.9 33.33 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.087 -0.96 . . . . 10.0 110.594 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.86 149.88 46.34 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.86 -0.609 . . . . 10.0 110.306 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . 0.43 HD11 HG21 ' B' ' 68' ' ' ILE . 10.7 mt -91.21 88.42 2.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.234 -0.654 . . . . 10.0 109.234 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 31.6 mt 72.26 -85.1 0.03 OUTLIER 'General case' 0 C--O 1.233 0.193 0 CA-C-N 114.987 -1.006 . . . . 10.0 110.022 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -131.45 -10.89 3.61 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.724 0.297 . . . . 10.0 110.237 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 30.7 m 61.48 25.93 15.77 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.853 -0.612 . . . . 10.0 112.043 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.152 0 CA-C-O 119.013 -0.518 . . . . 10.0 110.571 179.423 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' -1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.477 0.889 0 CA-C-O 120.515 0.198 . . . . 10.0 110.671 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 0' ' ' VAL . . . . . . . . . . . . . 27.7 m -110.66 -164.99 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.398 -0.364 . . . . 10.0 110.53 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 1' ' ' ASP . . . . . 0.541 ' OD1' ' HG3' ' C' ' 61' ' ' LYS . 6.5 t70 -156.76 -72.43 0.1 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.21 0.528 . . . . 10.0 109.804 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 43.9 t -165.12 16.35 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.406 -0.815 . . . . 10.0 109.738 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -103.23 150.94 23.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.253 -0.431 . . . . 10.0 110.652 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 4' ' ' SER . . . . . . . . . . . . . 21.6 p -108.99 167.96 9.71 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.265 -0.425 . . . . 10.0 110.047 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . 0.564 ' HE2' ' O ' ' B' ' 24' ' ' GLU . 6.6 ptpp? -55.27 -42.28 73.33 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.445 0.535 . . . . 10.0 112.445 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 6' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -62.64 -38.79 91.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.497 -0.319 . . . . 10.0 111.788 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -76.22 -40.64 51.62 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.619 0.247 . . . . 10.0 110.866 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 8' ' ' ILE . . . . . 0.404 HG13 ' CE1' ' B' ' 15' ' ' TYR . 17.0 mm -60.93 -46.34 96.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.33 -0.395 . . . . 10.0 110.361 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.18 -41.67 97.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.108 -0.496 . . . . 10.0 110.072 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.84 -44.61 95.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.633 -0.712 . . . . 10.0 110.811 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.35 -37.95 89.24 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.041 -0.527 . . . . 10.0 110.934 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 12' ' ' ILE . . . . . . . . . . . . . 1.3 mp -68.23 -47.73 76.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.179 -0.464 . . . . 10.0 111.606 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 35.9 m -65.91 -25.16 35.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-O 121.136 0.493 . . . . 10.0 110.175 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.91 -41.91 50.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.925 -0.579 . . . . 10.0 109.778 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 15' ' ' TYR . . . . . 0.512 ' O ' HG12 ' C' ' 19' ' ' ILE . 0.5 OUTLIER -72.59 -37.44 68.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.567 -179.637 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -59.77 -47.84 84.06 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.373 -0.376 . . . . 10.0 110.787 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 17' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' C' ' 21' ' ' GLU . 2.6 p -61.48 -42.42 98.75 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.645 -0.252 . . . . 10.0 110.945 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 2.0 p -68.22 -25.51 65.24 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 111.865 0.32 . . . . 10.0 111.865 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 19' ' ' ILE . . . . . 0.512 HG12 ' O ' ' C' ' 15' ' ' TYR . 20.8 mm -78.65 -42.99 25.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 121.057 0.456 . . . . 10.0 110.448 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 20' ' ' VAL . . . . . . . . . . . . . 16.1 m -77.11 -23.69 14.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.869 0.366 . . . . 10.0 110.267 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' C' ' 17' ' ' SER . 5.0 tp10 -63.51 -51.2 66.53 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.341 -0.614 . . . . 10.0 109.341 178.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -77.01 -5.24 47.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.04 -0.982 . . . . 10.0 111.483 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm 58.03 42.93 21.82 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.317 0.579 . . . . 10.0 109.708 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . 0.44 ' O ' ' HE2' ' B' ' 5' ' ' LYS . 9.0 mt-10 -81.48 3.14 25.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.547 -0.751 . . . . 10.0 110.922 -178.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 18.2 tt -141.88 152.33 18.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 109.415 -0.587 . . . . 10.0 109.415 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.33 161.41 5.61 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 123.426 0.454 . . . . 10.0 111.844 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -54.27 -42.51 70.06 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.376 -0.374 . . . . 10.0 111.113 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.37 -49.9 71.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.774 -0.648 . . . . 10.0 110.493 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 29' ' ' GLY . . . . . 0.656 ' O ' ' HG ' ' C' ' 33' ' ' LEU . . . -68.64 -44.29 72.03 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.696 -0.684 . . . . 10.0 111.979 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.54 -45.67 81.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.87 0.367 . . . . 10.0 111.163 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 31' ' ' ASP . . . . . 0.537 ' CG ' ' HZ3' ' A' ' 79' ' ' LYS . 4.5 t70 -62.92 -44.81 95.08 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.969 -0.559 . . . . 10.0 110.076 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 53.5 m -60.59 -40.41 91.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.634 -0.712 . . . . 10.0 110.944 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 33' ' ' LEU . . . . . 0.656 ' HG ' ' O ' ' C' ' 29' ' ' GLY . 34.9 mt -67.16 -36.66 82.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.636 -0.256 . . . . 10.0 110.538 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -58.74 -57.76 11.59 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.083 -0.508 . . . . 10.0 111.013 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 35' ' ' VAL . . . . . . . . . . . . . 3.0 p -65.39 -38.53 82.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.394 -0.366 . . . . 10.0 111.194 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.48 -32.49 70.31 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.636 0.255 . . . . 10.0 110.918 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 49.1 mtm -60.92 -44.04 97.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.244 -0.435 . . . . 10.0 110.702 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 38' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -69.68 -30.96 68.74 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 109.819 -0.438 . . . . 10.0 109.819 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 39' ' ' CYS . . . . . 0.744 ' SG ' ' HA2' ' A' ' 123' ' ' GLY . 32.0 m -63.18 -48.22 79.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.28 0.562 . . . . 10.0 109.642 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 40' ' ' ILE . . . . . . . . . . . . . 66.4 mt -66.76 -45.68 87.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.21 -0.905 . . . . 10.0 110.776 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 41' ' ' SER . . . . . 0.513 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 27.9 m -62.31 -42.12 99.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.83 -0.623 . . . . 10.0 111.7 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -68.04 -39.99 82.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.869 0.366 . . . . 10.0 110.47 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.88 -49.21 78.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.777 -0.647 . . . . 10.0 111.967 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 44' ' ' PHE . . . . . 0.497 ' CE1' ' HB2' ' C' ' 5' ' ' LYS . 86.4 m-85 -88.17 -3.2 58.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.791 0.329 . . . . 10.0 111.477 -179.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.75 64.31 4.42 Favored Glycine 0 C--N 1.331 0.253 0 CA-C-N 116.116 -0.493 . . . . 10.0 113.781 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 46' ' ' PHE . . . . . 0.513 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 13.8 p90 -153.29 157.57 40.32 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.18 -0.304 . . . . 10.0 110.18 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 19.3 mp0 -83.98 137.92 33.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.4 -0.364 . . . . 10.0 110.614 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 48' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -65.78 -36.24 82.96 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.503 0.668 . . . . 10.0 110.229 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -79.95 15.0 1.57 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.114 -0.948 . . . . 10.0 111.782 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -104.15 1.05 30.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.968 0.413 . . . . 10.0 110.596 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 4.1 m -45.72 -42.06 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 113.053 0.76 . . . . 10.0 113.053 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 52' ' ' SER . . . . . . . . . . . . . 1.5 m -58.16 -28.53 64.81 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.325 0.491 . . . . 10.0 112.325 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.41 -28.25 27.95 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.66 -0.781 . . . . 10.0 112.408 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 54' ' ' ILE . . . . . . . . . . . . . 35.3 mt -85.21 -62.13 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.726 0.298 . . . . 10.0 110.913 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 47.5 mt -63.2 -44.31 95.71 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.777 -0.647 . . . . 10.0 110.854 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.34 -132.71 52.09 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.942 -0.647 . . . . 10.0 112.752 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 22.1 tttt -116.96 11.41 14.32 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.931 0.396 . . . . 10.0 110.237 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 2.0 m -78.19 136.81 37.89 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.798 -0.637 . . . . 10.0 110.984 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 59' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' C' ' 59' ' ' GLU . 1.1 pm0 -87.68 116.59 25.92 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.049 0.452 . . . . 10.0 109.879 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 60' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -78.02 167.99 20.58 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.231 -0.441 . . . . 10.0 110.619 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 61' ' ' LYS . . . . . 0.541 ' HG3' ' OD1' ' C' ' 1' ' ' ASP . 4.9 ptmm? -148.86 164.42 34.51 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.346 -0.388 . . . . 10.0 110.894 -179.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -147.74 55.79 0.51 Allowed Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.229 -0.749 . . . . 10.0 111.229 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 63' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -84.21 144.18 29.12 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.801 0.334 . . . . 10.0 110.391 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 64' ' ' HIS . . . . . . . . . . . . . 27.0 p-80 -153.99 107.52 2.95 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.001 0.429 . . . . 10.0 110.349 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -76.59 -13.49 60.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.768 -0.651 . . . . 10.0 109.979 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -89.57 151.36 21.98 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.651 -0.704 . . . . 10.0 109.896 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -83.71 148.2 27.21 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.114 -0.328 . . . . 10.0 110.114 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 68' ' ' ILE . . . . . . . . . . . . . 49.3 mt -84.68 83.17 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.028 0.442 . . . . 10.0 109.972 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 61.8 mt 63.53 -87.02 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.008 -0.996 . . . . 10.0 111.071 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 70' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -118.93 -11.53 9.69 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.207 -0.451 . . . . 10.0 111.308 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 71' ' ' SER . . . . . . . . . . . . . 11.4 m 58.1 30.0 18.67 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 123.566 0.541 . . . . 10.0 110.456 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.149 0 CA-C-O 118.196 -0.907 . . . . 10.0 110.095 -179.207 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 33.6 mtm . . . . . 0 N--CA 1.477 0.92 0 N-CA-C 110.277 -0.268 . . . . 10.0 110.277 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.9 t -115.4 130.94 69.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.609 -0.515 . . . . 10.0 109.609 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -87.41 125.31 34.19 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.836 0.35 . . . . 10.0 110.181 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 mp -120.94 122.29 39.86 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.679 -0.489 . . . . 10.0 109.679 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.7 m -101.01 113.93 27.39 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 110.089 -0.337 . . . . 10.0 110.089 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 87' ' ' SER . 2.8 mm? -88.41 117.73 27.54 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.183 -0.303 . . . . 10.0 110.183 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.402 ' HZ1' ' CG ' ' C' ' 31' ' ' ASP . 13.0 ttpt -114.63 99.19 7.35 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.923 -0.58 . . . . 10.0 109.714 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 85' ' ' LYS . 19.4 tptm -88.39 113.67 24.22 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.827 -0.624 . . . . 10.0 109.963 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 96.0 mt -81.46 -54.73 9.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.65 -0.704 . . . . 10.0 111.215 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -66.67 162.98 19.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.15 -0.477 . . . . 10.0 111.722 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.91 139.09 40.0 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.123 -0.49 . . . . 10.0 111.437 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -75.37 132.11 26.48 Favored 'Cis proline' 0 C--O 1.236 0.382 0 C-N-CA 123.047 -1.647 . . . . 10.0 110.378 -1.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -91.7 159.05 16.04 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.823 0.344 . . . . 10.0 111.458 -178.413 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -176.27 169.42 2.74 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.71 -0.677 . . . . 10.0 109.985 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 70.0 m -146.81 110.25 4.85 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.15 0.5 . . . . 10.0 110.184 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 33.8 pt -122.54 147.63 26.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.862 -0.608 . . . . 10.0 110.915 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -119.23 122.53 42.16 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.969 -0.56 . . . . 10.0 110.044 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -142.52 164.86 28.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.567 -0.288 . . . . 10.0 110.399 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.98 136.31 51.48 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.091 0.472 . . . . 10.0 110.565 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -126.81 170.2 12.43 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.741 -0.663 . . . . 10.0 109.684 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.568 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 5.3 m -92.31 148.27 36.2 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 109.862 -0.422 . . . . 10.0 109.862 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -51.8 -31.01 40.36 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.738 2.292 . . . . 10.0 112.683 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.75 10.84 19.45 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 112.295 0.48 . . . . 10.0 112.295 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.568 ' HB2' ' O ' ' A' ' 93' ' ' SER . 0.5 OUTLIER -81.03 152.72 27.78 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.746 -0.464 . . . . 10.0 109.746 179.111 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.17 154.39 21.26 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.156 -0.474 . . . . 10.0 110.068 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 39.3 mm -63.28 -21.87 29.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.53 0.681 . . . . 10.0 109.364 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.27 -44.04 75.24 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 114.756 -1.111 . . . . 10.0 110.474 178.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -62.79 -41.93 99.48 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.7 -0.682 . . . . 10.0 110.733 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.507 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 49.3 mt -60.64 -48.59 88.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.673 -0.694 . . . . 10.0 109.932 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -54.06 -43.79 70.56 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.219 -0.9 . . . . 10.0 111.609 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -62.78 -35.56 80.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.011 0.434 . . . . 10.0 110.589 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.565 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 36.1 t60 -66.08 -37.78 86.64 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.088 -0.505 . . . . 10.0 110.627 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 101' ' ' ILE . 11.3 mt -63.9 -40.12 95.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.208 0.528 . . . . 10.0 110.179 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 32.8 mt -69.97 -38.04 74.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.911 -0.586 . . . . 10.0 109.558 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 32.4 t -66.72 -22.28 66.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.396 -0.82 . . . . 10.0 111.076 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.565 ' HG2' ' O ' ' A' ' 104' ' ' HIS . 19.9 mm-40 -94.08 11.65 29.14 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 121.071 -0.252 . . . . 10.0 110.399 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 58.58 30.09 19.35 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.014 -0.539 . . . . 10.0 111.235 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.5 mmpp? -106.57 -5.67 18.58 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.127 -0.488 . . . . 10.0 110.513 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.419 ' HB3' HD12 ' A' ' 148' ' ' ILE . . . -135.54 154.44 51.38 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.711 -0.677 . . . . 10.0 109.946 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.7 m -107.81 -30.39 8.55 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.914 -0.315 . . . . 10.0 111.624 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.414 ' O ' HG13 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -152.75 136.83 16.41 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.22 -0.289 . . . . 10.0 110.22 -178.694 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.464 HG21 ' N ' ' A' ' 115' ' ' SER . 15.8 tt -65.77 -36.24 77.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.567 0.699 . . . . 10.0 109.983 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.528 ' HB2' ' OE2' ' A' ' 116' ' ' GLU . 0.7 OUTLIER -50.23 -34.98 24.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.278 -1.328 . . . . 10.0 113.232 179.398 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.528 ' OE2' ' HB2' ' A' ' 115' ' ' SER . 1.0 OUTLIER -99.08 12.01 37.34 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.402 0.519 . . . . 10.0 112.402 -178.707 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 113' ' ' HIS . 57.0 mt -93.71 121.07 44.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.64 -0.424 . . . . 10.0 110.5 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.452 ' HZ3' ' CG ' ' B' ' 31' ' ' ASP . 18.1 mmmt -121.79 114.4 21.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.297 -0.41 . . . . 10.0 110.464 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -91.4 128.23 37.15 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.976 0.417 . . . . 10.0 111.241 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 125' ' ' VAL . 2.8 mm? -116.01 137.43 52.12 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.982 -0.748 . . . . 10.0 108.982 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 16.5 tp -121.06 95.68 4.79 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.26 -1.015 . . . . 10.0 108.26 178.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.404 ' HD2' ' HA ' ' A' ' 122' ' ' LYS . 4.1 tptp 42.36 60.32 2.38 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.11 -0.95 . . . . 10.0 110.584 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.588 ' HA2' ' SG ' ' C' ' 39' ' ' CYS . . . 86.69 -46.05 3.52 Favored Glycine 0 C--N 1.331 0.299 0 CA-C-N 115.792 -0.64 . . . . 10.0 113.238 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.9 tttp -60.46 121.23 11.58 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 120.631 0.253 . . . . 10.0 110.554 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 120' ' ' LEU . 12.8 p -79.59 136.49 23.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.097 0.475 . . . . 10.0 111.458 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.2 mp -106.03 157.31 17.61 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.041 -0.527 . . . . 10.0 111.202 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -116.98 158.5 24.0 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 116.315 -0.402 . . . . 10.0 110.433 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.64 -48.25 82.39 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.491 -0.777 . . . . 10.0 112.143 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -82.97 5.52 21.76 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.93 -0.577 . . . . 10.0 111.162 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.0 tp -73.84 139.58 45.17 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.114 0.483 . . . . 10.0 111.447 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -102.82 148.8 25.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.382 -0.826 . . . . 10.0 109.641 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 60.4 mt -56.51 -39.11 72.75 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.991 0.367 . . . . 10.0 111.991 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.8 p -75.58 -19.19 59.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.821 0.343 . . . . 10.0 111.076 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -81.28 -42.5 20.55 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.253 -0.43 . . . . 10.0 111.255 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.2 pp -82.62 -22.51 34.71 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 121.084 -0.246 . . . . 10.0 110.876 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt 67.58 88.46 0.11 Allowed 'General case' 0 N--CA 1.463 0.218 0 O-C-N 123.723 0.639 . . . . 10.0 110.755 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 30.8 t -63.72 105.85 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.613 -0.721 . . . . 10.0 110.644 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.79 117.43 35.22 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.895 -0.593 . . . . 10.0 111.403 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -67.85 -11.75 33.11 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.822 2.348 . . . . 10.0 112.718 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -88.69 6.44 38.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.507 0.67 . . . . 10.0 110.014 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -134.97 -66.35 0.59 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.193 -0.912 . . . . 10.0 109.295 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.1 m 52.71 22.92 2.45 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.205 -0.907 . . . . 10.0 112.2 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 36.4 m -123.69 125.72 45.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.05 0.452 . . . . 10.0 110.188 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.27 117.59 55.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 108.292 -1.003 . . . . 10.0 108.292 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.37 126.6 31.38 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.318 -0.623 . . . . 10.0 109.318 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.2 t -99.7 130.75 48.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.89 -0.595 . . . . 10.0 112.095 -177.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' MET . . . . . 0.511 ' HE1' ' SG ' ' B' ' 39' ' ' CYS . 1.6 mpt? -122.64 117.71 26.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.089 -0.96 . . . . 10.0 109.257 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.419 HD12 ' HB3' ' A' ' 111' ' ' ALA . 21.1 mt -138.3 143.73 32.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.503 -0.317 . . . . 10.0 111.175 -177.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.505 ' HZ3' ' CG ' ' B' ' 38' ' ' ASP . 28.6 mmmt -112.2 117.98 46.72 Favored Pre-proline 0 N--CA 1.452 -0.371 0 CA-C-N 116.339 -0.391 . . . . 10.0 110.093 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -67.07 112.83 2.62 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.535 2.157 . . . . 10.0 112.653 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -85.46 -22.16 28.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.058 0.456 . . . . 10.0 110.34 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 90.3 mt -71.71 130.6 41.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.59 -0.732 . . . . 10.0 110.488 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.95 0 CA-C-O 118.399 -0.81 . . . . 10.0 110.253 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' -1' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.476 0.839 0 N-CA-C 110.434 -0.21 . . . . 10.0 110.434 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 0' ' ' VAL . . . . . . . . . . . . . 16.2 m -123.47 -165.87 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.223 -0.444 . . . . 10.0 110.852 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -161.34 -80.93 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.075 0.464 . . . . 10.0 109.955 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 37.2 m -163.48 7.08 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.488 -0.778 . . . . 10.0 110.087 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.97 147.24 24.41 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.904 -0.589 . . . . 10.0 109.891 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 48.9 p -91.43 169.27 10.92 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.919 0.39 . . . . 10.0 111.008 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -59.38 -44.07 92.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.977 -0.556 . . . . 10.0 111.106 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -61.21 -47.89 84.02 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.317 -0.401 . . . . 10.0 111.133 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -57.29 -41.16 79.25 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.34 -0.391 . . . . 10.0 110.694 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.701 ' O ' HG13 ' B' ' 12' ' ' ILE . 26.0 mm -61.49 -48.43 88.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.787 -0.449 . . . . 10.0 109.787 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.409 ' HA ' HD11 ' B' ' 12' ' ' ILE . . . -57.22 -43.37 82.76 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.965 -0.561 . . . . 10.0 111.264 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.8 -34.44 77.91 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.025 -0.534 . . . . 10.0 110.614 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 26.0 mt -71.78 -34.11 69.16 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.164 -0.471 . . . . 10.0 110.282 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.701 HG13 ' O ' ' B' ' 8' ' ' ILE . 21.4 mt -63.5 -52.48 57.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.229 -0.441 . . . . 10.0 110.571 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.41 HG12 ' HG3' ' B' ' 37' ' ' MET . 34.4 m -63.26 -30.51 49.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 116.358 -0.383 . . . . 10.0 111.06 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -68.85 -50.46 49.69 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.969 0.414 . . . . 10.0 110.793 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' TYR . . . . . 0.487 ' O ' HG12 ' B' ' 19' ' ' ILE . 1.7 m-85 -70.66 -36.22 73.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.885 -0.598 . . . . 10.0 111.669 -178.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -61.22 -54.63 41.77 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 121.191 -0.204 . . . . 10.0 111.547 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 12.4 p -60.37 -40.07 89.46 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.712 0.264 . . . . 10.0 111.712 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 4.8 p -70.69 -23.53 62.49 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 111.846 0.313 . . . . 10.0 111.846 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.487 HG12 ' O ' ' B' ' 15' ' ' TYR . 10.8 mm -79.95 -41.57 21.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 120.955 0.407 . . . . 10.0 109.934 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 10.6 m -77.77 -29.01 15.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.842 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . 0.452 ' HA ' ' OE1' ' B' ' 21' ' ' GLU . 3.8 tp10 -70.03 -43.88 70.39 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.616 -0.513 . . . . 10.0 109.616 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -71.32 -8.83 56.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.125 -0.488 . . . . 10.0 110.389 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm 60.36 46.35 10.1 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.692 -0.685 . . . . 10.0 110.131 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.465 ' O ' ' HE2' ' C' ' 5' ' ' LYS . 43.1 mt-10 -96.6 13.32 28.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.139 -0.937 . . . . 10.0 110.471 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 15.0 tt -148.64 154.44 10.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.659 -0.701 . . . . 10.0 109.759 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 1.8 p -67.86 162.73 23.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.485 -0.325 . . . . 10.0 110.926 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 41.5 mp0 -56.09 -46.79 78.92 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.422 -0.354 . . . . 10.0 111.945 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -57.54 -41.22 80.53 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.19 0.519 . . . . 10.0 110.255 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . 0.458 ' O ' ' HG ' ' B' ' 33' ' ' LEU . . . -71.29 -42.43 57.29 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.707 -0.678 . . . . 10.0 111.585 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.25 -44.76 95.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.754 -0.223 . . . . 10.0 111.239 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.452 ' CG ' ' HZ3' ' A' ' 118' ' ' LYS . 6.4 t0 -69.08 -33.26 73.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.833 0.349 . . . . 10.0 110.59 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 69.4 m -65.03 -42.04 94.69 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.593 -0.521 . . . . 10.0 109.593 178.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' B' ' 29' ' ' GLY . 79.1 mt -72.51 -31.18 65.14 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.438 -0.579 . . . . 10.0 109.438 178.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -62.38 -53.6 52.53 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.463 -0.789 . . . . 10.0 110.985 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 12.0 p -73.2 -33.73 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 116.363 -0.38 . . . . 10.0 110.654 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . 0.462 ' O ' HG13 ' B' ' 40' ' ' ILE . . . -62.53 -43.49 98.68 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.213 -0.662 . . . . 10.0 109.213 178.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' MET . . . . . 0.41 ' HG3' HG12 ' B' ' 13' ' ' VAL . 15.3 ttm -56.49 -41.6 76.91 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.089 -0.96 . . . . 10.0 110.316 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . 0.505 ' CG ' ' HZ3' ' A' ' 149' ' ' LYS . 27.3 t70 -62.15 -47.63 83.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.275 -0.875 . . . . 10.0 110.532 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' CYS . . . . . 0.511 ' SG ' ' HE1' ' A' ' 147' ' ' MET . 17.4 m -62.3 -46.89 86.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.937 -0.574 . . . . 10.0 110.82 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' ILE . . . . . 0.462 HG13 ' O ' ' B' ' 36' ' ' ALA . 58.3 mt -60.35 -38.44 77.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.171 -0.468 . . . . 10.0 110.757 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.604 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 0.1 OUTLIER -59.85 -47.37 86.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 10.0 110.99 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -77.69 -23.49 49.54 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.495 -0.321 . . . . 10.0 111.39 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.21 -39.35 92.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.443 -0.344 . . . . 10.0 111.124 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -100.92 2.57 40.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.197 -0.456 . . . . 10.0 111.093 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 62.2 55.67 26.51 Favored Glycine 0 CA--C 1.519 0.289 0 CA-C-N 115.859 -0.61 . . . . 10.0 113.599 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.604 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 6.6 p90 -149.37 160.78 43.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 117.079 0.44 . . . . 10.0 110.541 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.86 150.84 20.28 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.792 -0.448 . . . . 10.0 109.792 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.444 ' H ' ' HG3' ' B' ' 48' ' ' ARG . 1.4 mtm180 -63.8 -28.63 69.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.226 0.536 . . . . 10.0 110.73 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -78.31 7.86 5.85 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.787 -0.642 . . . . 10.0 111.691 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.32 2.89 55.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.013 0.435 . . . . 10.0 110.502 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.472 HG23 ' H ' ' B' ' 52' ' ' SER . 1.5 m -47.29 -64.02 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.248 -0.887 . . . . 10.0 112.792 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' SER . . . . . 0.472 ' H ' HG23 ' B' ' 51' ' ' VAL . 0.8 OUTLIER -56.33 -36.38 68.67 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.675 0.62 . . . . 10.0 112.675 -179.201 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.79 -44.99 60.23 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.818 -0.706 . . . . 10.0 112.906 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 57.8 mt -78.3 -50.44 19.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.856 0.36 . . . . 10.0 111.618 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 41.4 mt -71.18 -51.74 23.13 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.233 -0.44 . . . . 10.0 111.504 -178.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.94 -145.74 50.14 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.582 -0.818 . . . . 10.0 111.292 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 38.7 tttt -97.98 -8.98 26.89 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.005 0.431 . . . . 10.0 110.287 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.54 123.74 18.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.402 -0.817 . . . . 10.0 111.718 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -76.63 151.72 36.1 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.708 -0.678 . . . . 10.0 110.378 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -111.45 169.73 8.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.292 -0.413 . . . . 10.0 110.155 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 5.7 ptmm? -155.97 165.47 36.36 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.002 0.429 . . . . 10.0 110.883 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -141.42 55.98 0.6 Allowed Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.091 -0.959 . . . . 10.0 110.765 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -79.51 133.68 36.49 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.225 0.536 . . . . 10.0 110.682 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 44.5 p-80 -154.15 112.16 3.53 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.694 -0.685 . . . . 10.0 110.14 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -78.84 -10.43 59.79 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.425 0.631 . . . . 10.0 109.49 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.47 142.65 27.52 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.2 -0.909 . . . . 10.0 110.411 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -84.63 138.07 32.91 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.263 -0.426 . . . . 10.0 110.337 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 44.4 mt -71.95 97.55 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.996 -0.742 . . . . 10.0 108.996 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 76.6 mt 66.22 -87.06 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.279 -0.873 . . . . 10.0 109.792 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 20.7 p-10 -138.69 1.92 2.15 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.558 0.218 . . . . 10.0 110.599 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 75.3 m 59.08 21.93 9.95 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.992 -0.549 . . . . 10.0 112.187 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.924 0 CA-C-O 118.911 -0.566 . . . . 10.0 110.378 179.664 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' -1' ' ' SER . . . . . . . . . . . . . 49.3 m . . . . . 0 N--CA 1.48 1.051 0 CA-C-O 120.928 0.394 . . . . 10.0 110.927 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 0' ' ' VAL . . . . . . . . . . . . . 6.1 m -121.9 -166.91 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.153 -0.476 . . . . 10.0 109.776 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -151.66 -79.7 0.11 Allowed 'General case' 0 C--N 1.327 -0.404 0 O-C-N 123.583 0.552 . . . . 10.0 110.374 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 1.5 m -158.89 1.4 0.09 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.731 -0.668 . . . . 10.0 109.596 -178.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -87.53 157.98 19.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.973 -0.558 . . . . 10.0 110.592 -179.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 4' ' ' SER . . . . . 0.533 ' O ' HG12 ' C' ' 8' ' ' ILE . 33.3 p -102.78 166.28 10.57 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.355 -0.384 . . . . 10.0 110.729 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . 0.465 ' HE2' ' O ' ' B' ' 24' ' ' GLU . 10.1 ptpp? -59.5 -39.56 84.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.246 -0.433 . . . . 10.0 110.916 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 6' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -60.87 -45.25 95.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 10.0 110.719 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -65.6 -37.36 86.4 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.304 -0.407 . . . . 10.0 110.588 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 8' ' ' ILE . . . . . 0.533 HG12 ' O ' ' C' ' 4' ' ' SER . 38.6 mm -64.85 -45.69 94.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 10.0 110.084 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.89 -45.9 85.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.918 -0.583 . . . . 10.0 110.222 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.33 -37.56 87.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.603 -0.726 . . . . 10.0 111.264 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 2.2 mt -68.33 -44.77 74.62 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.836 0.35 . . . . 10.0 110.977 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 12' ' ' ILE . . . . . . . . . . . . . 1.4 mp -63.03 -45.9 97.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.76 -0.654 . . . . 10.0 111.521 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 28.8 m -66.61 -27.76 41.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-O 120.919 0.39 . . . . 10.0 110.612 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.18 -44.03 54.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.029 -0.532 . . . . 10.0 110.358 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 15' ' ' TYR . . . . . 0.531 ' O ' HG12 ' C' ' 19' ' ' ILE . 1.1 m-85 -68.04 -37.15 81.01 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.482 -0.326 . . . . 10.0 110.298 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 5.9 m-30 -58.31 -51.33 70.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.397 -0.365 . . . . 10.0 110.657 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 1.5 p -62.44 -38.5 89.98 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.865 -0.607 . . . . 10.0 111.542 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 11.7 p -71.11 -21.33 62.23 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.743 0.306 . . . . 10.0 111.419 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 19' ' ' ILE . . . . . 0.531 HG12 ' O ' ' C' ' 15' ' ' TYR . 25.2 mm -85.71 -44.56 17.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 CA-C-O 120.941 0.4 . . . . 10.0 111.143 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 20' ' ' VAL . . . . . . . . . . . . . 35.5 m -72.66 -32.64 41.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.202 -0.454 . . . . 10.0 111.721 -177.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . 0.473 ' HA ' ' OE1' ' C' ' 21' ' ' GLU . 1.1 tp10 -78.6 -18.81 54.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.864 0.364 . . . . 10.0 111.098 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -95.19 -6.26 42.06 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.718 -0.475 . . . . 10.0 109.718 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm 59.11 50.81 7.66 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.355 -0.839 . . . . 10.0 110.916 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -98.62 4.2 47.99 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.541 -0.754 . . . . 10.0 111.27 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 19.9 tt -143.73 153.66 16.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.936 -0.394 . . . . 10.0 109.936 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.82 162.41 13.61 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.415 -0.357 . . . . 10.0 111.386 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -56.23 -40.74 74.59 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.182 -0.463 . . . . 10.0 111.585 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 28' ' ' ASP . . . . . 0.452 ' CG ' ' HZ3' ' A' ' 85' ' ' LYS . 0.5 OUTLIER -56.38 -48.07 77.61 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.385 0.612 . . . . 10.0 109.96 179.147 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 29' ' ' GLY . . . . . 0.585 ' O ' ' HG ' ' C' ' 33' ' ' LEU . . . -70.33 -38.31 70.85 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.314 -0.857 . . . . 10.0 112.224 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.17 -46.79 79.19 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.52 0.2 . . . . 10.0 111.273 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 31' ' ' ASP . . . . . 0.402 ' CG ' ' HZ1' ' A' ' 79' ' ' LYS . 17.1 t70 -66.7 -39.29 88.02 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.823 -0.436 . . . . 10.0 109.823 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 50.7 m -59.0 -39.17 81.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.7 -0.682 . . . . 10.0 110.218 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 33' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' C' ' 29' ' ' GLY . 52.1 mt -75.68 -27.78 58.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.013 -0.539 . . . . 10.0 110.179 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -71.08 -49.92 39.33 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 116.07 -0.513 . . . . 10.0 110.816 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 35' ' ' VAL . . . . . . . . . . . . . 8.9 p -67.01 -43.32 89.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-N 116.573 -0.285 . . . . 10.0 111.272 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' C' ' 39' ' ' CYS . . . -63.82 -30.99 72.02 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.886 0.374 . . . . 10.0 111.246 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 37' ' ' MET . . . . . 0.423 ' HB2' ' O ' ' C' ' 33' ' ' LEU . 26.7 ttm -59.01 -49.79 76.54 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.091 -0.504 . . . . 10.0 110.545 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 38' ' ' ASP . . . . . 0.542 ' CB ' ' HA3' ' A' ' 123' ' ' GLY . 15.2 m-20 -68.61 -26.15 65.22 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.968 -0.56 . . . . 10.0 110.623 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 39' ' ' CYS . . . . . 0.588 ' SG ' ' HA2' ' A' ' 123' ' ' GLY . 84.9 m -58.49 -46.35 86.84 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.515 0.674 . . . . 10.0 109.534 178.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 40' ' ' ILE . . . . . . . . . . . . . 6.6 mt -73.06 -39.73 57.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.244 -0.889 . . . . 10.0 110.346 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 41' ' ' SER . . . . . 0.528 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 19.7 m -60.45 -44.39 95.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.618 -0.719 . . . . 10.0 111.863 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -71.79 -41.07 68.77 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.896 -0.322 . . . . 10.0 110.772 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.75 -40.22 91.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.328 -0.396 . . . . 10.0 111.679 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 44' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -90.98 -10.73 41.28 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.52 -0.309 . . . . 10.0 111.166 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 66.22 47.85 68.94 Favored Glycine 0 CA--C 1.517 0.188 0 C-N-CA 121.238 -0.506 . . . . 10.0 112.711 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 46' ' ' PHE . . . . . 0.528 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 3.3 p90 -142.62 156.75 45.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.795 0.331 . . . . 10.0 110.6 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -89.01 142.33 27.73 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.085 -0.507 . . . . 10.0 110.133 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 48' ' ' ARG . . . . . 0.456 ' HD3' ' OD1' ' C' ' 38' ' ' ASP . 0.1 OUTLIER -61.41 -33.52 73.84 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.128 0.489 . . . . 10.0 111.202 -179.928 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -76.95 8.58 3.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.726 -0.67 . . . . 10.0 112.169 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.18 1.36 57.26 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.059 0.456 . . . . 10.0 110.684 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 51' ' ' VAL . . . . . 0.414 HG11 ' O ' ' C' ' 48' ' ' ARG . 5.9 m -46.53 -46.46 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 115.282 -0.872 . . . . 10.0 112.902 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.36 -35.12 64.91 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.499 0.555 . . . . 10.0 112.499 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.9 -34.79 23.52 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.547 -0.835 . . . . 10.0 113.248 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 54' ' ' ILE . . . . . . . . . . . . . 56.1 mt -80.84 -59.17 3.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.943 0.401 . . . . 10.0 111.175 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 36.1 mt -67.12 -49.51 64.64 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.246 -0.433 . . . . 10.0 111.078 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.13 -135.3 45.83 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.993 -0.622 . . . . 10.0 112.654 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 8.9 tttt -105.45 -5.67 20.12 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.122 0.487 . . . . 10.0 110.003 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.21 130.26 44.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.667 -0.697 . . . . 10.0 111.408 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -90.11 134.54 34.2 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 120.992 0.425 . . . . 10.0 109.946 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 60' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -94.89 168.87 10.53 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.538 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 12.1 ptmm? -150.44 161.17 43.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.285 -0.416 . . . . 10.0 110.831 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -137.59 55.77 0.68 Allowed Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.741 -0.943 . . . . 10.0 110.741 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 63' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -78.59 134.74 37.18 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.429 -0.386 . . . . 10.0 110.066 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 64' ' ' HIS . . . . . . . . . . . . . 36.6 p-80 -154.98 107.83 2.78 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.643 -0.423 . . . . 10.0 111.216 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -76.25 -20.74 57.12 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.157 -0.683 . . . . 10.0 109.157 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.25 127.22 33.45 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.5 -0.773 . . . . 10.0 110.163 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.0 143.62 56.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.274 -0.421 . . . . 10.0 110.212 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 68' ' ' ILE . . . . . 0.42 HG22 HD11 ' C' ' 68' ' ' ILE . 38.8 mt -79.91 90.23 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.063 0.458 . . . . 10.0 110.873 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 68.9 mt 72.35 -65.31 0.36 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 114.99 -1.005 . . . . 10.0 111.14 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 70' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -162.25 -29.59 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.17 -0.468 . . . . 10.0 110.502 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 71' ' ' SER . . . . . . . . . . . . . 71.3 m 61.92 44.19 8.56 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.976 -0.556 . . . . 10.0 111.418 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.662 -0.685 . . . . 10.0 110.639 -179.978 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.523 ' SD ' ' HB2' ' A' ' 91' ' ' ASP . 5.2 mtm . . . . . 0 N--CA 1.479 1.008 0 CA-C-O 121.094 0.474 . . . . 10.0 110.642 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.3 t -81.43 123.84 38.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.922 -0.581 . . . . 10.0 110.278 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -93.79 125.31 38.34 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.539 -0.464 . . . . 10.0 110.504 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.6 mp -127.93 139.85 52.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.812 -0.631 . . . . 10.0 110.744 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.2 m -102.43 115.36 30.41 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.136 -0.484 . . . . 10.0 110.146 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.418 ' O ' ' HA ' ' A' ' 87' ' ' SER . 2.2 mm? -85.91 110.45 19.44 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.795 -0.446 . . . . 10.0 109.795 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 51.4 tttt -108.9 102.56 11.56 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.215 -0.448 . . . . 10.0 111.267 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.524 ' HG2' ' O ' ' A' ' 84' ' ' PRO . 17.8 tptm -95.88 106.13 18.23 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.952 0.406 . . . . 10.0 110.097 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 91.9 mt -73.43 -55.94 11.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.512 -0.767 . . . . 10.0 111.548 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -70.19 164.54 24.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.405 -0.361 . . . . 10.0 110.88 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.471 ' HA ' ' C ' ' A' ' 84' ' ' PRO . . . -83.75 143.2 43.27 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 111.678 0.251 . . . . 10.0 111.678 -178.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.524 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 10.8 Cg_exo -69.14 128.37 11.81 Favored 'Cis proline' 0 C--N 1.347 0.495 0 C-N-CA 123.019 -1.659 . . . . 10.0 110.585 -1.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.44 ' N ' ' HA ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -86.77 148.08 25.57 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.418 -0.355 . . . . 10.0 111.204 -178.618 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -170.73 166.0 7.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.074 -0.512 . . . . 10.0 110.065 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 38.6 m -150.39 106.31 3.43 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.585 -0.524 . . . . 10.0 109.585 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 43.9 pt -126.86 158.88 37.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.314 -0.403 . . . . 10.0 111.058 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -121.39 139.82 52.94 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.506 -0.553 . . . . 10.0 109.506 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -149.61 165.01 33.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.883 0.373 . . . . 10.0 111.357 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.523 ' HB2' ' SD ' ' A' ' 73' ' ' MET . 0.0 OUTLIER -110.39 124.64 52.09 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.665 -0.698 . . . . 10.0 109.863 179.38 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -118.45 171.04 8.43 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.994 -0.548 . . . . 10.0 110.512 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.566 ' O ' HD11 ' A' ' 132' ' ' LEU . 1.5 m -80.15 144.87 59.39 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.424 -0.353 . . . . 10.0 110.368 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -59.04 -15.11 26.19 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.815 2.343 . . . . 10.0 112.332 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.0 t -119.21 19.98 12.72 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 116.244 -0.435 . . . . 10.0 110.434 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.477 ' HB2' ' O ' ' A' ' 93' ' ' SER . 0.3 OUTLIER -73.15 164.7 26.31 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.149 0.499 . . . . 10.0 111.182 -179.163 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.04 147.76 35.32 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.763 -0.653 . . . . 10.0 110.429 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 38.3 mm -58.83 -24.83 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 121.518 0.675 . . . . 10.0 110.49 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.39 -39.08 60.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.912 -1.04 . . . . 10.0 111.185 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 72.7 mm-40 -66.28 -39.9 89.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 10.0 110.978 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.644 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 18.0 mt -65.01 -51.05 71.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.171 -0.468 . . . . 10.0 109.956 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.462 ' HZ2' ' CG ' ' A' ' 128' ' ' ASP . 9.0 mttm -54.97 -50.46 68.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.496 -0.774 . . . . 10.0 111.759 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -62.49 -32.01 72.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.653 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 15.9 t60 -67.66 -39.17 84.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.048 -0.524 . . . . 10.0 109.999 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 101' ' ' ILE . 28.2 mt -59.71 -39.58 85.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.056 -0.52 . . . . 10.0 110.293 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 16.6 mt -72.91 -34.37 46.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 116.022 -0.536 . . . . 10.0 110.159 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.8 t -64.78 -22.79 67.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.794 -0.639 . . . . 10.0 111.128 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -100.09 7.28 44.76 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.828 -0.434 . . . . 10.0 109.828 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 60.21 31.62 20.56 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.687 -0.688 . . . . 10.0 111.172 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -101.56 -9.22 21.19 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.385 -0.598 . . . . 10.0 109.385 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.13 148.17 52.11 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.105 -0.952 . . . . 10.0 109.96 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.34 -55.74 3.19 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.806 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.562 ' O ' HG13 ' A' ' 117' ' ' ILE . 32.7 m170 -131.39 139.12 49.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.667 -0.242 . . . . 10.0 110.949 -179.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.41 HG21 ' H ' ' A' ' 115' ' ' SER . 4.5 tt -64.87 -44.34 96.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.362 0.601 . . . . 10.0 110.405 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.41 ' H ' HG21 ' A' ' 114' ' ' ILE . 16.3 t -52.31 -33.34 41.92 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.903 -1.044 . . . . 10.0 111.73 178.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.466 ' HG3' ' OD1' ' A' ' 151' ' ' ASN . 7.1 mm-40 -93.27 16.01 14.2 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.32 0.489 . . . . 10.0 112.32 -177.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.562 HG13 ' O ' ' A' ' 113' ' ' HIS . 55.2 mt -106.66 123.52 61.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.346 -0.388 . . . . 10.0 110.188 178.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -120.11 116.59 25.99 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.659 -0.497 . . . . 10.0 109.659 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.504 HD22 ' N ' ' A' ' 119' ' ' LEU . 3.5 mm? -94.34 123.48 37.77 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.739 0.304 . . . . 10.0 110.216 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.42 HD21 ' SD ' ' A' ' 147' ' ' MET . 2.8 mm? -109.21 141.1 41.96 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.193 -0.669 . . . . 10.0 109.193 179.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 24.7 tp -126.1 98.33 5.45 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.145 -1.057 . . . . 10.0 108.145 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 11.1 tptp 46.49 51.62 11.65 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.497 0.665 . . . . 10.0 110.246 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.623 ' HA3' ' CB ' ' C' ' 38' ' ' ASP . . . 89.72 -44.14 3.01 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.231 -0.895 . . . . 10.0 113.384 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.535 ' HZ2' ' CD ' ' C' ' 42' ' ' GLU . 0.4 OUTLIER -59.09 129.77 43.77 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.489 0.185 . . . . 10.0 110.88 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 8.8 p -82.61 139.29 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.136 0.493 . . . . 10.0 112.102 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 4.4 mp -112.46 154.37 25.95 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 115.654 -0.703 . . . . 10.0 111.055 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -117.16 159.48 22.54 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 121.763 -0.586 . . . . 10.0 112.208 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.462 ' CG ' ' HZ2' ' A' ' 102' ' ' LYS . 1.1 m-20 -56.38 -51.69 67.38 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.212 1.005 . . . . 10.0 112.229 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -83.18 6.94 17.6 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.3 -0.863 . . . . 10.0 112.194 -177.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.2 tp -79.77 148.69 31.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.928 0.394 . . . . 10.0 111.308 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -109.62 151.77 26.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.803 -0.635 . . . . 10.0 110.33 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.566 HD11 ' O ' ' A' ' 93' ' ' SER . 79.5 mt -59.09 -37.13 76.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 10.0 111.96 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.72 -17.53 60.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.086 0.47 . . . . 10.0 111.221 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -88.98 -40.06 13.29 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.176 -0.465 . . . . 10.0 110.958 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.0 pp -82.41 -26.44 32.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.612 -0.267 . . . . 10.0 111.301 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 26.2 mtmt 64.7 96.1 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 O-C-N 123.887 0.742 . . . . 10.0 111.131 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.8 t -71.83 121.03 21.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.86 -0.609 . . . . 10.0 110.632 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.76 119.73 65.75 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 10.0 110.723 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -58.72 -34.5 98.99 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.924 2.416 . . . . 10.0 113.531 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -84.41 15.84 3.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.019 0.438 . . . . 10.0 111.47 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -128.26 -74.14 0.58 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.977 -0.556 . . . . 10.0 109.853 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.2 m 58.58 9.89 1.24 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.792 -0.64 . . . . 10.0 112.639 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.8 m -109.24 123.82 49.87 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.321 0.582 . . . . 10.0 111.326 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 14.7 mm -107.61 119.23 56.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.479 -0.782 . . . . 10.0 109.984 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.4 124.53 30.75 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.856 0.36 . . . . 10.0 110.359 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.6 t -99.48 124.63 52.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.935 -0.575 . . . . 10.0 111.282 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' MET . . . . . 0.42 ' SD ' HD21 ' A' ' 120' ' ' LEU . 2.0 mpt? -122.67 121.69 37.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.884 -0.598 . . . . 10.0 110.633 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 22.0 mt -137.74 142.23 36.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.609 -0.269 . . . . 10.0 111.027 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.448 ' HD3' ' HD2' ' A' ' 150' ' ' PRO . 0.4 OUTLIER -125.99 107.86 25.08 Favored Pre-proline 0 N--CA 1.454 -0.274 0 N-CA-C 109.943 -0.391 . . . . 10.0 109.943 178.282 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.448 ' HD2' ' HD3' ' A' ' 149' ' ' LYS . 19.4 Cg_endo -59.54 119.44 6.66 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.889 2.393 . . . . 10.0 113.067 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.466 ' OD1' ' HG3' ' A' ' 116' ' ' GLU . 27.0 m120 -73.07 -27.07 61.52 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.155 0.502 . . . . 10.0 109.964 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 79.7 mt -78.39 155.78 29.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.585 -0.734 . . . . 10.0 110.239 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 . . . . . 0 C--O 1.251 1.147 0 CA-C-O 117.941 -1.028 . . . . 10.0 109.901 178.916 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' -1' ' ' SER . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.476 0.86 0 CA-C-O 120.757 0.313 . . . . 10.0 111.216 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 0' ' ' VAL . . . . . . . . . . . . . 27.3 m -117.96 -151.98 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 115.856 -0.611 . . . . 10.0 109.822 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -174.81 -75.9 0.01 OUTLIER 'General case' 0 C--N 1.339 0.14 0 CA-C-O 120.713 0.292 . . . . 10.0 111.533 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 15.2 m -147.29 13.0 1.08 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.536 0.208 . . . . 10.0 111.442 -177.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -109.24 143.61 38.45 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 121.197 -0.201 . . . . 10.0 110.86 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.26 176.35 5.94 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.44 -0.578 . . . . 10.0 109.44 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -56.52 -46.56 80.53 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.248 -0.433 . . . . 10.0 111.438 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -56.64 -53.33 58.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.515 . . . . 10.0 112.033 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -57.24 -46.17 83.25 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.252 0.345 . . . . 10.0 110.814 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 17.2 mm -59.22 -45.9 92.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 10.0 110.41 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.64 -43.62 97.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.996 -0.547 . . . . 10.0 111.027 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.25 -36.11 82.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.035 -0.53 . . . . 10.0 110.616 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 17.7 mt -64.95 -36.25 83.79 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.343 0.592 . . . . 10.0 109.566 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.431 HG22 HD13 ' B' ' 40' ' ' ILE . 14.5 mt -61.42 -57.68 11.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.057 -0.974 . . . . 10.0 110.965 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 16.5 m -62.33 -25.98 39.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.989 0.423 . . . . 10.0 110.61 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -69.61 -51.53 34.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.777 -0.647 . . . . 10.0 110.657 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' TYR . . . . . 0.473 ' O ' HG12 ' B' ' 19' ' ' ILE . 2.3 m-85 -72.99 -39.67 65.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 10.0 111.844 -178.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -56.03 -50.85 69.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.67 0.271 . . . . 10.0 110.353 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 4.6 p -59.04 -46.32 88.52 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.654 -0.248 . . . . 10.0 111.338 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 6.7 p -65.06 -20.5 66.51 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.148 0.425 . . . . 10.0 112.148 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.473 HG12 ' O ' ' B' ' 15' ' ' TYR . 29.3 mm -85.05 -43.46 16.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 121.074 0.464 . . . . 10.0 110.349 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 35.2 m -75.97 -29.04 19.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.201 -0.454 . . . . 10.0 110.532 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . 0.522 ' HA ' ' OE1' ' B' ' 21' ' ' GLU . 1.8 tp10 -75.67 -34.79 60.48 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.269 -0.423 . . . . 10.0 110.766 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -81.86 -5.12 57.97 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.825 0.345 . . . . 10.0 110.446 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 34.0 mmtt 59.3 52.65 5.83 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.529 -0.759 . . . . 10.0 111.046 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -108.13 16.34 23.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.807 -0.633 . . . . 10.0 111.802 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -147.19 151.77 13.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 116.199 -0.455 . . . . 10.0 110.14 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 10.5 p -60.82 161.94 7.43 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.277 -0.419 . . . . 10.0 111.435 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -60.0 -49.68 76.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.074 0.464 . . . . 10.0 110.887 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.55 -42.97 93.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.427 -0.806 . . . . 10.0 110.003 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.13 -39.51 92.66 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.767 -0.73 . . . . 10.0 111.975 178.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.0 -44.55 97.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.875 0.369 . . . . 10.0 110.357 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -65.24 -35.59 81.51 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.374 -0.602 . . . . 10.0 109.374 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 47.9 m -60.95 -44.18 97.65 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 115.824 -0.625 . . . . 10.0 109.747 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 69.7 mt -72.11 -36.51 69.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.075 0.464 . . . . 10.0 110.044 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 12.7 t30 -60.02 -48.69 80.65 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.745 -0.662 . . . . 10.0 111.531 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 8.4 p -72.86 -35.61 49.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 120.85 0.357 . . . . 10.0 110.755 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.53 -39.36 93.62 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.534 -0.543 . . . . 10.0 109.534 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' MET . . . . . . . . . . . . . 24.1 ttm -57.79 -45.55 85.88 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.352 -0.84 . . . . 10.0 110.15 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -61.91 -42.13 98.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.562 -0.744 . . . . 10.0 110.801 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 59.3 m -63.43 -40.91 98.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.068 -0.514 . . . . 10.0 110.857 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' ILE . . . . . 0.431 HD13 HG22 ' B' ' 12' ' ' ILE . 55.0 mt -67.3 -40.35 84.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 110.144 -0.317 . . . . 10.0 110.144 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.638 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 9.7 m -63.1 -39.13 93.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.105 0.479 . . . . 10.0 110.081 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -70.86 -45.36 64.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.627 -0.715 . . . . 10.0 110.491 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.56 -48.66 78.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.539 -0.755 . . . . 10.0 112.547 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -83.42 -2.47 55.92 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.902 -0.319 . . . . 10.0 111.496 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 57.69 58.89 12.23 Favored Glycine 0 CA--C 1.518 0.236 0 CA-C-N 116.125 -0.489 . . . . 10.0 113.54 178.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.638 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 9.1 p90 -148.78 170.94 17.1 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.968 -0.382 . . . . 10.0 109.968 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -105.7 146.21 30.08 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.147 -0.316 . . . . 10.0 110.147 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 1.3 mtm180 -71.55 -26.87 62.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.278 0.561 . . . . 10.0 110.507 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -82.92 14.95 2.95 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.655 -0.702 . . . . 10.0 111.306 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -104.51 4.13 32.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.64 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -41.12 -63.52 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 114.011 1.115 . . . . 10.0 114.011 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' SER . . . . . 0.449 ' HB3' ' HA ' ' C' ' 71' ' ' SER . 1.9 m -53.9 -31.86 51.46 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.578 0.584 . . . . 10.0 112.578 -178.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.33 -41.68 30.15 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.986 -0.626 . . . . 10.0 113.352 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 19.6 mt -83.01 -43.54 18.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.999 0.428 . . . . 10.0 111.45 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 57.1 mt -71.52 -56.71 5.38 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.052 -0.522 . . . . 10.0 111.017 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.97 -150.38 45.9 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.692 -0.766 . . . . 10.0 111.298 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 32.8 tttt -103.8 2.5 32.9 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.357 0.599 . . . . 10.0 109.734 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.69 131.89 47.43 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.102 -0.954 . . . . 10.0 111.747 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -78.39 134.65 37.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.983 -0.553 . . . . 10.0 109.946 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . 0.47 ' O ' ' HA ' ' C' ' 61' ' ' LYS . 78.3 m-85 -90.11 158.1 17.45 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.174 -0.466 . . . . 10.0 110.737 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' C' ' 60' ' ' PHE . 11.0 ptmm? -147.57 149.47 32.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.931 0.396 . . . . 10.0 111.289 -178.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -140.71 51.08 0.73 Allowed Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 111.387 -0.685 . . . . 10.0 111.387 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -77.72 143.47 38.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.784 0.326 . . . . 10.0 110.852 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 39.4 p-80 -159.06 114.62 2.55 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.025 0.44 . . . . 10.0 110.407 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -84.68 -15.39 45.44 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.04 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -82.7 145.4 29.63 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.34 -0.615 . . . . 10.0 109.34 178.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' ASP . . . . . 0.454 ' CG ' ' HZ3' ' C' ' 57' ' ' LYS . 12.3 m-20 -83.34 133.3 34.96 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.911 0.386 . . . . 10.0 110.524 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . 0.418 ' O ' ' HB2' ' B' ' 69' ' ' LEU . 4.2 mt -71.57 92.83 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.976 -0.556 . . . . 10.0 110.683 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' B' ' 68' ' ' ILE . 21.3 mt 73.71 -57.46 0.62 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.604 0.762 . . . . 10.0 111.031 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -171.75 -22.52 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.606 -0.724 . . . . 10.0 109.574 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 2.6 m 62.71 37.34 12.74 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.069 -0.969 . . . . 10.0 110.654 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.214 0 CA-C-O 118.648 -0.691 . . . . 10.0 110.442 179.833 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' -1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 120.683 0.278 . . . . 10.0 110.559 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 0' ' ' VAL . . . . . . . . . . . . . 21.6 m -122.08 -168.21 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.205 -0.452 . . . . 10.0 110.274 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 1' ' ' ASP . . . . . 0.447 ' C ' ' HG ' ' C' ' 2' ' ' SER . 9.8 t70 -157.79 -71.2 0.09 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.881 0.372 . . . . 10.0 110.38 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 2' ' ' SER . . . . . 0.447 ' HG ' ' C ' ' C' ' 1' ' ' ASP . 53.3 m -160.24 -42.04 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.476 -0.565 . . . . 10.0 109.476 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -40.59 144.78 0.22 Allowed 'General case' 0 CA--C 1.533 0.313 0 O-C-N 124.515 1.134 . . . . 10.0 111.551 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 4' ' ' SER . . . . . 0.51 ' O ' HG12 ' C' ' 8' ' ' ILE . 23.0 p -98.3 163.68 12.62 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.339 -0.391 . . . . 10.0 110.213 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -57.76 -35.39 70.69 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 110.521 -0.178 . . . . 10.0 110.521 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 6' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -60.25 -49.67 76.7 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.219 0.533 . . . . 10.0 109.651 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -62.71 -42.32 99.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.365 -0.834 . . . . 10.0 110.817 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 8' ' ' ILE . . . . . 0.51 HG12 ' O ' ' C' ' 4' ' ' SER . 39.4 mm -59.15 -46.1 92.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.99 -0.55 . . . . 10.0 110.171 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.82 -43.66 94.4 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.086 -0.506 . . . . 10.0 110.554 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.91 -40.36 94.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.025 -0.534 . . . . 10.0 111.086 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 22.3 mt -65.15 -40.47 94.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.031 -0.531 . . . . 10.0 109.76 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 12' ' ' ILE . . . . . . . . . . . . . 1.2 mp -63.15 -47.86 90.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.187 -0.915 . . . . 10.0 111.869 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 34.1 m -71.09 -25.49 25.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.669 -0.412 . . . . 10.0 111.448 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -73.27 -40.59 64.46 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.063 0.459 . . . . 10.0 109.987 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 15' ' ' TYR . . . . . 0.533 ' O ' HG12 ' C' ' 19' ' ' ILE . 9.1 m-85 -71.74 -42.85 66.76 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.12 -0.491 . . . . 10.0 110.849 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -54.27 -49.48 69.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.737 0.304 . . . . 10.0 110.508 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 17' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' C' ' 21' ' ' GLU . 2.2 p -61.97 -41.66 98.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.139 -0.482 . . . . 10.0 111.4 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 3.6 p -69.36 -22.51 63.73 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 120.617 -0.433 . . . . 10.0 111.843 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 19' ' ' ILE . . . . . 0.533 HG12 ' O ' ' C' ' 15' ' ' TYR . 37.7 mm -80.83 -41.1 19.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 109.8 -0.444 . . . . 10.0 109.8 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 20' ' ' VAL . . . . . . . . . . . . . 16.8 m -77.85 -18.65 13.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.171 -0.677 . . . . 10.0 109.171 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' C' ' 17' ' ' SER . 4.1 tp10 -73.47 -50.67 20.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.551 -0.749 . . . . 10.0 110.734 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -84.07 1.09 45.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.368 -0.378 . . . . 10.0 111.782 -178.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 34.3 mmtt 55.79 46.83 21.6 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.162 0.506 . . . . 10.0 110.234 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -83.41 1.13 43.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.962 -0.563 . . . . 10.0 111.376 -178.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 16.0 tt -142.96 161.2 17.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.36 -0.607 . . . . 10.0 109.36 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 5.3 p -59.95 156.29 14.9 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.182 0.301 . . . . 10.0 110.607 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -60.76 -23.6 65.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.02 0.438 . . . . 10.0 110.337 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 28' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -68.39 -54.09 19.5 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.066 -0.716 . . . . 10.0 109.066 178.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 29' ' ' GLY . . . . . 0.407 ' O ' ' HG ' ' C' ' 33' ' ' LEU . . . -65.82 -33.05 84.74 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.318 -0.855 . . . . 10.0 110.984 178.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.72 -42.84 94.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.968 0.413 . . . . 10.0 110.441 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -68.02 -38.03 82.11 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.264 -0.643 . . . . 10.0 109.264 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 6.0 m -61.0 -43.48 98.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.407 -0.815 . . . . 10.0 110.046 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 33' ' ' LEU . . . . . 0.426 ' O ' ' HB2' ' C' ' 37' ' ' MET . 87.6 mt -71.05 -25.38 62.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.051 0.453 . . . . 10.0 110.373 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -72.25 -52.97 13.97 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.056 -0.52 . . . . 10.0 111.004 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 35' ' ' VAL . . . . . . . . . . . . . 7.6 p -69.21 -39.6 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 116.421 -0.354 . . . . 10.0 110.49 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . 0.532 ' O ' HD13 ' C' ' 40' ' ' ILE . . . -63.75 -32.25 73.69 Favored 'General case' 0 C--O 1.226 -0.163 0 CA-C-O 120.448 0.166 . . . . 10.0 110.661 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 37' ' ' MET . . . . . 0.426 ' HB2' ' O ' ' C' ' 33' ' ' LEU . 30.6 ttm -53.92 -52.44 60.59 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.178 0.513 . . . . 10.0 110.879 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 38' ' ' ASP . . . . . 0.623 ' CB ' ' HA3' ' A' ' 123' ' ' GLY . 1.7 m-20 -70.73 -26.44 63.39 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 116.176 -0.465 . . . . 10.0 111.124 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 39' ' ' CYS . . . . . 0.503 ' SG ' ' HA2' ' A' ' 123' ' ' GLY . 77.5 m -61.09 -42.24 98.15 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.773 -0.825 . . . . 10.0 108.773 177.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 40' ' ' ILE . . . . . 0.532 HD13 ' O ' ' C' ' 36' ' ' ALA . 1.4 mp -70.99 -40.74 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 115.097 -0.956 . . . . 10.0 109.891 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 41' ' ' SER . . . . . 0.629 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 13.4 m -60.18 -43.9 95.51 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.686 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . 0.535 ' CD ' ' HZ2' ' A' ' 124' ' ' LYS . 13.4 tt0 -72.2 -42.07 66.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.187 -0.461 . . . . 10.0 111.448 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.77 -48.46 75.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.286 -0.416 . . . . 10.0 111.626 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 44' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -88.96 -1.17 57.98 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.479 -0.328 . . . . 10.0 111.378 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 59.02 57.92 17.29 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.352 -0.451 . . . . 10.0 113.184 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 46' ' ' PHE . . . . . 0.629 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 4.3 p90 -145.65 156.36 43.6 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.989 0.395 . . . . 10.0 110.172 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 26.1 mp0 -81.84 128.04 33.62 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.488 -0.324 . . . . 10.0 110.302 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.5 -17.13 58.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.55 -0.295 . . . . 10.0 111.667 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -85.15 -2.53 58.13 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 122.321 0.249 . . . . 10.0 111.583 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.8 4.96 30.59 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.763 0.653 . . . . 10.0 112.763 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 3.6 m -42.98 -57.36 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 114.427 1.269 . . . . 10.0 114.427 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 52' ' ' SER . . . . . . . . . . . . . 1.2 m -61.31 -18.92 60.91 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.874 0.694 . . . . 10.0 112.874 -178.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.39 -48.59 4.99 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.809 -0.71 . . . . 10.0 112.953 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 54' ' ' ILE . . . . . . . . . . . . . 64.3 mt -74.66 -45.73 43.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.936 0.398 . . . . 10.0 110.311 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 45.7 mt -71.84 -47.82 50.45 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.178 0.513 . . . . 10.0 109.979 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 56.57 -137.0 48.83 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.373 -0.83 . . . . 10.0 112.371 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 57' ' ' LYS . . . . . 0.454 ' HZ3' ' CG ' ' B' ' 67' ' ' ASP . 30.2 tttt -111.6 24.07 13.19 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.954 -0.758 . . . . 10.0 108.954 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 6.8 m -91.7 139.92 30.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.181 -0.918 . . . . 10.0 111.006 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.71 145.89 24.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.165 -0.471 . . . . 10.0 109.84 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 60' ' ' PHE . . . . . 0.451 ' O ' ' HA ' ' B' ' 61' ' ' LYS . 76.9 m-85 -109.1 155.61 20.78 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.278 -0.419 . . . . 10.0 110.428 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 61' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' B' ' 60' ' ' PHE . 8.5 ptmm? -144.45 154.82 43.34 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.158 -0.473 . . . . 10.0 111.1 -178.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -139.57 60.25 0.58 Allowed Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.132 -0.787 . . . . 10.0 111.132 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 63' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -82.03 136.62 35.21 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.912 0.387 . . . . 10.0 110.175 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 64' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -149.13 111.96 4.83 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.334 0.588 . . . . 10.0 110.865 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -81.2 -13.62 58.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.367 -0.833 . . . . 10.0 108.887 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.61 137.31 32.46 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.284 -0.871 . . . . 10.0 109.919 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -72.34 149.8 44.07 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.892 -0.595 . . . . 10.0 109.566 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 68' ' ' ILE . . . . . . . . . . . . . 55.7 mt -88.68 97.82 7.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.987 0.423 . . . . 10.0 110.728 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 29.8 mt 62.48 -94.34 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.096 -0.956 . . . . 10.0 111.063 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 70' ' ' ASN . . . . . 0.48 ' ND2' ' HB2' ' C' ' 72' ' ' ALA . 29.0 p-10 -118.02 -14.27 9.98 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.733 -0.212 . . . . 10.0 111.367 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 71' ' ' SER . . . . . 0.449 ' HA ' ' HB3' ' B' ' 52' ' ' SER . 1.2 m 54.59 35.67 24.11 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.182 0.515 . . . . 10.0 110.795 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 72' ' ' ALA . . . . . 0.48 ' HB2' ' ND2' ' C' ' 70' ' ' ASN . . . . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.338 -0.839 . . . . 10.0 110.337 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 2.9 ttm . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 109.784 -0.45 . . . . 10.0 109.784 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.6 t -101.67 126.78 55.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.594 0.235 . . . . 10.0 110.684 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -86.2 127.46 34.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.58 -0.282 . . . . 10.0 110.381 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.2 mp -127.29 129.76 48.3 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.449 -0.341 . . . . 10.0 110.5 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 20.5 m -101.32 114.18 27.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.866 -0.606 . . . . 10.0 110.402 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' A' ' 87' ' ' SER . 2.0 mm? -90.54 126.1 35.82 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.727 -0.472 . . . . 10.0 109.727 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.6 tttp -130.21 106.78 8.82 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.491 -0.322 . . . . 10.0 110.746 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' ' 82' ' ' GLN . 47.0 tttm -93.71 110.39 22.02 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.959 -0.385 . . . . 10.0 109.959 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.456 HG23 HD11 ' A' ' 81' ' ' ILE . 63.5 mt -74.92 -34.33 32.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 115.381 -0.827 . . . . 10.0 111.312 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.404 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 71.6 mt-30 -83.24 156.13 23.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.344 -0.389 . . . . 10.0 110.418 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.406 ' HA ' ' C ' ' A' ' 84' ' ' PRO . . . -78.54 138.93 58.8 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.458 -0.337 . . . . 10.0 111.421 -178.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.406 ' C ' ' HA ' ' A' ' 83' ' ' ALA . 17.0 Cg_exo -70.29 131.63 20.5 Favored 'Cis proline' 0 C--N 1.347 0.488 0 C-N-CA 123.613 -1.411 . . . . 10.0 112.137 -1.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -83.64 148.2 27.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.275 -0.42 . . . . 10.0 110.813 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -170.07 161.86 8.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.869 0.366 . . . . 10.0 110.915 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 39.8 m -146.8 108.09 4.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.715 -0.675 . . . . 10.0 109.72 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 41.7 pt -129.35 162.33 37.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.534 -0.303 . . . . 10.0 110.532 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -125.54 137.97 53.95 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.882 0.372 . . . . 10.0 110.563 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 46.1 t60 -149.72 151.25 33.34 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.771 -0.649 . . . . 10.0 109.491 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -99.49 132.03 45.1 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.047 0.451 . . . . 10.0 110.135 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -121.25 169.29 10.71 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.041 0.448 . . . . 10.0 111.283 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.501 ' O ' HD11 ' A' ' 132' ' ' LEU . 38.2 t -81.87 144.99 52.72 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.566 -0.743 . . . . 10.0 110.194 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.62 -14.52 31.6 Favored 'Trans proline' 0 CA--C 1.531 0.33 0 C-N-CA 122.55 2.167 . . . . 10.0 111.952 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -114.51 17.44 17.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.122 -0.49 . . . . 10.0 110.486 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 93' ' ' SER . 0.2 OUTLIER -77.04 161.19 28.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.36 -0.382 . . . . 10.0 110.591 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -111.41 151.29 28.68 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.032 -0.531 . . . . 10.0 111.129 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 19.0 mm -59.81 -29.48 43.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 120.973 0.416 . . . . 10.0 110.808 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.28 -35.86 65.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.788 -0.642 . . . . 10.0 110.638 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -62.46 -44.71 95.74 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.606 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.599 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 23.3 mt -65.12 -44.3 95.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.52 -0.548 . . . . 10.0 109.52 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.548 ' HZ2' ' CG ' ' A' ' 128' ' ' ASP . 56.1 mttt -54.46 -50.06 68.6 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.283 -0.871 . . . . 10.0 111.292 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -58.33 -40.34 81.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.941 -0.572 . . . . 10.0 111.233 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -64.07 -36.71 84.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 10.0 110.588 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.599 ' HG ' ' O ' ' A' ' 101' ' ' ILE . 44.4 mt -63.61 -38.66 91.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.969 0.414 . . . . 10.0 110.528 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 22.3 mt -72.95 -43.26 59.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.205 -0.452 . . . . 10.0 110.135 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.5 t -63.39 -21.47 66.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.758 -0.655 . . . . 10.0 111.718 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -95.23 13.27 26.06 Favored 'General case' 0 C--N 1.331 -0.197 0 O-C-N 122.341 -0.224 . . . . 10.0 111.018 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 61.6 27.99 17.32 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 123.462 0.476 . . . . 10.0 111.366 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.74 -22.7 13.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.877 0.37 . . . . 10.0 111.167 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -113.38 150.53 32.53 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.116 -0.493 . . . . 10.0 110.153 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.424 ' OG ' ' HG ' ' A' ' 152' ' ' LEU . 1.5 m -106.29 -18.21 14.06 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.352 -0.385 . . . . 10.0 111.579 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.469 ' HB3' ' CD ' ' A' ' 116' ' ' GLU . 0.2 OUTLIER -169.49 136.58 1.7 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.461 -0.57 . . . . 10.0 109.461 -178.5 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.544 HG13 ' HD3' ' A' ' 102' ' ' LYS . 0.8 OUTLIER -66.03 -39.83 85.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 121.191 0.519 . . . . 10.0 111.074 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.418 ' HB2' ' OE1' ' A' ' 116' ' ' GLU . 14.8 m -48.35 -44.13 34.12 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.86 -1.064 . . . . 10.0 113.209 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.469 ' CD ' ' HB3' ' A' ' 113' ' ' HIS . 0.7 OUTLIER -89.69 14.47 11.66 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.263 0.838 . . . . 10.0 113.263 -178.234 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 113' ' ' HIS . 51.5 mt -91.77 121.34 42.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.371 -0.532 . . . . 10.0 110.249 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.461 ' HZ1' ' CG ' ' B' ' 31' ' ' ASP . 9.5 mmmt -123.54 115.06 20.92 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.739 -0.467 . . . . 10.0 109.739 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -94.6 124.88 38.9 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.151 0.501 . . . . 10.0 110.856 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.85 139.51 44.85 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.538 -0.755 . . . . 10.0 109.98 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 31.9 tp -128.65 94.74 3.93 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.133 -1.432 . . . . 10.0 107.133 178.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 48.2 tttp 33.88 65.3 0.3 Allowed 'General case' 0 N--CA 1.464 0.274 0 O-C-N 124.261 0.976 . . . . 10.0 111.495 -177.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.479 ' HA3' ' CB ' ' C' ' 38' ' ' ASP . . . 87.41 -46.0 3.44 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.668 -0.696 . . . . 10.0 113.559 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.417 ' HE2' ' O ' ' A' ' 135' ' ' LEU . 43.1 tttp -63.04 121.23 13.06 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.683 -0.488 . . . . 10.0 109.683 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.0 p -84.11 133.84 28.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.354 0.597 . . . . 10.0 112.075 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.6 mp -100.49 152.34 20.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.647 -0.706 . . . . 10.0 110.083 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.462 ' H ' HD21 ' A' ' 130' ' ' LEU . 56.3 m-70 -120.93 157.44 29.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.621 0.248 . . . . 10.0 110.733 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.548 ' CG ' ' HZ2' ' A' ' 102' ' ' LYS . 1.0 OUTLIER -49.81 -47.32 51.45 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.628 0.973 . . . . 10.0 113.628 -178.902 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -92.29 12.96 20.7 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.412 0.523 . . . . 10.0 112.412 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.462 HD21 ' H ' ' A' ' 127' ' ' HIS . 3.2 tp -75.36 142.35 43.16 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.103 0.478 . . . . 10.0 111.37 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -104.7 149.27 25.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.562 -0.744 . . . . 10.0 109.614 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.501 HD11 ' O ' ' A' ' 93' ' ' SER . 35.2 mt -56.79 -33.07 66.29 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.787 0.292 . . . . 10.0 111.787 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.7 p -77.7 -14.27 59.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.051 0.453 . . . . 10.0 111.101 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -90.58 -40.71 11.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.267 -0.424 . . . . 10.0 110.841 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.417 ' O ' ' HE2' ' A' ' 124' ' ' LYS . 0.7 OUTLIER -83.86 -20.61 32.82 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 121.124 -0.23 . . . . 10.0 110.915 179.701 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 30.2 mtmt 64.41 91.55 0.08 Allowed 'General case' 0 C--O 1.234 0.266 0 O-C-N 123.756 0.66 . . . . 10.0 111.268 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 29.4 t -63.55 109.4 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.93 -0.577 . . . . 10.0 110.073 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.94 122.99 88.8 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.881 -0.6 . . . . 10.0 110.923 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -66.79 -17.9 52.52 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.652 2.234 . . . . 10.0 112.056 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -87.49 2.58 50.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.892 -0.594 . . . . 10.0 110.379 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -121.76 -73.08 0.66 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.572 -0.74 . . . . 10.0 109.593 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.2 m 59.78 8.52 1.37 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.506 -0.77 . . . . 10.0 112.75 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.7 m -122.56 131.47 53.85 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.879 0.371 . . . . 10.0 111.215 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 25.0 mm -112.97 122.61 67.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.772 -0.649 . . . . 10.0 109.923 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.18 121.01 26.51 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.411 -0.588 . . . . 10.0 109.411 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 12.6 t -97.62 127.22 50.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.177 0.513 . . . . 10.0 112.033 -178.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' MET . . . . . 0.546 ' HE1' ' SG ' ' B' ' 39' ' ' CYS . 2.1 mpt? -122.94 116.89 24.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.376 -0.829 . . . . 10.0 109.357 179.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 49.3 mt -138.1 143.13 33.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 110.012 -0.366 . . . . 10.0 110.012 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.402 ' HZ3' ' CG ' ' B' ' 38' ' ' ASP . 25.7 mmmt -97.81 110.07 53.83 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 108.834 -0.802 . . . . 10.0 108.834 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.13 113.29 3.74 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.434 2.089 . . . . 10.0 113.063 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 28.0 p30 -108.03 7.55 27.84 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.867 -0.606 . . . . 10.0 109.784 178.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.424 ' HG ' ' OG ' ' A' ' 112' ' ' SER . 72.8 mt -78.74 118.28 20.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.477 -0.783 . . . . 10.0 109.843 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 . . . . . 0 C--O 1.251 1.173 0 CA-C-O 118.583 -0.722 . . . . 10.0 110.198 -179.866 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' -1' ' ' SER . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.48 1.036 0 CA-C-O 120.62 0.248 . . . . 10.0 110.527 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 0' ' ' VAL . . . . . . . . . . . . . 24.2 t -70.45 -67.59 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 109.136 -0.69 . . . . 10.0 109.136 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . 0.482 ' HA ' ' O ' ' B' ' 63' ' ' GLN . 18.8 m-20 43.42 78.72 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 O-C-N 124.303 1.002 . . . . 10.0 111.828 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.15 26.77 1.32 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.366 -0.834 . . . . 10.0 111.463 -178.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -97.44 122.02 40.01 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.68 0.276 . . . . 10.0 110.828 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.37 143.26 27.92 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.429 -0.582 . . . . 10.0 109.429 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -59.94 -46.63 88.77 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.946 0.35 . . . . 10.0 111.946 -178.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -59.56 -46.27 89.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.673 0.273 . . . . 10.0 111.439 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -62.24 -46.62 88.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.34 -0.391 . . . . 10.0 111.167 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.718 ' O ' HG13 ' B' ' 12' ' ' ILE . 32.0 mm -62.94 -45.27 99.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 110.041 -0.355 . . . . 10.0 110.041 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.47 -45.2 73.1 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.388 -0.369 . . . . 10.0 110.752 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.09 -36.29 83.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.864 -0.607 . . . . 10.0 110.55 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.03 -38.02 87.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.275 -0.42 . . . . 10.0 110.653 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.718 HG13 ' O ' ' B' ' 8' ' ' ILE . 13.3 mt -63.35 -55.52 22.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.252 -0.431 . . . . 10.0 111.12 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 35.3 m -64.18 -32.35 57.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.034 -0.53 . . . . 10.0 111.253 -178.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -70.03 -40.91 74.9 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.586 -0.524 . . . . 10.0 109.586 178.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' TYR . . . . . 0.613 ' O ' HG12 ' B' ' 19' ' ' ILE . 21.3 t80 -64.91 -47.8 76.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.988 -0.551 . . . . 10.0 110.08 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 14.7 m-30 -58.04 -44.09 87.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 10.0 111.077 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 70.8 m -57.54 -40.82 79.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 10.0 110.609 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 10.9 m -74.41 -20.89 59.89 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.936 -0.575 . . . . 10.0 111.621 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.613 HG12 ' O ' ' B' ' 15' ' ' TYR . 29.4 mm -79.22 -42.26 23.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.608 0.242 . . . . 10.0 110.555 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 27.0 m -79.15 -21.27 12.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.144 0.497 . . . . 10.0 109.808 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -58.15 -42.61 86.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.172 -0.922 . . . . 10.0 110.67 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 4.4 mttp -109.59 0.56 19.18 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.755 -0.657 . . . . 10.0 109.962 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 33.2 mttt 54.7 52.13 12.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.214 -0.903 . . . . 10.0 110.706 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -82.94 35.16 0.47 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.299 -0.864 . . . . 10.0 110.44 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' ILE . . . . . 0.424 HG12 ' N ' ' B' ' 26' ' ' SER . 12.4 tt -163.68 164.8 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.592 -0.731 . . . . 10.0 109.374 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' SER . . . . . 0.424 ' N ' HG12 ' B' ' 25' ' ' ILE . 0.7 OUTLIER -62.73 160.2 14.77 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.728 0.411 . . . . 10.0 111.957 -179.855 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -55.94 -55.21 35.44 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.045 -0.525 . . . . 10.0 111.681 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.75 -42.64 89.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.006 0.431 . . . . 10.0 110.159 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . 0.517 ' O ' ' HG ' ' B' ' 33' ' ' LEU . . . -61.15 -42.77 99.89 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.698 -0.683 . . . . 10.0 112.26 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.37 -38.76 88.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.024 0.44 . . . . 10.0 110.437 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.461 ' CG ' ' HZ1' ' A' ' 118' ' ' LYS . 23.8 t70 -68.33 -35.84 78.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.707 -0.679 . . . . 10.0 109.875 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 14.6 m -65.85 -38.46 88.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.669 -0.696 . . . . 10.0 110.024 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' B' ' 29' ' ' GLY . 53.9 mt -70.63 -31.81 68.91 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.0 0.429 . . . . 10.0 109.903 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -61.38 -51.76 67.43 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.743 -0.662 . . . . 10.0 110.685 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 12.2 p -70.25 -32.77 51.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.902 -0.59 . . . . 10.0 110.831 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.6 -45.43 86.99 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 109.245 -0.65 . . . . 10.0 109.245 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' MET . . . . . . . . . . . . . 6.0 ttm -59.91 -37.98 80.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.707 -0.679 . . . . 10.0 109.636 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . 0.402 ' CG ' ' HZ3' ' A' ' 149' ' ' LYS . 19.7 t0 -66.78 -51.59 53.96 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.914 -1.039 . . . . 10.0 111.278 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' CYS . . . . . 0.546 ' SG ' ' HE1' ' A' ' 147' ' ' MET . 0.1 OUTLIER -66.66 -33.41 75.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.49 -0.323 . . . . 10.0 111.642 -179.526 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 50.6 mt -66.99 -46.27 85.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 110.133 -0.321 . . . . 10.0 110.133 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.52 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 28.7 m -59.4 -33.3 71.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.204 0.526 . . . . 10.0 109.982 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -74.38 -47.26 35.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.548 -0.751 . . . . 10.0 110.874 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.16 -37.5 85.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.088 -0.505 . . . . 10.0 112.258 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -94.0 -4.03 50.37 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 121.014 -0.274 . . . . 10.0 111.553 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.57 59.99 9.76 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 121.399 -0.429 . . . . 10.0 113.517 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.52 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 7.1 p90 -153.1 165.04 36.87 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.994 -0.372 . . . . 10.0 109.994 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -101.22 135.25 43.0 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.769 0.319 . . . . 10.0 111.382 -179.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.53 -20.45 64.66 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.101 -0.5 . . . . 10.0 111.623 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -83.17 -15.49 50.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.86 0.362 . . . . 10.0 111.303 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.6 3.54 47.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.365 -0.379 . . . . 10.0 111.748 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 2.6 m -47.24 -49.23 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 112.778 0.659 . . . . 10.0 112.778 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -50.61 -34.16 24.98 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 113.367 0.877 . . . . 10.0 113.367 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.63 -27.49 50.89 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.813 -0.708 . . . . 10.0 112.616 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 49.6 mt -87.02 -50.71 13.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.031 0.443 . . . . 10.0 111.976 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 69.1 mt -81.45 -67.4 0.78 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.106 -0.497 . . . . 10.0 112.228 -178.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.23 -129.06 8.81 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.567 -0.825 . . . . 10.0 111.044 -178.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -158.33 23.27 0.24 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.429 0.633 . . . . 10.0 110.012 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.1 32.88 0.89 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.507 -0.769 . . . . 10.0 111.466 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 64.44 104.78 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.713 -0.676 . . . . 10.0 111.978 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -80.1 82.4 6.17 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.638 -0.71 . . . . 10.0 109.885 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -80.68 57.66 3.03 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.954 -0.567 . . . . 10.0 111.513 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.6 70.83 2.94 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 111.145 -0.782 . . . . 10.0 111.145 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' GLN . . . . . 0.482 ' O ' ' HA ' ' B' ' 1' ' ' ASP . 0.6 OUTLIER -68.6 87.58 0.33 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.942 0.401 . . . . 10.0 111.785 -178.791 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 34.3 t60 -97.66 76.62 2.51 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.08 -0.711 . . . . 10.0 109.08 178.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 79.0 mt -57.84 -41.17 81.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.346 -0.843 . . . . 10.0 111.217 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . 58.45 16.7 4.33 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 123.692 0.62 . . . . 10.0 111.111 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 50.29 49.39 20.65 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-N 115.199 -0.909 . . . . 10.0 111.63 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 72.6 mt -85.3 84.46 2.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.268 0.556 . . . . 10.0 110.202 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -78.96 -24.99 43.51 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.995 -0.743 . . . . 10.0 108.995 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . 0.547 ' O ' ' HB3' ' C' ' 52' ' ' SER . 58.3 t30 -81.91 55.2 2.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.58 -0.736 . . . . 10.0 109.54 178.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.71 -32.79 16.03 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.794 -0.639 . . . . 10.0 110.144 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.167 0 CA-C-O 117.939 -1.029 . . . . 10.0 109.624 179.707 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' -1' ' ' SER . . . . . . . . . . . . . 5.5 p . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 120.908 0.385 . . . . 10.0 111.795 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 0' ' ' VAL . . . . . . . . . . . . . 35.6 m -91.72 37.06 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-O 121.254 0.55 . . . . 10.0 111.532 -178.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -68.82 96.29 0.74 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.74 -0.663 . . . . 10.0 110.702 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.47 65.86 2.32 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.432 -0.804 . . . . 10.0 110.655 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -132.51 139.54 47.96 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.082 -0.508 . . . . 10.0 110.021 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 4' ' ' SER . . . . . 0.517 ' O ' HG12 ' C' ' 8' ' ' ILE . 0.0 OUTLIER -89.42 137.79 32.02 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.386 -0.37 . . . . 10.0 110.719 -179.491 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . 0.431 ' HE3' HD11 ' B' ' 19' ' ' ILE . 49.5 mttp -63.77 -45.24 90.67 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.708 0.289 . . . . 10.0 110.486 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 6' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -54.47 -57.19 12.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.577 -0.738 . . . . 10.0 111.299 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . 0.531 ' HG3' ' O ' ' C' ' 54' ' ' ILE . 1.5 mp0 -61.61 -39.38 91.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.76 -0.654 . . . . 10.0 112.272 -179.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 8' ' ' ILE . . . . . 0.517 HG12 ' O ' ' C' ' 4' ' ' SER . 27.2 mm -66.7 -47.93 81.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.89 0.376 . . . . 10.0 110.247 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.48 -42.05 95.47 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.088 -0.505 . . . . 10.0 110.1 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.68 -40.46 92.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.621 -0.718 . . . . 10.0 110.926 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.5 -33.82 76.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.931 0.396 . . . . 10.0 110.392 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 12' ' ' ILE . . . . . 0.465 HG13 HG12 ' B' ' 12' ' ' ILE . 1.2 mp -70.89 -48.3 57.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.064 -0.516 . . . . 10.0 111.064 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 26.8 m -65.69 -28.03 43.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-O 121.218 0.532 . . . . 10.0 110.05 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -73.25 -39.77 65.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.66 -0.7 . . . . 10.0 109.382 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 15' ' ' TYR . . . . . 0.453 ' O ' HG12 ' C' ' 19' ' ' ILE . 32.7 t80 -68.89 -43.49 75.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 10.0 110.308 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 10.1 m-30 -55.63 -46.88 77.36 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.171 -0.468 . . . . 10.0 110.412 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 19.9 m -60.84 -43.89 97.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.868 -0.605 . . . . 10.0 111.364 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 12.7 m -67.67 -22.67 65.29 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.982 0.364 . . . . 10.0 111.982 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 19' ' ' ILE . . . . . 0.453 HG12 ' O ' ' C' ' 15' ' ' TYR . 29.5 mm -82.62 -39.7 16.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.589 0.233 . . . . 10.0 111.052 -179.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 20' ' ' VAL . . . . . . . . . . . . . 13.6 m -77.5 -23.69 14.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.289 0.566 . . . . 10.0 109.814 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -66.86 -48.08 69.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.122 -0.944 . . . . 10.0 111.018 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 33.7 mttp -91.12 -5.49 55.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.676 -0.238 . . . . 10.0 110.911 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 64.6 mttm 63.72 49.33 2.99 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.82 -0.627 . . . . 10.0 110.825 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -81.94 -5.44 58.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.894 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 12.7 tt -131.62 162.34 39.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.545 -0.539 . . . . 10.0 109.545 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.09 153.62 11.25 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 122.59 0.356 . . . . 10.0 111.156 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -58.4 -40.2 81.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.852 0.358 . . . . 10.0 110.858 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 28' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -67.12 -40.81 86.87 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.183 0.516 . . . . 10.0 109.697 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 29' ' ' GLY . . . . . 0.508 ' O ' ' HG ' ' C' ' 33' ' ' LEU . . . -65.16 -33.18 86.26 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.514 -0.766 . . . . 10.0 111.23 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.32 -39.63 95.08 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.815 -0.439 . . . . 10.0 109.815 178.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -63.17 -35.76 81.38 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.89 -0.596 . . . . 10.0 109.666 178.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 1.2 t -65.66 -43.83 88.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.494 -0.775 . . . . 10.0 109.81 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 33' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' C' ' 29' ' ' GLY . 43.5 mt -66.93 -34.52 77.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.074 0.464 . . . . 10.0 109.765 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -60.89 -50.43 73.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.388 -0.823 . . . . 10.0 110.94 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 35' ' ' VAL . . . . . 0.43 HG11 ' N ' ' C' ' 36' ' ' ALA . 12.2 p -71.86 -36.29 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 116.425 -0.352 . . . . 10.0 111.416 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . 0.43 ' N ' HG11 ' C' ' 35' ' ' VAL . . . -68.13 -33.34 74.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.875 0.369 . . . . 10.0 110.462 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 34.7 ttm -53.83 -59.96 3.94 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.643 -0.708 . . . . 10.0 111.036 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 38' ' ' ASP . . . . . 0.564 ' OD2' ' HD3' ' C' ' 48' ' ' ARG . 3.3 m-20 -67.03 -27.19 67.2 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.243 -0.435 . . . . 10.0 111.139 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 39' ' ' CYS . . . . . . . . . . . . . 1.1 t -65.04 -49.12 71.38 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.047 0.451 . . . . 10.0 110.48 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 40' ' ' ILE . . . . . . . . . . . . . 53.6 mt -66.94 -38.28 81.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.735 -0.666 . . . . 10.0 109.837 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 41' ' ' SER . . . . . 0.715 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 35.5 m -62.21 -47.22 85.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.546 -0.752 . . . . 10.0 110.716 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -65.1 -40.94 95.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.165 -0.471 . . . . 10.0 110.724 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.97 -43.92 91.42 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.519 0.562 . . . . 10.0 112.519 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 44' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -94.82 -2.47 50.8 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.969 0.359 . . . . 10.0 111.969 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.75 53.02 12.65 Favored Glycine 0 CA--C 1.52 0.387 0 N-CA-C 114.4 0.52 . . . . 10.0 114.4 178.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 46' ' ' PHE . . . . . 0.715 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 30.2 p90 -144.67 157.11 44.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 117.165 0.483 . . . . 10.0 110.473 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -83.18 146.15 28.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.528 -0.306 . . . . 10.0 110.298 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 48' ' ' ARG . . . . . 0.564 ' HD3' ' OD2' ' C' ' 38' ' ' ASP . 0.0 OUTLIER -61.91 -28.91 69.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.379 0.609 . . . . 10.0 110.578 179.619 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 49' ' ' GLU . . . . . 0.471 ' C ' ' H ' ' C' ' 51' ' ' VAL . 4.3 mp0 -84.91 18.88 2.28 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.437 -0.801 . . . . 10.0 112.393 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.1 8.26 0.22 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.941 0.896 . . . . 10.0 112.695 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 51' ' ' VAL . . . . . 0.471 ' H ' ' C ' ' C' ' 49' ' ' GLU . 3.5 m -34.67 -38.61 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 N-CA-C 117.708 2.484 . . . . 10.0 117.708 -176.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 52' ' ' SER . . . . . 0.547 ' HB3' ' O ' ' B' ' 70' ' ' ASN . 0.0 OUTLIER -88.17 -54.03 4.42 Favored 'General case' 0 C--O 1.217 -0.63 0 N-CA-C 118.653 2.834 . . . . 10.0 118.653 -175.794 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.11 -56.87 9.43 Favored Glycine 0 CA--C 1.494 -1.254 0 C-N-CA 119.869 -1.158 . . . . 10.0 115.799 -171.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 54' ' ' ILE . . . . . 0.531 ' O ' ' HG3' ' C' ' 7' ' ' GLU . 0.5 OUTLIER -82.0 -35.18 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 C-N-CA 119.847 -0.741 . . . . 10.0 110.561 -179.355 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.4 -75.38 0.33 Allowed 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 116.101 1.889 . . . . 10.0 116.101 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.36 -145.71 49.12 Favored Glycine 0 N--CA 1.471 1.014 0 C-N-CA 121.538 -0.363 . . . . 10.0 112.437 -177.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -150.44 22.46 0.82 Allowed 'General case' 0 C--O 1.233 0.186 0 N-CA-C 109.541 -0.541 . . . . 10.0 109.541 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.12 42.36 0.65 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.529 -0.76 . . . . 10.0 112.043 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 65.1 107.77 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.61 0.719 . . . . 10.0 111.613 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 60' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -82.8 78.97 9.32 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.684 -0.689 . . . . 10.0 110.497 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 35.4 mttp -83.98 64.96 8.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.941 -0.572 . . . . 10.0 111.395 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.8 86.36 1.42 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.704 -0.76 . . . . 10.0 111.374 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 63' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -80.28 75.99 7.08 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.467 0.543 . . . . 10.0 112.467 -178.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 64' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -103.05 81.68 2.0 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.089 -0.708 . . . . 10.0 109.089 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 50.7 mt -69.92 -37.14 75.82 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.703 -0.68 . . . . 10.0 111.139 -179.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . 59.62 20.59 9.19 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 123.555 0.534 . . . . 10.0 111.109 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 56.42 45.58 22.39 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.555 -0.748 . . . . 10.0 111.337 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 68' ' ' ILE . . . . . . . . . . . . . 97.1 mt -84.42 99.52 6.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.318 0.58 . . . . 10.0 110.978 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -106.87 -11.8 15.64 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.65 0.738 . . . . 10.0 109.044 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 70' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -89.37 42.49 1.09 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.753 -1.112 . . . . 10.0 110.906 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -78.57 -18.3 54.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.897 -0.592 . . . . 10.0 110.289 179.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.033 0 CA-C-N 115.747 -0.66 . . . . 10.0 110.077 -179.999 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 49.1 mtm . . . . . 0 N--CA 1.483 1.191 0 N-CA-C 110.076 -0.342 . . . . 10.0 110.076 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 15.4 t -94.51 133.81 34.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.811 -0.44 . . . . 10.0 109.811 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -91.87 122.38 34.34 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.835 0.35 . . . . 10.0 110.569 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.1 mp -125.38 121.36 33.65 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.388 -0.369 . . . . 10.0 110.432 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.6 m -93.97 113.17 25.11 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 120.829 0.347 . . . . 10.0 110.202 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.549 ' O ' ' HA ' ' A' ' 87' ' ' SER . 2.6 mm? -84.94 119.33 25.25 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.948 -0.569 . . . . 10.0 109.771 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.526 ' HZ2' ' CG ' ' C' ' 31' ' ' ASP . 72.6 tttt -121.16 100.89 7.31 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.131 0.491 . . . . 10.0 110.921 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -87.13 114.86 24.1 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.579 -0.737 . . . . 10.0 110.757 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 16.0 mt -77.66 -66.41 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 O-C-N 123.915 0.759 . . . . 10.0 111.285 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -60.43 160.8 8.24 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.893 -0.594 . . . . 10.0 111.323 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.43 ' HA ' ' C ' ' A' ' 84' ' ' PRO . . . -86.02 143.13 36.95 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.225 -0.443 . . . . 10.0 111.134 -178.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.43 ' C ' ' HA ' ' A' ' 83' ' ' ALA . 43.7 Cg_endo -71.6 127.54 12.64 Favored 'Cis proline' 0 C--N 1.346 0.423 0 C-N-CA 123.068 -1.638 . . . . 10.0 111.202 -0.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.43 ' N ' ' HA ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -93.34 158.58 15.67 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.175 -0.466 . . . . 10.0 112.001 -178.627 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -178.96 172.4 1.3 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.318 -0.856 . . . . 10.0 109.316 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.549 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 66.4 m -152.95 110.34 3.53 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.899 0.381 . . . . 10.0 110.301 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.8 pt -119.15 158.82 20.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.875 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -114.81 113.9 24.84 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.085 -0.709 . . . . 10.0 109.085 179.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -129.51 147.88 51.36 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.175 0.512 . . . . 10.0 110.415 -178.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.91 130.65 53.82 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.862 -0.608 . . . . 10.0 109.368 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -121.39 171.6 8.65 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.09 0.472 . . . . 10.0 111.425 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.57 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 0.7 OUTLIER -80.02 151.2 72.92 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.732 -0.667 . . . . 10.0 110.977 -179.779 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -65.39 -16.73 55.59 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 122.311 2.007 . . . . 10.0 112.504 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.1 m -110.72 15.52 21.9 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.434 -0.58 . . . . 10.0 109.434 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.57 ' HB2' ' O ' ' A' ' 93' ' ' SER . 0.3 OUTLIER -75.38 161.81 28.93 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.699 -0.682 . . . . 10.0 110.806 -179.759 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.97 157.82 26.04 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.605 -0.725 . . . . 10.0 110.886 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.53 ' O ' ' HG3' ' A' ' 102' ' ' LYS . 41.2 mm -67.25 -22.29 28.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.343 -0.614 . . . . 10.0 109.343 178.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.42 -38.73 71.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.205 -0.907 . . . . 10.0 110.141 178.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -68.24 -40.61 81.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.035 -0.529 . . . . 10.0 110.996 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.522 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 51.7 mt -62.26 -47.26 93.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.796 -0.638 . . . . 10.0 109.588 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.53 ' HG3' ' O ' ' A' ' 98' ' ' ILE . 79.9 mttt -55.46 -44.4 76.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.927 -1.033 . . . . 10.0 111.436 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.484 ' OE1' ' HA ' ' A' ' 103' ' ' GLN . 10.0 mm-40 -62.26 -37.67 86.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.62 -0.264 . . . . 10.0 111.21 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -65.11 -39.77 93.61 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.906 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 101' ' ' ILE . 34.2 mt -63.03 -44.75 95.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.097 -0.501 . . . . 10.0 111.397 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 102' ' ' LYS . 12.6 mt -67.94 -42.21 85.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.121 -0.49 . . . . 10.0 111.404 -178.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 49.8 m -69.84 -9.89 56.44 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.013 0.375 . . . . 10.0 112.013 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -107.72 16.12 23.95 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 121.104 -0.238 . . . . 10.0 110.895 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 58.83 26.35 14.69 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.707 -0.679 . . . . 10.0 111.673 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.6 mmpp? -96.36 -16.48 21.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.369 0.604 . . . . 10.0 110.069 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -137.08 166.52 23.5 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.294 -0.866 . . . . 10.0 110.349 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.476 ' HB2' ' OD1' ' A' ' 151' ' ' ASN . 4.6 m -108.18 -49.46 3.19 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.766 0.317 . . . . 10.0 110.94 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.481 ' O ' HG13 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -136.87 139.01 41.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.138 -179.45 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.0 tt -64.07 -39.06 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.513 0.673 . . . . 10.0 109.865 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.0 m -52.39 -27.93 17.67 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.321 -1.309 . . . . 10.0 112.45 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.23 -4.56 38.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.71 0.291 . . . . 10.0 111.417 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 113' ' ' HIS . 59.1 mt -89.75 127.11 42.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.022 0.439 . . . . 10.0 110.945 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.62 128.83 20.99 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.544 -0.91 . . . . 10.0 108.544 177.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -91.24 136.69 32.92 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.387 0.613 . . . . 10.0 111.21 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.414 ' HB3' ' OG1' ' A' ' 145' ' ' THR . 3.7 tp -110.46 126.45 54.35 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.78 -1.1 . . . . 10.0 108.633 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 47.3 tp -113.76 93.04 4.19 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 106.624 -1.621 . . . . 10.0 106.624 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? 38.68 60.98 1.27 Allowed 'General case' 0 CA--C 1.539 0.546 0 O-C-N 123.944 0.778 . . . . 10.0 110.587 -177.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.496 ' HA3' ' CB ' ' C' ' 38' ' ' ASP . . . 87.95 -45.87 3.36 Favored Glycine 0 C--N 1.332 0.349 0 CA-C-N 115.544 -0.753 . . . . 10.0 113.999 -178.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.2 tttp -59.76 118.65 6.4 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 110.189 -0.3 . . . . 10.0 110.189 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.4 p -78.99 137.18 22.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.62 0.724 . . . . 10.0 112.205 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.8 mp -104.34 156.91 17.52 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 114.824 -1.08 . . . . 10.0 110.624 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.544 ' H ' HD21 ' A' ' 130' ' ' LEU . 35.8 m-70 -116.26 164.17 14.9 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.004 0.43 . . . . 10.0 112.005 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.418 ' CG ' ' HZ1' ' A' ' 102' ' ' LYS . 9.4 m-20 -55.15 -56.04 24.43 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 114.071 1.137 . . . . 10.0 114.071 -179.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -91.72 14.7 14.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.864 0.364 . . . . 10.0 111.322 -178.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.544 HD21 ' H ' ' A' ' 127' ' ' HIS . 15.1 tp -68.22 139.84 56.05 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.718 0.294 . . . . 10.0 110.501 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -97.4 145.24 26.36 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.261 -0.427 . . . . 10.0 110.484 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.492 HD11 ' O ' ' A' ' 93' ' ' SER . 10.7 mt -54.03 -38.75 65.5 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.747 0.647 . . . . 10.0 112.747 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.35 -17.14 56.92 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.817 0.303 . . . . 10.0 111.817 -179.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -79.13 -45.8 19.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.833 0.349 . . . . 10.0 110.278 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.7 pp -77.01 -23.7 52.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.875 -0.602 . . . . 10.0 110.81 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.2 mtmt 65.89 90.57 0.09 Allowed 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.618 0.574 . . . . 10.0 111.767 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.5 t -68.2 103.63 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.812 -0.631 . . . . 10.0 109.923 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.39 135.38 86.54 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.975 -0.557 . . . . 10.0 111.007 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -68.8 -22.23 37.14 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.224 1.95 . . . . 10.0 110.973 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -78.53 -3.55 44.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.306 -0.861 . . . . 10.0 110.485 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -122.69 -83.65 0.66 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.934 -0.575 . . . . 10.0 110.093 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.2 m 61.01 3.14 0.63 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.715 -0.675 . . . . 10.0 112.198 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.5 m -102.32 114.54 28.79 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-O 120.96 0.41 . . . . 10.0 110.044 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.408 HG22 HD12 ' A' ' 144' ' ' ILE . 1.4 mm -104.92 109.03 26.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 108.287 -1.005 . . . . 10.0 108.287 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.414 ' OG1' ' HB3' ' A' ' 120' ' ' LEU . 0.0 OUTLIER -79.6 122.03 26.0 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.653 -0.869 . . . . 10.0 108.653 -179.172 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.0 t -91.43 121.83 42.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.414 -0.812 . . . . 10.0 111.431 -177.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 81.5 mmm -115.56 113.96 24.31 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.008 -0.996 . . . . 10.0 109.732 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 11.3 mt -139.35 144.38 29.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.579 -0.737 . . . . 10.0 111.465 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -107.96 120.9 45.57 Favored Pre-proline 0 C--N 1.321 -0.656 0 N-CA-C 108.134 -1.062 . . . . 10.0 108.134 178.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -70.11 111.3 2.84 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.332 2.022 . . . . 10.0 112.434 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.476 ' OD1' ' HB2' ' A' ' 112' ' ' SER . 3.3 m120 -87.67 18.08 4.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.934 -0.575 . . . . 10.0 109.989 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.6 mt -75.31 91.27 2.67 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.757 -0.656 . . . . 10.0 109.929 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.411 ' H ' ' HG3' ' A' ' 153' ' ' GLU . 0.8 OUTLIER . . . . . 0 C--O 1.245 0.846 0 CA-C-O 118.007 -0.997 . . . . 10.0 110.097 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' -1' ' ' SER . . . . . . . . . . . . . 7.0 p . . . . . 0 N--CA 1.474 0.747 0 CA-C-O 120.656 0.265 . . . . 10.0 111.207 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 0' ' ' VAL . . . . . . . . . . . . . 1.9 t -91.44 13.11 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 116.29 -0.414 . . . . 10.0 112.089 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -58.82 102.55 0.12 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.063 0.459 . . . . 10.0 111.08 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.33 12.37 31.38 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.236 -0.438 . . . . 10.0 111.782 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.6 129.56 34.96 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 121.117 -0.233 . . . . 10.0 110.654 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.01 142.86 27.28 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.985 -0.376 . . . . 10.0 109.985 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 4.4 ptpp? -60.35 -40.88 92.27 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.456 -0.338 . . . . 10.0 111.577 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -58.3 -43.13 87.94 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.858 0.361 . . . . 10.0 110.534 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -66.91 -46.19 75.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.03 -0.532 . . . . 10.0 111.424 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.539 ' O ' HD13 ' B' ' 12' ' ' ILE . 32.5 mm -65.0 -46.09 92.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.747 0.308 . . . . 10.0 110.532 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.76 -43.72 81.05 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.015 0.436 . . . . 10.0 110.622 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.59 -34.82 77.8 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.687 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.57 -35.73 77.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.911 0.386 . . . . 10.0 110.282 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.539 HD13 ' O ' ' B' ' 8' ' ' ILE . 1.6 mp -68.23 -50.55 56.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.775 -0.648 . . . . 10.0 111.138 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 31.4 m -63.92 -32.28 56.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 N-CA-C 109.694 -0.484 . . . . 10.0 109.694 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -64.18 -53.46 48.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.571 -0.741 . . . . 10.0 109.843 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' TYR . . . . . 0.593 ' O ' HG12 ' B' ' 19' ' ' ILE . 39.1 t80 -60.3 -48.16 82.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.766 -0.652 . . . . 10.0 111.217 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 10.1 m-30 -53.95 -47.74 70.97 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.813 0.34 . . . . 10.0 110.526 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 50.7 m -57.5 -36.45 71.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.18 -0.464 . . . . 10.0 111.247 178.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 1.2 m -74.84 -19.29 60.23 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.268 -0.423 . . . . 10.0 111.193 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.593 HG12 ' O ' ' B' ' 15' ' ' TYR . 35.8 mm -81.39 -43.01 20.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.392 -0.367 . . . . 10.0 111.549 -178.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 16.8 m -76.26 -25.89 16.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.232 0.539 . . . . 10.0 109.93 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -62.12 -43.92 97.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.264 -0.88 . . . . 10.0 111.344 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -102.61 4.33 38.24 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.894 -0.323 . . . . 10.0 110.433 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 54.0 mttm 52.07 54.85 10.11 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 115.454 -0.794 . . . . 10.0 110.675 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -88.82 25.54 1.75 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.34 -0.846 . . . . 10.0 110.8 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 15.9 tt -161.7 164.02 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.756 -0.656 . . . . 10.0 109.405 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 2.4 p -64.5 155.64 32.19 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.627 -0.26 . . . . 10.0 111.175 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -59.07 -42.31 90.06 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.927 0.394 . . . . 10.0 110.901 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -59.93 -41.37 91.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.789 -0.641 . . . . 10.0 109.948 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . 0.415 ' O ' ' HG ' ' B' ' 33' ' ' LEU . . . -73.09 -34.7 58.16 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.805 -0.712 . . . . 10.0 111.583 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.37 -42.76 99.23 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-O 120.822 0.344 . . . . 10.0 110.542 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -63.6 -41.14 98.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.233 0.54 . . . . 10.0 109.597 178.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 42.4 m -61.8 -46.38 89.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.243 -0.89 . . . . 10.0 110.923 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' B' ' 29' ' ' GLY . 68.5 mt -68.52 -30.27 69.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.381 -0.372 . . . . 10.0 110.938 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -65.63 -51.93 55.81 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.35 -0.386 . . . . 10.0 111.048 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 14.6 p -67.09 -33.92 66.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.916 -0.584 . . . . 10.0 110.538 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.79 -42.1 91.14 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.647 -0.501 . . . . 10.0 109.647 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' MET . . . . . 0.585 ' SD ' ' HD2' ' B' ' 48' ' ' ARG . 11.0 ttm -56.5 -53.02 62.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.259 -0.882 . . . . 10.0 110.354 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.66 -46.41 88.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 10.0 111.42 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 50.2 t -58.08 -44.68 87.68 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.513 -0.312 . . . . 10.0 111.749 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 87.5 mt -64.66 -39.0 84.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.269 0.557 . . . . 10.0 109.92 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.414 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 24.3 m -64.75 -40.32 95.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.597 -0.729 . . . . 10.0 110.442 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -75.82 -24.78 55.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.468 -0.333 . . . . 10.0 110.847 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.86 -33.38 66.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.052 -0.522 . . . . 10.0 111.09 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -102.36 -3.23 27.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.879 0.371 . . . . 10.0 111.241 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 66.48 59.65 7.03 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 114.466 0.547 . . . . 10.0 114.466 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.414 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 22.0 p90 -154.16 159.83 41.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 117.271 0.536 . . . . 10.0 110.335 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -86.52 144.06 27.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.879 0.371 . . . . 10.0 110.766 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.585 ' HD2' ' SD ' ' B' ' 37' ' ' MET . 3.1 mtm180 -64.88 -25.9 68.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.053 -0.522 . . . . 10.0 110.685 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 55.7 mp0 -85.07 -8.47 58.66 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.15 -0.477 . . . . 10.0 112.118 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.11 2.68 17.16 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 111.937 0.347 . . . . 10.0 111.937 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.442 HG11 ' O ' ' B' ' 48' ' ' ARG . 13.4 m -45.63 -53.16 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 113.06 0.763 . . . . 10.0 113.06 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 1.4 m -49.68 -41.59 43.5 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.321 0.86 . . . . 10.0 113.321 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.77 -29.55 65.15 Favored Glycine 0 C--O 1.23 -0.139 0 C-N-CA 120.686 -0.769 . . . . 10.0 112.456 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 25.5 mt -87.96 -51.0 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 112.902 0.705 . . . . 10.0 112.902 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 26.3 mt -82.29 -69.32 0.63 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.136 0.791 . . . . 10.0 113.136 -177.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.0 -132.91 11.44 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.618 -0.801 . . . . 10.0 111.701 -178.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -156.94 29.94 0.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.394 0.616 . . . . 10.0 109.942 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.03 30.48 1.61 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.39 -0.823 . . . . 10.0 111.361 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 60.94 75.08 0.42 Allowed 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.838 -0.619 . . . . 10.0 110.208 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -70.03 101.67 1.85 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.224 -0.898 . . . . 10.0 110.653 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 16.8 mttp -95.51 93.45 7.2 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.765 -0.652 . . . . 10.0 110.903 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.87 68.15 2.58 Favored Glycine 0 N--CA 1.451 -0.356 0 N-CA-C 111.115 -0.794 . . . . 10.0 111.115 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -63.36 100.16 0.23 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.287 0.565 . . . . 10.0 111.513 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 69.2 t60 -142.1 90.29 2.24 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.237 -0.892 . . . . 10.0 109.025 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 73.7 mt -80.6 -26.03 38.1 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.614 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . 58.41 18.69 5.79 Favored 'General case' 0 N--CA 1.462 0.158 0 O-C-N 123.672 0.607 . . . . 10.0 111.277 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 61.56 34.34 17.88 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.918 -0.583 . . . . 10.0 111.39 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . 0.44 HG21 ' HA ' ' C' ' 52' ' ' SER . 73.2 mt -78.77 95.89 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.145 0.498 . . . . 10.0 110.207 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -86.12 -38.72 17.46 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.585 -0.734 . . . . 10.0 111.087 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -81.49 75.3 8.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.367 0.603 . . . . 10.0 110.954 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.86 5.67 35.99 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.767 -0.651 . . . . 10.0 110.29 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.399 -0.81 . . . . 10.0 110.625 -179.3 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' -1' ' ' SER . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.475 0.777 0 CA-C-O 120.947 0.403 . . . . 10.0 110.55 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 0' ' ' VAL . . . . . . . . . . . . . 1.9 t -85.22 39.42 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.919 -0.582 . . . . 10.0 111.378 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -73.33 105.18 4.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.542 0.687 . . . . 10.0 111.023 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.7 48.56 1.07 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.802 -1.09 . . . . 10.0 111.25 -178.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -126.7 132.26 51.19 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.57 -0.53 . . . . 10.0 109.57 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 4' ' ' SER . . . . . 0.497 ' HB2' ' OE1' ' C' ' 7' ' ' GLU . 0.8 OUTLIER -96.98 154.2 17.45 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.727 0.298 . . . . 10.0 110.695 -178.016 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . 0.452 ' HB3' ' CE1' ' C' ' 44' ' ' PHE . 17.7 mttp -61.78 -40.99 97.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.083 -0.508 . . . . 10.0 111.757 -178.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 6' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -57.9 -57.94 10.56 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.459 0.474 . . . . 10.0 110.374 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . 0.497 ' OE1' ' HB2' ' C' ' 4' ' ' SER . 2.6 mp0 -55.79 -44.91 78.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.684 -0.689 . . . . 10.0 111.772 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 8' ' ' ILE . . . . . 0.641 ' O ' HG13 ' C' ' 12' ' ' ILE . 38.8 mm -62.58 -53.18 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 C-N-CA 121.233 -0.187 . . . . 10.0 110.604 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.99 -45.26 75.0 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.347 -0.388 . . . . 10.0 110.774 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.63 -35.0 79.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.797 -0.638 . . . . 10.0 110.942 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.6 -35.66 80.73 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.216 -0.447 . . . . 10.0 111.06 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 12' ' ' ILE . . . . . 0.641 HG13 ' O ' ' C' ' 8' ' ' ILE . 6.6 mt -69.87 -50.41 49.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.928 0.394 . . . . 10.0 111.265 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 16.4 m -68.11 -27.94 39.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 116.005 -0.543 . . . . 10.0 110.965 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -74.22 -43.06 58.62 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.256 -0.646 . . . . 10.0 109.256 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 15' ' ' TYR . . . . . 0.586 ' O ' HG12 ' C' ' 19' ' ' ILE . 13.1 t80 -64.28 -49.01 73.51 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.521 -0.763 . . . . 10.0 110.882 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 11.9 m-30 -55.75 -43.77 76.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.502 -0.317 . . . . 10.0 111.711 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 66.6 m -59.48 -40.61 87.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.569 -0.287 . . . . 10.0 111.522 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 1.3 m -76.25 -23.13 54.47 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.024 0.379 . . . . 10.0 112.024 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 19' ' ' ILE . . . . . 0.586 HG12 ' O ' ' C' ' 15' ' ' TYR . 29.2 mm -77.13 -38.48 27.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.067 0.461 . . . . 10.0 110.684 -178.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 20' ' ' VAL . . . . . . . . . . . . . 33.4 m -79.74 -20.12 12.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.377 0.608 . . . . 10.0 109.775 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -62.91 -51.63 66.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.973 -1.012 . . . . 10.0 110.838 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -92.7 -2.36 56.1 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.676 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 63.6 mttm 56.03 56.4 5.97 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.704 -0.68 . . . . 10.0 109.911 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -84.96 13.02 6.46 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.177 -0.92 . . . . 10.0 110.529 -179.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 15.9 tt -150.09 163.3 3.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.658 -0.867 . . . . 10.0 108.658 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 13.8 m -66.07 162.76 18.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.662 0.267 . . . . 10.0 110.639 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -60.82 -39.57 89.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.516 -0.311 . . . . 10.0 111.626 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 28' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -59.75 -47.84 84.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.018 0.437 . . . . 10.0 110.256 179.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 29' ' ' GLY . . . . . 0.526 ' O ' ' HG ' ' C' ' 33' ' ' LEU . . . -65.58 -41.36 96.14 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.855 -0.688 . . . . 10.0 111.587 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.5 -42.34 96.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.709 0.29 . . . . 10.0 111.36 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 31' ' ' ASP . . . . . 0.526 ' CG ' ' HZ2' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -63.9 -38.82 92.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.082 0.468 . . . . 10.0 110.319 179.424 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 6.3 m -62.46 -40.15 95.69 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.679 -0.691 . . . . 10.0 110.067 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 33' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' C' ' 29' ' ' GLY . 62.4 mt -72.2 -31.51 65.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.833 -0.621 . . . . 10.0 111.169 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -64.42 -53.77 43.18 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.256 -0.429 . . . . 10.0 111.717 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 35' ' ' VAL . . . . . 0.411 HG23 ' HG ' ' A' ' 120' ' ' LEU . 11.3 p -67.79 -35.06 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-O 120.888 0.375 . . . . 10.0 110.664 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.72 -29.2 66.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.794 0.331 . . . . 10.0 110.529 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 30.5 ttm -58.55 -50.94 71.97 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.006 -0.543 . . . . 10.0 110.514 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 38' ' ' ASP . . . . . 0.496 ' CB ' ' HA3' ' A' ' 123' ' ' GLY . 1.0 OUTLIER -69.71 -28.65 66.0 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 116.43 -0.35 . . . . 10.0 110.62 -179.721 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 39' ' ' CYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 123' ' ' GLY . 7.8 t -61.61 -50.25 73.33 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.423 -0.584 . . . . 10.0 109.423 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 40' ' ' ILE . . . . . . . . . . . . . 79.4 mt -60.57 -46.04 96.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.323 -0.853 . . . . 10.0 109.927 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 41' ' ' SER . . . . . 0.819 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 47.4 m -58.87 -38.18 78.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.55 -0.75 . . . . 10.0 111.366 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -70.71 -44.98 65.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.714 -0.675 . . . . 10.0 110.863 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.41 -37.44 72.74 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.819 0.674 . . . . 10.0 112.819 -178.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 44' ' ' PHE . . . . . 0.452 ' CE1' ' HB3' ' C' ' 5' ' ' LYS . 94.1 m-85 -97.9 2.35 49.08 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.179 -0.326 . . . . 10.0 111.633 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.74 57.93 16.39 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.314 -0.47 . . . . 10.0 113.518 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 46' ' ' PHE . . . . . 0.819 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 10.5 p90 -147.71 175.64 10.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 117.121 0.46 . . . . 10.0 110.404 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -100.97 136.19 41.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.642 -0.253 . . . . 10.0 110.355 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 48' ' ' ARG . . . . . . . . . . . . . 5.1 ptm180 -58.98 -37.47 76.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 10.0 111.293 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.61 18.58 3.86 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.752 1.019 . . . . 10.0 113.752 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.92 1.66 37.08 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.989 0.424 . . . . 10.0 111.421 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 27.2 m -45.22 -35.78 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 114.097 1.147 . . . . 10.0 114.097 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 52' ' ' SER . . . . . 0.44 ' HA ' HG21 ' B' ' 68' ' ' ILE . 0.7 OUTLIER -57.98 -35.6 71.43 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.316 0.858 . . . . 10.0 113.316 -179.164 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.55 -20.31 69.19 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 111.087 -0.805 . . . . 10.0 111.087 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 54' ' ' ILE . . . . . . . . . . . . . 50.5 mt -91.69 -65.38 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 114.35 1.241 . . . . 10.0 114.35 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 72.8 mt -78.43 -66.73 0.82 Allowed 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.222 -0.899 . . . . 10.0 112.984 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 75.39 -141.37 27.67 Favored Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 120.156 -1.021 . . . . 10.0 110.849 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 12.6 pttp -136.42 22.35 3.18 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.103 0.477 . . . . 10.0 110.546 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.44 19.09 1.31 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.747 -0.66 . . . . 10.0 111.337 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 60.2 88.15 0.08 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.623 -0.717 . . . . 10.0 111.039 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 60' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -69.68 104.98 2.55 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.666 -0.697 . . . . 10.0 111.254 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -86.48 72.78 10.22 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.077 -0.51 . . . . 10.0 110.427 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.98 78.72 1.93 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 121.158 -0.544 . . . . 10.0 111.944 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 63' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -78.21 86.97 4.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.953 0.406 . . . . 10.0 111.741 -178.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 64' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -110.01 88.33 2.73 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.221 -0.659 . . . . 10.0 109.221 177.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 46.2 mt -75.13 -30.06 60.7 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.919 -0.582 . . . . 10.0 110.896 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . 59.12 13.73 3.11 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.695 -0.684 . . . . 10.0 111.89 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 69.54 29.93 4.17 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 123.688 0.618 . . . . 10.0 111.556 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 68' ' ' ILE . . . . . . . . . . . . . 83.3 mt -85.65 107.52 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.223 0.535 . . . . 10.0 111.068 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -108.59 -16.19 14.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.737 -0.665 . . . . 10.0 110.079 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 70' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -83.16 54.2 2.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.791 -0.641 . . . . 10.0 111.912 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.31 -10.54 57.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.067 0.46 . . . . 10.0 110.862 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.244 0 CA-C-O 118.508 -0.758 . . . . 10.0 110.519 -179.489 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.453 -0.282 0 N-CA-C 109.99 -0.374 . . . . 10.0 109.99 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -86.25 120.13 27.28 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.268 -0.424 . . . . 10.0 110.858 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.1 mp -125.72 120.08 29.7 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.881 -0.599 . . . . 10.0 109.844 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.437 HG23 ' HG2' ' A' ' 89' ' ' GLU . 15.6 m -99.54 112.97 25.1 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.968 0.413 . . . . 10.0 109.943 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 87' ' ' SER . 3.0 mm? -84.57 114.65 22.12 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.873 -0.603 . . . . 10.0 109.645 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -117.93 103.83 10.31 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.079 -0.51 . . . . 10.0 110.232 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 84' ' ' PRO . 15.9 tptm -92.17 121.8 34.04 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.806 -0.633 . . . . 10.0 109.348 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.4 HD13 ' HB2' ' C' ' 32' ' ' SER . 75.6 mt -84.97 -57.78 4.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 O-C-N 123.631 0.582 . . . . 10.0 111.543 -179.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -66.15 158.51 28.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.856 -0.611 . . . . 10.0 111.023 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.28 139.71 56.22 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 120.877 0.37 . . . . 10.0 111.188 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.509 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 7.3 Cg_exo -75.17 129.44 18.67 Favored 'Cis proline' 0 C--O 1.235 0.335 0 C-N-CA 123.297 -1.543 . . . . 10.0 110.708 -1.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.444 ' HE3' ' HB2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -92.08 158.99 15.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.191 0.519 . . . . 10.0 110.953 -179.179 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -173.23 167.9 4.77 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.396 -0.82 . . . . 10.0 109.879 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.552 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 46.4 m -146.61 97.66 2.95 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.275 -0.639 . . . . 10.0 109.275 178.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 38.0 pt -110.45 146.01 16.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.804 -0.634 . . . . 10.0 110.657 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.437 ' HG2' HG23 ' A' ' 77' ' ' THR . 19.7 mt-10 -110.98 126.16 54.48 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.062 -0.718 . . . . 10.0 109.062 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 12.0 m80 -142.5 159.42 42.26 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.393 0.616 . . . . 10.0 111.976 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -105.75 126.76 52.54 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.044 -0.98 . . . . 10.0 109.922 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -117.89 167.65 11.22 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.935 -0.575 . . . . 10.0 110.587 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.574 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 1.7 m -89.72 153.73 47.81 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.144 -0.48 . . . . 10.0 110.463 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -60.52 -27.88 85.66 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.342 2.028 . . . . 10.0 112.329 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.6 m -103.97 17.93 23.07 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.002 -0.545 . . . . 10.0 110.678 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.574 ' HB2' ' O ' ' A' ' 93' ' ' SER . 0.3 OUTLIER -73.33 152.1 41.03 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.985 -0.552 . . . . 10.0 110.153 179.565 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.58 147.09 28.01 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.707 -0.679 . . . . 10.0 110.457 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 30.9 mm -62.3 -23.76 32.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.189 0.519 . . . . 10.0 110.511 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.447 HD22 ' HA ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -59.2 -37.94 78.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.61 -0.723 . . . . 10.0 110.509 179.187 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -61.77 -40.02 93.69 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.457 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.591 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 45.9 mt -63.15 -47.49 92.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.974 -0.557 . . . . 10.0 109.65 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -56.49 -47.36 79.43 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.448 -0.796 . . . . 10.0 110.962 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -61.35 -39.99 92.62 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.963 -0.562 . . . . 10.0 110.598 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 25.1 t60 -62.7 -38.54 90.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.476 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 101' ' ' ILE . 58.1 mt -65.43 -39.62 92.3 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.953 0.406 . . . . 10.0 110.671 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 43.2 mt -69.73 -39.7 78.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.103 0.478 . . . . 10.0 110.313 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.1 m -67.09 -20.33 65.79 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.893 -0.594 . . . . 10.0 111.305 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -98.8 14.6 28.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.633 -0.258 . . . . 10.0 111.242 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 58.11 35.12 24.86 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.121 -0.491 . . . . 10.0 111.166 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 8.6 mmtp -112.99 -13.34 13.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.547 -0.297 . . . . 10.0 111.335 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.466 ' HB2' HD13 ' A' ' 148' ' ' ILE . . . -135.06 155.81 50.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.394 -0.366 . . . . 10.0 110.762 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.1 m -94.46 -61.35 1.53 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.246 -0.434 . . . . 10.0 111.266 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -137.98 147.8 44.6 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.964 -0.384 . . . . 10.0 109.964 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.546 ' HA ' HD12 ' A' ' 117' ' ' ILE . 48.1 pt -60.43 -32.95 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.378 0.608 . . . . 10.0 110.843 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.4 m -58.59 -28.82 65.93 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.694 -1.139 . . . . 10.0 112.961 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.93 14.57 24.97 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.168 0.433 . . . . 10.0 112.168 -177.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.546 HD12 ' HA ' ' A' ' 114' ' ' ILE . 32.6 mt -115.87 135.44 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 113.288 0.847 . . . . 10.0 113.288 -178.09 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 52.7 tttt -140.88 129.12 22.27 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 109.198 -0.667 . . . . 10.0 109.198 175.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -96.18 136.1 37.09 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.274 0.559 . . . . 10.0 111.342 -179.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.402 ' HB3' ' HB ' ' A' ' 145' ' ' THR . 0.0 OUTLIER -112.46 134.67 53.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.263 -0.88 . . . . 10.0 110.029 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.525 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 43.0 tp -127.49 96.63 4.61 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 107.429 -1.322 . . . . 10.0 107.429 177.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.412 ' HA ' HG23 ' C' ' 35' ' ' VAL . 21.7 tptp 36.43 59.39 0.98 Allowed 'General case' 0 N--CA 1.467 0.387 0 O-C-N 124.059 0.849 . . . . 10.0 111.457 -177.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.27 -43.99 3.16 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 121.001 -0.619 . . . . 10.0 112.734 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.525 ' HB3' ' O ' ' A' ' 121' ' ' LEU . 26.9 tptt -59.73 126.87 29.3 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.916 -0.642 . . . . 10.0 109.765 178.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.0 m -94.15 140.72 16.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.688 0.625 . . . . 10.0 112.688 -178.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 7.2 mp -106.69 154.39 21.03 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.746 -0.661 . . . . 10.0 110.462 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -115.26 158.41 22.38 Favored 'General case' 0 C--O 1.226 -0.153 0 CA-C-O 120.677 0.275 . . . . 10.0 110.823 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.4 -55.01 20.93 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.827 1.047 . . . . 10.0 113.827 -178.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -94.02 19.35 9.23 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.756 0.312 . . . . 10.0 111.57 -177.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 12.8 tp -78.3 149.58 33.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.91 0.386 . . . . 10.0 111.088 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -108.9 150.28 27.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.768 -0.651 . . . . 10.0 110.031 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.492 HD12 ' O ' ' A' ' 93' ' ' SER . 64.3 mt -59.1 -28.18 66.27 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.211 0.449 . . . . 10.0 112.211 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.14 -12.55 59.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.118 0.485 . . . . 10.0 111.024 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -92.08 -49.86 5.99 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.131 -0.486 . . . . 10.0 110.839 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.3 pp -75.1 -25.93 58.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.017 -0.538 . . . . 10.0 111.274 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt 67.94 99.38 0.05 Allowed 'General case' 0 N--CA 1.465 0.313 0 O-C-N 124.062 0.851 . . . . 10.0 111.578 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.8 t -72.97 107.68 3.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.755 -0.461 . . . . 10.0 109.755 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.422 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 2.2 p -66.62 123.53 86.02 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.315 -0.402 . . . . 10.0 110.964 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 138' ' ' THR . 16.7 Cg_exo -63.95 -24.0 67.66 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.731 2.288 . . . . 10.0 111.66 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -78.26 4.29 13.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.55 -0.75 . . . . 10.0 111.402 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -132.83 -72.61 0.51 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.758 -0.201 . . . . 10.0 110.991 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.0 m 60.33 14.94 5.02 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.321 0.581 . . . . 10.0 111.366 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.7 m -114.02 120.15 39.61 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.948 -0.569 . . . . 10.0 110.316 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.426 HD13 HD13 ' A' ' 121' ' ' LEU . 19.3 mm -110.22 119.71 59.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.964 -0.562 . . . . 10.0 109.737 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' A' ' 120' ' ' LEU . 1.6 m -83.19 123.91 30.02 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.345 -0.389 . . . . 10.0 110.32 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 13.4 t -97.52 124.95 50.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.135 -0.484 . . . . 10.0 111.942 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 13.7 mmt -117.94 118.37 31.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.53 -0.759 . . . . 10.0 109.494 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.466 HD13 ' HB2' ' A' ' 111' ' ' ALA . 35.4 mt -136.51 140.84 42.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 111.548 0.203 . . . . 10.0 111.548 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -106.68 120.13 49.31 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 108.264 -1.013 . . . . 10.0 108.264 178.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo . . . . . 0 N--CA 1.463 -0.281 0 C-N-CA 122.39 2.06 . . . . 10.0 113.264 -178.993 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.451 -0.423 0 N-CA-C 109.764 -0.458 . . . . 10.0 109.764 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 5' ' ' LYS . . . . . 0.446 ' H ' ' HG2' ' B' ' 5' ' ' LYS . 1.6 ptpp? -60.14 -43.36 95.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.329 -0.396 . . . . 10.0 111.501 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -59.04 -36.27 74.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.574 0.226 . . . . 10.0 110.972 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -64.66 -50.96 65.0 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.073 0.464 . . . . 10.0 109.88 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.508 ' O ' HD13 ' B' ' 12' ' ' ILE . 44.3 mm -61.51 -46.79 95.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.567 -0.742 . . . . 10.0 110.961 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.36 -47.77 75.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.9 0.381 . . . . 10.0 110.971 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.94 -32.11 73.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.986 -0.552 . . . . 10.0 110.694 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.3 mt -69.48 -38.06 77.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.362 -0.381 . . . . 10.0 110.399 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.508 HD13 ' O ' ' B' ' 8' ' ' ILE . 1.4 mp -63.46 -50.94 76.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.027 -0.533 . . . . 10.0 110.622 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 12.3 m -67.83 -33.61 62.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.758 0.314 . . . . 10.0 110.722 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -67.38 -48.37 67.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.282 0.563 . . . . 10.0 110.074 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 15' ' ' TYR . . . . . 0.653 ' O ' HG12 ' B' ' 19' ' ' ILE . 15.9 t80 -60.56 -52.31 65.71 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.456 -0.793 . . . . 10.0 110.931 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -54.75 -46.76 74.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.27 -0.423 . . . . 10.0 111.64 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 27.3 m -59.55 -42.55 92.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.695 0.283 . . . . 10.0 111.279 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 23.6 p -72.44 -19.07 61.64 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 122.205 -0.309 . . . . 10.0 111.271 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.653 HG12 ' O ' ' B' ' 15' ' ' TYR . 31.5 mm -79.86 -39.8 20.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.996 0.427 . . . . 10.0 110.09 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 5.3 m -75.66 -22.79 16.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 121.503 0.668 . . . . 10.0 109.303 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -60.03 -48.99 79.44 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 114.616 -1.175 . . . . 10.0 110.862 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 3.5 mttp -102.08 6.73 41.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.809 -0.632 . . . . 10.0 110.797 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 26.9 mtpt 50.82 56.94 7.22 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.356 0.598 . . . . 10.0 110.589 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -90.6 33.68 0.91 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.425 -0.807 . . . . 10.0 110.973 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' ILE . . . . . 0.475 HG12 ' H ' ' B' ' 26' ' ' SER . 13.3 tt -168.44 168.63 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.218 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 26' ' ' SER . . . . . 0.475 ' H ' HG12 ' B' ' 25' ' ' ILE . 1.9 m -58.21 154.8 12.47 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.926 0.491 . . . . 10.0 112.105 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -52.12 -58.22 7.25 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.911 0.708 . . . . 10.0 112.911 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -70.56 -23.59 62.63 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.244 0.545 . . . . 10.0 109.68 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.607 ' O ' ' HG ' ' B' ' 33' ' ' LEU . . . -63.96 -44.16 96.39 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 110.233 -1.147 . . . . 10.0 110.233 178.297 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.59 -40.69 95.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.168 0.509 . . . . 10.0 110.083 178.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -62.56 -43.22 99.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.465 -0.789 . . . . 10.0 110.051 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 50.9 m -62.64 -42.49 99.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.428 -0.806 . . . . 10.0 110.393 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 33' ' ' LEU . . . . . 0.607 ' HG ' ' O ' ' B' ' 29' ' ' GLY . 82.2 mt -64.1 -38.91 92.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.35 -0.386 . . . . 10.0 110.341 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -65.77 -46.72 77.68 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.207 -0.451 . . . . 10.0 111.481 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.8 -38.33 80.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 116.451 -0.341 . . . . 10.0 111.091 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.55 -39.9 88.76 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.204 -0.665 . . . . 10.0 109.204 178.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 37' ' ' MET . . . . . 0.602 ' SD ' ' HD2' ' B' ' 48' ' ' ARG . 0.7 OUTLIER -59.23 -45.14 91.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.362 -0.836 . . . . 10.0 110.142 178.915 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -61.09 -46.2 91.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.427 -0.806 . . . . 10.0 110.691 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 7.8 t -67.58 -38.39 83.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 10.0 111.01 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 40' ' ' ILE . . . . . 0.484 HD13 HG21 ' B' ' 12' ' ' ILE . 55.9 mt -63.58 -39.02 83.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.878 0.37 . . . . 10.0 110.034 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.708 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 14.2 m -63.01 -38.49 91.38 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.52 -0.548 . . . . 10.0 109.52 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -69.78 -40.99 75.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.857 -0.61 . . . . 10.0 110.286 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.96 -39.45 81.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.48 -0.782 . . . . 10.0 111.975 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -94.89 -0.72 53.77 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.671 -0.24 . . . . 10.0 111.3 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.4 39.82 97.8 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-N 116.203 -0.453 . . . . 10.0 113.2 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.708 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 6.5 p90 -131.26 160.78 33.9 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.358 -0.608 . . . . 10.0 109.358 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -94.15 140.44 29.75 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.834 0.35 . . . . 10.0 110.61 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.602 ' HD2' ' SD ' ' B' ' 37' ' ' MET . 17.3 mtm180 -57.7 -29.68 64.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.899 -0.591 . . . . 10.0 111.664 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 30.4 mp0 -83.82 -0.42 51.05 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.594 -0.73 . . . . 10.0 112.894 -177.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.65 3.52 40.59 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 122.309 -0.245 . . . . 10.0 111.582 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.539 HG23 ' H ' ' B' ' 52' ' ' SER . 4.3 m -41.45 -59.75 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 113.215 0.82 . . . . 10.0 113.215 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 52' ' ' SER . . . . . 0.539 ' H ' HG23 ' B' ' 51' ' ' VAL . 0.1 OUTLIER -59.03 -20.96 58.04 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 113.103 0.779 . . . . 10.0 113.103 -179.527 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.88 -38.43 13.74 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.569 -0.824 . . . . 10.0 112.027 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 32.5 mt -86.25 -51.72 12.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 112.266 0.469 . . . . 10.0 112.266 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 83.5 mt -83.56 -67.31 0.8 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.18 0.515 . . . . 10.0 111.998 -178.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.03 -114.78 4.06 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 110.993 -0.843 . . . . 10.0 110.993 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 45.1 pttt -157.72 23.63 0.28 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.21 0.528 . . . . 10.0 110.381 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.61 35.53 0.41 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.757 -0.656 . . . . 10.0 111.391 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 . . . . . 0 N--CA 1.46 0.072 0 CA-C-N 116.292 -0.413 . . . . 10.0 110.653 -179.19 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.505 0 N-CA-C 109.773 -0.455 . . . . 10.0 109.773 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -98.78 138.52 35.81 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.489 -0.56 . . . . 10.0 109.489 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 5' ' ' LYS . . . . . 0.545 ' HB2' ' CE1' ' C' ' 44' ' ' PHE . 0.2 OUTLIER -60.64 -32.73 71.88 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.387 -0.37 . . . . 10.0 111.199 -179.233 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 6' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -59.75 -52.33 65.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.198 0.523 . . . . 10.0 110.288 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -55.62 -51.45 67.13 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.767 -0.651 . . . . 10.0 110.986 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 8' ' ' ILE . . . . . 0.668 ' O ' HG13 ' C' ' 12' ' ' ILE . 48.6 mm -57.18 -48.86 81.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.707 -0.679 . . . . 10.0 110.99 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.31 -44.98 72.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.044 0.45 . . . . 10.0 110.808 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.68 -33.78 76.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.752 -0.658 . . . . 10.0 110.877 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.58 -37.42 79.84 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.123 -0.325 . . . . 10.0 110.123 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 12' ' ' ILE . . . . . 0.668 HG13 ' O ' ' C' ' 8' ' ' ILE . 21.6 mt -64.01 -57.09 13.08 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.517 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 13' ' ' VAL . . . . . 0.55 HG12 ' HG2' ' C' ' 37' ' ' MET . 33.0 m -63.61 -26.2 40.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.682 -0.69 . . . . 10.0 111.506 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -75.73 -46.76 29.19 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.323 0.582 . . . . 10.0 109.603 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 15' ' ' TYR . . . . . 0.508 ' O ' HG12 ' C' ' 19' ' ' ILE . 46.9 t80 -64.07 -43.73 94.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.671 -0.695 . . . . 10.0 110.002 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -57.15 -42.67 81.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.982 -0.553 . . . . 10.0 110.292 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 67.0 m -57.95 -42.9 85.92 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.972 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.55 -20.68 58.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.541 -0.299 . . . . 10.0 111.647 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 19' ' ' ILE . . . . . 0.508 HG12 ' O ' ' C' ' 15' ' ' TYR . 19.7 mm -74.59 -40.45 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.181 0.515 . . . . 10.0 109.764 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 20' ' ' VAL . . . . . . . . . . . . . 17.8 m -82.14 -17.2 11.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.787 -0.642 . . . . 10.0 109.728 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -64.47 -59.61 4.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.369 -0.832 . . . . 10.0 110.163 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -87.73 -3.31 58.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.371 -0.377 . . . . 10.0 110.493 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 64.4 mttm 59.49 58.22 3.03 Favored 'General case' 0 C--N 1.334 -0.066 0 CA-C-N 115.747 -0.661 . . . . 10.0 109.954 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -86.23 9.84 16.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.469 -0.787 . . . . 10.0 110.935 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 15.2 tt -144.36 165.53 13.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.361 -0.607 . . . . 10.0 109.361 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.04 154.67 22.16 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 122.524 0.329 . . . . 10.0 111.243 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -56.3 -46.99 79.56 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.386 -0.37 . . . . 10.0 111.151 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 28' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -64.34 -35.2 80.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.229 0.538 . . . . 10.0 109.736 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 29' ' ' GLY . . . . . 0.575 ' O ' ' HG ' ' C' ' 33' ' ' LEU . . . -66.3 -39.97 94.52 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 110.918 -0.873 . . . . 10.0 110.918 178.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.14 -39.15 93.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.923 0.392 . . . . 10.0 110.27 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -62.81 -42.06 99.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.591 -0.731 . . . . 10.0 109.812 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 32' ' ' SER . . . . . 0.4 ' HB2' HD13 ' A' ' 81' ' ' ILE . 19.4 t -64.96 -43.76 91.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.365 -0.834 . . . . 10.0 110.763 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 33' ' ' LEU . . . . . 0.575 ' HG ' ' O ' ' C' ' 29' ' ' GLY . 64.2 mt -67.96 -27.73 66.85 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.336 -0.393 . . . . 10.0 110.933 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -73.04 -39.25 66.09 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 116.477 -0.328 . . . . 10.0 111.561 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 35' ' ' VAL . . . . . 0.412 HG23 ' HA ' ' A' ' 122' ' ' LYS . 10.2 p -75.17 -36.05 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 N-CA-C 109.535 -0.543 . . . . 10.0 109.535 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.96 -34.58 78.07 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.702 -0.681 . . . . 10.0 110.097 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 37' ' ' MET . . . . . 0.55 ' HG2' HG12 ' C' ' 13' ' ' VAL . 2.9 ttm -54.3 -53.48 53.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.54 -0.755 . . . . 10.0 110.986 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 38' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -69.92 -25.97 63.92 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 121.096 -0.242 . . . . 10.0 110.905 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 39' ' ' CYS . . . . . . . . . . . . . 1.1 t -66.47 -47.62 72.5 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.587 -0.523 . . . . 10.0 109.587 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 40' ' ' ILE . . . . . . . . . . . . . 11.4 mt -67.99 -37.86 78.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.688 -0.687 . . . . 10.0 109.835 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 41' ' ' SER . . . . . 0.609 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 35.4 m -63.25 -43.51 97.79 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.916 -0.584 . . . . 10.0 110.274 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -66.67 -39.76 88.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.789 -0.641 . . . . 10.0 110.47 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.82 -39.06 80.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.921 -0.581 . . . . 10.0 112.027 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 44' ' ' PHE . . . . . 0.545 ' CE1' ' HB2' ' C' ' 5' ' ' LYS . 65.2 m-85 -96.98 -3.33 41.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.68 -0.236 . . . . 10.0 111.59 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.68 39.53 97.62 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.212 -0.518 . . . . 10.0 113.446 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 46' ' ' PHE . . . . . 0.609 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 4.8 p90 -131.88 154.7 48.94 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.397 -0.594 . . . . 10.0 109.397 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -94.24 145.27 24.84 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.644 -0.422 . . . . 10.0 110.656 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 48' ' ' ARG . . . . . 0.411 ' H ' ' HG3' ' C' ' 48' ' ' ARG . 10.8 mtm-85 -63.27 -15.74 58.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.301 0.572 . . . . 10.0 110.233 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -80.16 -11.08 59.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.57 -0.741 . . . . 10.0 112.406 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -93.53 2.41 56.43 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.254 0.465 . . . . 10.0 112.254 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 12.1 m -47.58 -44.92 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 113.39 0.885 . . . . 10.0 113.39 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.21 -44.7 92.26 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.821 0.674 . . . . 10.0 112.821 -179.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.2 -26.69 74.42 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.338 -0.934 . . . . 10.0 112.679 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 54' ' ' ILE . . . . . . . . . . . . . 67.3 mt -84.56 -63.44 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.947 0.403 . . . . 10.0 111.962 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 19.0 mt -70.82 -61.1 1.89 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.591 0.589 . . . . 10.0 112.591 -178.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 66.28 -130.0 31.94 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 111.04 -0.824 . . . . 10.0 111.04 -177.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 11.2 pttp -151.35 28.75 0.64 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.187 0.518 . . . . 10.0 110.35 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.55 30.82 0.78 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.013 -0.539 . . . . 10.0 111.121 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 . . . . . 0 C--O 1.232 0.151 0 CA-C-N 115.747 -0.661 . . . . 10.0 111.022 -179.925 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.0 p . . . . . 0 N--CA 1.452 -0.344 0 CA-C-O 121.191 0.52 . . . . 10.0 110.307 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -85.36 138.66 32.14 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.837 -0.62 . . . . 10.0 110.285 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.8 mp -127.97 125.22 39.06 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.964 -0.562 . . . . 10.0 109.929 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.45 HG23 ' HG2' ' A' ' 89' ' ' GLU . 3.0 m -93.45 106.84 18.77 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.015 -0.539 . . . . 10.0 110.417 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 87' ' ' SER . 3.4 mm? -80.73 110.53 16.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.958 -0.565 . . . . 10.0 110.089 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -121.42 108.63 13.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.654 -0.703 . . . . 10.0 110.626 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.1 tttm -106.15 125.69 51.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.245 -0.434 . . . . 10.0 110.959 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.46 HG21 ' OG ' ' C' ' 32' ' ' SER . 2.0 mp -83.91 -49.31 16.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 115.525 -0.761 . . . . 10.0 110.546 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -64.8 151.55 45.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.093 -0.503 . . . . 10.0 110.76 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.94 136.47 76.6 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.334 -0.393 . . . . 10.0 111.437 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -74.31 135.79 41.91 Favored 'Cis proline' 0 C--N 1.345 0.387 0 C-N-CA 123.73 -1.363 . . . . 10.0 111.682 -1.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -92.02 151.76 20.31 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.36 -0.382 . . . . 10.0 110.572 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.522 ' CZ ' ' HB3' ' A' ' 110' ' ' LYS . 33.8 p90 -171.18 165.73 7.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.124 -0.489 . . . . 10.0 111.193 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 51.1 m -148.41 103.57 3.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.547 -0.751 . . . . 10.0 109.591 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.5 pt -135.13 163.73 35.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.423 -0.353 . . . . 10.0 110.436 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.45 ' HG2' HG23 ' A' ' 77' ' ' THR . 5.2 mt-10 -114.8 148.72 38.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.712 0.291 . . . . 10.0 111.316 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 24.4 m80 -145.89 145.74 30.83 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.05 -0.722 . . . . 10.0 109.05 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -102.01 127.42 48.9 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.175 -0.676 . . . . 10.0 109.175 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -121.44 170.32 9.76 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.483 0.659 . . . . 10.0 111.618 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.0 145.76 33.74 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 115.172 -0.922 . . . . 10.0 109.16 178.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.12 -25.67 37.29 Favored 'Trans proline' 0 CA--C 1.527 0.156 0 C-N-CA 122.108 1.872 . . . . 10.0 112.523 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.89 17.06 8.28 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.823 0.344 . . . . 10.0 111.02 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -91.98 170.19 10.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.392 -0.367 . . . . 10.0 110.453 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.85 159.55 22.89 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.022 -0.536 . . . . 10.0 110.387 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.546 ' HB ' ' HA ' ' A' ' 128' ' ' ASP . 49.2 mm -66.8 -23.43 31.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.49 0.662 . . . . 10.0 109.835 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -57.96 -43.26 86.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.428 -0.806 . . . . 10.0 110.642 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -63.47 -33.9 76.59 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.16 -0.473 . . . . 10.0 111.275 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 47.7 mt -64.85 -44.75 96.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.3 -0.409 . . . . 10.0 110.184 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -54.76 -45.58 74.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.762 -0.653 . . . . 10.0 110.81 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -71.59 -33.09 68.74 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.701 -0.681 . . . . 10.0 110.425 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -64.62 -43.52 93.46 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.814 -0.63 . . . . 10.0 110.363 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 36.6 mt -60.53 -41.57 94.71 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.332 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 85.2 mt -62.35 -38.35 80.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.048 -0.523 . . . . 10.0 110.601 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.1 m -65.36 -26.82 68.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.074 -0.512 . . . . 10.0 111.547 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -98.83 12.92 34.24 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.936 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 59.94 24.5 13.62 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.69 -0.686 . . . . 10.0 111.558 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.522 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 41.6 mmtm -91.02 -16.85 27.25 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.475 0.655 . . . . 10.0 109.339 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.415 ' CB ' HD13 ' A' ' 148' ' ' ILE . . . -137.86 151.2 47.81 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.89 -1.05 . . . . 10.0 109.837 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.4 m -101.86 -46.73 4.81 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.812 -0.355 . . . . 10.0 111.643 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.496 ' O ' HG13 ' A' ' 117' ' ' ILE . 1.7 t-160 -134.72 127.92 31.95 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.789 -0.364 . . . . 10.0 111.498 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.554 ' HA ' HD12 ' A' ' 117' ' ' ILE . 11.2 tt -56.47 -41.85 73.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 115.746 -0.661 . . . . 10.0 111.572 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.43 -14.19 26.32 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.291 -0.868 . . . . 10.0 113.274 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -114.22 13.6 17.97 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.076 -0.39 . . . . 10.0 111.797 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.554 HD12 ' HA ' ' A' ' 114' ' ' ILE . 62.0 mt -99.61 121.31 50.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.751 0.31 . . . . 10.0 111.038 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -126.11 117.96 24.26 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.473 -0.33 . . . . 10.0 110.248 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -94.4 138.27 32.55 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.235 0.541 . . . . 10.0 111.562 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -120.38 133.45 55.44 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.102 -1.073 . . . . 10.0 108.102 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 53.6 tp -115.96 96.53 5.63 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 106.009 -1.849 . . . . 10.0 106.009 178.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.9 tptm 43.8 64.9 1.13 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 114.648 -1.16 . . . . 10.0 110.628 -177.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.689 ' HA2' ' SG ' ' C' ' 39' ' ' CYS . . . 80.88 -47.87 3.62 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.556 -0.747 . . . . 10.0 113.859 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 39.5 tttp -67.38 120.76 14.41 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 109.419 -0.586 . . . . 10.0 109.419 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.1 p -66.06 139.42 21.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.356 0.598 . . . . 10.0 112.499 -178.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 126' ' ' LEU . 2.3 tp -105.69 103.1 12.54 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.645 -0.707 . . . . 10.0 110.253 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -69.98 143.46 52.6 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.074 -0.966 . . . . 10.0 111.876 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.546 ' HA ' ' HB ' ' A' ' 98' ' ' ILE . 0.3 OUTLIER -61.57 -39.87 92.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.718 -0.674 . . . . 10.0 112.223 -179.561 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -73.88 -9.35 58.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.331 -0.395 . . . . 10.0 111.553 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 17.1 tp -76.85 142.01 40.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.251 -0.432 . . . . 10.0 110.356 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.467 ' HB2' ' HB2' ' A' ' 134' ' ' ASP . 41.2 m-85 -93.8 149.74 20.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.057 -0.52 . . . . 10.0 110.659 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 34.3 mt -59.32 -38.52 80.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.93 0.395 . . . . 10.0 111.21 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.24 -19.73 61.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.257 -0.429 . . . . 10.0 111.01 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.467 ' HB2' ' HB2' ' A' ' 131' ' ' PHE . 13.3 t0 -81.56 -40.37 23.18 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.738 -0.664 . . . . 10.0 111.108 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.3 pp -83.87 -26.36 29.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.508 -0.315 . . . . 10.0 111.317 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 96.0 mttt 63.07 99.18 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 O-C-N 123.659 0.599 . . . . 10.0 112.202 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.0 t -79.92 114.23 20.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.073 -0.512 . . . . 10.0 110.298 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.85 137.76 76.59 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.34 -0.391 . . . . 10.0 111.289 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -62.78 -16.99 57.0 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.818 2.345 . . . . 10.0 112.692 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -106.03 6.32 31.08 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.067 0.461 . . . . 10.0 110.924 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -140.34 71.28 1.37 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.753 -0.658 . . . . 10.0 109.536 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.4 t -99.27 11.81 38.0 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.654 -0.703 . . . . 10.0 110.17 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.35 95.58 5.76 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.127 0.489 . . . . 10.0 110.672 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 24.9 mm -92.37 104.4 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 N-CA-C 107.527 -1.286 . . . . 10.0 107.527 177.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.93 121.45 26.5 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.203 -0.453 . . . . 10.0 110.234 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 10.4 t -105.62 136.95 37.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.777 -0.647 . . . . 10.0 111.775 -178.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 25.1 mmt -136.0 120.78 18.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.126 -0.943 . . . . 10.0 108.643 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.415 HD13 ' CB ' ' A' ' 111' ' ' ALA . 11.8 mt -139.68 94.05 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.723 -0.391 . . . . 10.0 111.119 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -94.35 107.09 27.03 Favored Pre-proline 0 C--N 1.32 -0.706 0 N-CA-C 109.213 -0.662 . . . . 10.0 109.213 175.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 N--CA 1.462 -0.37 0 C-N-CA 122.508 2.139 . . . . 10.0 112.759 -178.184 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 4' ' ' SER . . . . . 0.487 ' O ' HG12 ' B' ' 8' ' ' ILE . 64.6 p . . . . . 0 N--CA 1.451 -0.425 0 CA-C-O 120.589 0.233 . . . . 10.0 110.717 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 5' ' ' LYS . . . . . 0.403 ' HE2' ' O ' ' C' ' 24' ' ' GLU . 7.8 ptpp? -54.34 -44.69 72.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.046 -0.525 . . . . 10.0 111.33 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -59.04 -47.19 86.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.408 -0.36 . . . . 10.0 111.487 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -59.86 -45.4 92.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.828 0.347 . . . . 10.0 110.511 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.487 HG12 ' O ' ' B' ' 4' ' ' SER . 37.2 mm -60.17 -49.62 83.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.739 -0.664 . . . . 10.0 110.505 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.4 -41.76 85.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.392 -0.367 . . . . 10.0 111.191 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.57 -38.09 89.81 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.207 0.527 . . . . 10.0 110.44 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 40.7 mt -66.1 -39.32 89.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.949 -0.569 . . . . 10.0 109.63 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.421 HD13 ' O ' ' B' ' 8' ' ' ILE . 1.3 mp -56.8 -46.85 83.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.311 -0.858 . . . . 10.0 111.406 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 12.9 m -71.72 -29.78 35.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.579 -0.448 . . . . 10.0 111.731 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -73.88 -41.62 61.91 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.749 0.309 . . . . 10.0 111.288 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -69.38 -43.6 73.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.379 -0.373 . . . . 10.0 111.199 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 16' ' ' PHE . . . . . 0.404 ' CE2' HG23 ' B' ' 12' ' ' ILE . 14.7 m-30 -61.43 -49.86 75.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.408 -0.36 . . . . 10.0 111.03 -179.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 6.0 p -57.65 -45.26 85.74 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.929 0.344 . . . . 10.0 111.929 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 5.0 p -69.02 -21.25 64.13 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.036 0.384 . . . . 10.0 112.036 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 22.5 mm -85.65 -43.58 16.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 120.689 -0.404 . . . . 10.0 110.676 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 26.9 m -73.54 -35.2 44.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.891 -0.324 . . . . 10.0 111.294 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -68.8 -38.28 79.82 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 120.487 -0.485 . . . . 10.0 110.235 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 33.2 mtmt -75.12 -7.15 52.97 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.132 -0.322 . . . . 10.0 110.132 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 29.8 mmtm 57.63 41.33 25.69 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.808 -0.633 . . . . 10.0 110.375 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.467 ' O ' ' HE2' ' C' ' 5' ' ' LYS . 38.4 mt-10 -91.61 9.83 30.61 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.529 -0.759 . . . . 10.0 110.338 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 9.0 tp -141.99 150.18 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 N-CA-C 108.834 -0.802 . . . . 10.0 108.834 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 1.2 p -62.65 154.95 27.62 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.287 -0.264 . . . . 10.0 110.287 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -57.21 -32.56 66.62 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.672 0.273 . . . . 10.0 110.712 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -63.2 -46.64 86.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.419 0.628 . . . . 10.0 109.716 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.539 ' O ' ' HG ' ' B' ' 33' ' ' LEU . . . -71.13 -40.72 61.37 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.542 -0.754 . . . . 10.0 111.384 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.73 -42.77 93.9 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.898 0.38 . . . . 10.0 111.069 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.415 ' O ' HG12 ' B' ' 35' ' ' VAL . 27.7 t0 -61.34 -44.19 97.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.619 -0.719 . . . . 10.0 110.214 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 13.4 m -65.52 -41.52 93.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.703 -0.68 . . . . 10.0 110.64 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 33' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' B' ' 29' ' ' GLY . 82.1 mt -66.08 -43.63 86.79 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.792 0.33 . . . . 10.0 111.296 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -60.3 -51.02 71.3 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 116.001 -0.545 . . . . 10.0 112.206 -178.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.415 HG12 ' O ' ' B' ' 31' ' ' ASP . 7.1 p -66.64 -42.06 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 120.797 -0.361 . . . . 10.0 111.063 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.43 -35.0 77.88 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.947 0.403 . . . . 10.0 110.419 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 37' ' ' MET . . . . . . . . . . . . . 22.7 ttm -56.24 -51.12 69.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.578 -0.737 . . . . 10.0 111.033 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.97 -33.63 76.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.073 -0.512 . . . . 10.0 111.508 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 39.9 m -65.28 -42.95 92.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.015 0.436 . . . . 10.0 110.284 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 46.7 mt -67.27 -34.52 69.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.844 -0.617 . . . . 10.0 110.321 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.665 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 50.9 m -65.23 -40.51 94.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.061 -0.518 . . . . 10.0 110.74 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -72.72 -27.47 62.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 10.0 111.284 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.45 -39.37 81.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.981 -0.554 . . . . 10.0 111.54 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -97.13 -0.84 46.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.333 -0.394 . . . . 10.0 111.869 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.23 60.62 7.29 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.351 -0.452 . . . . 10.0 114.168 178.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.665 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 13.6 p90 -154.11 167.78 28.7 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.028 -0.36 . . . . 10.0 110.028 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -98.93 151.62 20.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.013 0.435 . . . . 10.0 110.379 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 3.9 mtm180 -71.34 -28.21 63.91 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.129 0.49 . . . . 10.0 110.632 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -84.51 7.34 20.24 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.054 -0.521 . . . . 10.0 112.257 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.13 4.38 48.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.513 0.197 . . . . 10.0 111.523 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.453 HG23 ' H ' ' B' ' 52' ' ' SER . 4.8 m -41.37 -57.39 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 113.425 0.898 . . . . 10.0 113.425 -179.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 52' ' ' SER . . . . . 0.453 ' H ' HG23 ' B' ' 51' ' ' VAL . 0.6 OUTLIER -53.72 -36.54 62.37 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.824 0.675 . . . . 10.0 112.824 -179.28 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.72 -42.25 32.35 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.934 -0.651 . . . . 10.0 113.353 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 24.8 mt -83.69 -45.64 18.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 112.253 0.464 . . . . 10.0 112.253 -178.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 81.0 mt -73.17 -64.27 1.01 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.949 0.404 . . . . 10.0 111.378 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.25 -151.05 48.11 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.912 -0.661 . . . . 10.0 112.403 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 10.0 tttt -100.08 6.92 44.96 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.073 0.463 . . . . 10.0 110.466 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.47 134.89 55.42 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.565 -0.743 . . . . 10.0 110.289 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 . . . . . 0 C--N 1.321 -0.655 0 CA-C-O 121.178 0.513 . . . . 10.0 110.648 -179.582 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.184 0 CA-C-O 120.857 0.361 . . . . 10.0 111.336 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 4' ' ' SER . . . . . 0.553 ' O ' HG12 ' C' ' 8' ' ' ILE . 0.7 OUTLIER -109.89 166.32 11.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.246 -0.434 . . . . 10.0 110.106 179.857 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 5' ' ' LYS . . . . . 0.491 ' HB2' ' CE1' ' C' ' 44' ' ' PHE . 10.3 ptpp? -51.86 -38.67 56.9 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 123.515 0.51 . . . . 10.0 111.863 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 6' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 -59.39 -54.59 44.93 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.381 -0.372 . . . . 10.0 111.494 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -60.91 -40.3 92.62 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.688 0.28 . . . . 10.0 110.34 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 8' ' ' ILE . . . . . 0.553 HG12 ' O ' ' C' ' 4' ' ' SER . 48.4 mm -60.0 -47.73 90.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.88 -0.6 . . . . 10.0 109.658 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.39 -44.82 76.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.966 -0.561 . . . . 10.0 111.203 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 10' ' ' ALA . . . . . 0.41 ' HB2' HD12 ' C' ' 54' ' ' ILE . . . -65.82 -40.56 91.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.913 -0.585 . . . . 10.0 111.089 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 32.4 mt -61.36 -39.1 89.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.903 0.382 . . . . 10.0 110.26 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 12' ' ' ILE . . . . . 0.538 HD13 ' O ' ' C' ' 8' ' ' ILE . 1.6 mp -63.17 -54.87 27.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.656 -0.702 . . . . 10.0 111.75 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 28.5 m -66.56 -26.04 36.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.262 0.467 . . . . 10.0 112.262 -178.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 14' ' ' ASN . . . . . 0.549 ' HB2' HG11 ' C' ' 51' ' ' VAL . 0.7 OUTLIER -76.24 -40.09 52.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.981 0.419 . . . . 10.0 110.433 -179.668 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 15' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -72.6 -45.11 60.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.151 -0.477 . . . . 10.0 111.32 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -56.51 -49.67 74.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.371 -0.377 . . . . 10.0 110.846 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 10.0 p -58.48 -45.07 89.43 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.43 -0.35 . . . . 10.0 111.586 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 4.4 p -69.33 -22.24 63.78 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.805 -0.358 . . . . 10.0 111.845 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 19' ' ' ILE . . . . . . . . . . . . . 20.2 mm -79.34 -43.39 23.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 110.129 -0.322 . . . . 10.0 110.129 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 20' ' ' VAL . . . . . . . . . . . . . 4.2 m -73.99 -27.83 22.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.71 0.29 . . . . 10.0 110.385 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -69.84 -53.62 17.3 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.905 -0.406 . . . . 10.0 109.905 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 34.5 mtmt -70.67 -6.79 39.74 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.843 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm 61.48 47.03 6.96 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.251 0.548 . . . . 10.0 110.426 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 24' ' ' GLU . . . . . 0.403 ' O ' ' HE2' ' B' ' 5' ' ' LYS . 9.1 mt-10 -85.41 -3.93 59.0 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.827 -0.624 . . . . 10.0 110.422 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 11.2 tt -134.94 159.45 41.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.056 -0.52 . . . . 10.0 110.129 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -68.19 166.35 16.45 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.218 0.207 . . . . 10.0 111.272 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -53.74 -50.34 66.18 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.066 0.395 . . . . 10.0 112.066 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.76 -47.37 77.11 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.033 0.444 . . . . 10.0 110.48 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.09 -42.44 91.94 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.833 -0.699 . . . . 10.0 112.028 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.35 -41.68 80.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.881 0.372 . . . . 10.0 110.963 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -68.07 -38.47 82.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.952 -0.567 . . . . 10.0 110.163 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 32' ' ' SER . . . . . 0.46 ' OG ' HG21 ' A' ' 81' ' ' ILE . 48.7 m -61.74 -29.37 70.07 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.455 -0.793 . . . . 10.0 109.938 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 33' ' ' LEU . . . . . 0.464 ' O ' ' HG3' ' C' ' 37' ' ' MET . 48.4 mt -77.76 -37.11 49.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.341 -0.39 . . . . 10.0 110.359 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -58.36 -53.63 56.13 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.06 -0.518 . . . . 10.0 110.369 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 35' ' ' VAL . . . . . 0.4 HG23 ' H ' ' A' ' 123' ' ' GLY . 9.4 p -67.2 -38.58 81.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 115.361 -0.836 . . . . 10.0 110.681 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.94 -40.97 95.3 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 120.669 0.271 . . . . 10.0 111.257 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 37' ' ' MET . . . . . 0.464 ' HG3' ' O ' ' C' ' 33' ' ' LEU . 70.8 mtm -54.74 -47.14 74.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.426 -0.352 . . . . 10.0 110.593 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 38' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -69.41 -28.65 66.33 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 116.468 -0.333 . . . . 10.0 110.855 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 39' ' ' CYS . . . . . 0.689 ' SG ' ' HA2' ' A' ' 123' ' ' GLY . 91.8 m -61.25 -42.84 99.32 Favored 'General case' 0 CA--C 1.522 -0.115 0 N-CA-C 108.871 -0.789 . . . . 10.0 108.871 177.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 40' ' ' ILE . . . . . . . . . . . . . 1.4 mp -73.25 -46.11 51.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 114.84 -1.073 . . . . 10.0 110.704 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 41' ' ' SER . . . . . 0.621 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 9.2 m -60.98 -42.09 97.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.406 -0.361 . . . . 10.0 111.585 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -72.96 -29.28 62.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.412 -0.358 . . . . 10.0 110.506 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.6 -46.8 65.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.154 -0.476 . . . . 10.0 111.727 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 44' ' ' PHE . . . . . 0.491 ' CE1' ' HB2' ' C' ' 5' ' ' LYS . 93.4 m-85 -92.18 -7.03 49.49 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.089 0.403 . . . . 10.0 112.089 -178.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.36 60.86 5.18 Favored Glycine 0 C--O 1.227 -0.309 0 C-N-CA 121.244 -0.503 . . . . 10.0 113.889 178.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 46' ' ' PHE . . . . . 0.621 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 3.6 p90 -153.56 169.25 23.67 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 110.179 -0.304 . . . . 10.0 110.179 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 51.5 mp0 -99.23 144.08 28.76 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.803 0.335 . . . . 10.0 110.85 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.95 -28.36 69.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.214 0.53 . . . . 10.0 110.965 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -80.1 14.33 1.92 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.733 -0.667 . . . . 10.0 112.509 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -104.72 2.82 30.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.24 0.543 . . . . 10.0 110.753 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 51' ' ' VAL . . . . . 0.549 HG11 ' HB2' ' C' ' 14' ' ' ASN . 1.7 m -49.44 -45.78 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 113.546 0.943 . . . . 10.0 113.546 -179.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.63 -27.22 67.61 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.785 0.291 . . . . 10.0 111.785 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.91 -37.78 12.54 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.845 -0.693 . . . . 10.0 112.667 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 54' ' ' ILE . . . . . 0.41 HD12 ' HB2' ' C' ' 10' ' ' ALA . 40.0 mt -81.14 -56.35 6.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 O-C-N 122.697 -0.296 . . . . 10.0 111.253 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 26.5 mt -67.01 -41.24 87.0 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.229 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 58.08 -139.41 47.61 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.621 -0.718 . . . . 10.0 112.077 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 66.2 tttt -108.76 -6.34 15.93 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.074 0.464 . . . . 10.0 110.32 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 3.1 m -65.34 148.21 52.09 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.622 -0.717 . . . . 10.0 111.27 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.482 0 CA-C-O 121.068 0.461 . . . . 10.0 110.146 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.4 t . . . . . 0 CA--C 1.521 -0.146 0 CA-C-O 120.845 0.355 . . . . 10.0 111.475 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.448 ' CD2' ' HB3' ' A' ' 91' ' ' ASP . 4.8 m170 -91.53 126.3 36.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.075 -0.511 . . . . 10.0 110.629 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.6 mp -126.9 120.03 28.18 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.01 -0.541 . . . . 10.0 109.923 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.1 m -94.07 114.75 26.97 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.452 -0.573 . . . . 10.0 109.452 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.426 ' O ' ' HA ' ' A' ' 87' ' ' SER . 2.5 mm? -88.3 122.67 32.08 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.283 -0.417 . . . . 10.0 110.679 -178.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -122.95 104.58 9.33 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.969 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -92.11 120.57 32.84 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.909 -0.404 . . . . 10.0 109.909 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 20.8 mt -86.83 -59.46 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.573 -0.285 . . . . 10.0 111.649 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -57.0 158.12 5.21 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.75 0.309 . . . . 10.0 111.397 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.28 138.6 55.92 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.42 -0.355 . . . . 10.0 111.059 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -74.2 130.73 21.54 Favored 'Cis proline' 0 C--O 1.237 0.435 0 C-N-CA 123.039 -1.65 . . . . 10.0 111.87 -1.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.4 ' HG3' ' H ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -87.8 152.62 21.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.422 -0.353 . . . . 10.0 111.271 -179.277 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -177.52 170.75 2.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.736 -0.665 . . . . 10.0 110.03 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 15.2 m -151.17 133.42 15.32 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.123 -0.49 . . . . 10.0 109.696 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.411 HG13 ' HB2' ' A' ' 78' ' ' LEU . 9.1 pt -138.16 150.31 24.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.932 0.396 . . . . 10.0 111.383 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -113.58 120.4 40.82 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.359 -0.608 . . . . 10.0 109.359 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.39 167.39 23.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.014 0.435 . . . . 10.0 111.433 -178.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.448 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -121.4 131.57 54.25 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.848 -0.614 . . . . 10.0 110.905 179.101 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -118.74 168.8 10.39 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.727 -0.669 . . . . 10.0 109.85 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.608 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 7.4 t -80.89 146.95 60.74 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 116.545 -0.298 . . . . 10.0 110.398 -179.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.1 -22.62 70.47 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.245 1.963 . . . . 10.0 111.747 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 43.3 m -100.08 13.32 34.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.978 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.608 ' HB2' ' O ' ' A' ' 93' ' ' SER . 1.0 OUTLIER -80.52 163.11 23.97 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.528 -179.889 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.4 p -115.49 160.66 19.63 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.583 -0.735 . . . . 10.0 110.576 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 47.7 mm -65.28 -21.31 29.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.368 0.604 . . . . 10.0 109.438 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.28 -39.29 82.46 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.41 -0.814 . . . . 10.0 110.235 178.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -63.84 -40.24 96.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.103 -0.498 . . . . 10.0 110.316 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.526 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 54.1 mt -65.93 -48.6 81.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.841 -0.618 . . . . 10.0 109.499 178.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.418 ' CD ' HG13 ' A' ' 114' ' ' ILE . 53.2 mttt -53.64 -48.01 69.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.322 -0.854 . . . . 10.0 111.151 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.481 ' OE1' ' HA ' ' A' ' 103' ' ' GLN . 11.4 mm-40 -59.8 -41.16 90.6 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.883 -0.599 . . . . 10.0 111.102 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.538 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 19.1 t60 -68.46 -33.75 74.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.29 -0.414 . . . . 10.0 110.539 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 101' ' ' ILE . 90.8 mt -62.55 -46.04 90.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.79 0.329 . . . . 10.0 110.989 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.6 mt -67.41 -32.35 56.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.124 0.488 . . . . 10.0 110.05 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.1 m -68.02 -15.49 63.62 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.511 -0.768 . . . . 10.0 112.159 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.538 ' HG2' ' O ' ' A' ' 104' ' ' HIS . 17.5 mm-40 -95.1 6.88 47.83 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.628 -0.508 . . . . 10.0 109.628 178.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.459 ' HA ' ' OE1' ' A' ' 109' ' ' GLU . 3.4 mm-40 60.35 32.1 20.58 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.486 -0.779 . . . . 10.0 111.039 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -110.98 -5.64 14.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.111 -0.495 . . . . 10.0 110.795 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.62 ' HB2' HD13 ' A' ' 148' ' ' ILE . . . -135.57 148.69 49.17 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.81 -0.632 . . . . 10.0 109.952 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.533 ' OG ' ' HA ' ' A' ' 150' ' ' PRO . 0.6 OUTLIER -87.71 -59.18 2.32 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.948 0.404 . . . . 10.0 110.901 -179.81 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.501 ' O ' HG13 ' A' ' 117' ' ' ILE . 40.8 m80 -138.26 154.02 49.07 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.345 -0.389 . . . . 10.0 110.919 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.418 HG13 ' CD ' ' A' ' 102' ' ' LYS . 0.3 OUTLIER -63.34 -36.75 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 115.502 -0.772 . . . . 10.0 110.386 179.562 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.87 -24.0 34.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.821 -1.081 . . . . 10.0 112.463 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.19 0.16 31.32 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 121.182 -0.207 . . . . 10.0 111.397 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 113' ' ' HIS . 28.2 mt -90.75 119.91 38.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 120.266 -0.574 . . . . 10.0 109.534 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.4 mmmt -118.1 112.15 19.82 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.114 0.483 . . . . 10.0 110.174 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.434 ' O ' ' HB2' ' A' ' 126' ' ' LEU . 3.2 mm? -92.99 113.7 26.06 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.653 0.74 . . . . 10.0 110.995 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.534 HD13 ' HA ' ' A' ' 125' ' ' VAL . 4.5 mm? -110.75 140.43 45.16 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 107.406 -1.331 . . . . 10.0 107.406 178.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.582 HD13 HD13 ' A' ' 144' ' ' ILE . 17.9 tp -121.98 97.91 5.7 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.821 -0.807 . . . . 10.0 108.821 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? 46.82 58.27 4.86 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.612 0.72 . . . . 10.0 109.972 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.686 ' HA2' ' SG ' ' C' ' 39' ' ' CYS . . . 83.87 -44.41 3.31 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 114.6 -1.182 . . . . 10.0 114.154 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 22.9 tttp -59.64 140.03 56.73 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 120.696 0.284 . . . . 10.0 111.006 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.534 ' HA ' HD13 ' A' ' 120' ' ' LEU . 7.2 p -90.35 136.16 24.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 112.942 0.719 . . . . 10.0 112.942 -178.307 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.434 ' HB2' ' O ' ' A' ' 119' ' ' LEU . 6.0 mp -110.83 156.29 21.34 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 114.983 -1.008 . . . . 10.0 110.001 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -116.0 158.38 23.19 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.452 0.538 . . . . 10.0 112.452 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -52.81 -55.1 25.41 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 113.377 0.88 . . . . 10.0 113.377 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -91.26 14.13 15.28 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.242 0.46 . . . . 10.0 112.242 -178.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 9.4 tp -70.24 143.87 52.02 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.708 0.289 . . . . 10.0 110.428 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -98.85 146.84 25.54 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.72 -0.673 . . . . 10.0 110.18 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.497 HD12 ' O ' ' A' ' 93' ' ' SER . 13.0 mt -57.53 -39.09 75.84 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.414 -0.357 . . . . 10.0 111.183 178.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.4 p -73.17 -21.96 60.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.123 0.487 . . . . 10.0 111.198 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -82.25 -45.56 14.86 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 120.812 0.339 . . . . 10.0 110.519 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.2 pp -74.1 -21.97 59.68 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.352 -0.385 . . . . 10.0 110.846 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.6 mtmt 63.43 92.2 0.07 Allowed 'General case' 0 C--O 1.236 0.352 0 O-C-N 123.691 0.619 . . . . 10.0 110.785 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.0 t -66.07 101.5 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.6 -0.727 . . . . 10.0 110.38 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.52 119.66 48.88 Favored Pre-proline 0 N--CA 1.451 -0.415 0 CA-C-N 116.098 -0.501 . . . . 10.0 110.652 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -65.57 -11.46 30.59 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.773 2.315 . . . . 10.0 112.727 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -93.04 7.3 44.7 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.965 -0.561 . . . . 10.0 110.19 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -128.63 -75.02 0.56 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.518 -0.765 . . . . 10.0 110.14 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 38.6 m 57.66 13.27 1.89 Allowed 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.486 0.55 . . . . 10.0 112.486 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.9 m -121.46 121.75 38.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.619 0.247 . . . . 10.0 110.882 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.582 HD13 HD13 ' A' ' 121' ' ' LEU . 10.7 mm -102.85 126.12 57.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.714 -0.675 . . . . 10.0 109.666 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.425 HG21 HG11 ' C' ' 35' ' ' VAL . 0.2 OUTLIER -86.43 107.15 17.92 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.887 -0.783 . . . . 10.0 108.887 179.302 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 21.7 t -87.34 126.08 41.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.663 -0.699 . . . . 10.0 110.209 -178.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 62.7 mtt -125.35 115.0 19.63 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.706 -1.134 . . . . 10.0 109.866 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.62 HD13 ' HB2' ' A' ' 111' ' ' ALA . 9.9 mt -138.96 146.11 26.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.35 -0.841 . . . . 10.0 110.674 -178.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.514 ' HD3' ' OD2' ' B' ' 38' ' ' ASP . 2.0 mmmm -125.94 115.51 24.24 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 109.37 -0.604 . . . . 10.0 109.37 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.533 ' HA ' ' OG ' ' A' ' 112' ' ' SER . 19.5 Cg_endo . . . . . 0 C--N 1.347 0.491 0 C-N-CA 122.425 2.084 . . . . 10.0 112.65 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 80.1 p . . . . . 0 N--CA 1.449 -0.507 0 N-CA-C 109.376 -0.601 . . . . 10.0 109.376 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -53.1 -40.54 64.22 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.85 0.315 . . . . 10.0 111.85 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -60.91 -47.25 87.27 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.668 -0.242 . . . . 10.0 110.838 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -58.84 -39.83 82.43 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.114 0.483 . . . . 10.0 110.075 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.443 ' O ' HD12 ' B' ' 12' ' ' ILE . 50.1 mm -64.52 -49.3 81.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.726 -0.67 . . . . 10.0 110.084 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.27 -36.65 78.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.193 0.52 . . . . 10.0 110.335 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.99 -32.77 74.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.534 -0.757 . . . . 10.0 110.221 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 28.1 mt -70.98 -34.96 71.91 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.421 -0.585 . . . . 10.0 109.421 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.658 HG21 HD13 ' B' ' 40' ' ' ILE . 0.7 OUTLIER -59.37 -54.74 30.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.974 -0.557 . . . . 10.0 110.442 179.117 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 28.4 m -62.27 -33.51 59.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.33 -0.396 . . . . 10.0 111.117 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -68.72 -48.77 62.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.093 -0.503 . . . . 10.0 110.897 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' TYR . . . . . 0.484 ' O ' HG12 ' B' ' 19' ' ' ILE . 8.3 m-85 -70.94 -41.9 70.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.156 -0.474 . . . . 10.0 112.04 -178.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -55.92 -52.94 62.35 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 122.982 0.176 . . . . 10.0 111.45 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 17' ' ' SER . . . . . 0.5 ' O ' ' HB2' ' B' ' 21' ' ' GLU . 4.9 p -58.74 -46.85 86.48 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.448 -0.342 . . . . 10.0 111.357 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 28.8 p -65.45 -20.59 66.43 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.225 0.454 . . . . 10.0 112.225 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.484 HG12 ' O ' ' B' ' 15' ' ' TYR . 22.9 mm -84.93 -42.12 16.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.798 0.332 . . . . 10.0 111.221 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 34.5 m -77.43 -31.6 17.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.006 0.431 . . . . 10.0 111.311 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 21' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' B' ' 17' ' ' SER . 0.4 OUTLIER -71.64 -25.69 62.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.075 -0.511 . . . . 10.0 111.188 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -94.59 1.13 55.62 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.397 0.618 . . . . 10.0 109.578 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 14.7 mmtt 55.33 45.56 25.28 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 114.805 -1.089 . . . . 10.0 111.573 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -93.66 24.32 4.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.946 0.403 . . . . 10.0 111.223 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 16.8 tt -160.87 161.39 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 116.173 -0.467 . . . . 10.0 110.41 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.84 159.86 29.53 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.817 -0.629 . . . . 10.0 111.443 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -56.97 -41.86 79.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.65 -0.705 . . . . 10.0 111.412 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.33 -50.67 72.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.998 -0.547 . . . . 10.0 109.845 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.501 ' O ' ' HG ' ' B' ' 33' ' ' LEU . . . -60.39 -41.08 98.37 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.622 -0.717 . . . . 10.0 111.677 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.25 -31.87 73.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.883 -0.158 . . . . 10.0 110.913 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -71.5 -43.3 66.79 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.43 -0.582 . . . . 10.0 109.43 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 4.1 m -62.54 -51.14 68.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.313 -0.858 . . . . 10.0 110.288 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' B' ' 29' ' ' GLY . 89.6 mt -59.12 -41.92 89.35 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.127 -0.488 . . . . 10.0 110.173 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -57.83 -49.61 76.09 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.752 -0.658 . . . . 10.0 111.106 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.439 HG11 HD21 ' A' ' 120' ' ' LEU . 2.6 p -70.93 -33.81 53.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.738 -0.385 . . . . 10.0 111.691 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.23 -39.25 89.43 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 109.625 -0.509 . . . . 10.0 109.625 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 37' ' ' MET . . . . . . . . . . . . . 32.8 ttm -54.65 -45.6 73.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.305 -0.861 . . . . 10.0 109.574 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 38' ' ' ASP . . . . . 0.514 ' OD2' ' HD3' ' A' ' 149' ' ' LYS . 18.4 t70 -62.6 -53.73 50.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.118 -0.947 . . . . 10.0 110.886 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 59.8 m -52.09 -47.76 65.07 Favored 'General case' 0 N--CA 1.462 0.137 0 O-C-N 123.581 0.551 . . . . 10.0 111.529 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 40' ' ' ILE . . . . . 0.658 HD13 HG21 ' B' ' 12' ' ' ILE . 59.7 mt -62.6 -44.83 99.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.02 -0.536 . . . . 10.0 110.69 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.556 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 49.0 m -61.28 -43.32 99.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.026 -0.534 . . . . 10.0 110.876 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -67.52 -42.39 82.87 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.679 -0.691 . . . . 10.0 111.243 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.2 -33.61 74.74 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.28 0.474 . . . . 10.0 112.28 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -90.38 -7.2 53.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.671 0.272 . . . . 10.0 111.062 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.84 46.74 90.96 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.201 -0.523 . . . . 10.0 112.864 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.556 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 3.7 p90 -144.34 154.71 43.31 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 122.569 -0.371 . . . . 10.0 110.474 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -92.93 147.08 23.14 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.404 -0.362 . . . . 10.0 110.408 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.415 ' H ' ' NE ' ' B' ' 48' ' ' ARG . 0.0 OUTLIER -64.98 -27.34 68.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.548 -0.296 . . . . 10.0 111.483 -179.134 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -72.68 -10.32 59.65 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.404 -0.362 . . . . 10.0 111.839 -179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.28 4.38 27.3 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.592 -0.276 . . . . 10.0 111.351 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.422 HG23 ' H ' ' B' ' 52' ' ' SER . 0.1 OUTLIER -42.77 -59.94 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 112.653 0.612 . . . . 10.0 112.653 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 52' ' ' SER . . . . . 0.422 ' H ' HG23 ' B' ' 51' ' ' VAL . 0.9 OUTLIER -60.89 -19.56 60.56 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.229 0.826 . . . . 10.0 113.229 -179.421 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.46 -38.5 12.35 Favored Glycine 0 C--O 1.235 0.203 0 C-N-CA 120.879 -0.677 . . . . 10.0 112.382 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 6.2 mt -86.63 -47.34 16.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.816 0.341 . . . . 10.0 111.23 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 53.4 mt -73.08 -57.88 3.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.306 0.574 . . . . 10.0 110.424 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.83 -144.7 48.56 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.327 -0.851 . . . . 10.0 112.569 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -91.67 -11.03 38.13 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.465 -0.367 . . . . 10.0 110.918 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.56 131.79 52.02 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.798 0.666 . . . . 10.0 112.798 -178.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 C--N 1.326 -0.45 0 N-CA-C 108.814 -0.81 . . . . 10.0 108.814 177.878 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.575 0.226 . . . . 10.0 111.047 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 4' ' ' SER . . . . . 0.532 ' O ' HG12 ' C' ' 8' ' ' ILE . 31.4 p -102.16 161.88 13.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.383 -0.371 . . . . 10.0 110.984 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -56.08 -39.34 71.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.294 -0.412 . . . . 10.0 111.498 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 6' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -61.2 -48.58 80.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.011 0.434 . . . . 10.0 110.911 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -63.49 -39.07 93.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.857 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 8' ' ' ILE . . . . . 0.532 HG12 ' O ' ' C' ' 4' ' ' SER . 43.6 mm -60.89 -46.83 95.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.564 -0.532 . . . . 10.0 109.564 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 9' ' ' ALA . . . . . 0.498 ' HB1' ' CE1' ' C' ' 46' ' ' PHE . . . -60.04 -44.09 94.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.692 -0.686 . . . . 10.0 110.825 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.99 -41.93 98.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.94 -0.573 . . . . 10.0 111.224 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 16.6 mt -62.44 -41.72 98.93 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.463 0.649 . . . . 10.0 110.006 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 12' ' ' ILE . . . . . 0.716 HG21 HD13 ' C' ' 40' ' ' ILE . 1.3 mp -59.22 -51.42 72.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.749 -1.114 . . . . 10.0 111.876 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 30.0 m -67.93 -24.95 31.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.028 0.442 . . . . 10.0 111.758 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -76.45 -42.56 43.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.749 0.309 . . . . 10.0 110.227 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 15' ' ' TYR . . . . . 0.469 ' O ' HG12 ' C' ' 19' ' ' ILE . 3.1 m-85 -73.32 -40.28 64.61 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.7 -0.4 . . . . 10.0 110.82 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -58.32 -49.48 77.03 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 109.998 -0.371 . . . . 10.0 109.998 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 35.4 p -62.05 -43.6 98.49 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.302 -0.408 . . . . 10.0 111.123 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 32.9 p -66.95 -24.45 66.07 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 111.69 0.256 . . . . 10.0 111.69 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 19' ' ' ILE . . . . . 0.469 HG12 ' O ' ' C' ' 15' ' ' TYR . 26.8 mm -80.6 -39.67 18.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 110.011 -0.366 . . . . 10.0 110.011 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 20' ' ' VAL . . . . . 0.402 HG12 ' HA ' ' C' ' 30' ' ' ALA . 19.5 m -77.43 -27.23 15.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.84 -0.344 . . . . 10.0 111.124 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 21' ' ' GLU . . . . . 0.402 ' HA ' ' OE1' ' C' ' 21' ' ' GLU . 2.5 tp10 -68.71 -50.33 51.66 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.846 -0.427 . . . . 10.0 109.846 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -71.92 -10.02 59.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.047 -0.524 . . . . 10.0 110.205 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm 58.95 42.31 19.66 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.506 0.67 . . . . 10.0 109.505 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -81.41 -6.28 58.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.232 -0.894 . . . . 10.0 110.729 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 18.1 tt -125.61 160.08 32.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.101 -0.5 . . . . 10.0 109.761 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -58.94 152.51 19.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.463 -0.335 . . . . 10.0 110.482 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -57.4 -34.49 68.94 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.81 0.338 . . . . 10.0 110.41 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 28' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -61.8 -50.77 71.0 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.51 -0.768 . . . . 10.0 109.983 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 29' ' ' GLY . . . . . 0.532 ' O ' ' HG ' ' C' ' 33' ' ' LEU . . . -67.33 -31.13 76.3 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.144 -0.934 . . . . 10.0 112.643 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 30' ' ' ALA . . . . . 0.402 ' HA ' HG12 ' C' ' 20' ' ' VAL . . . -59.96 -46.66 88.7 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.557 0.218 . . . . 10.0 110.461 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 31' ' ' ASP . . . . . 0.402 ' O ' HG12 ' C' ' 35' ' ' VAL . 14.5 t70 -63.64 -37.81 88.74 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.529 -0.545 . . . . 10.0 109.529 179.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 14.0 m -57.61 -44.91 85.82 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.449 -0.796 . . . . 10.0 109.784 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 33' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' C' ' 29' ' ' GLY . 51.6 mt -70.25 -37.37 74.93 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.026 -0.534 . . . . 10.0 110.501 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -59.17 -55.83 29.96 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.048 -0.524 . . . . 10.0 111.429 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 35' ' ' VAL . . . . . 0.425 HG11 HG21 ' A' ' 145' ' ' THR . 8.4 p -66.07 -41.77 90.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 115.961 -0.563 . . . . 10.0 111.117 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.55 -28.47 69.96 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.676 0.274 . . . . 10.0 111.032 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 9.0 mtm -59.98 -51.33 70.14 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.262 -0.426 . . . . 10.0 110.45 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 38' ' ' ASP . . . . . 0.629 ' CB ' ' HA3' ' A' ' 123' ' ' GLY . 1.2 m-20 -69.94 -27.47 64.78 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 109.639 -0.504 . . . . 10.0 109.639 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 39' ' ' CYS . . . . . 0.686 ' SG ' ' HA2' ' A' ' 123' ' ' GLY . 62.6 m -61.49 -50.25 73.46 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 109.297 -0.631 . . . . 10.0 109.297 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 40' ' ' ILE . . . . . 0.716 HD13 HG21 ' C' ' 12' ' ' ILE . 54.6 mt -67.2 -35.76 74.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.993 -1.003 . . . . 10.0 109.957 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 41' ' ' SER . . . . . 0.691 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 53.1 m -61.36 -51.81 67.27 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.713 -0.676 . . . . 10.0 110.536 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.82 -35.67 80.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.793 0.33 . . . . 10.0 110.867 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.66 -42.69 93.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.099 -0.5 . . . . 10.0 111.808 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 44' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -96.3 -2.48 45.79 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.869 0.366 . . . . 10.0 111.634 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.4 51.22 38.78 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.103 -0.57 . . . . 10.0 112.945 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 46' ' ' PHE . . . . . 0.691 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 4.3 p90 -144.48 157.58 44.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.055 0.455 . . . . 10.0 110.327 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -96.4 136.75 36.46 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.111 -0.495 . . . . 10.0 109.685 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 48' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -60.88 -13.97 19.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.757 -0.656 . . . . 10.0 112.111 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -84.03 -6.56 59.43 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.745 0.646 . . . . 10.0 112.745 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.53 4.55 27.57 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.134 0.42 . . . . 10.0 112.134 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 51' ' ' VAL . . . . . 0.4 HG23 ' H ' ' C' ' 52' ' ' SER . 4.9 m -45.03 -54.4 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 113.548 0.944 . . . . 10.0 113.548 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 52' ' ' SER . . . . . 0.4 ' H ' HG23 ' C' ' 51' ' ' VAL . 0.0 OUTLIER -58.93 -30.88 68.19 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.775 0.658 . . . . 10.0 112.775 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.13 -49.81 5.77 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.426 -0.892 . . . . 10.0 112.912 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 54' ' ' ILE . . . . . . . . . . . . . 80.0 mt -69.67 -54.6 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-O 120.642 0.258 . . . . 10.0 111.328 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 70.0 mt -68.77 -52.76 26.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.433 -0.349 . . . . 10.0 111.009 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.38 -136.66 47.57 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.261 -0.495 . . . . 10.0 112.837 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 30.9 tttt -108.3 3.43 23.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.222 0.534 . . . . 10.0 110.094 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 9.1 t -73.62 138.15 44.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.966 -0.561 . . . . 10.0 110.555 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 . . . . . 0 C--N 1.321 -0.646 0 CA-C-N 115.585 -0.734 . . . . 10.0 109.721 178.49 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.1 t . . . . . 0 N--CA 1.455 -0.182 0 N-CA-C 110.352 -0.24 . . . . 10.0 110.352 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -87.57 129.29 35.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.57 0.224 . . . . 10.0 110.729 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.5 mp -127.87 129.17 46.46 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.126 0.489 . . . . 10.0 110.149 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.3 m -94.69 109.12 21.09 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.653 -0.703 . . . . 10.0 110.389 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -85.16 118.77 24.92 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.876 -0.787 . . . . 10.0 108.876 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -119.47 108.42 14.51 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.284 -0.416 . . . . 10.0 111.28 -178.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.521 ' HG2' ' O ' ' A' ' 84' ' ' PRO . 19.1 tptm -94.91 113.28 24.98 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 116.484 -0.326 . . . . 10.0 110.922 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.582 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 52.4 mt -80.49 -59.86 2.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 O-C-N 124.168 0.917 . . . . 10.0 111.542 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -63.13 160.31 15.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.787 0.327 . . . . 10.0 110.983 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.4 140.4 72.34 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 120.695 0.283 . . . . 10.0 111.401 -179.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.521 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 59.6 Cg_endo -76.9 140.61 66.02 Favored 'Cis proline' 0 C--N 1.343 0.266 0 C-N-CA 122.992 -1.67 . . . . 10.0 111.392 -1.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.582 ' HG2' ' O ' ' A' ' 81' ' ' ILE . 27.7 mtpp -82.91 145.1 29.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.436 -0.347 . . . . 10.0 110.965 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.424 ' CE2' ' HB3' ' A' ' 110' ' ' LYS . 34.1 p90 -165.73 156.08 13.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.714 0.292 . . . . 10.0 111.055 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.9 m -140.82 114.21 8.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.724 -0.671 . . . . 10.0 110.371 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 10.6 pt -134.87 149.02 29.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.558 -0.292 . . . . 10.0 110.816 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -117.16 116.62 27.65 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.384 -0.598 . . . . 10.0 109.384 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 25.7 t60 -130.3 146.31 51.88 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.412 -0.588 . . . . 10.0 109.412 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -99.11 139.66 34.43 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.201 0.524 . . . . 10.0 110.22 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -129.75 170.46 13.81 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.816 -0.629 . . . . 10.0 110.664 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.559 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 19.3 t -81.34 146.98 59.1 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 115.914 -0.585 . . . . 10.0 109.683 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -62.4 -18.02 60.73 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.126 1.884 . . . . 10.0 111.094 178.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.4 m -102.73 15.17 30.07 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.616 -0.72 . . . . 10.0 110.589 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.559 ' HB2' ' O ' ' A' ' 93' ' ' SER . 0.4 OUTLIER -83.5 167.88 17.0 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.043 0.449 . . . . 10.0 110.833 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.81 156.43 29.43 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.787 -0.642 . . . . 10.0 110.638 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 43.1 mm -63.3 -23.4 33.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.969 -0.559 . . . . 10.0 110.254 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.39 -40.58 65.14 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.355 -0.839 . . . . 10.0 110.873 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -64.02 -43.68 94.86 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 120.937 0.399 . . . . 10.0 110.864 -179.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.54 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 44.6 mt -62.12 -47.57 92.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.87 -0.605 . . . . 10.0 109.568 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -54.44 -46.41 73.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.341 -0.845 . . . . 10.0 111.237 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.437 ' OE1' ' HA ' ' A' ' 103' ' ' GLN . 16.0 mm-40 -65.04 -34.47 78.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.161 -0.472 . . . . 10.0 110.881 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 48.0 t60 -62.91 -39.56 94.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.342 -0.39 . . . . 10.0 110.326 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 101' ' ' ILE . 17.3 mt -63.14 -41.11 99.24 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.187 -0.46 . . . . 10.0 110.139 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 14.6 mt -68.53 -39.42 80.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.302 -0.408 . . . . 10.0 109.929 178.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.4 m -65.05 -26.07 68.09 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.214 0.531 . . . . 10.0 111.285 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -88.06 2.76 51.14 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.315 -0.402 . . . . 10.0 110.806 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 62.95 25.36 15.02 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.336 0.588 . . . . 10.0 109.997 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.424 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 22.5 mmtp -99.18 -8.16 25.51 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.565 -0.743 . . . . 10.0 109.89 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -130.6 154.46 47.84 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.397 -0.819 . . . . 10.0 110.371 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.1 m -107.77 -33.28 7.31 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.021 -0.536 . . . . 10.0 111.516 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.442 ' O ' HG13 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -154.57 129.89 9.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.582 -0.281 . . . . 10.0 110.777 -178.306 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.526 ' HA ' HD12 ' A' ' 117' ' ' ILE . 9.3 tt -61.77 -38.84 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-O 120.937 0.398 . . . . 10.0 111.451 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.565 ' HB3' ' OE2' ' A' ' 116' ' ' GLU . 8.1 t -49.48 -38.27 29.38 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.12 -0.946 . . . . 10.0 112.461 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.565 ' OE2' ' HB3' ' A' ' 115' ' ' SER . 1.3 pm0 -94.73 11.6 30.79 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.176 0.436 . . . . 10.0 112.176 -178.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' A' ' 114' ' ' ILE . 65.9 mt -95.6 119.98 44.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.992 -0.744 . . . . 10.0 108.992 178.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.8 mmmt -126.22 120.37 29.86 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.777 -0.453 . . . . 10.0 109.777 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -95.79 127.24 41.65 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.132 0.491 . . . . 10.0 111.248 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.59 HD21 HG11 ' B' ' 35' ' ' VAL . 3.0 mm? -110.33 138.46 46.69 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.493 -0.776 . . . . 10.0 108.98 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 25.3 tp -124.0 99.71 6.38 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.36 -0.607 . . . . 10.0 109.36 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 23.2 tptp 46.34 57.14 5.6 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 123.903 0.752 . . . . 10.0 110.416 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.568 ' HA3' ' CB ' ' C' ' 38' ' ' ASP . . . 81.48 -45.01 3.17 Favored Glycine 0 C--N 1.332 0.35 0 CA-C-N 115.567 -0.742 . . . . 10.0 113.097 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 40.1 tttp -62.61 133.16 54.49 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.807 -0.442 . . . . 10.0 109.807 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.3 p -83.03 141.03 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 113.341 0.867 . . . . 10.0 113.341 -177.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.5 mp -107.71 154.58 21.28 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.421 -0.808 . . . . 10.0 110.489 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 56.7 m-70 -111.9 154.61 24.95 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.781 0.324 . . . . 10.0 110.708 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -50.17 -54.04 23.54 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.727 1.01 . . . . 10.0 113.727 -178.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -96.51 18.69 13.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.921 0.391 . . . . 10.0 111.919 -177.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 130' ' ' LEU . 12.0 tp -68.81 146.77 52.59 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.029 0.442 . . . . 10.0 111.048 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -99.7 143.62 29.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.779 -0.646 . . . . 10.0 110.082 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.402 HD12 ' O ' ' A' ' 93' ' ' SER . 49.7 mt -56.8 -28.99 62.25 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.255 0.347 . . . . 10.0 111.692 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.69 -22.37 56.73 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.988 0.423 . . . . 10.0 111.687 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -83.11 -49.13 9.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.532 -0.304 . . . . 10.0 110.588 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.6 pp -72.72 -25.24 61.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 10.0 111.06 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt 65.85 91.96 0.08 Allowed 'General case' 0 N--CA 1.463 0.216 0 O-C-N 123.884 0.74 . . . . 10.0 112.064 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.2 t -66.99 110.08 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.415 -0.587 . . . . 10.0 109.415 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -81.51 124.69 79.92 Favored Pre-proline 0 N--CA 1.447 -0.584 0 CA-C-N 115.95 -0.568 . . . . 10.0 111.156 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -64.92 -17.07 58.38 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.819 2.346 . . . . 10.0 111.967 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -79.72 0.12 31.85 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.914 -0.585 . . . . 10.0 110.789 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -136.48 -63.88 0.61 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.119 -0.492 . . . . 10.0 109.787 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 30.5 m 51.6 24.48 2.34 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.634 -0.712 . . . . 10.0 112.543 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 32.4 m -124.71 126.32 45.51 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.142 0.496 . . . . 10.0 111.094 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 24.3 mm -106.73 120.51 58.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.567 -0.742 . . . . 10.0 109.584 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.24 117.85 23.23 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.242 -0.435 . . . . 10.0 109.83 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 29.1 t -93.46 127.73 45.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.689 -0.687 . . . . 10.0 111.221 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -124.65 117.26 23.88 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.47 -0.786 . . . . 10.0 109.247 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 10.2 mt -138.72 143.56 31.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.197 -0.456 . . . . 10.0 111.165 -177.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -109.8 114.56 56.45 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 108.846 -0.798 . . . . 10.0 108.846 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo . . . . . 0 CA--C 1.53 0.292 0 C-N-CA 122.447 2.098 . . . . 10.0 113.215 -178.792 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 4' ' ' SER . . . . . 0.484 ' O ' HG12 ' B' ' 8' ' ' ILE . 26.0 t . . . . . 0 CA--C 1.53 0.209 0 CA-C-O 120.529 0.204 . . . . 10.0 110.515 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 5.2 ptpp? -57.88 -44.17 86.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.284 -0.416 . . . . 10.0 110.664 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -58.11 -46.25 85.88 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.004 0.43 . . . . 10.0 110.549 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -62.29 -38.94 91.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.932 -0.577 . . . . 10.0 110.458 179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.494 HG13 ' CE2' ' C' ' 15' ' ' TYR . 38.7 mm -63.63 -45.8 96.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.992 -0.549 . . . . 10.0 109.99 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.41 -36.72 83.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.736 -0.665 . . . . 10.0 110.994 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.36 -34.03 77.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.984 -0.553 . . . . 10.0 110.48 179.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 22.9 mt -67.02 -35.63 80.32 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.57 -0.53 . . . . 10.0 109.57 178.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.479 HG23 HD13 ' C' ' 12' ' ' ILE . 53.4 mt -59.91 -56.96 13.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.515 -0.766 . . . . 10.0 111.396 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.468 ' HB ' ' HG2' ' B' ' 48' ' ' ARG . 24.4 m -65.44 -31.95 56.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.432 -0.349 . . . . 10.0 111.613 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -65.26 -51.38 61.2 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.215 0.531 . . . . 10.0 110.179 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 15' ' ' TYR . . . . . 0.48 ' O ' HG12 ' B' ' 19' ' ' ILE . 16.5 m-85 -64.28 -44.97 90.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.974 -0.557 . . . . 10.0 111.338 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 9.3 m-30 -58.32 -50.37 73.87 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.559 0.207 . . . . 10.0 111.559 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 24.2 m -56.97 -38.5 73.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.933 0.397 . . . . 10.0 111.456 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 2.7 p -79.03 -20.11 49.79 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.293 -0.255 . . . . 10.0 111.256 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.48 HG12 ' O ' ' B' ' 15' ' ' TYR . 13.6 mm -76.72 -41.2 33.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 109.487 -0.56 . . . . 10.0 109.487 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 26.6 m -76.04 -27.78 18.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.937 -0.574 . . . . 10.0 110.369 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 tm-20 -65.22 -52.08 56.91 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.531 -0.544 . . . . 10.0 109.531 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 21.4 mmtm -79.89 -8.75 59.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.642 -0.708 . . . . 10.0 110.545 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 52.1 mttt 55.36 52.78 10.82 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.486 -0.779 . . . . 10.0 110.843 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.482 ' O ' ' HE2' ' C' ' 5' ' ' LYS . 87.7 mt-10 -89.35 26.64 1.61 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.249 -0.887 . . . . 10.0 110.105 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 13.7 tt -162.25 160.77 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.598 -0.728 . . . . 10.0 109.848 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.48 153.22 36.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.597 -0.274 . . . . 10.0 110.847 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -59.15 -44.44 92.09 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.379 0.511 . . . . 10.0 112.379 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.79 -47.48 82.45 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.089 0.471 . . . . 10.0 110.228 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.445 ' O ' ' HG ' ' B' ' 33' ' ' LEU . . . -67.36 -34.54 85.41 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.791 -0.64 . . . . 10.0 111.901 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.9 -39.3 94.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.698 0.285 . . . . 10.0 111.02 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -70.55 -30.43 67.15 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.751 -0.463 . . . . 10.0 109.751 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 2.0 m -62.23 -43.14 99.5 Favored 'General case' 0 C--N 1.334 -0.097 0 N-CA-C 109.126 -0.694 . . . . 10.0 109.126 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 33' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' B' ' 29' ' ' GLY . 26.7 mt -70.23 -36.4 74.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.751 -0.659 . . . . 10.0 109.851 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -54.82 -56.2 21.95 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.227 -0.897 . . . . 10.0 110.853 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.59 HG11 HD21 ' A' ' 120' ' ' LEU . 7.1 p -73.17 -34.32 44.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 115.947 -0.57 . . . . 10.0 111.397 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.09 -32.68 74.11 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.991 -0.374 . . . . 10.0 109.991 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 37' ' ' MET . . . . . . . . . . . . . 22.7 mtm -60.05 -44.12 94.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.414 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.27 -47.65 85.11 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.234 -0.439 . . . . 10.0 110.006 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 15.8 m -58.18 -43.44 87.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.789 -0.641 . . . . 10.0 110.817 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 40' ' ' ILE . . . . . 0.445 HD13 HG21 ' B' ' 12' ' ' ILE . 96.5 mt -67.21 -48.65 77.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-O 120.742 0.305 . . . . 10.0 111.555 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.54 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 10.6 m -60.06 -46.4 89.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.361 -0.381 . . . . 10.0 110.895 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -67.41 -37.99 83.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.384 -0.371 . . . . 10.0 111.209 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.26 -42.36 99.13 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.877 0.325 . . . . 10.0 111.877 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -87.6 -7.87 56.96 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.889 0.329 . . . . 10.0 111.889 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.62 49.82 17.27 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.986 -0.626 . . . . 10.0 113.54 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.54 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 8.2 p90 -151.98 166.75 30.57 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.433 -0.58 . . . . 10.0 109.433 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -117.09 157.82 25.25 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.199 0.523 . . . . 10.0 110.554 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.468 ' HG2' ' HB ' ' B' ' 13' ' ' VAL . 0.6 OUTLIER -68.99 -22.94 64.06 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.473 -0.785 . . . . 10.0 111.597 -178.554 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -69.07 -8.57 46.39 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.179 0.807 . . . . 10.0 113.179 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -103.34 5.62 37.39 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.813 0.671 . . . . 10.0 112.813 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.548 HG23 ' H ' ' B' ' 52' ' ' SER . 2.6 m -40.69 -61.61 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 113.638 0.977 . . . . 10.0 113.638 -178.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 52' ' ' SER . . . . . 0.548 ' H ' HG23 ' B' ' 51' ' ' VAL . 1.0 OUTLIER -62.01 -23.14 66.25 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.991 0.737 . . . . 10.0 112.991 -178.696 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.66 -40.81 30.88 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.646 -0.788 . . . . 10.0 112.43 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 72.8 mt -81.34 -47.37 19.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.711 0.291 . . . . 10.0 111.226 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 67.0 mt -74.99 -67.99 0.59 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.742 0.306 . . . . 10.0 110.573 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 55.06 -106.13 0.49 Allowed Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.777 -0.647 . . . . 10.0 113.381 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 16.0 pttt -126.96 18.81 7.16 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.205 0.526 . . . . 10.0 110.211 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 13.1 m -76.68 -59.13 2.9 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.707 -0.678 . . . . 10.0 110.406 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 . . . . . 0 N--CA 1.447 -0.595 0 CA-C-N 116.359 -0.382 . . . . 10.0 110.051 -179.779 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.458 0 N-CA-C 110.27 -0.27 . . . . 10.0 110.27 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 4' ' ' SER . . . . . 0.474 ' O ' HG12 ' C' ' 8' ' ' ILE . 8.6 t -97.8 171.77 8.1 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.347 -0.612 . . . . 10.0 109.347 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 5' ' ' LYS . . . . . 0.482 ' HE2' ' O ' ' B' ' 24' ' ' GLU . 3.4 ptpp? -59.23 -37.97 78.85 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 121.407 -0.117 . . . . 10.0 110.903 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 6' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -58.27 -45.55 87.66 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.055 0.455 . . . . 10.0 110.725 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -69.99 -41.44 74.38 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.19 -0.459 . . . . 10.0 110.735 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 8' ' ' ILE . . . . . 0.474 HG12 ' O ' ' C' ' 4' ' ' SER . 40.1 mm -59.19 -44.89 92.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.825 -0.435 . . . . 10.0 109.825 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.41 -39.93 92.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.824 -0.625 . . . . 10.0 110.442 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.42 -43.03 99.58 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.816 -0.629 . . . . 10.0 110.41 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 11' ' ' LEU . . . . . 0.472 ' HG ' ' CD2' ' C' ' 55' ' ' LEU . 7.0 mt -61.04 -40.43 93.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.457 -0.338 . . . . 10.0 110.743 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 12' ' ' ILE . . . . . 0.479 HD13 HG23 ' B' ' 12' ' ' ILE . 73.1 mt -65.2 -54.13 32.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.038 -0.528 . . . . 10.0 111.668 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 18.1 m -64.86 -27.47 42.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.899 0.38 . . . . 10.0 110.952 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -71.67 -47.08 56.65 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 120.986 0.422 . . . . 10.0 110.186 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 15' ' ' TYR . . . . . 0.494 ' CE2' HG13 ' B' ' 8' ' ' ILE . 3.2 m-85 -62.59 -42.66 99.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.829 -0.623 . . . . 10.0 110.598 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -59.18 -45.05 92.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.192 -0.458 . . . . 10.0 111.027 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 35.8 m -58.6 -39.7 81.15 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.119 -0.491 . . . . 10.0 111.692 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.71 -19.29 45.4 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.973 0.416 . . . . 10.0 111.139 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 19' ' ' ILE . . . . . . . . . . . . . 4.2 mm -75.87 -45.12 38.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.006 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 20' ' ' VAL . . . . . . . . . . . . . 27.3 m -75.44 -18.09 15.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 121.235 0.54 . . . . 10.0 110.676 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -70.91 -56.35 6.43 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.534 -0.757 . . . . 10.0 110.794 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 22' ' ' LYS . . . . . 0.5 ' HD2' ' OE2' ' C' ' 24' ' ' GLU . 45.5 mttm -81.22 -2.01 47.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.399 -0.818 . . . . 10.0 111.735 -178.182 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 87.7 mttt 55.58 49.23 16.98 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.475 0.655 . . . . 10.0 110.571 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 24' ' ' GLU . . . . . 0.5 ' OE2' ' HD2' ' C' ' 22' ' ' LYS . 46.3 mt-10 -82.47 -15.36 52.79 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.546 -0.752 . . . . 10.0 110.096 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 17.1 tt -114.2 161.14 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 115.608 -0.724 . . . . 10.0 109.829 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.31 154.08 39.29 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 123.288 0.368 . . . . 10.0 110.11 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -52.25 -44.5 64.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.95 0.405 . . . . 10.0 111.46 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 28' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -59.03 -45.07 91.65 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.882 -0.599 . . . . 10.0 110.646 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 29' ' ' GLY . . . . . 0.643 ' O ' ' HG ' ' C' ' 33' ' ' LEU . . . -68.12 -38.11 87.82 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.639 -0.709 . . . . 10.0 112.183 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.55 -43.31 84.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.047 0.451 . . . . 10.0 110.402 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 31' ' ' ASP . . . . . 0.488 ' O ' ' HB3' ' C' ' 34' ' ' ASN . 31.1 t70 -69.41 -37.59 77.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.904 -0.589 . . . . 10.0 110.347 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 24.3 m -64.23 -36.11 83.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.676 -0.693 . . . . 10.0 110.39 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 33' ' ' LEU . . . . . 0.643 ' HG ' ' O ' ' C' ' 29' ' ' GLY . 46.5 mt -73.05 -26.86 61.44 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.849 -0.426 . . . . 10.0 109.849 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 34' ' ' ASN . . . . . 0.488 ' HB3' ' O ' ' C' ' 31' ' ' ASP . 24.8 t30 -61.83 -56.6 17.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.917 -0.583 . . . . 10.0 110.303 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 35' ' ' VAL . . . . . 0.411 HG23 ' H ' ' A' ' 123' ' ' GLY . 6.3 p -66.64 -38.23 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 115.672 -0.695 . . . . 10.0 110.639 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 36' ' ' ALA . . . . . 0.478 ' O ' HG13 ' C' ' 40' ' ' ILE . . . -64.28 -32.57 74.22 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.389 -0.369 . . . . 10.0 110.995 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 14.0 mtm -59.29 -52.8 64.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.636 -0.256 . . . . 10.0 111.024 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 38' ' ' ASP . . . . . 0.568 ' CB ' ' HA3' ' A' ' 123' ' ' GLY . 28.1 m-20 -63.99 -26.55 68.62 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.462 -0.335 . . . . 10.0 110.597 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 39' ' ' CYS . . . . . 0.476 ' HB2' ' O ' ' C' ' 36' ' ' ALA . 62.7 m -60.23 -43.41 96.06 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 109.351 -0.611 . . . . 10.0 109.351 178.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 40' ' ' ILE . . . . . 0.478 HG13 ' O ' ' C' ' 36' ' ' ALA . 14.8 mt -69.03 -47.75 73.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.554 -0.748 . . . . 10.0 110.551 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 41' ' ' SER . . . . . 0.472 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 17.8 m -59.78 -43.18 94.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.916 -0.583 . . . . 10.0 111.712 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -68.59 -43.23 76.93 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.281 -0.418 . . . . 10.0 111.238 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.9 -44.86 75.98 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.355 0.502 . . . . 10.0 112.355 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 44' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -86.36 -7.31 58.56 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.95 0.352 . . . . 10.0 111.95 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.16 55.38 21.83 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.893 -0.67 . . . . 10.0 113.326 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 46' ' ' PHE . . . . . 0.472 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 4.7 p90 -153.98 177.7 10.75 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.896 -0.779 . . . . 10.0 108.896 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -125.27 150.87 46.67 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.263 0.554 . . . . 10.0 111.576 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 48' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -71.83 -27.63 63.04 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.499 -0.773 . . . . 10.0 110.954 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -72.15 2.8 5.27 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.006 -0.543 . . . . 10.0 111.246 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -108.96 0.88 20.3 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.436 0.532 . . . . 10.0 112.436 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 10.5 m -50.24 -43.21 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 114.379 1.252 . . . . 10.0 114.379 -177.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 52' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.77 -30.06 67.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.868 0.365 . . . . 10.0 111.174 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.91 -38.16 10.7 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.957 -0.64 . . . . 10.0 112.786 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 54' ' ' ILE . . . . . . . . . . . . . 37.3 mt -73.84 -62.68 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.853 0.359 . . . . 10.0 111.035 -179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 55' ' ' LEU . . . . . 0.472 ' CD2' ' HG ' ' C' ' 11' ' ' LEU . 68.9 mt -66.25 -54.97 18.66 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.628 -0.714 . . . . 10.0 110.71 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 52.67 -99.5 0.04 OUTLIER Glycine 0 CA--C 1.518 0.279 0 O-C-N 123.931 0.769 . . . . 10.0 112.457 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -138.89 21.09 2.65 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.187 -0.672 . . . . 10.0 109.187 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 18.4 m -78.69 -59.67 2.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.27 -0.877 . . . . 10.0 111.399 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 . . . . . 0 C--N 1.321 -0.636 0 N-CA-C 109.956 -0.387 . . . . 10.0 109.956 -179.901 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.8 p . . . . . 0 N--CA 1.453 -0.322 0 CA-C-O 120.807 0.336 . . . . 10.0 110.121 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -89.16 132.1 34.99 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.411 -0.359 . . . . 10.0 110.981 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -120.73 122.48 40.49 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.466 -0.938 . . . . 10.0 108.466 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.7 m -92.17 109.74 21.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.921 0.391 . . . . 10.0 110.346 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.542 ' O ' ' HA ' ' A' ' 87' ' ' SER . 2.3 mm? -81.67 110.65 17.21 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.239 -0.652 . . . . 10.0 109.239 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -120.52 107.11 12.47 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.316 -0.402 . . . . 10.0 111.059 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 46.5 tttm -96.74 120.57 37.31 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.587 -0.523 . . . . 10.0 109.587 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.488 HG23 ' OD2' ' C' ' 28' ' ' ASP . 18.1 mt -83.87 -36.21 11.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 O-C-N 123.863 0.727 . . . . 10.0 111.087 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.456 ' OE1' ' HA ' ' A' ' 147' ' ' MET . 19.7 mt-30 -65.42 149.17 50.46 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.993 -0.283 . . . . 10.0 110.394 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.91 134.05 78.49 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 116.437 -0.347 . . . . 10.0 111.041 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -80.07 142.14 60.91 Favored 'Cis proline' 0 C--O 1.236 0.4 0 C-N-CA 124.23 -1.154 . . . . 10.0 111.836 -1.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -80.36 158.13 26.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.029 -0.532 . . . . 10.0 111.585 -178.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -165.87 157.07 13.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.694 -0.685 . . . . 10.0 110.524 177.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.542 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 70.4 m -149.81 99.88 2.9 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.552 -0.536 . . . . 10.0 109.552 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.3 pt -121.03 155.32 24.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.039 -0.528 . . . . 10.0 110.761 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -114.91 119.33 36.18 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.554 -0.293 . . . . 10.0 110.546 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -118.11 156.05 29.34 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 110.059 -0.349 . . . . 10.0 110.059 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -107.89 110.99 22.89 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.098 -0.705 . . . . 10.0 109.098 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -117.56 151.55 36.92 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.788 0.328 . . . . 10.0 110.922 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.507 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 0.6 OUTLIER -66.93 134.01 93.95 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.072 -0.513 . . . . 10.0 110.626 179.682 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -52.46 -32.26 51.94 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.549 2.166 . . . . 10.0 112.853 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.4 m -97.52 20.27 12.03 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.042 -0.526 . . . . 10.0 111.529 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.507 ' HB2' ' O ' ' A' ' 93' ' ' SER . 0.6 OUTLIER -83.45 171.35 13.52 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.88 0.371 . . . . 10.0 110.896 -179.546 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.467 HG22 ' H ' ' A' ' 99' ' ' LEU . 4.9 m -105.99 146.41 30.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.963 -0.562 . . . . 10.0 111.006 -179.185 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.439 HG12 ' O ' ' A' ' 130' ' ' LEU . 39.2 mm -61.76 -29.52 46.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 121.31 0.576 . . . . 10.0 110.392 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.467 ' H ' HG22 ' A' ' 97' ' ' THR . 0.6 OUTLIER -56.32 -42.78 78.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.591 -0.732 . . . . 10.0 110.942 179.723 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -64.6 -36.38 84.06 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 120.695 0.283 . . . . 10.0 110.981 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 59.2 mt -65.8 -48.27 82.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.267 -0.424 . . . . 10.0 109.886 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.459 ' HE2' HG13 ' A' ' 114' ' ' ILE . 23.5 mtpt -60.15 -44.06 95.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.786 -0.643 . . . . 10.0 110.331 178.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -64.21 -33.46 75.85 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.776 -0.647 . . . . 10.0 110.227 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.414 ' O ' ' HG3' ' A' ' 108' ' ' GLU . 61.2 t60 -69.89 -37.7 76.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.822 -0.627 . . . . 10.0 110.398 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 60.8 mt -60.55 -39.97 89.85 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.115 0.483 . . . . 10.0 110.165 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 102' ' ' LYS . 12.2 mt -70.14 -38.5 75.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.996 -0.547 . . . . 10.0 109.905 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 48.9 m -66.02 -23.73 66.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.741 -0.663 . . . . 10.0 110.965 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 104' ' ' HIS . 47.2 mt-10 -96.75 7.05 47.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.154 -0.475 . . . . 10.0 110.202 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 58.13 32.09 21.56 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.452 -0.795 . . . . 10.0 111.683 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 6.3 mmpp? -100.39 -8.01 23.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.633 -0.712 . . . . 10.0 109.455 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -130.55 167.23 19.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.297 -0.865 . . . . 10.0 111.258 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.8 t -101.1 -61.36 1.38 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.876 -0.602 . . . . 10.0 110.138 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.495 ' O ' HG13 ' A' ' 117' ' ' ILE . 20.2 m170 -139.59 143.76 37.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.351 -0.386 . . . . 10.0 110.335 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.498 ' HA ' HD12 ' A' ' 117' ' ' ILE . 3.9 tt -59.5 -42.91 89.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 121.317 0.58 . . . . 10.0 110.811 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.49 -15.03 33.87 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.084 -0.962 . . . . 10.0 112.304 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -110.94 14.95 22.0 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.493 0.553 . . . . 10.0 112.493 -178.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.498 HD12 ' HA ' ' A' ' 114' ' ' ILE . 71.1 mt -105.79 120.96 57.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-O 120.973 0.416 . . . . 10.0 110.725 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -121.9 114.07 20.5 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.961 -0.755 . . . . 10.0 108.961 178.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 126' ' ' LEU . 69.8 mt -100.37 131.37 46.33 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.746 0.784 . . . . 10.0 110.988 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.548 HD11 ' SG ' ' C' ' 39' ' ' CYS . 0.4 OUTLIER -118.06 144.29 45.73 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.914 -1.039 . . . . 10.0 108.753 179.187 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.541 HD23 ' HD2' ' A' ' 124' ' ' LYS . 27.6 tp -128.87 93.34 3.58 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 107.45 -1.315 . . . . 10.0 107.45 178.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.532 ' HG2' ' ND2' ' A' ' 141' ' ' ASN . 0.2 OUTLIER 35.29 69.33 0.17 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 113.903 -1.499 . . . . 10.0 112.498 -179.473 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.514 ' HA3' ' HB3' ' C' ' 38' ' ' ASP . . . 86.51 -45.28 3.43 Favored Glycine 0 CA--C 1.51 -0.256 0 C-N-CA 121.071 -0.585 . . . . 10.0 112.399 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.541 ' HD2' HD23 ' A' ' 121' ' ' LEU . 39.7 ttmt -63.33 121.7 14.38 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.556 -0.535 . . . . 10.0 109.556 178.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.9 t -85.8 128.42 39.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 111.79 0.293 . . . . 10.0 111.79 -178.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' A' ' 119' ' ' LEU . 5.3 mp -96.88 144.71 26.56 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.149 -0.315 . . . . 10.0 110.149 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.734 ' HB2' HD13 ' A' ' 130' ' ' LEU . 88.2 m-70 -122.7 161.1 24.51 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.598 -0.441 . . . . 10.0 110.259 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.09 -34.19 68.06 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.224 0.824 . . . . 10.0 113.224 -178.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -96.93 8.35 44.63 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.985 0.365 . . . . 10.0 111.985 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.734 HD13 ' HB2' ' A' ' 127' ' ' HIS . 1.1 mp -80.54 144.92 32.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.985 0.421 . . . . 10.0 110.65 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -107.68 148.67 29.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.769 -0.65 . . . . 10.0 109.362 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 51.0 mt -57.12 -39.18 74.61 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.106 0.409 . . . . 10.0 112.106 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.87 -18.52 58.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.749 0.309 . . . . 10.0 110.746 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -78.62 -49.33 13.42 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.811 -0.632 . . . . 10.0 110.623 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.437 HD22 ' HG ' ' A' ' 126' ' ' LEU . 1.2 pp -76.4 -26.49 55.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.283 -0.417 . . . . 10.0 111.159 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 10.8 mttp 60.84 100.52 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 O-C-N 123.634 0.584 . . . . 10.0 111.409 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.9 p -88.14 128.93 40.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.986 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.88 128.64 89.16 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.982 -0.554 . . . . 10.0 111.435 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -69.25 -9.69 26.97 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.479 2.119 . . . . 10.0 111.924 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -92.02 8.67 36.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.457 0.646 . . . . 10.0 109.484 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.532 ' ND2' ' HG2' ' A' ' 122' ' ' LYS . 5.9 t-20 -134.61 -74.52 0.47 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.229 -0.896 . . . . 10.0 109.737 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.3 m 55.87 26.5 9.77 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.881 0.697 . . . . 10.0 112.881 178.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 19.4 m -121.0 124.24 44.38 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.009 0.433 . . . . 10.0 111.12 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.445 HD13 HD13 ' A' ' 121' ' ' LEU . 24.5 mm -103.19 125.77 57.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.82 -0.627 . . . . 10.0 110.115 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.19 106.44 14.09 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.355 -0.98 . . . . 10.0 108.355 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 30.0 t -89.35 122.27 40.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.668 -0.696 . . . . 10.0 111.816 -177.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' MET . . . . . 0.456 ' HA ' ' OE1' ' A' ' 82' ' ' GLN . 26.1 mmt -122.67 117.73 26.46 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.434 -0.803 . . . . 10.0 109.486 178.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 23.1 mt -135.45 138.26 48.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.798 -0.637 . . . . 10.0 110.233 -178.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 9.0 mtpt -103.83 115.02 64.1 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.928 -0.578 . . . . 10.0 110.903 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo . . . . . 0 N--CA 1.462 -0.34 0 C-N-CA 122.053 1.835 . . . . 10.0 111.503 179.248 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.449 -0.511 0 N-CA-C 110.09 -0.337 . . . . 10.0 110.09 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 7.1 ptpp? -57.2 -34.95 69.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.38 -0.373 . . . . 10.0 111.341 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -61.65 -44.17 97.47 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.239 -0.437 . . . . 10.0 110.64 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -56.99 -48.09 79.25 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.467 0.651 . . . . 10.0 109.571 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.607 ' O ' HG12 ' B' ' 12' ' ' ILE . 42.8 mm -63.4 -47.8 90.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.145 -0.934 . . . . 10.0 110.911 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.87 -41.26 70.62 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.983 0.421 . . . . 10.0 110.824 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.8 -31.4 70.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.904 -0.589 . . . . 10.0 110.554 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.36 -33.22 67.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.181 0.515 . . . . 10.0 109.676 179.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.715 HD12 HG12 ' C' ' 12' ' ' ILE . 18.6 mm -66.08 -50.33 69.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.572 -0.74 . . . . 10.0 111.2 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 28.8 m -65.19 -32.18 57.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.804 0.335 . . . . 10.0 110.608 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 14' ' ' ASN . . . . . 0.415 ' HB2' HG11 ' B' ' 51' ' ' VAL . 41.8 t30 -68.73 -48.92 62.59 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.244 -0.435 . . . . 10.0 109.954 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 15' ' ' TYR . . . . . 0.589 ' O ' HG12 ' B' ' 19' ' ' ILE . 5.5 t80 -59.54 -43.2 93.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.235 -0.439 . . . . 10.0 110.708 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 11.4 m-30 -56.82 -45.5 82.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.773 0.32 . . . . 10.0 110.315 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 74.2 m -58.54 -42.45 87.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.903 -0.59 . . . . 10.0 111.2 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 1.5 m -70.14 -21.72 63.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.377 -0.374 . . . . 10.0 111.501 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.589 HG12 ' O ' ' B' ' 15' ' ' TYR . 34.2 mm -87.27 -39.3 12.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.873 -0.331 . . . . 10.0 110.944 -178.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 30.3 m -73.33 -32.2 36.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.61 0.243 . . . . 10.0 110.469 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -65.1 -51.43 61.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.293 -0.412 . . . . 10.0 111.109 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -84.11 -4.6 58.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.329 -0.396 . . . . 10.0 111.492 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 53.0 mttm 57.03 47.44 17.51 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.49 0.662 . . . . 10.0 111.088 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.507 ' O ' ' HE2' ' C' ' 5' ' ' LYS . 80.9 mt-10 -89.31 30.01 1.03 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.702 -0.681 . . . . 10.0 110.348 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 13.3 tt -158.78 171.38 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.764 -0.828 . . . . 10.0 108.764 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.91 155.87 39.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.753 0.311 . . . . 10.0 110.368 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -59.96 -48.0 83.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.234 -0.439 . . . . 10.0 111.072 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.59 -39.17 93.7 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.197 -0.456 . . . . 10.0 109.875 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.503 ' O ' ' HG ' ' B' ' 33' ' ' LEU . . . -66.71 -31.78 79.42 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.756 -0.656 . . . . 10.0 111.514 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.74 -38.07 89.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.648 0.261 . . . . 10.0 110.546 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -66.53 -36.52 82.88 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 108.713 -0.847 . . . . 10.0 108.713 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 32' ' ' SER . . . . . 0.64 ' HB3' ' SG ' ' C' ' 39' ' ' CYS . 2.4 m -64.79 -33.36 75.81 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.18 -0.918 . . . . 10.0 110.095 178.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 33' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' B' ' 29' ' ' GLY . 25.2 mt -73.35 -40.53 64.33 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.192 -0.458 . . . . 10.0 110.099 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 55.9 m-20 -62.75 -44.86 95.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.818 -0.628 . . . . 10.0 110.986 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.452 ' CG2' ' HG3' ' A' ' 147' ' ' MET . 11.9 p -72.22 -37.53 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 116.331 -0.395 . . . . 10.0 110.564 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.7 -35.04 79.6 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 109.621 -0.511 . . . . 10.0 109.621 178.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 37' ' ' MET . . . . . . . . . . . . . 25.0 ttm -56.18 -51.62 67.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.388 -0.824 . . . . 10.0 110.028 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 38' ' ' ASP . . . . . 0.528 ' OD1' ' HD3' ' B' ' 48' ' ' ARG . 0.7 OUTLIER -69.09 -40.11 78.62 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.45 -0.795 . . . . 10.0 110.054 -179.905 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 4.5 t -52.64 -45.45 66.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.268 -0.878 . . . . 10.0 110.6 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 75.8 mt -74.42 -44.34 48.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.51 -0.768 . . . . 10.0 111.196 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.699 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 34.6 m -57.75 -43.74 85.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.85 0.357 . . . . 10.0 110.893 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -68.67 -41.73 78.85 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.955 -0.566 . . . . 10.0 110.849 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.29 -27.96 69.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.262 -0.426 . . . . 10.0 111.807 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -104.15 0.61 29.79 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.81 0.338 . . . . 10.0 111.479 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.08 46.68 84.47 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 116.052 -0.522 . . . . 10.0 113.718 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.699 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 9.2 p90 -135.51 154.91 51.24 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 117.176 0.488 . . . . 10.0 109.953 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -71.61 141.66 49.98 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.267 0.556 . . . . 10.0 112.044 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.528 ' HD3' ' OD1' ' B' ' 38' ' ' ASP . 0.1 OUTLIER -59.31 -42.47 91.47 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.066 -0.97 . . . . 10.0 110.257 179.409 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -88.69 5.23 44.18 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.084 0.772 . . . . 10.0 113.084 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.54 3.39 11.48 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.282 0.475 . . . . 10.0 112.282 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.428 HG23 ' H ' ' B' ' 52' ' ' SER . 13.0 m -43.91 -54.38 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 113.02 0.748 . . . . 10.0 113.02 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 52' ' ' SER . . . . . 0.428 ' H ' HG23 ' B' ' 51' ' ' VAL . 18.3 m -52.88 -35.94 58.49 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 113.213 0.82 . . . . 10.0 113.213 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.28 -33.79 55.99 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.128 -1.034 . . . . 10.0 112.349 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 22.7 mt -89.5 -59.5 2.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 113.759 1.022 . . . . 10.0 113.759 -178.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 60.2 mt -66.07 -67.89 0.41 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.402 0.89 . . . . 10.0 113.402 -177.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.52 -152.51 39.52 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.456 -0.878 . . . . 10.0 111.04 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.75 23.65 3.64 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.564 0.697 . . . . 10.0 109.674 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 1.4 m -86.94 40.42 0.91 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.972 -1.013 . . . . 10.0 111.416 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 . . . . . 0 CA--C 1.531 0.218 0 CA-C-N 115.955 -0.566 . . . . 10.0 111.586 179.919 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.231 0 N-CA-C 109.69 -0.485 . . . . 10.0 109.69 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -101.56 142.82 32.36 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.934 -0.395 . . . . 10.0 109.934 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 5' ' ' LYS . . . . . 0.507 ' HE2' ' O ' ' B' ' 24' ' ' GLU . 7.2 ptpp? -62.87 -37.08 85.45 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.32 0.489 . . . . 10.0 112.32 -178.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 6' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -62.08 -43.4 98.92 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.654 0.264 . . . . 10.0 110.29 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 7' ' ' GLU . . . . . 0.487 ' O ' HD21 ' C' ' 55' ' ' LEU . 69.9 mt-10 -64.02 -49.9 70.59 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.767 -0.651 . . . . 10.0 110.249 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 8' ' ' ILE . . . . . 0.603 ' O ' HG13 ' C' ' 12' ' ' ILE . 50.0 mm -61.64 -43.72 97.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.813 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.43 -45.36 76.77 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.249 -0.432 . . . . 10.0 111.121 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.84 -34.88 79.41 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.781 -0.645 . . . . 10.0 110.867 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 1.3 mt -65.36 -32.45 74.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.573 -0.285 . . . . 10.0 110.651 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 12' ' ' ILE . . . . . 0.715 HG12 HD12 ' B' ' 12' ' ' ILE . 7.5 mt -67.71 -55.13 18.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.341 -0.391 . . . . 10.0 110.748 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 17.9 m -64.37 -30.86 51.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.812 -0.631 . . . . 10.0 111.311 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 14' ' ' ASN . . . . . 0.523 ' HB2' HG11 ' C' ' 51' ' ' VAL . 45.9 t30 -70.39 -45.72 65.41 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.126 0.488 . . . . 10.0 109.716 178.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 15' ' ' TYR . . . . . 0.6 ' CE2' HG13 ' B' ' 8' ' ' ILE . 4.7 t80 -62.84 -46.99 85.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.863 -0.608 . . . . 10.0 110.454 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -56.11 -47.58 77.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.07 -0.514 . . . . 10.0 111.356 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 37.0 m -58.92 -41.25 86.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 10.0 111.584 -179.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 3.4 p -75.21 -20.84 59.06 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.297 0.481 . . . . 10.0 112.297 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 19' ' ' ILE . . . . . 0.502 HG12 ' O ' ' C' ' 15' ' ' TYR . 20.4 mm -84.06 -35.33 10.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.771 0.32 . . . . 10.0 110.666 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 20' ' ' VAL . . . . . . . . . . . . . 29.4 m -78.7 -28.12 14.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.866 -0.333 . . . . 10.0 110.385 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.1 -50.83 62.69 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.966 0.413 . . . . 10.0 110.221 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -85.8 1.69 48.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.241 -0.436 . . . . 10.0 110.064 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 63.7 mttm 48.03 53.54 11.45 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.105 -0.952 . . . . 10.0 111.989 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -85.09 13.73 5.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.468 . . . . 10.0 110.197 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 13.5 tt -138.82 167.6 20.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.744 -0.662 . . . . 10.0 109.823 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 8.2 p -66.22 160.42 24.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.524 0.202 . . . . 10.0 110.589 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -59.69 -41.99 91.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.919 0.39 . . . . 10.0 110.53 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 28' ' ' ASP . . . . . 0.488 ' OD2' HG23 ' A' ' 81' ' ' ILE . 31.0 t70 -68.84 -39.86 79.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.971 -0.558 . . . . 10.0 109.865 179.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 29' ' ' GLY . . . . . 0.537 ' O ' ' HG ' ' C' ' 33' ' ' LEU . . . -64.57 -35.66 92.2 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.927 -0.654 . . . . 10.0 111.627 178.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.4 -45.92 91.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.345 0.593 . . . . 10.0 110.113 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -60.9 -38.22 84.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.415 -0.811 . . . . 10.0 110.025 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 3.0 t -62.09 -34.37 76.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.358 -0.837 . . . . 10.0 110.593 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 33' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' C' ' 29' ' ' GLY . 50.1 mt -74.94 -29.58 60.98 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.17 -0.468 . . . . 10.0 110.475 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -71.61 -47.57 53.82 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.428 -0.351 . . . . 10.0 110.965 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 35' ' ' VAL . . . . . 0.492 HG23 ' H ' ' A' ' 123' ' ' GLY . 2.5 p -64.16 -40.73 90.08 Favored 'Isoleucine or valine' 0 C--N 1.343 0.304 0 CA-C-O 120.684 0.278 . . . . 10.0 110.449 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.6 -35.61 79.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.847 0.356 . . . . 10.0 110.32 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 40.5 ttm -53.34 -59.89 3.99 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.585 -0.734 . . . . 10.0 111.769 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 38' ' ' ASP . . . . . 0.514 ' HB3' ' HA3' ' A' ' 123' ' ' GLY . 4.1 m-20 -65.89 -33.77 76.59 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 121.028 -0.269 . . . . 10.0 111.504 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 39' ' ' CYS . . . . . 0.64 ' SG ' ' HB3' ' B' ' 32' ' ' SER . 0.5 OUTLIER -60.86 -47.89 84.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.107 0.48 . . . . 10.0 110.064 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 40' ' ' ILE . . . . . . . . . . . . . 59.8 mt -68.34 -44.52 83.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.526 -0.761 . . . . 10.0 110.956 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 41' ' ' SER . . . . . 0.57 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 40.4 m -59.52 -45.75 90.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.063 -0.517 . . . . 10.0 111.432 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 -69.32 -40.12 77.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.312 -0.404 . . . . 10.0 110.839 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.52 -44.43 93.15 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.989 -0.55 . . . . 10.0 112.256 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 44' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -89.1 -6.82 56.77 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.633 0.254 . . . . 10.0 111.521 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.9 58.0 7.26 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 114.397 0.519 . . . . 10.0 114.397 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 46' ' ' PHE . . . . . 0.57 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 13.2 p90 -153.24 154.02 33.83 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.46 -0.57 . . . . 10.0 109.46 178.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 47' ' ' GLU . . . . . 0.432 ' HA ' ' OE1' ' C' ' 47' ' ' GLU . 0.0 OUTLIER -80.54 144.18 32.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.861 0.362 . . . . 10.0 111.155 -179.805 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 48' ' ' ARG . . . . . 0.452 ' HD3' ' OD1' ' C' ' 38' ' ' ASP . 0.0 OUTLIER -61.03 -34.94 75.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.978 -0.555 . . . . 10.0 111.001 -179.42 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.42 3.16 37.38 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.079 0.4 . . . . 10.0 112.079 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.4 1.79 47.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.805 0.336 . . . . 10.0 111.242 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 51' ' ' VAL . . . . . 0.523 HG11 ' HB2' ' C' ' 14' ' ' ASN . 5.9 m -49.72 -44.43 20.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 112.651 0.611 . . . . 10.0 112.651 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.7 -35.28 70.41 Favored 'General case' 0 C--O 1.225 -0.199 0 N-CA-C 112.461 0.541 . . . . 10.0 112.461 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.21 -28.22 58.56 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 119.712 -1.232 . . . . 10.0 112.642 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 54' ' ' ILE . . . . . . . . . . . . . 61.3 mt -89.05 -62.98 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 113.241 0.83 . . . . 10.0 113.241 -178.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 55' ' ' LEU . . . . . 0.487 HD21 ' O ' ' C' ' 7' ' ' GLU . 20.7 mt -74.81 -62.6 1.49 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.529 0.937 . . . . 10.0 113.529 -177.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.16 -119.79 6.89 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.216 -0.754 . . . . 10.0 111.216 -178.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -160.03 22.12 0.17 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.35 0.595 . . . . 10.0 110.086 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.52 44.87 1.14 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.587 -0.733 . . . . 10.0 111.617 -178.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 . . . . . 0 N--CA 1.463 0.204 0 CA-C-O 120.958 0.408 . . . . 10.0 110.785 -179.647 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.453 -0.308 0 CA-C-O 120.445 0.164 . . . . 10.0 110.68 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -91.16 124.78 35.64 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.957 -0.386 . . . . 10.0 109.957 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.6 mp -126.39 133.49 51.29 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.014 0.435 . . . . 10.0 110.861 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.419 HG23 ' HG2' ' A' ' 89' ' ' GLU . 8.8 m -102.97 117.08 33.8 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.246 -0.434 . . . . 10.0 110.701 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -85.68 107.78 17.72 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.12 0.486 . . . . 10.0 110.025 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.3 tptm -106.41 98.93 8.54 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.536 -0.756 . . . . 10.0 110.457 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -99.27 114.09 26.73 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.404 -0.362 . . . . 10.0 110.308 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 57.5 mt -84.05 -57.86 4.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.823 -0.626 . . . . 10.0 111.124 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -61.96 158.94 15.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.883 -0.598 . . . . 10.0 112.066 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -77.94 138.76 61.35 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.924 -0.58 . . . . 10.0 112.318 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -76.33 130.66 21.97 Favored 'Cis proline' 0 C--O 1.235 0.334 0 C-N-CA 123.247 -1.564 . . . . 10.0 110.619 -1.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.49 153.26 22.58 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.253 0.549 . . . . 10.0 111.459 -178.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.453 ' CE1' ' HB3' ' A' ' 110' ' ' LYS . 47.6 p90 -168.15 160.01 11.42 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.173 -0.921 . . . . 10.0 109.416 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.0 m -143.09 98.77 3.33 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.863 -0.791 . . . . 10.0 108.863 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 24.1 pt -119.75 153.44 22.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.18 -0.464 . . . . 10.0 111.048 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.419 ' HG2' HG23 ' A' ' 77' ' ' THR . 43.3 mt-10 -115.62 127.6 55.33 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 109.246 -0.649 . . . . 10.0 109.246 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.54 157.0 44.77 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.065 0.46 . . . . 10.0 110.402 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -114.54 137.79 51.44 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.126 -0.488 . . . . 10.0 109.911 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -129.75 165.09 22.6 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.251 -0.431 . . . . 10.0 110.416 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.537 ' O ' HD12 ' A' ' 132' ' ' LEU . 7.3 m -75.78 147.37 81.04 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.119 -0.492 . . . . 10.0 110.568 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.47 -22.57 59.75 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.864 2.376 . . . . 10.0 113.322 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.59 18.12 22.35 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.962 0.411 . . . . 10.0 110.791 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.47 ' HB2' ' O ' ' A' ' 93' ' ' SER . 0.3 OUTLIER -80.34 162.82 24.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.98 0.419 . . . . 10.0 110.83 179.872 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.6 m -109.38 150.77 27.56 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.976 -0.556 . . . . 10.0 111.506 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 37.8 mm -61.86 -22.05 27.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.272 0.558 . . . . 10.0 110.379 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.13 -38.45 68.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.281 -0.872 . . . . 10.0 110.418 178.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 73.3 mm-40 -62.09 -44.38 96.78 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.136 -0.484 . . . . 10.0 111.137 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.554 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 35.6 mt -63.7 -50.09 79.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.839 -0.619 . . . . 10.0 109.875 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -55.37 -44.55 76.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.626 -0.716 . . . . 10.0 110.854 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -63.73 -39.19 93.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 10.0 110.905 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -63.57 -39.81 95.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.131 -0.486 . . . . 10.0 110.918 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 101' ' ' ILE . 40.9 mt -62.13 -42.19 99.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.867 0.365 . . . . 10.0 110.478 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 48.8 mt -68.81 -44.24 82.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.439 -0.346 . . . . 10.0 110.563 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.5 m -61.07 -27.45 68.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.848 -0.615 . . . . 10.0 111.82 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -95.8 12.86 28.55 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 120.797 0.332 . . . . 10.0 111.145 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 59.76 34.43 21.96 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.696 -0.684 . . . . 10.0 111.925 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.453 ' HB3' ' CE1' ' A' ' 86' ' ' PHE . 17.5 mmtp -107.2 -7.17 16.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.324 0.583 . . . . 10.0 110.472 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.487 ' HB2' HD13 ' A' ' 148' ' ' ILE . . . -141.67 142.02 33.36 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.439 -0.8 . . . . 10.0 109.81 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.33 -41.84 17.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.728 0.299 . . . . 10.0 111.387 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.404 ' O ' HG13 ' A' ' 117' ' ' ILE . 2.6 t-80 -151.69 141.59 22.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.613 -0.267 . . . . 10.0 110.845 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.489 ' HA ' HD12 ' A' ' 117' ' ' ILE . 4.1 tt -62.21 -41.92 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 116.279 -0.419 . . . . 10.0 111.876 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.508 ' HB2' ' OE2' ' A' ' 116' ' ' GLU . 11.2 m -53.67 -17.93 2.61 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.922 0.712 . . . . 10.0 112.922 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.508 ' OE2' ' HB2' ' A' ' 115' ' ' SER . 0.9 OUTLIER -109.74 7.27 24.19 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 122.102 -0.374 . . . . 10.0 111.341 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.489 HD12 ' HA ' ' A' ' 114' ' ' ILE . 66.1 mt -93.48 120.68 43.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.635 -0.505 . . . . 10.0 109.635 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.9 mmmt -124.24 118.57 27.11 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.297 -0.41 . . . . 10.0 110.377 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.448 ' O ' ' HB2' ' A' ' 126' ' ' LEU . 3.9 mm? -95.52 110.73 22.76 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.397 -0.365 . . . . 10.0 110.757 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.647 HD21 HG11 ' B' ' 35' ' ' VAL . 2.7 mm? -101.26 107.36 18.71 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.491 -0.929 . . . . 10.0 108.491 177.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.402 HD13 HD13 ' A' ' 144' ' ' ILE . 5.0 tp -90.94 101.22 13.99 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.713 0.768 . . . . 10.0 109.278 178.313 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.431 ' HD2' ' HA ' ' A' ' 122' ' ' LYS . 13.5 tptp 52.33 56.34 7.85 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 113.957 -1.474 . . . . 10.0 109.142 -177.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.758 ' HA2' ' SG ' ' C' ' 39' ' ' CYS . . . 79.05 -43.56 2.48 Favored Glycine 0 C--O 1.228 -0.245 0 CA-C-N 114.581 -1.191 . . . . 10.0 112.509 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 22.0 tttp -58.07 119.65 7.17 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.001 -0.6 . . . . 10.0 111.351 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.4 p -72.34 136.38 25.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 113.562 0.949 . . . . 10.0 113.562 -177.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' A' ' 119' ' ' LEU . 1.5 mp -102.31 156.83 17.33 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 114.901 -1.045 . . . . 10.0 109.332 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 62.6 m-70 -116.65 152.73 33.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.061 0.458 . . . . 10.0 110.822 -178.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -52.77 -52.23 57.47 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.575 0.954 . . . . 10.0 113.575 -178.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -89.42 11.05 20.37 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.002 0.371 . . . . 10.0 112.002 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.1 tp -74.03 146.58 43.63 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.905 0.383 . . . . 10.0 111.022 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -106.54 150.56 26.01 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.927 -0.578 . . . . 10.0 110.003 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.537 HD12 ' O ' ' A' ' 93' ' ' SER . 81.4 mt -58.22 -31.73 67.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.015 0.436 . . . . 10.0 111.282 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.1 -33.08 67.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.892 -0.595 . . . . 10.0 111.218 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -77.39 -44.9 27.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.277 -0.42 . . . . 10.0 111.29 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.5 pp -74.08 -25.76 59.99 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.8 -0.36 . . . . 10.0 111.1 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt 65.1 93.01 0.07 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.238 0.542 . . . . 10.0 111.758 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.8 t -71.68 112.24 6.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.975 -0.557 . . . . 10.0 110.06 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.12 125.05 84.29 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.515 -0.311 . . . . 10.0 110.916 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.1 -12.67 36.95 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.068 2.512 . . . . 10.0 112.633 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -82.8 -0.86 49.85 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.241 0.543 . . . . 10.0 110.367 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 55.1 m-20 -131.7 -71.32 0.56 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.629 -0.714 . . . . 10.0 109.271 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 31.9 m 58.16 17.75 4.79 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.491 -0.777 . . . . 10.0 111.649 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.22 124.22 47.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.22 -0.445 . . . . 10.0 110.689 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.402 HD13 HD13 ' A' ' 121' ' ' LEU . 4.5 mm -110.96 124.4 67.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.324 -0.621 . . . . 10.0 109.324 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.54 129.99 34.99 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.684 -0.488 . . . . 10.0 109.684 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 2.2 t -107.65 131.14 58.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.349 0.595 . . . . 10.0 111.252 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' MET . . . . . 0.41 ' SD ' HD23 ' A' ' 120' ' ' LEU . 1.8 mpt? -129.72 125.31 35.63 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.201 -1.037 . . . . 10.0 108.201 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.487 HD13 ' HB2' ' A' ' 111' ' ' ALA . 47.6 mt -135.84 139.4 46.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 116.562 -0.29 . . . . 10.0 110.326 -178.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -101.69 113.72 65.78 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 109.053 -0.721 . . . . 10.0 109.053 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo . . . . . 0 C--O 1.233 0.249 0 C-N-CA 122.387 2.058 . . . . 10.0 112.863 -178.812 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 51.8 p . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 109.898 -0.408 . . . . 10.0 109.898 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 5' ' ' LYS . . . . . 0.455 ' HB2' ' CE1' ' B' ' 44' ' ' PHE . 7.8 ptpp? -57.81 -41.17 81.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.368 -0.378 . . . . 10.0 110.859 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -59.87 -50.46 73.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 10.0 111.811 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -59.1 -42.37 90.32 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.705 0.288 . . . . 10.0 110.852 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.607 ' O ' HG13 ' B' ' 12' ' ' ILE . 47.8 mm -62.02 -47.5 92.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.77 -0.455 . . . . 10.0 109.77 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.521 ' HA ' HD12 ' B' ' 12' ' ' ILE . . . -57.43 -41.99 81.5 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.75 -0.659 . . . . 10.0 111.053 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.03 -36.9 85.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.108 -0.496 . . . . 10.0 110.597 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 23.9 mt -69.64 -33.52 72.74 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.789 -0.448 . . . . 10.0 109.789 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.607 HG13 ' O ' ' B' ' 8' ' ' ILE . 86.1 mt -64.07 -57.0 13.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.984 -0.553 . . . . 10.0 111.025 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 29.4 m -59.41 -32.84 49.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.21 -0.45 . . . . 10.0 111.274 -178.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -72.19 -46.18 57.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.244 -0.434 . . . . 10.0 110.835 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' TYR . . . . . 0.545 ' O ' HG12 ' B' ' 19' ' ' ILE . 2.1 m-85 -68.89 -46.82 67.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.453 -0.34 . . . . 10.0 111.459 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -55.26 -52.15 64.34 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.683 0.278 . . . . 10.0 111.179 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 17' ' ' SER . . . . . 0.506 ' O ' ' HB2' ' B' ' 21' ' ' GLU . 18.8 p -59.53 -38.06 80.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.408 -0.36 . . . . 10.0 111.369 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 76.6 p -74.89 -20.72 59.6 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.073 0.397 . . . . 10.0 112.073 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.545 HG12 ' O ' ' B' ' 15' ' ' TYR . 25.9 mm -80.39 -42.48 21.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.165 0.507 . . . . 10.0 109.808 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 19.5 m -75.92 -27.78 18.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.775 -0.648 . . . . 10.0 110.433 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 21' ' ' GLU . . . . . 0.506 ' HB2' ' O ' ' B' ' 17' ' ' SER . 2.4 tp10 -70.06 -42.51 72.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.124 -0.489 . . . . 10.0 110.33 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 30.9 mtmt -78.36 -1.68 34.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 10.0 110.755 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 66.6 mmtt 55.73 38.84 30.61 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.745 -0.662 . . . . 10.0 110.847 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.563 ' O ' ' HE2' ' C' ' 5' ' ' LYS . 25.1 mt-10 -90.55 24.31 2.69 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.27 -0.423 . . . . 10.0 111.497 -178.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 17.6 tt -155.31 161.16 2.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.401 -0.363 . . . . 10.0 110.128 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.62 160.42 32.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.471 -0.332 . . . . 10.0 110.524 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -57.89 -46.25 85.2 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 111.738 0.273 . . . . 10.0 111.738 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -56.52 -42.08 77.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.846 0.355 . . . . 10.0 110.301 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.67 -42.67 61.9 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.021 -0.609 . . . . 10.0 111.912 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.85 -36.66 77.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.93 0.395 . . . . 10.0 110.526 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -71.82 -43.01 66.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.791 -0.64 . . . . 10.0 110.139 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 38.5 m -63.12 -38.64 91.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.69 -0.687 . . . . 10.0 110.282 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 92.7 mt -72.79 -39.27 66.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.255 -0.43 . . . . 10.0 110.316 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -61.33 -46.19 91.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.125 -0.489 . . . . 10.0 111.242 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.647 HG11 HD21 ' A' ' 120' ' ' LEU . 13.1 p -71.18 -34.62 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 116.516 -0.311 . . . . 10.0 110.342 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.12 -38.06 87.25 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.458 -0.571 . . . . 10.0 109.458 178.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' MET . . . . . . . . . . . . . 18.0 ttm -57.43 -44.46 84.69 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.688 -0.687 . . . . 10.0 110.01 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -60.88 -45.8 93.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.676 -0.693 . . . . 10.0 110.58 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 76.0 m -62.85 -40.99 99.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.0 -0.546 . . . . 10.0 110.384 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 40' ' ' ILE . . . . . 0.515 HD13 HG21 ' B' ' 12' ' ' ILE . 89.3 mt -65.32 -47.01 88.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.033 -0.53 . . . . 10.0 111.001 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.647 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 48.9 m -59.07 -42.3 90.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.86 0.362 . . . . 10.0 111.064 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -72.48 -39.46 67.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.247 -0.433 . . . . 10.0 111.232 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.59 -43.14 93.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.32 -0.4 . . . . 10.0 111.997 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 44' ' ' PHE . . . . . 0.455 ' CE1' ' HB2' ' B' ' 5' ' ' LYS . 58.0 m-85 -87.08 -4.28 59.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.679 -0.237 . . . . 10.0 111.377 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 62.46 52.22 50.66 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.238 -0.506 . . . . 10.0 113.023 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.647 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 4.7 p90 -146.58 164.46 32.55 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.241 -0.281 . . . . 10.0 110.241 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.99 148.87 21.86 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.436 -0.347 . . . . 10.0 110.496 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.411 ' HG3' ' H ' ' B' ' 48' ' ' ARG . 6.6 mtm180 -65.83 -32.92 74.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.317 0.579 . . . . 10.0 110.611 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -78.75 4.2 14.48 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.416 -0.811 . . . . 10.0 112.269 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.41 3.1 29.42 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.771 0.319 . . . . 10.0 110.386 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.537 HG23 ' H ' ' B' ' 52' ' ' SER . 0.8 OUTLIER -44.97 -64.01 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 115.54 -0.754 . . . . 10.0 112.804 -179.142 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 52' ' ' SER . . . . . 0.537 ' H ' HG23 ' B' ' 51' ' ' VAL . 0.2 OUTLIER -53.49 -30.01 39.05 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.688 0.625 . . . . 10.0 112.688 -179.901 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.14 -44.61 22.62 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.562 -0.828 . . . . 10.0 112.793 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 48.4 mt -82.58 -46.33 19.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 112.233 0.457 . . . . 10.0 112.233 -178.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 67.3 mt -73.16 -57.31 4.11 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.837 0.351 . . . . 10.0 111.071 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.72 -143.31 45.14 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.591 -0.814 . . . . 10.0 111.468 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 48.7 tttt -109.83 14.03 23.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.187 0.518 . . . . 10.0 110.213 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 5.1 m -79.34 138.54 37.74 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.842 -0.617 . . . . 10.0 110.408 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.323 -0.563 0 CA-C-O 121.049 0.452 . . . . 10.0 110.574 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.256 0 CA-C-O 120.835 0.35 . . . . 10.0 110.652 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 4' ' ' SER . . . . . . . . . . . . . 21.6 p -108.99 167.96 9.71 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.265 -0.425 . . . . 10.0 110.047 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 5' ' ' LYS . . . . . 0.563 ' HE2' ' O ' ' B' ' 24' ' ' GLU . 6.6 ptpp? -55.27 -42.28 73.33 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.445 0.535 . . . . 10.0 112.445 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 6' ' ' GLU . . . . . 0.448 ' H ' ' HG2' ' C' ' 6' ' ' GLU . 5.7 pt-20 -62.64 -38.79 91.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.497 -0.319 . . . . 10.0 111.788 -178.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -76.22 -40.64 51.62 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.619 0.247 . . . . 10.0 110.866 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 8' ' ' ILE . . . . . 0.409 HG13 ' CE1' ' B' ' 15' ' ' TYR . 17.0 mm -60.93 -46.34 96.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.33 -0.395 . . . . 10.0 110.361 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.18 -41.67 97.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.108 -0.496 . . . . 10.0 110.072 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.84 -44.61 95.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.633 -0.712 . . . . 10.0 110.811 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.35 -37.95 89.24 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.041 -0.527 . . . . 10.0 110.934 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 12' ' ' ILE . . . . . 0.405 HD13 ' O ' ' C' ' 8' ' ' ILE . 1.3 mp -68.23 -47.73 76.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.179 -0.464 . . . . 10.0 111.606 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 35.9 m -65.91 -25.16 35.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-O 121.136 0.493 . . . . 10.0 110.175 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.91 -41.91 50.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.925 -0.579 . . . . 10.0 109.778 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 15' ' ' TYR . . . . . 0.527 ' O ' HG12 ' C' ' 19' ' ' ILE . 0.5 OUTLIER -72.59 -37.44 68.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.567 -179.637 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -59.77 -47.84 84.06 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.373 -0.376 . . . . 10.0 110.787 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 17' ' ' SER . . . . . 0.491 ' O ' ' HB2' ' C' ' 21' ' ' GLU . 2.6 p -61.48 -42.42 98.75 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.645 -0.252 . . . . 10.0 110.945 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 2.0 p -68.22 -25.51 65.24 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 111.865 0.32 . . . . 10.0 111.865 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 19' ' ' ILE . . . . . 0.527 HG12 ' O ' ' C' ' 15' ' ' TYR . 20.8 mm -78.65 -42.99 25.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 121.057 0.456 . . . . 10.0 110.448 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 20' ' ' VAL . . . . . . . . . . . . . 16.1 m -77.11 -23.69 14.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.869 0.366 . . . . 10.0 110.267 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 21' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' C' ' 17' ' ' SER . 5.0 tp10 -63.51 -51.2 66.53 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.341 -0.614 . . . . 10.0 109.341 178.235 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -77.01 -5.24 47.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.04 -0.982 . . . . 10.0 111.483 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm 58.03 42.93 21.82 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.317 0.579 . . . . 10.0 109.708 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 24' ' ' GLU . . . . . 0.445 ' O ' ' HE2' ' B' ' 5' ' ' LYS . 9.0 mt-10 -81.48 3.14 25.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.547 -0.751 . . . . 10.0 110.922 -178.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 18.2 tt -141.88 152.33 18.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 109.415 -0.587 . . . . 10.0 109.415 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.33 161.41 5.61 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 123.426 0.454 . . . . 10.0 111.844 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -54.27 -42.51 70.06 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.376 -0.374 . . . . 10.0 111.113 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.37 -49.9 71.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.774 -0.648 . . . . 10.0 110.493 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 29' ' ' GLY . . . . . 0.669 ' O ' ' HG ' ' C' ' 33' ' ' LEU . . . -68.64 -44.29 72.03 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.696 -0.684 . . . . 10.0 111.979 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.54 -45.67 81.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.87 0.367 . . . . 10.0 111.163 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -62.92 -44.81 95.08 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.969 -0.559 . . . . 10.0 110.076 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 53.5 m -60.59 -40.41 91.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.634 -0.712 . . . . 10.0 110.944 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 33' ' ' LEU . . . . . 0.669 ' HG ' ' O ' ' C' ' 29' ' ' GLY . 34.9 mt -67.16 -36.66 82.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.636 -0.256 . . . . 10.0 110.538 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -58.74 -57.76 11.59 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.083 -0.508 . . . . 10.0 111.013 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 35' ' ' VAL . . . . . . . . . . . . . 3.0 p -65.39 -38.53 82.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.394 -0.366 . . . . 10.0 111.194 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.48 -32.49 70.31 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.636 0.255 . . . . 10.0 110.918 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 49.1 mtm -60.92 -44.04 97.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.244 -0.435 . . . . 10.0 110.702 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 38' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -69.68 -30.96 68.74 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 109.819 -0.438 . . . . 10.0 109.819 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 39' ' ' CYS . . . . . 0.758 ' SG ' ' HA2' ' A' ' 123' ' ' GLY . 32.0 m -63.18 -48.22 79.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.28 0.562 . . . . 10.0 109.642 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 40' ' ' ILE . . . . . . . . . . . . . 66.4 mt -66.76 -45.68 87.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.21 -0.905 . . . . 10.0 110.776 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 41' ' ' SER . . . . . 0.519 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 27.9 m -62.31 -42.12 99.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.83 -0.623 . . . . 10.0 111.7 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -68.04 -39.99 82.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.869 0.366 . . . . 10.0 110.47 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.88 -49.21 78.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.777 -0.647 . . . . 10.0 111.967 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 44' ' ' PHE . . . . . 0.506 ' CE1' ' HB2' ' C' ' 5' ' ' LYS . 86.4 m-85 -88.17 -3.2 58.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.791 0.329 . . . . 10.0 111.477 -179.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.75 64.31 4.42 Favored Glycine 0 C--N 1.331 0.253 0 CA-C-N 116.116 -0.493 . . . . 10.0 113.781 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 46' ' ' PHE . . . . . 0.519 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 13.8 p90 -153.29 157.57 40.32 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.18 -0.304 . . . . 10.0 110.18 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 19.3 mp0 -83.98 137.92 33.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.4 -0.364 . . . . 10.0 110.614 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 48' ' ' ARG . . . . . 0.404 ' H ' ' HG3' ' C' ' 48' ' ' ARG . 7.8 mtm180 -65.78 -36.24 82.96 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.503 0.668 . . . . 10.0 110.229 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -79.95 15.0 1.57 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.114 -0.948 . . . . 10.0 111.782 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -104.15 1.05 30.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.968 0.413 . . . . 10.0 110.596 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 4.1 m -45.72 -42.06 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 113.053 0.76 . . . . 10.0 113.053 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 52' ' ' SER . . . . . . . . . . . . . 1.5 m -58.16 -28.53 64.81 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.325 0.491 . . . . 10.0 112.325 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.41 -28.25 27.95 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.66 -0.781 . . . . 10.0 112.408 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 54' ' ' ILE . . . . . . . . . . . . . 35.3 mt -85.21 -62.13 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.726 0.298 . . . . 10.0 110.913 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 47.5 mt -63.2 -44.31 95.71 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.777 -0.647 . . . . 10.0 110.854 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.34 -132.71 52.09 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.942 -0.647 . . . . 10.0 112.752 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 22.1 tttt -116.96 11.41 14.32 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.931 0.396 . . . . 10.0 110.237 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 2.0 m -78.19 136.81 37.89 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.798 -0.637 . . . . 10.0 110.984 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 59' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' C' ' 59' ' ' GLU . 1.1 pm0 . . . . . 0 N--CA 1.449 -0.51 0 CA-C-O 121.049 0.452 . . . . 10.0 109.879 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.9 t . . . . . 0 N--CA 1.45 -0.462 0 N-CA-C 109.609 -0.515 . . . . 10.0 109.609 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -87.41 125.31 34.19 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.836 0.35 . . . . 10.0 110.181 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 mp -120.94 122.29 39.86 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.679 -0.489 . . . . 10.0 109.679 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.7 m -101.01 113.93 27.39 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 110.089 -0.337 . . . . 10.0 110.089 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.463 ' O ' ' HA ' ' A' ' 87' ' ' SER . 2.8 mm? -88.41 117.73 27.54 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.183 -0.303 . . . . 10.0 110.183 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -114.63 99.19 7.35 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.923 -0.58 . . . . 10.0 109.714 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 85' ' ' LYS . 19.4 tptm -88.39 113.67 24.22 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.827 -0.624 . . . . 10.0 109.963 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 96.0 mt -81.46 -54.73 9.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.65 -0.704 . . . . 10.0 111.215 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -66.67 162.98 19.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.15 -0.477 . . . . 10.0 111.722 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.91 139.09 40.0 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.123 -0.49 . . . . 10.0 111.437 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.404 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 7.9 Cg_exo -75.37 132.11 26.48 Favored 'Cis proline' 0 C--O 1.236 0.382 0 C-N-CA 123.047 -1.647 . . . . 10.0 110.378 -1.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -91.7 159.05 16.04 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.823 0.344 . . . . 10.0 111.458 -178.413 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -176.27 169.42 2.74 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.71 -0.677 . . . . 10.0 109.985 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 70.0 m -146.81 110.25 4.85 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.15 0.5 . . . . 10.0 110.184 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 33.8 pt -122.54 147.63 26.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.862 -0.608 . . . . 10.0 110.915 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -119.23 122.53 42.16 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.969 -0.56 . . . . 10.0 110.044 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -142.52 164.86 28.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.567 -0.288 . . . . 10.0 110.399 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.98 136.31 51.48 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.091 0.472 . . . . 10.0 110.565 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -126.81 170.2 12.43 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.741 -0.663 . . . . 10.0 109.684 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.568 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 5.3 m -92.31 148.27 36.2 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 109.862 -0.422 . . . . 10.0 109.862 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -51.8 -31.01 40.36 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.738 2.292 . . . . 10.0 112.683 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.75 10.84 19.45 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 112.295 0.48 . . . . 10.0 112.295 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.568 ' HB2' ' O ' ' A' ' 93' ' ' SER . 0.5 OUTLIER -81.03 152.72 27.78 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.746 -0.464 . . . . 10.0 109.746 179.111 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.17 154.39 21.26 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.156 -0.474 . . . . 10.0 110.068 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 39.3 mm -63.28 -21.87 29.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.53 0.681 . . . . 10.0 109.364 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.27 -44.04 75.24 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 114.756 -1.111 . . . . 10.0 110.474 178.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -62.79 -41.93 99.48 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.7 -0.682 . . . . 10.0 110.733 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.512 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 49.3 mt -60.64 -48.59 88.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.673 -0.694 . . . . 10.0 109.932 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.407 ' HA ' HD12 ' A' ' 105' ' ' LEU . 84.6 mttt -54.06 -43.79 70.56 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.219 -0.9 . . . . 10.0 111.609 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -62.78 -35.56 80.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.011 0.434 . . . . 10.0 110.589 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.577 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 36.1 t60 -66.08 -37.78 86.64 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.088 -0.505 . . . . 10.0 110.627 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 101' ' ' ILE . 11.3 mt -63.9 -40.12 95.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.208 0.528 . . . . 10.0 110.179 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 32.8 mt -69.97 -38.04 74.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.911 -0.586 . . . . 10.0 109.558 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 32.4 t -66.72 -22.28 66.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.396 -0.82 . . . . 10.0 111.076 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.577 ' HG2' ' O ' ' A' ' 104' ' ' HIS . 19.9 mm-40 -94.08 11.65 29.14 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 121.071 -0.252 . . . . 10.0 110.399 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 58.58 30.09 19.35 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.014 -0.539 . . . . 10.0 111.235 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.5 mmpp? -106.57 -5.67 18.58 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.127 -0.488 . . . . 10.0 110.513 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.613 ' HB2' HD13 ' A' ' 148' ' ' ILE . . . -135.54 154.44 51.38 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.711 -0.677 . . . . 10.0 109.946 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.7 m -107.81 -30.39 8.55 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.914 -0.315 . . . . 10.0 111.624 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.423 ' O ' HG13 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -152.75 136.83 16.41 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.22 -0.289 . . . . 10.0 110.22 -178.694 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.419 ' HA ' HD12 ' A' ' 117' ' ' ILE . 15.8 tt -65.77 -36.24 77.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.567 0.699 . . . . 10.0 109.983 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.533 ' HB2' ' OE2' ' A' ' 116' ' ' GLU . 0.7 OUTLIER -50.23 -34.98 24.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.278 -1.328 . . . . 10.0 113.232 179.398 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.533 ' OE2' ' HB2' ' A' ' 115' ' ' SER . 1.0 OUTLIER -99.08 12.01 37.34 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.402 0.519 . . . . 10.0 112.402 -178.707 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 113' ' ' HIS . 57.0 mt -93.71 121.07 44.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.64 -0.424 . . . . 10.0 110.5 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.1 mmmt -121.79 114.4 21.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.297 -0.41 . . . . 10.0 110.464 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.406 ' HA ' HD13 ' A' ' 119' ' ' LEU . 2.9 mm? -91.4 128.23 37.15 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.976 0.417 . . . . 10.0 111.241 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.643 HD21 HG11 ' B' ' 35' ' ' VAL . 2.8 mm? -116.01 137.43 52.12 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.982 -0.748 . . . . 10.0 108.982 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 16.5 tp -121.06 95.68 4.79 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.26 -1.015 . . . . 10.0 108.26 178.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.436 ' HD2' ' HA ' ' A' ' 122' ' ' LYS . 4.1 tptp 42.36 60.32 2.38 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.11 -0.95 . . . . 10.0 110.584 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.594 ' HA2' ' SG ' ' C' ' 39' ' ' CYS . . . 86.69 -46.05 3.52 Favored Glycine 0 C--N 1.331 0.299 0 CA-C-N 115.792 -0.64 . . . . 10.0 113.238 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.9 tttp -60.46 121.23 11.58 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 120.631 0.253 . . . . 10.0 110.554 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.472 ' HA ' HD13 ' A' ' 120' ' ' LEU . 12.8 p -79.59 136.49 23.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.097 0.475 . . . . 10.0 111.458 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.2 mp -106.03 157.31 17.61 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.041 -0.527 . . . . 10.0 111.202 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.429 ' H ' HD22 ' A' ' 130' ' ' LEU . 85.5 m-70 -116.98 158.5 24.0 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 116.315 -0.402 . . . . 10.0 110.433 -178.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.64 -48.25 82.39 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.491 -0.777 . . . . 10.0 112.143 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -82.97 5.52 21.76 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.93 -0.577 . . . . 10.0 111.162 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.429 HD22 ' H ' ' A' ' 127' ' ' HIS . 4.0 tp -73.84 139.58 45.17 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.114 0.483 . . . . 10.0 111.447 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -102.82 148.8 25.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.382 -0.826 . . . . 10.0 109.641 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 60.4 mt -56.51 -39.11 72.75 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.991 0.367 . . . . 10.0 111.991 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.8 p -75.58 -19.19 59.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.821 0.343 . . . . 10.0 111.076 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -81.28 -42.5 20.55 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.253 -0.43 . . . . 10.0 111.255 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.2 pp -82.62 -22.51 34.71 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 121.084 -0.246 . . . . 10.0 110.876 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt 67.58 88.46 0.11 Allowed 'General case' 0 N--CA 1.463 0.218 0 O-C-N 123.723 0.639 . . . . 10.0 110.755 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 30.8 t -63.72 105.85 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.613 -0.721 . . . . 10.0 110.644 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.79 117.43 35.22 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.895 -0.593 . . . . 10.0 111.403 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -67.85 -11.75 33.11 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.822 2.348 . . . . 10.0 112.718 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -88.69 6.44 38.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.507 0.67 . . . . 10.0 110.014 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -134.97 -66.35 0.59 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.193 -0.912 . . . . 10.0 109.295 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.1 m 52.71 22.92 2.45 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.205 -0.907 . . . . 10.0 112.2 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 36.4 m -123.69 125.72 45.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.05 0.452 . . . . 10.0 110.188 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.27 117.59 55.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 108.292 -1.003 . . . . 10.0 108.292 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.37 126.6 31.38 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.318 -0.623 . . . . 10.0 109.318 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.2 t -99.7 130.75 48.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.89 -0.595 . . . . 10.0 112.095 -177.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -122.64 117.71 26.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.089 -0.96 . . . . 10.0 109.257 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.613 HD13 ' HB2' ' A' ' 111' ' ' ALA . 21.1 mt -138.3 143.73 32.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.503 -0.317 . . . . 10.0 111.175 -177.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -112.2 117.98 46.72 Favored Pre-proline 0 N--CA 1.452 -0.371 0 CA-C-N 116.339 -0.391 . . . . 10.0 110.093 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo . . . . . 0 C--O 1.236 0.39 0 C-N-CA 122.535 2.157 . . . . 10.0 112.653 179.771 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 48.9 p . . . . . 0 N--CA 1.448 -0.565 0 CA-C-O 120.919 0.39 . . . . 10.0 111.008 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -59.38 -44.07 92.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.977 -0.556 . . . . 10.0 111.106 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -61.21 -47.89 84.02 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.317 -0.401 . . . . 10.0 111.133 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -57.29 -41.16 79.25 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.34 -0.391 . . . . 10.0 110.694 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.715 ' O ' HG13 ' B' ' 12' ' ' ILE . 26.0 mm -61.49 -48.43 88.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.787 -0.449 . . . . 10.0 109.787 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.22 -43.37 82.76 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.965 -0.561 . . . . 10.0 111.264 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.8 -34.44 77.91 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.025 -0.534 . . . . 10.0 110.614 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 26.0 mt -71.78 -34.11 69.16 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.164 -0.471 . . . . 10.0 110.282 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.715 HG13 ' O ' ' B' ' 8' ' ' ILE . 21.4 mt -63.5 -52.48 57.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.229 -0.441 . . . . 10.0 110.571 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.529 HG12 ' HG3' ' B' ' 37' ' ' MET . 34.4 m -63.26 -30.51 49.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 116.358 -0.383 . . . . 10.0 111.06 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -68.85 -50.46 49.69 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.969 0.414 . . . . 10.0 110.793 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' TYR . . . . . 0.503 ' O ' HG12 ' B' ' 19' ' ' ILE . 1.7 m-85 -70.66 -36.22 73.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.885 -0.598 . . . . 10.0 111.669 -178.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -61.22 -54.63 41.77 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 121.191 -0.204 . . . . 10.0 111.547 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 12.4 p -60.37 -40.07 89.46 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.712 0.264 . . . . 10.0 111.712 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 4.8 p -70.69 -23.53 62.49 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 111.846 0.313 . . . . 10.0 111.846 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.503 HG12 ' O ' ' B' ' 15' ' ' TYR . 10.8 mm -79.95 -41.57 21.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 120.955 0.407 . . . . 10.0 109.934 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 10.6 m -77.77 -29.01 15.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.842 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 21' ' ' GLU . . . . . 0.477 ' HA ' ' OE1' ' B' ' 21' ' ' GLU . 3.8 tp10 -70.03 -43.88 70.39 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.616 -0.513 . . . . 10.0 109.616 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -71.32 -8.83 56.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.125 -0.488 . . . . 10.0 110.389 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm 60.36 46.35 10.1 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.692 -0.685 . . . . 10.0 110.131 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.475 ' O ' ' HE2' ' C' ' 5' ' ' LYS . 43.1 mt-10 -96.6 13.32 28.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.139 -0.937 . . . . 10.0 110.471 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 15.0 tt -148.64 154.44 10.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.659 -0.701 . . . . 10.0 109.759 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 1.8 p -67.86 162.73 23.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.485 -0.325 . . . . 10.0 110.926 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 41.5 mp0 -56.09 -46.79 78.92 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.422 -0.354 . . . . 10.0 111.945 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -57.54 -41.22 80.53 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.19 0.519 . . . . 10.0 110.255 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.47 ' O ' ' HG ' ' B' ' 33' ' ' LEU . . . -71.29 -42.43 57.29 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.707 -0.678 . . . . 10.0 111.585 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.25 -44.76 95.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.754 -0.223 . . . . 10.0 111.239 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -69.08 -33.26 73.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.833 0.349 . . . . 10.0 110.59 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 69.4 m -65.03 -42.04 94.69 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.593 -0.521 . . . . 10.0 109.593 178.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 33' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' B' ' 29' ' ' GLY . 79.1 mt -72.51 -31.18 65.14 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.438 -0.579 . . . . 10.0 109.438 178.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -62.38 -53.6 52.53 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.463 -0.789 . . . . 10.0 110.985 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.643 HG11 HD21 ' A' ' 120' ' ' LEU . 12.0 p -73.2 -33.73 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 116.363 -0.38 . . . . 10.0 110.654 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 36' ' ' ALA . . . . . 0.45 ' O ' HG13 ' B' ' 40' ' ' ILE . . . -62.53 -43.49 98.68 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.213 -0.662 . . . . 10.0 109.213 178.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 37' ' ' MET . . . . . 0.529 ' HG3' HG12 ' B' ' 13' ' ' VAL . 15.3 ttm -56.49 -41.6 76.91 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.089 -0.96 . . . . 10.0 110.316 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -62.15 -47.63 83.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.275 -0.875 . . . . 10.0 110.532 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 17.4 m -62.3 -46.89 86.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.937 -0.574 . . . . 10.0 110.82 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 40' ' ' ILE . . . . . 0.45 HG13 ' O ' ' B' ' 36' ' ' ALA . 58.3 mt -60.35 -38.44 77.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.171 -0.468 . . . . 10.0 110.757 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.615 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 0.1 OUTLIER -59.85 -47.37 86.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 10.0 110.99 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -77.69 -23.49 49.54 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.495 -0.321 . . . . 10.0 111.39 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.21 -39.35 92.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.443 -0.344 . . . . 10.0 111.124 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -100.92 2.57 40.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.197 -0.456 . . . . 10.0 111.093 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 62.2 55.67 26.51 Favored Glycine 0 CA--C 1.519 0.289 0 CA-C-N 115.859 -0.61 . . . . 10.0 113.599 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.615 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 6.6 p90 -149.37 160.78 43.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 117.079 0.44 . . . . 10.0 110.541 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.86 150.84 20.28 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.792 -0.448 . . . . 10.0 109.792 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 1.4 mtm180 -63.8 -28.63 69.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.226 0.536 . . . . 10.0 110.73 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -78.31 7.86 5.85 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.787 -0.642 . . . . 10.0 111.691 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.32 2.89 55.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.013 0.435 . . . . 10.0 110.502 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.545 HG23 ' H ' ' B' ' 52' ' ' SER . 1.5 m -47.29 -64.02 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.248 -0.887 . . . . 10.0 112.792 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 52' ' ' SER . . . . . 0.545 ' H ' HG23 ' B' ' 51' ' ' VAL . 0.8 OUTLIER -56.33 -36.38 68.67 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.675 0.62 . . . . 10.0 112.675 -179.201 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.79 -44.99 60.23 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.818 -0.706 . . . . 10.0 112.906 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 57.8 mt -78.3 -50.44 19.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.856 0.36 . . . . 10.0 111.618 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 41.4 mt -71.18 -51.74 23.13 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.233 -0.44 . . . . 10.0 111.504 -178.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.94 -145.74 50.14 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.582 -0.818 . . . . 10.0 111.292 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 38.7 tttt -97.98 -8.98 26.89 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.005 0.431 . . . . 10.0 110.287 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.54 123.74 18.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.402 -0.817 . . . . 10.0 111.718 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 . . . . . 0 C--N 1.323 -0.564 0 CA-C-N 115.708 -0.678 . . . . 10.0 110.378 179.197 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 120.551 0.215 . . . . 10.0 110.592 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 4' ' ' SER . . . . . 0.547 ' O ' HG12 ' C' ' 8' ' ' ILE . 33.3 p -102.78 166.28 10.57 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.355 -0.384 . . . . 10.0 110.729 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 5' ' ' LYS . . . . . 0.475 ' HE2' ' O ' ' B' ' 24' ' ' GLU . 10.1 ptpp? -59.5 -39.56 84.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.246 -0.433 . . . . 10.0 110.916 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 6' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -60.87 -45.25 95.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 10.0 110.719 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -65.6 -37.36 86.4 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.304 -0.407 . . . . 10.0 110.588 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 8' ' ' ILE . . . . . 0.547 HG12 ' O ' ' C' ' 4' ' ' SER . 38.6 mm -64.85 -45.69 94.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 10.0 110.084 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.89 -45.9 85.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.918 -0.583 . . . . 10.0 110.222 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.33 -37.56 87.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.603 -0.726 . . . . 10.0 111.264 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 2.2 mt -68.33 -44.77 74.62 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.836 0.35 . . . . 10.0 110.977 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 12' ' ' ILE . . . . . . . . . . . . . 1.4 mp -63.03 -45.9 97.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.76 -0.654 . . . . 10.0 111.521 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 28.8 m -66.61 -27.76 41.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-O 120.919 0.39 . . . . 10.0 110.612 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 14' ' ' ASN . . . . . 0.428 ' HB2' HG11 ' C' ' 51' ' ' VAL . 0.3 OUTLIER -74.18 -44.03 54.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.029 -0.532 . . . . 10.0 110.358 178.909 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 15' ' ' TYR . . . . . 0.549 ' O ' HG12 ' C' ' 19' ' ' ILE . 1.1 m-85 -68.04 -37.15 81.01 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.482 -0.326 . . . . 10.0 110.298 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 5.9 m-30 -58.31 -51.33 70.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.397 -0.365 . . . . 10.0 110.657 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 1.5 p -62.44 -38.5 89.98 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.865 -0.607 . . . . 10.0 111.542 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 11.7 p -71.11 -21.33 62.23 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.743 0.306 . . . . 10.0 111.419 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 19' ' ' ILE . . . . . 0.549 HG12 ' O ' ' C' ' 15' ' ' TYR . 25.2 mm -85.71 -44.56 17.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 CA-C-O 120.941 0.4 . . . . 10.0 111.143 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 20' ' ' VAL . . . . . . . . . . . . . 35.5 m -72.66 -32.64 41.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.202 -0.454 . . . . 10.0 111.721 -177.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 21' ' ' GLU . . . . . 0.483 ' HA ' ' OE1' ' C' ' 21' ' ' GLU . 1.1 tp10 -78.6 -18.81 54.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.864 0.364 . . . . 10.0 111.098 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -95.19 -6.26 42.06 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.718 -0.475 . . . . 10.0 109.718 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm 59.11 50.81 7.66 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.355 -0.839 . . . . 10.0 110.916 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -98.62 4.2 47.99 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.541 -0.754 . . . . 10.0 111.27 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 19.9 tt -143.73 153.66 16.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.936 -0.394 . . . . 10.0 109.936 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.82 162.41 13.61 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.415 -0.357 . . . . 10.0 111.386 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -56.23 -40.74 74.59 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.182 -0.463 . . . . 10.0 111.585 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.38 -48.07 77.61 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.385 0.612 . . . . 10.0 109.96 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 29' ' ' GLY . . . . . 0.595 ' O ' ' HG ' ' C' ' 33' ' ' LEU . . . -70.33 -38.31 70.85 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.314 -0.857 . . . . 10.0 112.224 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.17 -46.79 79.19 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.52 0.2 . . . . 10.0 111.273 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -66.7 -39.29 88.02 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.823 -0.436 . . . . 10.0 109.823 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 50.7 m -59.0 -39.17 81.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.7 -0.682 . . . . 10.0 110.218 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 33' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' C' ' 29' ' ' GLY . 52.1 mt -75.68 -27.78 58.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.013 -0.539 . . . . 10.0 110.179 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -71.08 -49.92 39.33 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 116.07 -0.513 . . . . 10.0 110.816 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 35' ' ' VAL . . . . . 0.462 HG23 ' H ' ' A' ' 123' ' ' GLY . 8.9 p -67.01 -43.32 89.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-N 116.573 -0.285 . . . . 10.0 111.272 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 36' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' C' ' 39' ' ' CYS . . . -63.82 -30.99 72.02 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.886 0.374 . . . . 10.0 111.246 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 37' ' ' MET . . . . . 0.437 ' HB2' ' O ' ' C' ' 33' ' ' LEU . 26.7 ttm -59.01 -49.79 76.54 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.091 -0.504 . . . . 10.0 110.545 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 38' ' ' ASP . . . . . 0.559 ' CB ' ' HA3' ' A' ' 123' ' ' GLY . 15.2 m-20 -68.61 -26.15 65.22 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.968 -0.56 . . . . 10.0 110.623 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 39' ' ' CYS . . . . . 0.594 ' SG ' ' HA2' ' A' ' 123' ' ' GLY . 84.9 m -58.49 -46.35 86.84 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.515 0.674 . . . . 10.0 109.534 178.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 40' ' ' ILE . . . . . . . . . . . . . 6.6 mt -73.06 -39.73 57.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.244 -0.889 . . . . 10.0 110.346 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 41' ' ' SER . . . . . 0.533 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 19.7 m -60.45 -44.39 95.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.618 -0.719 . . . . 10.0 111.863 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -71.79 -41.07 68.77 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.896 -0.322 . . . . 10.0 110.772 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.75 -40.22 91.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.328 -0.396 . . . . 10.0 111.679 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 44' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -90.98 -10.73 41.28 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.52 -0.309 . . . . 10.0 111.166 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 66.22 47.85 68.94 Favored Glycine 0 CA--C 1.517 0.188 0 C-N-CA 121.238 -0.506 . . . . 10.0 112.711 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 46' ' ' PHE . . . . . 0.533 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 3.3 p90 -142.62 156.75 45.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.795 0.331 . . . . 10.0 110.6 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -89.01 142.33 27.73 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.085 -0.507 . . . . 10.0 110.133 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 48' ' ' ARG . . . . . 0.511 ' O ' HG13 ' C' ' 51' ' ' VAL . 0.1 OUTLIER -61.41 -33.52 73.84 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.128 0.489 . . . . 10.0 111.202 -179.928 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 49' ' ' GLU . . . . . 0.401 ' H ' ' CD ' ' C' ' 49' ' ' GLU . 1.7 pm0 -76.95 8.58 3.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.726 -0.67 . . . . 10.0 112.169 -179.119 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.18 1.36 57.26 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.059 0.456 . . . . 10.0 110.684 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 51' ' ' VAL . . . . . 0.511 HG13 ' O ' ' C' ' 48' ' ' ARG . 5.9 m -46.53 -46.46 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 115.282 -0.872 . . . . 10.0 112.902 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.36 -35.12 64.91 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.499 0.555 . . . . 10.0 112.499 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.9 -34.79 23.52 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.547 -0.835 . . . . 10.0 113.248 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 54' ' ' ILE . . . . . . . . . . . . . 56.1 mt -80.84 -59.17 3.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.943 0.401 . . . . 10.0 111.175 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 36.1 mt -67.12 -49.51 64.64 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.246 -0.433 . . . . 10.0 111.078 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.13 -135.3 45.83 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.993 -0.622 . . . . 10.0 112.654 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 8.9 tttt -105.45 -5.67 20.12 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.122 0.487 . . . . 10.0 110.003 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.21 130.26 44.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.667 -0.697 . . . . 10.0 111.408 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 . . . . . 0 N--CA 1.449 -0.516 0 CA-C-O 120.992 0.425 . . . . 10.0 109.946 179.318 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.3 t . . . . . 0 N--CA 1.451 -0.408 0 N-CA-C 110.278 -0.267 . . . . 10.0 110.278 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -93.79 125.31 38.34 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.539 -0.464 . . . . 10.0 110.504 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.6 mp -127.93 139.85 52.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.812 -0.631 . . . . 10.0 110.744 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.2 m -102.43 115.36 30.41 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.136 -0.484 . . . . 10.0 110.146 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 87' ' ' SER . 2.2 mm? -85.91 110.45 19.44 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.795 -0.446 . . . . 10.0 109.795 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 51.4 tttt -108.9 102.56 11.56 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.215 -0.448 . . . . 10.0 111.267 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.549 ' HG2' ' O ' ' A' ' 84' ' ' PRO . 17.8 tptm -95.88 106.13 18.23 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.952 0.406 . . . . 10.0 110.097 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 91.9 mt -73.43 -55.94 11.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.512 -0.767 . . . . 10.0 111.548 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -70.19 164.54 24.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.405 -0.361 . . . . 10.0 110.88 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.496 ' HA ' ' C ' ' A' ' 84' ' ' PRO . . . -83.75 143.2 43.27 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 111.678 0.251 . . . . 10.0 111.678 -178.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.549 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 10.8 Cg_exo -69.14 128.37 11.81 Favored 'Cis proline' 0 C--N 1.347 0.495 0 C-N-CA 123.019 -1.659 . . . . 10.0 110.585 -1.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.459 ' N ' ' HA ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -86.77 148.08 25.57 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.418 -0.355 . . . . 10.0 111.204 -178.618 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -170.73 166.0 7.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.074 -0.512 . . . . 10.0 110.065 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.432 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 38.6 m -150.39 106.31 3.43 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.585 -0.524 . . . . 10.0 109.585 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 43.9 pt -126.86 158.88 37.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.314 -0.403 . . . . 10.0 111.058 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -121.39 139.82 52.94 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.506 -0.553 . . . . 10.0 109.506 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -149.61 165.01 33.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.883 0.373 . . . . 10.0 111.357 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -110.39 124.64 52.09 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.665 -0.698 . . . . 10.0 109.863 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -118.45 171.04 8.43 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.994 -0.548 . . . . 10.0 110.512 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.582 ' O ' HD12 ' A' ' 132' ' ' LEU . 1.5 m -80.15 144.87 59.39 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.424 -0.353 . . . . 10.0 110.368 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -59.04 -15.11 26.19 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.815 2.343 . . . . 10.0 112.332 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.0 t -119.21 19.98 12.72 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 116.244 -0.435 . . . . 10.0 110.434 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 93' ' ' SER . 0.3 OUTLIER -73.15 164.7 26.31 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.149 0.499 . . . . 10.0 111.182 -179.163 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.04 147.76 35.32 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.763 -0.653 . . . . 10.0 110.429 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 38.3 mm -58.83 -24.83 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 121.518 0.675 . . . . 10.0 110.49 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.39 -39.08 60.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.912 -1.04 . . . . 10.0 111.185 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 72.7 mm-40 -66.28 -39.9 89.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 10.0 110.978 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.652 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 18.0 mt -65.01 -51.05 71.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.171 -0.468 . . . . 10.0 109.956 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 9.0 mttm -54.97 -50.46 68.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.496 -0.774 . . . . 10.0 111.759 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -62.49 -32.01 72.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.653 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.41 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 15.9 t60 -67.66 -39.17 84.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.048 -0.524 . . . . 10.0 109.999 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 101' ' ' ILE . 28.2 mt -59.71 -39.58 85.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.056 -0.52 . . . . 10.0 110.293 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 16.6 mt -72.91 -34.37 46.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 116.022 -0.536 . . . . 10.0 110.159 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.8 t -64.78 -22.79 67.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.794 -0.639 . . . . 10.0 111.128 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 104' ' ' HIS . 16.3 mm-40 -100.09 7.28 44.76 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.828 -0.434 . . . . 10.0 109.828 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 60.21 31.62 20.56 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.687 -0.688 . . . . 10.0 111.172 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -101.56 -9.22 21.19 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.385 -0.598 . . . . 10.0 109.385 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.13 148.17 52.11 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.105 -0.952 . . . . 10.0 109.96 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.34 -55.74 3.19 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.806 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.569 ' O ' HG13 ' A' ' 117' ' ' ILE . 32.7 m170 -131.39 139.12 49.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.667 -0.242 . . . . 10.0 110.949 -179.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.476 ' HA ' HD12 ' A' ' 117' ' ' ILE . 4.5 tt -64.87 -44.34 96.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.362 0.601 . . . . 10.0 110.405 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 16.3 t -52.31 -33.34 41.92 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.903 -1.044 . . . . 10.0 111.73 178.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -93.27 16.01 14.2 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.32 0.489 . . . . 10.0 112.32 -177.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.569 HG13 ' O ' ' A' ' 113' ' ' HIS . 55.2 mt -106.66 123.52 61.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.346 -0.388 . . . . 10.0 110.188 178.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -120.11 116.59 25.99 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.659 -0.497 . . . . 10.0 109.659 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -94.34 123.48 37.77 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.739 0.304 . . . . 10.0 110.216 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.502 HD21 HG11 ' B' ' 35' ' ' VAL . 2.8 mm? -109.21 141.1 41.96 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.193 -0.669 . . . . 10.0 109.193 179.164 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 24.7 tp -126.1 98.33 5.45 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.145 -1.057 . . . . 10.0 108.145 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 11.1 tptp 46.49 51.62 11.65 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.497 0.665 . . . . 10.0 110.246 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.64 ' HA3' ' CB ' ' C' ' 38' ' ' ASP . . . 89.72 -44.14 3.01 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.231 -0.895 . . . . 10.0 113.384 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.405 ' HZ2' ' CD ' ' C' ' 42' ' ' GLU . 0.4 OUTLIER -59.09 129.77 43.77 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.489 0.185 . . . . 10.0 110.88 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.448 ' HA ' HD13 ' A' ' 120' ' ' LEU . 8.8 p -82.61 139.29 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.136 0.493 . . . . 10.0 112.102 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 4.4 mp -112.46 154.37 25.95 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 115.654 -0.703 . . . . 10.0 111.055 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -117.16 159.48 22.54 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 121.763 -0.586 . . . . 10.0 112.208 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.38 -51.69 67.38 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.212 1.005 . . . . 10.0 112.229 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -83.18 6.94 17.6 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.3 -0.863 . . . . 10.0 112.194 -177.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.2 tp -79.77 148.69 31.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.928 0.394 . . . . 10.0 111.308 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -109.62 151.77 26.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.803 -0.635 . . . . 10.0 110.33 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.582 HD12 ' O ' ' A' ' 93' ' ' SER . 79.5 mt -59.09 -37.13 76.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 10.0 111.96 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.72 -17.53 60.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.086 0.47 . . . . 10.0 111.221 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -88.98 -40.06 13.29 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.176 -0.465 . . . . 10.0 110.958 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.432 HD11 HG22 ' A' ' 137' ' ' VAL . 3.0 pp -82.41 -26.44 32.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.612 -0.267 . . . . 10.0 111.301 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 26.2 mtmt 64.7 96.1 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 O-C-N 123.887 0.742 . . . . 10.0 111.131 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.432 HG22 HD11 ' A' ' 135' ' ' LEU . 6.8 t -71.83 121.03 21.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.86 -0.609 . . . . 10.0 110.632 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.76 119.73 65.75 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 10.0 110.723 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -58.72 -34.5 98.99 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.924 2.416 . . . . 10.0 113.531 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -84.41 15.84 3.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.019 0.438 . . . . 10.0 111.47 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -128.26 -74.14 0.58 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.977 -0.556 . . . . 10.0 109.853 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.2 m 58.58 9.89 1.24 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.792 -0.64 . . . . 10.0 112.639 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.8 m -109.24 123.82 49.87 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.321 0.582 . . . . 10.0 111.326 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 14.7 mm -107.61 119.23 56.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.479 -0.782 . . . . 10.0 109.984 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.4 124.53 30.75 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.856 0.36 . . . . 10.0 110.359 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.6 t -99.48 124.63 52.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.935 -0.575 . . . . 10.0 111.282 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' MET . . . . . 0.431 ' SD ' HD23 ' A' ' 120' ' ' LEU . 2.0 mpt? -122.67 121.69 37.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.884 -0.598 . . . . 10.0 110.633 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 22.0 mt -137.74 142.23 36.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.609 -0.269 . . . . 10.0 111.027 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.486 ' HD3' ' HD2' ' A' ' 150' ' ' PRO . 0.4 OUTLIER -125.99 107.86 25.08 Favored Pre-proline 0 N--CA 1.454 -0.274 0 N-CA-C 109.943 -0.391 . . . . 10.0 109.943 178.282 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.486 ' HD2' ' HD3' ' A' ' 149' ' ' LYS . 19.4 Cg_endo . . . . . 0 C--N 1.349 0.554 0 C-N-CA 122.889 2.393 . . . . 10.0 113.067 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.45 -0.432 0 N-CA-C 109.44 -0.578 . . . . 10.0 109.44 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -56.52 -46.56 80.53 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.248 -0.433 . . . . 10.0 111.438 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -56.64 -53.33 58.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.515 . . . . 10.0 112.033 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -57.24 -46.17 83.25 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.252 0.345 . . . . 10.0 110.814 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.41 ' HA ' HD13 ' B' ' 8' ' ' ILE . 17.2 mm -59.22 -45.9 92.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 10.0 110.41 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.571 ' HA ' HD12 ' B' ' 12' ' ' ILE . . . -60.64 -43.62 97.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.996 -0.547 . . . . 10.0 111.027 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.25 -36.11 82.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.035 -0.53 . . . . 10.0 110.616 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 17.7 mt -64.95 -36.25 83.79 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.343 0.592 . . . . 10.0 109.566 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.571 HD12 ' HA ' ' B' ' 9' ' ' ALA . 14.5 mt -61.42 -57.68 11.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.057 -0.974 . . . . 10.0 110.965 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.471 HG21 ' HA ' ' B' ' 48' ' ' ARG . 16.5 m -62.33 -25.98 39.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.989 0.423 . . . . 10.0 110.61 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -69.61 -51.53 34.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.777 -0.647 . . . . 10.0 110.657 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 15' ' ' TYR . . . . . 0.491 ' O ' HG12 ' B' ' 19' ' ' ILE . 2.3 m-85 -72.99 -39.67 65.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 10.0 111.844 -178.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -56.03 -50.85 69.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.67 0.271 . . . . 10.0 110.353 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 4.6 p -59.04 -46.32 88.52 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.654 -0.248 . . . . 10.0 111.338 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 6.7 p -65.06 -20.5 66.51 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.148 0.425 . . . . 10.0 112.148 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.491 HG12 ' O ' ' B' ' 15' ' ' TYR . 29.3 mm -85.05 -43.46 16.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 121.074 0.464 . . . . 10.0 110.349 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 35.2 m -75.97 -29.04 19.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.201 -0.454 . . . . 10.0 110.532 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 21' ' ' GLU . . . . . 0.534 ' HA ' ' OE1' ' B' ' 21' ' ' GLU . 1.8 tp10 -75.67 -34.79 60.48 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.269 -0.423 . . . . 10.0 110.766 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -81.86 -5.12 57.97 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.825 0.345 . . . . 10.0 110.446 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 34.0 mmtt 59.3 52.65 5.83 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.529 -0.759 . . . . 10.0 111.046 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -108.13 16.34 23.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.807 -0.633 . . . . 10.0 111.802 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -147.19 151.77 13.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 116.199 -0.455 . . . . 10.0 110.14 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 10.5 p -60.82 161.94 7.43 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.277 -0.419 . . . . 10.0 111.435 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -60.0 -49.68 76.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.074 0.464 . . . . 10.0 110.887 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.55 -42.97 93.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.427 -0.806 . . . . 10.0 110.003 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.13 -39.51 92.66 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.767 -0.73 . . . . 10.0 111.975 178.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.0 -44.55 97.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.875 0.369 . . . . 10.0 110.357 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -65.24 -35.59 81.51 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.374 -0.602 . . . . 10.0 109.374 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 47.9 m -60.95 -44.18 97.65 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 115.824 -0.625 . . . . 10.0 109.747 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 69.7 mt -72.11 -36.51 69.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.075 0.464 . . . . 10.0 110.044 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 12.7 t30 -60.02 -48.69 80.65 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.745 -0.662 . . . . 10.0 111.531 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.502 HG11 HD21 ' A' ' 120' ' ' LEU . 8.4 p -72.86 -35.61 49.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 120.85 0.357 . . . . 10.0 110.755 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.53 -39.36 93.62 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.534 -0.543 . . . . 10.0 109.534 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 37' ' ' MET . . . . . . . . . . . . . 24.1 ttm -57.79 -45.55 85.88 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.352 -0.84 . . . . 10.0 110.15 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -61.91 -42.13 98.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.562 -0.744 . . . . 10.0 110.801 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 39' ' ' CYS . . . . . 0.411 ' SG ' ' HG2' ' A' ' 147' ' ' MET . 59.3 m -63.43 -40.91 98.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.068 -0.514 . . . . 10.0 110.857 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 40' ' ' ILE . . . . . 0.557 HD13 HG21 ' B' ' 12' ' ' ILE . 55.0 mt -67.3 -40.35 84.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 110.144 -0.317 . . . . 10.0 110.144 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.644 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 9.7 m -63.1 -39.13 93.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.105 0.479 . . . . 10.0 110.081 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -70.86 -45.36 64.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.627 -0.715 . . . . 10.0 110.491 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.56 -48.66 78.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.539 -0.755 . . . . 10.0 112.547 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -83.42 -2.47 55.92 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.902 -0.319 . . . . 10.0 111.496 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 57.69 58.89 12.23 Favored Glycine 0 CA--C 1.518 0.236 0 CA-C-N 116.125 -0.489 . . . . 10.0 113.54 178.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.644 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 9.1 p90 -148.78 170.94 17.1 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.968 -0.382 . . . . 10.0 109.968 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -105.7 146.21 30.08 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.147 -0.316 . . . . 10.0 110.147 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.471 ' HA ' HG21 ' B' ' 13' ' ' VAL . 1.3 mtm180 -71.55 -26.87 62.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.278 0.561 . . . . 10.0 110.507 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -82.92 14.95 2.95 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.655 -0.702 . . . . 10.0 111.306 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -104.51 4.13 32.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.64 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -41.12 -63.52 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 114.011 1.115 . . . . 10.0 114.011 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 1.9 m -53.9 -31.86 51.46 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.578 0.584 . . . . 10.0 112.578 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.33 -41.68 30.15 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.986 -0.626 . . . . 10.0 113.352 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 19.6 mt -83.01 -43.54 18.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.999 0.428 . . . . 10.0 111.45 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 57.1 mt -71.52 -56.71 5.38 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.052 -0.522 . . . . 10.0 111.017 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.97 -150.38 45.9 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.692 -0.766 . . . . 10.0 111.298 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 32.8 tttt -103.8 2.5 32.9 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.357 0.599 . . . . 10.0 109.734 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.69 131.89 47.43 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.102 -0.954 . . . . 10.0 111.747 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.983 -0.553 . . . . 10.0 109.946 179.155 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.313 0 CA-C-O 120.823 0.344 . . . . 10.0 111.551 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 4' ' ' SER . . . . . 0.52 ' O ' HG12 ' C' ' 8' ' ' ILE . 23.0 p -98.3 163.68 12.62 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.339 -0.391 . . . . 10.0 110.213 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -57.76 -35.39 70.69 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 110.521 -0.178 . . . . 10.0 110.521 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 6' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -60.25 -49.67 76.7 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.219 0.533 . . . . 10.0 109.651 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -62.71 -42.32 99.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.365 -0.834 . . . . 10.0 110.817 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 8' ' ' ILE . . . . . 0.52 HG12 ' O ' ' C' ' 4' ' ' SER . 39.4 mm -59.15 -46.1 92.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.99 -0.55 . . . . 10.0 110.171 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 9' ' ' ALA . . . . . 0.438 ' HB1' ' CE1' ' C' ' 46' ' ' PHE . . . -59.82 -43.66 94.4 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.086 -0.506 . . . . 10.0 110.554 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.91 -40.36 94.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.025 -0.534 . . . . 10.0 111.086 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 22.3 mt -65.15 -40.47 94.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.031 -0.531 . . . . 10.0 109.76 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 12' ' ' ILE . . . . . . . . . . . . . 1.2 mp -63.15 -47.86 90.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.187 -0.915 . . . . 10.0 111.869 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 34.1 m -71.09 -25.49 25.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.669 -0.412 . . . . 10.0 111.448 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -73.27 -40.59 64.46 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.063 0.459 . . . . 10.0 109.987 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 15' ' ' TYR . . . . . 0.544 ' O ' HG12 ' C' ' 19' ' ' ILE . 9.1 m-85 -71.74 -42.85 66.76 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.12 -0.491 . . . . 10.0 110.849 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -54.27 -49.48 69.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.737 0.304 . . . . 10.0 110.508 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 17' ' ' SER . . . . . 0.496 ' O ' ' HB2' ' C' ' 21' ' ' GLU . 2.2 p -61.97 -41.66 98.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.139 -0.482 . . . . 10.0 111.4 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 3.6 p -69.36 -22.51 63.73 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 120.617 -0.433 . . . . 10.0 111.843 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 19' ' ' ILE . . . . . 0.544 HG12 ' O ' ' C' ' 15' ' ' TYR . 37.7 mm -80.83 -41.1 19.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 109.8 -0.444 . . . . 10.0 109.8 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 20' ' ' VAL . . . . . . . . . . . . . 16.8 m -77.85 -18.65 13.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.171 -0.677 . . . . 10.0 109.171 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 21' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' C' ' 17' ' ' SER . 4.1 tp10 -73.47 -50.67 20.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.551 -0.749 . . . . 10.0 110.734 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -84.07 1.09 45.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.368 -0.378 . . . . 10.0 111.782 -178.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 34.3 mmtt 55.79 46.83 21.6 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.162 0.506 . . . . 10.0 110.234 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -83.41 1.13 43.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.962 -0.563 . . . . 10.0 111.376 -178.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 16.0 tt -142.96 161.2 17.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.36 -0.607 . . . . 10.0 109.36 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 5.3 p -59.95 156.29 14.9 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.182 0.301 . . . . 10.0 110.607 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -60.76 -23.6 65.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.02 0.438 . . . . 10.0 110.337 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 28' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -68.39 -54.09 19.5 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.066 -0.716 . . . . 10.0 109.066 178.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 29' ' ' GLY . . . . . 0.42 ' O ' ' HG ' ' C' ' 33' ' ' LEU . . . -65.82 -33.05 84.74 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.318 -0.855 . . . . 10.0 110.984 178.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.72 -42.84 94.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.968 0.413 . . . . 10.0 110.441 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -68.02 -38.03 82.11 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.264 -0.643 . . . . 10.0 109.264 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 6.0 m -61.0 -43.48 98.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.407 -0.815 . . . . 10.0 110.046 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 33' ' ' LEU . . . . . 0.438 ' O ' ' HB2' ' C' ' 37' ' ' MET . 87.6 mt -71.05 -25.38 62.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.051 0.453 . . . . 10.0 110.373 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -72.25 -52.97 13.97 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.056 -0.52 . . . . 10.0 111.004 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 35' ' ' VAL . . . . . 0.53 HG23 ' H ' ' A' ' 123' ' ' GLY . 7.6 p -69.21 -39.6 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 116.421 -0.354 . . . . 10.0 110.49 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 36' ' ' ALA . . . . . 0.56 ' O ' HD12 ' C' ' 40' ' ' ILE . . . -63.75 -32.25 73.69 Favored 'General case' 0 C--O 1.226 -0.163 0 CA-C-O 120.448 0.166 . . . . 10.0 110.661 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 37' ' ' MET . . . . . 0.438 ' HB2' ' O ' ' C' ' 33' ' ' LEU . 30.6 ttm -53.92 -52.44 60.59 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.178 0.513 . . . . 10.0 110.879 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 38' ' ' ASP . . . . . 0.64 ' CB ' ' HA3' ' A' ' 123' ' ' GLY . 1.7 m-20 -70.73 -26.44 63.39 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 116.176 -0.465 . . . . 10.0 111.124 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 39' ' ' CYS . . . . . 0.505 ' SG ' ' HA2' ' A' ' 123' ' ' GLY . 77.5 m -61.09 -42.24 98.15 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.773 -0.825 . . . . 10.0 108.773 177.345 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 40' ' ' ILE . . . . . 0.56 HD12 ' O ' ' C' ' 36' ' ' ALA . 1.4 mp -70.99 -40.74 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 115.097 -0.956 . . . . 10.0 109.891 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 41' ' ' SER . . . . . 0.638 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 13.4 m -60.18 -43.9 95.51 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.686 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 42' ' ' GLU . . . . . 0.405 ' CD ' ' HZ2' ' A' ' 124' ' ' LYS . 13.4 tt0 -72.2 -42.07 66.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.187 -0.461 . . . . 10.0 111.448 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.77 -48.46 75.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.286 -0.416 . . . . 10.0 111.626 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 44' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -88.96 -1.17 57.98 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.479 -0.328 . . . . 10.0 111.378 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 59.02 57.92 17.29 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.352 -0.451 . . . . 10.0 113.184 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 46' ' ' PHE . . . . . 0.638 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 4.3 p90 -145.65 156.36 43.6 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.989 0.395 . . . . 10.0 110.172 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 26.1 mp0 -81.84 128.04 33.62 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.488 -0.324 . . . . 10.0 110.302 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.5 -17.13 58.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.55 -0.295 . . . . 10.0 111.667 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -85.15 -2.53 58.13 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 122.321 0.249 . . . . 10.0 111.583 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.8 4.96 30.59 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.763 0.653 . . . . 10.0 112.763 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 51' ' ' VAL . . . . . 0.437 HG23 ' H ' ' C' ' 52' ' ' SER . 3.6 m -42.98 -57.36 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 114.427 1.269 . . . . 10.0 114.427 -178.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 52' ' ' SER . . . . . 0.437 ' H ' HG23 ' C' ' 51' ' ' VAL . 1.2 m -61.31 -18.92 60.91 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.874 0.694 . . . . 10.0 112.874 -178.253 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.39 -48.59 4.99 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.809 -0.71 . . . . 10.0 112.953 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 54' ' ' ILE . . . . . . . . . . . . . 64.3 mt -74.66 -45.73 43.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.936 0.398 . . . . 10.0 110.311 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 45.7 mt -71.84 -47.82 50.45 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.178 0.513 . . . . 10.0 109.979 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 56.57 -137.0 48.83 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.373 -0.83 . . . . 10.0 112.371 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -111.6 24.07 13.19 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.954 -0.758 . . . . 10.0 108.954 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 6.8 m -91.7 139.92 30.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.181 -0.918 . . . . 10.0 111.006 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.324 -0.539 0 CA-C-N 116.165 -0.471 . . . . 10.0 109.84 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.6 t . . . . . 0 N--CA 1.457 -0.122 0 CA-C-O 120.594 0.235 . . . . 10.0 110.684 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -86.2 127.46 34.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.58 -0.282 . . . . 10.0 110.381 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.2 mp -127.29 129.76 48.3 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.449 -0.341 . . . . 10.0 110.5 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 20.5 m -101.32 114.18 27.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.866 -0.606 . . . . 10.0 110.402 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.489 ' O ' ' HA ' ' A' ' 87' ' ' SER . 2.0 mm? -90.54 126.1 35.82 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.727 -0.472 . . . . 10.0 109.727 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.6 tttp -130.21 106.78 8.82 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.491 -0.322 . . . . 10.0 110.746 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 82' ' ' GLN . 47.0 tttm -93.71 110.39 22.02 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.959 -0.385 . . . . 10.0 109.959 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 63.5 mt -74.92 -34.33 32.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 115.381 -0.827 . . . . 10.0 111.312 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.413 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 71.6 mt-30 -83.24 156.13 23.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.344 -0.389 . . . . 10.0 110.418 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.431 ' HA ' ' C ' ' A' ' 84' ' ' PRO . . . -78.54 138.93 58.8 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.458 -0.337 . . . . 10.0 111.421 -178.544 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.431 ' C ' ' HA ' ' A' ' 83' ' ' ALA . 17.0 Cg_exo -70.29 131.63 20.5 Favored 'Cis proline' 0 C--N 1.347 0.488 0 C-N-CA 123.613 -1.411 . . . . 10.0 112.137 -1.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -83.64 148.2 27.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.275 -0.42 . . . . 10.0 110.813 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.413 ' HZ ' HD22 ' A' ' 105' ' ' LEU . 27.8 p90 -170.07 161.86 8.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.869 0.366 . . . . 10.0 110.915 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.489 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 39.8 m -146.8 108.09 4.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.715 -0.675 . . . . 10.0 109.72 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 41.7 pt -129.35 162.33 37.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.534 -0.303 . . . . 10.0 110.532 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -125.54 137.97 53.95 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.882 0.372 . . . . 10.0 110.563 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 46.1 t60 -149.72 151.25 33.34 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.771 -0.649 . . . . 10.0 109.491 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -99.49 132.03 45.1 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.047 0.451 . . . . 10.0 110.135 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -121.25 169.29 10.71 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.041 0.448 . . . . 10.0 111.283 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.518 ' O ' HD12 ' A' ' 132' ' ' LEU . 38.2 t -81.87 144.99 52.72 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.566 -0.743 . . . . 10.0 110.194 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.62 -14.52 31.6 Favored 'Trans proline' 0 CA--C 1.531 0.33 0 C-N-CA 122.55 2.167 . . . . 10.0 111.952 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -114.51 17.44 17.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.122 -0.49 . . . . 10.0 110.486 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.476 ' HB2' ' O ' ' A' ' 93' ' ' SER . 0.2 OUTLIER -77.04 161.19 28.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.36 -0.382 . . . . 10.0 110.591 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -111.41 151.29 28.68 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.032 -0.531 . . . . 10.0 111.129 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 19.0 mm -59.81 -29.48 43.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 120.973 0.416 . . . . 10.0 110.808 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.28 -35.86 65.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.788 -0.642 . . . . 10.0 110.638 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -62.46 -44.71 95.74 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.606 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.608 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 23.3 mt -65.12 -44.3 95.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.52 -0.548 . . . . 10.0 109.52 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.597 ' HD3' HG13 ' A' ' 114' ' ' ILE . 56.1 mttt -54.46 -50.06 68.6 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.283 -0.871 . . . . 10.0 111.292 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -58.33 -40.34 81.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.941 -0.572 . . . . 10.0 111.233 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -64.07 -36.71 84.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 10.0 110.588 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.608 ' HG ' ' O ' ' A' ' 101' ' ' ILE . 44.4 mt -63.61 -38.66 91.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.969 0.414 . . . . 10.0 110.528 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 22.3 mt -72.95 -43.26 59.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.205 -0.452 . . . . 10.0 110.135 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.5 t -63.39 -21.47 66.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.758 -0.655 . . . . 10.0 111.718 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -95.23 13.27 26.06 Favored 'General case' 0 C--N 1.331 -0.197 0 O-C-N 122.341 -0.224 . . . . 10.0 111.018 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 61.6 27.99 17.32 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 123.462 0.476 . . . . 10.0 111.366 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.74 -22.7 13.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.877 0.37 . . . . 10.0 111.167 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -113.38 150.53 32.53 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.116 -0.493 . . . . 10.0 110.153 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.5 m -106.29 -18.21 14.06 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.352 -0.385 . . . . 10.0 111.579 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.478 ' HB3' ' CD ' ' A' ' 116' ' ' GLU . 0.2 OUTLIER -169.49 136.58 1.7 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.461 -0.57 . . . . 10.0 109.461 -178.5 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.597 HG13 ' HD3' ' A' ' 102' ' ' LYS . 0.8 OUTLIER -66.03 -39.83 85.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 121.191 0.519 . . . . 10.0 111.074 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.43 ' HB2' ' OE1' ' A' ' 116' ' ' GLU . 14.8 m -48.35 -44.13 34.12 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.86 -1.064 . . . . 10.0 113.209 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.478 ' CD ' ' HB3' ' A' ' 113' ' ' HIS . 0.7 OUTLIER -89.69 14.47 11.66 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.263 0.838 . . . . 10.0 113.263 -178.234 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 113' ' ' HIS . 51.5 mt -91.77 121.34 42.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.371 -0.532 . . . . 10.0 110.249 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.5 mmmt -123.54 115.06 20.92 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.739 -0.467 . . . . 10.0 109.739 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -94.6 124.88 38.9 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.151 0.501 . . . . 10.0 110.856 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.433 ' HB3' HG21 ' C' ' 35' ' ' VAL . 0.0 OUTLIER -109.85 139.51 44.85 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.538 -0.755 . . . . 10.0 109.98 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.458 HD13 HD13 ' A' ' 144' ' ' ILE . 31.9 tp -128.65 94.74 3.93 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.133 -1.432 . . . . 10.0 107.133 178.103 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 48.2 tttp 33.88 65.3 0.3 Allowed 'General case' 0 N--CA 1.464 0.274 0 O-C-N 124.261 0.976 . . . . 10.0 111.495 -177.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.49 ' HA3' ' CB ' ' C' ' 38' ' ' ASP . . . 87.41 -46.0 3.44 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.668 -0.696 . . . . 10.0 113.559 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.429 ' HE2' ' O ' ' A' ' 135' ' ' LEU . 43.1 tttp -63.04 121.23 13.06 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.683 -0.488 . . . . 10.0 109.683 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.0 p -84.11 133.84 28.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.354 0.597 . . . . 10.0 112.075 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.6 mp -100.49 152.34 20.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.647 -0.706 . . . . 10.0 110.083 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -120.93 157.44 29.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.621 0.248 . . . . 10.0 110.733 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.81 -47.32 51.45 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.628 0.973 . . . . 10.0 113.628 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -92.29 12.96 20.7 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.412 0.523 . . . . 10.0 112.412 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 130' ' ' LEU . 3.2 tp -75.36 142.35 43.16 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.103 0.478 . . . . 10.0 111.37 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -104.7 149.27 25.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.562 -0.744 . . . . 10.0 109.614 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.518 HD12 ' O ' ' A' ' 93' ' ' SER . 35.2 mt -56.79 -33.07 66.29 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.787 0.292 . . . . 10.0 111.787 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.7 p -77.7 -14.27 59.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.051 0.453 . . . . 10.0 111.101 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -90.58 -40.71 11.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.267 -0.424 . . . . 10.0 110.841 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.429 ' O ' ' HE2' ' A' ' 124' ' ' LYS . 0.7 OUTLIER -83.86 -20.61 32.82 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 121.124 -0.23 . . . . 10.0 110.915 179.701 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 30.2 mtmt 64.41 91.55 0.08 Allowed 'General case' 0 C--O 1.234 0.266 0 O-C-N 123.756 0.66 . . . . 10.0 111.268 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 29.4 t -63.55 109.4 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.93 -0.577 . . . . 10.0 110.073 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.94 122.99 88.8 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.881 -0.6 . . . . 10.0 110.923 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -66.79 -17.9 52.52 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.652 2.234 . . . . 10.0 112.056 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -87.49 2.58 50.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.892 -0.594 . . . . 10.0 110.379 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -121.76 -73.08 0.66 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.572 -0.74 . . . . 10.0 109.593 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.2 m 59.78 8.52 1.37 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.506 -0.77 . . . . 10.0 112.75 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.7 m -122.56 131.47 53.85 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.879 0.371 . . . . 10.0 111.215 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.458 HD13 HD13 ' A' ' 121' ' ' LEU . 25.0 mm -112.97 122.61 67.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.772 -0.649 . . . . 10.0 109.923 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.18 121.01 26.51 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.411 -0.588 . . . . 10.0 109.411 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 12.6 t -97.62 127.22 50.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.177 0.513 . . . . 10.0 112.033 -178.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -122.94 116.89 24.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.376 -0.829 . . . . 10.0 109.357 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 49.3 mt -138.1 143.13 33.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 110.012 -0.366 . . . . 10.0 110.012 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 25.7 mmmt -97.81 110.07 53.83 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 108.834 -0.802 . . . . 10.0 108.834 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo . . . . . 0 N--CA 1.46 -0.471 0 C-N-CA 122.434 2.089 . . . . 10.0 113.063 -178.786 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.235 0.29 0 N-CA-C 109.429 -0.582 . . . . 10.0 109.429 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -59.94 -46.63 88.77 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.946 0.35 . . . . 10.0 111.946 -178.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -59.56 -46.27 89.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.673 0.273 . . . . 10.0 111.439 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -62.24 -46.62 88.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.34 -0.391 . . . . 10.0 111.167 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.723 ' O ' HG13 ' B' ' 12' ' ' ILE . 32.0 mm -62.94 -45.27 99.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 110.041 -0.355 . . . . 10.0 110.041 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.47 -45.2 73.1 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.388 -0.369 . . . . 10.0 110.752 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.09 -36.29 83.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.864 -0.607 . . . . 10.0 110.55 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.03 -38.02 87.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.275 -0.42 . . . . 10.0 110.653 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.723 HG13 ' O ' ' B' ' 8' ' ' ILE . 13.3 mt -63.35 -55.52 22.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.252 -0.431 . . . . 10.0 111.12 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 35.3 m -64.18 -32.35 57.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.034 -0.53 . . . . 10.0 111.253 -178.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -70.03 -40.91 74.9 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.586 -0.524 . . . . 10.0 109.586 178.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' TYR . . . . . 0.619 ' O ' HG12 ' B' ' 19' ' ' ILE . 21.3 t80 -64.91 -47.8 76.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.988 -0.551 . . . . 10.0 110.08 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 14.7 m-30 -58.04 -44.09 87.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 10.0 111.077 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 70.8 m -57.54 -40.82 79.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 10.0 110.609 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 10.9 m -74.41 -20.89 59.89 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.936 -0.575 . . . . 10.0 111.621 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.619 HG12 ' O ' ' B' ' 15' ' ' TYR . 29.4 mm -79.22 -42.26 23.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.608 0.242 . . . . 10.0 110.555 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 27.0 m -79.15 -21.27 12.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.144 0.497 . . . . 10.0 109.808 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -58.15 -42.61 86.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.172 -0.922 . . . . 10.0 110.67 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 4.4 mttp -109.59 0.56 19.18 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.755 -0.657 . . . . 10.0 109.962 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 33.2 mttt 54.7 52.13 12.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.214 -0.903 . . . . 10.0 110.706 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -82.94 35.16 0.47 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.299 -0.864 . . . . 10.0 110.44 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 25' ' ' ILE . . . . . 0.446 HG12 ' N ' ' B' ' 26' ' ' SER . 12.4 tt -163.68 164.8 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.592 -0.731 . . . . 10.0 109.374 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 26' ' ' SER . . . . . 0.446 ' N ' HG12 ' B' ' 25' ' ' ILE . 0.7 OUTLIER -62.73 160.2 14.77 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.728 0.411 . . . . 10.0 111.957 -179.855 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -55.94 -55.21 35.44 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.045 -0.525 . . . . 10.0 111.681 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.75 -42.64 89.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.006 0.431 . . . . 10.0 110.159 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.527 ' O ' ' HG ' ' B' ' 33' ' ' LEU . . . -61.15 -42.77 99.89 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.698 -0.683 . . . . 10.0 112.26 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.37 -38.76 88.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.024 0.44 . . . . 10.0 110.437 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -68.33 -35.84 78.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.707 -0.679 . . . . 10.0 109.875 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 14.6 m -65.85 -38.46 88.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.669 -0.696 . . . . 10.0 110.024 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 33' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' B' ' 29' ' ' GLY . 53.9 mt -70.63 -31.81 68.91 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.0 0.429 . . . . 10.0 109.903 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -61.38 -51.76 67.43 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.743 -0.662 . . . . 10.0 110.685 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 12.2 p -70.25 -32.77 51.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.902 -0.59 . . . . 10.0 110.831 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.6 -45.43 86.99 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 109.245 -0.65 . . . . 10.0 109.245 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 37' ' ' MET . . . . . . . . . . . . . 6.0 ttm -59.91 -37.98 80.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.707 -0.679 . . . . 10.0 109.636 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -66.78 -51.59 53.96 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.914 -1.039 . . . . 10.0 111.278 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.66 -33.41 75.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.49 -0.323 . . . . 10.0 111.642 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 50.6 mt -66.99 -46.27 85.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 110.133 -0.321 . . . . 10.0 110.133 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.526 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 28.7 m -59.4 -33.3 71.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.204 0.526 . . . . 10.0 109.982 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -74.38 -47.26 35.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.548 -0.751 . . . . 10.0 110.874 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.16 -37.5 85.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.088 -0.505 . . . . 10.0 112.258 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -94.0 -4.03 50.37 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 121.014 -0.274 . . . . 10.0 111.553 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.57 59.99 9.76 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 121.399 -0.429 . . . . 10.0 113.517 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.526 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 7.1 p90 -153.1 165.04 36.87 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.994 -0.372 . . . . 10.0 109.994 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -101.22 135.25 43.0 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.769 0.319 . . . . 10.0 111.382 -179.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.53 -20.45 64.66 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.101 -0.5 . . . . 10.0 111.623 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -83.17 -15.49 50.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.86 0.362 . . . . 10.0 111.303 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.6 3.54 47.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.365 -0.379 . . . . 10.0 111.748 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 2.6 m -47.24 -49.23 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 112.778 0.659 . . . . 10.0 112.778 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -50.61 -34.16 24.98 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 113.367 0.877 . . . . 10.0 113.367 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.63 -27.49 50.89 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.813 -0.708 . . . . 10.0 112.616 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 49.6 mt -87.02 -50.71 13.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.031 0.443 . . . . 10.0 111.976 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 69.1 mt -81.45 -67.4 0.78 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.106 -0.497 . . . . 10.0 112.228 -178.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.23 -129.06 8.81 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.567 -0.825 . . . . 10.0 111.044 -178.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -158.33 23.27 0.24 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.429 0.633 . . . . 10.0 110.012 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.1 32.88 0.89 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.507 -0.769 . . . . 10.0 111.466 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 . . . . . 0 N--CA 1.464 0.239 0 CA-C-N 115.713 -0.676 . . . . 10.0 111.978 179.856 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 110.021 -0.363 . . . . 10.0 110.021 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 4' ' ' SER . . . . . 0.535 ' O ' HG12 ' C' ' 8' ' ' ILE . 0.0 OUTLIER -89.42 137.79 32.02 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.386 -0.37 . . . . 10.0 110.719 -179.491 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 5' ' ' LYS . . . . . 0.519 ' HE3' HD12 ' B' ' 19' ' ' ILE . 49.5 mttp -63.77 -45.24 90.67 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.708 0.289 . . . . 10.0 110.486 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 6' ' ' GLU . . . . . 0.487 ' HB3' HG21 ' C' ' 54' ' ' ILE . 7.5 mt-10 -54.47 -57.19 12.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.577 -0.738 . . . . 10.0 111.299 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 7' ' ' GLU . . . . . 0.55 ' HG3' ' O ' ' C' ' 54' ' ' ILE . 1.5 mp0 -61.61 -39.38 91.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.76 -0.654 . . . . 10.0 112.272 -179.4 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 8' ' ' ILE . . . . . 0.535 HG12 ' O ' ' C' ' 4' ' ' SER . 27.2 mm -66.7 -47.93 81.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.89 0.376 . . . . 10.0 110.247 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.48 -42.05 95.47 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.088 -0.505 . . . . 10.0 110.1 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.68 -40.46 92.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.621 -0.718 . . . . 10.0 110.926 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.5 -33.82 76.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.931 0.396 . . . . 10.0 110.392 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 12' ' ' ILE . . . . . 0.468 HG13 HG12 ' B' ' 12' ' ' ILE . 1.2 mp -70.89 -48.3 57.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.064 -0.516 . . . . 10.0 111.064 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 26.8 m -65.69 -28.03 43.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-O 121.218 0.532 . . . . 10.0 110.05 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -73.25 -39.77 65.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.66 -0.7 . . . . 10.0 109.382 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 15' ' ' TYR . . . . . 0.471 ' O ' HG12 ' C' ' 19' ' ' ILE . 32.7 t80 -68.89 -43.49 75.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 10.0 110.308 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 10.1 m-30 -55.63 -46.88 77.36 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.171 -0.468 . . . . 10.0 110.412 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 19.9 m -60.84 -43.89 97.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.868 -0.605 . . . . 10.0 111.364 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 12.7 m -67.67 -22.67 65.29 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.982 0.364 . . . . 10.0 111.982 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 19' ' ' ILE . . . . . 0.471 HG12 ' O ' ' C' ' 15' ' ' TYR . 29.5 mm -82.62 -39.7 16.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.589 0.233 . . . . 10.0 111.052 -179.111 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 20' ' ' VAL . . . . . . . . . . . . . 13.6 m -77.5 -23.69 14.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.289 0.566 . . . . 10.0 109.814 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -66.86 -48.08 69.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.122 -0.944 . . . . 10.0 111.018 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 33.7 mttp -91.12 -5.49 55.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.676 -0.238 . . . . 10.0 110.911 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 64.6 mttm 63.72 49.33 2.99 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.82 -0.627 . . . . 10.0 110.825 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -81.94 -5.44 58.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.894 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 12.7 tt -131.62 162.34 39.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.545 -0.539 . . . . 10.0 109.545 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.09 153.62 11.25 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 122.59 0.356 . . . . 10.0 111.156 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -58.4 -40.2 81.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.852 0.358 . . . . 10.0 110.858 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 28' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -67.12 -40.81 86.87 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.183 0.516 . . . . 10.0 109.697 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 29' ' ' GLY . . . . . 0.517 ' O ' ' HG ' ' C' ' 33' ' ' LEU . . . -65.16 -33.18 86.26 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.514 -0.766 . . . . 10.0 111.23 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.32 -39.63 95.08 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.815 -0.439 . . . . 10.0 109.815 178.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -63.17 -35.76 81.38 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.89 -0.596 . . . . 10.0 109.666 178.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 1.2 t -65.66 -43.83 88.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.494 -0.775 . . . . 10.0 109.81 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 33' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' C' ' 29' ' ' GLY . 43.5 mt -66.93 -34.52 77.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.074 0.464 . . . . 10.0 109.765 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -60.89 -50.43 73.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.388 -0.823 . . . . 10.0 110.94 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 35' ' ' VAL . . . . . 0.433 HG21 ' HB3' ' A' ' 120' ' ' LEU . 12.2 p -71.86 -36.29 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 116.425 -0.352 . . . . 10.0 111.416 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.13 -33.34 74.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.875 0.369 . . . . 10.0 110.462 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 34.7 ttm -53.83 -59.96 3.94 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.643 -0.708 . . . . 10.0 111.036 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 38' ' ' ASP . . . . . 0.578 ' OD2' ' HD3' ' C' ' 48' ' ' ARG . 3.3 m-20 -67.03 -27.19 67.2 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.243 -0.435 . . . . 10.0 111.139 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 39' ' ' CYS . . . . . 0.415 ' N ' ' HA2' ' A' ' 123' ' ' GLY . 1.1 t -65.04 -49.12 71.38 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.047 0.451 . . . . 10.0 110.48 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 40' ' ' ILE . . . . . . . . . . . . . 53.6 mt -66.94 -38.28 81.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.735 -0.666 . . . . 10.0 109.837 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 41' ' ' SER . . . . . 0.722 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 35.5 m -62.21 -47.22 85.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.546 -0.752 . . . . 10.0 110.716 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -65.1 -40.94 95.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.165 -0.471 . . . . 10.0 110.724 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.97 -43.92 91.42 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.519 0.562 . . . . 10.0 112.519 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 44' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -94.82 -2.47 50.8 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.969 0.359 . . . . 10.0 111.969 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.75 53.02 12.65 Favored Glycine 0 CA--C 1.52 0.387 0 N-CA-C 114.4 0.52 . . . . 10.0 114.4 178.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 46' ' ' PHE . . . . . 0.722 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 30.2 p90 -144.67 157.11 44.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 117.165 0.483 . . . . 10.0 110.473 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -83.18 146.15 28.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.528 -0.306 . . . . 10.0 110.298 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 48' ' ' ARG . . . . . 0.578 ' HD3' ' OD2' ' C' ' 38' ' ' ASP . 0.0 OUTLIER -61.91 -28.91 69.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.379 0.609 . . . . 10.0 110.578 179.619 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 49' ' ' GLU . . . . . 0.438 ' C ' ' H ' ' C' ' 51' ' ' VAL . 4.3 mp0 -84.91 18.88 2.28 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.437 -0.801 . . . . 10.0 112.393 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.1 8.26 0.22 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.941 0.896 . . . . 10.0 112.695 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 51' ' ' VAL . . . . . 0.438 ' H ' ' C ' ' C' ' 49' ' ' GLU . 3.5 m -34.67 -38.61 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 N-CA-C 117.708 2.484 . . . . 10.0 117.708 -176.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 52' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.17 -54.03 4.42 Favored 'General case' 0 C--O 1.217 -0.63 0 N-CA-C 118.653 2.834 . . . . 10.0 118.653 -175.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.11 -56.87 9.43 Favored Glycine 0 CA--C 1.494 -1.254 0 C-N-CA 119.869 -1.158 . . . . 10.0 115.799 -171.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 54' ' ' ILE . . . . . 0.55 ' O ' ' HG3' ' C' ' 7' ' ' GLU . 0.5 OUTLIER -82.0 -35.18 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 C-N-CA 119.847 -0.741 . . . . 10.0 110.561 -179.355 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.4 -75.38 0.33 Allowed 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 116.101 1.889 . . . . 10.0 116.101 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.36 -145.71 49.12 Favored Glycine 0 N--CA 1.471 1.014 0 C-N-CA 121.538 -0.363 . . . . 10.0 112.437 -177.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -150.44 22.46 0.82 Allowed 'General case' 0 C--O 1.233 0.186 0 N-CA-C 109.541 -0.541 . . . . 10.0 109.541 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.12 42.36 0.65 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.529 -0.76 . . . . 10.0 112.043 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 . . . . . 0 N--CA 1.467 0.38 0 CA-C-O 121.61 0.719 . . . . 10.0 111.613 -179.868 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 15.4 t . . . . . 0 N--CA 1.454 -0.227 0 N-CA-C 109.811 -0.44 . . . . 10.0 109.811 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -91.87 122.38 34.34 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.835 0.35 . . . . 10.0 110.569 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.1 mp -125.38 121.36 33.65 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.388 -0.369 . . . . 10.0 110.432 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.6 m -93.97 113.17 25.11 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 120.829 0.347 . . . . 10.0 110.202 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.562 ' O ' ' HA ' ' A' ' 87' ' ' SER . 2.6 mm? -84.94 119.33 25.25 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.948 -0.569 . . . . 10.0 109.771 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -121.16 100.89 7.31 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.131 0.491 . . . . 10.0 110.921 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 84' ' ' PRO . 20.5 tptm -87.13 114.86 24.1 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.579 -0.737 . . . . 10.0 110.757 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 16.0 mt -77.66 -66.41 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 O-C-N 123.915 0.759 . . . . 10.0 111.285 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -60.43 160.8 8.24 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.893 -0.594 . . . . 10.0 111.323 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.454 ' HA ' ' C ' ' A' ' 84' ' ' PRO . . . -86.02 143.13 36.95 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.225 -0.443 . . . . 10.0 111.134 -178.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.454 ' C ' ' HA ' ' A' ' 83' ' ' ALA . 43.7 Cg_endo -71.6 127.54 12.64 Favored 'Cis proline' 0 C--N 1.346 0.423 0 C-N-CA 123.068 -1.638 . . . . 10.0 111.202 -0.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.445 ' N ' ' HA ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -93.34 158.58 15.67 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.175 -0.466 . . . . 10.0 112.001 -178.627 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -178.96 172.4 1.3 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.318 -0.856 . . . . 10.0 109.316 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 66.4 m -152.95 110.34 3.53 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.899 0.381 . . . . 10.0 110.301 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.8 pt -119.15 158.82 20.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.875 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -114.81 113.9 24.84 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.085 -0.709 . . . . 10.0 109.085 179.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -129.51 147.88 51.36 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.175 0.512 . . . . 10.0 110.415 -178.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.91 130.65 53.82 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.862 -0.608 . . . . 10.0 109.368 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -121.39 171.6 8.65 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.09 0.472 . . . . 10.0 111.425 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.577 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 0.7 OUTLIER -80.02 151.2 72.92 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.732 -0.667 . . . . 10.0 110.977 -179.779 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -65.39 -16.73 55.59 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 122.311 2.007 . . . . 10.0 112.504 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.1 m -110.72 15.52 21.9 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.434 -0.58 . . . . 10.0 109.434 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.577 ' HB2' ' O ' ' A' ' 93' ' ' SER . 0.3 OUTLIER -75.38 161.81 28.93 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.699 -0.682 . . . . 10.0 110.806 -179.759 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.97 157.82 26.04 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.605 -0.725 . . . . 10.0 110.886 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.542 ' O ' ' HG3' ' A' ' 102' ' ' LYS . 41.2 mm -67.25 -22.29 28.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.343 -0.614 . . . . 10.0 109.343 178.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.42 -38.73 71.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.205 -0.907 . . . . 10.0 110.141 178.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -68.24 -40.61 81.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.035 -0.529 . . . . 10.0 110.996 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.531 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 51.7 mt -62.26 -47.26 93.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.796 -0.638 . . . . 10.0 109.588 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.542 ' HG3' ' O ' ' A' ' 98' ' ' ILE . 79.9 mttt -55.46 -44.4 76.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.927 -1.033 . . . . 10.0 111.436 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.487 ' OE1' ' HA ' ' A' ' 103' ' ' GLN . 10.0 mm-40 -62.26 -37.67 86.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.62 -0.264 . . . . 10.0 111.21 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -65.11 -39.77 93.61 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.906 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 101' ' ' ILE . 34.2 mt -63.03 -44.75 95.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.097 -0.501 . . . . 10.0 111.397 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 102' ' ' LYS . 12.6 mt -67.94 -42.21 85.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.121 -0.49 . . . . 10.0 111.404 -178.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 49.8 m -69.84 -9.89 56.44 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.013 0.375 . . . . 10.0 112.013 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -107.72 16.12 23.95 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 121.104 -0.238 . . . . 10.0 110.895 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 58.83 26.35 14.69 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.707 -0.679 . . . . 10.0 111.673 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.6 mmpp? -96.36 -16.48 21.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.369 0.604 . . . . 10.0 110.069 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.689 ' HB2' HD13 ' A' ' 148' ' ' ILE . . . -137.08 166.52 23.5 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.294 -0.866 . . . . 10.0 110.349 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.6 m -108.18 -49.46 3.19 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.766 0.317 . . . . 10.0 110.94 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.488 ' O ' HG13 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -136.87 139.01 41.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.138 -179.45 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.435 ' HB ' HD11 ' A' ' 106' ' ' ILE . 6.0 tt -64.07 -39.06 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.513 0.673 . . . . 10.0 109.865 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.0 m -52.39 -27.93 17.67 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.321 -1.309 . . . . 10.0 112.45 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.23 -4.56 38.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.71 0.291 . . . . 10.0 111.417 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 113' ' ' HIS . 59.1 mt -89.75 127.11 42.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.022 0.439 . . . . 10.0 110.945 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.62 128.83 20.99 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.544 -0.91 . . . . 10.0 108.544 177.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.433 HD12 HG22 ' A' ' 144' ' ' ILE . 4.2 mm? -91.24 136.69 32.92 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.387 0.613 . . . . 10.0 111.21 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.542 ' HG ' HG22 ' C' ' 35' ' ' VAL . 3.7 tp -110.46 126.45 54.35 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.78 -1.1 . . . . 10.0 108.633 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 47.3 tp -113.76 93.04 4.19 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 106.624 -1.621 . . . . 10.0 106.624 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.42 ' HD3' ' HA ' ' A' ' 122' ' ' LYS . 2.7 tppp? 38.68 60.98 1.27 Allowed 'General case' 0 CA--C 1.539 0.546 0 O-C-N 123.944 0.778 . . . . 10.0 110.587 -177.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.504 ' HA3' ' CB ' ' C' ' 38' ' ' ASP . . . 87.95 -45.87 3.36 Favored Glycine 0 C--N 1.332 0.349 0 CA-C-N 115.544 -0.753 . . . . 10.0 113.999 -178.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.2 tttp -59.76 118.65 6.4 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 110.189 -0.3 . . . . 10.0 110.189 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.4 p -78.99 137.18 22.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.62 0.724 . . . . 10.0 112.205 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.432 ' HG ' HD23 ' A' ' 130' ' ' LEU . 6.8 mp -104.34 156.91 17.52 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 114.824 -1.08 . . . . 10.0 110.624 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -116.26 164.17 14.9 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.004 0.43 . . . . 10.0 112.005 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -55.15 -56.04 24.43 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 114.071 1.137 . . . . 10.0 114.071 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -91.72 14.7 14.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.864 0.364 . . . . 10.0 111.322 -178.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.432 HD23 ' HG ' ' A' ' 126' ' ' LEU . 15.1 tp -68.22 139.84 56.05 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.718 0.294 . . . . 10.0 110.501 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -97.4 145.24 26.36 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.261 -0.427 . . . . 10.0 110.484 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.482 HD12 ' O ' ' A' ' 93' ' ' SER . 10.7 mt -54.03 -38.75 65.5 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.747 0.647 . . . . 10.0 112.747 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.35 -17.14 56.92 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.817 0.303 . . . . 10.0 111.817 -179.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -79.13 -45.8 19.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.833 0.349 . . . . 10.0 110.278 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.7 pp -77.01 -23.7 52.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.875 -0.602 . . . . 10.0 110.81 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.2 mtmt 65.89 90.57 0.09 Allowed 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.618 0.574 . . . . 10.0 111.767 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.5 t -68.2 103.63 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.812 -0.631 . . . . 10.0 109.923 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.39 135.38 86.54 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.975 -0.557 . . . . 10.0 111.007 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -68.8 -22.23 37.14 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.224 1.95 . . . . 10.0 110.973 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -78.53 -3.55 44.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.306 -0.861 . . . . 10.0 110.485 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -122.69 -83.65 0.66 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.934 -0.575 . . . . 10.0 110.093 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.2 m 61.01 3.14 0.63 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.715 -0.675 . . . . 10.0 112.198 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.5 m -102.32 114.54 28.79 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-O 120.96 0.41 . . . . 10.0 110.044 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.433 HG22 HD12 ' A' ' 119' ' ' LEU . 1.4 mm -104.92 109.03 26.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 108.287 -1.005 . . . . 10.0 108.287 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.441 ' OG1' HG21 ' C' ' 35' ' ' VAL . 0.0 OUTLIER -79.6 122.03 26.0 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.653 -0.869 . . . . 10.0 108.653 -179.172 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.0 t -91.43 121.83 42.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.414 -0.812 . . . . 10.0 111.431 -177.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 81.5 mmm -115.56 113.96 24.31 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.008 -0.996 . . . . 10.0 109.732 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.689 HD13 ' HB2' ' A' ' 111' ' ' ALA . 11.3 mt -139.35 144.38 29.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.579 -0.737 . . . . 10.0 111.465 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -107.96 120.9 45.57 Favored Pre-proline 0 C--N 1.321 -0.656 0 N-CA-C 108.134 -1.062 . . . . 10.0 108.134 178.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo . . . . . 0 N--CA 1.462 -0.353 0 C-N-CA 122.332 2.022 . . . . 10.0 112.434 -179.109 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 109.985 -0.376 . . . . 10.0 109.985 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 5' ' ' LYS . . . . . 0.406 ' HG2' ' H ' ' B' ' 5' ' ' LYS . 4.4 ptpp? -60.35 -40.88 92.27 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.456 -0.338 . . . . 10.0 111.577 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -58.3 -43.13 87.94 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.858 0.361 . . . . 10.0 110.534 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -66.91 -46.19 75.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.03 -0.532 . . . . 10.0 111.424 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.449 ' O ' HD13 ' B' ' 12' ' ' ILE . 32.5 mm -65.0 -46.09 92.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.747 0.308 . . . . 10.0 110.532 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.76 -43.72 81.05 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.015 0.436 . . . . 10.0 110.622 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.59 -34.82 77.8 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.687 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.57 -35.73 77.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.911 0.386 . . . . 10.0 110.282 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.516 HG12 HG23 ' C' ' 12' ' ' ILE . 1.6 mp -68.23 -50.55 56.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.775 -0.648 . . . . 10.0 111.138 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 31.4 m -63.92 -32.28 56.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 N-CA-C 109.694 -0.484 . . . . 10.0 109.694 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -64.18 -53.46 48.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.571 -0.741 . . . . 10.0 109.843 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 15' ' ' TYR . . . . . 0.603 ' O ' HG12 ' B' ' 19' ' ' ILE . 39.1 t80 -60.3 -48.16 82.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.766 -0.652 . . . . 10.0 111.217 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 10.1 m-30 -53.95 -47.74 70.97 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.813 0.34 . . . . 10.0 110.526 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 50.7 m -57.5 -36.45 71.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.18 -0.464 . . . . 10.0 111.247 178.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 1.2 m -74.84 -19.29 60.23 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.268 -0.423 . . . . 10.0 111.193 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.603 HG12 ' O ' ' B' ' 15' ' ' TYR . 35.8 mm -81.39 -43.01 20.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.392 -0.367 . . . . 10.0 111.549 -178.028 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 16.8 m -76.26 -25.89 16.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.232 0.539 . . . . 10.0 109.93 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -62.12 -43.92 97.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.264 -0.88 . . . . 10.0 111.344 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -102.61 4.33 38.24 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.894 -0.323 . . . . 10.0 110.433 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 54.0 mttm 52.07 54.85 10.11 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 115.454 -0.794 . . . . 10.0 110.675 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -88.82 25.54 1.75 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.34 -0.846 . . . . 10.0 110.8 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 15.9 tt -161.7 164.02 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.756 -0.656 . . . . 10.0 109.405 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 2.4 p -64.5 155.64 32.19 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.627 -0.26 . . . . 10.0 111.175 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -59.07 -42.31 90.06 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.927 0.394 . . . . 10.0 110.901 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -59.93 -41.37 91.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.789 -0.641 . . . . 10.0 109.948 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.426 ' O ' ' HG ' ' B' ' 33' ' ' LEU . . . -73.09 -34.7 58.16 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.805 -0.712 . . . . 10.0 111.583 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.37 -42.76 99.23 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-O 120.822 0.344 . . . . 10.0 110.542 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -63.6 -41.14 98.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.233 0.54 . . . . 10.0 109.597 178.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 42.4 m -61.8 -46.38 89.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.243 -0.89 . . . . 10.0 110.923 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 33' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' B' ' 29' ' ' GLY . 68.5 mt -68.52 -30.27 69.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.381 -0.372 . . . . 10.0 110.938 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -65.63 -51.93 55.81 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.35 -0.386 . . . . 10.0 111.048 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 14.6 p -67.09 -33.92 66.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.916 -0.584 . . . . 10.0 110.538 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.79 -42.1 91.14 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.647 -0.501 . . . . 10.0 109.647 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 37' ' ' MET . . . . . 0.586 ' SD ' ' HD2' ' B' ' 48' ' ' ARG . 11.0 ttm -56.5 -53.02 62.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.259 -0.882 . . . . 10.0 110.354 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.66 -46.41 88.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 10.0 111.42 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 50.2 t -58.08 -44.68 87.68 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.513 -0.312 . . . . 10.0 111.749 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 87.5 mt -64.66 -39.0 84.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.269 0.557 . . . . 10.0 109.92 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.424 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 24.3 m -64.75 -40.32 95.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.597 -0.729 . . . . 10.0 110.442 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -75.82 -24.78 55.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.468 -0.333 . . . . 10.0 110.847 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.86 -33.38 66.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.052 -0.522 . . . . 10.0 111.09 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -102.36 -3.23 27.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.879 0.371 . . . . 10.0 111.241 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 66.48 59.65 7.03 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 114.466 0.547 . . . . 10.0 114.466 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.424 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 22.0 p90 -154.16 159.83 41.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 117.271 0.536 . . . . 10.0 110.335 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -86.52 144.06 27.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.879 0.371 . . . . 10.0 110.766 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.586 ' HD2' ' SD ' ' B' ' 37' ' ' MET . 3.1 mtm180 -64.88 -25.9 68.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.053 -0.522 . . . . 10.0 110.685 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 55.7 mp0 -85.07 -8.47 58.66 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.15 -0.477 . . . . 10.0 112.118 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.11 2.68 17.16 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 111.937 0.347 . . . . 10.0 111.937 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 13.4 m -45.63 -53.16 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 113.06 0.763 . . . . 10.0 113.06 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 1.4 m -49.68 -41.59 43.5 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.321 0.86 . . . . 10.0 113.321 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.77 -29.55 65.15 Favored Glycine 0 C--O 1.23 -0.139 0 C-N-CA 120.686 -0.769 . . . . 10.0 112.456 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 25.5 mt -87.96 -51.0 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 112.902 0.705 . . . . 10.0 112.902 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 26.3 mt -82.29 -69.32 0.63 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.136 0.791 . . . . 10.0 113.136 -177.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.0 -132.91 11.44 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.618 -0.801 . . . . 10.0 111.701 -178.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -156.94 29.94 0.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.394 0.616 . . . . 10.0 109.942 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.03 30.48 1.61 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.39 -0.823 . . . . 10.0 111.361 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 . . . . . 0 C--O 1.235 0.324 0 CA-C-N 115.838 -0.619 . . . . 10.0 110.208 -178.903 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.427 0 N-CA-C 109.57 -0.53 . . . . 10.0 109.57 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 4' ' ' SER . . . . . 0.503 ' HB2' ' OE1' ' C' ' 7' ' ' GLU . 0.8 OUTLIER -96.98 154.2 17.45 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.727 0.298 . . . . 10.0 110.695 -178.016 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 5' ' ' LYS . . . . . 0.457 ' HB3' ' CE1' ' C' ' 44' ' ' PHE . 17.7 mttp -61.78 -40.99 97.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.083 -0.508 . . . . 10.0 111.757 -178.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 6' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -57.9 -57.94 10.56 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.459 0.474 . . . . 10.0 110.374 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 7' ' ' GLU . . . . . 0.503 ' OE1' ' HB2' ' C' ' 4' ' ' SER . 2.6 mp0 -55.79 -44.91 78.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.684 -0.689 . . . . 10.0 111.772 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 8' ' ' ILE . . . . . 0.65 ' O ' HG13 ' C' ' 12' ' ' ILE . 38.8 mm -62.58 -53.18 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 C-N-CA 121.233 -0.187 . . . . 10.0 110.604 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.99 -45.26 75.0 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.347 -0.388 . . . . 10.0 110.774 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.63 -35.0 79.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.797 -0.638 . . . . 10.0 110.942 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.6 -35.66 80.73 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.216 -0.447 . . . . 10.0 111.06 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 12' ' ' ILE . . . . . 0.65 HG13 ' O ' ' C' ' 8' ' ' ILE . 6.6 mt -69.87 -50.41 49.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.928 0.394 . . . . 10.0 111.265 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 13' ' ' VAL . . . . . 0.407 ' HA ' ' HG3' ' C' ' 37' ' ' MET . 16.4 m -68.11 -27.94 39.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 116.005 -0.543 . . . . 10.0 110.965 -178.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 14' ' ' ASN . . . . . 0.461 ' HB2' HG11 ' C' ' 51' ' ' VAL . 33.9 t30 -74.22 -43.06 58.62 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.256 -0.646 . . . . 10.0 109.256 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 15' ' ' TYR . . . . . 0.598 ' O ' HG12 ' C' ' 19' ' ' ILE . 13.1 t80 -64.28 -49.01 73.51 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.521 -0.763 . . . . 10.0 110.882 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 11.9 m-30 -55.75 -43.77 76.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.502 -0.317 . . . . 10.0 111.711 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 66.6 m -59.48 -40.61 87.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.569 -0.287 . . . . 10.0 111.522 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 1.3 m -76.25 -23.13 54.47 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.024 0.379 . . . . 10.0 112.024 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 19' ' ' ILE . . . . . 0.598 HG12 ' O ' ' C' ' 15' ' ' TYR . 29.2 mm -77.13 -38.48 27.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.067 0.461 . . . . 10.0 110.684 -178.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 20' ' ' VAL . . . . . . . . . . . . . 33.4 m -79.74 -20.12 12.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.377 0.608 . . . . 10.0 109.775 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -62.91 -51.63 66.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.973 -1.012 . . . . 10.0 110.838 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -92.7 -2.36 56.1 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.676 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 63.6 mttm 56.03 56.4 5.97 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.704 -0.68 . . . . 10.0 109.911 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -84.96 13.02 6.46 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.177 -0.92 . . . . 10.0 110.529 -179.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 15.9 tt -150.09 163.3 3.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.658 -0.867 . . . . 10.0 108.658 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 13.8 m -66.07 162.76 18.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.662 0.267 . . . . 10.0 110.639 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -60.82 -39.57 89.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.516 -0.311 . . . . 10.0 111.626 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 28' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -59.75 -47.84 84.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.018 0.437 . . . . 10.0 110.256 179.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 29' ' ' GLY . . . . . 0.535 ' O ' ' HG ' ' C' ' 33' ' ' LEU . . . -65.58 -41.36 96.14 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.855 -0.688 . . . . 10.0 111.587 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.5 -42.34 96.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.709 0.29 . . . . 10.0 111.36 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.9 -38.82 92.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.082 0.468 . . . . 10.0 110.319 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 6.3 m -62.46 -40.15 95.69 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.679 -0.691 . . . . 10.0 110.067 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 33' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' C' ' 29' ' ' GLY . 62.4 mt -72.2 -31.51 65.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.833 -0.621 . . . . 10.0 111.169 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -64.42 -53.77 43.18 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.256 -0.429 . . . . 10.0 111.717 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 35' ' ' VAL . . . . . 0.542 HG22 ' HG ' ' A' ' 120' ' ' LEU . 11.3 p -67.79 -35.06 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-O 120.888 0.375 . . . . 10.0 110.664 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.72 -29.2 66.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.794 0.331 . . . . 10.0 110.529 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 37' ' ' MET . . . . . 0.407 ' HG3' ' HA ' ' C' ' 13' ' ' VAL . 30.5 ttm -58.55 -50.94 71.97 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.006 -0.543 . . . . 10.0 110.514 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 38' ' ' ASP . . . . . 0.504 ' CB ' ' HA3' ' A' ' 123' ' ' GLY . 1.0 OUTLIER -69.71 -28.65 66.0 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 116.43 -0.35 . . . . 10.0 110.62 -179.721 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 39' ' ' CYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 123' ' ' GLY . 7.8 t -61.61 -50.25 73.33 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.423 -0.584 . . . . 10.0 109.423 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 40' ' ' ILE . . . . . . . . . . . . . 79.4 mt -60.57 -46.04 96.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.323 -0.853 . . . . 10.0 109.927 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 41' ' ' SER . . . . . 0.835 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 47.4 m -58.87 -38.18 78.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.55 -0.75 . . . . 10.0 111.366 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -70.71 -44.98 65.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.714 -0.675 . . . . 10.0 110.863 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.41 -37.44 72.74 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.819 0.674 . . . . 10.0 112.819 -178.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 44' ' ' PHE . . . . . 0.457 ' CE1' ' HB3' ' C' ' 5' ' ' LYS . 94.1 m-85 -97.9 2.35 49.08 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.179 -0.326 . . . . 10.0 111.633 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.74 57.93 16.39 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.314 -0.47 . . . . 10.0 113.518 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 46' ' ' PHE . . . . . 0.835 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 10.5 p90 -147.71 175.64 10.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 117.121 0.46 . . . . 10.0 110.404 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -100.97 136.19 41.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.642 -0.253 . . . . 10.0 110.355 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 48' ' ' ARG . . . . . 0.435 ' O ' HG13 ' C' ' 51' ' ' VAL . 5.1 ptm180 -58.98 -37.47 76.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 10.0 111.293 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.61 18.58 3.86 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.752 1.019 . . . . 10.0 113.752 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.92 1.66 37.08 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.989 0.424 . . . . 10.0 111.421 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 51' ' ' VAL . . . . . 0.461 HG11 ' HB2' ' C' ' 14' ' ' ASN . 27.2 m -45.22 -35.78 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 114.097 1.147 . . . . 10.0 114.097 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.98 -35.6 71.43 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.316 0.858 . . . . 10.0 113.316 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.55 -20.31 69.19 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 111.087 -0.805 . . . . 10.0 111.087 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 54' ' ' ILE . . . . . . . . . . . . . 50.5 mt -91.69 -65.38 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 114.35 1.241 . . . . 10.0 114.35 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 72.8 mt -78.43 -66.73 0.82 Allowed 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.222 -0.899 . . . . 10.0 112.984 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 75.39 -141.37 27.67 Favored Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 120.156 -1.021 . . . . 10.0 110.849 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 12.6 pttp -136.42 22.35 3.18 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.103 0.477 . . . . 10.0 110.546 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.44 19.09 1.31 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.747 -0.66 . . . . 10.0 111.337 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 . . . . . 0 N--CA 1.464 0.229 0 CA-C-N 115.623 -0.717 . . . . 10.0 111.039 -179.783 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 35.6 mtm . . . . . 0 N--CA 1.481 1.093 0 N-CA-C 109.826 -0.435 . . . . 10.0 109.826 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.2 t -101.54 133.38 45.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.99 -0.374 . . . . 10.0 109.99 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -86.25 120.13 27.28 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.268 -0.424 . . . . 10.0 110.858 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.1 mp -125.72 120.08 29.7 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.881 -0.599 . . . . 10.0 109.844 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.437 HG23 ' HG2' ' A' ' 89' ' ' GLU . 15.6 m -99.54 112.97 25.1 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.968 0.413 . . . . 10.0 109.943 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 87' ' ' SER . 3.0 mm? -84.57 114.65 22.12 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.873 -0.603 . . . . 10.0 109.645 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -117.93 103.83 10.31 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.079 -0.51 . . . . 10.0 110.232 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 84' ' ' PRO . 15.9 tptm -92.17 121.8 34.04 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.806 -0.633 . . . . 10.0 109.348 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.4 HD13 ' HB2' ' C' ' 32' ' ' SER . 75.6 mt -84.97 -57.78 4.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 O-C-N 123.631 0.582 . . . . 10.0 111.543 -179.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -66.15 158.51 28.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.856 -0.611 . . . . 10.0 111.023 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.28 139.71 56.22 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 120.877 0.37 . . . . 10.0 111.188 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.509 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 7.3 Cg_exo -75.17 129.44 18.67 Favored 'Cis proline' 0 C--O 1.235 0.335 0 C-N-CA 123.297 -1.543 . . . . 10.0 110.708 -1.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.444 ' HE3' ' HB2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -92.08 158.99 15.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.191 0.519 . . . . 10.0 110.953 -179.179 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -173.23 167.9 4.77 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.396 -0.82 . . . . 10.0 109.879 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.552 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 46.4 m -146.61 97.66 2.95 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.275 -0.639 . . . . 10.0 109.275 178.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 38.0 pt -110.45 146.01 16.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.804 -0.634 . . . . 10.0 110.657 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.437 ' HG2' HG23 ' A' ' 77' ' ' THR . 19.7 mt-10 -110.98 126.16 54.48 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.062 -0.718 . . . . 10.0 109.062 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 12.0 m80 -142.5 159.42 42.26 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.393 0.616 . . . . 10.0 111.976 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -105.75 126.76 52.54 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.044 -0.98 . . . . 10.0 109.922 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -117.89 167.65 11.22 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.935 -0.575 . . . . 10.0 110.587 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.574 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 1.7 m -89.72 153.73 47.81 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.144 -0.48 . . . . 10.0 110.463 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -60.52 -27.88 85.66 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.342 2.028 . . . . 10.0 112.329 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.6 m -103.97 17.93 23.07 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.002 -0.545 . . . . 10.0 110.678 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.574 ' HB2' ' O ' ' A' ' 93' ' ' SER . 0.3 OUTLIER -73.33 152.1 41.03 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.985 -0.552 . . . . 10.0 110.153 179.565 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.58 147.09 28.01 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.707 -0.679 . . . . 10.0 110.457 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 30.9 mm -62.3 -23.76 32.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.189 0.519 . . . . 10.0 110.511 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.447 HD22 ' HA ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -59.2 -37.94 78.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.61 -0.723 . . . . 10.0 110.509 179.187 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -61.77 -40.02 93.69 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.457 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.591 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 45.9 mt -63.15 -47.49 92.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.974 -0.557 . . . . 10.0 109.65 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -56.49 -47.36 79.43 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.448 -0.796 . . . . 10.0 110.962 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -61.35 -39.99 92.62 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.963 -0.562 . . . . 10.0 110.598 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 25.1 t60 -62.7 -38.54 90.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.476 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 101' ' ' ILE . 58.1 mt -65.43 -39.62 92.3 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.953 0.406 . . . . 10.0 110.671 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 43.2 mt -69.73 -39.7 78.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.103 0.478 . . . . 10.0 110.313 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.1 m -67.09 -20.33 65.79 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.893 -0.594 . . . . 10.0 111.305 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -98.8 14.6 28.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.633 -0.258 . . . . 10.0 111.242 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 58.11 35.12 24.86 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.121 -0.491 . . . . 10.0 111.166 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 8.6 mmtp -112.99 -13.34 13.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.547 -0.297 . . . . 10.0 111.335 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.466 ' HB2' HD13 ' A' ' 148' ' ' ILE . . . -135.06 155.81 50.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.394 -0.366 . . . . 10.0 110.762 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.1 m -94.46 -61.35 1.53 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.246 -0.434 . . . . 10.0 111.266 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -137.98 147.8 44.6 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.964 -0.384 . . . . 10.0 109.964 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.546 ' HA ' HD12 ' A' ' 117' ' ' ILE . 48.1 pt -60.43 -32.95 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.378 0.608 . . . . 10.0 110.843 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.4 m -58.59 -28.82 65.93 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.694 -1.139 . . . . 10.0 112.961 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.93 14.57 24.97 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.168 0.433 . . . . 10.0 112.168 -177.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.546 HD12 ' HA ' ' A' ' 114' ' ' ILE . 32.6 mt -115.87 135.44 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 113.288 0.847 . . . . 10.0 113.288 -178.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 52.7 tttt -140.88 129.12 22.27 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 109.198 -0.667 . . . . 10.0 109.198 175.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -96.18 136.1 37.09 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.274 0.559 . . . . 10.0 111.342 -179.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.402 ' HB3' ' HB ' ' A' ' 145' ' ' THR . 0.0 OUTLIER -112.46 134.67 53.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.263 -0.88 . . . . 10.0 110.029 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.525 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 43.0 tp -127.49 96.63 4.61 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 107.429 -1.322 . . . . 10.0 107.429 177.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.412 ' HA ' HG23 ' C' ' 35' ' ' VAL . 21.7 tptp 36.43 59.39 0.98 Allowed 'General case' 0 N--CA 1.467 0.387 0 O-C-N 124.059 0.849 . . . . 10.0 111.457 -177.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.27 -43.99 3.16 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 121.001 -0.619 . . . . 10.0 112.734 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.525 ' HB3' ' O ' ' A' ' 121' ' ' LEU . 26.9 tptt -59.73 126.87 29.3 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.916 -0.642 . . . . 10.0 109.765 178.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.0 m -94.15 140.72 16.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.688 0.625 . . . . 10.0 112.688 -178.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 7.2 mp -106.69 154.39 21.03 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.746 -0.661 . . . . 10.0 110.462 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -115.26 158.41 22.38 Favored 'General case' 0 C--O 1.226 -0.153 0 CA-C-O 120.677 0.275 . . . . 10.0 110.823 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.4 -55.01 20.93 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.827 1.047 . . . . 10.0 113.827 -178.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -94.02 19.35 9.23 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.756 0.312 . . . . 10.0 111.57 -177.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 12.8 tp -78.3 149.58 33.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.91 0.386 . . . . 10.0 111.088 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -108.9 150.28 27.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.768 -0.651 . . . . 10.0 110.031 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.492 HD12 ' O ' ' A' ' 93' ' ' SER . 64.3 mt -59.1 -28.18 66.27 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.211 0.449 . . . . 10.0 112.211 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.14 -12.55 59.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.118 0.485 . . . . 10.0 111.024 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -92.08 -49.86 5.99 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.131 -0.486 . . . . 10.0 110.839 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.3 pp -75.1 -25.93 58.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.017 -0.538 . . . . 10.0 111.274 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt 67.94 99.38 0.05 Allowed 'General case' 0 N--CA 1.465 0.313 0 O-C-N 124.062 0.851 . . . . 10.0 111.578 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.8 t -72.97 107.68 3.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.755 -0.461 . . . . 10.0 109.755 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.422 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 2.2 p -66.62 123.53 86.02 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.315 -0.402 . . . . 10.0 110.964 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 138' ' ' THR . 16.7 Cg_exo -63.95 -24.0 67.66 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.731 2.288 . . . . 10.0 111.66 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -78.26 4.29 13.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.55 -0.75 . . . . 10.0 111.402 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -132.83 -72.61 0.51 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.758 -0.201 . . . . 10.0 110.991 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.0 m 60.33 14.94 5.02 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.321 0.581 . . . . 10.0 111.366 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.7 m -114.02 120.15 39.61 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.948 -0.569 . . . . 10.0 110.316 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.426 HD13 HD13 ' A' ' 121' ' ' LEU . 19.3 mm -110.22 119.71 59.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.964 -0.562 . . . . 10.0 109.737 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' A' ' 120' ' ' LEU . 1.6 m -83.19 123.91 30.02 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.345 -0.389 . . . . 10.0 110.32 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 13.4 t -97.52 124.95 50.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.135 -0.484 . . . . 10.0 111.942 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 13.7 mmt -117.94 118.37 31.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.53 -0.759 . . . . 10.0 109.494 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.466 HD13 ' HB2' ' A' ' 111' ' ' ALA . 35.4 mt -136.51 140.84 42.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 111.548 0.203 . . . . 10.0 111.548 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -106.68 120.13 49.31 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 108.264 -1.013 . . . . 10.0 108.264 178.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.87 126.19 12.95 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.39 2.06 . . . . 10.0 113.264 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -95.97 -13.17 24.04 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.731 -0.668 . . . . 10.0 110.197 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 68.8 mt -88.44 125.22 34.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.59 -0.732 . . . . 10.0 109.802 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.288 -0.863 . . . . 10.0 110.81 -179.235 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' -1' ' ' SER . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.477 0.878 0 CA-C-O 120.793 0.33 . . . . 10.0 111.668 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 0' ' ' VAL . . . . . . . . . . . . . 1.1 t -83.08 14.02 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 112.556 0.576 . . . . 10.0 112.556 -177.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -56.4 106.78 0.31 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.054 0.454 . . . . 10.0 111.594 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.16 13.23 31.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.505 -0.77 . . . . 10.0 111.288 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -81.12 126.08 31.02 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.398 -0.365 . . . . 10.0 110.559 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 1.3 m -84.82 142.54 29.69 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.764 -0.458 . . . . 10.0 109.764 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' LYS . . . . . 0.446 ' H ' ' HG2' ' B' ' 5' ' ' LYS . 1.6 ptpp? -60.14 -43.36 95.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.329 -0.396 . . . . 10.0 111.501 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -59.04 -36.27 74.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.574 0.226 . . . . 10.0 110.972 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -64.66 -50.96 65.0 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.073 0.464 . . . . 10.0 109.88 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.508 ' O ' HD13 ' B' ' 12' ' ' ILE . 44.3 mm -61.51 -46.79 95.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.567 -0.742 . . . . 10.0 110.961 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.36 -47.77 75.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.9 0.381 . . . . 10.0 110.971 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.94 -32.11 73.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.986 -0.552 . . . . 10.0 110.694 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.3 mt -69.48 -38.06 77.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.362 -0.381 . . . . 10.0 110.399 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.508 HD13 ' O ' ' B' ' 8' ' ' ILE . 1.4 mp -63.46 -50.94 76.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.027 -0.533 . . . . 10.0 110.622 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 12.3 m -67.83 -33.61 62.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.758 0.314 . . . . 10.0 110.722 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -67.38 -48.37 67.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.282 0.563 . . . . 10.0 110.074 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' TYR . . . . . 0.653 ' O ' HG12 ' B' ' 19' ' ' ILE . 15.9 t80 -60.56 -52.31 65.71 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.456 -0.793 . . . . 10.0 110.931 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -54.75 -46.76 74.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.27 -0.423 . . . . 10.0 111.64 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 27.3 m -59.55 -42.55 92.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.695 0.283 . . . . 10.0 111.279 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 23.6 p -72.44 -19.07 61.64 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 122.205 -0.309 . . . . 10.0 111.271 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.653 HG12 ' O ' ' B' ' 15' ' ' TYR . 31.5 mm -79.86 -39.8 20.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.996 0.427 . . . . 10.0 110.09 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 5.3 m -75.66 -22.79 16.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 121.503 0.668 . . . . 10.0 109.303 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -60.03 -48.99 79.44 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 114.616 -1.175 . . . . 10.0 110.862 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 3.5 mttp -102.08 6.73 41.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.809 -0.632 . . . . 10.0 110.797 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 26.9 mtpt 50.82 56.94 7.22 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.356 0.598 . . . . 10.0 110.589 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -90.6 33.68 0.91 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.425 -0.807 . . . . 10.0 110.973 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' ILE . . . . . 0.475 HG12 ' H ' ' B' ' 26' ' ' SER . 13.3 tt -168.44 168.63 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.218 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' SER . . . . . 0.475 ' H ' HG12 ' B' ' 25' ' ' ILE . 1.9 m -58.21 154.8 12.47 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.926 0.491 . . . . 10.0 112.105 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -52.12 -58.22 7.25 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.911 0.708 . . . . 10.0 112.911 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -70.56 -23.59 62.63 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.244 0.545 . . . . 10.0 109.68 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.607 ' O ' ' HG ' ' B' ' 33' ' ' LEU . . . -63.96 -44.16 96.39 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 110.233 -1.147 . . . . 10.0 110.233 178.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.59 -40.69 95.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.168 0.509 . . . . 10.0 110.083 178.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -62.56 -43.22 99.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.465 -0.789 . . . . 10.0 110.051 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 50.9 m -62.64 -42.49 99.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.428 -0.806 . . . . 10.0 110.393 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 0.607 ' HG ' ' O ' ' B' ' 29' ' ' GLY . 82.2 mt -64.1 -38.91 92.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.35 -0.386 . . . . 10.0 110.341 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -65.77 -46.72 77.68 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.207 -0.451 . . . . 10.0 111.481 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.8 -38.33 80.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 116.451 -0.341 . . . . 10.0 111.091 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.55 -39.9 88.76 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.204 -0.665 . . . . 10.0 109.204 178.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' MET . . . . . 0.602 ' SD ' ' HD2' ' B' ' 48' ' ' ARG . 0.7 OUTLIER -59.23 -45.14 91.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.362 -0.836 . . . . 10.0 110.142 178.915 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -61.09 -46.2 91.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.427 -0.806 . . . . 10.0 110.691 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 7.8 t -67.58 -38.39 83.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 10.0 111.01 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' ILE . . . . . 0.484 HD13 HG21 ' B' ' 12' ' ' ILE . 55.9 mt -63.58 -39.02 83.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.878 0.37 . . . . 10.0 110.034 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.708 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 14.2 m -63.01 -38.49 91.38 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.52 -0.548 . . . . 10.0 109.52 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -69.78 -40.99 75.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.857 -0.61 . . . . 10.0 110.286 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.96 -39.45 81.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.48 -0.782 . . . . 10.0 111.975 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -94.89 -0.72 53.77 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.671 -0.24 . . . . 10.0 111.3 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.4 39.82 97.8 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-N 116.203 -0.453 . . . . 10.0 113.2 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.708 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 6.5 p90 -131.26 160.78 33.9 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.358 -0.608 . . . . 10.0 109.358 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -94.15 140.44 29.75 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.834 0.35 . . . . 10.0 110.61 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.602 ' HD2' ' SD ' ' B' ' 37' ' ' MET . 17.3 mtm180 -57.7 -29.68 64.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.899 -0.591 . . . . 10.0 111.664 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 30.4 mp0 -83.82 -0.42 51.05 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.594 -0.73 . . . . 10.0 112.894 -177.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.65 3.52 40.59 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 122.309 -0.245 . . . . 10.0 111.582 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.539 HG23 ' H ' ' B' ' 52' ' ' SER . 4.3 m -41.45 -59.75 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 113.215 0.82 . . . . 10.0 113.215 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 52' ' ' SER . . . . . 0.539 ' H ' HG23 ' B' ' 51' ' ' VAL . 0.1 OUTLIER -59.03 -20.96 58.04 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 113.103 0.779 . . . . 10.0 113.103 -179.527 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.88 -38.43 13.74 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.569 -0.824 . . . . 10.0 112.027 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 32.5 mt -86.25 -51.72 12.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 112.266 0.469 . . . . 10.0 112.266 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 83.5 mt -83.56 -67.31 0.8 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.18 0.515 . . . . 10.0 111.998 -178.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 56' ' ' GLY . . . . . 0.49 ' HA2' ' HB3' ' C' ' 71' ' ' SER . . . 78.03 -114.78 4.06 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 110.993 -0.843 . . . . 10.0 110.993 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 45.1 pttt -157.72 23.63 0.28 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.21 0.528 . . . . 10.0 110.381 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.61 35.53 0.41 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.757 -0.656 . . . . 10.0 111.391 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 50.82 73.04 0.31 Allowed 'General case' 0 N--CA 1.46 0.072 0 CA-C-N 116.292 -0.413 . . . . 10.0 110.653 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.23 94.93 0.39 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.314 0.578 . . . . 10.0 111.119 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 7.5 mttt -95.31 90.37 5.81 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.677 -0.692 . . . . 10.0 109.77 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -71.42 78.32 0.58 Allowed Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.733 -0.667 . . . . 10.0 112.219 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -67.34 90.56 0.23 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.255 0.55 . . . . 10.0 110.906 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -139.73 91.77 2.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.686 -0.688 . . . . 10.0 109.849 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 81.1 mt -85.41 -23.53 27.88 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.952 -0.567 . . . . 10.0 110.589 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . 59.51 19.83 8.29 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.664 0.602 . . . . 10.0 110.876 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 59.43 41.34 19.57 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.262 -0.881 . . . . 10.0 111.156 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 59.3 mt -94.99 106.74 18.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.106 0.479 . . . . 10.0 110.972 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -112.78 10.49 19.2 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.768 -0.651 . . . . 10.0 109.529 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -100.74 41.67 1.16 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.387 -0.824 . . . . 10.0 109.399 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.52 -32.92 73.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.371 -0.831 . . . . 10.0 110.964 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.543 -0.741 . . . . 10.0 109.512 179.715 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' -1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.483 1.197 0 CA-C-O 120.593 0.235 . . . . 10.0 111.448 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 0' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -106.54 50.37 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-O 121.531 0.682 . . . . 10.0 109.595 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -68.96 96.32 0.77 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.975 -1.012 . . . . 10.0 110.632 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.42 61.2 5.52 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.481 -0.781 . . . . 10.0 110.996 -178.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -139.8 143.44 36.87 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.773 -0.455 . . . . 10.0 109.773 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -98.78 138.52 35.81 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.489 -0.56 . . . . 10.0 109.489 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 5' ' ' LYS . . . . . 0.545 ' HB2' ' CE1' ' C' ' 44' ' ' PHE . 0.2 OUTLIER -60.64 -32.73 71.88 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.387 -0.37 . . . . 10.0 111.199 -179.233 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 6' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -59.75 -52.33 65.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.198 0.523 . . . . 10.0 110.288 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -55.62 -51.45 67.13 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.767 -0.651 . . . . 10.0 110.986 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 8' ' ' ILE . . . . . 0.668 ' O ' HG13 ' C' ' 12' ' ' ILE . 48.6 mm -57.18 -48.86 81.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.707 -0.679 . . . . 10.0 110.99 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.31 -44.98 72.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.044 0.45 . . . . 10.0 110.808 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.68 -33.78 76.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.752 -0.658 . . . . 10.0 110.877 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.58 -37.42 79.84 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.123 -0.325 . . . . 10.0 110.123 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 12' ' ' ILE . . . . . 0.668 HG13 ' O ' ' C' ' 8' ' ' ILE . 21.6 mt -64.01 -57.09 13.08 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.517 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 13' ' ' VAL . . . . . 0.55 HG12 ' HG2' ' C' ' 37' ' ' MET . 33.0 m -63.61 -26.2 40.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.682 -0.69 . . . . 10.0 111.506 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -75.73 -46.76 29.19 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.323 0.582 . . . . 10.0 109.603 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 15' ' ' TYR . . . . . 0.508 ' O ' HG12 ' C' ' 19' ' ' ILE . 46.9 t80 -64.07 -43.73 94.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.671 -0.695 . . . . 10.0 110.002 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -57.15 -42.67 81.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.982 -0.553 . . . . 10.0 110.292 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 67.0 m -57.95 -42.9 85.92 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.972 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.55 -20.68 58.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.541 -0.299 . . . . 10.0 111.647 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 19' ' ' ILE . . . . . 0.508 HG12 ' O ' ' C' ' 15' ' ' TYR . 19.7 mm -74.59 -40.45 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.181 0.515 . . . . 10.0 109.764 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 20' ' ' VAL . . . . . . . . . . . . . 17.8 m -82.14 -17.2 11.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.787 -0.642 . . . . 10.0 109.728 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -64.47 -59.61 4.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.369 -0.832 . . . . 10.0 110.163 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -87.73 -3.31 58.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.371 -0.377 . . . . 10.0 110.493 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 64.4 mttm 59.49 58.22 3.03 Favored 'General case' 0 C--N 1.334 -0.066 0 CA-C-N 115.747 -0.661 . . . . 10.0 109.954 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -86.23 9.84 16.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.469 -0.787 . . . . 10.0 110.935 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 15.2 tt -144.36 165.53 13.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.361 -0.607 . . . . 10.0 109.361 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.04 154.67 22.16 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 122.524 0.329 . . . . 10.0 111.243 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -56.3 -46.99 79.56 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.386 -0.37 . . . . 10.0 111.151 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 28' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -64.34 -35.2 80.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.229 0.538 . . . . 10.0 109.736 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 29' ' ' GLY . . . . . 0.575 ' O ' ' HG ' ' C' ' 33' ' ' LEU . . . -66.3 -39.97 94.52 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 110.918 -0.873 . . . . 10.0 110.918 178.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.14 -39.15 93.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.923 0.392 . . . . 10.0 110.27 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -62.81 -42.06 99.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.591 -0.731 . . . . 10.0 109.812 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 32' ' ' SER . . . . . 0.4 ' HB2' HD13 ' A' ' 81' ' ' ILE . 19.4 t -64.96 -43.76 91.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.365 -0.834 . . . . 10.0 110.763 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 33' ' ' LEU . . . . . 0.575 ' HG ' ' O ' ' C' ' 29' ' ' GLY . 64.2 mt -67.96 -27.73 66.85 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.336 -0.393 . . . . 10.0 110.933 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -73.04 -39.25 66.09 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 116.477 -0.328 . . . . 10.0 111.561 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 35' ' ' VAL . . . . . 0.412 HG23 ' HA ' ' A' ' 122' ' ' LYS . 10.2 p -75.17 -36.05 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 N-CA-C 109.535 -0.543 . . . . 10.0 109.535 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.96 -34.58 78.07 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.702 -0.681 . . . . 10.0 110.097 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 37' ' ' MET . . . . . 0.55 ' HG2' HG12 ' C' ' 13' ' ' VAL . 2.9 ttm -54.3 -53.48 53.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.54 -0.755 . . . . 10.0 110.986 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 38' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -69.92 -25.97 63.92 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 121.096 -0.242 . . . . 10.0 110.905 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 39' ' ' CYS . . . . . . . . . . . . . 1.1 t -66.47 -47.62 72.5 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.587 -0.523 . . . . 10.0 109.587 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 40' ' ' ILE . . . . . . . . . . . . . 11.4 mt -67.99 -37.86 78.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.688 -0.687 . . . . 10.0 109.835 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 41' ' ' SER . . . . . 0.609 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 35.4 m -63.25 -43.51 97.79 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.916 -0.584 . . . . 10.0 110.274 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -66.67 -39.76 88.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.789 -0.641 . . . . 10.0 110.47 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.82 -39.06 80.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.921 -0.581 . . . . 10.0 112.027 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 44' ' ' PHE . . . . . 0.545 ' CE1' ' HB2' ' C' ' 5' ' ' LYS . 65.2 m-85 -96.98 -3.33 41.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.68 -0.236 . . . . 10.0 111.59 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.68 39.53 97.62 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.212 -0.518 . . . . 10.0 113.446 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 46' ' ' PHE . . . . . 0.609 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 4.8 p90 -131.88 154.7 48.94 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.397 -0.594 . . . . 10.0 109.397 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -94.24 145.27 24.84 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.644 -0.422 . . . . 10.0 110.656 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 48' ' ' ARG . . . . . 0.411 ' H ' ' HG3' ' C' ' 48' ' ' ARG . 10.8 mtm-85 -63.27 -15.74 58.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.301 0.572 . . . . 10.0 110.233 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -80.16 -11.08 59.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.57 -0.741 . . . . 10.0 112.406 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -93.53 2.41 56.43 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.254 0.465 . . . . 10.0 112.254 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 12.1 m -47.58 -44.92 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 113.39 0.885 . . . . 10.0 113.39 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.21 -44.7 92.26 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.821 0.674 . . . . 10.0 112.821 -179.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.2 -26.69 74.42 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.338 -0.934 . . . . 10.0 112.679 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 54' ' ' ILE . . . . . . . . . . . . . 67.3 mt -84.56 -63.44 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.947 0.403 . . . . 10.0 111.962 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 19.0 mt -70.82 -61.1 1.89 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.591 0.589 . . . . 10.0 112.591 -178.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 66.28 -130.0 31.94 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 111.04 -0.824 . . . . 10.0 111.04 -177.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 11.2 pttp -151.35 28.75 0.64 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.187 0.518 . . . . 10.0 110.35 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.55 30.82 0.78 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.013 -0.539 . . . . 10.0 111.121 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 61.05 86.33 0.1 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.747 -0.661 . . . . 10.0 111.022 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 60' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -72.58 81.32 1.09 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.364 0.602 . . . . 10.0 110.707 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -83.39 71.36 10.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.616 -0.72 . . . . 10.0 110.277 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.81 74.04 2.03 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.756 -0.656 . . . . 10.0 112.369 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 63' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -66.74 100.31 0.69 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.909 0.385 . . . . 10.0 110.298 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 64' ' ' HIS . . . . . . . . . . . . . 17.0 t60 -133.4 85.73 2.23 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.183 -0.462 . . . . 10.0 109.872 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 74.1 mt -67.57 -31.03 70.82 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.687 -0.688 . . . . 10.0 111.327 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . 60.86 23.22 13.26 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.485 0.491 . . . . 10.0 110.715 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 63.63 35.84 11.3 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.243 -0.89 . . . . 10.0 111.743 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 68' ' ' ILE . . . . . . . . . . . . . 96.5 mt -83.49 109.01 16.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.086 0.47 . . . . 10.0 111.417 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.86 -5.63 10.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.018 -0.537 . . . . 10.0 109.99 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 70' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -92.16 44.71 1.18 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.345 0.593 . . . . 10.0 110.135 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 71' ' ' SER . . . . . 0.49 ' HB3' ' HA2' ' B' ' 56' ' ' GLY . 1.9 p -94.21 31.58 1.67 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.945 -0.571 . . . . 10.0 110.598 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.887 0 CA-C-N 115.864 -0.607 . . . . 10.0 109.532 -179.737 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 84.4 mmm . . . . . 0 N--CA 1.478 0.974 0 CA-C-O 120.553 0.216 . . . . 10.0 110.754 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.0 p -114.74 121.75 67.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.191 0.52 . . . . 10.0 110.307 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -85.36 138.66 32.14 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.837 -0.62 . . . . 10.0 110.285 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.8 mp -127.97 125.22 39.06 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.964 -0.562 . . . . 10.0 109.929 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.45 HG23 ' HG2' ' A' ' 89' ' ' GLU . 3.0 m -93.45 106.84 18.77 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.015 -0.539 . . . . 10.0 110.417 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 87' ' ' SER . 3.4 mm? -80.73 110.53 16.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.958 -0.565 . . . . 10.0 110.089 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -121.42 108.63 13.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.654 -0.703 . . . . 10.0 110.626 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.1 tttm -106.15 125.69 51.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.245 -0.434 . . . . 10.0 110.959 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.46 HG21 ' OG ' ' C' ' 32' ' ' SER . 2.0 mp -83.91 -49.31 16.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 115.525 -0.761 . . . . 10.0 110.546 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -64.8 151.55 45.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.093 -0.503 . . . . 10.0 110.76 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.94 136.47 76.6 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.334 -0.393 . . . . 10.0 111.437 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -74.31 135.79 41.91 Favored 'Cis proline' 0 C--N 1.345 0.387 0 C-N-CA 123.73 -1.363 . . . . 10.0 111.682 -1.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -92.02 151.76 20.31 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.36 -0.382 . . . . 10.0 110.572 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.522 ' CZ ' ' HB3' ' A' ' 110' ' ' LYS . 33.8 p90 -171.18 165.73 7.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.124 -0.489 . . . . 10.0 111.193 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 51.1 m -148.41 103.57 3.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.547 -0.751 . . . . 10.0 109.591 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.5 pt -135.13 163.73 35.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.423 -0.353 . . . . 10.0 110.436 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.45 ' HG2' HG23 ' A' ' 77' ' ' THR . 5.2 mt-10 -114.8 148.72 38.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.712 0.291 . . . . 10.0 111.316 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 24.4 m80 -145.89 145.74 30.83 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.05 -0.722 . . . . 10.0 109.05 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -102.01 127.42 48.9 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.175 -0.676 . . . . 10.0 109.175 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -121.44 170.32 9.76 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.483 0.659 . . . . 10.0 111.618 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.0 145.76 33.74 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 115.172 -0.922 . . . . 10.0 109.16 178.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.12 -25.67 37.29 Favored 'Trans proline' 0 CA--C 1.527 0.156 0 C-N-CA 122.108 1.872 . . . . 10.0 112.523 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.89 17.06 8.28 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.823 0.344 . . . . 10.0 111.02 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -91.98 170.19 10.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.392 -0.367 . . . . 10.0 110.453 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.85 159.55 22.89 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.022 -0.536 . . . . 10.0 110.387 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.546 ' HB ' ' HA ' ' A' ' 128' ' ' ASP . 49.2 mm -66.8 -23.43 31.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.49 0.662 . . . . 10.0 109.835 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -57.96 -43.26 86.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.428 -0.806 . . . . 10.0 110.642 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -63.47 -33.9 76.59 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.16 -0.473 . . . . 10.0 111.275 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 47.7 mt -64.85 -44.75 96.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.3 -0.409 . . . . 10.0 110.184 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -54.76 -45.58 74.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.762 -0.653 . . . . 10.0 110.81 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -71.59 -33.09 68.74 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.701 -0.681 . . . . 10.0 110.425 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -64.62 -43.52 93.46 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.814 -0.63 . . . . 10.0 110.363 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 36.6 mt -60.53 -41.57 94.71 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.332 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 85.2 mt -62.35 -38.35 80.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.048 -0.523 . . . . 10.0 110.601 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.1 m -65.36 -26.82 68.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.074 -0.512 . . . . 10.0 111.547 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -98.83 12.92 34.24 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.936 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 59.94 24.5 13.62 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.69 -0.686 . . . . 10.0 111.558 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.522 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 41.6 mmtm -91.02 -16.85 27.25 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.475 0.655 . . . . 10.0 109.339 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.415 ' CB ' HD13 ' A' ' 148' ' ' ILE . . . -137.86 151.2 47.81 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.89 -1.05 . . . . 10.0 109.837 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.4 m -101.86 -46.73 4.81 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.812 -0.355 . . . . 10.0 111.643 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.496 ' O ' HG13 ' A' ' 117' ' ' ILE . 1.7 t-160 -134.72 127.92 31.95 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.789 -0.364 . . . . 10.0 111.498 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.554 ' HA ' HD12 ' A' ' 117' ' ' ILE . 11.2 tt -56.47 -41.85 73.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 115.746 -0.661 . . . . 10.0 111.572 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.43 -14.19 26.32 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.291 -0.868 . . . . 10.0 113.274 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -114.22 13.6 17.97 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.076 -0.39 . . . . 10.0 111.797 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.554 HD12 ' HA ' ' A' ' 114' ' ' ILE . 62.0 mt -99.61 121.31 50.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.751 0.31 . . . . 10.0 111.038 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -126.11 117.96 24.26 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.473 -0.33 . . . . 10.0 110.248 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -94.4 138.27 32.55 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.235 0.541 . . . . 10.0 111.562 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -120.38 133.45 55.44 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.102 -1.073 . . . . 10.0 108.102 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 53.6 tp -115.96 96.53 5.63 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 106.009 -1.849 . . . . 10.0 106.009 178.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.9 tptm 43.8 64.9 1.13 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 114.648 -1.16 . . . . 10.0 110.628 -177.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.689 ' HA2' ' SG ' ' C' ' 39' ' ' CYS . . . 80.88 -47.87 3.62 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.556 -0.747 . . . . 10.0 113.859 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 39.5 tttp -67.38 120.76 14.41 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 109.419 -0.586 . . . . 10.0 109.419 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.1 p -66.06 139.42 21.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.356 0.598 . . . . 10.0 112.499 -178.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 126' ' ' LEU . 2.3 tp -105.69 103.1 12.54 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.645 -0.707 . . . . 10.0 110.253 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -69.98 143.46 52.6 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.074 -0.966 . . . . 10.0 111.876 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.546 ' HA ' ' HB ' ' A' ' 98' ' ' ILE . 0.3 OUTLIER -61.57 -39.87 92.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.718 -0.674 . . . . 10.0 112.223 -179.561 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -73.88 -9.35 58.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.331 -0.395 . . . . 10.0 111.553 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 17.1 tp -76.85 142.01 40.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.251 -0.432 . . . . 10.0 110.356 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.467 ' HB2' ' HB2' ' A' ' 134' ' ' ASP . 41.2 m-85 -93.8 149.74 20.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.057 -0.52 . . . . 10.0 110.659 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 34.3 mt -59.32 -38.52 80.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.93 0.395 . . . . 10.0 111.21 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.24 -19.73 61.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.257 -0.429 . . . . 10.0 111.01 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.467 ' HB2' ' HB2' ' A' ' 131' ' ' PHE . 13.3 t0 -81.56 -40.37 23.18 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.738 -0.664 . . . . 10.0 111.108 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.3 pp -83.87 -26.36 29.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.508 -0.315 . . . . 10.0 111.317 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 96.0 mttt 63.07 99.18 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 O-C-N 123.659 0.599 . . . . 10.0 112.202 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.0 t -79.92 114.23 20.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.073 -0.512 . . . . 10.0 110.298 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.85 137.76 76.59 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.34 -0.391 . . . . 10.0 111.289 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -62.78 -16.99 57.0 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.818 2.345 . . . . 10.0 112.692 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -106.03 6.32 31.08 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.067 0.461 . . . . 10.0 110.924 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -140.34 71.28 1.37 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.753 -0.658 . . . . 10.0 109.536 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.4 t -99.27 11.81 38.0 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.654 -0.703 . . . . 10.0 110.17 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.35 95.58 5.76 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.127 0.489 . . . . 10.0 110.672 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 24.9 mm -92.37 104.4 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 N-CA-C 107.527 -1.286 . . . . 10.0 107.527 177.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.93 121.45 26.5 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.203 -0.453 . . . . 10.0 110.234 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 10.4 t -105.62 136.95 37.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.777 -0.647 . . . . 10.0 111.775 -178.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 25.1 mmt -136.0 120.78 18.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.126 -0.943 . . . . 10.0 108.643 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.415 HD13 ' CB ' ' A' ' 111' ' ' ALA . 11.8 mt -139.68 94.05 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.723 -0.391 . . . . 10.0 111.119 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -94.35 107.09 27.03 Favored Pre-proline 0 C--N 1.32 -0.706 0 N-CA-C 109.213 -0.662 . . . . 10.0 109.213 175.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.96 147.23 43.23 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.508 2.139 . . . . 10.0 112.759 -178.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -83.9 101.98 12.06 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.536 -0.756 . . . . 10.0 110.174 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 46.3 mt -90.01 148.88 22.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.22 -0.446 . . . . 10.0 110.413 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.494 -0.765 . . . . 10.0 109.946 -179.72 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' -1' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.474 0.735 0 CA-C-O 120.47 0.176 . . . . 10.0 110.779 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 0' ' ' VAL . . . . . . . . . . . . . 3.6 m -135.86 -175.0 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.304 -0.628 . . . . 10.0 109.304 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -171.11 -79.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.002 0.429 . . . . 10.0 110.12 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 70.6 m -155.53 -31.72 0.1 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.144 -0.48 . . . . 10.0 110.382 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.39 134.51 57.07 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.222 -0.445 . . . . 10.0 110.588 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' SER . . . . . 0.487 ' O ' HG12 ' B' ' 8' ' ' ILE . 64.6 p -94.68 178.86 5.45 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.062 -0.517 . . . . 10.0 110.717 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 5' ' ' LYS . . . . . 0.403 ' HE2' ' O ' ' C' ' 24' ' ' GLU . 7.8 ptpp? -54.34 -44.69 72.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.046 -0.525 . . . . 10.0 111.33 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -59.04 -47.19 86.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.408 -0.36 . . . . 10.0 111.487 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -59.86 -45.4 92.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.828 0.347 . . . . 10.0 110.511 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.487 HG12 ' O ' ' B' ' 4' ' ' SER . 37.2 mm -60.17 -49.62 83.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.739 -0.664 . . . . 10.0 110.505 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.4 -41.76 85.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.392 -0.367 . . . . 10.0 111.191 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.57 -38.09 89.81 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.207 0.527 . . . . 10.0 110.44 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 40.7 mt -66.1 -39.32 89.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.949 -0.569 . . . . 10.0 109.63 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.421 HD13 ' O ' ' B' ' 8' ' ' ILE . 1.3 mp -56.8 -46.85 83.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.311 -0.858 . . . . 10.0 111.406 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 12.9 m -71.72 -29.78 35.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.579 -0.448 . . . . 10.0 111.731 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -73.88 -41.62 61.91 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.749 0.309 . . . . 10.0 111.288 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -69.38 -43.6 73.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.379 -0.373 . . . . 10.0 111.199 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' PHE . . . . . 0.404 ' CE2' HG23 ' B' ' 12' ' ' ILE . 14.7 m-30 -61.43 -49.86 75.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.408 -0.36 . . . . 10.0 111.03 -179.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 6.0 p -57.65 -45.26 85.74 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.929 0.344 . . . . 10.0 111.929 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 5.0 p -69.02 -21.25 64.13 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.036 0.384 . . . . 10.0 112.036 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 22.5 mm -85.65 -43.58 16.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 120.689 -0.404 . . . . 10.0 110.676 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 26.9 m -73.54 -35.2 44.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.891 -0.324 . . . . 10.0 111.294 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -68.8 -38.28 79.82 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 120.487 -0.485 . . . . 10.0 110.235 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 33.2 mtmt -75.12 -7.15 52.97 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.132 -0.322 . . . . 10.0 110.132 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 29.8 mmtm 57.63 41.33 25.69 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.808 -0.633 . . . . 10.0 110.375 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.467 ' O ' ' HE2' ' C' ' 5' ' ' LYS . 38.4 mt-10 -91.61 9.83 30.61 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.529 -0.759 . . . . 10.0 110.338 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 9.0 tp -141.99 150.18 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 N-CA-C 108.834 -0.802 . . . . 10.0 108.834 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 1.2 p -62.65 154.95 27.62 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.287 -0.264 . . . . 10.0 110.287 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -57.21 -32.56 66.62 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.672 0.273 . . . . 10.0 110.712 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -63.2 -46.64 86.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.419 0.628 . . . . 10.0 109.716 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.539 ' O ' ' HG ' ' B' ' 33' ' ' LEU . . . -71.13 -40.72 61.37 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.542 -0.754 . . . . 10.0 111.384 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.73 -42.77 93.9 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.898 0.38 . . . . 10.0 111.069 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.415 ' O ' HG12 ' B' ' 35' ' ' VAL . 27.7 t0 -61.34 -44.19 97.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.619 -0.719 . . . . 10.0 110.214 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 13.4 m -65.52 -41.52 93.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.703 -0.68 . . . . 10.0 110.64 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' B' ' 29' ' ' GLY . 82.1 mt -66.08 -43.63 86.79 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.792 0.33 . . . . 10.0 111.296 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -60.3 -51.02 71.3 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 116.001 -0.545 . . . . 10.0 112.206 -178.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.415 HG12 ' O ' ' B' ' 31' ' ' ASP . 7.1 p -66.64 -42.06 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 120.797 -0.361 . . . . 10.0 111.063 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.43 -35.0 77.88 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.947 0.403 . . . . 10.0 110.419 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 37' ' ' MET . . . . . . . . . . . . . 22.7 ttm -56.24 -51.12 69.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.578 -0.737 . . . . 10.0 111.033 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.97 -33.63 76.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.073 -0.512 . . . . 10.0 111.508 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 39.9 m -65.28 -42.95 92.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.015 0.436 . . . . 10.0 110.284 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 46.7 mt -67.27 -34.52 69.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.844 -0.617 . . . . 10.0 110.321 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.665 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 50.9 m -65.23 -40.51 94.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.061 -0.518 . . . . 10.0 110.74 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -72.72 -27.47 62.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 10.0 111.284 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.45 -39.37 81.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.981 -0.554 . . . . 10.0 111.54 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -97.13 -0.84 46.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.333 -0.394 . . . . 10.0 111.869 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.23 60.62 7.29 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.351 -0.452 . . . . 10.0 114.168 178.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.665 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 13.6 p90 -154.11 167.78 28.7 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.028 -0.36 . . . . 10.0 110.028 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -98.93 151.62 20.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.013 0.435 . . . . 10.0 110.379 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 3.9 mtm180 -71.34 -28.21 63.91 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.129 0.49 . . . . 10.0 110.632 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -84.51 7.34 20.24 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.054 -0.521 . . . . 10.0 112.257 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.13 4.38 48.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.513 0.197 . . . . 10.0 111.523 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.453 HG23 ' H ' ' B' ' 52' ' ' SER . 4.8 m -41.37 -57.39 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 113.425 0.898 . . . . 10.0 113.425 -179.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 52' ' ' SER . . . . . 0.453 ' H ' HG23 ' B' ' 51' ' ' VAL . 0.6 OUTLIER -53.72 -36.54 62.37 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.824 0.675 . . . . 10.0 112.824 -179.28 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.72 -42.25 32.35 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.934 -0.651 . . . . 10.0 113.353 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 24.8 mt -83.69 -45.64 18.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 112.253 0.464 . . . . 10.0 112.253 -178.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 81.0 mt -73.17 -64.27 1.01 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.949 0.404 . . . . 10.0 111.378 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.25 -151.05 48.11 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.912 -0.661 . . . . 10.0 112.403 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 10.0 tttt -100.08 6.92 44.96 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.073 0.463 . . . . 10.0 110.466 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.47 134.89 55.42 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.565 -0.743 . . . . 10.0 110.289 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -87.59 122.97 31.97 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.178 0.513 . . . . 10.0 110.648 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -88.0 156.44 19.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.767 -0.651 . . . . 10.0 110.371 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -154.82 168.07 28.14 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.163 -0.472 . . . . 10.0 110.306 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -150.16 60.6 0.42 Allowed Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 111.455 -0.658 . . . . 10.0 111.455 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -79.52 127.89 32.7 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.769 -0.456 . . . . 10.0 109.769 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 46.0 p-80 -145.76 109.08 4.65 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.02 -0.537 . . . . 10.0 110.395 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -82.63 -13.05 57.16 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.453 0.644 . . . . 10.0 109.623 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -84.51 120.92 26.88 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.26 -0.882 . . . . 10.0 109.199 178.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.6 148.03 49.93 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.103 -0.499 . . . . 10.0 110.692 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 68' ' ' ILE . . . . . 0.406 HD12 ' HA ' ' C' ' 52' ' ' SER . 15.7 mt -81.57 83.69 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.294 -0.412 . . . . 10.0 109.901 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 97.4 mt 70.66 -67.8 0.23 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.142 -0.935 . . . . 10.0 111.039 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -148.88 -14.43 0.31 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.224 -0.444 . . . . 10.0 110.871 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 14.2 m 58.21 35.52 25.06 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 123.488 0.493 . . . . 10.0 111.013 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.696 -0.669 . . . . 10.0 110.667 -179.888 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' -1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.478 0.946 0 CA-C-O 120.901 0.381 . . . . 10.0 111.105 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 0' ' ' VAL . . . . . . . . . . . . . 13.5 m -128.54 168.31 22.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.978 -0.379 . . . . 10.0 109.978 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -135.39 -58.93 0.78 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.598 0.237 . . . . 10.0 111.289 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 48.2 m -157.01 -21.53 0.09 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.929 0.395 . . . . 10.0 110.785 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.31 145.8 55.43 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.972 -0.558 . . . . 10.0 111.336 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 4' ' ' SER . . . . . 0.553 ' O ' HG12 ' C' ' 8' ' ' ILE . 0.7 OUTLIER -109.89 166.32 11.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.246 -0.434 . . . . 10.0 110.106 179.857 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 5' ' ' LYS . . . . . 0.491 ' HB2' ' CE1' ' C' ' 44' ' ' PHE . 10.3 ptpp? -51.86 -38.67 56.9 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 123.515 0.51 . . . . 10.0 111.863 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 6' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 -59.39 -54.59 44.93 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.381 -0.372 . . . . 10.0 111.494 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -60.91 -40.3 92.62 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.688 0.28 . . . . 10.0 110.34 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 8' ' ' ILE . . . . . 0.553 HG12 ' O ' ' C' ' 4' ' ' SER . 48.4 mm -60.0 -47.73 90.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.88 -0.6 . . . . 10.0 109.658 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.39 -44.82 76.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.966 -0.561 . . . . 10.0 111.203 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 10' ' ' ALA . . . . . 0.41 ' HB2' HD12 ' C' ' 54' ' ' ILE . . . -65.82 -40.56 91.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.913 -0.585 . . . . 10.0 111.089 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 32.4 mt -61.36 -39.1 89.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.903 0.382 . . . . 10.0 110.26 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 12' ' ' ILE . . . . . 0.538 HD13 ' O ' ' C' ' 8' ' ' ILE . 1.6 mp -63.17 -54.87 27.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.656 -0.702 . . . . 10.0 111.75 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 28.5 m -66.56 -26.04 36.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.262 0.467 . . . . 10.0 112.262 -178.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 14' ' ' ASN . . . . . 0.549 ' HB2' HG11 ' C' ' 51' ' ' VAL . 0.7 OUTLIER -76.24 -40.09 52.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.981 0.419 . . . . 10.0 110.433 -179.668 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 15' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -72.6 -45.11 60.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.151 -0.477 . . . . 10.0 111.32 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -56.51 -49.67 74.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.371 -0.377 . . . . 10.0 110.846 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 10.0 p -58.48 -45.07 89.43 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.43 -0.35 . . . . 10.0 111.586 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 4.4 p -69.33 -22.24 63.78 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.805 -0.358 . . . . 10.0 111.845 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 19' ' ' ILE . . . . . . . . . . . . . 20.2 mm -79.34 -43.39 23.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 110.129 -0.322 . . . . 10.0 110.129 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 20' ' ' VAL . . . . . . . . . . . . . 4.2 m -73.99 -27.83 22.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.71 0.29 . . . . 10.0 110.385 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -69.84 -53.62 17.3 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.905 -0.406 . . . . 10.0 109.905 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 34.5 mtmt -70.67 -6.79 39.74 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.843 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm 61.48 47.03 6.96 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.251 0.548 . . . . 10.0 110.426 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 24' ' ' GLU . . . . . 0.403 ' O ' ' HE2' ' B' ' 5' ' ' LYS . 9.1 mt-10 -85.41 -3.93 59.0 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.827 -0.624 . . . . 10.0 110.422 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 11.2 tt -134.94 159.45 41.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.056 -0.52 . . . . 10.0 110.129 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -68.19 166.35 16.45 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.218 0.207 . . . . 10.0 111.272 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -53.74 -50.34 66.18 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.066 0.395 . . . . 10.0 112.066 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.76 -47.37 77.11 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.033 0.444 . . . . 10.0 110.48 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.09 -42.44 91.94 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.833 -0.699 . . . . 10.0 112.028 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.35 -41.68 80.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.881 0.372 . . . . 10.0 110.963 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -68.07 -38.47 82.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.952 -0.567 . . . . 10.0 110.163 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 32' ' ' SER . . . . . 0.46 ' OG ' HG21 ' A' ' 81' ' ' ILE . 48.7 m -61.74 -29.37 70.07 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.455 -0.793 . . . . 10.0 109.938 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 33' ' ' LEU . . . . . 0.464 ' O ' ' HG3' ' C' ' 37' ' ' MET . 48.4 mt -77.76 -37.11 49.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.341 -0.39 . . . . 10.0 110.359 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -58.36 -53.63 56.13 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.06 -0.518 . . . . 10.0 110.369 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 35' ' ' VAL . . . . . 0.4 HG23 ' H ' ' A' ' 123' ' ' GLY . 9.4 p -67.2 -38.58 81.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 115.361 -0.836 . . . . 10.0 110.681 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.94 -40.97 95.3 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 120.669 0.271 . . . . 10.0 111.257 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 37' ' ' MET . . . . . 0.464 ' HG3' ' O ' ' C' ' 33' ' ' LEU . 70.8 mtm -54.74 -47.14 74.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.426 -0.352 . . . . 10.0 110.593 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 38' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -69.41 -28.65 66.33 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 116.468 -0.333 . . . . 10.0 110.855 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 39' ' ' CYS . . . . . 0.689 ' SG ' ' HA2' ' A' ' 123' ' ' GLY . 91.8 m -61.25 -42.84 99.32 Favored 'General case' 0 CA--C 1.522 -0.115 0 N-CA-C 108.871 -0.789 . . . . 10.0 108.871 177.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 40' ' ' ILE . . . . . . . . . . . . . 1.4 mp -73.25 -46.11 51.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 114.84 -1.073 . . . . 10.0 110.704 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 41' ' ' SER . . . . . 0.621 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 9.2 m -60.98 -42.09 97.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.406 -0.361 . . . . 10.0 111.585 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -72.96 -29.28 62.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.412 -0.358 . . . . 10.0 110.506 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.6 -46.8 65.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.154 -0.476 . . . . 10.0 111.727 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 44' ' ' PHE . . . . . 0.491 ' CE1' ' HB2' ' C' ' 5' ' ' LYS . 93.4 m-85 -92.18 -7.03 49.49 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.089 0.403 . . . . 10.0 112.089 -178.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.36 60.86 5.18 Favored Glycine 0 C--O 1.227 -0.309 0 C-N-CA 121.244 -0.503 . . . . 10.0 113.889 178.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 46' ' ' PHE . . . . . 0.621 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 3.6 p90 -153.56 169.25 23.67 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 110.179 -0.304 . . . . 10.0 110.179 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 51.5 mp0 -99.23 144.08 28.76 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.803 0.335 . . . . 10.0 110.85 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.95 -28.36 69.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.214 0.53 . . . . 10.0 110.965 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -80.1 14.33 1.92 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.733 -0.667 . . . . 10.0 112.509 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -104.72 2.82 30.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.24 0.543 . . . . 10.0 110.753 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 51' ' ' VAL . . . . . 0.549 HG11 ' HB2' ' C' ' 14' ' ' ASN . 1.7 m -49.44 -45.78 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 113.546 0.943 . . . . 10.0 113.546 -179.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 52' ' ' SER . . . . . 0.406 ' HA ' HD12 ' B' ' 68' ' ' ILE . 0.4 OUTLIER -60.63 -27.22 67.61 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.785 0.291 . . . . 10.0 111.785 -179.338 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.91 -37.78 12.54 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.845 -0.693 . . . . 10.0 112.667 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 54' ' ' ILE . . . . . 0.41 HD12 ' HB2' ' C' ' 10' ' ' ALA . 40.0 mt -81.14 -56.35 6.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 O-C-N 122.697 -0.296 . . . . 10.0 111.253 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 26.5 mt -67.01 -41.24 87.0 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.229 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 58.08 -139.41 47.61 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.621 -0.718 . . . . 10.0 112.077 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 66.2 tttt -108.76 -6.34 15.93 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.074 0.464 . . . . 10.0 110.32 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 3.1 m -65.34 148.21 52.09 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.622 -0.717 . . . . 10.0 111.27 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -97.01 134.39 40.44 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.068 0.461 . . . . 10.0 110.146 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 60' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -98.87 153.33 18.88 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.373 -0.376 . . . . 10.0 110.465 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 7.8 ptmm? -134.64 162.03 33.47 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.424 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -138.78 39.22 1.59 Allowed Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 111.381 -0.687 . . . . 10.0 111.381 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 63' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -60.98 145.03 52.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.784 0.326 . . . . 10.0 110.42 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 64' ' ' HIS . . . . . . . . . . . . . 42.2 p-80 -161.67 113.16 1.72 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.064 -0.516 . . . . 10.0 109.958 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 65' ' ' LEU . . . . . 0.402 HD22 ' N ' ' C' ' 65' ' ' LEU . 3.2 mm? -89.34 -20.64 23.79 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.927 -0.579 . . . . 10.0 109.825 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -76.92 147.57 36.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.47 -0.786 . . . . 10.0 110.056 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -79.33 149.03 31.87 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.994 0.426 . . . . 10.0 110.96 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 68' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -91.53 82.34 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.89 -0.596 . . . . 10.0 110.324 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 93.4 mt 69.53 -73.95 0.09 Allowed 'General case' 0 N--CA 1.465 0.279 0 O-C-N 124.068 0.855 . . . . 10.0 110.696 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 70' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -132.27 -21.95 2.28 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.818 -0.628 . . . . 10.0 110.95 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 71' ' ' SER . . . . . . . . . . . . . 15.2 m 60.42 30.59 19.91 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.954 -0.566 . . . . 10.0 111.335 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.869 0 CA-C-O 118.522 -0.751 . . . . 10.0 109.868 179.961 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.4 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 33.7 mtm . . . . . 0 N--CA 1.481 1.084 0 N-CA-C 110.321 -0.251 . . . . 10.0 110.321 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.4 t -95.58 139.36 19.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.845 0.355 . . . . 10.0 111.475 -178.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.448 ' CD2' ' HB3' ' A' ' 91' ' ' ASP . 4.8 m170 -91.53 126.3 36.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.075 -0.511 . . . . 10.0 110.629 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.6 mp -126.9 120.03 28.18 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.01 -0.541 . . . . 10.0 109.923 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.1 m -94.07 114.75 26.97 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.452 -0.573 . . . . 10.0 109.452 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.426 ' O ' ' HA ' ' A' ' 87' ' ' SER . 2.5 mm? -88.3 122.67 32.08 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.283 -0.417 . . . . 10.0 110.679 -178.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -122.95 104.58 9.33 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.969 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -92.11 120.57 32.84 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.909 -0.404 . . . . 10.0 109.909 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 20.8 mt -86.83 -59.46 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.573 -0.285 . . . . 10.0 111.649 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -57.0 158.12 5.21 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.75 0.309 . . . . 10.0 111.397 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.28 138.6 55.92 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.42 -0.355 . . . . 10.0 111.059 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -74.2 130.73 21.54 Favored 'Cis proline' 0 C--O 1.237 0.435 0 C-N-CA 123.039 -1.65 . . . . 10.0 111.87 -1.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.4 ' HG3' ' H ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -87.8 152.62 21.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.422 -0.353 . . . . 10.0 111.271 -179.277 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -177.52 170.75 2.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.736 -0.665 . . . . 10.0 110.03 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 15.2 m -151.17 133.42 15.32 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.123 -0.49 . . . . 10.0 109.696 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.411 HG13 ' HB2' ' A' ' 78' ' ' LEU . 9.1 pt -138.16 150.31 24.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.932 0.396 . . . . 10.0 111.383 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -113.58 120.4 40.82 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.359 -0.608 . . . . 10.0 109.359 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.39 167.39 23.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.014 0.435 . . . . 10.0 111.433 -178.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.448 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -121.4 131.57 54.25 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.848 -0.614 . . . . 10.0 110.905 179.101 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.4 ' O ' ' HB3' ' A' ' 73' ' ' MET . 86.0 m-85 -118.74 168.8 10.39 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.727 -0.669 . . . . 10.0 109.85 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.608 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 7.4 t -80.89 146.95 60.74 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 116.545 -0.298 . . . . 10.0 110.398 -179.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.1 -22.62 70.47 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.245 1.963 . . . . 10.0 111.747 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 43.3 m -100.08 13.32 34.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.978 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.608 ' HB2' ' O ' ' A' ' 93' ' ' SER . 1.0 OUTLIER -80.52 163.11 23.97 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.528 -179.889 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.4 p -115.49 160.66 19.63 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.583 -0.735 . . . . 10.0 110.576 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 47.7 mm -65.28 -21.31 29.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.368 0.604 . . . . 10.0 109.438 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.28 -39.29 82.46 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.41 -0.814 . . . . 10.0 110.235 178.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -63.84 -40.24 96.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.103 -0.498 . . . . 10.0 110.316 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.526 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 54.1 mt -65.93 -48.6 81.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.841 -0.618 . . . . 10.0 109.499 178.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.418 ' CD ' HG13 ' A' ' 114' ' ' ILE . 53.2 mttt -53.64 -48.01 69.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.322 -0.854 . . . . 10.0 111.151 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.481 ' OE1' ' HA ' ' A' ' 103' ' ' GLN . 11.4 mm-40 -59.8 -41.16 90.6 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.883 -0.599 . . . . 10.0 111.102 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.538 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 19.1 t60 -68.46 -33.75 74.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.29 -0.414 . . . . 10.0 110.539 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 101' ' ' ILE . 90.8 mt -62.55 -46.04 90.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.79 0.329 . . . . 10.0 110.989 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.6 mt -67.41 -32.35 56.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.124 0.488 . . . . 10.0 110.05 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.1 m -68.02 -15.49 63.62 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.511 -0.768 . . . . 10.0 112.159 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.538 ' HG2' ' O ' ' A' ' 104' ' ' HIS . 17.5 mm-40 -95.1 6.88 47.83 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.628 -0.508 . . . . 10.0 109.628 178.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.459 ' HA ' ' OE1' ' A' ' 109' ' ' GLU . 3.4 mm-40 60.35 32.1 20.58 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.486 -0.779 . . . . 10.0 111.039 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -110.98 -5.64 14.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.111 -0.495 . . . . 10.0 110.795 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.62 ' HB2' HD13 ' A' ' 148' ' ' ILE . . . -135.57 148.69 49.17 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.81 -0.632 . . . . 10.0 109.952 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.533 ' OG ' ' HA ' ' A' ' 150' ' ' PRO . 0.6 OUTLIER -87.71 -59.18 2.32 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.948 0.404 . . . . 10.0 110.901 -179.81 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.501 ' O ' HG13 ' A' ' 117' ' ' ILE . 40.8 m80 -138.26 154.02 49.07 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.345 -0.389 . . . . 10.0 110.919 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.418 HG13 ' CD ' ' A' ' 102' ' ' LYS . 0.3 OUTLIER -63.34 -36.75 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 115.502 -0.772 . . . . 10.0 110.386 179.562 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.87 -24.0 34.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.821 -1.081 . . . . 10.0 112.463 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.439 ' HG3' ' OD1' ' A' ' 151' ' ' ASN . 0.3 OUTLIER -103.19 0.16 31.32 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 121.182 -0.207 . . . . 10.0 111.397 -179.117 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 113' ' ' HIS . 28.2 mt -90.75 119.91 38.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 120.266 -0.574 . . . . 10.0 109.534 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.4 mmmt -118.1 112.15 19.82 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.114 0.483 . . . . 10.0 110.174 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.434 ' O ' ' HB2' ' A' ' 126' ' ' LEU . 3.2 mm? -92.99 113.7 26.06 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.653 0.74 . . . . 10.0 110.995 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.534 HD13 ' HA ' ' A' ' 125' ' ' VAL . 4.5 mm? -110.75 140.43 45.16 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 107.406 -1.331 . . . . 10.0 107.406 178.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.582 HD13 HD13 ' A' ' 144' ' ' ILE . 17.9 tp -121.98 97.91 5.7 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.821 -0.807 . . . . 10.0 108.821 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? 46.82 58.27 4.86 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.612 0.72 . . . . 10.0 109.972 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.686 ' HA2' ' SG ' ' C' ' 39' ' ' CYS . . . 83.87 -44.41 3.31 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 114.6 -1.182 . . . . 10.0 114.154 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 22.9 tttp -59.64 140.03 56.73 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 120.696 0.284 . . . . 10.0 111.006 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.534 ' HA ' HD13 ' A' ' 120' ' ' LEU . 7.2 p -90.35 136.16 24.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 112.942 0.719 . . . . 10.0 112.942 -178.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.434 ' HB2' ' O ' ' A' ' 119' ' ' LEU . 6.0 mp -110.83 156.29 21.34 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 114.983 -1.008 . . . . 10.0 110.001 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -116.0 158.38 23.19 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.452 0.538 . . . . 10.0 112.452 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -52.81 -55.1 25.41 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 113.377 0.88 . . . . 10.0 113.377 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -91.26 14.13 15.28 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.242 0.46 . . . . 10.0 112.242 -178.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 9.4 tp -70.24 143.87 52.02 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.708 0.289 . . . . 10.0 110.428 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -98.85 146.84 25.54 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.72 -0.673 . . . . 10.0 110.18 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.497 HD12 ' O ' ' A' ' 93' ' ' SER . 13.0 mt -57.53 -39.09 75.84 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.414 -0.357 . . . . 10.0 111.183 178.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.4 p -73.17 -21.96 60.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.123 0.487 . . . . 10.0 111.198 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -82.25 -45.56 14.86 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 120.812 0.339 . . . . 10.0 110.519 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.2 pp -74.1 -21.97 59.68 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.352 -0.385 . . . . 10.0 110.846 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.6 mtmt 63.43 92.2 0.07 Allowed 'General case' 0 C--O 1.236 0.352 0 O-C-N 123.691 0.619 . . . . 10.0 110.785 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.0 t -66.07 101.5 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.6 -0.727 . . . . 10.0 110.38 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.52 119.66 48.88 Favored Pre-proline 0 N--CA 1.451 -0.415 0 CA-C-N 116.098 -0.501 . . . . 10.0 110.652 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -65.57 -11.46 30.59 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.773 2.315 . . . . 10.0 112.727 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -93.04 7.3 44.7 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.965 -0.561 . . . . 10.0 110.19 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -128.63 -75.02 0.56 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.518 -0.765 . . . . 10.0 110.14 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 38.6 m 57.66 13.27 1.89 Allowed 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.486 0.55 . . . . 10.0 112.486 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.9 m -121.46 121.75 38.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.619 0.247 . . . . 10.0 110.882 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.582 HD13 HD13 ' A' ' 121' ' ' LEU . 10.7 mm -102.85 126.12 57.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.714 -0.675 . . . . 10.0 109.666 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.425 HG21 HG11 ' C' ' 35' ' ' VAL . 0.2 OUTLIER -86.43 107.15 17.92 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.887 -0.783 . . . . 10.0 108.887 179.302 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 21.7 t -87.34 126.08 41.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.663 -0.699 . . . . 10.0 110.209 -178.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 62.7 mtt -125.35 115.0 19.63 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.706 -1.134 . . . . 10.0 109.866 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.62 HD13 ' HB2' ' A' ' 111' ' ' ALA . 9.9 mt -138.96 146.11 26.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.35 -0.841 . . . . 10.0 110.674 -178.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.514 ' HD3' ' OD2' ' B' ' 38' ' ' ASP . 2.0 mmmm -125.94 115.51 24.24 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 109.37 -0.604 . . . . 10.0 109.37 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.533 ' HA ' ' OG ' ' A' ' 112' ' ' SER . 19.5 Cg_endo -61.82 117.47 4.3 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.425 2.084 . . . . 10.0 112.65 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.439 ' OD1' ' HG3' ' A' ' 116' ' ' GLU . 11.0 m120 -74.99 -38.23 61.67 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 108.954 -0.758 . . . . 10.0 108.954 178.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 69.3 mt -87.5 165.79 15.25 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.072 -0.967 . . . . 10.0 111.244 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.416 ' HG3' ' H ' ' A' ' 153' ' ' GLU . 11.8 mt-10 . . . . . 0 C--O 1.251 1.178 0 CA-C-N 115.606 -0.725 . . . . 10.0 110.698 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' -1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.482 1.175 0 CA-C-O 120.85 0.357 . . . . 10.0 110.709 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 0' ' ' VAL . . . . . . . . . . . . . 34.0 m -118.31 -162.57 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.975 -0.557 . . . . 10.0 109.968 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -156.96 -84.67 0.05 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.108 -0.33 . . . . 10.0 110.108 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 70.8 m -162.94 12.91 0.07 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 122.724 0.409 . . . . 10.0 110.378 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -97.87 151.28 20.4 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 122.292 -0.255 . . . . 10.0 110.599 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 80.1 p -86.82 157.11 19.64 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.376 -0.601 . . . . 10.0 109.376 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -53.1 -40.54 64.22 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.85 0.315 . . . . 10.0 111.85 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -60.91 -47.25 87.27 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.668 -0.242 . . . . 10.0 110.838 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -58.84 -39.83 82.43 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.114 0.483 . . . . 10.0 110.075 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.443 ' O ' HD12 ' B' ' 12' ' ' ILE . 50.1 mm -64.52 -49.3 81.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.726 -0.67 . . . . 10.0 110.084 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.27 -36.65 78.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.193 0.52 . . . . 10.0 110.335 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.99 -32.77 74.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.534 -0.757 . . . . 10.0 110.221 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 28.1 mt -70.98 -34.96 71.91 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.421 -0.585 . . . . 10.0 109.421 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.658 HG21 HD13 ' B' ' 40' ' ' ILE . 0.7 OUTLIER -59.37 -54.74 30.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.974 -0.557 . . . . 10.0 110.442 179.117 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 28.4 m -62.27 -33.51 59.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.33 -0.396 . . . . 10.0 111.117 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -68.72 -48.77 62.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.093 -0.503 . . . . 10.0 110.897 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' TYR . . . . . 0.484 ' O ' HG12 ' B' ' 19' ' ' ILE . 8.3 m-85 -70.94 -41.9 70.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.156 -0.474 . . . . 10.0 112.04 -178.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -55.92 -52.94 62.35 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 122.982 0.176 . . . . 10.0 111.45 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 17' ' ' SER . . . . . 0.5 ' O ' ' HB2' ' B' ' 21' ' ' GLU . 4.9 p -58.74 -46.85 86.48 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.448 -0.342 . . . . 10.0 111.357 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 28.8 p -65.45 -20.59 66.43 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.225 0.454 . . . . 10.0 112.225 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.484 HG12 ' O ' ' B' ' 15' ' ' TYR . 22.9 mm -84.93 -42.12 16.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.798 0.332 . . . . 10.0 111.221 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 34.5 m -77.43 -31.6 17.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.006 0.431 . . . . 10.0 111.311 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 21' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' B' ' 17' ' ' SER . 0.4 OUTLIER -71.64 -25.69 62.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.075 -0.511 . . . . 10.0 111.188 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -94.59 1.13 55.62 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.397 0.618 . . . . 10.0 109.578 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 14.7 mmtt 55.33 45.56 25.28 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 114.805 -1.089 . . . . 10.0 111.573 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -93.66 24.32 4.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.946 0.403 . . . . 10.0 111.223 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 16.8 tt -160.87 161.39 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 116.173 -0.467 . . . . 10.0 110.41 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.84 159.86 29.53 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.817 -0.629 . . . . 10.0 111.443 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -56.97 -41.86 79.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.65 -0.705 . . . . 10.0 111.412 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.33 -50.67 72.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.998 -0.547 . . . . 10.0 109.845 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.501 ' O ' ' HG ' ' B' ' 33' ' ' LEU . . . -60.39 -41.08 98.37 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.622 -0.717 . . . . 10.0 111.677 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.25 -31.87 73.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.883 -0.158 . . . . 10.0 110.913 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -71.5 -43.3 66.79 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.43 -0.582 . . . . 10.0 109.43 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 4.1 m -62.54 -51.14 68.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.313 -0.858 . . . . 10.0 110.288 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' B' ' 29' ' ' GLY . 89.6 mt -59.12 -41.92 89.35 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.127 -0.488 . . . . 10.0 110.173 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -57.83 -49.61 76.09 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.752 -0.658 . . . . 10.0 111.106 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.439 HG11 HD21 ' A' ' 120' ' ' LEU . 2.6 p -70.93 -33.81 53.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.738 -0.385 . . . . 10.0 111.691 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.23 -39.25 89.43 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 109.625 -0.509 . . . . 10.0 109.625 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' MET . . . . . . . . . . . . . 32.8 ttm -54.65 -45.6 73.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.305 -0.861 . . . . 10.0 109.574 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 38' ' ' ASP . . . . . 0.514 ' OD2' ' HD3' ' A' ' 149' ' ' LYS . 18.4 t70 -62.6 -53.73 50.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.118 -0.947 . . . . 10.0 110.886 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 59.8 m -52.09 -47.76 65.07 Favored 'General case' 0 N--CA 1.462 0.137 0 O-C-N 123.581 0.551 . . . . 10.0 111.529 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 40' ' ' ILE . . . . . 0.658 HD13 HG21 ' B' ' 12' ' ' ILE . 59.7 mt -62.6 -44.83 99.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.02 -0.536 . . . . 10.0 110.69 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.556 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 49.0 m -61.28 -43.32 99.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.026 -0.534 . . . . 10.0 110.876 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -67.52 -42.39 82.87 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.679 -0.691 . . . . 10.0 111.243 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.2 -33.61 74.74 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.28 0.474 . . . . 10.0 112.28 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -90.38 -7.2 53.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.671 0.272 . . . . 10.0 111.062 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.84 46.74 90.96 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.201 -0.523 . . . . 10.0 112.864 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.556 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 3.7 p90 -144.34 154.71 43.31 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 122.569 -0.371 . . . . 10.0 110.474 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -92.93 147.08 23.14 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.404 -0.362 . . . . 10.0 110.408 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.415 ' H ' ' NE ' ' B' ' 48' ' ' ARG . 0.0 OUTLIER -64.98 -27.34 68.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.548 -0.296 . . . . 10.0 111.483 -179.134 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -72.68 -10.32 59.65 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.404 -0.362 . . . . 10.0 111.839 -179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.28 4.38 27.3 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.592 -0.276 . . . . 10.0 111.351 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.422 HG23 ' H ' ' B' ' 52' ' ' SER . 0.1 OUTLIER -42.77 -59.94 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 112.653 0.612 . . . . 10.0 112.653 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 52' ' ' SER . . . . . 0.422 ' H ' HG23 ' B' ' 51' ' ' VAL . 0.9 OUTLIER -60.89 -19.56 60.56 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.229 0.826 . . . . 10.0 113.229 -179.421 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.46 -38.5 12.35 Favored Glycine 0 C--O 1.235 0.203 0 C-N-CA 120.879 -0.677 . . . . 10.0 112.382 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 6.2 mt -86.63 -47.34 16.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.816 0.341 . . . . 10.0 111.23 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 53.4 mt -73.08 -57.88 3.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.306 0.574 . . . . 10.0 110.424 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.83 -144.7 48.56 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.327 -0.851 . . . . 10.0 112.569 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -91.67 -11.03 38.13 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.465 -0.367 . . . . 10.0 110.918 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.56 131.79 52.02 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.798 0.666 . . . . 10.0 112.798 -178.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -81.22 155.13 26.28 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.814 -0.81 . . . . 10.0 108.814 177.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -120.92 165.1 15.69 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 109.731 -0.47 . . . . 10.0 109.731 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? -157.03 160.95 39.47 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.046 0.45 . . . . 10.0 110.564 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -136.58 57.88 0.66 Allowed Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 115.54 -0.755 . . . . 10.0 111.631 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -78.28 130.38 36.15 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.765 -0.457 . . . . 10.0 109.765 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 48.7 p-80 -150.06 111.23 4.39 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.786 -0.643 . . . . 10.0 109.649 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.06 -8.51 58.65 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.447 -0.797 . . . . 10.0 110.487 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -86.24 126.86 34.59 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.527 -0.76 . . . . 10.0 110.306 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.83 126.16 27.61 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.834 -0.621 . . . . 10.0 110.367 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 19.9 mt -68.7 97.26 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.527 -0.306 . . . . 10.0 110.206 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 55.6 mt 63.8 -96.37 0.05 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.764 -0.653 . . . . 10.0 110.269 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -126.95 -1.45 6.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.627 0.251 . . . . 10.0 110.423 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 60.7 m 57.4 26.71 12.85 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.796 -0.638 . . . . 10.0 111.962 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.944 0 CA-C-O 118.422 -0.799 . . . . 10.0 111.206 179.952 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' -1' ' ' SER . . . . . . . . . . . . . 2.2 m . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 120.581 0.229 . . . . 10.0 110.465 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 0' ' ' VAL . . . . . . . . . . . . . 18.8 m -135.37 -179.97 3.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.2 -0.455 . . . . 10.0 110.631 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 1' ' ' ASP . . . . . 0.465 ' OD1' ' HG3' ' C' ' 61' ' ' LYS . 6.6 t70 -150.09 -77.63 0.14 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.713 -0.847 . . . . 10.0 108.713 178.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 35.4 m -170.35 9.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.628 -0.715 . . . . 10.0 110.418 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -90.25 153.86 20.16 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.644 -0.253 . . . . 10.0 111.047 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 4' ' ' SER . . . . . 0.532 ' O ' HG12 ' C' ' 8' ' ' ILE . 31.4 p -102.16 161.88 13.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.383 -0.371 . . . . 10.0 110.984 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -56.08 -39.34 71.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.294 -0.412 . . . . 10.0 111.498 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 6' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -61.2 -48.58 80.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.011 0.434 . . . . 10.0 110.911 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -63.49 -39.07 93.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.857 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 8' ' ' ILE . . . . . 0.532 HG12 ' O ' ' C' ' 4' ' ' SER . 43.6 mm -60.89 -46.83 95.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.564 -0.532 . . . . 10.0 109.564 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 9' ' ' ALA . . . . . 0.498 ' HB1' ' CE1' ' C' ' 46' ' ' PHE . . . -60.04 -44.09 94.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.692 -0.686 . . . . 10.0 110.825 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.99 -41.93 98.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.94 -0.573 . . . . 10.0 111.224 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 16.6 mt -62.44 -41.72 98.93 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.463 0.649 . . . . 10.0 110.006 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 12' ' ' ILE . . . . . 0.716 HG21 HD13 ' C' ' 40' ' ' ILE . 1.3 mp -59.22 -51.42 72.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.749 -1.114 . . . . 10.0 111.876 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 30.0 m -67.93 -24.95 31.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.028 0.442 . . . . 10.0 111.758 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -76.45 -42.56 43.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.749 0.309 . . . . 10.0 110.227 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 15' ' ' TYR . . . . . 0.469 ' O ' HG12 ' C' ' 19' ' ' ILE . 3.1 m-85 -73.32 -40.28 64.61 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.7 -0.4 . . . . 10.0 110.82 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -58.32 -49.48 77.03 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 109.998 -0.371 . . . . 10.0 109.998 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 35.4 p -62.05 -43.6 98.49 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.302 -0.408 . . . . 10.0 111.123 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 32.9 p -66.95 -24.45 66.07 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 111.69 0.256 . . . . 10.0 111.69 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 19' ' ' ILE . . . . . 0.469 HG12 ' O ' ' C' ' 15' ' ' TYR . 26.8 mm -80.6 -39.67 18.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 110.011 -0.366 . . . . 10.0 110.011 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 20' ' ' VAL . . . . . 0.402 HG12 ' HA ' ' C' ' 30' ' ' ALA . 19.5 m -77.43 -27.23 15.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.84 -0.344 . . . . 10.0 111.124 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 21' ' ' GLU . . . . . 0.402 ' HA ' ' OE1' ' C' ' 21' ' ' GLU . 2.5 tp10 -68.71 -50.33 51.66 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.846 -0.427 . . . . 10.0 109.846 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -71.92 -10.02 59.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.047 -0.524 . . . . 10.0 110.205 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm 58.95 42.31 19.66 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.506 0.67 . . . . 10.0 109.505 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -81.41 -6.28 58.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.232 -0.894 . . . . 10.0 110.729 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 18.1 tt -125.61 160.08 32.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.101 -0.5 . . . . 10.0 109.761 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -58.94 152.51 19.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.463 -0.335 . . . . 10.0 110.482 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -57.4 -34.49 68.94 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.81 0.338 . . . . 10.0 110.41 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 28' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -61.8 -50.77 71.0 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.51 -0.768 . . . . 10.0 109.983 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 29' ' ' GLY . . . . . 0.532 ' O ' ' HG ' ' C' ' 33' ' ' LEU . . . -67.33 -31.13 76.3 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.144 -0.934 . . . . 10.0 112.643 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 30' ' ' ALA . . . . . 0.402 ' HA ' HG12 ' C' ' 20' ' ' VAL . . . -59.96 -46.66 88.7 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.557 0.218 . . . . 10.0 110.461 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 31' ' ' ASP . . . . . 0.402 ' O ' HG12 ' C' ' 35' ' ' VAL . 14.5 t70 -63.64 -37.81 88.74 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.529 -0.545 . . . . 10.0 109.529 179.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 14.0 m -57.61 -44.91 85.82 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.449 -0.796 . . . . 10.0 109.784 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 33' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' C' ' 29' ' ' GLY . 51.6 mt -70.25 -37.37 74.93 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.026 -0.534 . . . . 10.0 110.501 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -59.17 -55.83 29.96 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.048 -0.524 . . . . 10.0 111.429 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 35' ' ' VAL . . . . . 0.425 HG11 HG21 ' A' ' 145' ' ' THR . 8.4 p -66.07 -41.77 90.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 115.961 -0.563 . . . . 10.0 111.117 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.55 -28.47 69.96 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.676 0.274 . . . . 10.0 111.032 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 9.0 mtm -59.98 -51.33 70.14 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.262 -0.426 . . . . 10.0 110.45 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 38' ' ' ASP . . . . . 0.629 ' CB ' ' HA3' ' A' ' 123' ' ' GLY . 1.2 m-20 -69.94 -27.47 64.78 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 109.639 -0.504 . . . . 10.0 109.639 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 39' ' ' CYS . . . . . 0.686 ' SG ' ' HA2' ' A' ' 123' ' ' GLY . 62.6 m -61.49 -50.25 73.46 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 109.297 -0.631 . . . . 10.0 109.297 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 40' ' ' ILE . . . . . 0.716 HD13 HG21 ' C' ' 12' ' ' ILE . 54.6 mt -67.2 -35.76 74.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.993 -1.003 . . . . 10.0 109.957 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 41' ' ' SER . . . . . 0.691 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 53.1 m -61.36 -51.81 67.27 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.713 -0.676 . . . . 10.0 110.536 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.82 -35.67 80.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.793 0.33 . . . . 10.0 110.867 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.66 -42.69 93.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.099 -0.5 . . . . 10.0 111.808 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 44' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -96.3 -2.48 45.79 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.869 0.366 . . . . 10.0 111.634 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.4 51.22 38.78 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.103 -0.57 . . . . 10.0 112.945 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 46' ' ' PHE . . . . . 0.691 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 4.3 p90 -144.48 157.58 44.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.055 0.455 . . . . 10.0 110.327 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -96.4 136.75 36.46 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.111 -0.495 . . . . 10.0 109.685 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 48' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -60.88 -13.97 19.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.757 -0.656 . . . . 10.0 112.111 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -84.03 -6.56 59.43 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.745 0.646 . . . . 10.0 112.745 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.53 4.55 27.57 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.134 0.42 . . . . 10.0 112.134 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 51' ' ' VAL . . . . . 0.4 HG23 ' H ' ' C' ' 52' ' ' SER . 4.9 m -45.03 -54.4 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 113.548 0.944 . . . . 10.0 113.548 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 52' ' ' SER . . . . . 0.4 ' H ' HG23 ' C' ' 51' ' ' VAL . 0.0 OUTLIER -58.93 -30.88 68.19 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.775 0.658 . . . . 10.0 112.775 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.13 -49.81 5.77 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.426 -0.892 . . . . 10.0 112.912 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 54' ' ' ILE . . . . . . . . . . . . . 80.0 mt -69.67 -54.6 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-O 120.642 0.258 . . . . 10.0 111.328 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 70.0 mt -68.77 -52.76 26.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.433 -0.349 . . . . 10.0 111.009 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.38 -136.66 47.57 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.261 -0.495 . . . . 10.0 112.837 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 30.9 tttt -108.3 3.43 23.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.222 0.534 . . . . 10.0 110.094 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 9.1 t -73.62 138.15 44.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.966 -0.561 . . . . 10.0 110.555 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -87.86 143.41 27.14 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.585 -0.734 . . . . 10.0 109.721 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 60' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -108.02 160.74 15.55 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.294 -0.632 . . . . 10.0 109.294 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 61' ' ' LYS . . . . . 0.465 ' HG3' ' OD1' ' C' ' 1' ' ' ASP . 10.2 ptmm? -140.97 170.45 15.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.917 0.389 . . . . 10.0 111.34 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -151.18 54.98 0.47 Allowed Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.284 -0.871 . . . . 10.0 111.081 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 63' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -82.2 133.05 35.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.147 0.498 . . . . 10.0 110.68 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 64' ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -153.33 112.43 3.77 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.118 0.485 . . . . 10.0 110.366 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -76.21 -28.51 57.24 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.775 -0.648 . . . . 10.0 109.475 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.17 137.46 35.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.3 -0.864 . . . . 10.0 109.646 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.44 155.53 36.2 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.178 -0.465 . . . . 10.0 110.365 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 68' ' ' ILE . . . . . . . . . . . . . 34.3 mt -83.85 100.08 6.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.453 -0.573 . . . . 10.0 109.453 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 33.6 mt 68.36 -74.62 0.07 Allowed 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.75 0.656 . . . . 10.0 110.508 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 70' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -150.26 -26.48 0.24 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.818 -0.628 . . . . 10.0 110.054 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 71' ' ' SER . . . . . 0.419 ' HA ' ' HB2' ' B' ' 52' ' ' SER . 16.8 m 56.45 47.34 19.04 Favored 'General case' 0 C--N 1.335 -0.044 0 CA-C-N 115.439 -0.8 . . . . 10.0 110.922 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.133 0 CA-C-N 115.384 -0.825 . . . . 10.0 110.321 -179.613 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 74.4 mmm . . . . . 0 N--CA 1.485 1.317 0 N-CA-C 110.079 -0.341 . . . . 10.0 110.079 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.1 t -104.45 135.78 40.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.927 -0.579 . . . . 10.0 110.352 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -87.57 129.29 35.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.57 0.224 . . . . 10.0 110.729 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.5 mp -127.87 129.17 46.46 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.126 0.489 . . . . 10.0 110.149 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.3 m -94.69 109.12 21.09 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.653 -0.703 . . . . 10.0 110.389 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -85.16 118.77 24.92 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.876 -0.787 . . . . 10.0 108.876 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -119.47 108.42 14.51 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.284 -0.416 . . . . 10.0 111.28 -178.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.521 ' HG2' ' O ' ' A' ' 84' ' ' PRO . 19.1 tptm -94.91 113.28 24.98 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 116.484 -0.326 . . . . 10.0 110.922 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.582 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 52.4 mt -80.49 -59.86 2.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 O-C-N 124.168 0.917 . . . . 10.0 111.542 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -63.13 160.31 15.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.787 0.327 . . . . 10.0 110.983 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.4 140.4 72.34 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 120.695 0.283 . . . . 10.0 111.401 -179.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.521 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 59.6 Cg_endo -76.9 140.61 66.02 Favored 'Cis proline' 0 C--N 1.343 0.266 0 C-N-CA 122.992 -1.67 . . . . 10.0 111.392 -1.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.582 ' HG2' ' O ' ' A' ' 81' ' ' ILE . 27.7 mtpp -82.91 145.1 29.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.436 -0.347 . . . . 10.0 110.965 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.424 ' CE2' ' HB3' ' A' ' 110' ' ' LYS . 34.1 p90 -165.73 156.08 13.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.714 0.292 . . . . 10.0 111.055 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.9 m -140.82 114.21 8.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.724 -0.671 . . . . 10.0 110.371 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 10.6 pt -134.87 149.02 29.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.558 -0.292 . . . . 10.0 110.816 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -117.16 116.62 27.65 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.384 -0.598 . . . . 10.0 109.384 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 25.7 t60 -130.3 146.31 51.88 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.412 -0.588 . . . . 10.0 109.412 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -99.11 139.66 34.43 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.201 0.524 . . . . 10.0 110.22 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -129.75 170.46 13.81 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.816 -0.629 . . . . 10.0 110.664 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.559 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 19.3 t -81.34 146.98 59.1 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 115.914 -0.585 . . . . 10.0 109.683 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -62.4 -18.02 60.73 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.126 1.884 . . . . 10.0 111.094 178.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.4 m -102.73 15.17 30.07 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.616 -0.72 . . . . 10.0 110.589 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.559 ' HB2' ' O ' ' A' ' 93' ' ' SER . 0.4 OUTLIER -83.5 167.88 17.0 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.043 0.449 . . . . 10.0 110.833 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.81 156.43 29.43 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.787 -0.642 . . . . 10.0 110.638 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 43.1 mm -63.3 -23.4 33.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.969 -0.559 . . . . 10.0 110.254 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.39 -40.58 65.14 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.355 -0.839 . . . . 10.0 110.873 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -64.02 -43.68 94.86 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 120.937 0.399 . . . . 10.0 110.864 -179.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.54 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 44.6 mt -62.12 -47.57 92.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.87 -0.605 . . . . 10.0 109.568 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -54.44 -46.41 73.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.341 -0.845 . . . . 10.0 111.237 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.437 ' OE1' ' HA ' ' A' ' 103' ' ' GLN . 16.0 mm-40 -65.04 -34.47 78.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.161 -0.472 . . . . 10.0 110.881 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 48.0 t60 -62.91 -39.56 94.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.342 -0.39 . . . . 10.0 110.326 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 101' ' ' ILE . 17.3 mt -63.14 -41.11 99.24 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.187 -0.46 . . . . 10.0 110.139 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 14.6 mt -68.53 -39.42 80.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.302 -0.408 . . . . 10.0 109.929 178.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.4 m -65.05 -26.07 68.09 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.214 0.531 . . . . 10.0 111.285 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -88.06 2.76 51.14 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.315 -0.402 . . . . 10.0 110.806 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 62.95 25.36 15.02 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.336 0.588 . . . . 10.0 109.997 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.424 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 22.5 mmtp -99.18 -8.16 25.51 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.565 -0.743 . . . . 10.0 109.89 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -130.6 154.46 47.84 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.397 -0.819 . . . . 10.0 110.371 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.1 m -107.77 -33.28 7.31 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.021 -0.536 . . . . 10.0 111.516 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.442 ' O ' HG13 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -154.57 129.89 9.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.582 -0.281 . . . . 10.0 110.777 -178.306 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.526 ' HA ' HD12 ' A' ' 117' ' ' ILE . 9.3 tt -61.77 -38.84 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-O 120.937 0.398 . . . . 10.0 111.451 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.565 ' HB3' ' OE2' ' A' ' 116' ' ' GLU . 8.1 t -49.48 -38.27 29.38 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.12 -0.946 . . . . 10.0 112.461 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.565 ' OE2' ' HB3' ' A' ' 115' ' ' SER . 1.3 pm0 -94.73 11.6 30.79 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.176 0.436 . . . . 10.0 112.176 -178.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' A' ' 114' ' ' ILE . 65.9 mt -95.6 119.98 44.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.992 -0.744 . . . . 10.0 108.992 178.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.8 mmmt -126.22 120.37 29.86 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.777 -0.453 . . . . 10.0 109.777 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -95.79 127.24 41.65 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.132 0.491 . . . . 10.0 111.248 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.59 HD21 HG11 ' B' ' 35' ' ' VAL . 3.0 mm? -110.33 138.46 46.69 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.493 -0.776 . . . . 10.0 108.98 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 25.3 tp -124.0 99.71 6.38 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.36 -0.607 . . . . 10.0 109.36 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 23.2 tptp 46.34 57.14 5.6 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 123.903 0.752 . . . . 10.0 110.416 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.568 ' HA3' ' CB ' ' C' ' 38' ' ' ASP . . . 81.48 -45.01 3.17 Favored Glycine 0 C--N 1.332 0.35 0 CA-C-N 115.567 -0.742 . . . . 10.0 113.097 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 40.1 tttp -62.61 133.16 54.49 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.807 -0.442 . . . . 10.0 109.807 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.3 p -83.03 141.03 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 113.341 0.867 . . . . 10.0 113.341 -177.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.5 mp -107.71 154.58 21.28 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.421 -0.808 . . . . 10.0 110.489 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 56.7 m-70 -111.9 154.61 24.95 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.781 0.324 . . . . 10.0 110.708 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -50.17 -54.04 23.54 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.727 1.01 . . . . 10.0 113.727 -178.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -96.51 18.69 13.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.921 0.391 . . . . 10.0 111.919 -177.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 130' ' ' LEU . 12.0 tp -68.81 146.77 52.59 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.029 0.442 . . . . 10.0 111.048 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -99.7 143.62 29.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.779 -0.646 . . . . 10.0 110.082 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.402 HD12 ' O ' ' A' ' 93' ' ' SER . 49.7 mt -56.8 -28.99 62.25 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.255 0.347 . . . . 10.0 111.692 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.69 -22.37 56.73 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.988 0.423 . . . . 10.0 111.687 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -83.11 -49.13 9.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.532 -0.304 . . . . 10.0 110.588 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.6 pp -72.72 -25.24 61.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 10.0 111.06 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt 65.85 91.96 0.08 Allowed 'General case' 0 N--CA 1.463 0.216 0 O-C-N 123.884 0.74 . . . . 10.0 112.064 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.2 t -66.99 110.08 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.415 -0.587 . . . . 10.0 109.415 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -81.51 124.69 79.92 Favored Pre-proline 0 N--CA 1.447 -0.584 0 CA-C-N 115.95 -0.568 . . . . 10.0 111.156 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -64.92 -17.07 58.38 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.819 2.346 . . . . 10.0 111.967 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -79.72 0.12 31.85 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.914 -0.585 . . . . 10.0 110.789 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -136.48 -63.88 0.61 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.119 -0.492 . . . . 10.0 109.787 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 30.5 m 51.6 24.48 2.34 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.634 -0.712 . . . . 10.0 112.543 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 32.4 m -124.71 126.32 45.51 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.142 0.496 . . . . 10.0 111.094 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 24.3 mm -106.73 120.51 58.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.567 -0.742 . . . . 10.0 109.584 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.24 117.85 23.23 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.242 -0.435 . . . . 10.0 109.83 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 29.1 t -93.46 127.73 45.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.689 -0.687 . . . . 10.0 111.221 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -124.65 117.26 23.88 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.47 -0.786 . . . . 10.0 109.247 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 10.2 mt -138.72 143.56 31.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.197 -0.456 . . . . 10.0 111.165 -177.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -109.8 114.56 56.45 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 108.846 -0.798 . . . . 10.0 108.846 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -61.54 124.97 15.67 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.447 2.098 . . . . 10.0 113.215 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -95.05 -0.06 53.99 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.535 -0.543 . . . . 10.0 109.535 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 26.8 mt -79.94 110.21 15.1 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.409 -0.814 . . . . 10.0 110.63 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.49 -0.767 . . . . 10.0 110.152 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' -1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.477 0 N-CA-C 110.082 -0.34 . . . . 10.0 110.082 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 0' ' ' VAL . . . . . . . . . . . . . 16.6 m -139.36 150.14 22.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.337 -0.392 . . . . 10.0 110.077 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -156.99 -86.92 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.878 -0.601 . . . . 10.0 109.513 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 2' ' ' SER . . . . . 0.402 ' HB2' ' OE1' ' B' ' 59' ' ' GLU . 2.0 p -86.59 -43.14 12.91 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 121.078 0.466 . . . . 10.0 110.091 178.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -115.18 168.62 9.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.804 -0.634 . . . . 10.0 110.46 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' SER . . . . . 0.484 ' O ' HG12 ' B' ' 8' ' ' ILE . 26.0 t -87.25 168.36 13.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.387 -0.37 . . . . 10.0 110.515 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 5.2 ptpp? -57.88 -44.17 86.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.284 -0.416 . . . . 10.0 110.664 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -58.11 -46.25 85.88 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.004 0.43 . . . . 10.0 110.549 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -62.29 -38.94 91.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.932 -0.577 . . . . 10.0 110.458 179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.494 HG13 ' CE2' ' C' ' 15' ' ' TYR . 38.7 mm -63.63 -45.8 96.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.992 -0.549 . . . . 10.0 109.99 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.41 -36.72 83.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.736 -0.665 . . . . 10.0 110.994 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.36 -34.03 77.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.984 -0.553 . . . . 10.0 110.48 179.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 22.9 mt -67.02 -35.63 80.32 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.57 -0.53 . . . . 10.0 109.57 178.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.479 HG23 HD13 ' C' ' 12' ' ' ILE . 53.4 mt -59.91 -56.96 13.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.515 -0.766 . . . . 10.0 111.396 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.468 ' HB ' ' HG2' ' B' ' 48' ' ' ARG . 24.4 m -65.44 -31.95 56.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.432 -0.349 . . . . 10.0 111.613 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -65.26 -51.38 61.2 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.215 0.531 . . . . 10.0 110.179 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' TYR . . . . . 0.48 ' O ' HG12 ' B' ' 19' ' ' ILE . 16.5 m-85 -64.28 -44.97 90.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.974 -0.557 . . . . 10.0 111.338 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 9.3 m-30 -58.32 -50.37 73.87 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.559 0.207 . . . . 10.0 111.559 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 24.2 m -56.97 -38.5 73.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.933 0.397 . . . . 10.0 111.456 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 2.7 p -79.03 -20.11 49.79 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.293 -0.255 . . . . 10.0 111.256 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.48 HG12 ' O ' ' B' ' 15' ' ' TYR . 13.6 mm -76.72 -41.2 33.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 109.487 -0.56 . . . . 10.0 109.487 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 26.6 m -76.04 -27.78 18.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.937 -0.574 . . . . 10.0 110.369 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 tm-20 -65.22 -52.08 56.91 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.531 -0.544 . . . . 10.0 109.531 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 21.4 mmtm -79.89 -8.75 59.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.642 -0.708 . . . . 10.0 110.545 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 52.1 mttt 55.36 52.78 10.82 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.486 -0.779 . . . . 10.0 110.843 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.482 ' O ' ' HE2' ' C' ' 5' ' ' LYS . 87.7 mt-10 -89.35 26.64 1.61 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.249 -0.887 . . . . 10.0 110.105 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 13.7 tt -162.25 160.77 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.598 -0.728 . . . . 10.0 109.848 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.48 153.22 36.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.597 -0.274 . . . . 10.0 110.847 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -59.15 -44.44 92.09 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.379 0.511 . . . . 10.0 112.379 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.79 -47.48 82.45 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.089 0.471 . . . . 10.0 110.228 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.445 ' O ' ' HG ' ' B' ' 33' ' ' LEU . . . -67.36 -34.54 85.41 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.791 -0.64 . . . . 10.0 111.901 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.9 -39.3 94.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.698 0.285 . . . . 10.0 111.02 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -70.55 -30.43 67.15 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.751 -0.463 . . . . 10.0 109.751 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 2.0 m -62.23 -43.14 99.5 Favored 'General case' 0 C--N 1.334 -0.097 0 N-CA-C 109.126 -0.694 . . . . 10.0 109.126 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' B' ' 29' ' ' GLY . 26.7 mt -70.23 -36.4 74.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.751 -0.659 . . . . 10.0 109.851 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -54.82 -56.2 21.95 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.227 -0.897 . . . . 10.0 110.853 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.59 HG11 HD21 ' A' ' 120' ' ' LEU . 7.1 p -73.17 -34.32 44.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 115.947 -0.57 . . . . 10.0 111.397 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.09 -32.68 74.11 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.991 -0.374 . . . . 10.0 109.991 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 37' ' ' MET . . . . . . . . . . . . . 22.7 mtm -60.05 -44.12 94.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.414 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.27 -47.65 85.11 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.234 -0.439 . . . . 10.0 110.006 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 15.8 m -58.18 -43.44 87.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.789 -0.641 . . . . 10.0 110.817 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' ILE . . . . . 0.445 HD13 HG21 ' B' ' 12' ' ' ILE . 96.5 mt -67.21 -48.65 77.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-O 120.742 0.305 . . . . 10.0 111.555 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.54 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 10.6 m -60.06 -46.4 89.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.361 -0.381 . . . . 10.0 110.895 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -67.41 -37.99 83.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.384 -0.371 . . . . 10.0 111.209 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.26 -42.36 99.13 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.877 0.325 . . . . 10.0 111.877 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -87.6 -7.87 56.96 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.889 0.329 . . . . 10.0 111.889 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.62 49.82 17.27 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.986 -0.626 . . . . 10.0 113.54 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.54 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 8.2 p90 -151.98 166.75 30.57 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.433 -0.58 . . . . 10.0 109.433 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -117.09 157.82 25.25 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.199 0.523 . . . . 10.0 110.554 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.468 ' HG2' ' HB ' ' B' ' 13' ' ' VAL . 0.6 OUTLIER -68.99 -22.94 64.06 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.473 -0.785 . . . . 10.0 111.597 -178.554 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -69.07 -8.57 46.39 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.179 0.807 . . . . 10.0 113.179 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -103.34 5.62 37.39 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.813 0.671 . . . . 10.0 112.813 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.548 HG23 ' H ' ' B' ' 52' ' ' SER . 2.6 m -40.69 -61.61 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 113.638 0.977 . . . . 10.0 113.638 -178.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 52' ' ' SER . . . . . 0.548 ' H ' HG23 ' B' ' 51' ' ' VAL . 1.0 OUTLIER -62.01 -23.14 66.25 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.991 0.737 . . . . 10.0 112.991 -178.696 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.66 -40.81 30.88 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.646 -0.788 . . . . 10.0 112.43 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 72.8 mt -81.34 -47.37 19.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.711 0.291 . . . . 10.0 111.226 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 67.0 mt -74.99 -67.99 0.59 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.742 0.306 . . . . 10.0 110.573 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 56' ' ' GLY . . . . . 0.555 ' HA2' ' HB3' ' C' ' 71' ' ' SER . . . 55.06 -106.13 0.49 Allowed Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.777 -0.647 . . . . 10.0 113.381 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 16.0 pttt -126.96 18.81 7.16 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.205 0.526 . . . . 10.0 110.211 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 13.1 m -76.68 -59.13 2.9 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.707 -0.678 . . . . 10.0 110.406 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 59' ' ' GLU . . . . . 0.402 ' OE1' ' HB2' ' B' ' 2' ' ' SER . 8.5 tt0 -152.61 146.8 25.49 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.359 -0.382 . . . . 10.0 110.051 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -166.54 -41.09 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.211 -0.45 . . . . 10.0 110.553 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -129.96 147.64 51.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.077 -0.51 . . . . 10.0 109.892 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 62' ' ' GLY . . . . . 0.505 ' CA ' ' HA2' ' C' ' 62' ' ' GLY . . . -127.14 -156.13 9.05 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.577 -0.82 . . . . 10.0 113.09 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -143.16 170.4 15.8 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.832 0.348 . . . . 10.0 110.646 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 64' ' ' HIS . . . . . 0.464 ' CD2' ' HA ' ' C' ' 58' ' ' SER . 6.7 m80 -71.31 101.64 2.4 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.631 -0.713 . . . . 10.0 110.297 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -121.85 131.01 53.81 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.935 -0.575 . . . . 10.0 110.303 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -89.38 54.16 2.85 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.356 0.598 . . . . 10.0 110.907 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.1 -24.29 35.25 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.813 -0.631 . . . . 10.0 110.726 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 5.3 mt -92.28 121.7 43.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.806 -0.634 . . . . 10.0 110.212 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 41.1 mt -97.22 -5.24 37.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.362 -0.381 . . . . 10.0 110.834 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -80.12 -22.31 42.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.156 0.503 . . . . 10.0 110.436 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.14 82.8 3.23 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.041 -0.527 . . . . 10.0 111.177 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.442 -0.79 . . . . 10.0 111.445 179.252 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' -1' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.475 0.797 0 CA-C-O 120.817 0.341 . . . . 10.0 110.858 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 0' ' ' VAL . . . . . 0.546 HG12 ' HA ' ' C' ' 4' ' ' SER . 2.2 m -137.68 70.26 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.391 0.615 . . . . 10.0 110.682 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.15 -90.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.527 -0.761 . . . . 10.0 111.343 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 3.3 p -83.84 -45.46 13.25 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.242 0.544 . . . . 10.0 110.604 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -104.66 172.88 6.56 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.388 -0.824 . . . . 10.0 110.27 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 4' ' ' SER . . . . . 0.546 ' HA ' HG12 ' C' ' 0' ' ' VAL . 8.6 t -97.8 171.77 8.1 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.347 -0.612 . . . . 10.0 109.347 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 5' ' ' LYS . . . . . 0.482 ' HE2' ' O ' ' B' ' 24' ' ' GLU . 3.4 ptpp? -59.23 -37.97 78.85 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 121.407 -0.117 . . . . 10.0 110.903 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 6' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -58.27 -45.55 87.66 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.055 0.455 . . . . 10.0 110.725 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -69.99 -41.44 74.38 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.19 -0.459 . . . . 10.0 110.735 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 8' ' ' ILE . . . . . 0.474 HG12 ' O ' ' C' ' 4' ' ' SER . 40.1 mm -59.19 -44.89 92.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.825 -0.435 . . . . 10.0 109.825 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.41 -39.93 92.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.824 -0.625 . . . . 10.0 110.442 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.42 -43.03 99.58 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.816 -0.629 . . . . 10.0 110.41 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 11' ' ' LEU . . . . . 0.472 ' HG ' ' CD2' ' C' ' 55' ' ' LEU . 7.0 mt -61.04 -40.43 93.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.457 -0.338 . . . . 10.0 110.743 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 12' ' ' ILE . . . . . 0.479 HD13 HG23 ' B' ' 12' ' ' ILE . 73.1 mt -65.2 -54.13 32.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.038 -0.528 . . . . 10.0 111.668 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 18.1 m -64.86 -27.47 42.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.899 0.38 . . . . 10.0 110.952 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -71.67 -47.08 56.65 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 120.986 0.422 . . . . 10.0 110.186 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 15' ' ' TYR . . . . . 0.494 ' CE2' HG13 ' B' ' 8' ' ' ILE . 3.2 m-85 -62.59 -42.66 99.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.829 -0.623 . . . . 10.0 110.598 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -59.18 -45.05 92.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.192 -0.458 . . . . 10.0 111.027 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 35.8 m -58.6 -39.7 81.15 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.119 -0.491 . . . . 10.0 111.692 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.71 -19.29 45.4 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.973 0.416 . . . . 10.0 111.139 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 19' ' ' ILE . . . . . . . . . . . . . 4.2 mm -75.87 -45.12 38.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.006 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 20' ' ' VAL . . . . . . . . . . . . . 27.3 m -75.44 -18.09 15.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 121.235 0.54 . . . . 10.0 110.676 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -70.91 -56.35 6.43 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.534 -0.757 . . . . 10.0 110.794 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 22' ' ' LYS . . . . . 0.5 ' HD2' ' OE2' ' C' ' 24' ' ' GLU . 45.5 mttm -81.22 -2.01 47.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.399 -0.818 . . . . 10.0 111.735 -178.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 87.7 mttt 55.58 49.23 16.98 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.475 0.655 . . . . 10.0 110.571 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 24' ' ' GLU . . . . . 0.5 ' OE2' ' HD2' ' C' ' 22' ' ' LYS . 46.3 mt-10 -82.47 -15.36 52.79 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.546 -0.752 . . . . 10.0 110.096 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 17.1 tt -114.2 161.14 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 115.608 -0.724 . . . . 10.0 109.829 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.31 154.08 39.29 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 123.288 0.368 . . . . 10.0 110.11 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -52.25 -44.5 64.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.95 0.405 . . . . 10.0 111.46 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 28' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -59.03 -45.07 91.65 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.882 -0.599 . . . . 10.0 110.646 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 29' ' ' GLY . . . . . 0.643 ' O ' ' HG ' ' C' ' 33' ' ' LEU . . . -68.12 -38.11 87.82 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.639 -0.709 . . . . 10.0 112.183 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.55 -43.31 84.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.047 0.451 . . . . 10.0 110.402 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 31' ' ' ASP . . . . . 0.488 ' O ' ' HB3' ' C' ' 34' ' ' ASN . 31.1 t70 -69.41 -37.59 77.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.904 -0.589 . . . . 10.0 110.347 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 24.3 m -64.23 -36.11 83.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.676 -0.693 . . . . 10.0 110.39 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 33' ' ' LEU . . . . . 0.643 ' HG ' ' O ' ' C' ' 29' ' ' GLY . 46.5 mt -73.05 -26.86 61.44 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.849 -0.426 . . . . 10.0 109.849 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 34' ' ' ASN . . . . . 0.488 ' HB3' ' O ' ' C' ' 31' ' ' ASP . 24.8 t30 -61.83 -56.6 17.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.917 -0.583 . . . . 10.0 110.303 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 35' ' ' VAL . . . . . 0.411 HG23 ' H ' ' A' ' 123' ' ' GLY . 6.3 p -66.64 -38.23 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 115.672 -0.695 . . . . 10.0 110.639 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 36' ' ' ALA . . . . . 0.478 ' O ' HG13 ' C' ' 40' ' ' ILE . . . -64.28 -32.57 74.22 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.389 -0.369 . . . . 10.0 110.995 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 14.0 mtm -59.29 -52.8 64.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.636 -0.256 . . . . 10.0 111.024 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 38' ' ' ASP . . . . . 0.568 ' CB ' ' HA3' ' A' ' 123' ' ' GLY . 28.1 m-20 -63.99 -26.55 68.62 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.462 -0.335 . . . . 10.0 110.597 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 39' ' ' CYS . . . . . 0.476 ' HB2' ' O ' ' C' ' 36' ' ' ALA . 62.7 m -60.23 -43.41 96.06 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 109.351 -0.611 . . . . 10.0 109.351 178.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 40' ' ' ILE . . . . . 0.478 HG13 ' O ' ' C' ' 36' ' ' ALA . 14.8 mt -69.03 -47.75 73.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.554 -0.748 . . . . 10.0 110.551 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 41' ' ' SER . . . . . 0.472 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 17.8 m -59.78 -43.18 94.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.916 -0.583 . . . . 10.0 111.712 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -68.59 -43.23 76.93 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.281 -0.418 . . . . 10.0 111.238 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.9 -44.86 75.98 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.355 0.502 . . . . 10.0 112.355 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 44' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -86.36 -7.31 58.56 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.95 0.352 . . . . 10.0 111.95 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.16 55.38 21.83 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.893 -0.67 . . . . 10.0 113.326 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 46' ' ' PHE . . . . . 0.472 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 4.7 p90 -153.98 177.7 10.75 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.896 -0.779 . . . . 10.0 108.896 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -125.27 150.87 46.67 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.263 0.554 . . . . 10.0 111.576 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 48' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -71.83 -27.63 63.04 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.499 -0.773 . . . . 10.0 110.954 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -72.15 2.8 5.27 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.006 -0.543 . . . . 10.0 111.246 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -108.96 0.88 20.3 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.436 0.532 . . . . 10.0 112.436 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 10.5 m -50.24 -43.21 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 114.379 1.252 . . . . 10.0 114.379 -177.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 52' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.77 -30.06 67.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.868 0.365 . . . . 10.0 111.174 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.91 -38.16 10.7 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.957 -0.64 . . . . 10.0 112.786 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 54' ' ' ILE . . . . . . . . . . . . . 37.3 mt -73.84 -62.68 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.853 0.359 . . . . 10.0 111.035 -179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 55' ' ' LEU . . . . . 0.472 ' CD2' ' HG ' ' C' ' 11' ' ' LEU . 68.9 mt -66.25 -54.97 18.66 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.628 -0.714 . . . . 10.0 110.71 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 52.67 -99.5 0.04 OUTLIER Glycine 0 CA--C 1.518 0.279 0 O-C-N 123.931 0.769 . . . . 10.0 112.457 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -138.89 21.09 2.65 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.187 -0.672 . . . . 10.0 109.187 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 58' ' ' SER . . . . . 0.464 ' HA ' ' CD2' ' B' ' 64' ' ' HIS . 18.4 m -78.69 -59.67 2.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.27 -0.877 . . . . 10.0 111.399 -179.062 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -139.28 136.74 35.22 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.956 -0.387 . . . . 10.0 109.956 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 60' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -168.72 -62.63 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.952 -0.567 . . . . 10.0 110.133 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp -87.74 119.89 28.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.915 -0.584 . . . . 10.0 109.86 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 62' ' ' GLY . . . . . 0.505 ' HA2' ' CA ' ' B' ' 62' ' ' GLY . . . -91.8 165.95 29.82 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.682 -0.771 . . . . 10.0 112.446 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 63' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -119.46 171.3 8.44 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.216 -0.661 . . . . 10.0 109.216 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 64' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -86.35 105.34 16.62 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.046 0.45 . . . . 10.0 110.519 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -107.84 -176.96 3.2 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.899 -0.591 . . . . 10.0 110.397 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.4 28.72 0.56 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.194 0.521 . . . . 10.0 109.953 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -67.91 -34.74 77.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.596 -0.729 . . . . 10.0 110.267 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 68' ' ' ILE . . . . . . . . . . . . . 25.7 mt -81.19 104.3 9.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.987 -0.551 . . . . 10.0 110.063 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 95.6 mt -94.97 -0.78 53.55 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.146 -0.479 . . . . 10.0 110.746 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 70' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -87.79 6.15 36.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.245 0.545 . . . . 10.0 110.532 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 71' ' ' SER . . . . . 0.555 ' HB3' ' HA2' ' B' ' 56' ' ' GLY . 36.3 m -108.87 47.49 0.91 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.12 -0.491 . . . . 10.0 111.022 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.003 0 CA-C-N 115.936 -0.574 . . . . 10.0 110.891 -179.87 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.413 ' HB2' ' OD2' ' A' ' 91' ' ' ASP . 29.8 mtt . . . . . 0 N--CA 1.479 0.994 0 N-CA-C 109.565 -0.531 . . . . 10.0 109.565 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.8 p -95.35 135.8 28.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.647 -0.421 . . . . 10.0 110.121 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -89.16 132.1 34.99 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.411 -0.359 . . . . 10.0 110.981 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -120.73 122.48 40.49 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.466 -0.938 . . . . 10.0 108.466 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.7 m -92.17 109.74 21.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.921 0.391 . . . . 10.0 110.346 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.542 ' O ' ' HA ' ' A' ' 87' ' ' SER . 2.3 mm? -81.67 110.65 17.21 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.239 -0.652 . . . . 10.0 109.239 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -120.52 107.11 12.47 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.316 -0.402 . . . . 10.0 111.059 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 46.5 tttm -96.74 120.57 37.31 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.587 -0.523 . . . . 10.0 109.587 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.488 HG23 ' OD2' ' C' ' 28' ' ' ASP . 18.1 mt -83.87 -36.21 11.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 O-C-N 123.863 0.727 . . . . 10.0 111.087 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.456 ' OE1' ' HA ' ' A' ' 147' ' ' MET . 19.7 mt-30 -65.42 149.17 50.46 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.993 -0.283 . . . . 10.0 110.394 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.91 134.05 78.49 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 116.437 -0.347 . . . . 10.0 111.041 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -80.07 142.14 60.91 Favored 'Cis proline' 0 C--O 1.236 0.4 0 C-N-CA 124.23 -1.154 . . . . 10.0 111.836 -1.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -80.36 158.13 26.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.029 -0.532 . . . . 10.0 111.585 -178.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -165.87 157.07 13.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.694 -0.685 . . . . 10.0 110.524 177.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.542 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 70.4 m -149.81 99.88 2.9 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.552 -0.536 . . . . 10.0 109.552 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.3 pt -121.03 155.32 24.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.039 -0.528 . . . . 10.0 110.761 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -114.91 119.33 36.18 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.554 -0.293 . . . . 10.0 110.546 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -118.11 156.05 29.34 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 110.059 -0.349 . . . . 10.0 110.059 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.413 ' OD2' ' HB2' ' A' ' 73' ' ' MET . 2.0 t70 -107.89 110.99 22.89 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.098 -0.705 . . . . 10.0 109.098 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -117.56 151.55 36.92 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.788 0.328 . . . . 10.0 110.922 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.507 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 0.6 OUTLIER -66.93 134.01 93.95 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.072 -0.513 . . . . 10.0 110.626 179.682 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -52.46 -32.26 51.94 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.549 2.166 . . . . 10.0 112.853 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.4 m -97.52 20.27 12.03 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.042 -0.526 . . . . 10.0 111.529 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.507 ' HB2' ' O ' ' A' ' 93' ' ' SER . 0.6 OUTLIER -83.45 171.35 13.52 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.88 0.371 . . . . 10.0 110.896 -179.546 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.467 HG22 ' H ' ' A' ' 99' ' ' LEU . 4.9 m -105.99 146.41 30.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.963 -0.562 . . . . 10.0 111.006 -179.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.439 HG12 ' O ' ' A' ' 130' ' ' LEU . 39.2 mm -61.76 -29.52 46.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 121.31 0.576 . . . . 10.0 110.392 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.467 ' H ' HG22 ' A' ' 97' ' ' THR . 0.6 OUTLIER -56.32 -42.78 78.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.591 -0.732 . . . . 10.0 110.942 179.723 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -64.6 -36.38 84.06 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 120.695 0.283 . . . . 10.0 110.981 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 59.2 mt -65.8 -48.27 82.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.267 -0.424 . . . . 10.0 109.886 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.459 ' HE2' HG13 ' A' ' 114' ' ' ILE . 23.5 mtpt -60.15 -44.06 95.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.786 -0.643 . . . . 10.0 110.331 178.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -64.21 -33.46 75.85 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.776 -0.647 . . . . 10.0 110.227 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.414 ' O ' ' HG3' ' A' ' 108' ' ' GLU . 61.2 t60 -69.89 -37.7 76.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.822 -0.627 . . . . 10.0 110.398 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 60.8 mt -60.55 -39.97 89.85 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.115 0.483 . . . . 10.0 110.165 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 102' ' ' LYS . 12.2 mt -70.14 -38.5 75.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.996 -0.547 . . . . 10.0 109.905 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 48.9 m -66.02 -23.73 66.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.741 -0.663 . . . . 10.0 110.965 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 104' ' ' HIS . 47.2 mt-10 -96.75 7.05 47.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.154 -0.475 . . . . 10.0 110.202 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 58.13 32.09 21.56 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.452 -0.795 . . . . 10.0 111.683 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 6.3 mmpp? -100.39 -8.01 23.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.633 -0.712 . . . . 10.0 109.455 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -130.55 167.23 19.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.297 -0.865 . . . . 10.0 111.258 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.8 t -101.1 -61.36 1.38 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.876 -0.602 . . . . 10.0 110.138 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.495 ' O ' HG13 ' A' ' 117' ' ' ILE . 20.2 m170 -139.59 143.76 37.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.351 -0.386 . . . . 10.0 110.335 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.498 ' HA ' HD12 ' A' ' 117' ' ' ILE . 3.9 tt -59.5 -42.91 89.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 121.317 0.58 . . . . 10.0 110.811 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.49 -15.03 33.87 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.084 -0.962 . . . . 10.0 112.304 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -110.94 14.95 22.0 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.493 0.553 . . . . 10.0 112.493 -178.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.498 HD12 ' HA ' ' A' ' 114' ' ' ILE . 71.1 mt -105.79 120.96 57.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-O 120.973 0.416 . . . . 10.0 110.725 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -121.9 114.07 20.5 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.961 -0.755 . . . . 10.0 108.961 178.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 126' ' ' LEU . 69.8 mt -100.37 131.37 46.33 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.746 0.784 . . . . 10.0 110.988 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.548 HD11 ' SG ' ' C' ' 39' ' ' CYS . 0.4 OUTLIER -118.06 144.29 45.73 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.914 -1.039 . . . . 10.0 108.753 179.187 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.541 HD23 ' HD2' ' A' ' 124' ' ' LYS . 27.6 tp -128.87 93.34 3.58 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 107.45 -1.315 . . . . 10.0 107.45 178.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.532 ' HG2' ' ND2' ' A' ' 141' ' ' ASN . 0.2 OUTLIER 35.29 69.33 0.17 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 113.903 -1.499 . . . . 10.0 112.498 -179.473 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.514 ' HA3' ' HB3' ' C' ' 38' ' ' ASP . . . 86.51 -45.28 3.43 Favored Glycine 0 CA--C 1.51 -0.256 0 C-N-CA 121.071 -0.585 . . . . 10.0 112.399 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.541 ' HD2' HD23 ' A' ' 121' ' ' LEU . 39.7 ttmt -63.33 121.7 14.38 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.556 -0.535 . . . . 10.0 109.556 178.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.9 t -85.8 128.42 39.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 111.79 0.293 . . . . 10.0 111.79 -178.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' A' ' 119' ' ' LEU . 5.3 mp -96.88 144.71 26.56 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.149 -0.315 . . . . 10.0 110.149 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.734 ' HB2' HD13 ' A' ' 130' ' ' LEU . 88.2 m-70 -122.7 161.1 24.51 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.598 -0.441 . . . . 10.0 110.259 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.09 -34.19 68.06 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.224 0.824 . . . . 10.0 113.224 -178.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -96.93 8.35 44.63 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.985 0.365 . . . . 10.0 111.985 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.734 HD13 ' HB2' ' A' ' 127' ' ' HIS . 1.1 mp -80.54 144.92 32.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.985 0.421 . . . . 10.0 110.65 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -107.68 148.67 29.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.769 -0.65 . . . . 10.0 109.362 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 51.0 mt -57.12 -39.18 74.61 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.106 0.409 . . . . 10.0 112.106 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.87 -18.52 58.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.749 0.309 . . . . 10.0 110.746 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -78.62 -49.33 13.42 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.811 -0.632 . . . . 10.0 110.623 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.437 HD22 ' HG ' ' A' ' 126' ' ' LEU . 1.2 pp -76.4 -26.49 55.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.283 -0.417 . . . . 10.0 111.159 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 10.8 mttp 60.84 100.52 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 O-C-N 123.634 0.584 . . . . 10.0 111.409 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.9 p -88.14 128.93 40.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.986 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.88 128.64 89.16 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.982 -0.554 . . . . 10.0 111.435 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -69.25 -9.69 26.97 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.479 2.119 . . . . 10.0 111.924 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -92.02 8.67 36.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.457 0.646 . . . . 10.0 109.484 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.532 ' ND2' ' HG2' ' A' ' 122' ' ' LYS . 5.9 t-20 -134.61 -74.52 0.47 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.229 -0.896 . . . . 10.0 109.737 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.3 m 55.87 26.5 9.77 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.881 0.697 . . . . 10.0 112.881 178.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 19.4 m -121.0 124.24 44.38 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.009 0.433 . . . . 10.0 111.12 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.445 HD13 HD13 ' A' ' 121' ' ' LEU . 24.5 mm -103.19 125.77 57.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.82 -0.627 . . . . 10.0 110.115 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.19 106.44 14.09 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.355 -0.98 . . . . 10.0 108.355 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 30.0 t -89.35 122.27 40.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.668 -0.696 . . . . 10.0 111.816 -177.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' MET . . . . . 0.456 ' HA ' ' OE1' ' A' ' 82' ' ' GLN . 26.1 mmt -122.67 117.73 26.46 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.434 -0.803 . . . . 10.0 109.486 178.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 23.1 mt -135.45 138.26 48.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.798 -0.637 . . . . 10.0 110.233 -178.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 9.0 mtpt -103.83 115.02 64.1 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.928 -0.578 . . . . 10.0 110.903 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.43 108.59 1.62 Allowed 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.053 1.835 . . . . 10.0 111.503 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -78.57 61.51 2.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.235 0.54 . . . . 10.0 111.174 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 89.1 mt -94.31 -22.57 18.27 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.031 -0.532 . . . . 10.0 110.529 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.207 -0.901 . . . . 10.0 109.696 179.12 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' -1' ' ' SER . . . . . . . . . . . . . 6.7 p . . . . . 0 N--CA 1.478 0.936 0 CA-C-O 121.006 0.431 . . . . 10.0 110.827 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 0' ' ' VAL . . . . . . . . . . . . . 2.5 t -96.81 -0.01 10.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.0 0.429 . . . . 10.0 109.977 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -54.04 94.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.402 -0.817 . . . . 10.0 111.315 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.31 69.17 0.78 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.563 -0.744 . . . . 10.0 110.539 -178.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -144.92 148.53 33.97 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.039 -0.726 . . . . 10.0 109.039 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.34 134.38 34.36 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.594 -0.442 . . . . 10.0 110.09 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 7.1 ptpp? -57.2 -34.95 69.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.38 -0.373 . . . . 10.0 111.341 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -61.65 -44.17 97.47 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.239 -0.437 . . . . 10.0 110.64 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -56.99 -48.09 79.25 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.467 0.651 . . . . 10.0 109.571 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.607 ' O ' HG12 ' B' ' 12' ' ' ILE . 42.8 mm -63.4 -47.8 90.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.145 -0.934 . . . . 10.0 110.911 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.87 -41.26 70.62 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.983 0.421 . . . . 10.0 110.824 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.8 -31.4 70.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.904 -0.589 . . . . 10.0 110.554 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.36 -33.22 67.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.181 0.515 . . . . 10.0 109.676 179.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.715 HD12 HG12 ' C' ' 12' ' ' ILE . 18.6 mm -66.08 -50.33 69.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.572 -0.74 . . . . 10.0 111.2 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 28.8 m -65.19 -32.18 57.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.804 0.335 . . . . 10.0 110.608 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' ASN . . . . . 0.415 ' HB2' HG11 ' B' ' 51' ' ' VAL . 41.8 t30 -68.73 -48.92 62.59 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.244 -0.435 . . . . 10.0 109.954 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 15' ' ' TYR . . . . . 0.589 ' O ' HG12 ' B' ' 19' ' ' ILE . 5.5 t80 -59.54 -43.2 93.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.235 -0.439 . . . . 10.0 110.708 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 11.4 m-30 -56.82 -45.5 82.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.773 0.32 . . . . 10.0 110.315 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 74.2 m -58.54 -42.45 87.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.903 -0.59 . . . . 10.0 111.2 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 1.5 m -70.14 -21.72 63.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.377 -0.374 . . . . 10.0 111.501 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.589 HG12 ' O ' ' B' ' 15' ' ' TYR . 34.2 mm -87.27 -39.3 12.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.873 -0.331 . . . . 10.0 110.944 -178.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 30.3 m -73.33 -32.2 36.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.61 0.243 . . . . 10.0 110.469 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -65.1 -51.43 61.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.293 -0.412 . . . . 10.0 111.109 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -84.11 -4.6 58.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.329 -0.396 . . . . 10.0 111.492 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 53.0 mttm 57.03 47.44 17.51 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.49 0.662 . . . . 10.0 111.088 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.507 ' O ' ' HE2' ' C' ' 5' ' ' LYS . 80.9 mt-10 -89.31 30.01 1.03 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.702 -0.681 . . . . 10.0 110.348 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 13.3 tt -158.78 171.38 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.764 -0.828 . . . . 10.0 108.764 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.91 155.87 39.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.753 0.311 . . . . 10.0 110.368 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -59.96 -48.0 83.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.234 -0.439 . . . . 10.0 111.072 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.59 -39.17 93.7 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.197 -0.456 . . . . 10.0 109.875 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.503 ' O ' ' HG ' ' B' ' 33' ' ' LEU . . . -66.71 -31.78 79.42 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.756 -0.656 . . . . 10.0 111.514 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.74 -38.07 89.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.648 0.261 . . . . 10.0 110.546 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -66.53 -36.52 82.88 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 108.713 -0.847 . . . . 10.0 108.713 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 32' ' ' SER . . . . . 0.64 ' HB3' ' SG ' ' C' ' 39' ' ' CYS . 2.4 m -64.79 -33.36 75.81 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.18 -0.918 . . . . 10.0 110.095 178.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' B' ' 29' ' ' GLY . 25.2 mt -73.35 -40.53 64.33 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.192 -0.458 . . . . 10.0 110.099 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 55.9 m-20 -62.75 -44.86 95.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.818 -0.628 . . . . 10.0 110.986 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.452 ' CG2' ' HG3' ' A' ' 147' ' ' MET . 11.9 p -72.22 -37.53 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 116.331 -0.395 . . . . 10.0 110.564 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.7 -35.04 79.6 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 109.621 -0.511 . . . . 10.0 109.621 178.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 37' ' ' MET . . . . . . . . . . . . . 25.0 ttm -56.18 -51.62 67.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.388 -0.824 . . . . 10.0 110.028 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 38' ' ' ASP . . . . . 0.528 ' OD1' ' HD3' ' B' ' 48' ' ' ARG . 0.7 OUTLIER -69.09 -40.11 78.62 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.45 -0.795 . . . . 10.0 110.054 -179.905 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 4.5 t -52.64 -45.45 66.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.268 -0.878 . . . . 10.0 110.6 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 75.8 mt -74.42 -44.34 48.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.51 -0.768 . . . . 10.0 111.196 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.699 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 34.6 m -57.75 -43.74 85.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.85 0.357 . . . . 10.0 110.893 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -68.67 -41.73 78.85 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.955 -0.566 . . . . 10.0 110.849 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.29 -27.96 69.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.262 -0.426 . . . . 10.0 111.807 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -104.15 0.61 29.79 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.81 0.338 . . . . 10.0 111.479 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.08 46.68 84.47 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 116.052 -0.522 . . . . 10.0 113.718 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.699 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 9.2 p90 -135.51 154.91 51.24 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 117.176 0.488 . . . . 10.0 109.953 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -71.61 141.66 49.98 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.267 0.556 . . . . 10.0 112.044 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.528 ' HD3' ' OD1' ' B' ' 38' ' ' ASP . 0.1 OUTLIER -59.31 -42.47 91.47 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.066 -0.97 . . . . 10.0 110.257 179.409 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -88.69 5.23 44.18 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.084 0.772 . . . . 10.0 113.084 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.54 3.39 11.48 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.282 0.475 . . . . 10.0 112.282 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.428 HG23 ' H ' ' B' ' 52' ' ' SER . 13.0 m -43.91 -54.38 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 113.02 0.748 . . . . 10.0 113.02 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 52' ' ' SER . . . . . 0.428 ' H ' HG23 ' B' ' 51' ' ' VAL . 18.3 m -52.88 -35.94 58.49 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 113.213 0.82 . . . . 10.0 113.213 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.28 -33.79 55.99 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.128 -1.034 . . . . 10.0 112.349 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 22.7 mt -89.5 -59.5 2.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 113.759 1.022 . . . . 10.0 113.759 -178.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 60.2 mt -66.07 -67.89 0.41 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.402 0.89 . . . . 10.0 113.402 -177.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 56' ' ' GLY . . . . . 0.609 ' HA2' ' OG ' ' C' ' 71' ' ' SER . . . 77.52 -152.51 39.52 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.456 -0.878 . . . . 10.0 111.04 -177.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.75 23.65 3.64 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.564 0.697 . . . . 10.0 109.674 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 1.4 m -86.94 40.42 0.91 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.972 -1.013 . . . . 10.0 111.416 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 54.51 82.51 0.09 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.955 -0.566 . . . . 10.0 111.586 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -73.96 78.69 1.67 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.123 0.487 . . . . 10.0 110.609 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -85.3 90.4 7.9 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.074 -0.512 . . . . 10.0 110.109 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -78.0 78.43 1.55 Allowed Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.477 -0.649 . . . . 10.0 111.477 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -69.3 93.62 0.65 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.314 0.578 . . . . 10.0 110.86 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 44.8 t60 -134.11 87.29 2.35 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.643 -0.708 . . . . 10.0 109.373 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 7.3 mt -78.15 -24.77 47.19 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.467 -0.788 . . . . 10.0 110.838 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . 57.33 19.26 4.91 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.156 -0.474 . . . . 10.0 111.004 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 57.07 37.93 28.89 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.478 -0.783 . . . . 10.0 111.391 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 93.7 mt -80.99 97.05 3.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.179 0.514 . . . . 10.0 110.341 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -104.4 26.41 8.98 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.041 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -126.83 54.95 1.58 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.951 -0.568 . . . . 10.0 109.902 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.87 0.41 35.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.748 -0.66 . . . . 10.0 111.247 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.553 -0.737 . . . . 10.0 110.987 -179.486 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' -1' ' ' SER . . . . . . . . . . . . . 9.2 p . . . . . 0 N--CA 1.478 0.958 0 CA-C-O 120.924 0.392 . . . . 10.0 110.197 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 0' ' ' VAL . . . . . . . . . . . . . 3.0 t -106.65 49.27 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.434 0.635 . . . . 10.0 109.573 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -71.65 96.29 1.56 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.722 -0.672 . . . . 10.0 109.273 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.35 62.45 7.43 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.744 -0.662 . . . . 10.0 111.987 -178.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -140.95 141.95 34.41 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.1 -0.5 . . . . 10.0 109.69 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -101.56 142.82 32.36 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.934 -0.395 . . . . 10.0 109.934 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 5' ' ' LYS . . . . . 0.507 ' HE2' ' O ' ' B' ' 24' ' ' GLU . 7.2 ptpp? -62.87 -37.08 85.45 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.32 0.489 . . . . 10.0 112.32 -178.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 6' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -62.08 -43.4 98.92 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.654 0.264 . . . . 10.0 110.29 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 7' ' ' GLU . . . . . 0.487 ' O ' HD21 ' C' ' 55' ' ' LEU . 69.9 mt-10 -64.02 -49.9 70.59 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.767 -0.651 . . . . 10.0 110.249 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 8' ' ' ILE . . . . . 0.603 ' O ' HG13 ' C' ' 12' ' ' ILE . 50.0 mm -61.64 -43.72 97.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.813 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.43 -45.36 76.77 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.249 -0.432 . . . . 10.0 111.121 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.84 -34.88 79.41 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.781 -0.645 . . . . 10.0 110.867 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 1.3 mt -65.36 -32.45 74.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.573 -0.285 . . . . 10.0 110.651 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 12' ' ' ILE . . . . . 0.715 HG12 HD12 ' B' ' 12' ' ' ILE . 7.5 mt -67.71 -55.13 18.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.341 -0.391 . . . . 10.0 110.748 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 17.9 m -64.37 -30.86 51.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.812 -0.631 . . . . 10.0 111.311 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 14' ' ' ASN . . . . . 0.523 ' HB2' HG11 ' C' ' 51' ' ' VAL . 45.9 t30 -70.39 -45.72 65.41 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.126 0.488 . . . . 10.0 109.716 178.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 15' ' ' TYR . . . . . 0.6 ' CE2' HG13 ' B' ' 8' ' ' ILE . 4.7 t80 -62.84 -46.99 85.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.863 -0.608 . . . . 10.0 110.454 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -56.11 -47.58 77.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.07 -0.514 . . . . 10.0 111.356 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 37.0 m -58.92 -41.25 86.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 10.0 111.584 -179.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 3.4 p -75.21 -20.84 59.06 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.297 0.481 . . . . 10.0 112.297 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 19' ' ' ILE . . . . . 0.502 HG12 ' O ' ' C' ' 15' ' ' TYR . 20.4 mm -84.06 -35.33 10.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.771 0.32 . . . . 10.0 110.666 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 20' ' ' VAL . . . . . . . . . . . . . 29.4 m -78.7 -28.12 14.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.866 -0.333 . . . . 10.0 110.385 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.1 -50.83 62.69 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.966 0.413 . . . . 10.0 110.221 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -85.8 1.69 48.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.241 -0.436 . . . . 10.0 110.064 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 63.7 mttm 48.03 53.54 11.45 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.105 -0.952 . . . . 10.0 111.989 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -85.09 13.73 5.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.468 . . . . 10.0 110.197 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 13.5 tt -138.82 167.6 20.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.744 -0.662 . . . . 10.0 109.823 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 8.2 p -66.22 160.42 24.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.524 0.202 . . . . 10.0 110.589 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -59.69 -41.99 91.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.919 0.39 . . . . 10.0 110.53 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 28' ' ' ASP . . . . . 0.488 ' OD2' HG23 ' A' ' 81' ' ' ILE . 31.0 t70 -68.84 -39.86 79.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.971 -0.558 . . . . 10.0 109.865 179.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 29' ' ' GLY . . . . . 0.537 ' O ' ' HG ' ' C' ' 33' ' ' LEU . . . -64.57 -35.66 92.2 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.927 -0.654 . . . . 10.0 111.627 178.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.4 -45.92 91.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.345 0.593 . . . . 10.0 110.113 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -60.9 -38.22 84.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.415 -0.811 . . . . 10.0 110.025 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 3.0 t -62.09 -34.37 76.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.358 -0.837 . . . . 10.0 110.593 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 33' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' C' ' 29' ' ' GLY . 50.1 mt -74.94 -29.58 60.98 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.17 -0.468 . . . . 10.0 110.475 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -71.61 -47.57 53.82 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.428 -0.351 . . . . 10.0 110.965 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 35' ' ' VAL . . . . . 0.492 HG23 ' H ' ' A' ' 123' ' ' GLY . 2.5 p -64.16 -40.73 90.08 Favored 'Isoleucine or valine' 0 C--N 1.343 0.304 0 CA-C-O 120.684 0.278 . . . . 10.0 110.449 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.6 -35.61 79.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.847 0.356 . . . . 10.0 110.32 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 40.5 ttm -53.34 -59.89 3.99 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.585 -0.734 . . . . 10.0 111.769 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 38' ' ' ASP . . . . . 0.514 ' HB3' ' HA3' ' A' ' 123' ' ' GLY . 4.1 m-20 -65.89 -33.77 76.59 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 121.028 -0.269 . . . . 10.0 111.504 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 39' ' ' CYS . . . . . 0.64 ' SG ' ' HB3' ' B' ' 32' ' ' SER . 0.5 OUTLIER -60.86 -47.89 84.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.107 0.48 . . . . 10.0 110.064 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 40' ' ' ILE . . . . . . . . . . . . . 59.8 mt -68.34 -44.52 83.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.526 -0.761 . . . . 10.0 110.956 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 41' ' ' SER . . . . . 0.57 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 40.4 m -59.52 -45.75 90.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.063 -0.517 . . . . 10.0 111.432 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 -69.32 -40.12 77.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.312 -0.404 . . . . 10.0 110.839 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.52 -44.43 93.15 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.989 -0.55 . . . . 10.0 112.256 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 44' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -89.1 -6.82 56.77 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.633 0.254 . . . . 10.0 111.521 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.9 58.0 7.26 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 114.397 0.519 . . . . 10.0 114.397 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 46' ' ' PHE . . . . . 0.57 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 13.2 p90 -153.24 154.02 33.83 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.46 -0.57 . . . . 10.0 109.46 178.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 47' ' ' GLU . . . . . 0.432 ' HA ' ' OE1' ' C' ' 47' ' ' GLU . 0.0 OUTLIER -80.54 144.18 32.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.861 0.362 . . . . 10.0 111.155 -179.805 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 48' ' ' ARG . . . . . 0.452 ' HD3' ' OD1' ' C' ' 38' ' ' ASP . 0.0 OUTLIER -61.03 -34.94 75.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.978 -0.555 . . . . 10.0 111.001 -179.42 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.42 3.16 37.38 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.079 0.4 . . . . 10.0 112.079 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.4 1.79 47.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.805 0.336 . . . . 10.0 111.242 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 51' ' ' VAL . . . . . 0.523 HG11 ' HB2' ' C' ' 14' ' ' ASN . 5.9 m -49.72 -44.43 20.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 112.651 0.611 . . . . 10.0 112.651 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.7 -35.28 70.41 Favored 'General case' 0 C--O 1.225 -0.199 0 N-CA-C 112.461 0.541 . . . . 10.0 112.461 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.21 -28.22 58.56 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 119.712 -1.232 . . . . 10.0 112.642 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 54' ' ' ILE . . . . . . . . . . . . . 61.3 mt -89.05 -62.98 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 113.241 0.83 . . . . 10.0 113.241 -178.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 55' ' ' LEU . . . . . 0.487 HD21 ' O ' ' C' ' 7' ' ' GLU . 20.7 mt -74.81 -62.6 1.49 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.529 0.937 . . . . 10.0 113.529 -177.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.16 -119.79 6.89 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.216 -0.754 . . . . 10.0 111.216 -178.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -160.03 22.12 0.17 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.35 0.595 . . . . 10.0 110.086 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.52 44.87 1.14 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.587 -0.733 . . . . 10.0 111.617 -178.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 57.21 71.71 0.56 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.958 0.408 . . . . 10.0 110.785 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 60' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -74.66 80.44 2.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.237 0.541 . . . . 10.0 109.9 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -94.52 94.88 8.46 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.71 -0.677 . . . . 10.0 111.004 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.58 83.78 1.42 Allowed Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.127 -0.789 . . . . 10.0 111.127 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 63' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -72.67 81.98 1.13 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.229 0.538 . . . . 10.0 111.471 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 64' ' ' HIS . . . . . . . . . . . . . 65.5 t60 -115.78 73.51 0.85 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.812 -0.81 . . . . 10.0 108.812 178.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 2.2 mt -59.76 -33.43 71.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.442 -0.799 . . . . 10.0 111.439 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . 62.21 10.28 3.7 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 123.422 0.451 . . . . 10.0 110.846 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 59.59 37.02 22.78 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.636 -0.711 . . . . 10.0 110.486 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 68' ' ' ILE . . . . . . . . . . . . . 75.7 mt -76.2 106.97 6.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.977 -0.556 . . . . 10.0 110.994 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 69' ' ' LEU . . . . . 0.442 HD13 ' HA ' ' C' ' 69' ' ' LEU . 3.6 mm? -114.32 11.4 17.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.862 -0.608 . . . . 10.0 109.789 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 70' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -95.04 23.04 5.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.494 -0.775 . . . . 10.0 111.231 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 71' ' ' SER . . . . . 0.609 ' OG ' ' HA2' ' B' ' 56' ' ' GLY . 6.8 m -107.34 31.83 5.11 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.109 -0.496 . . . . 10.0 110.756 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.442 -0.79 . . . . 10.0 110.853 -179.714 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 29.9 mtm . . . . . 0 N--CA 1.48 1.068 0 N-CA-C 109.702 -0.481 . . . . 10.0 109.702 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.7 t -90.18 124.75 42.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 121.089 -0.244 . . . . 10.0 110.68 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -91.16 124.78 35.64 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.957 -0.386 . . . . 10.0 109.957 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.6 mp -126.39 133.49 51.29 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.014 0.435 . . . . 10.0 110.861 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.419 HG23 ' HG2' ' A' ' 89' ' ' GLU . 8.8 m -102.97 117.08 33.8 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.246 -0.434 . . . . 10.0 110.701 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -85.68 107.78 17.72 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.12 0.486 . . . . 10.0 110.025 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.3 tptm -106.41 98.93 8.54 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.536 -0.756 . . . . 10.0 110.457 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -99.27 114.09 26.73 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.404 -0.362 . . . . 10.0 110.308 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 57.5 mt -84.05 -57.86 4.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.823 -0.626 . . . . 10.0 111.124 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -61.96 158.94 15.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.883 -0.598 . . . . 10.0 112.066 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -77.94 138.76 61.35 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.924 -0.58 . . . . 10.0 112.318 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -76.33 130.66 21.97 Favored 'Cis proline' 0 C--O 1.235 0.334 0 C-N-CA 123.247 -1.564 . . . . 10.0 110.619 -1.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.49 153.26 22.58 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.253 0.549 . . . . 10.0 111.459 -178.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.453 ' CE1' ' HB3' ' A' ' 110' ' ' LYS . 47.6 p90 -168.15 160.01 11.42 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.173 -0.921 . . . . 10.0 109.416 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.0 m -143.09 98.77 3.33 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.863 -0.791 . . . . 10.0 108.863 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 24.1 pt -119.75 153.44 22.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.18 -0.464 . . . . 10.0 111.048 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.419 ' HG2' HG23 ' A' ' 77' ' ' THR . 43.3 mt-10 -115.62 127.6 55.33 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 109.246 -0.649 . . . . 10.0 109.246 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.54 157.0 44.77 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.065 0.46 . . . . 10.0 110.402 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -114.54 137.79 51.44 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.126 -0.488 . . . . 10.0 109.911 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -129.75 165.09 22.6 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.251 -0.431 . . . . 10.0 110.416 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.537 ' O ' HD12 ' A' ' 132' ' ' LEU . 7.3 m -75.78 147.37 81.04 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.119 -0.492 . . . . 10.0 110.568 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.47 -22.57 59.75 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.864 2.376 . . . . 10.0 113.322 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.59 18.12 22.35 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.962 0.411 . . . . 10.0 110.791 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.47 ' HB2' ' O ' ' A' ' 93' ' ' SER . 0.3 OUTLIER -80.34 162.82 24.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.98 0.419 . . . . 10.0 110.83 179.872 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.6 m -109.38 150.77 27.56 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.976 -0.556 . . . . 10.0 111.506 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 37.8 mm -61.86 -22.05 27.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.272 0.558 . . . . 10.0 110.379 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.13 -38.45 68.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.281 -0.872 . . . . 10.0 110.418 178.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 73.3 mm-40 -62.09 -44.38 96.78 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.136 -0.484 . . . . 10.0 111.137 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.554 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 35.6 mt -63.7 -50.09 79.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.839 -0.619 . . . . 10.0 109.875 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -55.37 -44.55 76.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.626 -0.716 . . . . 10.0 110.854 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -63.73 -39.19 93.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 10.0 110.905 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -63.57 -39.81 95.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.131 -0.486 . . . . 10.0 110.918 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 101' ' ' ILE . 40.9 mt -62.13 -42.19 99.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.867 0.365 . . . . 10.0 110.478 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 48.8 mt -68.81 -44.24 82.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.439 -0.346 . . . . 10.0 110.563 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.5 m -61.07 -27.45 68.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.848 -0.615 . . . . 10.0 111.82 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -95.8 12.86 28.55 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 120.797 0.332 . . . . 10.0 111.145 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 59.76 34.43 21.96 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.696 -0.684 . . . . 10.0 111.925 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.453 ' HB3' ' CE1' ' A' ' 86' ' ' PHE . 17.5 mmtp -107.2 -7.17 16.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.324 0.583 . . . . 10.0 110.472 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.487 ' HB2' HD13 ' A' ' 148' ' ' ILE . . . -141.67 142.02 33.36 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.439 -0.8 . . . . 10.0 109.81 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.33 -41.84 17.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.728 0.299 . . . . 10.0 111.387 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.404 ' O ' HG13 ' A' ' 117' ' ' ILE . 2.6 t-80 -151.69 141.59 22.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.613 -0.267 . . . . 10.0 110.845 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.489 ' HA ' HD12 ' A' ' 117' ' ' ILE . 4.1 tt -62.21 -41.92 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 116.279 -0.419 . . . . 10.0 111.876 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.508 ' HB2' ' OE2' ' A' ' 116' ' ' GLU . 11.2 m -53.67 -17.93 2.61 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.922 0.712 . . . . 10.0 112.922 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.508 ' OE2' ' HB2' ' A' ' 115' ' ' SER . 0.9 OUTLIER -109.74 7.27 24.19 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 122.102 -0.374 . . . . 10.0 111.341 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.489 HD12 ' HA ' ' A' ' 114' ' ' ILE . 66.1 mt -93.48 120.68 43.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.635 -0.505 . . . . 10.0 109.635 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.9 mmmt -124.24 118.57 27.11 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.297 -0.41 . . . . 10.0 110.377 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.448 ' O ' ' HB2' ' A' ' 126' ' ' LEU . 3.9 mm? -95.52 110.73 22.76 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.397 -0.365 . . . . 10.0 110.757 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.647 HD21 HG11 ' B' ' 35' ' ' VAL . 2.7 mm? -101.26 107.36 18.71 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.491 -0.929 . . . . 10.0 108.491 177.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.402 HD13 HD13 ' A' ' 144' ' ' ILE . 5.0 tp -90.94 101.22 13.99 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.713 0.768 . . . . 10.0 109.278 178.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.431 ' HD2' ' HA ' ' A' ' 122' ' ' LYS . 13.5 tptp 52.33 56.34 7.85 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 113.957 -1.474 . . . . 10.0 109.142 -177.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.758 ' HA2' ' SG ' ' C' ' 39' ' ' CYS . . . 79.05 -43.56 2.48 Favored Glycine 0 C--O 1.228 -0.245 0 CA-C-N 114.581 -1.191 . . . . 10.0 112.509 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 22.0 tttp -58.07 119.65 7.17 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.001 -0.6 . . . . 10.0 111.351 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.4 p -72.34 136.38 25.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 113.562 0.949 . . . . 10.0 113.562 -177.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' A' ' 119' ' ' LEU . 1.5 mp -102.31 156.83 17.33 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 114.901 -1.045 . . . . 10.0 109.332 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 62.6 m-70 -116.65 152.73 33.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.061 0.458 . . . . 10.0 110.822 -178.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -52.77 -52.23 57.47 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.575 0.954 . . . . 10.0 113.575 -178.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -89.42 11.05 20.37 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.002 0.371 . . . . 10.0 112.002 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.1 tp -74.03 146.58 43.63 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.905 0.383 . . . . 10.0 111.022 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -106.54 150.56 26.01 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.927 -0.578 . . . . 10.0 110.003 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.537 HD12 ' O ' ' A' ' 93' ' ' SER . 81.4 mt -58.22 -31.73 67.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.015 0.436 . . . . 10.0 111.282 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.1 -33.08 67.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.892 -0.595 . . . . 10.0 111.218 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -77.39 -44.9 27.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.277 -0.42 . . . . 10.0 111.29 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.5 pp -74.08 -25.76 59.99 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.8 -0.36 . . . . 10.0 111.1 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt 65.1 93.01 0.07 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.238 0.542 . . . . 10.0 111.758 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.8 t -71.68 112.24 6.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.975 -0.557 . . . . 10.0 110.06 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.12 125.05 84.29 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.515 -0.311 . . . . 10.0 110.916 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.1 -12.67 36.95 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.068 2.512 . . . . 10.0 112.633 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -82.8 -0.86 49.85 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.241 0.543 . . . . 10.0 110.367 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 55.1 m-20 -131.7 -71.32 0.56 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.629 -0.714 . . . . 10.0 109.271 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 31.9 m 58.16 17.75 4.79 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.491 -0.777 . . . . 10.0 111.649 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.22 124.22 47.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.22 -0.445 . . . . 10.0 110.689 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.402 HD13 HD13 ' A' ' 121' ' ' LEU . 4.5 mm -110.96 124.4 67.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.324 -0.621 . . . . 10.0 109.324 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.54 129.99 34.99 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.684 -0.488 . . . . 10.0 109.684 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 2.2 t -107.65 131.14 58.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.349 0.595 . . . . 10.0 111.252 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' MET . . . . . 0.41 ' SD ' HD23 ' A' ' 120' ' ' LEU . 1.8 mpt? -129.72 125.31 35.63 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.201 -1.037 . . . . 10.0 108.201 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.487 HD13 ' HB2' ' A' ' 111' ' ' ALA . 47.6 mt -135.84 139.4 46.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 116.562 -0.29 . . . . 10.0 110.326 -178.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -101.69 113.72 65.78 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 109.053 -0.721 . . . . 10.0 109.053 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.44 118.28 5.47 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.387 2.058 . . . . 10.0 112.863 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -92.54 -3.17 55.51 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.723 -0.671 . . . . 10.0 109.469 178.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 98.1 mt -102.32 128.22 48.97 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.581 -0.736 . . . . 10.0 110.329 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.476 -0.773 . . . . 10.0 110.345 179.984 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' -1' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.476 0.87 0 CA-C-O 120.787 0.327 . . . . 10.0 110.895 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 0' ' ' VAL . . . . . . . . . . . . . 29.9 m -117.01 -168.15 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.054 -0.521 . . . . 10.0 110.491 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 1' ' ' ASP . . . . . 0.452 ' OD2' ' HG3' ' B' ' 61' ' ' LYS . 32.4 t70 -159.92 -81.45 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.651 -0.25 . . . . 10.0 110.505 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 15.6 t -161.59 26.36 0.12 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.375 0.607 . . . . 10.0 110.343 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -116.35 144.69 43.94 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.856 -0.611 . . . . 10.0 109.859 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 51.8 p -97.75 177.2 5.55 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.612 -0.435 . . . . 10.0 109.898 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' LYS . . . . . 0.455 ' HB2' ' CE1' ' B' ' 44' ' ' PHE . 7.8 ptpp? -57.81 -41.17 81.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.368 -0.378 . . . . 10.0 110.859 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -59.87 -50.46 73.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 10.0 111.811 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -59.1 -42.37 90.32 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.705 0.288 . . . . 10.0 110.852 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.607 ' O ' HG13 ' B' ' 12' ' ' ILE . 47.8 mm -62.02 -47.5 92.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.77 -0.455 . . . . 10.0 109.77 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.521 ' HA ' HD12 ' B' ' 12' ' ' ILE . . . -57.43 -41.99 81.5 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.75 -0.659 . . . . 10.0 111.053 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.03 -36.9 85.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.108 -0.496 . . . . 10.0 110.597 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 23.9 mt -69.64 -33.52 72.74 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.789 -0.448 . . . . 10.0 109.789 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.607 HG13 ' O ' ' B' ' 8' ' ' ILE . 86.1 mt -64.07 -57.0 13.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.984 -0.553 . . . . 10.0 111.025 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 29.4 m -59.41 -32.84 49.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.21 -0.45 . . . . 10.0 111.274 -178.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -72.19 -46.18 57.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.244 -0.434 . . . . 10.0 110.835 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' TYR . . . . . 0.545 ' O ' HG12 ' B' ' 19' ' ' ILE . 2.1 m-85 -68.89 -46.82 67.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.453 -0.34 . . . . 10.0 111.459 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -55.26 -52.15 64.34 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.683 0.278 . . . . 10.0 111.179 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 17' ' ' SER . . . . . 0.506 ' O ' ' HB2' ' B' ' 21' ' ' GLU . 18.8 p -59.53 -38.06 80.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.408 -0.36 . . . . 10.0 111.369 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 76.6 p -74.89 -20.72 59.6 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.073 0.397 . . . . 10.0 112.073 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.545 HG12 ' O ' ' B' ' 15' ' ' TYR . 25.9 mm -80.39 -42.48 21.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.165 0.507 . . . . 10.0 109.808 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 19.5 m -75.92 -27.78 18.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.775 -0.648 . . . . 10.0 110.433 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 21' ' ' GLU . . . . . 0.506 ' HB2' ' O ' ' B' ' 17' ' ' SER . 2.4 tp10 -70.06 -42.51 72.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.124 -0.489 . . . . 10.0 110.33 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 30.9 mtmt -78.36 -1.68 34.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 10.0 110.755 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 66.6 mmtt 55.73 38.84 30.61 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.745 -0.662 . . . . 10.0 110.847 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.563 ' O ' ' HE2' ' C' ' 5' ' ' LYS . 25.1 mt-10 -90.55 24.31 2.69 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.27 -0.423 . . . . 10.0 111.497 -178.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 17.6 tt -155.31 161.16 2.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.401 -0.363 . . . . 10.0 110.128 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.62 160.42 32.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.471 -0.332 . . . . 10.0 110.524 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -57.89 -46.25 85.2 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 111.738 0.273 . . . . 10.0 111.738 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -56.52 -42.08 77.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.846 0.355 . . . . 10.0 110.301 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.67 -42.67 61.9 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.021 -0.609 . . . . 10.0 111.912 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.85 -36.66 77.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.93 0.395 . . . . 10.0 110.526 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -71.82 -43.01 66.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.791 -0.64 . . . . 10.0 110.139 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 38.5 m -63.12 -38.64 91.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.69 -0.687 . . . . 10.0 110.282 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 92.7 mt -72.79 -39.27 66.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.255 -0.43 . . . . 10.0 110.316 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -61.33 -46.19 91.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.125 -0.489 . . . . 10.0 111.242 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.647 HG11 HD21 ' A' ' 120' ' ' LEU . 13.1 p -71.18 -34.62 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 116.516 -0.311 . . . . 10.0 110.342 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.12 -38.06 87.25 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.458 -0.571 . . . . 10.0 109.458 178.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' MET . . . . . . . . . . . . . 18.0 ttm -57.43 -44.46 84.69 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.688 -0.687 . . . . 10.0 110.01 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -60.88 -45.8 93.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.676 -0.693 . . . . 10.0 110.58 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 76.0 m -62.85 -40.99 99.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.0 -0.546 . . . . 10.0 110.384 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' ILE . . . . . 0.515 HD13 HG21 ' B' ' 12' ' ' ILE . 89.3 mt -65.32 -47.01 88.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.033 -0.53 . . . . 10.0 111.001 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.647 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 48.9 m -59.07 -42.3 90.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.86 0.362 . . . . 10.0 111.064 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -72.48 -39.46 67.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.247 -0.433 . . . . 10.0 111.232 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.59 -43.14 93.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.32 -0.4 . . . . 10.0 111.997 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 44' ' ' PHE . . . . . 0.455 ' CE1' ' HB2' ' B' ' 5' ' ' LYS . 58.0 m-85 -87.08 -4.28 59.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.679 -0.237 . . . . 10.0 111.377 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 62.46 52.22 50.66 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.238 -0.506 . . . . 10.0 113.023 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.647 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 4.7 p90 -146.58 164.46 32.55 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.241 -0.281 . . . . 10.0 110.241 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.99 148.87 21.86 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.436 -0.347 . . . . 10.0 110.496 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.411 ' HG3' ' H ' ' B' ' 48' ' ' ARG . 6.6 mtm180 -65.83 -32.92 74.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.317 0.579 . . . . 10.0 110.611 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -78.75 4.2 14.48 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.416 -0.811 . . . . 10.0 112.269 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.41 3.1 29.42 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.771 0.319 . . . . 10.0 110.386 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.537 HG23 ' H ' ' B' ' 52' ' ' SER . 0.8 OUTLIER -44.97 -64.01 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 115.54 -0.754 . . . . 10.0 112.804 -179.142 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 52' ' ' SER . . . . . 0.537 ' H ' HG23 ' B' ' 51' ' ' VAL . 0.2 OUTLIER -53.49 -30.01 39.05 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.688 0.625 . . . . 10.0 112.688 -179.901 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.14 -44.61 22.62 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.562 -0.828 . . . . 10.0 112.793 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 48.4 mt -82.58 -46.33 19.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 112.233 0.457 . . . . 10.0 112.233 -178.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 67.3 mt -73.16 -57.31 4.11 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.837 0.351 . . . . 10.0 111.071 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.72 -143.31 45.14 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.591 -0.814 . . . . 10.0 111.468 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 57' ' ' LYS . . . . . 0.427 ' HA ' ' HE2' ' C' ' 64' ' ' HIS . 48.7 tttt -109.83 14.03 23.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.187 0.518 . . . . 10.0 110.213 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 5.1 m -79.34 138.54 37.74 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.842 -0.617 . . . . 10.0 110.408 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.51 145.3 26.85 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.049 0.452 . . . . 10.0 110.574 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -106.69 172.09 7.0 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.029 -0.532 . . . . 10.0 109.957 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 61' ' ' LYS . . . . . 0.456 ' HA ' ' HA ' ' C' ' 61' ' ' LYS . 6.3 ptmm? -163.47 172.68 14.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.85 0.357 . . . . 10.0 110.882 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -146.01 52.99 0.56 Allowed Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 110.86 -0.896 . . . . 10.0 110.86 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -73.25 125.81 28.65 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.097 0.475 . . . . 10.0 110.571 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 50.4 p-80 -148.04 113.2 5.53 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.78 -0.645 . . . . 10.0 110.456 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -82.58 -12.52 57.65 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.135 -0.691 . . . . 10.0 109.135 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -86.38 135.9 33.33 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.087 -0.96 . . . . 10.0 110.594 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.86 149.88 46.34 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.86 -0.609 . . . . 10.0 110.306 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 10.7 mt -91.21 88.42 2.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.234 -0.654 . . . . 10.0 109.234 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 31.6 mt 72.26 -85.1 0.03 OUTLIER 'General case' 0 C--O 1.233 0.193 0 CA-C-N 114.987 -1.006 . . . . 10.0 110.022 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -131.45 -10.89 3.61 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.724 0.297 . . . . 10.0 110.237 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 30.7 m 61.48 25.93 15.77 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.853 -0.612 . . . . 10.0 112.043 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.152 0 CA-C-O 119.013 -0.518 . . . . 10.0 110.571 179.423 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' -1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.477 0.889 0 CA-C-O 120.515 0.198 . . . . 10.0 110.671 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 0' ' ' VAL . . . . . . . . . . . . . 27.7 m -110.66 -164.99 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.398 -0.364 . . . . 10.0 110.53 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 1' ' ' ASP . . . . . 0.542 ' OD1' ' HG3' ' C' ' 61' ' ' LYS . 6.5 t70 -156.76 -72.43 0.1 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.21 0.528 . . . . 10.0 109.804 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 43.9 t -165.12 16.35 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.406 -0.815 . . . . 10.0 109.738 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -103.23 150.94 23.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.253 -0.431 . . . . 10.0 110.652 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 4' ' ' SER . . . . . . . . . . . . . 21.6 p -108.99 167.96 9.71 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.265 -0.425 . . . . 10.0 110.047 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 5' ' ' LYS . . . . . 0.563 ' HE2' ' O ' ' B' ' 24' ' ' GLU . 6.6 ptpp? -55.27 -42.28 73.33 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.445 0.535 . . . . 10.0 112.445 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 6' ' ' GLU . . . . . 0.448 ' H ' ' HG2' ' C' ' 6' ' ' GLU . 5.7 pt-20 -62.64 -38.79 91.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.497 -0.319 . . . . 10.0 111.788 -178.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -76.22 -40.64 51.62 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.619 0.247 . . . . 10.0 110.866 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 8' ' ' ILE . . . . . 0.409 HG13 ' CE1' ' B' ' 15' ' ' TYR . 17.0 mm -60.93 -46.34 96.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.33 -0.395 . . . . 10.0 110.361 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.18 -41.67 97.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.108 -0.496 . . . . 10.0 110.072 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.84 -44.61 95.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.633 -0.712 . . . . 10.0 110.811 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.35 -37.95 89.24 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.041 -0.527 . . . . 10.0 110.934 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 12' ' ' ILE . . . . . 0.405 HD13 ' O ' ' C' ' 8' ' ' ILE . 1.3 mp -68.23 -47.73 76.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.179 -0.464 . . . . 10.0 111.606 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 35.9 m -65.91 -25.16 35.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-O 121.136 0.493 . . . . 10.0 110.175 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.91 -41.91 50.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.925 -0.579 . . . . 10.0 109.778 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 15' ' ' TYR . . . . . 0.527 ' O ' HG12 ' C' ' 19' ' ' ILE . 0.5 OUTLIER -72.59 -37.44 68.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.567 -179.637 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -59.77 -47.84 84.06 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.373 -0.376 . . . . 10.0 110.787 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 17' ' ' SER . . . . . 0.491 ' O ' ' HB2' ' C' ' 21' ' ' GLU . 2.6 p -61.48 -42.42 98.75 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.645 -0.252 . . . . 10.0 110.945 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 2.0 p -68.22 -25.51 65.24 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 111.865 0.32 . . . . 10.0 111.865 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 19' ' ' ILE . . . . . 0.527 HG12 ' O ' ' C' ' 15' ' ' TYR . 20.8 mm -78.65 -42.99 25.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 121.057 0.456 . . . . 10.0 110.448 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 20' ' ' VAL . . . . . . . . . . . . . 16.1 m -77.11 -23.69 14.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.869 0.366 . . . . 10.0 110.267 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 21' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' C' ' 17' ' ' SER . 5.0 tp10 -63.51 -51.2 66.53 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.341 -0.614 . . . . 10.0 109.341 178.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -77.01 -5.24 47.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.04 -0.982 . . . . 10.0 111.483 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm 58.03 42.93 21.82 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.317 0.579 . . . . 10.0 109.708 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 24' ' ' GLU . . . . . 0.445 ' O ' ' HE2' ' B' ' 5' ' ' LYS . 9.0 mt-10 -81.48 3.14 25.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.547 -0.751 . . . . 10.0 110.922 -178.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 18.2 tt -141.88 152.33 18.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 109.415 -0.587 . . . . 10.0 109.415 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.33 161.41 5.61 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 123.426 0.454 . . . . 10.0 111.844 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -54.27 -42.51 70.06 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.376 -0.374 . . . . 10.0 111.113 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.37 -49.9 71.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.774 -0.648 . . . . 10.0 110.493 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 29' ' ' GLY . . . . . 0.669 ' O ' ' HG ' ' C' ' 33' ' ' LEU . . . -68.64 -44.29 72.03 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.696 -0.684 . . . . 10.0 111.979 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.54 -45.67 81.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.87 0.367 . . . . 10.0 111.163 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -62.92 -44.81 95.08 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.969 -0.559 . . . . 10.0 110.076 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 53.5 m -60.59 -40.41 91.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.634 -0.712 . . . . 10.0 110.944 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 33' ' ' LEU . . . . . 0.669 ' HG ' ' O ' ' C' ' 29' ' ' GLY . 34.9 mt -67.16 -36.66 82.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.636 -0.256 . . . . 10.0 110.538 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -58.74 -57.76 11.59 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.083 -0.508 . . . . 10.0 111.013 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 35' ' ' VAL . . . . . . . . . . . . . 3.0 p -65.39 -38.53 82.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.394 -0.366 . . . . 10.0 111.194 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.48 -32.49 70.31 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.636 0.255 . . . . 10.0 110.918 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 49.1 mtm -60.92 -44.04 97.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.244 -0.435 . . . . 10.0 110.702 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 38' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -69.68 -30.96 68.74 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 109.819 -0.438 . . . . 10.0 109.819 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 39' ' ' CYS . . . . . 0.758 ' SG ' ' HA2' ' A' ' 123' ' ' GLY . 32.0 m -63.18 -48.22 79.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.28 0.562 . . . . 10.0 109.642 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 40' ' ' ILE . . . . . . . . . . . . . 66.4 mt -66.76 -45.68 87.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.21 -0.905 . . . . 10.0 110.776 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 41' ' ' SER . . . . . 0.519 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 27.9 m -62.31 -42.12 99.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.83 -0.623 . . . . 10.0 111.7 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -68.04 -39.99 82.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.869 0.366 . . . . 10.0 110.47 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.88 -49.21 78.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.777 -0.647 . . . . 10.0 111.967 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 44' ' ' PHE . . . . . 0.506 ' CE1' ' HB2' ' C' ' 5' ' ' LYS . 86.4 m-85 -88.17 -3.2 58.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.791 0.329 . . . . 10.0 111.477 -179.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.75 64.31 4.42 Favored Glycine 0 C--N 1.331 0.253 0 CA-C-N 116.116 -0.493 . . . . 10.0 113.781 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 46' ' ' PHE . . . . . 0.519 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 13.8 p90 -153.29 157.57 40.32 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.18 -0.304 . . . . 10.0 110.18 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 19.3 mp0 -83.98 137.92 33.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.4 -0.364 . . . . 10.0 110.614 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 48' ' ' ARG . . . . . 0.404 ' H ' ' HG3' ' C' ' 48' ' ' ARG . 7.8 mtm180 -65.78 -36.24 82.96 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.503 0.668 . . . . 10.0 110.229 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -79.95 15.0 1.57 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.114 -0.948 . . . . 10.0 111.782 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -104.15 1.05 30.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.968 0.413 . . . . 10.0 110.596 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 4.1 m -45.72 -42.06 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 113.053 0.76 . . . . 10.0 113.053 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 52' ' ' SER . . . . . . . . . . . . . 1.5 m -58.16 -28.53 64.81 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.325 0.491 . . . . 10.0 112.325 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.41 -28.25 27.95 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.66 -0.781 . . . . 10.0 112.408 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 54' ' ' ILE . . . . . . . . . . . . . 35.3 mt -85.21 -62.13 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.726 0.298 . . . . 10.0 110.913 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 47.5 mt -63.2 -44.31 95.71 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.777 -0.647 . . . . 10.0 110.854 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.34 -132.71 52.09 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.942 -0.647 . . . . 10.0 112.752 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 22.1 tttt -116.96 11.41 14.32 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.931 0.396 . . . . 10.0 110.237 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 2.0 m -78.19 136.81 37.89 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.798 -0.637 . . . . 10.0 110.984 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 59' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' C' ' 59' ' ' GLU . 1.1 pm0 -87.68 116.59 25.92 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.049 0.452 . . . . 10.0 109.879 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 60' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -78.02 167.99 20.58 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.231 -0.441 . . . . 10.0 110.619 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 61' ' ' LYS . . . . . 0.542 ' HG3' ' OD1' ' C' ' 1' ' ' ASP . 4.9 ptmm? -148.86 164.42 34.51 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.346 -0.388 . . . . 10.0 110.894 -179.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -147.74 55.79 0.51 Allowed Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.229 -0.749 . . . . 10.0 111.229 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 63' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -84.21 144.18 29.12 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.801 0.334 . . . . 10.0 110.391 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 64' ' ' HIS . . . . . 0.427 ' HE2' ' HA ' ' B' ' 57' ' ' LYS . 27.0 p-80 -153.99 107.52 2.95 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.001 0.429 . . . . 10.0 110.349 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -76.59 -13.49 60.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.768 -0.651 . . . . 10.0 109.979 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -89.57 151.36 21.98 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.651 -0.704 . . . . 10.0 109.896 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -83.71 148.2 27.21 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.114 -0.328 . . . . 10.0 110.114 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 68' ' ' ILE . . . . . . . . . . . . . 49.3 mt -84.68 83.17 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.028 0.442 . . . . 10.0 109.972 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 61.8 mt 63.53 -87.02 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.008 -0.996 . . . . 10.0 111.071 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 70' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -118.93 -11.53 9.69 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.207 -0.451 . . . . 10.0 111.308 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 71' ' ' SER . . . . . . . . . . . . . 11.4 m 58.1 30.0 18.67 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 123.566 0.541 . . . . 10.0 110.456 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.149 0 CA-C-O 118.196 -0.907 . . . . 10.0 110.095 -179.207 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 33.6 mtm . . . . . 0 N--CA 1.477 0.92 0 N-CA-C 110.277 -0.268 . . . . 10.0 110.277 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.9 t -115.4 130.94 69.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.609 -0.515 . . . . 10.0 109.609 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -87.41 125.31 34.19 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.836 0.35 . . . . 10.0 110.181 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 mp -120.94 122.29 39.86 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.679 -0.489 . . . . 10.0 109.679 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.7 m -101.01 113.93 27.39 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 110.089 -0.337 . . . . 10.0 110.089 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.463 ' O ' ' HA ' ' A' ' 87' ' ' SER . 2.8 mm? -88.41 117.73 27.54 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.183 -0.303 . . . . 10.0 110.183 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -114.63 99.19 7.35 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.923 -0.58 . . . . 10.0 109.714 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 85' ' ' LYS . 19.4 tptm -88.39 113.67 24.22 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.827 -0.624 . . . . 10.0 109.963 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 96.0 mt -81.46 -54.73 9.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.65 -0.704 . . . . 10.0 111.215 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -66.67 162.98 19.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.15 -0.477 . . . . 10.0 111.722 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.91 139.09 40.0 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.123 -0.49 . . . . 10.0 111.437 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.404 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 7.9 Cg_exo -75.37 132.11 26.48 Favored 'Cis proline' 0 C--O 1.236 0.382 0 C-N-CA 123.047 -1.647 . . . . 10.0 110.378 -1.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -91.7 159.05 16.04 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.823 0.344 . . . . 10.0 111.458 -178.413 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -176.27 169.42 2.74 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.71 -0.677 . . . . 10.0 109.985 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 70.0 m -146.81 110.25 4.85 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.15 0.5 . . . . 10.0 110.184 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 33.8 pt -122.54 147.63 26.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.862 -0.608 . . . . 10.0 110.915 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -119.23 122.53 42.16 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.969 -0.56 . . . . 10.0 110.044 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -142.52 164.86 28.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.567 -0.288 . . . . 10.0 110.399 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.98 136.31 51.48 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.091 0.472 . . . . 10.0 110.565 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -126.81 170.2 12.43 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.741 -0.663 . . . . 10.0 109.684 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.568 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 5.3 m -92.31 148.27 36.2 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 109.862 -0.422 . . . . 10.0 109.862 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -51.8 -31.01 40.36 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.738 2.292 . . . . 10.0 112.683 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.75 10.84 19.45 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 112.295 0.48 . . . . 10.0 112.295 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.568 ' HB2' ' O ' ' A' ' 93' ' ' SER . 0.5 OUTLIER -81.03 152.72 27.78 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.746 -0.464 . . . . 10.0 109.746 179.111 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.17 154.39 21.26 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.156 -0.474 . . . . 10.0 110.068 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 39.3 mm -63.28 -21.87 29.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.53 0.681 . . . . 10.0 109.364 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.27 -44.04 75.24 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 114.756 -1.111 . . . . 10.0 110.474 178.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -62.79 -41.93 99.48 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.7 -0.682 . . . . 10.0 110.733 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.512 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 49.3 mt -60.64 -48.59 88.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.673 -0.694 . . . . 10.0 109.932 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.407 ' HA ' HD12 ' A' ' 105' ' ' LEU . 84.6 mttt -54.06 -43.79 70.56 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.219 -0.9 . . . . 10.0 111.609 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -62.78 -35.56 80.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.011 0.434 . . . . 10.0 110.589 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.577 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 36.1 t60 -66.08 -37.78 86.64 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.088 -0.505 . . . . 10.0 110.627 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 101' ' ' ILE . 11.3 mt -63.9 -40.12 95.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.208 0.528 . . . . 10.0 110.179 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 32.8 mt -69.97 -38.04 74.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.911 -0.586 . . . . 10.0 109.558 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 32.4 t -66.72 -22.28 66.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.396 -0.82 . . . . 10.0 111.076 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.577 ' HG2' ' O ' ' A' ' 104' ' ' HIS . 19.9 mm-40 -94.08 11.65 29.14 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 121.071 -0.252 . . . . 10.0 110.399 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 58.58 30.09 19.35 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.014 -0.539 . . . . 10.0 111.235 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.5 mmpp? -106.57 -5.67 18.58 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.127 -0.488 . . . . 10.0 110.513 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.613 ' HB2' HD13 ' A' ' 148' ' ' ILE . . . -135.54 154.44 51.38 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.711 -0.677 . . . . 10.0 109.946 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.7 m -107.81 -30.39 8.55 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.914 -0.315 . . . . 10.0 111.624 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.423 ' O ' HG13 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -152.75 136.83 16.41 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.22 -0.289 . . . . 10.0 110.22 -178.694 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.419 ' HA ' HD12 ' A' ' 117' ' ' ILE . 15.8 tt -65.77 -36.24 77.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.567 0.699 . . . . 10.0 109.983 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.533 ' HB2' ' OE2' ' A' ' 116' ' ' GLU . 0.7 OUTLIER -50.23 -34.98 24.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.278 -1.328 . . . . 10.0 113.232 179.398 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.533 ' OE2' ' HB2' ' A' ' 115' ' ' SER . 1.0 OUTLIER -99.08 12.01 37.34 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.402 0.519 . . . . 10.0 112.402 -178.707 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 113' ' ' HIS . 57.0 mt -93.71 121.07 44.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.64 -0.424 . . . . 10.0 110.5 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.1 mmmt -121.79 114.4 21.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.297 -0.41 . . . . 10.0 110.464 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.406 ' HA ' HD13 ' A' ' 119' ' ' LEU . 2.9 mm? -91.4 128.23 37.15 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.976 0.417 . . . . 10.0 111.241 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.643 HD21 HG11 ' B' ' 35' ' ' VAL . 2.8 mm? -116.01 137.43 52.12 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.982 -0.748 . . . . 10.0 108.982 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 16.5 tp -121.06 95.68 4.79 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.26 -1.015 . . . . 10.0 108.26 178.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.436 ' HD2' ' HA ' ' A' ' 122' ' ' LYS . 4.1 tptp 42.36 60.32 2.38 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.11 -0.95 . . . . 10.0 110.584 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.594 ' HA2' ' SG ' ' C' ' 39' ' ' CYS . . . 86.69 -46.05 3.52 Favored Glycine 0 C--N 1.331 0.299 0 CA-C-N 115.792 -0.64 . . . . 10.0 113.238 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.9 tttp -60.46 121.23 11.58 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 120.631 0.253 . . . . 10.0 110.554 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.472 ' HA ' HD13 ' A' ' 120' ' ' LEU . 12.8 p -79.59 136.49 23.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.097 0.475 . . . . 10.0 111.458 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.2 mp -106.03 157.31 17.61 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.041 -0.527 . . . . 10.0 111.202 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.429 ' H ' HD22 ' A' ' 130' ' ' LEU . 85.5 m-70 -116.98 158.5 24.0 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 116.315 -0.402 . . . . 10.0 110.433 -178.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.64 -48.25 82.39 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.491 -0.777 . . . . 10.0 112.143 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -82.97 5.52 21.76 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.93 -0.577 . . . . 10.0 111.162 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.429 HD22 ' H ' ' A' ' 127' ' ' HIS . 4.0 tp -73.84 139.58 45.17 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.114 0.483 . . . . 10.0 111.447 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -102.82 148.8 25.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.382 -0.826 . . . . 10.0 109.641 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 60.4 mt -56.51 -39.11 72.75 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.991 0.367 . . . . 10.0 111.991 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.8 p -75.58 -19.19 59.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.821 0.343 . . . . 10.0 111.076 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -81.28 -42.5 20.55 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.253 -0.43 . . . . 10.0 111.255 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.2 pp -82.62 -22.51 34.71 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 121.084 -0.246 . . . . 10.0 110.876 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt 67.58 88.46 0.11 Allowed 'General case' 0 N--CA 1.463 0.218 0 O-C-N 123.723 0.639 . . . . 10.0 110.755 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 30.8 t -63.72 105.85 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.613 -0.721 . . . . 10.0 110.644 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.79 117.43 35.22 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.895 -0.593 . . . . 10.0 111.403 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -67.85 -11.75 33.11 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.822 2.348 . . . . 10.0 112.718 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -88.69 6.44 38.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.507 0.67 . . . . 10.0 110.014 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -134.97 -66.35 0.59 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.193 -0.912 . . . . 10.0 109.295 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.1 m 52.71 22.92 2.45 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.205 -0.907 . . . . 10.0 112.2 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 36.4 m -123.69 125.72 45.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.05 0.452 . . . . 10.0 110.188 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.27 117.59 55.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 108.292 -1.003 . . . . 10.0 108.292 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.37 126.6 31.38 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.318 -0.623 . . . . 10.0 109.318 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.2 t -99.7 130.75 48.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.89 -0.595 . . . . 10.0 112.095 -177.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -122.64 117.71 26.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.089 -0.96 . . . . 10.0 109.257 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.613 HD13 ' HB2' ' A' ' 111' ' ' ALA . 21.1 mt -138.3 143.73 32.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.503 -0.317 . . . . 10.0 111.175 -177.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -112.2 117.98 46.72 Favored Pre-proline 0 N--CA 1.452 -0.371 0 CA-C-N 116.339 -0.391 . . . . 10.0 110.093 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -67.07 112.83 2.62 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.535 2.157 . . . . 10.0 112.653 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -85.46 -22.16 28.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.058 0.456 . . . . 10.0 110.34 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 90.3 mt -71.71 130.6 41.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.59 -0.732 . . . . 10.0 110.488 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.95 0 CA-C-O 118.399 -0.81 . . . . 10.0 110.253 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' -1' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.476 0.839 0 N-CA-C 110.434 -0.21 . . . . 10.0 110.434 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 0' ' ' VAL . . . . . . . . . . . . . 16.2 m -123.47 -165.87 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.223 -0.444 . . . . 10.0 110.852 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -161.34 -80.93 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.075 0.464 . . . . 10.0 109.955 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 37.2 m -163.48 7.08 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.488 -0.778 . . . . 10.0 110.087 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.97 147.24 24.41 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.904 -0.589 . . . . 10.0 109.891 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 48.9 p -91.43 169.27 10.92 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.919 0.39 . . . . 10.0 111.008 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -59.38 -44.07 92.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.977 -0.556 . . . . 10.0 111.106 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -61.21 -47.89 84.02 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.317 -0.401 . . . . 10.0 111.133 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -57.29 -41.16 79.25 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.34 -0.391 . . . . 10.0 110.694 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.715 ' O ' HG13 ' B' ' 12' ' ' ILE . 26.0 mm -61.49 -48.43 88.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.787 -0.449 . . . . 10.0 109.787 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.22 -43.37 82.76 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.965 -0.561 . . . . 10.0 111.264 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.8 -34.44 77.91 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.025 -0.534 . . . . 10.0 110.614 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 26.0 mt -71.78 -34.11 69.16 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.164 -0.471 . . . . 10.0 110.282 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.715 HG13 ' O ' ' B' ' 8' ' ' ILE . 21.4 mt -63.5 -52.48 57.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.229 -0.441 . . . . 10.0 110.571 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.529 HG12 ' HG3' ' B' ' 37' ' ' MET . 34.4 m -63.26 -30.51 49.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 116.358 -0.383 . . . . 10.0 111.06 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -68.85 -50.46 49.69 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.969 0.414 . . . . 10.0 110.793 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' TYR . . . . . 0.503 ' O ' HG12 ' B' ' 19' ' ' ILE . 1.7 m-85 -70.66 -36.22 73.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.885 -0.598 . . . . 10.0 111.669 -178.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -61.22 -54.63 41.77 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 121.191 -0.204 . . . . 10.0 111.547 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 12.4 p -60.37 -40.07 89.46 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.712 0.264 . . . . 10.0 111.712 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 4.8 p -70.69 -23.53 62.49 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 111.846 0.313 . . . . 10.0 111.846 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.503 HG12 ' O ' ' B' ' 15' ' ' TYR . 10.8 mm -79.95 -41.57 21.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 120.955 0.407 . . . . 10.0 109.934 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 10.6 m -77.77 -29.01 15.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.842 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 21' ' ' GLU . . . . . 0.477 ' HA ' ' OE1' ' B' ' 21' ' ' GLU . 3.8 tp10 -70.03 -43.88 70.39 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.616 -0.513 . . . . 10.0 109.616 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -71.32 -8.83 56.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.125 -0.488 . . . . 10.0 110.389 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm 60.36 46.35 10.1 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.692 -0.685 . . . . 10.0 110.131 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.475 ' O ' ' HE2' ' C' ' 5' ' ' LYS . 43.1 mt-10 -96.6 13.32 28.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.139 -0.937 . . . . 10.0 110.471 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 15.0 tt -148.64 154.44 10.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.659 -0.701 . . . . 10.0 109.759 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 1.8 p -67.86 162.73 23.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.485 -0.325 . . . . 10.0 110.926 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 41.5 mp0 -56.09 -46.79 78.92 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.422 -0.354 . . . . 10.0 111.945 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -57.54 -41.22 80.53 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.19 0.519 . . . . 10.0 110.255 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.47 ' O ' ' HG ' ' B' ' 33' ' ' LEU . . . -71.29 -42.43 57.29 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.707 -0.678 . . . . 10.0 111.585 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.25 -44.76 95.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.754 -0.223 . . . . 10.0 111.239 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -69.08 -33.26 73.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.833 0.349 . . . . 10.0 110.59 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 69.4 m -65.03 -42.04 94.69 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.593 -0.521 . . . . 10.0 109.593 178.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' B' ' 29' ' ' GLY . 79.1 mt -72.51 -31.18 65.14 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.438 -0.579 . . . . 10.0 109.438 178.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -62.38 -53.6 52.53 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.463 -0.789 . . . . 10.0 110.985 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.643 HG11 HD21 ' A' ' 120' ' ' LEU . 12.0 p -73.2 -33.73 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 116.363 -0.38 . . . . 10.0 110.654 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 36' ' ' ALA . . . . . 0.45 ' O ' HG13 ' B' ' 40' ' ' ILE . . . -62.53 -43.49 98.68 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.213 -0.662 . . . . 10.0 109.213 178.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 37' ' ' MET . . . . . 0.529 ' HG3' HG12 ' B' ' 13' ' ' VAL . 15.3 ttm -56.49 -41.6 76.91 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.089 -0.96 . . . . 10.0 110.316 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -62.15 -47.63 83.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.275 -0.875 . . . . 10.0 110.532 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 17.4 m -62.3 -46.89 86.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.937 -0.574 . . . . 10.0 110.82 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 40' ' ' ILE . . . . . 0.45 HG13 ' O ' ' B' ' 36' ' ' ALA . 58.3 mt -60.35 -38.44 77.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.171 -0.468 . . . . 10.0 110.757 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.615 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 0.1 OUTLIER -59.85 -47.37 86.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 10.0 110.99 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -77.69 -23.49 49.54 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.495 -0.321 . . . . 10.0 111.39 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.21 -39.35 92.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.443 -0.344 . . . . 10.0 111.124 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -100.92 2.57 40.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.197 -0.456 . . . . 10.0 111.093 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 62.2 55.67 26.51 Favored Glycine 0 CA--C 1.519 0.289 0 CA-C-N 115.859 -0.61 . . . . 10.0 113.599 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.615 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 6.6 p90 -149.37 160.78 43.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 117.079 0.44 . . . . 10.0 110.541 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.86 150.84 20.28 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.792 -0.448 . . . . 10.0 109.792 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 1.4 mtm180 -63.8 -28.63 69.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.226 0.536 . . . . 10.0 110.73 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -78.31 7.86 5.85 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.787 -0.642 . . . . 10.0 111.691 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.32 2.89 55.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.013 0.435 . . . . 10.0 110.502 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.545 HG23 ' H ' ' B' ' 52' ' ' SER . 1.5 m -47.29 -64.02 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.248 -0.887 . . . . 10.0 112.792 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 52' ' ' SER . . . . . 0.545 ' H ' HG23 ' B' ' 51' ' ' VAL . 0.8 OUTLIER -56.33 -36.38 68.67 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.675 0.62 . . . . 10.0 112.675 -179.201 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.79 -44.99 60.23 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.818 -0.706 . . . . 10.0 112.906 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 57.8 mt -78.3 -50.44 19.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.856 0.36 . . . . 10.0 111.618 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 41.4 mt -71.18 -51.74 23.13 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.233 -0.44 . . . . 10.0 111.504 -178.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.94 -145.74 50.14 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.582 -0.818 . . . . 10.0 111.292 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 38.7 tttt -97.98 -8.98 26.89 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.005 0.431 . . . . 10.0 110.287 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.54 123.74 18.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.402 -0.817 . . . . 10.0 111.718 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -76.63 151.72 36.1 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.708 -0.678 . . . . 10.0 110.378 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -111.45 169.73 8.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.292 -0.413 . . . . 10.0 110.155 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 5.7 ptmm? -155.97 165.47 36.36 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.002 0.429 . . . . 10.0 110.883 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -141.42 55.98 0.6 Allowed Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.091 -0.959 . . . . 10.0 110.765 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -79.51 133.68 36.49 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.225 0.536 . . . . 10.0 110.682 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 44.5 p-80 -154.15 112.16 3.53 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.694 -0.685 . . . . 10.0 110.14 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -78.84 -10.43 59.79 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.425 0.631 . . . . 10.0 109.49 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.47 142.65 27.52 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.2 -0.909 . . . . 10.0 110.411 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -84.63 138.07 32.91 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.263 -0.426 . . . . 10.0 110.337 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 44.4 mt -71.95 97.55 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.996 -0.742 . . . . 10.0 108.996 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 76.6 mt 66.22 -87.06 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.279 -0.873 . . . . 10.0 109.792 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 20.7 p-10 -138.69 1.92 2.15 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.558 0.218 . . . . 10.0 110.599 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 75.3 m 59.08 21.93 9.95 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.992 -0.549 . . . . 10.0 112.187 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.924 0 CA-C-O 118.911 -0.566 . . . . 10.0 110.378 179.664 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' -1' ' ' SER . . . . . . . . . . . . . 49.3 m . . . . . 0 N--CA 1.48 1.051 0 CA-C-O 120.928 0.394 . . . . 10.0 110.927 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 0' ' ' VAL . . . . . . . . . . . . . 6.1 m -121.9 -166.91 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.153 -0.476 . . . . 10.0 109.776 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -151.66 -79.7 0.11 Allowed 'General case' 0 C--N 1.327 -0.404 0 O-C-N 123.583 0.552 . . . . 10.0 110.374 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 1.5 m -158.89 1.4 0.09 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.731 -0.668 . . . . 10.0 109.596 -178.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -87.53 157.98 19.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.973 -0.558 . . . . 10.0 110.592 -179.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 4' ' ' SER . . . . . 0.547 ' O ' HG12 ' C' ' 8' ' ' ILE . 33.3 p -102.78 166.28 10.57 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.355 -0.384 . . . . 10.0 110.729 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 5' ' ' LYS . . . . . 0.475 ' HE2' ' O ' ' B' ' 24' ' ' GLU . 10.1 ptpp? -59.5 -39.56 84.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.246 -0.433 . . . . 10.0 110.916 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 6' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -60.87 -45.25 95.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 10.0 110.719 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -65.6 -37.36 86.4 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.304 -0.407 . . . . 10.0 110.588 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 8' ' ' ILE . . . . . 0.547 HG12 ' O ' ' C' ' 4' ' ' SER . 38.6 mm -64.85 -45.69 94.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 10.0 110.084 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.89 -45.9 85.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.918 -0.583 . . . . 10.0 110.222 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.33 -37.56 87.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.603 -0.726 . . . . 10.0 111.264 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 2.2 mt -68.33 -44.77 74.62 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.836 0.35 . . . . 10.0 110.977 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 12' ' ' ILE . . . . . . . . . . . . . 1.4 mp -63.03 -45.9 97.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.76 -0.654 . . . . 10.0 111.521 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 28.8 m -66.61 -27.76 41.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-O 120.919 0.39 . . . . 10.0 110.612 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 14' ' ' ASN . . . . . 0.428 ' HB2' HG11 ' C' ' 51' ' ' VAL . 0.3 OUTLIER -74.18 -44.03 54.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.029 -0.532 . . . . 10.0 110.358 178.909 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 15' ' ' TYR . . . . . 0.549 ' O ' HG12 ' C' ' 19' ' ' ILE . 1.1 m-85 -68.04 -37.15 81.01 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.482 -0.326 . . . . 10.0 110.298 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 5.9 m-30 -58.31 -51.33 70.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.397 -0.365 . . . . 10.0 110.657 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 1.5 p -62.44 -38.5 89.98 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.865 -0.607 . . . . 10.0 111.542 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 11.7 p -71.11 -21.33 62.23 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.743 0.306 . . . . 10.0 111.419 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 19' ' ' ILE . . . . . 0.549 HG12 ' O ' ' C' ' 15' ' ' TYR . 25.2 mm -85.71 -44.56 17.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 CA-C-O 120.941 0.4 . . . . 10.0 111.143 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 20' ' ' VAL . . . . . . . . . . . . . 35.5 m -72.66 -32.64 41.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.202 -0.454 . . . . 10.0 111.721 -177.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 21' ' ' GLU . . . . . 0.483 ' HA ' ' OE1' ' C' ' 21' ' ' GLU . 1.1 tp10 -78.6 -18.81 54.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.864 0.364 . . . . 10.0 111.098 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -95.19 -6.26 42.06 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.718 -0.475 . . . . 10.0 109.718 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm 59.11 50.81 7.66 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.355 -0.839 . . . . 10.0 110.916 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -98.62 4.2 47.99 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.541 -0.754 . . . . 10.0 111.27 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 19.9 tt -143.73 153.66 16.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.936 -0.394 . . . . 10.0 109.936 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.82 162.41 13.61 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.415 -0.357 . . . . 10.0 111.386 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -56.23 -40.74 74.59 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.182 -0.463 . . . . 10.0 111.585 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.38 -48.07 77.61 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.385 0.612 . . . . 10.0 109.96 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 29' ' ' GLY . . . . . 0.595 ' O ' ' HG ' ' C' ' 33' ' ' LEU . . . -70.33 -38.31 70.85 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.314 -0.857 . . . . 10.0 112.224 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.17 -46.79 79.19 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.52 0.2 . . . . 10.0 111.273 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -66.7 -39.29 88.02 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.823 -0.436 . . . . 10.0 109.823 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 50.7 m -59.0 -39.17 81.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.7 -0.682 . . . . 10.0 110.218 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 33' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' C' ' 29' ' ' GLY . 52.1 mt -75.68 -27.78 58.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.013 -0.539 . . . . 10.0 110.179 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -71.08 -49.92 39.33 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 116.07 -0.513 . . . . 10.0 110.816 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 35' ' ' VAL . . . . . 0.462 HG23 ' H ' ' A' ' 123' ' ' GLY . 8.9 p -67.01 -43.32 89.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-N 116.573 -0.285 . . . . 10.0 111.272 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 36' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' C' ' 39' ' ' CYS . . . -63.82 -30.99 72.02 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.886 0.374 . . . . 10.0 111.246 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 37' ' ' MET . . . . . 0.437 ' HB2' ' O ' ' C' ' 33' ' ' LEU . 26.7 ttm -59.01 -49.79 76.54 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.091 -0.504 . . . . 10.0 110.545 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 38' ' ' ASP . . . . . 0.559 ' CB ' ' HA3' ' A' ' 123' ' ' GLY . 15.2 m-20 -68.61 -26.15 65.22 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.968 -0.56 . . . . 10.0 110.623 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 39' ' ' CYS . . . . . 0.594 ' SG ' ' HA2' ' A' ' 123' ' ' GLY . 84.9 m -58.49 -46.35 86.84 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.515 0.674 . . . . 10.0 109.534 178.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 40' ' ' ILE . . . . . . . . . . . . . 6.6 mt -73.06 -39.73 57.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.244 -0.889 . . . . 10.0 110.346 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 41' ' ' SER . . . . . 0.533 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 19.7 m -60.45 -44.39 95.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.618 -0.719 . . . . 10.0 111.863 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -71.79 -41.07 68.77 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.896 -0.322 . . . . 10.0 110.772 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.75 -40.22 91.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.328 -0.396 . . . . 10.0 111.679 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 44' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -90.98 -10.73 41.28 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.52 -0.309 . . . . 10.0 111.166 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 66.22 47.85 68.94 Favored Glycine 0 CA--C 1.517 0.188 0 C-N-CA 121.238 -0.506 . . . . 10.0 112.711 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 46' ' ' PHE . . . . . 0.533 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 3.3 p90 -142.62 156.75 45.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.795 0.331 . . . . 10.0 110.6 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -89.01 142.33 27.73 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.085 -0.507 . . . . 10.0 110.133 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 48' ' ' ARG . . . . . 0.511 ' O ' HG13 ' C' ' 51' ' ' VAL . 0.1 OUTLIER -61.41 -33.52 73.84 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.128 0.489 . . . . 10.0 111.202 -179.928 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 49' ' ' GLU . . . . . 0.401 ' H ' ' CD ' ' C' ' 49' ' ' GLU . 1.7 pm0 -76.95 8.58 3.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.726 -0.67 . . . . 10.0 112.169 -179.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.18 1.36 57.26 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.059 0.456 . . . . 10.0 110.684 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 51' ' ' VAL . . . . . 0.511 HG13 ' O ' ' C' ' 48' ' ' ARG . 5.9 m -46.53 -46.46 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 115.282 -0.872 . . . . 10.0 112.902 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.36 -35.12 64.91 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.499 0.555 . . . . 10.0 112.499 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.9 -34.79 23.52 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.547 -0.835 . . . . 10.0 113.248 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 54' ' ' ILE . . . . . . . . . . . . . 56.1 mt -80.84 -59.17 3.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.943 0.401 . . . . 10.0 111.175 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 36.1 mt -67.12 -49.51 64.64 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.246 -0.433 . . . . 10.0 111.078 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.13 -135.3 45.83 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.993 -0.622 . . . . 10.0 112.654 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 8.9 tttt -105.45 -5.67 20.12 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.122 0.487 . . . . 10.0 110.003 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.21 130.26 44.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.667 -0.697 . . . . 10.0 111.408 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -90.11 134.54 34.2 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 120.992 0.425 . . . . 10.0 109.946 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 60' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -94.89 168.87 10.53 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.538 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 12.1 ptmm? -150.44 161.17 43.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.285 -0.416 . . . . 10.0 110.831 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -137.59 55.77 0.68 Allowed Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.741 -0.943 . . . . 10.0 110.741 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 63' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -78.59 134.74 37.18 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.429 -0.386 . . . . 10.0 110.066 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 64' ' ' HIS . . . . . . . . . . . . . 36.6 p-80 -154.98 107.83 2.78 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.643 -0.423 . . . . 10.0 111.216 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -76.25 -20.74 57.12 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.157 -0.683 . . . . 10.0 109.157 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.25 127.22 33.45 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.5 -0.773 . . . . 10.0 110.163 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.0 143.62 56.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.274 -0.421 . . . . 10.0 110.212 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 68' ' ' ILE . . . . . . . . . . . . . 38.8 mt -79.91 90.23 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.063 0.458 . . . . 10.0 110.873 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 68.9 mt 72.35 -65.31 0.36 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 114.99 -1.005 . . . . 10.0 111.14 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 70' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -162.25 -29.59 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.17 -0.468 . . . . 10.0 110.502 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 71' ' ' SER . . . . . . . . . . . . . 71.3 m 61.92 44.19 8.56 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.976 -0.556 . . . . 10.0 111.418 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.662 -0.685 . . . . 10.0 110.639 -179.978 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.525 ' SD ' ' HB2' ' A' ' 91' ' ' ASP . 5.2 mtm . . . . . 0 N--CA 1.479 1.008 0 CA-C-O 121.094 0.474 . . . . 10.0 110.642 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.3 t -81.43 123.84 38.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.922 -0.581 . . . . 10.0 110.278 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -93.79 125.31 38.34 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.539 -0.464 . . . . 10.0 110.504 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.6 mp -127.93 139.85 52.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.812 -0.631 . . . . 10.0 110.744 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.2 m -102.43 115.36 30.41 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.136 -0.484 . . . . 10.0 110.146 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 87' ' ' SER . 2.2 mm? -85.91 110.45 19.44 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.795 -0.446 . . . . 10.0 109.795 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 51.4 tttt -108.9 102.56 11.56 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.215 -0.448 . . . . 10.0 111.267 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.549 ' HG2' ' O ' ' A' ' 84' ' ' PRO . 17.8 tptm -95.88 106.13 18.23 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.952 0.406 . . . . 10.0 110.097 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 91.9 mt -73.43 -55.94 11.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.512 -0.767 . . . . 10.0 111.548 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -70.19 164.54 24.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.405 -0.361 . . . . 10.0 110.88 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.496 ' HA ' ' C ' ' A' ' 84' ' ' PRO . . . -83.75 143.2 43.27 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 111.678 0.251 . . . . 10.0 111.678 -178.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.549 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 10.8 Cg_exo -69.14 128.37 11.81 Favored 'Cis proline' 0 C--N 1.347 0.495 0 C-N-CA 123.019 -1.659 . . . . 10.0 110.585 -1.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.459 ' N ' ' HA ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -86.77 148.08 25.57 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.418 -0.355 . . . . 10.0 111.204 -178.618 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -170.73 166.0 7.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.074 -0.512 . . . . 10.0 110.065 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.432 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 38.6 m -150.39 106.31 3.43 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.585 -0.524 . . . . 10.0 109.585 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 43.9 pt -126.86 158.88 37.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.314 -0.403 . . . . 10.0 111.058 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -121.39 139.82 52.94 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.506 -0.553 . . . . 10.0 109.506 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -149.61 165.01 33.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.883 0.373 . . . . 10.0 111.357 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.525 ' HB2' ' SD ' ' A' ' 73' ' ' MET . 0.0 OUTLIER -110.39 124.64 52.09 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.665 -0.698 . . . . 10.0 109.863 179.38 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -118.45 171.04 8.43 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.994 -0.548 . . . . 10.0 110.512 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.582 ' O ' HD12 ' A' ' 132' ' ' LEU . 1.5 m -80.15 144.87 59.39 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.424 -0.353 . . . . 10.0 110.368 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -59.04 -15.11 26.19 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.815 2.343 . . . . 10.0 112.332 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.0 t -119.21 19.98 12.72 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 116.244 -0.435 . . . . 10.0 110.434 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 93' ' ' SER . 0.3 OUTLIER -73.15 164.7 26.31 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.149 0.499 . . . . 10.0 111.182 -179.163 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.04 147.76 35.32 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.763 -0.653 . . . . 10.0 110.429 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 38.3 mm -58.83 -24.83 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 121.518 0.675 . . . . 10.0 110.49 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.39 -39.08 60.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.912 -1.04 . . . . 10.0 111.185 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 72.7 mm-40 -66.28 -39.9 89.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 10.0 110.978 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.652 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 18.0 mt -65.01 -51.05 71.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.171 -0.468 . . . . 10.0 109.956 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 9.0 mttm -54.97 -50.46 68.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.496 -0.774 . . . . 10.0 111.759 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -62.49 -32.01 72.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.653 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.41 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 15.9 t60 -67.66 -39.17 84.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.048 -0.524 . . . . 10.0 109.999 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 101' ' ' ILE . 28.2 mt -59.71 -39.58 85.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.056 -0.52 . . . . 10.0 110.293 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 16.6 mt -72.91 -34.37 46.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 116.022 -0.536 . . . . 10.0 110.159 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.8 t -64.78 -22.79 67.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.794 -0.639 . . . . 10.0 111.128 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 104' ' ' HIS . 16.3 mm-40 -100.09 7.28 44.76 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.828 -0.434 . . . . 10.0 109.828 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 60.21 31.62 20.56 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.687 -0.688 . . . . 10.0 111.172 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -101.56 -9.22 21.19 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.385 -0.598 . . . . 10.0 109.385 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.13 148.17 52.11 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.105 -0.952 . . . . 10.0 109.96 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.34 -55.74 3.19 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.806 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.569 ' O ' HG13 ' A' ' 117' ' ' ILE . 32.7 m170 -131.39 139.12 49.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.667 -0.242 . . . . 10.0 110.949 -179.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.476 ' HA ' HD12 ' A' ' 117' ' ' ILE . 4.5 tt -64.87 -44.34 96.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.362 0.601 . . . . 10.0 110.405 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 16.3 t -52.31 -33.34 41.92 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.903 -1.044 . . . . 10.0 111.73 178.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.484 ' HG3' ' OD1' ' A' ' 151' ' ' ASN . 7.1 mm-40 -93.27 16.01 14.2 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.32 0.489 . . . . 10.0 112.32 -177.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.569 HG13 ' O ' ' A' ' 113' ' ' HIS . 55.2 mt -106.66 123.52 61.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.346 -0.388 . . . . 10.0 110.188 178.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -120.11 116.59 25.99 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.659 -0.497 . . . . 10.0 109.659 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -94.34 123.48 37.77 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.739 0.304 . . . . 10.0 110.216 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.502 HD21 HG11 ' B' ' 35' ' ' VAL . 2.8 mm? -109.21 141.1 41.96 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.193 -0.669 . . . . 10.0 109.193 179.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 24.7 tp -126.1 98.33 5.45 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.145 -1.057 . . . . 10.0 108.145 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 11.1 tptp 46.49 51.62 11.65 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.497 0.665 . . . . 10.0 110.246 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.64 ' HA3' ' CB ' ' C' ' 38' ' ' ASP . . . 89.72 -44.14 3.01 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.231 -0.895 . . . . 10.0 113.384 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.405 ' HZ2' ' CD ' ' C' ' 42' ' ' GLU . 0.4 OUTLIER -59.09 129.77 43.77 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.489 0.185 . . . . 10.0 110.88 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.448 ' HA ' HD13 ' A' ' 120' ' ' LEU . 8.8 p -82.61 139.29 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.136 0.493 . . . . 10.0 112.102 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 4.4 mp -112.46 154.37 25.95 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 115.654 -0.703 . . . . 10.0 111.055 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -117.16 159.48 22.54 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 121.763 -0.586 . . . . 10.0 112.208 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.38 -51.69 67.38 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.212 1.005 . . . . 10.0 112.229 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -83.18 6.94 17.6 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.3 -0.863 . . . . 10.0 112.194 -177.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.2 tp -79.77 148.69 31.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.928 0.394 . . . . 10.0 111.308 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -109.62 151.77 26.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.803 -0.635 . . . . 10.0 110.33 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.582 HD12 ' O ' ' A' ' 93' ' ' SER . 79.5 mt -59.09 -37.13 76.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 10.0 111.96 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.72 -17.53 60.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.086 0.47 . . . . 10.0 111.221 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -88.98 -40.06 13.29 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.176 -0.465 . . . . 10.0 110.958 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.432 HD11 HG22 ' A' ' 137' ' ' VAL . 3.0 pp -82.41 -26.44 32.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.612 -0.267 . . . . 10.0 111.301 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 26.2 mtmt 64.7 96.1 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 O-C-N 123.887 0.742 . . . . 10.0 111.131 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.432 HG22 HD11 ' A' ' 135' ' ' LEU . 6.8 t -71.83 121.03 21.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.86 -0.609 . . . . 10.0 110.632 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.76 119.73 65.75 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 10.0 110.723 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -58.72 -34.5 98.99 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.924 2.416 . . . . 10.0 113.531 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -84.41 15.84 3.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.019 0.438 . . . . 10.0 111.47 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -128.26 -74.14 0.58 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.977 -0.556 . . . . 10.0 109.853 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.2 m 58.58 9.89 1.24 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.792 -0.64 . . . . 10.0 112.639 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.8 m -109.24 123.82 49.87 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.321 0.582 . . . . 10.0 111.326 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 14.7 mm -107.61 119.23 56.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.479 -0.782 . . . . 10.0 109.984 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.4 124.53 30.75 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.856 0.36 . . . . 10.0 110.359 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.6 t -99.48 124.63 52.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.935 -0.575 . . . . 10.0 111.282 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' MET . . . . . 0.431 ' SD ' HD23 ' A' ' 120' ' ' LEU . 2.0 mpt? -122.67 121.69 37.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.884 -0.598 . . . . 10.0 110.633 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 22.0 mt -137.74 142.23 36.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.609 -0.269 . . . . 10.0 111.027 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.486 ' HD3' ' HD2' ' A' ' 150' ' ' PRO . 0.4 OUTLIER -125.99 107.86 25.08 Favored Pre-proline 0 N--CA 1.454 -0.274 0 N-CA-C 109.943 -0.391 . . . . 10.0 109.943 178.282 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.486 ' HD2' ' HD3' ' A' ' 149' ' ' LYS . 19.4 Cg_endo -59.54 119.44 6.66 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.889 2.393 . . . . 10.0 113.067 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.484 ' OD1' ' HG3' ' A' ' 116' ' ' GLU . 27.0 m120 -73.07 -27.07 61.52 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.155 0.502 . . . . 10.0 109.964 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 79.7 mt -78.39 155.78 29.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.585 -0.734 . . . . 10.0 110.239 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 . . . . . 0 C--O 1.251 1.147 0 CA-C-O 117.941 -1.028 . . . . 10.0 109.901 178.916 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' -1' ' ' SER . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.476 0.86 0 CA-C-O 120.757 0.313 . . . . 10.0 111.216 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 0' ' ' VAL . . . . . 0.401 ' HB ' ' H ' ' B' ' 1' ' ' ASP . 27.3 m -117.96 -151.98 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 115.856 -0.611 . . . . 10.0 109.822 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 1' ' ' ASP . . . . . 0.401 ' H ' ' HB ' ' B' ' 0' ' ' VAL . 43.0 t0 -174.81 -75.9 0.01 OUTLIER 'General case' 0 C--N 1.339 0.14 0 CA-C-O 120.713 0.292 . . . . 10.0 111.533 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 15.2 m -147.29 13.0 1.08 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.536 0.208 . . . . 10.0 111.442 -177.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -109.24 143.61 38.45 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 121.197 -0.201 . . . . 10.0 110.86 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.26 176.35 5.94 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.44 -0.578 . . . . 10.0 109.44 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -56.52 -46.56 80.53 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.248 -0.433 . . . . 10.0 111.438 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -56.64 -53.33 58.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.515 . . . . 10.0 112.033 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -57.24 -46.17 83.25 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.252 0.345 . . . . 10.0 110.814 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.41 ' HA ' HD13 ' B' ' 8' ' ' ILE . 17.2 mm -59.22 -45.9 92.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 10.0 110.41 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.571 ' HA ' HD12 ' B' ' 12' ' ' ILE . . . -60.64 -43.62 97.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.996 -0.547 . . . . 10.0 111.027 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.25 -36.11 82.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.035 -0.53 . . . . 10.0 110.616 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.418 HD21 ' CE2' ' B' ' 60' ' ' PHE . 17.7 mt -64.95 -36.25 83.79 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.343 0.592 . . . . 10.0 109.566 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.571 HD12 ' HA ' ' B' ' 9' ' ' ALA . 14.5 mt -61.42 -57.68 11.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.057 -0.974 . . . . 10.0 110.965 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.471 HG21 ' HA ' ' B' ' 48' ' ' ARG . 16.5 m -62.33 -25.98 39.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.989 0.423 . . . . 10.0 110.61 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -69.61 -51.53 34.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.777 -0.647 . . . . 10.0 110.657 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' TYR . . . . . 0.491 ' O ' HG12 ' B' ' 19' ' ' ILE . 2.3 m-85 -72.99 -39.67 65.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 10.0 111.844 -178.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -56.03 -50.85 69.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.67 0.271 . . . . 10.0 110.353 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 4.6 p -59.04 -46.32 88.52 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.654 -0.248 . . . . 10.0 111.338 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 6.7 p -65.06 -20.5 66.51 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.148 0.425 . . . . 10.0 112.148 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.491 HG12 ' O ' ' B' ' 15' ' ' TYR . 29.3 mm -85.05 -43.46 16.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 121.074 0.464 . . . . 10.0 110.349 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 35.2 m -75.97 -29.04 19.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.201 -0.454 . . . . 10.0 110.532 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 21' ' ' GLU . . . . . 0.534 ' HA ' ' OE1' ' B' ' 21' ' ' GLU . 1.8 tp10 -75.67 -34.79 60.48 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.269 -0.423 . . . . 10.0 110.766 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -81.86 -5.12 57.97 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.825 0.345 . . . . 10.0 110.446 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 34.0 mmtt 59.3 52.65 5.83 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.529 -0.759 . . . . 10.0 111.046 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -108.13 16.34 23.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.807 -0.633 . . . . 10.0 111.802 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -147.19 151.77 13.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 116.199 -0.455 . . . . 10.0 110.14 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 10.5 p -60.82 161.94 7.43 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.277 -0.419 . . . . 10.0 111.435 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -60.0 -49.68 76.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.074 0.464 . . . . 10.0 110.887 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.55 -42.97 93.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.427 -0.806 . . . . 10.0 110.003 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.13 -39.51 92.66 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.767 -0.73 . . . . 10.0 111.975 178.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.0 -44.55 97.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.875 0.369 . . . . 10.0 110.357 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -65.24 -35.59 81.51 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.374 -0.602 . . . . 10.0 109.374 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 47.9 m -60.95 -44.18 97.65 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 115.824 -0.625 . . . . 10.0 109.747 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 69.7 mt -72.11 -36.51 69.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.075 0.464 . . . . 10.0 110.044 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 12.7 t30 -60.02 -48.69 80.65 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.745 -0.662 . . . . 10.0 111.531 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.502 HG11 HD21 ' A' ' 120' ' ' LEU . 8.4 p -72.86 -35.61 49.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 120.85 0.357 . . . . 10.0 110.755 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.53 -39.36 93.62 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.534 -0.543 . . . . 10.0 109.534 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 37' ' ' MET . . . . . . . . . . . . . 24.1 ttm -57.79 -45.55 85.88 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.352 -0.84 . . . . 10.0 110.15 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -61.91 -42.13 98.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.562 -0.744 . . . . 10.0 110.801 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 39' ' ' CYS . . . . . 0.411 ' SG ' ' HG2' ' A' ' 147' ' ' MET . 59.3 m -63.43 -40.91 98.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.068 -0.514 . . . . 10.0 110.857 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 40' ' ' ILE . . . . . 0.557 HD13 HG21 ' B' ' 12' ' ' ILE . 55.0 mt -67.3 -40.35 84.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 110.144 -0.317 . . . . 10.0 110.144 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.644 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 9.7 m -63.1 -39.13 93.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.105 0.479 . . . . 10.0 110.081 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -70.86 -45.36 64.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.627 -0.715 . . . . 10.0 110.491 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.56 -48.66 78.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.539 -0.755 . . . . 10.0 112.547 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -83.42 -2.47 55.92 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.902 -0.319 . . . . 10.0 111.496 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 57.69 58.89 12.23 Favored Glycine 0 CA--C 1.518 0.236 0 CA-C-N 116.125 -0.489 . . . . 10.0 113.54 178.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.644 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 9.1 p90 -148.78 170.94 17.1 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.968 -0.382 . . . . 10.0 109.968 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -105.7 146.21 30.08 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.147 -0.316 . . . . 10.0 110.147 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.471 ' HA ' HG21 ' B' ' 13' ' ' VAL . 1.3 mtm180 -71.55 -26.87 62.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.278 0.561 . . . . 10.0 110.507 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -82.92 14.95 2.95 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.655 -0.702 . . . . 10.0 111.306 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -104.51 4.13 32.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.64 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -41.12 -63.52 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 114.011 1.115 . . . . 10.0 114.011 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 52' ' ' SER . . . . . 0.483 ' HB3' ' HA ' ' C' ' 71' ' ' SER . 1.9 m -53.9 -31.86 51.46 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.578 0.584 . . . . 10.0 112.578 -178.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.33 -41.68 30.15 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.986 -0.626 . . . . 10.0 113.352 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 19.6 mt -83.01 -43.54 18.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.999 0.428 . . . . 10.0 111.45 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 57.1 mt -71.52 -56.71 5.38 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.052 -0.522 . . . . 10.0 111.017 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.97 -150.38 45.9 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.692 -0.766 . . . . 10.0 111.298 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 32.8 tttt -103.8 2.5 32.9 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.357 0.599 . . . . 10.0 109.734 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.69 131.89 47.43 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.102 -0.954 . . . . 10.0 111.747 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -78.39 134.65 37.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.983 -0.553 . . . . 10.0 109.946 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 60' ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' C' ' 61' ' ' LYS . 78.3 m-85 -90.11 158.1 17.45 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.174 -0.466 . . . . 10.0 110.737 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 61' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' C' ' 60' ' ' PHE . 11.0 ptmm? -147.57 149.47 32.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.931 0.396 . . . . 10.0 111.289 -178.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -140.71 51.08 0.73 Allowed Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 111.387 -0.685 . . . . 10.0 111.387 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -77.72 143.47 38.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.784 0.326 . . . . 10.0 110.852 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 39.4 p-80 -159.06 114.62 2.55 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.025 0.44 . . . . 10.0 110.407 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.5 HD13 ' HA ' ' B' ' 65' ' ' LEU . 3.1 mm? -84.68 -15.39 45.44 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.04 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -82.7 145.4 29.63 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.34 -0.615 . . . . 10.0 109.34 178.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -83.34 133.3 34.96 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.911 0.386 . . . . 10.0 110.524 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 68' ' ' ILE . . . . . 0.416 ' O ' ' HB2' ' B' ' 69' ' ' LEU . 4.2 mt -71.57 92.83 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.976 -0.556 . . . . 10.0 110.683 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.416 ' HB2' ' O ' ' B' ' 68' ' ' ILE . 21.3 mt 73.71 -57.46 0.62 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.604 0.762 . . . . 10.0 111.031 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 70' ' ' ASN . . . . . 0.5 ' ND2' ' HB3' ' B' ' 72' ' ' ALA . 27.4 p-10 -171.75 -22.52 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.606 -0.724 . . . . 10.0 109.574 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 71' ' ' SER . . . . . 0.417 ' H ' ' H ' ' B' ' 70' ' ' ASN . 2.6 m 62.71 37.34 12.74 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.069 -0.969 . . . . 10.0 110.654 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 72' ' ' ALA . . . . . 0.5 ' HB3' ' ND2' ' B' ' 70' ' ' ASN . . . . . . . . 0 C--O 1.252 1.214 0 CA-C-O 118.648 -0.691 . . . . 10.0 110.442 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' -1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 120.683 0.278 . . . . 10.0 110.559 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 0' ' ' VAL . . . . . . . . . . . . . 21.6 m -122.08 -168.21 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.205 -0.452 . . . . 10.0 110.274 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -157.79 -71.2 0.09 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.881 0.372 . . . . 10.0 110.38 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 53.3 m -160.24 -42.04 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.476 -0.565 . . . . 10.0 109.476 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -40.59 144.78 0.22 Allowed 'General case' 0 CA--C 1.533 0.313 0 O-C-N 124.515 1.134 . . . . 10.0 111.551 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 4' ' ' SER . . . . . 0.52 ' O ' HG12 ' C' ' 8' ' ' ILE . 23.0 p -98.3 163.68 12.62 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.339 -0.391 . . . . 10.0 110.213 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -57.76 -35.39 70.69 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 110.521 -0.178 . . . . 10.0 110.521 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 6' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -60.25 -49.67 76.7 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.219 0.533 . . . . 10.0 109.651 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -62.71 -42.32 99.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.365 -0.834 . . . . 10.0 110.817 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 8' ' ' ILE . . . . . 0.52 HG12 ' O ' ' C' ' 4' ' ' SER . 39.4 mm -59.15 -46.1 92.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.99 -0.55 . . . . 10.0 110.171 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 9' ' ' ALA . . . . . 0.438 ' HB1' ' CE1' ' C' ' 46' ' ' PHE . . . -59.82 -43.66 94.4 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.086 -0.506 . . . . 10.0 110.554 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.91 -40.36 94.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.025 -0.534 . . . . 10.0 111.086 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 22.3 mt -65.15 -40.47 94.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.031 -0.531 . . . . 10.0 109.76 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 12' ' ' ILE . . . . . . . . . . . . . 1.2 mp -63.15 -47.86 90.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.187 -0.915 . . . . 10.0 111.869 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 34.1 m -71.09 -25.49 25.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.669 -0.412 . . . . 10.0 111.448 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -73.27 -40.59 64.46 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.063 0.459 . . . . 10.0 109.987 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 15' ' ' TYR . . . . . 0.544 ' O ' HG12 ' C' ' 19' ' ' ILE . 9.1 m-85 -71.74 -42.85 66.76 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.12 -0.491 . . . . 10.0 110.849 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -54.27 -49.48 69.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.737 0.304 . . . . 10.0 110.508 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 17' ' ' SER . . . . . 0.496 ' O ' ' HB2' ' C' ' 21' ' ' GLU . 2.2 p -61.97 -41.66 98.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.139 -0.482 . . . . 10.0 111.4 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 3.6 p -69.36 -22.51 63.73 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 120.617 -0.433 . . . . 10.0 111.843 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 19' ' ' ILE . . . . . 0.544 HG12 ' O ' ' C' ' 15' ' ' TYR . 37.7 mm -80.83 -41.1 19.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 109.8 -0.444 . . . . 10.0 109.8 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 20' ' ' VAL . . . . . . . . . . . . . 16.8 m -77.85 -18.65 13.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.171 -0.677 . . . . 10.0 109.171 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 21' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' C' ' 17' ' ' SER . 4.1 tp10 -73.47 -50.67 20.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.551 -0.749 . . . . 10.0 110.734 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -84.07 1.09 45.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.368 -0.378 . . . . 10.0 111.782 -178.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 34.3 mmtt 55.79 46.83 21.6 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.162 0.506 . . . . 10.0 110.234 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -83.41 1.13 43.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.962 -0.563 . . . . 10.0 111.376 -178.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 16.0 tt -142.96 161.2 17.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.36 -0.607 . . . . 10.0 109.36 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 5.3 p -59.95 156.29 14.9 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.182 0.301 . . . . 10.0 110.607 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -60.76 -23.6 65.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.02 0.438 . . . . 10.0 110.337 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 28' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -68.39 -54.09 19.5 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.066 -0.716 . . . . 10.0 109.066 178.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 29' ' ' GLY . . . . . 0.42 ' O ' ' HG ' ' C' ' 33' ' ' LEU . . . -65.82 -33.05 84.74 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.318 -0.855 . . . . 10.0 110.984 178.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.72 -42.84 94.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.968 0.413 . . . . 10.0 110.441 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -68.02 -38.03 82.11 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.264 -0.643 . . . . 10.0 109.264 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 6.0 m -61.0 -43.48 98.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.407 -0.815 . . . . 10.0 110.046 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 33' ' ' LEU . . . . . 0.438 ' O ' ' HB2' ' C' ' 37' ' ' MET . 87.6 mt -71.05 -25.38 62.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.051 0.453 . . . . 10.0 110.373 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -72.25 -52.97 13.97 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.056 -0.52 . . . . 10.0 111.004 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 35' ' ' VAL . . . . . 0.53 HG23 ' H ' ' A' ' 123' ' ' GLY . 7.6 p -69.21 -39.6 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 116.421 -0.354 . . . . 10.0 110.49 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 36' ' ' ALA . . . . . 0.56 ' O ' HD12 ' C' ' 40' ' ' ILE . . . -63.75 -32.25 73.69 Favored 'General case' 0 C--O 1.226 -0.163 0 CA-C-O 120.448 0.166 . . . . 10.0 110.661 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 37' ' ' MET . . . . . 0.438 ' HB2' ' O ' ' C' ' 33' ' ' LEU . 30.6 ttm -53.92 -52.44 60.59 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.178 0.513 . . . . 10.0 110.879 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 38' ' ' ASP . . . . . 0.64 ' CB ' ' HA3' ' A' ' 123' ' ' GLY . 1.7 m-20 -70.73 -26.44 63.39 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 116.176 -0.465 . . . . 10.0 111.124 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 39' ' ' CYS . . . . . 0.505 ' SG ' ' HA2' ' A' ' 123' ' ' GLY . 77.5 m -61.09 -42.24 98.15 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.773 -0.825 . . . . 10.0 108.773 177.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 40' ' ' ILE . . . . . 0.56 HD12 ' O ' ' C' ' 36' ' ' ALA . 1.4 mp -70.99 -40.74 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 115.097 -0.956 . . . . 10.0 109.891 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 41' ' ' SER . . . . . 0.638 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 13.4 m -60.18 -43.9 95.51 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.686 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 42' ' ' GLU . . . . . 0.405 ' CD ' ' HZ2' ' A' ' 124' ' ' LYS . 13.4 tt0 -72.2 -42.07 66.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.187 -0.461 . . . . 10.0 111.448 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.77 -48.46 75.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.286 -0.416 . . . . 10.0 111.626 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 44' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -88.96 -1.17 57.98 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.479 -0.328 . . . . 10.0 111.378 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 59.02 57.92 17.29 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.352 -0.451 . . . . 10.0 113.184 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 46' ' ' PHE . . . . . 0.638 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 4.3 p90 -145.65 156.36 43.6 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.989 0.395 . . . . 10.0 110.172 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 26.1 mp0 -81.84 128.04 33.62 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.488 -0.324 . . . . 10.0 110.302 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.5 -17.13 58.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.55 -0.295 . . . . 10.0 111.667 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -85.15 -2.53 58.13 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 122.321 0.249 . . . . 10.0 111.583 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.8 4.96 30.59 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.763 0.653 . . . . 10.0 112.763 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 51' ' ' VAL . . . . . 0.437 HG23 ' H ' ' C' ' 52' ' ' SER . 3.6 m -42.98 -57.36 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 114.427 1.269 . . . . 10.0 114.427 -178.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 52' ' ' SER . . . . . 0.437 ' H ' HG23 ' C' ' 51' ' ' VAL . 1.2 m -61.31 -18.92 60.91 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.874 0.694 . . . . 10.0 112.874 -178.253 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.39 -48.59 4.99 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.809 -0.71 . . . . 10.0 112.953 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 54' ' ' ILE . . . . . . . . . . . . . 64.3 mt -74.66 -45.73 43.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.936 0.398 . . . . 10.0 110.311 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 45.7 mt -71.84 -47.82 50.45 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.178 0.513 . . . . 10.0 109.979 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 56.57 -137.0 48.83 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.373 -0.83 . . . . 10.0 112.371 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -111.6 24.07 13.19 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.954 -0.758 . . . . 10.0 108.954 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 6.8 m -91.7 139.92 30.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.181 -0.918 . . . . 10.0 111.006 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.71 145.89 24.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.165 -0.471 . . . . 10.0 109.84 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 60' ' ' PHE . . . . . 0.472 ' O ' ' HA ' ' B' ' 61' ' ' LYS . 76.9 m-85 -109.1 155.61 20.78 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.278 -0.419 . . . . 10.0 110.428 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 61' ' ' LYS . . . . . 0.485 ' HA ' ' O ' ' B' ' 60' ' ' PHE . 8.5 ptmm? -144.45 154.82 43.34 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.158 -0.473 . . . . 10.0 111.1 -178.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -139.57 60.25 0.58 Allowed Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.132 -0.787 . . . . 10.0 111.132 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 63' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -82.03 136.62 35.21 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.912 0.387 . . . . 10.0 110.175 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 64' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -149.13 111.96 4.83 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.334 0.588 . . . . 10.0 110.865 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -81.2 -13.62 58.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.367 -0.833 . . . . 10.0 108.887 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.61 137.31 32.46 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.284 -0.871 . . . . 10.0 109.919 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -72.34 149.8 44.07 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.892 -0.595 . . . . 10.0 109.566 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 68' ' ' ILE . . . . . . . . . . . . . 55.7 mt -88.68 97.82 7.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.987 0.423 . . . . 10.0 110.728 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 29.8 mt 62.48 -94.34 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.096 -0.956 . . . . 10.0 111.063 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 70' ' ' ASN . . . . . 0.504 ' ND2' ' HB3' ' C' ' 72' ' ' ALA . 29.0 p-10 -118.02 -14.27 9.98 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.733 -0.212 . . . . 10.0 111.367 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 71' ' ' SER . . . . . 0.483 ' HA ' ' HB3' ' B' ' 52' ' ' SER . 1.2 m 54.59 35.67 24.11 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.182 0.515 . . . . 10.0 110.795 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 72' ' ' ALA . . . . . 0.504 ' HB3' ' ND2' ' C' ' 70' ' ' ASN . . . . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.338 -0.839 . . . . 10.0 110.337 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 2.9 ttm . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 109.784 -0.45 . . . . 10.0 109.784 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.6 t -101.67 126.78 55.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.594 0.235 . . . . 10.0 110.684 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -86.2 127.46 34.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.58 -0.282 . . . . 10.0 110.381 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.2 mp -127.29 129.76 48.3 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.449 -0.341 . . . . 10.0 110.5 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 20.5 m -101.32 114.18 27.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.866 -0.606 . . . . 10.0 110.402 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.489 ' O ' ' HA ' ' A' ' 87' ' ' SER . 2.0 mm? -90.54 126.1 35.82 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.727 -0.472 . . . . 10.0 109.727 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.6 tttp -130.21 106.78 8.82 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.491 -0.322 . . . . 10.0 110.746 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 82' ' ' GLN . 47.0 tttm -93.71 110.39 22.02 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.959 -0.385 . . . . 10.0 109.959 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 63.5 mt -74.92 -34.33 32.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 115.381 -0.827 . . . . 10.0 111.312 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.413 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 71.6 mt-30 -83.24 156.13 23.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.344 -0.389 . . . . 10.0 110.418 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.431 ' HA ' ' C ' ' A' ' 84' ' ' PRO . . . -78.54 138.93 58.8 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.458 -0.337 . . . . 10.0 111.421 -178.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.431 ' C ' ' HA ' ' A' ' 83' ' ' ALA . 17.0 Cg_exo -70.29 131.63 20.5 Favored 'Cis proline' 0 C--N 1.347 0.488 0 C-N-CA 123.613 -1.411 . . . . 10.0 112.137 -1.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -83.64 148.2 27.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.275 -0.42 . . . . 10.0 110.813 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.413 ' HZ ' HD22 ' A' ' 105' ' ' LEU . 27.8 p90 -170.07 161.86 8.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.869 0.366 . . . . 10.0 110.915 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.489 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 39.8 m -146.8 108.09 4.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.715 -0.675 . . . . 10.0 109.72 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 41.7 pt -129.35 162.33 37.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.534 -0.303 . . . . 10.0 110.532 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -125.54 137.97 53.95 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.882 0.372 . . . . 10.0 110.563 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 46.1 t60 -149.72 151.25 33.34 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.771 -0.649 . . . . 10.0 109.491 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -99.49 132.03 45.1 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.047 0.451 . . . . 10.0 110.135 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -121.25 169.29 10.71 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.041 0.448 . . . . 10.0 111.283 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.518 ' O ' HD12 ' A' ' 132' ' ' LEU . 38.2 t -81.87 144.99 52.72 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.566 -0.743 . . . . 10.0 110.194 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.62 -14.52 31.6 Favored 'Trans proline' 0 CA--C 1.531 0.33 0 C-N-CA 122.55 2.167 . . . . 10.0 111.952 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -114.51 17.44 17.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.122 -0.49 . . . . 10.0 110.486 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.476 ' HB2' ' O ' ' A' ' 93' ' ' SER . 0.2 OUTLIER -77.04 161.19 28.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.36 -0.382 . . . . 10.0 110.591 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -111.41 151.29 28.68 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.032 -0.531 . . . . 10.0 111.129 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 19.0 mm -59.81 -29.48 43.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 120.973 0.416 . . . . 10.0 110.808 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.28 -35.86 65.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.788 -0.642 . . . . 10.0 110.638 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -62.46 -44.71 95.74 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.606 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.608 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 23.3 mt -65.12 -44.3 95.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.52 -0.548 . . . . 10.0 109.52 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.597 ' HD3' HG13 ' A' ' 114' ' ' ILE . 56.1 mttt -54.46 -50.06 68.6 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.283 -0.871 . . . . 10.0 111.292 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -58.33 -40.34 81.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.941 -0.572 . . . . 10.0 111.233 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -64.07 -36.71 84.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 10.0 110.588 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.608 ' HG ' ' O ' ' A' ' 101' ' ' ILE . 44.4 mt -63.61 -38.66 91.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.969 0.414 . . . . 10.0 110.528 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 22.3 mt -72.95 -43.26 59.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.205 -0.452 . . . . 10.0 110.135 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.5 t -63.39 -21.47 66.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.758 -0.655 . . . . 10.0 111.718 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -95.23 13.27 26.06 Favored 'General case' 0 C--N 1.331 -0.197 0 O-C-N 122.341 -0.224 . . . . 10.0 111.018 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 61.6 27.99 17.32 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 123.462 0.476 . . . . 10.0 111.366 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.74 -22.7 13.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.877 0.37 . . . . 10.0 111.167 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -113.38 150.53 32.53 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.116 -0.493 . . . . 10.0 110.153 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.425 ' OG ' ' HG ' ' A' ' 152' ' ' LEU . 1.5 m -106.29 -18.21 14.06 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.352 -0.385 . . . . 10.0 111.579 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.478 ' HB3' ' CD ' ' A' ' 116' ' ' GLU . 0.2 OUTLIER -169.49 136.58 1.7 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.461 -0.57 . . . . 10.0 109.461 -178.5 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.597 HG13 ' HD3' ' A' ' 102' ' ' LYS . 0.8 OUTLIER -66.03 -39.83 85.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 121.191 0.519 . . . . 10.0 111.074 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.43 ' HB2' ' OE1' ' A' ' 116' ' ' GLU . 14.8 m -48.35 -44.13 34.12 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.86 -1.064 . . . . 10.0 113.209 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.478 ' CD ' ' HB3' ' A' ' 113' ' ' HIS . 0.7 OUTLIER -89.69 14.47 11.66 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.263 0.838 . . . . 10.0 113.263 -178.234 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 113' ' ' HIS . 51.5 mt -91.77 121.34 42.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.371 -0.532 . . . . 10.0 110.249 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.5 mmmt -123.54 115.06 20.92 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.739 -0.467 . . . . 10.0 109.739 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -94.6 124.88 38.9 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.151 0.501 . . . . 10.0 110.856 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.433 ' HB3' HG21 ' C' ' 35' ' ' VAL . 0.0 OUTLIER -109.85 139.51 44.85 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.538 -0.755 . . . . 10.0 109.98 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.458 HD13 HD13 ' A' ' 144' ' ' ILE . 31.9 tp -128.65 94.74 3.93 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.133 -1.432 . . . . 10.0 107.133 178.103 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 48.2 tttp 33.88 65.3 0.3 Allowed 'General case' 0 N--CA 1.464 0.274 0 O-C-N 124.261 0.976 . . . . 10.0 111.495 -177.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.49 ' HA3' ' CB ' ' C' ' 38' ' ' ASP . . . 87.41 -46.0 3.44 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.668 -0.696 . . . . 10.0 113.559 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.429 ' HE2' ' O ' ' A' ' 135' ' ' LEU . 43.1 tttp -63.04 121.23 13.06 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.683 -0.488 . . . . 10.0 109.683 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.0 p -84.11 133.84 28.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.354 0.597 . . . . 10.0 112.075 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.6 mp -100.49 152.34 20.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.647 -0.706 . . . . 10.0 110.083 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -120.93 157.44 29.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.621 0.248 . . . . 10.0 110.733 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.81 -47.32 51.45 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.628 0.973 . . . . 10.0 113.628 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -92.29 12.96 20.7 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.412 0.523 . . . . 10.0 112.412 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 130' ' ' LEU . 3.2 tp -75.36 142.35 43.16 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.103 0.478 . . . . 10.0 111.37 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -104.7 149.27 25.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.562 -0.744 . . . . 10.0 109.614 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.518 HD12 ' O ' ' A' ' 93' ' ' SER . 35.2 mt -56.79 -33.07 66.29 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.787 0.292 . . . . 10.0 111.787 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.7 p -77.7 -14.27 59.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.051 0.453 . . . . 10.0 111.101 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -90.58 -40.71 11.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.267 -0.424 . . . . 10.0 110.841 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.429 ' O ' ' HE2' ' A' ' 124' ' ' LYS . 0.7 OUTLIER -83.86 -20.61 32.82 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 121.124 -0.23 . . . . 10.0 110.915 179.701 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 30.2 mtmt 64.41 91.55 0.08 Allowed 'General case' 0 C--O 1.234 0.266 0 O-C-N 123.756 0.66 . . . . 10.0 111.268 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 29.4 t -63.55 109.4 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.93 -0.577 . . . . 10.0 110.073 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.94 122.99 88.8 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.881 -0.6 . . . . 10.0 110.923 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -66.79 -17.9 52.52 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.652 2.234 . . . . 10.0 112.056 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -87.49 2.58 50.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.892 -0.594 . . . . 10.0 110.379 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -121.76 -73.08 0.66 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.572 -0.74 . . . . 10.0 109.593 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.2 m 59.78 8.52 1.37 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.506 -0.77 . . . . 10.0 112.75 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.7 m -122.56 131.47 53.85 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.879 0.371 . . . . 10.0 111.215 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.458 HD13 HD13 ' A' ' 121' ' ' LEU . 25.0 mm -112.97 122.61 67.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.772 -0.649 . . . . 10.0 109.923 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.18 121.01 26.51 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.411 -0.588 . . . . 10.0 109.411 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 12.6 t -97.62 127.22 50.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.177 0.513 . . . . 10.0 112.033 -178.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -122.94 116.89 24.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.376 -0.829 . . . . 10.0 109.357 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 49.3 mt -138.1 143.13 33.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 110.012 -0.366 . . . . 10.0 110.012 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 25.7 mmmt -97.81 110.07 53.83 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 108.834 -0.802 . . . . 10.0 108.834 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.13 113.29 3.74 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.434 2.089 . . . . 10.0 113.063 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 28.0 p30 -108.03 7.55 27.84 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.867 -0.606 . . . . 10.0 109.784 178.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.425 ' HG ' ' OG ' ' A' ' 112' ' ' SER . 72.8 mt -78.74 118.28 20.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.477 -0.783 . . . . 10.0 109.843 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 . . . . . 0 C--O 1.251 1.173 0 CA-C-O 118.583 -0.722 . . . . 10.0 110.198 -179.866 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' -1' ' ' SER . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.48 1.036 0 CA-C-O 120.62 0.248 . . . . 10.0 110.527 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 0' ' ' VAL . . . . . . . . . . . . . 24.2 t -70.45 -67.59 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 109.136 -0.69 . . . . 10.0 109.136 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 1' ' ' ASP . . . . . 0.5 ' HA ' ' O ' ' B' ' 63' ' ' GLN . 18.8 m-20 43.42 78.72 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 O-C-N 124.303 1.002 . . . . 10.0 111.828 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.15 26.77 1.32 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.366 -0.834 . . . . 10.0 111.463 -178.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -97.44 122.02 40.01 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.68 0.276 . . . . 10.0 110.828 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.37 143.26 27.92 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.429 -0.582 . . . . 10.0 109.429 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -59.94 -46.63 88.77 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.946 0.35 . . . . 10.0 111.946 -178.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -59.56 -46.27 89.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.673 0.273 . . . . 10.0 111.439 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -62.24 -46.62 88.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.34 -0.391 . . . . 10.0 111.167 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.723 ' O ' HG13 ' B' ' 12' ' ' ILE . 32.0 mm -62.94 -45.27 99.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 110.041 -0.355 . . . . 10.0 110.041 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.47 -45.2 73.1 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.388 -0.369 . . . . 10.0 110.752 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.09 -36.29 83.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.864 -0.607 . . . . 10.0 110.55 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.03 -38.02 87.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.275 -0.42 . . . . 10.0 110.653 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.723 HG13 ' O ' ' B' ' 8' ' ' ILE . 13.3 mt -63.35 -55.52 22.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.252 -0.431 . . . . 10.0 111.12 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 35.3 m -64.18 -32.35 57.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.034 -0.53 . . . . 10.0 111.253 -178.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -70.03 -40.91 74.9 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.586 -0.524 . . . . 10.0 109.586 178.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' TYR . . . . . 0.619 ' O ' HG12 ' B' ' 19' ' ' ILE . 21.3 t80 -64.91 -47.8 76.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.988 -0.551 . . . . 10.0 110.08 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 14.7 m-30 -58.04 -44.09 87.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 10.0 111.077 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 70.8 m -57.54 -40.82 79.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 10.0 110.609 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 10.9 m -74.41 -20.89 59.89 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.936 -0.575 . . . . 10.0 111.621 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.619 HG12 ' O ' ' B' ' 15' ' ' TYR . 29.4 mm -79.22 -42.26 23.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.608 0.242 . . . . 10.0 110.555 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 27.0 m -79.15 -21.27 12.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.144 0.497 . . . . 10.0 109.808 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -58.15 -42.61 86.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.172 -0.922 . . . . 10.0 110.67 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 4.4 mttp -109.59 0.56 19.18 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.755 -0.657 . . . . 10.0 109.962 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 33.2 mttt 54.7 52.13 12.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.214 -0.903 . . . . 10.0 110.706 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -82.94 35.16 0.47 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.299 -0.864 . . . . 10.0 110.44 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 25' ' ' ILE . . . . . 0.446 HG12 ' N ' ' B' ' 26' ' ' SER . 12.4 tt -163.68 164.8 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.592 -0.731 . . . . 10.0 109.374 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' SER . . . . . 0.446 ' N ' HG12 ' B' ' 25' ' ' ILE . 0.7 OUTLIER -62.73 160.2 14.77 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.728 0.411 . . . . 10.0 111.957 -179.855 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -55.94 -55.21 35.44 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.045 -0.525 . . . . 10.0 111.681 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.75 -42.64 89.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.006 0.431 . . . . 10.0 110.159 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.527 ' O ' ' HG ' ' B' ' 33' ' ' LEU . . . -61.15 -42.77 99.89 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.698 -0.683 . . . . 10.0 112.26 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.37 -38.76 88.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.024 0.44 . . . . 10.0 110.437 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -68.33 -35.84 78.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.707 -0.679 . . . . 10.0 109.875 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 14.6 m -65.85 -38.46 88.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.669 -0.696 . . . . 10.0 110.024 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' B' ' 29' ' ' GLY . 53.9 mt -70.63 -31.81 68.91 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.0 0.429 . . . . 10.0 109.903 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -61.38 -51.76 67.43 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.743 -0.662 . . . . 10.0 110.685 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 12.2 p -70.25 -32.77 51.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.902 -0.59 . . . . 10.0 110.831 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.6 -45.43 86.99 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 109.245 -0.65 . . . . 10.0 109.245 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 37' ' ' MET . . . . . . . . . . . . . 6.0 ttm -59.91 -37.98 80.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.707 -0.679 . . . . 10.0 109.636 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -66.78 -51.59 53.96 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.914 -1.039 . . . . 10.0 111.278 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.66 -33.41 75.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.49 -0.323 . . . . 10.0 111.642 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 50.6 mt -66.99 -46.27 85.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 110.133 -0.321 . . . . 10.0 110.133 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.526 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 28.7 m -59.4 -33.3 71.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.204 0.526 . . . . 10.0 109.982 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -74.38 -47.26 35.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.548 -0.751 . . . . 10.0 110.874 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.16 -37.5 85.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.088 -0.505 . . . . 10.0 112.258 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -94.0 -4.03 50.37 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 121.014 -0.274 . . . . 10.0 111.553 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.57 59.99 9.76 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 121.399 -0.429 . . . . 10.0 113.517 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.526 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 7.1 p90 -153.1 165.04 36.87 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.994 -0.372 . . . . 10.0 109.994 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -101.22 135.25 43.0 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.769 0.319 . . . . 10.0 111.382 -179.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.53 -20.45 64.66 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.101 -0.5 . . . . 10.0 111.623 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -83.17 -15.49 50.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.86 0.362 . . . . 10.0 111.303 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.6 3.54 47.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.365 -0.379 . . . . 10.0 111.748 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 2.6 m -47.24 -49.23 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 112.778 0.659 . . . . 10.0 112.778 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -50.61 -34.16 24.98 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 113.367 0.877 . . . . 10.0 113.367 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.63 -27.49 50.89 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.813 -0.708 . . . . 10.0 112.616 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 49.6 mt -87.02 -50.71 13.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.031 0.443 . . . . 10.0 111.976 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 69.1 mt -81.45 -67.4 0.78 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.106 -0.497 . . . . 10.0 112.228 -178.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.23 -129.06 8.81 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.567 -0.825 . . . . 10.0 111.044 -178.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -158.33 23.27 0.24 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.429 0.633 . . . . 10.0 110.012 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.1 32.88 0.89 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.507 -0.769 . . . . 10.0 111.466 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 64.44 104.78 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.713 -0.676 . . . . 10.0 111.978 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -80.1 82.4 6.17 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.638 -0.71 . . . . 10.0 109.885 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -80.68 57.66 3.03 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.954 -0.567 . . . . 10.0 111.513 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.6 70.83 2.94 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 111.145 -0.782 . . . . 10.0 111.145 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 63' ' ' GLN . . . . . 0.5 ' O ' ' HA ' ' B' ' 1' ' ' ASP . 6.8 tp60 -68.6 87.58 0.33 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.942 0.401 . . . . 10.0 111.785 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 34.3 t60 -97.66 76.62 2.51 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.08 -0.711 . . . . 10.0 109.08 178.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 79.0 mt -57.84 -41.17 81.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.346 -0.843 . . . . 10.0 111.217 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . 58.45 16.7 4.33 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 123.692 0.62 . . . . 10.0 111.111 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 50.29 49.39 20.65 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-N 115.199 -0.909 . . . . 10.0 111.63 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 72.6 mt -85.3 84.46 2.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.268 0.556 . . . . 10.0 110.202 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -78.96 -24.99 43.51 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.995 -0.743 . . . . 10.0 108.995 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 70' ' ' ASN . . . . . 0.549 ' O ' ' HB3' ' C' ' 52' ' ' SER . 58.3 t30 -81.91 55.2 2.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.58 -0.736 . . . . 10.0 109.54 178.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.71 -32.79 16.03 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.794 -0.639 . . . . 10.0 110.144 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.167 0 CA-C-O 117.939 -1.029 . . . . 10.0 109.624 179.707 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' -1' ' ' SER . . . . . . . . . . . . . 5.5 p . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 120.908 0.385 . . . . 10.0 111.795 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 0' ' ' VAL . . . . . . . . . . . . . 35.6 m -91.72 37.06 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-O 121.254 0.55 . . . . 10.0 111.532 -178.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -68.82 96.29 0.74 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.74 -0.663 . . . . 10.0 110.702 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.47 65.86 2.32 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.432 -0.804 . . . . 10.0 110.655 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -132.51 139.54 47.96 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.082 -0.508 . . . . 10.0 110.021 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 4' ' ' SER . . . . . 0.535 ' O ' HG12 ' C' ' 8' ' ' ILE . 0.0 OUTLIER -89.42 137.79 32.02 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.386 -0.37 . . . . 10.0 110.719 -179.491 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 5' ' ' LYS . . . . . 0.519 ' HE3' HD12 ' B' ' 19' ' ' ILE . 49.5 mttp -63.77 -45.24 90.67 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.708 0.289 . . . . 10.0 110.486 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 6' ' ' GLU . . . . . 0.487 ' HB3' HG21 ' C' ' 54' ' ' ILE . 7.5 mt-10 -54.47 -57.19 12.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.577 -0.738 . . . . 10.0 111.299 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 7' ' ' GLU . . . . . 0.55 ' HG3' ' O ' ' C' ' 54' ' ' ILE . 1.5 mp0 -61.61 -39.38 91.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.76 -0.654 . . . . 10.0 112.272 -179.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 8' ' ' ILE . . . . . 0.535 HG12 ' O ' ' C' ' 4' ' ' SER . 27.2 mm -66.7 -47.93 81.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.89 0.376 . . . . 10.0 110.247 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.48 -42.05 95.47 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.088 -0.505 . . . . 10.0 110.1 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.68 -40.46 92.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.621 -0.718 . . . . 10.0 110.926 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.5 -33.82 76.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.931 0.396 . . . . 10.0 110.392 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 12' ' ' ILE . . . . . 0.468 HG13 HG12 ' B' ' 12' ' ' ILE . 1.2 mp -70.89 -48.3 57.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.064 -0.516 . . . . 10.0 111.064 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 26.8 m -65.69 -28.03 43.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-O 121.218 0.532 . . . . 10.0 110.05 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -73.25 -39.77 65.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.66 -0.7 . . . . 10.0 109.382 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 15' ' ' TYR . . . . . 0.471 ' O ' HG12 ' C' ' 19' ' ' ILE . 32.7 t80 -68.89 -43.49 75.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 10.0 110.308 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 10.1 m-30 -55.63 -46.88 77.36 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.171 -0.468 . . . . 10.0 110.412 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 19.9 m -60.84 -43.89 97.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.868 -0.605 . . . . 10.0 111.364 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 12.7 m -67.67 -22.67 65.29 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.982 0.364 . . . . 10.0 111.982 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 19' ' ' ILE . . . . . 0.471 HG12 ' O ' ' C' ' 15' ' ' TYR . 29.5 mm -82.62 -39.7 16.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.589 0.233 . . . . 10.0 111.052 -179.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 20' ' ' VAL . . . . . . . . . . . . . 13.6 m -77.5 -23.69 14.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.289 0.566 . . . . 10.0 109.814 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -66.86 -48.08 69.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.122 -0.944 . . . . 10.0 111.018 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 33.7 mttp -91.12 -5.49 55.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.676 -0.238 . . . . 10.0 110.911 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 64.6 mttm 63.72 49.33 2.99 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.82 -0.627 . . . . 10.0 110.825 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -81.94 -5.44 58.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.894 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 12.7 tt -131.62 162.34 39.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.545 -0.539 . . . . 10.0 109.545 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.09 153.62 11.25 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 122.59 0.356 . . . . 10.0 111.156 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -58.4 -40.2 81.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.852 0.358 . . . . 10.0 110.858 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 28' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -67.12 -40.81 86.87 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.183 0.516 . . . . 10.0 109.697 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 29' ' ' GLY . . . . . 0.517 ' O ' ' HG ' ' C' ' 33' ' ' LEU . . . -65.16 -33.18 86.26 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.514 -0.766 . . . . 10.0 111.23 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.32 -39.63 95.08 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.815 -0.439 . . . . 10.0 109.815 178.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -63.17 -35.76 81.38 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.89 -0.596 . . . . 10.0 109.666 178.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 1.2 t -65.66 -43.83 88.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.494 -0.775 . . . . 10.0 109.81 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 33' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' C' ' 29' ' ' GLY . 43.5 mt -66.93 -34.52 77.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.074 0.464 . . . . 10.0 109.765 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -60.89 -50.43 73.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.388 -0.823 . . . . 10.0 110.94 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 35' ' ' VAL . . . . . 0.433 HG21 ' HB3' ' A' ' 120' ' ' LEU . 12.2 p -71.86 -36.29 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 116.425 -0.352 . . . . 10.0 111.416 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.13 -33.34 74.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.875 0.369 . . . . 10.0 110.462 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 34.7 ttm -53.83 -59.96 3.94 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.643 -0.708 . . . . 10.0 111.036 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 38' ' ' ASP . . . . . 0.578 ' OD2' ' HD3' ' C' ' 48' ' ' ARG . 3.3 m-20 -67.03 -27.19 67.2 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.243 -0.435 . . . . 10.0 111.139 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 39' ' ' CYS . . . . . 0.415 ' N ' ' HA2' ' A' ' 123' ' ' GLY . 1.1 t -65.04 -49.12 71.38 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.047 0.451 . . . . 10.0 110.48 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 40' ' ' ILE . . . . . . . . . . . . . 53.6 mt -66.94 -38.28 81.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.735 -0.666 . . . . 10.0 109.837 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 41' ' ' SER . . . . . 0.722 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 35.5 m -62.21 -47.22 85.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.546 -0.752 . . . . 10.0 110.716 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -65.1 -40.94 95.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.165 -0.471 . . . . 10.0 110.724 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.97 -43.92 91.42 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.519 0.562 . . . . 10.0 112.519 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 44' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -94.82 -2.47 50.8 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.969 0.359 . . . . 10.0 111.969 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.75 53.02 12.65 Favored Glycine 0 CA--C 1.52 0.387 0 N-CA-C 114.4 0.52 . . . . 10.0 114.4 178.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 46' ' ' PHE . . . . . 0.722 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 30.2 p90 -144.67 157.11 44.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 117.165 0.483 . . . . 10.0 110.473 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -83.18 146.15 28.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.528 -0.306 . . . . 10.0 110.298 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 48' ' ' ARG . . . . . 0.578 ' HD3' ' OD2' ' C' ' 38' ' ' ASP . 0.0 OUTLIER -61.91 -28.91 69.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.379 0.609 . . . . 10.0 110.578 179.619 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 49' ' ' GLU . . . . . 0.438 ' C ' ' H ' ' C' ' 51' ' ' VAL . 4.3 mp0 -84.91 18.88 2.28 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.437 -0.801 . . . . 10.0 112.393 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.1 8.26 0.22 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.941 0.896 . . . . 10.0 112.695 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 51' ' ' VAL . . . . . 0.438 ' H ' ' C ' ' C' ' 49' ' ' GLU . 3.5 m -34.67 -38.61 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 N-CA-C 117.708 2.484 . . . . 10.0 117.708 -176.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 52' ' ' SER . . . . . 0.549 ' HB3' ' O ' ' B' ' 70' ' ' ASN . 0.0 OUTLIER -88.17 -54.03 4.42 Favored 'General case' 0 C--O 1.217 -0.63 0 N-CA-C 118.653 2.834 . . . . 10.0 118.653 -175.794 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.11 -56.87 9.43 Favored Glycine 0 CA--C 1.494 -1.254 0 C-N-CA 119.869 -1.158 . . . . 10.0 115.799 -171.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 54' ' ' ILE . . . . . 0.55 ' O ' ' HG3' ' C' ' 7' ' ' GLU . 0.5 OUTLIER -82.0 -35.18 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 C-N-CA 119.847 -0.741 . . . . 10.0 110.561 -179.355 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.4 -75.38 0.33 Allowed 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 116.101 1.889 . . . . 10.0 116.101 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.36 -145.71 49.12 Favored Glycine 0 N--CA 1.471 1.014 0 C-N-CA 121.538 -0.363 . . . . 10.0 112.437 -177.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -150.44 22.46 0.82 Allowed 'General case' 0 C--O 1.233 0.186 0 N-CA-C 109.541 -0.541 . . . . 10.0 109.541 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.12 42.36 0.65 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.529 -0.76 . . . . 10.0 112.043 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 65.1 107.77 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.61 0.719 . . . . 10.0 111.613 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 60' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -82.8 78.97 9.32 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.684 -0.689 . . . . 10.0 110.497 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 35.4 mttp -83.98 64.96 8.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.941 -0.572 . . . . 10.0 111.395 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.8 86.36 1.42 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.704 -0.76 . . . . 10.0 111.374 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 63' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -80.28 75.99 7.08 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.467 0.543 . . . . 10.0 112.467 -178.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 64' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -103.05 81.68 2.0 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.089 -0.708 . . . . 10.0 109.089 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 50.7 mt -69.92 -37.14 75.82 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.703 -0.68 . . . . 10.0 111.139 -179.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . 59.62 20.59 9.19 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 123.555 0.534 . . . . 10.0 111.109 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 56.42 45.58 22.39 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.555 -0.748 . . . . 10.0 111.337 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 68' ' ' ILE . . . . . . . . . . . . . 97.1 mt -84.42 99.52 6.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.318 0.58 . . . . 10.0 110.978 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 69' ' ' LEU . . . . . 0.42 HD13 ' HA ' ' C' ' 69' ' ' LEU . 3.8 mm? -106.87 -11.8 15.64 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.65 0.738 . . . . 10.0 109.044 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 70' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -89.37 42.49 1.09 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.753 -1.112 . . . . 10.0 110.906 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -78.57 -18.3 54.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.897 -0.592 . . . . 10.0 110.289 179.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.033 0 CA-C-N 115.747 -0.66 . . . . 10.0 110.077 -179.999 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 49.1 mtm . . . . . 0 N--CA 1.483 1.191 0 N-CA-C 110.076 -0.342 . . . . 10.0 110.076 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 15.4 t -94.51 133.81 34.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.811 -0.44 . . . . 10.0 109.811 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -91.87 122.38 34.34 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.835 0.35 . . . . 10.0 110.569 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.1 mp -125.38 121.36 33.65 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.388 -0.369 . . . . 10.0 110.432 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.6 m -93.97 113.17 25.11 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 120.829 0.347 . . . . 10.0 110.202 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.562 ' O ' ' HA ' ' A' ' 87' ' ' SER . 2.6 mm? -84.94 119.33 25.25 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.948 -0.569 . . . . 10.0 109.771 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -121.16 100.89 7.31 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.131 0.491 . . . . 10.0 110.921 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 84' ' ' PRO . 20.5 tptm -87.13 114.86 24.1 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.579 -0.737 . . . . 10.0 110.757 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 16.0 mt -77.66 -66.41 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 O-C-N 123.915 0.759 . . . . 10.0 111.285 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -60.43 160.8 8.24 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.893 -0.594 . . . . 10.0 111.323 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.454 ' HA ' ' C ' ' A' ' 84' ' ' PRO . . . -86.02 143.13 36.95 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.225 -0.443 . . . . 10.0 111.134 -178.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.454 ' C ' ' HA ' ' A' ' 83' ' ' ALA . 43.7 Cg_endo -71.6 127.54 12.64 Favored 'Cis proline' 0 C--N 1.346 0.423 0 C-N-CA 123.068 -1.638 . . . . 10.0 111.202 -0.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.445 ' N ' ' HA ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -93.34 158.58 15.67 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.175 -0.466 . . . . 10.0 112.001 -178.627 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -178.96 172.4 1.3 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.318 -0.856 . . . . 10.0 109.316 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 66.4 m -152.95 110.34 3.53 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.899 0.381 . . . . 10.0 110.301 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.8 pt -119.15 158.82 20.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.875 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -114.81 113.9 24.84 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.085 -0.709 . . . . 10.0 109.085 179.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -129.51 147.88 51.36 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.175 0.512 . . . . 10.0 110.415 -178.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.91 130.65 53.82 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.862 -0.608 . . . . 10.0 109.368 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -121.39 171.6 8.65 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.09 0.472 . . . . 10.0 111.425 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.577 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 0.7 OUTLIER -80.02 151.2 72.92 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.732 -0.667 . . . . 10.0 110.977 -179.779 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -65.39 -16.73 55.59 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 122.311 2.007 . . . . 10.0 112.504 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.1 m -110.72 15.52 21.9 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.434 -0.58 . . . . 10.0 109.434 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.577 ' HB2' ' O ' ' A' ' 93' ' ' SER . 0.3 OUTLIER -75.38 161.81 28.93 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.699 -0.682 . . . . 10.0 110.806 -179.759 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.97 157.82 26.04 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.605 -0.725 . . . . 10.0 110.886 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.542 ' O ' ' HG3' ' A' ' 102' ' ' LYS . 41.2 mm -67.25 -22.29 28.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.343 -0.614 . . . . 10.0 109.343 178.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.42 -38.73 71.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.205 -0.907 . . . . 10.0 110.141 178.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -68.24 -40.61 81.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.035 -0.529 . . . . 10.0 110.996 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.531 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 51.7 mt -62.26 -47.26 93.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.796 -0.638 . . . . 10.0 109.588 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.542 ' HG3' ' O ' ' A' ' 98' ' ' ILE . 79.9 mttt -55.46 -44.4 76.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.927 -1.033 . . . . 10.0 111.436 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.487 ' OE1' ' HA ' ' A' ' 103' ' ' GLN . 10.0 mm-40 -62.26 -37.67 86.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.62 -0.264 . . . . 10.0 111.21 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -65.11 -39.77 93.61 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.906 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 101' ' ' ILE . 34.2 mt -63.03 -44.75 95.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.097 -0.501 . . . . 10.0 111.397 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 102' ' ' LYS . 12.6 mt -67.94 -42.21 85.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.121 -0.49 . . . . 10.0 111.404 -178.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 49.8 m -69.84 -9.89 56.44 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.013 0.375 . . . . 10.0 112.013 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -107.72 16.12 23.95 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 121.104 -0.238 . . . . 10.0 110.895 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 58.83 26.35 14.69 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.707 -0.679 . . . . 10.0 111.673 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.6 mmpp? -96.36 -16.48 21.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.369 0.604 . . . . 10.0 110.069 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.689 ' HB2' HD13 ' A' ' 148' ' ' ILE . . . -137.08 166.52 23.5 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.294 -0.866 . . . . 10.0 110.349 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.497 ' HB2' ' OD1' ' A' ' 151' ' ' ASN . 4.6 m -108.18 -49.46 3.19 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.766 0.317 . . . . 10.0 110.94 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.488 ' O ' HG13 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -136.87 139.01 41.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.138 -179.45 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.435 ' HB ' HD11 ' A' ' 106' ' ' ILE . 6.0 tt -64.07 -39.06 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.513 0.673 . . . . 10.0 109.865 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.0 m -52.39 -27.93 17.67 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.321 -1.309 . . . . 10.0 112.45 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.23 -4.56 38.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.71 0.291 . . . . 10.0 111.417 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 113' ' ' HIS . 59.1 mt -89.75 127.11 42.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.022 0.439 . . . . 10.0 110.945 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.62 128.83 20.99 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.544 -0.91 . . . . 10.0 108.544 177.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.433 HD12 HG22 ' A' ' 144' ' ' ILE . 4.2 mm? -91.24 136.69 32.92 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.387 0.613 . . . . 10.0 111.21 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.542 ' HG ' HG22 ' C' ' 35' ' ' VAL . 3.7 tp -110.46 126.45 54.35 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.78 -1.1 . . . . 10.0 108.633 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 47.3 tp -113.76 93.04 4.19 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 106.624 -1.621 . . . . 10.0 106.624 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.42 ' HD3' ' HA ' ' A' ' 122' ' ' LYS . 2.7 tppp? 38.68 60.98 1.27 Allowed 'General case' 0 CA--C 1.539 0.546 0 O-C-N 123.944 0.778 . . . . 10.0 110.587 -177.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.504 ' HA3' ' CB ' ' C' ' 38' ' ' ASP . . . 87.95 -45.87 3.36 Favored Glycine 0 C--N 1.332 0.349 0 CA-C-N 115.544 -0.753 . . . . 10.0 113.999 -178.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.2 tttp -59.76 118.65 6.4 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 110.189 -0.3 . . . . 10.0 110.189 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.4 p -78.99 137.18 22.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.62 0.724 . . . . 10.0 112.205 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.432 ' HG ' HD23 ' A' ' 130' ' ' LEU . 6.8 mp -104.34 156.91 17.52 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 114.824 -1.08 . . . . 10.0 110.624 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -116.26 164.17 14.9 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.004 0.43 . . . . 10.0 112.005 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -55.15 -56.04 24.43 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 114.071 1.137 . . . . 10.0 114.071 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -91.72 14.7 14.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.864 0.364 . . . . 10.0 111.322 -178.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.432 HD23 ' HG ' ' A' ' 126' ' ' LEU . 15.1 tp -68.22 139.84 56.05 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.718 0.294 . . . . 10.0 110.501 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -97.4 145.24 26.36 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.261 -0.427 . . . . 10.0 110.484 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.482 HD12 ' O ' ' A' ' 93' ' ' SER . 10.7 mt -54.03 -38.75 65.5 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.747 0.647 . . . . 10.0 112.747 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.35 -17.14 56.92 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.817 0.303 . . . . 10.0 111.817 -179.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -79.13 -45.8 19.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.833 0.349 . . . . 10.0 110.278 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.7 pp -77.01 -23.7 52.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.875 -0.602 . . . . 10.0 110.81 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.2 mtmt 65.89 90.57 0.09 Allowed 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.618 0.574 . . . . 10.0 111.767 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.5 t -68.2 103.63 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.812 -0.631 . . . . 10.0 109.923 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.39 135.38 86.54 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.975 -0.557 . . . . 10.0 111.007 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -68.8 -22.23 37.14 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.224 1.95 . . . . 10.0 110.973 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -78.53 -3.55 44.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.306 -0.861 . . . . 10.0 110.485 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -122.69 -83.65 0.66 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.934 -0.575 . . . . 10.0 110.093 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.2 m 61.01 3.14 0.63 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.715 -0.675 . . . . 10.0 112.198 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.5 m -102.32 114.54 28.79 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-O 120.96 0.41 . . . . 10.0 110.044 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.433 HG22 HD12 ' A' ' 119' ' ' LEU . 1.4 mm -104.92 109.03 26.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 108.287 -1.005 . . . . 10.0 108.287 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.441 ' OG1' HG21 ' C' ' 35' ' ' VAL . 0.0 OUTLIER -79.6 122.03 26.0 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.653 -0.869 . . . . 10.0 108.653 -179.172 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.0 t -91.43 121.83 42.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.414 -0.812 . . . . 10.0 111.431 -177.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 81.5 mmm -115.56 113.96 24.31 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.008 -0.996 . . . . 10.0 109.732 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.689 HD13 ' HB2' ' A' ' 111' ' ' ALA . 11.3 mt -139.35 144.38 29.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.579 -0.737 . . . . 10.0 111.465 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -107.96 120.9 45.57 Favored Pre-proline 0 C--N 1.321 -0.656 0 N-CA-C 108.134 -1.062 . . . . 10.0 108.134 178.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -70.11 111.3 2.84 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.332 2.022 . . . . 10.0 112.434 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.497 ' OD1' ' HB2' ' A' ' 112' ' ' SER . 3.3 m120 -87.67 18.08 4.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.934 -0.575 . . . . 10.0 109.989 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.6 mt -75.31 91.27 2.67 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.757 -0.656 . . . . 10.0 109.929 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.245 0.846 0 CA-C-O 118.007 -0.997 . . . . 10.0 110.097 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' -1' ' ' SER . . . . . . . . . . . . . 7.0 p . . . . . 0 N--CA 1.474 0.747 0 CA-C-O 120.656 0.265 . . . . 10.0 111.207 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 0' ' ' VAL . . . . . . . . . . . . . 1.9 t -91.44 13.11 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 116.29 -0.414 . . . . 10.0 112.089 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -58.82 102.55 0.12 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.063 0.459 . . . . 10.0 111.08 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.33 12.37 31.38 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.236 -0.438 . . . . 10.0 111.782 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.6 129.56 34.96 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 121.117 -0.233 . . . . 10.0 110.654 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.01 142.86 27.28 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.985 -0.376 . . . . 10.0 109.985 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 5' ' ' LYS . . . . . 0.406 ' HG2' ' H ' ' B' ' 5' ' ' LYS . 4.4 ptpp? -60.35 -40.88 92.27 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.456 -0.338 . . . . 10.0 111.577 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -58.3 -43.13 87.94 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.858 0.361 . . . . 10.0 110.534 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -66.91 -46.19 75.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.03 -0.532 . . . . 10.0 111.424 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.449 ' O ' HD13 ' B' ' 12' ' ' ILE . 32.5 mm -65.0 -46.09 92.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.747 0.308 . . . . 10.0 110.532 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.76 -43.72 81.05 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.015 0.436 . . . . 10.0 110.622 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.59 -34.82 77.8 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.687 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.57 -35.73 77.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.911 0.386 . . . . 10.0 110.282 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.516 HG12 HG23 ' C' ' 12' ' ' ILE . 1.6 mp -68.23 -50.55 56.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.775 -0.648 . . . . 10.0 111.138 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 31.4 m -63.92 -32.28 56.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 N-CA-C 109.694 -0.484 . . . . 10.0 109.694 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -64.18 -53.46 48.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.571 -0.741 . . . . 10.0 109.843 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 15' ' ' TYR . . . . . 0.603 ' O ' HG12 ' B' ' 19' ' ' ILE . 39.1 t80 -60.3 -48.16 82.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.766 -0.652 . . . . 10.0 111.217 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 10.1 m-30 -53.95 -47.74 70.97 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.813 0.34 . . . . 10.0 110.526 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 50.7 m -57.5 -36.45 71.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.18 -0.464 . . . . 10.0 111.247 178.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 1.2 m -74.84 -19.29 60.23 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.268 -0.423 . . . . 10.0 111.193 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.603 HG12 ' O ' ' B' ' 15' ' ' TYR . 35.8 mm -81.39 -43.01 20.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.392 -0.367 . . . . 10.0 111.549 -178.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 16.8 m -76.26 -25.89 16.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.232 0.539 . . . . 10.0 109.93 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -62.12 -43.92 97.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.264 -0.88 . . . . 10.0 111.344 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -102.61 4.33 38.24 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.894 -0.323 . . . . 10.0 110.433 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 54.0 mttm 52.07 54.85 10.11 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 115.454 -0.794 . . . . 10.0 110.675 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -88.82 25.54 1.75 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.34 -0.846 . . . . 10.0 110.8 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 15.9 tt -161.7 164.02 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.756 -0.656 . . . . 10.0 109.405 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 2.4 p -64.5 155.64 32.19 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.627 -0.26 . . . . 10.0 111.175 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -59.07 -42.31 90.06 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.927 0.394 . . . . 10.0 110.901 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -59.93 -41.37 91.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.789 -0.641 . . . . 10.0 109.948 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.426 ' O ' ' HG ' ' B' ' 33' ' ' LEU . . . -73.09 -34.7 58.16 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.805 -0.712 . . . . 10.0 111.583 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.37 -42.76 99.23 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-O 120.822 0.344 . . . . 10.0 110.542 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -63.6 -41.14 98.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.233 0.54 . . . . 10.0 109.597 178.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 42.4 m -61.8 -46.38 89.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.243 -0.89 . . . . 10.0 110.923 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' B' ' 29' ' ' GLY . 68.5 mt -68.52 -30.27 69.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.381 -0.372 . . . . 10.0 110.938 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -65.63 -51.93 55.81 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.35 -0.386 . . . . 10.0 111.048 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 14.6 p -67.09 -33.92 66.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.916 -0.584 . . . . 10.0 110.538 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.79 -42.1 91.14 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.647 -0.501 . . . . 10.0 109.647 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 37' ' ' MET . . . . . 0.586 ' SD ' ' HD2' ' B' ' 48' ' ' ARG . 11.0 ttm -56.5 -53.02 62.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.259 -0.882 . . . . 10.0 110.354 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.66 -46.41 88.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 10.0 111.42 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 50.2 t -58.08 -44.68 87.68 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.513 -0.312 . . . . 10.0 111.749 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 87.5 mt -64.66 -39.0 84.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.269 0.557 . . . . 10.0 109.92 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.424 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 24.3 m -64.75 -40.32 95.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.597 -0.729 . . . . 10.0 110.442 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -75.82 -24.78 55.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.468 -0.333 . . . . 10.0 110.847 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.86 -33.38 66.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.052 -0.522 . . . . 10.0 111.09 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -102.36 -3.23 27.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.879 0.371 . . . . 10.0 111.241 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 66.48 59.65 7.03 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 114.466 0.547 . . . . 10.0 114.466 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.424 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 22.0 p90 -154.16 159.83 41.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 117.271 0.536 . . . . 10.0 110.335 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -86.52 144.06 27.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.879 0.371 . . . . 10.0 110.766 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.586 ' HD2' ' SD ' ' B' ' 37' ' ' MET . 3.1 mtm180 -64.88 -25.9 68.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.053 -0.522 . . . . 10.0 110.685 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 55.7 mp0 -85.07 -8.47 58.66 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.15 -0.477 . . . . 10.0 112.118 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.11 2.68 17.16 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 111.937 0.347 . . . . 10.0 111.937 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 13.4 m -45.63 -53.16 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 113.06 0.763 . . . . 10.0 113.06 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 1.4 m -49.68 -41.59 43.5 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.321 0.86 . . . . 10.0 113.321 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.77 -29.55 65.15 Favored Glycine 0 C--O 1.23 -0.139 0 C-N-CA 120.686 -0.769 . . . . 10.0 112.456 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 25.5 mt -87.96 -51.0 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 112.902 0.705 . . . . 10.0 112.902 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 26.3 mt -82.29 -69.32 0.63 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.136 0.791 . . . . 10.0 113.136 -177.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.0 -132.91 11.44 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.618 -0.801 . . . . 10.0 111.701 -178.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -156.94 29.94 0.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.394 0.616 . . . . 10.0 109.942 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.03 30.48 1.61 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.39 -0.823 . . . . 10.0 111.361 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 60.94 75.08 0.42 Allowed 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.838 -0.619 . . . . 10.0 110.208 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -70.03 101.67 1.85 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.224 -0.898 . . . . 10.0 110.653 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 16.8 mttp -95.51 93.45 7.2 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.765 -0.652 . . . . 10.0 110.903 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.87 68.15 2.58 Favored Glycine 0 N--CA 1.451 -0.356 0 N-CA-C 111.115 -0.794 . . . . 10.0 111.115 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -63.36 100.16 0.23 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.287 0.565 . . . . 10.0 111.513 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 69.2 t60 -142.1 90.29 2.24 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.237 -0.892 . . . . 10.0 109.025 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 73.7 mt -80.6 -26.03 38.1 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.614 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . 58.41 18.69 5.79 Favored 'General case' 0 N--CA 1.462 0.158 0 O-C-N 123.672 0.607 . . . . 10.0 111.277 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 61.56 34.34 17.88 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.918 -0.583 . . . . 10.0 111.39 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 68' ' ' ILE . . . . . 0.428 HG21 ' HA ' ' C' ' 52' ' ' SER . 73.2 mt -78.77 95.89 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.145 0.498 . . . . 10.0 110.207 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -86.12 -38.72 17.46 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.585 -0.734 . . . . 10.0 111.087 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -81.49 75.3 8.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.367 0.603 . . . . 10.0 110.954 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.86 5.67 35.99 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.767 -0.651 . . . . 10.0 110.29 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.399 -0.81 . . . . 10.0 110.625 -179.3 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' -1' ' ' SER . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.475 0.777 0 CA-C-O 120.947 0.403 . . . . 10.0 110.55 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 0' ' ' VAL . . . . . . . . . . . . . 1.9 t -85.22 39.42 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.919 -0.582 . . . . 10.0 111.378 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -73.33 105.18 4.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.542 0.687 . . . . 10.0 111.023 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.7 48.56 1.07 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.802 -1.09 . . . . 10.0 111.25 -178.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -126.7 132.26 51.19 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.57 -0.53 . . . . 10.0 109.57 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 4' ' ' SER . . . . . 0.503 ' HB2' ' OE1' ' C' ' 7' ' ' GLU . 0.8 OUTLIER -96.98 154.2 17.45 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.727 0.298 . . . . 10.0 110.695 -178.016 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 5' ' ' LYS . . . . . 0.457 ' HB3' ' CE1' ' C' ' 44' ' ' PHE . 17.7 mttp -61.78 -40.99 97.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.083 -0.508 . . . . 10.0 111.757 -178.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 6' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -57.9 -57.94 10.56 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.459 0.474 . . . . 10.0 110.374 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 7' ' ' GLU . . . . . 0.503 ' OE1' ' HB2' ' C' ' 4' ' ' SER . 2.6 mp0 -55.79 -44.91 78.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.684 -0.689 . . . . 10.0 111.772 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 8' ' ' ILE . . . . . 0.65 ' O ' HG13 ' C' ' 12' ' ' ILE . 38.8 mm -62.58 -53.18 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 C-N-CA 121.233 -0.187 . . . . 10.0 110.604 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.99 -45.26 75.0 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.347 -0.388 . . . . 10.0 110.774 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.63 -35.0 79.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.797 -0.638 . . . . 10.0 110.942 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.6 -35.66 80.73 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.216 -0.447 . . . . 10.0 111.06 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 12' ' ' ILE . . . . . 0.65 HG13 ' O ' ' C' ' 8' ' ' ILE . 6.6 mt -69.87 -50.41 49.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.928 0.394 . . . . 10.0 111.265 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 13' ' ' VAL . . . . . 0.407 ' HA ' ' HG3' ' C' ' 37' ' ' MET . 16.4 m -68.11 -27.94 39.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 116.005 -0.543 . . . . 10.0 110.965 -178.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 14' ' ' ASN . . . . . 0.461 ' HB2' HG11 ' C' ' 51' ' ' VAL . 33.9 t30 -74.22 -43.06 58.62 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.256 -0.646 . . . . 10.0 109.256 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 15' ' ' TYR . . . . . 0.598 ' O ' HG12 ' C' ' 19' ' ' ILE . 13.1 t80 -64.28 -49.01 73.51 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.521 -0.763 . . . . 10.0 110.882 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 11.9 m-30 -55.75 -43.77 76.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.502 -0.317 . . . . 10.0 111.711 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 66.6 m -59.48 -40.61 87.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.569 -0.287 . . . . 10.0 111.522 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 1.3 m -76.25 -23.13 54.47 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.024 0.379 . . . . 10.0 112.024 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 19' ' ' ILE . . . . . 0.598 HG12 ' O ' ' C' ' 15' ' ' TYR . 29.2 mm -77.13 -38.48 27.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.067 0.461 . . . . 10.0 110.684 -178.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 20' ' ' VAL . . . . . . . . . . . . . 33.4 m -79.74 -20.12 12.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.377 0.608 . . . . 10.0 109.775 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -62.91 -51.63 66.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.973 -1.012 . . . . 10.0 110.838 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -92.7 -2.36 56.1 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.676 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 63.6 mttm 56.03 56.4 5.97 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.704 -0.68 . . . . 10.0 109.911 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -84.96 13.02 6.46 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.177 -0.92 . . . . 10.0 110.529 -179.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 15.9 tt -150.09 163.3 3.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.658 -0.867 . . . . 10.0 108.658 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 13.8 m -66.07 162.76 18.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.662 0.267 . . . . 10.0 110.639 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -60.82 -39.57 89.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.516 -0.311 . . . . 10.0 111.626 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 28' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -59.75 -47.84 84.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.018 0.437 . . . . 10.0 110.256 179.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 29' ' ' GLY . . . . . 0.535 ' O ' ' HG ' ' C' ' 33' ' ' LEU . . . -65.58 -41.36 96.14 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.855 -0.688 . . . . 10.0 111.587 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.5 -42.34 96.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.709 0.29 . . . . 10.0 111.36 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.9 -38.82 92.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.082 0.468 . . . . 10.0 110.319 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 6.3 m -62.46 -40.15 95.69 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.679 -0.691 . . . . 10.0 110.067 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 33' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' C' ' 29' ' ' GLY . 62.4 mt -72.2 -31.51 65.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.833 -0.621 . . . . 10.0 111.169 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -64.42 -53.77 43.18 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.256 -0.429 . . . . 10.0 111.717 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 35' ' ' VAL . . . . . 0.542 HG22 ' HG ' ' A' ' 120' ' ' LEU . 11.3 p -67.79 -35.06 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-O 120.888 0.375 . . . . 10.0 110.664 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.72 -29.2 66.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.794 0.331 . . . . 10.0 110.529 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 37' ' ' MET . . . . . 0.407 ' HG3' ' HA ' ' C' ' 13' ' ' VAL . 30.5 ttm -58.55 -50.94 71.97 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.006 -0.543 . . . . 10.0 110.514 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 38' ' ' ASP . . . . . 0.504 ' CB ' ' HA3' ' A' ' 123' ' ' GLY . 1.0 OUTLIER -69.71 -28.65 66.0 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 116.43 -0.35 . . . . 10.0 110.62 -179.721 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 39' ' ' CYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 123' ' ' GLY . 7.8 t -61.61 -50.25 73.33 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.423 -0.584 . . . . 10.0 109.423 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 40' ' ' ILE . . . . . . . . . . . . . 79.4 mt -60.57 -46.04 96.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.323 -0.853 . . . . 10.0 109.927 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 41' ' ' SER . . . . . 0.835 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 47.4 m -58.87 -38.18 78.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.55 -0.75 . . . . 10.0 111.366 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -70.71 -44.98 65.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.714 -0.675 . . . . 10.0 110.863 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.41 -37.44 72.74 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.819 0.674 . . . . 10.0 112.819 -178.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 44' ' ' PHE . . . . . 0.457 ' CE1' ' HB3' ' C' ' 5' ' ' LYS . 94.1 m-85 -97.9 2.35 49.08 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.179 -0.326 . . . . 10.0 111.633 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.74 57.93 16.39 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.314 -0.47 . . . . 10.0 113.518 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 46' ' ' PHE . . . . . 0.835 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 10.5 p90 -147.71 175.64 10.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 117.121 0.46 . . . . 10.0 110.404 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -100.97 136.19 41.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.642 -0.253 . . . . 10.0 110.355 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 48' ' ' ARG . . . . . 0.435 ' O ' HG13 ' C' ' 51' ' ' VAL . 5.1 ptm180 -58.98 -37.47 76.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 10.0 111.293 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.61 18.58 3.86 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.752 1.019 . . . . 10.0 113.752 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.92 1.66 37.08 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.989 0.424 . . . . 10.0 111.421 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 51' ' ' VAL . . . . . 0.461 HG11 ' HB2' ' C' ' 14' ' ' ASN . 27.2 m -45.22 -35.78 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 114.097 1.147 . . . . 10.0 114.097 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 52' ' ' SER . . . . . 0.428 ' HA ' HG21 ' B' ' 68' ' ' ILE . 0.7 OUTLIER -57.98 -35.6 71.43 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.316 0.858 . . . . 10.0 113.316 -179.164 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.55 -20.31 69.19 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 111.087 -0.805 . . . . 10.0 111.087 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 54' ' ' ILE . . . . . . . . . . . . . 50.5 mt -91.69 -65.38 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 114.35 1.241 . . . . 10.0 114.35 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 72.8 mt -78.43 -66.73 0.82 Allowed 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.222 -0.899 . . . . 10.0 112.984 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 75.39 -141.37 27.67 Favored Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 120.156 -1.021 . . . . 10.0 110.849 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 12.6 pttp -136.42 22.35 3.18 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.103 0.477 . . . . 10.0 110.546 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.44 19.09 1.31 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.747 -0.66 . . . . 10.0 111.337 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 60.2 88.15 0.08 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.623 -0.717 . . . . 10.0 111.039 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 60' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -69.68 104.98 2.55 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.666 -0.697 . . . . 10.0 111.254 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -86.48 72.78 10.22 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.077 -0.51 . . . . 10.0 110.427 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.98 78.72 1.93 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 121.158 -0.544 . . . . 10.0 111.944 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 63' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -78.21 86.97 4.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.953 0.406 . . . . 10.0 111.741 -178.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 64' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -110.01 88.33 2.73 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.221 -0.659 . . . . 10.0 109.221 177.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 46.2 mt -75.13 -30.06 60.7 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.919 -0.582 . . . . 10.0 110.896 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . 59.12 13.73 3.11 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.695 -0.684 . . . . 10.0 111.89 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 69.54 29.93 4.17 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 123.688 0.618 . . . . 10.0 111.556 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 68' ' ' ILE . . . . . . . . . . . . . 83.3 mt -85.65 107.52 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.223 0.535 . . . . 10.0 111.068 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -108.59 -16.19 14.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.737 -0.665 . . . . 10.0 110.079 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 70' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -83.16 54.2 2.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.791 -0.641 . . . . 10.0 111.912 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.31 -10.54 57.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.067 0.46 . . . . 10.0 110.862 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.244 0 CA-C-O 118.508 -0.758 . . . . 10.0 110.519 -179.489 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.453 -0.282 0 N-CA-C 109.99 -0.374 . . . . 10.0 109.99 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -86.25 120.13 27.28 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.268 -0.424 . . . . 10.0 110.858 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.1 mp -125.72 120.08 29.7 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.881 -0.599 . . . . 10.0 109.844 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.437 HG23 ' HG2' ' A' ' 89' ' ' GLU . 15.6 m -99.54 112.97 25.1 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.968 0.413 . . . . 10.0 109.943 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 87' ' ' SER . 3.0 mm? -84.57 114.65 22.12 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.873 -0.603 . . . . 10.0 109.645 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -117.93 103.83 10.31 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.079 -0.51 . . . . 10.0 110.232 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 84' ' ' PRO . 15.9 tptm -92.17 121.8 34.04 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.806 -0.633 . . . . 10.0 109.348 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.4 HD13 ' HB2' ' C' ' 32' ' ' SER . 75.6 mt -84.97 -57.78 4.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 O-C-N 123.631 0.582 . . . . 10.0 111.543 -179.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -66.15 158.51 28.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.856 -0.611 . . . . 10.0 111.023 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.28 139.71 56.22 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 120.877 0.37 . . . . 10.0 111.188 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.509 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 7.3 Cg_exo -75.17 129.44 18.67 Favored 'Cis proline' 0 C--O 1.235 0.335 0 C-N-CA 123.297 -1.543 . . . . 10.0 110.708 -1.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.444 ' HE3' ' HB2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -92.08 158.99 15.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.191 0.519 . . . . 10.0 110.953 -179.179 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -173.23 167.9 4.77 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.396 -0.82 . . . . 10.0 109.879 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.552 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 46.4 m -146.61 97.66 2.95 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.275 -0.639 . . . . 10.0 109.275 178.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 38.0 pt -110.45 146.01 16.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.804 -0.634 . . . . 10.0 110.657 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.437 ' HG2' HG23 ' A' ' 77' ' ' THR . 19.7 mt-10 -110.98 126.16 54.48 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.062 -0.718 . . . . 10.0 109.062 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 12.0 m80 -142.5 159.42 42.26 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.393 0.616 . . . . 10.0 111.976 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -105.75 126.76 52.54 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.044 -0.98 . . . . 10.0 109.922 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -117.89 167.65 11.22 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.935 -0.575 . . . . 10.0 110.587 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.574 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 1.7 m -89.72 153.73 47.81 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.144 -0.48 . . . . 10.0 110.463 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -60.52 -27.88 85.66 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.342 2.028 . . . . 10.0 112.329 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.6 m -103.97 17.93 23.07 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.002 -0.545 . . . . 10.0 110.678 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.574 ' HB2' ' O ' ' A' ' 93' ' ' SER . 0.3 OUTLIER -73.33 152.1 41.03 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.985 -0.552 . . . . 10.0 110.153 179.565 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.58 147.09 28.01 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.707 -0.679 . . . . 10.0 110.457 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 30.9 mm -62.3 -23.76 32.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.189 0.519 . . . . 10.0 110.511 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.447 HD22 ' HA ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -59.2 -37.94 78.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.61 -0.723 . . . . 10.0 110.509 179.187 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -61.77 -40.02 93.69 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.457 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.591 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 45.9 mt -63.15 -47.49 92.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.974 -0.557 . . . . 10.0 109.65 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -56.49 -47.36 79.43 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.448 -0.796 . . . . 10.0 110.962 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -61.35 -39.99 92.62 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.963 -0.562 . . . . 10.0 110.598 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 25.1 t60 -62.7 -38.54 90.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.476 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 101' ' ' ILE . 58.1 mt -65.43 -39.62 92.3 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.953 0.406 . . . . 10.0 110.671 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 43.2 mt -69.73 -39.7 78.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.103 0.478 . . . . 10.0 110.313 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.1 m -67.09 -20.33 65.79 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.893 -0.594 . . . . 10.0 111.305 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -98.8 14.6 28.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.633 -0.258 . . . . 10.0 111.242 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 58.11 35.12 24.86 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.121 -0.491 . . . . 10.0 111.166 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 8.6 mmtp -112.99 -13.34 13.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.547 -0.297 . . . . 10.0 111.335 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.466 ' HB2' HD13 ' A' ' 148' ' ' ILE . . . -135.06 155.81 50.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.394 -0.366 . . . . 10.0 110.762 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.1 m -94.46 -61.35 1.53 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.246 -0.434 . . . . 10.0 111.266 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -137.98 147.8 44.6 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.964 -0.384 . . . . 10.0 109.964 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.546 ' HA ' HD12 ' A' ' 117' ' ' ILE . 48.1 pt -60.43 -32.95 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.378 0.608 . . . . 10.0 110.843 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.4 m -58.59 -28.82 65.93 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.694 -1.139 . . . . 10.0 112.961 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.93 14.57 24.97 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.168 0.433 . . . . 10.0 112.168 -177.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.546 HD12 ' HA ' ' A' ' 114' ' ' ILE . 32.6 mt -115.87 135.44 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 113.288 0.847 . . . . 10.0 113.288 -178.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 52.7 tttt -140.88 129.12 22.27 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 109.198 -0.667 . . . . 10.0 109.198 175.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -96.18 136.1 37.09 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.274 0.559 . . . . 10.0 111.342 -179.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.402 ' HB3' ' HB ' ' A' ' 145' ' ' THR . 0.0 OUTLIER -112.46 134.67 53.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.263 -0.88 . . . . 10.0 110.029 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.525 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 43.0 tp -127.49 96.63 4.61 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 107.429 -1.322 . . . . 10.0 107.429 177.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.412 ' HA ' HG23 ' C' ' 35' ' ' VAL . 21.7 tptp 36.43 59.39 0.98 Allowed 'General case' 0 N--CA 1.467 0.387 0 O-C-N 124.059 0.849 . . . . 10.0 111.457 -177.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.27 -43.99 3.16 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 121.001 -0.619 . . . . 10.0 112.734 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.525 ' HB3' ' O ' ' A' ' 121' ' ' LEU . 26.9 tptt -59.73 126.87 29.3 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.916 -0.642 . . . . 10.0 109.765 178.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.0 m -94.15 140.72 16.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.688 0.625 . . . . 10.0 112.688 -178.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 7.2 mp -106.69 154.39 21.03 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.746 -0.661 . . . . 10.0 110.462 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -115.26 158.41 22.38 Favored 'General case' 0 C--O 1.226 -0.153 0 CA-C-O 120.677 0.275 . . . . 10.0 110.823 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.4 -55.01 20.93 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.827 1.047 . . . . 10.0 113.827 -178.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -94.02 19.35 9.23 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.756 0.312 . . . . 10.0 111.57 -177.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 12.8 tp -78.3 149.58 33.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.91 0.386 . . . . 10.0 111.088 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -108.9 150.28 27.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.768 -0.651 . . . . 10.0 110.031 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.492 HD12 ' O ' ' A' ' 93' ' ' SER . 64.3 mt -59.1 -28.18 66.27 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.211 0.449 . . . . 10.0 112.211 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.14 -12.55 59.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.118 0.485 . . . . 10.0 111.024 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -92.08 -49.86 5.99 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.131 -0.486 . . . . 10.0 110.839 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.3 pp -75.1 -25.93 58.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.017 -0.538 . . . . 10.0 111.274 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt 67.94 99.38 0.05 Allowed 'General case' 0 N--CA 1.465 0.313 0 O-C-N 124.062 0.851 . . . . 10.0 111.578 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.8 t -72.97 107.68 3.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.755 -0.461 . . . . 10.0 109.755 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.422 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 2.2 p -66.62 123.53 86.02 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.315 -0.402 . . . . 10.0 110.964 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 138' ' ' THR . 16.7 Cg_exo -63.95 -24.0 67.66 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.731 2.288 . . . . 10.0 111.66 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -78.26 4.29 13.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.55 -0.75 . . . . 10.0 111.402 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -132.83 -72.61 0.51 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.758 -0.201 . . . . 10.0 110.991 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.0 m 60.33 14.94 5.02 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.321 0.581 . . . . 10.0 111.366 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.7 m -114.02 120.15 39.61 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.948 -0.569 . . . . 10.0 110.316 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.426 HD13 HD13 ' A' ' 121' ' ' LEU . 19.3 mm -110.22 119.71 59.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.964 -0.562 . . . . 10.0 109.737 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' A' ' 120' ' ' LEU . 1.6 m -83.19 123.91 30.02 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.345 -0.389 . . . . 10.0 110.32 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 13.4 t -97.52 124.95 50.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.135 -0.484 . . . . 10.0 111.942 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 13.7 mmt -117.94 118.37 31.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.53 -0.759 . . . . 10.0 109.494 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.466 HD13 ' HB2' ' A' ' 111' ' ' ALA . 35.4 mt -136.51 140.84 42.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 111.548 0.203 . . . . 10.0 111.548 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -106.68 120.13 49.31 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 108.264 -1.013 . . . . 10.0 108.264 178.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo . . . . . 0 N--CA 1.463 -0.281 0 C-N-CA 122.39 2.06 . . . . 10.0 113.264 -178.993 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.451 -0.423 0 N-CA-C 109.764 -0.458 . . . . 10.0 109.764 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . 0.446 ' H ' ' HG2' ' B' ' 5' ' ' LYS . 1.6 ptpp? -60.14 -43.36 95.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.329 -0.396 . . . . 10.0 111.501 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -59.04 -36.27 74.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.574 0.226 . . . . 10.0 110.972 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -64.66 -50.96 65.0 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.073 0.464 . . . . 10.0 109.88 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.508 ' O ' HD13 ' B' ' 12' ' ' ILE . 44.3 mm -61.51 -46.79 95.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.567 -0.742 . . . . 10.0 110.961 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.36 -47.77 75.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.9 0.381 . . . . 10.0 110.971 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.94 -32.11 73.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.986 -0.552 . . . . 10.0 110.694 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.3 mt -69.48 -38.06 77.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.362 -0.381 . . . . 10.0 110.399 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.508 HD13 ' O ' ' B' ' 8' ' ' ILE . 1.4 mp -63.46 -50.94 76.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.027 -0.533 . . . . 10.0 110.622 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 12.3 m -67.83 -33.61 62.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.758 0.314 . . . . 10.0 110.722 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -67.38 -48.37 67.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.282 0.563 . . . . 10.0 110.074 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' TYR . . . . . 0.653 ' O ' HG12 ' B' ' 19' ' ' ILE . 15.9 t80 -60.56 -52.31 65.71 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.456 -0.793 . . . . 10.0 110.931 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -54.75 -46.76 74.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.27 -0.423 . . . . 10.0 111.64 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 27.3 m -59.55 -42.55 92.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.695 0.283 . . . . 10.0 111.279 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 23.6 p -72.44 -19.07 61.64 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 122.205 -0.309 . . . . 10.0 111.271 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.653 HG12 ' O ' ' B' ' 15' ' ' TYR . 31.5 mm -79.86 -39.8 20.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.996 0.427 . . . . 10.0 110.09 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 5.3 m -75.66 -22.79 16.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 121.503 0.668 . . . . 10.0 109.303 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -60.03 -48.99 79.44 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 114.616 -1.175 . . . . 10.0 110.862 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 3.5 mttp -102.08 6.73 41.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.809 -0.632 . . . . 10.0 110.797 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 26.9 mtpt 50.82 56.94 7.22 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.356 0.598 . . . . 10.0 110.589 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -90.6 33.68 0.91 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.425 -0.807 . . . . 10.0 110.973 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' ILE . . . . . 0.475 HG12 ' H ' ' B' ' 26' ' ' SER . 13.3 tt -168.44 168.63 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.218 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' SER . . . . . 0.475 ' H ' HG12 ' B' ' 25' ' ' ILE . 1.9 m -58.21 154.8 12.47 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.926 0.491 . . . . 10.0 112.105 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -52.12 -58.22 7.25 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.911 0.708 . . . . 10.0 112.911 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -70.56 -23.59 62.63 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.244 0.545 . . . . 10.0 109.68 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.607 ' O ' ' HG ' ' B' ' 33' ' ' LEU . . . -63.96 -44.16 96.39 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 110.233 -1.147 . . . . 10.0 110.233 178.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.59 -40.69 95.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.168 0.509 . . . . 10.0 110.083 178.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -62.56 -43.22 99.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.465 -0.789 . . . . 10.0 110.051 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 50.9 m -62.64 -42.49 99.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.428 -0.806 . . . . 10.0 110.393 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . 0.607 ' HG ' ' O ' ' B' ' 29' ' ' GLY . 82.2 mt -64.1 -38.91 92.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.35 -0.386 . . . . 10.0 110.341 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -65.77 -46.72 77.68 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.207 -0.451 . . . . 10.0 111.481 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.8 -38.33 80.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 116.451 -0.341 . . . . 10.0 111.091 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.55 -39.9 88.76 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.204 -0.665 . . . . 10.0 109.204 178.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' MET . . . . . 0.602 ' SD ' ' HD2' ' B' ' 48' ' ' ARG . 0.7 OUTLIER -59.23 -45.14 91.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.362 -0.836 . . . . 10.0 110.142 178.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -61.09 -46.2 91.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.427 -0.806 . . . . 10.0 110.691 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 7.8 t -67.58 -38.39 83.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 10.0 111.01 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' ILE . . . . . 0.484 HD13 HG21 ' B' ' 12' ' ' ILE . 55.9 mt -63.58 -39.02 83.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.878 0.37 . . . . 10.0 110.034 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.708 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 14.2 m -63.01 -38.49 91.38 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.52 -0.548 . . . . 10.0 109.52 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -69.78 -40.99 75.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.857 -0.61 . . . . 10.0 110.286 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.96 -39.45 81.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.48 -0.782 . . . . 10.0 111.975 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -94.89 -0.72 53.77 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.671 -0.24 . . . . 10.0 111.3 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.4 39.82 97.8 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-N 116.203 -0.453 . . . . 10.0 113.2 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.708 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 6.5 p90 -131.26 160.78 33.9 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.358 -0.608 . . . . 10.0 109.358 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -94.15 140.44 29.75 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.834 0.35 . . . . 10.0 110.61 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.602 ' HD2' ' SD ' ' B' ' 37' ' ' MET . 17.3 mtm180 -57.7 -29.68 64.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.899 -0.591 . . . . 10.0 111.664 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 30.4 mp0 -83.82 -0.42 51.05 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.594 -0.73 . . . . 10.0 112.894 -177.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.65 3.52 40.59 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 122.309 -0.245 . . . . 10.0 111.582 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.539 HG23 ' H ' ' B' ' 52' ' ' SER . 4.3 m -41.45 -59.75 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 113.215 0.82 . . . . 10.0 113.215 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' SER . . . . . 0.539 ' H ' HG23 ' B' ' 51' ' ' VAL . 0.1 OUTLIER -59.03 -20.96 58.04 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 113.103 0.779 . . . . 10.0 113.103 -179.527 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.88 -38.43 13.74 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.569 -0.824 . . . . 10.0 112.027 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 32.5 mt -86.25 -51.72 12.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 112.266 0.469 . . . . 10.0 112.266 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 83.5 mt -83.56 -67.31 0.8 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.18 0.515 . . . . 10.0 111.998 -178.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.03 -114.78 4.06 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 110.993 -0.843 . . . . 10.0 110.993 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 45.1 pttt -157.72 23.63 0.28 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.21 0.528 . . . . 10.0 110.381 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.61 35.53 0.41 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.757 -0.656 . . . . 10.0 111.391 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 . . . . . 0 N--CA 1.46 0.072 0 CA-C-N 116.292 -0.413 . . . . 10.0 110.653 -179.19 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.505 0 N-CA-C 109.773 -0.455 . . . . 10.0 109.773 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -98.78 138.52 35.81 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.489 -0.56 . . . . 10.0 109.489 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 5' ' ' LYS . . . . . 0.545 ' HB2' ' CE1' ' C' ' 44' ' ' PHE . 0.2 OUTLIER -60.64 -32.73 71.88 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.387 -0.37 . . . . 10.0 111.199 -179.233 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 6' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -59.75 -52.33 65.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.198 0.523 . . . . 10.0 110.288 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -55.62 -51.45 67.13 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.767 -0.651 . . . . 10.0 110.986 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 8' ' ' ILE . . . . . 0.668 ' O ' HG13 ' C' ' 12' ' ' ILE . 48.6 mm -57.18 -48.86 81.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.707 -0.679 . . . . 10.0 110.99 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.31 -44.98 72.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.044 0.45 . . . . 10.0 110.808 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.68 -33.78 76.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.752 -0.658 . . . . 10.0 110.877 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.58 -37.42 79.84 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.123 -0.325 . . . . 10.0 110.123 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 12' ' ' ILE . . . . . 0.668 HG13 ' O ' ' C' ' 8' ' ' ILE . 21.6 mt -64.01 -57.09 13.08 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.517 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 13' ' ' VAL . . . . . 0.55 HG12 ' HG2' ' C' ' 37' ' ' MET . 33.0 m -63.61 -26.2 40.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.682 -0.69 . . . . 10.0 111.506 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -75.73 -46.76 29.19 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.323 0.582 . . . . 10.0 109.603 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 15' ' ' TYR . . . . . 0.508 ' O ' HG12 ' C' ' 19' ' ' ILE . 46.9 t80 -64.07 -43.73 94.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.671 -0.695 . . . . 10.0 110.002 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -57.15 -42.67 81.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.982 -0.553 . . . . 10.0 110.292 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 67.0 m -57.95 -42.9 85.92 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.972 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.55 -20.68 58.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.541 -0.299 . . . . 10.0 111.647 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 19' ' ' ILE . . . . . 0.508 HG12 ' O ' ' C' ' 15' ' ' TYR . 19.7 mm -74.59 -40.45 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.181 0.515 . . . . 10.0 109.764 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 20' ' ' VAL . . . . . . . . . . . . . 17.8 m -82.14 -17.2 11.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.787 -0.642 . . . . 10.0 109.728 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -64.47 -59.61 4.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.369 -0.832 . . . . 10.0 110.163 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -87.73 -3.31 58.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.371 -0.377 . . . . 10.0 110.493 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 64.4 mttm 59.49 58.22 3.03 Favored 'General case' 0 C--N 1.334 -0.066 0 CA-C-N 115.747 -0.661 . . . . 10.0 109.954 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -86.23 9.84 16.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.469 -0.787 . . . . 10.0 110.935 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 15.2 tt -144.36 165.53 13.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.361 -0.607 . . . . 10.0 109.361 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.04 154.67 22.16 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 122.524 0.329 . . . . 10.0 111.243 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -56.3 -46.99 79.56 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.386 -0.37 . . . . 10.0 111.151 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 28' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -64.34 -35.2 80.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.229 0.538 . . . . 10.0 109.736 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 29' ' ' GLY . . . . . 0.575 ' O ' ' HG ' ' C' ' 33' ' ' LEU . . . -66.3 -39.97 94.52 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 110.918 -0.873 . . . . 10.0 110.918 178.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.14 -39.15 93.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.923 0.392 . . . . 10.0 110.27 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -62.81 -42.06 99.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.591 -0.731 . . . . 10.0 109.812 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 32' ' ' SER . . . . . 0.4 ' HB2' HD13 ' A' ' 81' ' ' ILE . 19.4 t -64.96 -43.76 91.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.365 -0.834 . . . . 10.0 110.763 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 33' ' ' LEU . . . . . 0.575 ' HG ' ' O ' ' C' ' 29' ' ' GLY . 64.2 mt -67.96 -27.73 66.85 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.336 -0.393 . . . . 10.0 110.933 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -73.04 -39.25 66.09 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 116.477 -0.328 . . . . 10.0 111.561 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 35' ' ' VAL . . . . . 0.412 HG23 ' HA ' ' A' ' 122' ' ' LYS . 10.2 p -75.17 -36.05 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 N-CA-C 109.535 -0.543 . . . . 10.0 109.535 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.96 -34.58 78.07 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.702 -0.681 . . . . 10.0 110.097 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 37' ' ' MET . . . . . 0.55 ' HG2' HG12 ' C' ' 13' ' ' VAL . 2.9 ttm -54.3 -53.48 53.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.54 -0.755 . . . . 10.0 110.986 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 38' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -69.92 -25.97 63.92 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 121.096 -0.242 . . . . 10.0 110.905 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 39' ' ' CYS . . . . . . . . . . . . . 1.1 t -66.47 -47.62 72.5 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.587 -0.523 . . . . 10.0 109.587 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 40' ' ' ILE . . . . . . . . . . . . . 11.4 mt -67.99 -37.86 78.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.688 -0.687 . . . . 10.0 109.835 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 41' ' ' SER . . . . . 0.609 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 35.4 m -63.25 -43.51 97.79 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.916 -0.584 . . . . 10.0 110.274 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -66.67 -39.76 88.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.789 -0.641 . . . . 10.0 110.47 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.82 -39.06 80.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.921 -0.581 . . . . 10.0 112.027 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 44' ' ' PHE . . . . . 0.545 ' CE1' ' HB2' ' C' ' 5' ' ' LYS . 65.2 m-85 -96.98 -3.33 41.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.68 -0.236 . . . . 10.0 111.59 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.68 39.53 97.62 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.212 -0.518 . . . . 10.0 113.446 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 46' ' ' PHE . . . . . 0.609 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 4.8 p90 -131.88 154.7 48.94 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.397 -0.594 . . . . 10.0 109.397 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -94.24 145.27 24.84 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.644 -0.422 . . . . 10.0 110.656 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 48' ' ' ARG . . . . . 0.411 ' H ' ' HG3' ' C' ' 48' ' ' ARG . 10.8 mtm-85 -63.27 -15.74 58.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.301 0.572 . . . . 10.0 110.233 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -80.16 -11.08 59.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.57 -0.741 . . . . 10.0 112.406 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -93.53 2.41 56.43 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.254 0.465 . . . . 10.0 112.254 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 12.1 m -47.58 -44.92 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 113.39 0.885 . . . . 10.0 113.39 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.21 -44.7 92.26 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.821 0.674 . . . . 10.0 112.821 -179.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.2 -26.69 74.42 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.338 -0.934 . . . . 10.0 112.679 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 54' ' ' ILE . . . . . . . . . . . . . 67.3 mt -84.56 -63.44 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.947 0.403 . . . . 10.0 111.962 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 19.0 mt -70.82 -61.1 1.89 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.591 0.589 . . . . 10.0 112.591 -178.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 66.28 -130.0 31.94 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 111.04 -0.824 . . . . 10.0 111.04 -177.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 11.2 pttp -151.35 28.75 0.64 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.187 0.518 . . . . 10.0 110.35 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.55 30.82 0.78 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.013 -0.539 . . . . 10.0 111.121 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 . . . . . 0 C--O 1.232 0.151 0 CA-C-N 115.747 -0.661 . . . . 10.0 111.022 -179.925 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.0 p . . . . . 0 N--CA 1.452 -0.344 0 CA-C-O 121.191 0.52 . . . . 10.0 110.307 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -85.36 138.66 32.14 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.837 -0.62 . . . . 10.0 110.285 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.8 mp -127.97 125.22 39.06 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.964 -0.562 . . . . 10.0 109.929 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.45 HG23 ' HG2' ' A' ' 89' ' ' GLU . 3.0 m -93.45 106.84 18.77 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.015 -0.539 . . . . 10.0 110.417 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 87' ' ' SER . 3.4 mm? -80.73 110.53 16.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.958 -0.565 . . . . 10.0 110.089 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -121.42 108.63 13.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.654 -0.703 . . . . 10.0 110.626 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.1 tttm -106.15 125.69 51.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.245 -0.434 . . . . 10.0 110.959 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.46 HG21 ' OG ' ' C' ' 32' ' ' SER . 2.0 mp -83.91 -49.31 16.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 115.525 -0.761 . . . . 10.0 110.546 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -64.8 151.55 45.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.093 -0.503 . . . . 10.0 110.76 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.94 136.47 76.6 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.334 -0.393 . . . . 10.0 111.437 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -74.31 135.79 41.91 Favored 'Cis proline' 0 C--N 1.345 0.387 0 C-N-CA 123.73 -1.363 . . . . 10.0 111.682 -1.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -92.02 151.76 20.31 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.36 -0.382 . . . . 10.0 110.572 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.522 ' CZ ' ' HB3' ' A' ' 110' ' ' LYS . 33.8 p90 -171.18 165.73 7.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.124 -0.489 . . . . 10.0 111.193 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 51.1 m -148.41 103.57 3.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.547 -0.751 . . . . 10.0 109.591 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.5 pt -135.13 163.73 35.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.423 -0.353 . . . . 10.0 110.436 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.45 ' HG2' HG23 ' A' ' 77' ' ' THR . 5.2 mt-10 -114.8 148.72 38.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.712 0.291 . . . . 10.0 111.316 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 24.4 m80 -145.89 145.74 30.83 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.05 -0.722 . . . . 10.0 109.05 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -102.01 127.42 48.9 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.175 -0.676 . . . . 10.0 109.175 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -121.44 170.32 9.76 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.483 0.659 . . . . 10.0 111.618 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.0 145.76 33.74 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 115.172 -0.922 . . . . 10.0 109.16 178.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.12 -25.67 37.29 Favored 'Trans proline' 0 CA--C 1.527 0.156 0 C-N-CA 122.108 1.872 . . . . 10.0 112.523 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.89 17.06 8.28 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.823 0.344 . . . . 10.0 111.02 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -91.98 170.19 10.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.392 -0.367 . . . . 10.0 110.453 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.85 159.55 22.89 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.022 -0.536 . . . . 10.0 110.387 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.546 ' HB ' ' HA ' ' A' ' 128' ' ' ASP . 49.2 mm -66.8 -23.43 31.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.49 0.662 . . . . 10.0 109.835 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -57.96 -43.26 86.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.428 -0.806 . . . . 10.0 110.642 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -63.47 -33.9 76.59 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.16 -0.473 . . . . 10.0 111.275 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 47.7 mt -64.85 -44.75 96.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.3 -0.409 . . . . 10.0 110.184 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -54.76 -45.58 74.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.762 -0.653 . . . . 10.0 110.81 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -71.59 -33.09 68.74 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.701 -0.681 . . . . 10.0 110.425 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -64.62 -43.52 93.46 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.814 -0.63 . . . . 10.0 110.363 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 36.6 mt -60.53 -41.57 94.71 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.332 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 85.2 mt -62.35 -38.35 80.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.048 -0.523 . . . . 10.0 110.601 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.1 m -65.36 -26.82 68.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.074 -0.512 . . . . 10.0 111.547 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -98.83 12.92 34.24 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.936 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 59.94 24.5 13.62 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.69 -0.686 . . . . 10.0 111.558 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.522 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 41.6 mmtm -91.02 -16.85 27.25 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.475 0.655 . . . . 10.0 109.339 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.415 ' CB ' HD13 ' A' ' 148' ' ' ILE . . . -137.86 151.2 47.81 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.89 -1.05 . . . . 10.0 109.837 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.4 m -101.86 -46.73 4.81 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.812 -0.355 . . . . 10.0 111.643 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.496 ' O ' HG13 ' A' ' 117' ' ' ILE . 1.7 t-160 -134.72 127.92 31.95 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.789 -0.364 . . . . 10.0 111.498 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.554 ' HA ' HD12 ' A' ' 117' ' ' ILE . 11.2 tt -56.47 -41.85 73.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 115.746 -0.661 . . . . 10.0 111.572 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.43 -14.19 26.32 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.291 -0.868 . . . . 10.0 113.274 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -114.22 13.6 17.97 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.076 -0.39 . . . . 10.0 111.797 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.554 HD12 ' HA ' ' A' ' 114' ' ' ILE . 62.0 mt -99.61 121.31 50.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.751 0.31 . . . . 10.0 111.038 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -126.11 117.96 24.26 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.473 -0.33 . . . . 10.0 110.248 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -94.4 138.27 32.55 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.235 0.541 . . . . 10.0 111.562 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -120.38 133.45 55.44 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.102 -1.073 . . . . 10.0 108.102 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 53.6 tp -115.96 96.53 5.63 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 106.009 -1.849 . . . . 10.0 106.009 178.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.9 tptm 43.8 64.9 1.13 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 114.648 -1.16 . . . . 10.0 110.628 -177.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.689 ' HA2' ' SG ' ' C' ' 39' ' ' CYS . . . 80.88 -47.87 3.62 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.556 -0.747 . . . . 10.0 113.859 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 39.5 tttp -67.38 120.76 14.41 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 109.419 -0.586 . . . . 10.0 109.419 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.1 p -66.06 139.42 21.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.356 0.598 . . . . 10.0 112.499 -178.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 126' ' ' LEU . 2.3 tp -105.69 103.1 12.54 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.645 -0.707 . . . . 10.0 110.253 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -69.98 143.46 52.6 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.074 -0.966 . . . . 10.0 111.876 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.546 ' HA ' ' HB ' ' A' ' 98' ' ' ILE . 0.3 OUTLIER -61.57 -39.87 92.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.718 -0.674 . . . . 10.0 112.223 -179.561 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -73.88 -9.35 58.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.331 -0.395 . . . . 10.0 111.553 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 17.1 tp -76.85 142.01 40.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.251 -0.432 . . . . 10.0 110.356 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.467 ' HB2' ' HB2' ' A' ' 134' ' ' ASP . 41.2 m-85 -93.8 149.74 20.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.057 -0.52 . . . . 10.0 110.659 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 34.3 mt -59.32 -38.52 80.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.93 0.395 . . . . 10.0 111.21 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.24 -19.73 61.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.257 -0.429 . . . . 10.0 111.01 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.467 ' HB2' ' HB2' ' A' ' 131' ' ' PHE . 13.3 t0 -81.56 -40.37 23.18 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.738 -0.664 . . . . 10.0 111.108 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.3 pp -83.87 -26.36 29.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.508 -0.315 . . . . 10.0 111.317 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 96.0 mttt 63.07 99.18 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 O-C-N 123.659 0.599 . . . . 10.0 112.202 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.0 t -79.92 114.23 20.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.073 -0.512 . . . . 10.0 110.298 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.85 137.76 76.59 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.34 -0.391 . . . . 10.0 111.289 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -62.78 -16.99 57.0 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.818 2.345 . . . . 10.0 112.692 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -106.03 6.32 31.08 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.067 0.461 . . . . 10.0 110.924 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -140.34 71.28 1.37 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.753 -0.658 . . . . 10.0 109.536 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.4 t -99.27 11.81 38.0 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.654 -0.703 . . . . 10.0 110.17 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.35 95.58 5.76 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.127 0.489 . . . . 10.0 110.672 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 24.9 mm -92.37 104.4 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 N-CA-C 107.527 -1.286 . . . . 10.0 107.527 177.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.93 121.45 26.5 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.203 -0.453 . . . . 10.0 110.234 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 10.4 t -105.62 136.95 37.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.777 -0.647 . . . . 10.0 111.775 -178.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 25.1 mmt -136.0 120.78 18.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.126 -0.943 . . . . 10.0 108.643 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.415 HD13 ' CB ' ' A' ' 111' ' ' ALA . 11.8 mt -139.68 94.05 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.723 -0.391 . . . . 10.0 111.119 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -94.35 107.09 27.03 Favored Pre-proline 0 C--N 1.32 -0.706 0 N-CA-C 109.213 -0.662 . . . . 10.0 109.213 175.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 N--CA 1.462 -0.37 0 C-N-CA 122.508 2.139 . . . . 10.0 112.759 -178.184 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . 0.487 ' O ' HG12 ' B' ' 8' ' ' ILE . 64.6 p . . . . . 0 N--CA 1.451 -0.425 0 CA-C-O 120.589 0.233 . . . . 10.0 110.717 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . 0.403 ' HE2' ' O ' ' C' ' 24' ' ' GLU . 7.8 ptpp? -54.34 -44.69 72.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.046 -0.525 . . . . 10.0 111.33 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -59.04 -47.19 86.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.408 -0.36 . . . . 10.0 111.487 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -59.86 -45.4 92.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.828 0.347 . . . . 10.0 110.511 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.487 HG12 ' O ' ' B' ' 4' ' ' SER . 37.2 mm -60.17 -49.62 83.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.739 -0.664 . . . . 10.0 110.505 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.4 -41.76 85.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.392 -0.367 . . . . 10.0 111.191 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.57 -38.09 89.81 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.207 0.527 . . . . 10.0 110.44 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 40.7 mt -66.1 -39.32 89.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.949 -0.569 . . . . 10.0 109.63 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.421 HD13 ' O ' ' B' ' 8' ' ' ILE . 1.3 mp -56.8 -46.85 83.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.311 -0.858 . . . . 10.0 111.406 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 12.9 m -71.72 -29.78 35.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.579 -0.448 . . . . 10.0 111.731 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -73.88 -41.62 61.91 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.749 0.309 . . . . 10.0 111.288 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -69.38 -43.6 73.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.379 -0.373 . . . . 10.0 111.199 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' PHE . . . . . 0.404 ' CE2' HG23 ' B' ' 12' ' ' ILE . 14.7 m-30 -61.43 -49.86 75.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.408 -0.36 . . . . 10.0 111.03 -179.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 6.0 p -57.65 -45.26 85.74 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.929 0.344 . . . . 10.0 111.929 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 5.0 p -69.02 -21.25 64.13 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.036 0.384 . . . . 10.0 112.036 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 22.5 mm -85.65 -43.58 16.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 120.689 -0.404 . . . . 10.0 110.676 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 26.9 m -73.54 -35.2 44.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.891 -0.324 . . . . 10.0 111.294 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -68.8 -38.28 79.82 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 120.487 -0.485 . . . . 10.0 110.235 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 33.2 mtmt -75.12 -7.15 52.97 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.132 -0.322 . . . . 10.0 110.132 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 29.8 mmtm 57.63 41.33 25.69 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.808 -0.633 . . . . 10.0 110.375 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.467 ' O ' ' HE2' ' C' ' 5' ' ' LYS . 38.4 mt-10 -91.61 9.83 30.61 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.529 -0.759 . . . . 10.0 110.338 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 9.0 tp -141.99 150.18 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 N-CA-C 108.834 -0.802 . . . . 10.0 108.834 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 1.2 p -62.65 154.95 27.62 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.287 -0.264 . . . . 10.0 110.287 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -57.21 -32.56 66.62 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.672 0.273 . . . . 10.0 110.712 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -63.2 -46.64 86.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.419 0.628 . . . . 10.0 109.716 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.539 ' O ' ' HG ' ' B' ' 33' ' ' LEU . . . -71.13 -40.72 61.37 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.542 -0.754 . . . . 10.0 111.384 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.73 -42.77 93.9 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.898 0.38 . . . . 10.0 111.069 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.415 ' O ' HG12 ' B' ' 35' ' ' VAL . 27.7 t0 -61.34 -44.19 97.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.619 -0.719 . . . . 10.0 110.214 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 13.4 m -65.52 -41.52 93.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.703 -0.68 . . . . 10.0 110.64 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' B' ' 29' ' ' GLY . 82.1 mt -66.08 -43.63 86.79 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.792 0.33 . . . . 10.0 111.296 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -60.3 -51.02 71.3 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 116.001 -0.545 . . . . 10.0 112.206 -178.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.415 HG12 ' O ' ' B' ' 31' ' ' ASP . 7.1 p -66.64 -42.06 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 120.797 -0.361 . . . . 10.0 111.063 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.43 -35.0 77.88 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.947 0.403 . . . . 10.0 110.419 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' MET . . . . . . . . . . . . . 22.7 ttm -56.24 -51.12 69.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.578 -0.737 . . . . 10.0 111.033 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.97 -33.63 76.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.073 -0.512 . . . . 10.0 111.508 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 39.9 m -65.28 -42.95 92.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.015 0.436 . . . . 10.0 110.284 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 46.7 mt -67.27 -34.52 69.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.844 -0.617 . . . . 10.0 110.321 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.665 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 50.9 m -65.23 -40.51 94.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.061 -0.518 . . . . 10.0 110.74 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -72.72 -27.47 62.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 10.0 111.284 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.45 -39.37 81.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.981 -0.554 . . . . 10.0 111.54 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -97.13 -0.84 46.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.333 -0.394 . . . . 10.0 111.869 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.23 60.62 7.29 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.351 -0.452 . . . . 10.0 114.168 178.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.665 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 13.6 p90 -154.11 167.78 28.7 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.028 -0.36 . . . . 10.0 110.028 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -98.93 151.62 20.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.013 0.435 . . . . 10.0 110.379 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 3.9 mtm180 -71.34 -28.21 63.91 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.129 0.49 . . . . 10.0 110.632 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -84.51 7.34 20.24 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.054 -0.521 . . . . 10.0 112.257 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.13 4.38 48.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.513 0.197 . . . . 10.0 111.523 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.453 HG23 ' H ' ' B' ' 52' ' ' SER . 4.8 m -41.37 -57.39 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 113.425 0.898 . . . . 10.0 113.425 -179.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' SER . . . . . 0.453 ' H ' HG23 ' B' ' 51' ' ' VAL . 0.6 OUTLIER -53.72 -36.54 62.37 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.824 0.675 . . . . 10.0 112.824 -179.28 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.72 -42.25 32.35 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.934 -0.651 . . . . 10.0 113.353 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 24.8 mt -83.69 -45.64 18.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 112.253 0.464 . . . . 10.0 112.253 -178.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 81.0 mt -73.17 -64.27 1.01 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.949 0.404 . . . . 10.0 111.378 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.25 -151.05 48.11 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.912 -0.661 . . . . 10.0 112.403 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 10.0 tttt -100.08 6.92 44.96 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.073 0.463 . . . . 10.0 110.466 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.47 134.89 55.42 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.565 -0.743 . . . . 10.0 110.289 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 . . . . . 0 C--N 1.321 -0.655 0 CA-C-O 121.178 0.513 . . . . 10.0 110.648 -179.582 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.184 0 CA-C-O 120.857 0.361 . . . . 10.0 111.336 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 4' ' ' SER . . . . . 0.553 ' O ' HG12 ' C' ' 8' ' ' ILE . 0.7 OUTLIER -109.89 166.32 11.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.246 -0.434 . . . . 10.0 110.106 179.857 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 5' ' ' LYS . . . . . 0.491 ' HB2' ' CE1' ' C' ' 44' ' ' PHE . 10.3 ptpp? -51.86 -38.67 56.9 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 123.515 0.51 . . . . 10.0 111.863 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 6' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 -59.39 -54.59 44.93 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.381 -0.372 . . . . 10.0 111.494 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -60.91 -40.3 92.62 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.688 0.28 . . . . 10.0 110.34 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 8' ' ' ILE . . . . . 0.553 HG12 ' O ' ' C' ' 4' ' ' SER . 48.4 mm -60.0 -47.73 90.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.88 -0.6 . . . . 10.0 109.658 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.39 -44.82 76.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.966 -0.561 . . . . 10.0 111.203 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 10' ' ' ALA . . . . . 0.41 ' HB2' HD12 ' C' ' 54' ' ' ILE . . . -65.82 -40.56 91.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.913 -0.585 . . . . 10.0 111.089 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 32.4 mt -61.36 -39.1 89.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.903 0.382 . . . . 10.0 110.26 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 12' ' ' ILE . . . . . 0.538 HD13 ' O ' ' C' ' 8' ' ' ILE . 1.6 mp -63.17 -54.87 27.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.656 -0.702 . . . . 10.0 111.75 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 28.5 m -66.56 -26.04 36.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.262 0.467 . . . . 10.0 112.262 -178.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 14' ' ' ASN . . . . . 0.549 ' HB2' HG11 ' C' ' 51' ' ' VAL . 0.7 OUTLIER -76.24 -40.09 52.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.981 0.419 . . . . 10.0 110.433 -179.668 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 15' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -72.6 -45.11 60.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.151 -0.477 . . . . 10.0 111.32 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -56.51 -49.67 74.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.371 -0.377 . . . . 10.0 110.846 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 10.0 p -58.48 -45.07 89.43 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.43 -0.35 . . . . 10.0 111.586 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 4.4 p -69.33 -22.24 63.78 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.805 -0.358 . . . . 10.0 111.845 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 19' ' ' ILE . . . . . . . . . . . . . 20.2 mm -79.34 -43.39 23.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 110.129 -0.322 . . . . 10.0 110.129 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 20' ' ' VAL . . . . . . . . . . . . . 4.2 m -73.99 -27.83 22.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.71 0.29 . . . . 10.0 110.385 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -69.84 -53.62 17.3 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.905 -0.406 . . . . 10.0 109.905 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 34.5 mtmt -70.67 -6.79 39.74 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.843 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm 61.48 47.03 6.96 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.251 0.548 . . . . 10.0 110.426 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . 0.403 ' O ' ' HE2' ' B' ' 5' ' ' LYS . 9.1 mt-10 -85.41 -3.93 59.0 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.827 -0.624 . . . . 10.0 110.422 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 11.2 tt -134.94 159.45 41.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.056 -0.52 . . . . 10.0 110.129 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -68.19 166.35 16.45 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.218 0.207 . . . . 10.0 111.272 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -53.74 -50.34 66.18 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.066 0.395 . . . . 10.0 112.066 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.76 -47.37 77.11 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.033 0.444 . . . . 10.0 110.48 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.09 -42.44 91.94 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.833 -0.699 . . . . 10.0 112.028 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.35 -41.68 80.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.881 0.372 . . . . 10.0 110.963 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -68.07 -38.47 82.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.952 -0.567 . . . . 10.0 110.163 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 32' ' ' SER . . . . . 0.46 ' OG ' HG21 ' A' ' 81' ' ' ILE . 48.7 m -61.74 -29.37 70.07 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.455 -0.793 . . . . 10.0 109.938 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 33' ' ' LEU . . . . . 0.464 ' O ' ' HG3' ' C' ' 37' ' ' MET . 48.4 mt -77.76 -37.11 49.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.341 -0.39 . . . . 10.0 110.359 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -58.36 -53.63 56.13 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.06 -0.518 . . . . 10.0 110.369 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 35' ' ' VAL . . . . . 0.4 HG23 ' H ' ' A' ' 123' ' ' GLY . 9.4 p -67.2 -38.58 81.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 115.361 -0.836 . . . . 10.0 110.681 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.94 -40.97 95.3 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 120.669 0.271 . . . . 10.0 111.257 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 37' ' ' MET . . . . . 0.464 ' HG3' ' O ' ' C' ' 33' ' ' LEU . 70.8 mtm -54.74 -47.14 74.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.426 -0.352 . . . . 10.0 110.593 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 38' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -69.41 -28.65 66.33 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 116.468 -0.333 . . . . 10.0 110.855 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 39' ' ' CYS . . . . . 0.689 ' SG ' ' HA2' ' A' ' 123' ' ' GLY . 91.8 m -61.25 -42.84 99.32 Favored 'General case' 0 CA--C 1.522 -0.115 0 N-CA-C 108.871 -0.789 . . . . 10.0 108.871 177.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 40' ' ' ILE . . . . . . . . . . . . . 1.4 mp -73.25 -46.11 51.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 114.84 -1.073 . . . . 10.0 110.704 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 41' ' ' SER . . . . . 0.621 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 9.2 m -60.98 -42.09 97.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.406 -0.361 . . . . 10.0 111.585 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -72.96 -29.28 62.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.412 -0.358 . . . . 10.0 110.506 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.6 -46.8 65.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.154 -0.476 . . . . 10.0 111.727 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 44' ' ' PHE . . . . . 0.491 ' CE1' ' HB2' ' C' ' 5' ' ' LYS . 93.4 m-85 -92.18 -7.03 49.49 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.089 0.403 . . . . 10.0 112.089 -178.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.36 60.86 5.18 Favored Glycine 0 C--O 1.227 -0.309 0 C-N-CA 121.244 -0.503 . . . . 10.0 113.889 178.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 46' ' ' PHE . . . . . 0.621 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 3.6 p90 -153.56 169.25 23.67 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 110.179 -0.304 . . . . 10.0 110.179 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 51.5 mp0 -99.23 144.08 28.76 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.803 0.335 . . . . 10.0 110.85 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.95 -28.36 69.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.214 0.53 . . . . 10.0 110.965 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -80.1 14.33 1.92 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.733 -0.667 . . . . 10.0 112.509 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -104.72 2.82 30.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.24 0.543 . . . . 10.0 110.753 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 51' ' ' VAL . . . . . 0.549 HG11 ' HB2' ' C' ' 14' ' ' ASN . 1.7 m -49.44 -45.78 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 113.546 0.943 . . . . 10.0 113.546 -179.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.63 -27.22 67.61 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.785 0.291 . . . . 10.0 111.785 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.91 -37.78 12.54 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.845 -0.693 . . . . 10.0 112.667 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 54' ' ' ILE . . . . . 0.41 HD12 ' HB2' ' C' ' 10' ' ' ALA . 40.0 mt -81.14 -56.35 6.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 O-C-N 122.697 -0.296 . . . . 10.0 111.253 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 26.5 mt -67.01 -41.24 87.0 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.229 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 58.08 -139.41 47.61 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.621 -0.718 . . . . 10.0 112.077 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 66.2 tttt -108.76 -6.34 15.93 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.074 0.464 . . . . 10.0 110.32 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 3.1 m -65.34 148.21 52.09 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.622 -0.717 . . . . 10.0 111.27 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.482 0 CA-C-O 121.068 0.461 . . . . 10.0 110.146 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.4 t . . . . . 0 CA--C 1.521 -0.146 0 CA-C-O 120.845 0.355 . . . . 10.0 111.475 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.448 ' CD2' ' HB3' ' A' ' 91' ' ' ASP . 4.8 m170 -91.53 126.3 36.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.075 -0.511 . . . . 10.0 110.629 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.6 mp -126.9 120.03 28.18 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.01 -0.541 . . . . 10.0 109.923 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.1 m -94.07 114.75 26.97 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.452 -0.573 . . . . 10.0 109.452 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.426 ' O ' ' HA ' ' A' ' 87' ' ' SER . 2.5 mm? -88.3 122.67 32.08 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.283 -0.417 . . . . 10.0 110.679 -178.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -122.95 104.58 9.33 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.969 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -92.11 120.57 32.84 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.909 -0.404 . . . . 10.0 109.909 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 20.8 mt -86.83 -59.46 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.573 -0.285 . . . . 10.0 111.649 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -57.0 158.12 5.21 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.75 0.309 . . . . 10.0 111.397 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.28 138.6 55.92 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.42 -0.355 . . . . 10.0 111.059 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -74.2 130.73 21.54 Favored 'Cis proline' 0 C--O 1.237 0.435 0 C-N-CA 123.039 -1.65 . . . . 10.0 111.87 -1.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.4 ' HG3' ' H ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -87.8 152.62 21.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.422 -0.353 . . . . 10.0 111.271 -179.277 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -177.52 170.75 2.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.736 -0.665 . . . . 10.0 110.03 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 15.2 m -151.17 133.42 15.32 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.123 -0.49 . . . . 10.0 109.696 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.411 HG13 ' HB2' ' A' ' 78' ' ' LEU . 9.1 pt -138.16 150.31 24.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.932 0.396 . . . . 10.0 111.383 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -113.58 120.4 40.82 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.359 -0.608 . . . . 10.0 109.359 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.39 167.39 23.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.014 0.435 . . . . 10.0 111.433 -178.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.448 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -121.4 131.57 54.25 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.848 -0.614 . . . . 10.0 110.905 179.101 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -118.74 168.8 10.39 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.727 -0.669 . . . . 10.0 109.85 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.608 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 7.4 t -80.89 146.95 60.74 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 116.545 -0.298 . . . . 10.0 110.398 -179.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.1 -22.62 70.47 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.245 1.963 . . . . 10.0 111.747 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 43.3 m -100.08 13.32 34.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.978 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.608 ' HB2' ' O ' ' A' ' 93' ' ' SER . 1.0 OUTLIER -80.52 163.11 23.97 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.528 -179.889 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.4 p -115.49 160.66 19.63 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.583 -0.735 . . . . 10.0 110.576 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 47.7 mm -65.28 -21.31 29.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.368 0.604 . . . . 10.0 109.438 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.28 -39.29 82.46 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.41 -0.814 . . . . 10.0 110.235 178.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -63.84 -40.24 96.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.103 -0.498 . . . . 10.0 110.316 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.526 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 54.1 mt -65.93 -48.6 81.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.841 -0.618 . . . . 10.0 109.499 178.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.418 ' CD ' HG13 ' A' ' 114' ' ' ILE . 53.2 mttt -53.64 -48.01 69.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.322 -0.854 . . . . 10.0 111.151 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.481 ' OE1' ' HA ' ' A' ' 103' ' ' GLN . 11.4 mm-40 -59.8 -41.16 90.6 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.883 -0.599 . . . . 10.0 111.102 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.538 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 19.1 t60 -68.46 -33.75 74.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.29 -0.414 . . . . 10.0 110.539 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 101' ' ' ILE . 90.8 mt -62.55 -46.04 90.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.79 0.329 . . . . 10.0 110.989 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.6 mt -67.41 -32.35 56.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.124 0.488 . . . . 10.0 110.05 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.1 m -68.02 -15.49 63.62 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.511 -0.768 . . . . 10.0 112.159 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.538 ' HG2' ' O ' ' A' ' 104' ' ' HIS . 17.5 mm-40 -95.1 6.88 47.83 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.628 -0.508 . . . . 10.0 109.628 178.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.459 ' HA ' ' OE1' ' A' ' 109' ' ' GLU . 3.4 mm-40 60.35 32.1 20.58 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.486 -0.779 . . . . 10.0 111.039 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -110.98 -5.64 14.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.111 -0.495 . . . . 10.0 110.795 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.62 ' HB2' HD13 ' A' ' 148' ' ' ILE . . . -135.57 148.69 49.17 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.81 -0.632 . . . . 10.0 109.952 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.533 ' OG ' ' HA ' ' A' ' 150' ' ' PRO . 0.6 OUTLIER -87.71 -59.18 2.32 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.948 0.404 . . . . 10.0 110.901 -179.81 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.501 ' O ' HG13 ' A' ' 117' ' ' ILE . 40.8 m80 -138.26 154.02 49.07 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.345 -0.389 . . . . 10.0 110.919 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.418 HG13 ' CD ' ' A' ' 102' ' ' LYS . 0.3 OUTLIER -63.34 -36.75 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 115.502 -0.772 . . . . 10.0 110.386 179.562 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.87 -24.0 34.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.821 -1.081 . . . . 10.0 112.463 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.19 0.16 31.32 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 121.182 -0.207 . . . . 10.0 111.397 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 113' ' ' HIS . 28.2 mt -90.75 119.91 38.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 120.266 -0.574 . . . . 10.0 109.534 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.4 mmmt -118.1 112.15 19.82 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.114 0.483 . . . . 10.0 110.174 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.434 ' O ' ' HB2' ' A' ' 126' ' ' LEU . 3.2 mm? -92.99 113.7 26.06 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.653 0.74 . . . . 10.0 110.995 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.534 HD13 ' HA ' ' A' ' 125' ' ' VAL . 4.5 mm? -110.75 140.43 45.16 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 107.406 -1.331 . . . . 10.0 107.406 178.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.582 HD13 HD13 ' A' ' 144' ' ' ILE . 17.9 tp -121.98 97.91 5.7 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.821 -0.807 . . . . 10.0 108.821 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? 46.82 58.27 4.86 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.612 0.72 . . . . 10.0 109.972 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.686 ' HA2' ' SG ' ' C' ' 39' ' ' CYS . . . 83.87 -44.41 3.31 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 114.6 -1.182 . . . . 10.0 114.154 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 22.9 tttp -59.64 140.03 56.73 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 120.696 0.284 . . . . 10.0 111.006 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.534 ' HA ' HD13 ' A' ' 120' ' ' LEU . 7.2 p -90.35 136.16 24.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 112.942 0.719 . . . . 10.0 112.942 -178.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.434 ' HB2' ' O ' ' A' ' 119' ' ' LEU . 6.0 mp -110.83 156.29 21.34 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 114.983 -1.008 . . . . 10.0 110.001 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -116.0 158.38 23.19 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.452 0.538 . . . . 10.0 112.452 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -52.81 -55.1 25.41 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 113.377 0.88 . . . . 10.0 113.377 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -91.26 14.13 15.28 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.242 0.46 . . . . 10.0 112.242 -178.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 9.4 tp -70.24 143.87 52.02 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.708 0.289 . . . . 10.0 110.428 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -98.85 146.84 25.54 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.72 -0.673 . . . . 10.0 110.18 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.497 HD12 ' O ' ' A' ' 93' ' ' SER . 13.0 mt -57.53 -39.09 75.84 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.414 -0.357 . . . . 10.0 111.183 178.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.4 p -73.17 -21.96 60.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.123 0.487 . . . . 10.0 111.198 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -82.25 -45.56 14.86 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 120.812 0.339 . . . . 10.0 110.519 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.2 pp -74.1 -21.97 59.68 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.352 -0.385 . . . . 10.0 110.846 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.6 mtmt 63.43 92.2 0.07 Allowed 'General case' 0 C--O 1.236 0.352 0 O-C-N 123.691 0.619 . . . . 10.0 110.785 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.0 t -66.07 101.5 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.6 -0.727 . . . . 10.0 110.38 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.52 119.66 48.88 Favored Pre-proline 0 N--CA 1.451 -0.415 0 CA-C-N 116.098 -0.501 . . . . 10.0 110.652 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -65.57 -11.46 30.59 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.773 2.315 . . . . 10.0 112.727 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -93.04 7.3 44.7 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.965 -0.561 . . . . 10.0 110.19 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -128.63 -75.02 0.56 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.518 -0.765 . . . . 10.0 110.14 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 38.6 m 57.66 13.27 1.89 Allowed 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.486 0.55 . . . . 10.0 112.486 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.9 m -121.46 121.75 38.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.619 0.247 . . . . 10.0 110.882 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.582 HD13 HD13 ' A' ' 121' ' ' LEU . 10.7 mm -102.85 126.12 57.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.714 -0.675 . . . . 10.0 109.666 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.425 HG21 HG11 ' C' ' 35' ' ' VAL . 0.2 OUTLIER -86.43 107.15 17.92 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.887 -0.783 . . . . 10.0 108.887 179.302 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 21.7 t -87.34 126.08 41.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.663 -0.699 . . . . 10.0 110.209 -178.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 62.7 mtt -125.35 115.0 19.63 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.706 -1.134 . . . . 10.0 109.866 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.62 HD13 ' HB2' ' A' ' 111' ' ' ALA . 9.9 mt -138.96 146.11 26.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.35 -0.841 . . . . 10.0 110.674 -178.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.514 ' HD3' ' OD2' ' B' ' 38' ' ' ASP . 2.0 mmmm -125.94 115.51 24.24 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 109.37 -0.604 . . . . 10.0 109.37 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.533 ' HA ' ' OG ' ' A' ' 112' ' ' SER . 19.5 Cg_endo . . . . . 0 C--N 1.347 0.491 0 C-N-CA 122.425 2.084 . . . . 10.0 112.65 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 80.1 p . . . . . 0 N--CA 1.449 -0.507 0 N-CA-C 109.376 -0.601 . . . . 10.0 109.376 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -53.1 -40.54 64.22 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.85 0.315 . . . . 10.0 111.85 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -60.91 -47.25 87.27 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.668 -0.242 . . . . 10.0 110.838 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -58.84 -39.83 82.43 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.114 0.483 . . . . 10.0 110.075 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.443 ' O ' HD12 ' B' ' 12' ' ' ILE . 50.1 mm -64.52 -49.3 81.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.726 -0.67 . . . . 10.0 110.084 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.27 -36.65 78.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.193 0.52 . . . . 10.0 110.335 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.99 -32.77 74.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.534 -0.757 . . . . 10.0 110.221 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 28.1 mt -70.98 -34.96 71.91 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.421 -0.585 . . . . 10.0 109.421 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.658 HG21 HD13 ' B' ' 40' ' ' ILE . 0.7 OUTLIER -59.37 -54.74 30.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.974 -0.557 . . . . 10.0 110.442 179.117 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 28.4 m -62.27 -33.51 59.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.33 -0.396 . . . . 10.0 111.117 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -68.72 -48.77 62.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.093 -0.503 . . . . 10.0 110.897 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' TYR . . . . . 0.484 ' O ' HG12 ' B' ' 19' ' ' ILE . 8.3 m-85 -70.94 -41.9 70.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.156 -0.474 . . . . 10.0 112.04 -178.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -55.92 -52.94 62.35 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 122.982 0.176 . . . . 10.0 111.45 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . 0.5 ' O ' ' HB2' ' B' ' 21' ' ' GLU . 4.9 p -58.74 -46.85 86.48 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.448 -0.342 . . . . 10.0 111.357 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 28.8 p -65.45 -20.59 66.43 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.225 0.454 . . . . 10.0 112.225 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.484 HG12 ' O ' ' B' ' 15' ' ' TYR . 22.9 mm -84.93 -42.12 16.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.798 0.332 . . . . 10.0 111.221 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 34.5 m -77.43 -31.6 17.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.006 0.431 . . . . 10.0 111.311 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' B' ' 17' ' ' SER . 0.4 OUTLIER -71.64 -25.69 62.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.075 -0.511 . . . . 10.0 111.188 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -94.59 1.13 55.62 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.397 0.618 . . . . 10.0 109.578 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 14.7 mmtt 55.33 45.56 25.28 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 114.805 -1.089 . . . . 10.0 111.573 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -93.66 24.32 4.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.946 0.403 . . . . 10.0 111.223 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 16.8 tt -160.87 161.39 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 116.173 -0.467 . . . . 10.0 110.41 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.84 159.86 29.53 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.817 -0.629 . . . . 10.0 111.443 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -56.97 -41.86 79.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.65 -0.705 . . . . 10.0 111.412 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.33 -50.67 72.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.998 -0.547 . . . . 10.0 109.845 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.501 ' O ' ' HG ' ' B' ' 33' ' ' LEU . . . -60.39 -41.08 98.37 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.622 -0.717 . . . . 10.0 111.677 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.25 -31.87 73.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.883 -0.158 . . . . 10.0 110.913 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -71.5 -43.3 66.79 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.43 -0.582 . . . . 10.0 109.43 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 4.1 m -62.54 -51.14 68.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.313 -0.858 . . . . 10.0 110.288 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' B' ' 29' ' ' GLY . 89.6 mt -59.12 -41.92 89.35 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.127 -0.488 . . . . 10.0 110.173 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -57.83 -49.61 76.09 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.752 -0.658 . . . . 10.0 111.106 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.439 HG11 HD21 ' A' ' 120' ' ' LEU . 2.6 p -70.93 -33.81 53.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.738 -0.385 . . . . 10.0 111.691 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.23 -39.25 89.43 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 109.625 -0.509 . . . . 10.0 109.625 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' MET . . . . . . . . . . . . . 32.8 ttm -54.65 -45.6 73.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.305 -0.861 . . . . 10.0 109.574 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . 0.514 ' OD2' ' HD3' ' A' ' 149' ' ' LYS . 18.4 t70 -62.6 -53.73 50.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.118 -0.947 . . . . 10.0 110.886 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 59.8 m -52.09 -47.76 65.07 Favored 'General case' 0 N--CA 1.462 0.137 0 O-C-N 123.581 0.551 . . . . 10.0 111.529 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' ILE . . . . . 0.658 HD13 HG21 ' B' ' 12' ' ' ILE . 59.7 mt -62.6 -44.83 99.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.02 -0.536 . . . . 10.0 110.69 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.556 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 49.0 m -61.28 -43.32 99.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.026 -0.534 . . . . 10.0 110.876 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -67.52 -42.39 82.87 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.679 -0.691 . . . . 10.0 111.243 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.2 -33.61 74.74 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.28 0.474 . . . . 10.0 112.28 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -90.38 -7.2 53.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.671 0.272 . . . . 10.0 111.062 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.84 46.74 90.96 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.201 -0.523 . . . . 10.0 112.864 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.556 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 3.7 p90 -144.34 154.71 43.31 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 122.569 -0.371 . . . . 10.0 110.474 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -92.93 147.08 23.14 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.404 -0.362 . . . . 10.0 110.408 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.415 ' H ' ' NE ' ' B' ' 48' ' ' ARG . 0.0 OUTLIER -64.98 -27.34 68.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.548 -0.296 . . . . 10.0 111.483 -179.134 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -72.68 -10.32 59.65 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.404 -0.362 . . . . 10.0 111.839 -179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.28 4.38 27.3 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.592 -0.276 . . . . 10.0 111.351 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.422 HG23 ' H ' ' B' ' 52' ' ' SER . 0.1 OUTLIER -42.77 -59.94 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 112.653 0.612 . . . . 10.0 112.653 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' SER . . . . . 0.422 ' H ' HG23 ' B' ' 51' ' ' VAL . 0.9 OUTLIER -60.89 -19.56 60.56 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.229 0.826 . . . . 10.0 113.229 -179.421 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.46 -38.5 12.35 Favored Glycine 0 C--O 1.235 0.203 0 C-N-CA 120.879 -0.677 . . . . 10.0 112.382 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 6.2 mt -86.63 -47.34 16.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.816 0.341 . . . . 10.0 111.23 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 53.4 mt -73.08 -57.88 3.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.306 0.574 . . . . 10.0 110.424 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.83 -144.7 48.56 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.327 -0.851 . . . . 10.0 112.569 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -91.67 -11.03 38.13 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.465 -0.367 . . . . 10.0 110.918 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.56 131.79 52.02 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.798 0.666 . . . . 10.0 112.798 -178.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 C--N 1.326 -0.45 0 N-CA-C 108.814 -0.81 . . . . 10.0 108.814 177.878 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.575 0.226 . . . . 10.0 111.047 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 4' ' ' SER . . . . . 0.532 ' O ' HG12 ' C' ' 8' ' ' ILE . 31.4 p -102.16 161.88 13.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.383 -0.371 . . . . 10.0 110.984 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -56.08 -39.34 71.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.294 -0.412 . . . . 10.0 111.498 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 6' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -61.2 -48.58 80.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.011 0.434 . . . . 10.0 110.911 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -63.49 -39.07 93.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.857 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 8' ' ' ILE . . . . . 0.532 HG12 ' O ' ' C' ' 4' ' ' SER . 43.6 mm -60.89 -46.83 95.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.564 -0.532 . . . . 10.0 109.564 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 9' ' ' ALA . . . . . 0.498 ' HB1' ' CE1' ' C' ' 46' ' ' PHE . . . -60.04 -44.09 94.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.692 -0.686 . . . . 10.0 110.825 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.99 -41.93 98.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.94 -0.573 . . . . 10.0 111.224 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 16.6 mt -62.44 -41.72 98.93 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.463 0.649 . . . . 10.0 110.006 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 12' ' ' ILE . . . . . 0.716 HG21 HD13 ' C' ' 40' ' ' ILE . 1.3 mp -59.22 -51.42 72.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.749 -1.114 . . . . 10.0 111.876 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 30.0 m -67.93 -24.95 31.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.028 0.442 . . . . 10.0 111.758 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -76.45 -42.56 43.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.749 0.309 . . . . 10.0 110.227 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 15' ' ' TYR . . . . . 0.469 ' O ' HG12 ' C' ' 19' ' ' ILE . 3.1 m-85 -73.32 -40.28 64.61 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.7 -0.4 . . . . 10.0 110.82 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -58.32 -49.48 77.03 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 109.998 -0.371 . . . . 10.0 109.998 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 35.4 p -62.05 -43.6 98.49 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.302 -0.408 . . . . 10.0 111.123 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 32.9 p -66.95 -24.45 66.07 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 111.69 0.256 . . . . 10.0 111.69 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 19' ' ' ILE . . . . . 0.469 HG12 ' O ' ' C' ' 15' ' ' TYR . 26.8 mm -80.6 -39.67 18.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 110.011 -0.366 . . . . 10.0 110.011 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 20' ' ' VAL . . . . . 0.402 HG12 ' HA ' ' C' ' 30' ' ' ALA . 19.5 m -77.43 -27.23 15.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.84 -0.344 . . . . 10.0 111.124 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . 0.402 ' HA ' ' OE1' ' C' ' 21' ' ' GLU . 2.5 tp10 -68.71 -50.33 51.66 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.846 -0.427 . . . . 10.0 109.846 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -71.92 -10.02 59.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.047 -0.524 . . . . 10.0 110.205 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm 58.95 42.31 19.66 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.506 0.67 . . . . 10.0 109.505 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -81.41 -6.28 58.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.232 -0.894 . . . . 10.0 110.729 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 18.1 tt -125.61 160.08 32.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.101 -0.5 . . . . 10.0 109.761 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -58.94 152.51 19.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.463 -0.335 . . . . 10.0 110.482 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -57.4 -34.49 68.94 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.81 0.338 . . . . 10.0 110.41 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 28' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -61.8 -50.77 71.0 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.51 -0.768 . . . . 10.0 109.983 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 29' ' ' GLY . . . . . 0.532 ' O ' ' HG ' ' C' ' 33' ' ' LEU . . . -67.33 -31.13 76.3 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.144 -0.934 . . . . 10.0 112.643 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . 0.402 ' HA ' HG12 ' C' ' 20' ' ' VAL . . . -59.96 -46.66 88.7 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.557 0.218 . . . . 10.0 110.461 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 31' ' ' ASP . . . . . 0.402 ' O ' HG12 ' C' ' 35' ' ' VAL . 14.5 t70 -63.64 -37.81 88.74 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.529 -0.545 . . . . 10.0 109.529 179.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 14.0 m -57.61 -44.91 85.82 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.449 -0.796 . . . . 10.0 109.784 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 33' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' C' ' 29' ' ' GLY . 51.6 mt -70.25 -37.37 74.93 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.026 -0.534 . . . . 10.0 110.501 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -59.17 -55.83 29.96 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.048 -0.524 . . . . 10.0 111.429 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 35' ' ' VAL . . . . . 0.425 HG11 HG21 ' A' ' 145' ' ' THR . 8.4 p -66.07 -41.77 90.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 115.961 -0.563 . . . . 10.0 111.117 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.55 -28.47 69.96 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.676 0.274 . . . . 10.0 111.032 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 9.0 mtm -59.98 -51.33 70.14 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.262 -0.426 . . . . 10.0 110.45 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 38' ' ' ASP . . . . . 0.629 ' CB ' ' HA3' ' A' ' 123' ' ' GLY . 1.2 m-20 -69.94 -27.47 64.78 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 109.639 -0.504 . . . . 10.0 109.639 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 39' ' ' CYS . . . . . 0.686 ' SG ' ' HA2' ' A' ' 123' ' ' GLY . 62.6 m -61.49 -50.25 73.46 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 109.297 -0.631 . . . . 10.0 109.297 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 40' ' ' ILE . . . . . 0.716 HD13 HG21 ' C' ' 12' ' ' ILE . 54.6 mt -67.2 -35.76 74.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.993 -1.003 . . . . 10.0 109.957 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 41' ' ' SER . . . . . 0.691 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 53.1 m -61.36 -51.81 67.27 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.713 -0.676 . . . . 10.0 110.536 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.82 -35.67 80.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.793 0.33 . . . . 10.0 110.867 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.66 -42.69 93.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.099 -0.5 . . . . 10.0 111.808 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 44' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -96.3 -2.48 45.79 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.869 0.366 . . . . 10.0 111.634 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.4 51.22 38.78 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.103 -0.57 . . . . 10.0 112.945 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 46' ' ' PHE . . . . . 0.691 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 4.3 p90 -144.48 157.58 44.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.055 0.455 . . . . 10.0 110.327 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -96.4 136.75 36.46 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.111 -0.495 . . . . 10.0 109.685 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 48' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -60.88 -13.97 19.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.757 -0.656 . . . . 10.0 112.111 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -84.03 -6.56 59.43 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.745 0.646 . . . . 10.0 112.745 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.53 4.55 27.57 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.134 0.42 . . . . 10.0 112.134 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 51' ' ' VAL . . . . . 0.4 HG23 ' H ' ' C' ' 52' ' ' SER . 4.9 m -45.03 -54.4 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 113.548 0.944 . . . . 10.0 113.548 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 52' ' ' SER . . . . . 0.4 ' H ' HG23 ' C' ' 51' ' ' VAL . 0.0 OUTLIER -58.93 -30.88 68.19 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.775 0.658 . . . . 10.0 112.775 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.13 -49.81 5.77 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.426 -0.892 . . . . 10.0 112.912 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 54' ' ' ILE . . . . . . . . . . . . . 80.0 mt -69.67 -54.6 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-O 120.642 0.258 . . . . 10.0 111.328 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 70.0 mt -68.77 -52.76 26.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.433 -0.349 . . . . 10.0 111.009 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.38 -136.66 47.57 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.261 -0.495 . . . . 10.0 112.837 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 30.9 tttt -108.3 3.43 23.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.222 0.534 . . . . 10.0 110.094 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 9.1 t -73.62 138.15 44.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.966 -0.561 . . . . 10.0 110.555 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 . . . . . 0 C--N 1.321 -0.646 0 CA-C-N 115.585 -0.734 . . . . 10.0 109.721 178.49 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.1 t . . . . . 0 N--CA 1.455 -0.182 0 N-CA-C 110.352 -0.24 . . . . 10.0 110.352 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -87.57 129.29 35.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.57 0.224 . . . . 10.0 110.729 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.5 mp -127.87 129.17 46.46 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.126 0.489 . . . . 10.0 110.149 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.3 m -94.69 109.12 21.09 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.653 -0.703 . . . . 10.0 110.389 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -85.16 118.77 24.92 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.876 -0.787 . . . . 10.0 108.876 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -119.47 108.42 14.51 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.284 -0.416 . . . . 10.0 111.28 -178.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.521 ' HG2' ' O ' ' A' ' 84' ' ' PRO . 19.1 tptm -94.91 113.28 24.98 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 116.484 -0.326 . . . . 10.0 110.922 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.582 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 52.4 mt -80.49 -59.86 2.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 O-C-N 124.168 0.917 . . . . 10.0 111.542 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -63.13 160.31 15.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.787 0.327 . . . . 10.0 110.983 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.4 140.4 72.34 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 120.695 0.283 . . . . 10.0 111.401 -179.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.521 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 59.6 Cg_endo -76.9 140.61 66.02 Favored 'Cis proline' 0 C--N 1.343 0.266 0 C-N-CA 122.992 -1.67 . . . . 10.0 111.392 -1.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.582 ' HG2' ' O ' ' A' ' 81' ' ' ILE . 27.7 mtpp -82.91 145.1 29.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.436 -0.347 . . . . 10.0 110.965 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.424 ' CE2' ' HB3' ' A' ' 110' ' ' LYS . 34.1 p90 -165.73 156.08 13.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.714 0.292 . . . . 10.0 111.055 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.9 m -140.82 114.21 8.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.724 -0.671 . . . . 10.0 110.371 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 10.6 pt -134.87 149.02 29.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.558 -0.292 . . . . 10.0 110.816 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -117.16 116.62 27.65 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.384 -0.598 . . . . 10.0 109.384 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 25.7 t60 -130.3 146.31 51.88 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.412 -0.588 . . . . 10.0 109.412 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -99.11 139.66 34.43 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.201 0.524 . . . . 10.0 110.22 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -129.75 170.46 13.81 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.816 -0.629 . . . . 10.0 110.664 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.559 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 19.3 t -81.34 146.98 59.1 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 115.914 -0.585 . . . . 10.0 109.683 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -62.4 -18.02 60.73 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.126 1.884 . . . . 10.0 111.094 178.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.4 m -102.73 15.17 30.07 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.616 -0.72 . . . . 10.0 110.589 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.559 ' HB2' ' O ' ' A' ' 93' ' ' SER . 0.4 OUTLIER -83.5 167.88 17.0 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.043 0.449 . . . . 10.0 110.833 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.81 156.43 29.43 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.787 -0.642 . . . . 10.0 110.638 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 43.1 mm -63.3 -23.4 33.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.969 -0.559 . . . . 10.0 110.254 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.39 -40.58 65.14 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.355 -0.839 . . . . 10.0 110.873 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -64.02 -43.68 94.86 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 120.937 0.399 . . . . 10.0 110.864 -179.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.54 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 44.6 mt -62.12 -47.57 92.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.87 -0.605 . . . . 10.0 109.568 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -54.44 -46.41 73.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.341 -0.845 . . . . 10.0 111.237 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.437 ' OE1' ' HA ' ' A' ' 103' ' ' GLN . 16.0 mm-40 -65.04 -34.47 78.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.161 -0.472 . . . . 10.0 110.881 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 48.0 t60 -62.91 -39.56 94.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.342 -0.39 . . . . 10.0 110.326 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 101' ' ' ILE . 17.3 mt -63.14 -41.11 99.24 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.187 -0.46 . . . . 10.0 110.139 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 14.6 mt -68.53 -39.42 80.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.302 -0.408 . . . . 10.0 109.929 178.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.4 m -65.05 -26.07 68.09 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.214 0.531 . . . . 10.0 111.285 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -88.06 2.76 51.14 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.315 -0.402 . . . . 10.0 110.806 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 62.95 25.36 15.02 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.336 0.588 . . . . 10.0 109.997 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.424 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 22.5 mmtp -99.18 -8.16 25.51 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.565 -0.743 . . . . 10.0 109.89 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -130.6 154.46 47.84 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.397 -0.819 . . . . 10.0 110.371 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.1 m -107.77 -33.28 7.31 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.021 -0.536 . . . . 10.0 111.516 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.442 ' O ' HG13 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -154.57 129.89 9.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.582 -0.281 . . . . 10.0 110.777 -178.306 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.526 ' HA ' HD12 ' A' ' 117' ' ' ILE . 9.3 tt -61.77 -38.84 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-O 120.937 0.398 . . . . 10.0 111.451 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.565 ' HB3' ' OE2' ' A' ' 116' ' ' GLU . 8.1 t -49.48 -38.27 29.38 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.12 -0.946 . . . . 10.0 112.461 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.565 ' OE2' ' HB3' ' A' ' 115' ' ' SER . 1.3 pm0 -94.73 11.6 30.79 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.176 0.436 . . . . 10.0 112.176 -178.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' A' ' 114' ' ' ILE . 65.9 mt -95.6 119.98 44.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.992 -0.744 . . . . 10.0 108.992 178.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.8 mmmt -126.22 120.37 29.86 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.777 -0.453 . . . . 10.0 109.777 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -95.79 127.24 41.65 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.132 0.491 . . . . 10.0 111.248 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.59 HD21 HG11 ' B' ' 35' ' ' VAL . 3.0 mm? -110.33 138.46 46.69 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.493 -0.776 . . . . 10.0 108.98 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 25.3 tp -124.0 99.71 6.38 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.36 -0.607 . . . . 10.0 109.36 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 23.2 tptp 46.34 57.14 5.6 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 123.903 0.752 . . . . 10.0 110.416 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.568 ' HA3' ' CB ' ' C' ' 38' ' ' ASP . . . 81.48 -45.01 3.17 Favored Glycine 0 C--N 1.332 0.35 0 CA-C-N 115.567 -0.742 . . . . 10.0 113.097 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 40.1 tttp -62.61 133.16 54.49 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.807 -0.442 . . . . 10.0 109.807 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.3 p -83.03 141.03 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 113.341 0.867 . . . . 10.0 113.341 -177.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.5 mp -107.71 154.58 21.28 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.421 -0.808 . . . . 10.0 110.489 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 56.7 m-70 -111.9 154.61 24.95 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.781 0.324 . . . . 10.0 110.708 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -50.17 -54.04 23.54 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.727 1.01 . . . . 10.0 113.727 -178.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -96.51 18.69 13.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.921 0.391 . . . . 10.0 111.919 -177.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 130' ' ' LEU . 12.0 tp -68.81 146.77 52.59 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.029 0.442 . . . . 10.0 111.048 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -99.7 143.62 29.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.779 -0.646 . . . . 10.0 110.082 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.402 HD12 ' O ' ' A' ' 93' ' ' SER . 49.7 mt -56.8 -28.99 62.25 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.255 0.347 . . . . 10.0 111.692 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.69 -22.37 56.73 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.988 0.423 . . . . 10.0 111.687 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -83.11 -49.13 9.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.532 -0.304 . . . . 10.0 110.588 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.6 pp -72.72 -25.24 61.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 10.0 111.06 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt 65.85 91.96 0.08 Allowed 'General case' 0 N--CA 1.463 0.216 0 O-C-N 123.884 0.74 . . . . 10.0 112.064 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.2 t -66.99 110.08 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.415 -0.587 . . . . 10.0 109.415 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -81.51 124.69 79.92 Favored Pre-proline 0 N--CA 1.447 -0.584 0 CA-C-N 115.95 -0.568 . . . . 10.0 111.156 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -64.92 -17.07 58.38 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.819 2.346 . . . . 10.0 111.967 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -79.72 0.12 31.85 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.914 -0.585 . . . . 10.0 110.789 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -136.48 -63.88 0.61 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.119 -0.492 . . . . 10.0 109.787 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 30.5 m 51.6 24.48 2.34 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.634 -0.712 . . . . 10.0 112.543 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 32.4 m -124.71 126.32 45.51 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.142 0.496 . . . . 10.0 111.094 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 24.3 mm -106.73 120.51 58.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.567 -0.742 . . . . 10.0 109.584 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.24 117.85 23.23 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.242 -0.435 . . . . 10.0 109.83 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 29.1 t -93.46 127.73 45.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.689 -0.687 . . . . 10.0 111.221 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -124.65 117.26 23.88 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.47 -0.786 . . . . 10.0 109.247 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 10.2 mt -138.72 143.56 31.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.197 -0.456 . . . . 10.0 111.165 -177.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -109.8 114.56 56.45 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 108.846 -0.798 . . . . 10.0 108.846 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo . . . . . 0 CA--C 1.53 0.292 0 C-N-CA 122.447 2.098 . . . . 10.0 113.215 -178.792 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . 0.484 ' O ' HG12 ' B' ' 8' ' ' ILE . 26.0 t . . . . . 0 CA--C 1.53 0.209 0 CA-C-O 120.529 0.204 . . . . 10.0 110.515 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 5.2 ptpp? -57.88 -44.17 86.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.284 -0.416 . . . . 10.0 110.664 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -58.11 -46.25 85.88 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.004 0.43 . . . . 10.0 110.549 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -62.29 -38.94 91.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.932 -0.577 . . . . 10.0 110.458 179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.494 HG13 ' CE2' ' C' ' 15' ' ' TYR . 38.7 mm -63.63 -45.8 96.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.992 -0.549 . . . . 10.0 109.99 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.41 -36.72 83.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.736 -0.665 . . . . 10.0 110.994 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.36 -34.03 77.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.984 -0.553 . . . . 10.0 110.48 179.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 22.9 mt -67.02 -35.63 80.32 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.57 -0.53 . . . . 10.0 109.57 178.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.479 HG23 HD13 ' C' ' 12' ' ' ILE . 53.4 mt -59.91 -56.96 13.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.515 -0.766 . . . . 10.0 111.396 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.468 ' HB ' ' HG2' ' B' ' 48' ' ' ARG . 24.4 m -65.44 -31.95 56.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.432 -0.349 . . . . 10.0 111.613 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -65.26 -51.38 61.2 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.215 0.531 . . . . 10.0 110.179 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' TYR . . . . . 0.48 ' O ' HG12 ' B' ' 19' ' ' ILE . 16.5 m-85 -64.28 -44.97 90.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.974 -0.557 . . . . 10.0 111.338 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 9.3 m-30 -58.32 -50.37 73.87 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.559 0.207 . . . . 10.0 111.559 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 24.2 m -56.97 -38.5 73.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.933 0.397 . . . . 10.0 111.456 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 2.7 p -79.03 -20.11 49.79 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.293 -0.255 . . . . 10.0 111.256 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.48 HG12 ' O ' ' B' ' 15' ' ' TYR . 13.6 mm -76.72 -41.2 33.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 109.487 -0.56 . . . . 10.0 109.487 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 26.6 m -76.04 -27.78 18.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.937 -0.574 . . . . 10.0 110.369 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 tm-20 -65.22 -52.08 56.91 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.531 -0.544 . . . . 10.0 109.531 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 21.4 mmtm -79.89 -8.75 59.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.642 -0.708 . . . . 10.0 110.545 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 52.1 mttt 55.36 52.78 10.82 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.486 -0.779 . . . . 10.0 110.843 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.482 ' O ' ' HE2' ' C' ' 5' ' ' LYS . 87.7 mt-10 -89.35 26.64 1.61 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.249 -0.887 . . . . 10.0 110.105 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 13.7 tt -162.25 160.77 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.598 -0.728 . . . . 10.0 109.848 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.48 153.22 36.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.597 -0.274 . . . . 10.0 110.847 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -59.15 -44.44 92.09 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.379 0.511 . . . . 10.0 112.379 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.79 -47.48 82.45 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.089 0.471 . . . . 10.0 110.228 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.445 ' O ' ' HG ' ' B' ' 33' ' ' LEU . . . -67.36 -34.54 85.41 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.791 -0.64 . . . . 10.0 111.901 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.9 -39.3 94.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.698 0.285 . . . . 10.0 111.02 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -70.55 -30.43 67.15 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.751 -0.463 . . . . 10.0 109.751 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 2.0 m -62.23 -43.14 99.5 Favored 'General case' 0 C--N 1.334 -0.097 0 N-CA-C 109.126 -0.694 . . . . 10.0 109.126 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' B' ' 29' ' ' GLY . 26.7 mt -70.23 -36.4 74.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.751 -0.659 . . . . 10.0 109.851 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -54.82 -56.2 21.95 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.227 -0.897 . . . . 10.0 110.853 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.59 HG11 HD21 ' A' ' 120' ' ' LEU . 7.1 p -73.17 -34.32 44.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 115.947 -0.57 . . . . 10.0 111.397 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.09 -32.68 74.11 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.991 -0.374 . . . . 10.0 109.991 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' MET . . . . . . . . . . . . . 22.7 mtm -60.05 -44.12 94.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.414 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.27 -47.65 85.11 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.234 -0.439 . . . . 10.0 110.006 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 15.8 m -58.18 -43.44 87.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.789 -0.641 . . . . 10.0 110.817 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' ILE . . . . . 0.445 HD13 HG21 ' B' ' 12' ' ' ILE . 96.5 mt -67.21 -48.65 77.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-O 120.742 0.305 . . . . 10.0 111.555 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.54 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 10.6 m -60.06 -46.4 89.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.361 -0.381 . . . . 10.0 110.895 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -67.41 -37.99 83.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.384 -0.371 . . . . 10.0 111.209 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.26 -42.36 99.13 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.877 0.325 . . . . 10.0 111.877 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -87.6 -7.87 56.96 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.889 0.329 . . . . 10.0 111.889 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.62 49.82 17.27 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.986 -0.626 . . . . 10.0 113.54 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.54 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 8.2 p90 -151.98 166.75 30.57 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.433 -0.58 . . . . 10.0 109.433 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -117.09 157.82 25.25 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.199 0.523 . . . . 10.0 110.554 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.468 ' HG2' ' HB ' ' B' ' 13' ' ' VAL . 0.6 OUTLIER -68.99 -22.94 64.06 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.473 -0.785 . . . . 10.0 111.597 -178.554 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -69.07 -8.57 46.39 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.179 0.807 . . . . 10.0 113.179 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -103.34 5.62 37.39 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.813 0.671 . . . . 10.0 112.813 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.548 HG23 ' H ' ' B' ' 52' ' ' SER . 2.6 m -40.69 -61.61 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 113.638 0.977 . . . . 10.0 113.638 -178.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' SER . . . . . 0.548 ' H ' HG23 ' B' ' 51' ' ' VAL . 1.0 OUTLIER -62.01 -23.14 66.25 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.991 0.737 . . . . 10.0 112.991 -178.696 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.66 -40.81 30.88 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.646 -0.788 . . . . 10.0 112.43 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 72.8 mt -81.34 -47.37 19.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.711 0.291 . . . . 10.0 111.226 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 67.0 mt -74.99 -67.99 0.59 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.742 0.306 . . . . 10.0 110.573 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 55.06 -106.13 0.49 Allowed Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.777 -0.647 . . . . 10.0 113.381 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 16.0 pttt -126.96 18.81 7.16 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.205 0.526 . . . . 10.0 110.211 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 13.1 m -76.68 -59.13 2.9 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.707 -0.678 . . . . 10.0 110.406 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 . . . . . 0 N--CA 1.447 -0.595 0 CA-C-N 116.359 -0.382 . . . . 10.0 110.051 -179.779 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.458 0 N-CA-C 110.27 -0.27 . . . . 10.0 110.27 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 4' ' ' SER . . . . . 0.474 ' O ' HG12 ' C' ' 8' ' ' ILE . 8.6 t -97.8 171.77 8.1 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.347 -0.612 . . . . 10.0 109.347 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 5' ' ' LYS . . . . . 0.482 ' HE2' ' O ' ' B' ' 24' ' ' GLU . 3.4 ptpp? -59.23 -37.97 78.85 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 121.407 -0.117 . . . . 10.0 110.903 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 6' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -58.27 -45.55 87.66 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.055 0.455 . . . . 10.0 110.725 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -69.99 -41.44 74.38 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.19 -0.459 . . . . 10.0 110.735 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 8' ' ' ILE . . . . . 0.474 HG12 ' O ' ' C' ' 4' ' ' SER . 40.1 mm -59.19 -44.89 92.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.825 -0.435 . . . . 10.0 109.825 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.41 -39.93 92.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.824 -0.625 . . . . 10.0 110.442 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.42 -43.03 99.58 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.816 -0.629 . . . . 10.0 110.41 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . 0.472 ' HG ' ' CD2' ' C' ' 55' ' ' LEU . 7.0 mt -61.04 -40.43 93.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.457 -0.338 . . . . 10.0 110.743 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 12' ' ' ILE . . . . . 0.479 HD13 HG23 ' B' ' 12' ' ' ILE . 73.1 mt -65.2 -54.13 32.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.038 -0.528 . . . . 10.0 111.668 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 18.1 m -64.86 -27.47 42.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.899 0.38 . . . . 10.0 110.952 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -71.67 -47.08 56.65 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 120.986 0.422 . . . . 10.0 110.186 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 15' ' ' TYR . . . . . 0.494 ' CE2' HG13 ' B' ' 8' ' ' ILE . 3.2 m-85 -62.59 -42.66 99.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.829 -0.623 . . . . 10.0 110.598 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -59.18 -45.05 92.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.192 -0.458 . . . . 10.0 111.027 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 35.8 m -58.6 -39.7 81.15 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.119 -0.491 . . . . 10.0 111.692 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.71 -19.29 45.4 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.973 0.416 . . . . 10.0 111.139 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 19' ' ' ILE . . . . . . . . . . . . . 4.2 mm -75.87 -45.12 38.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.006 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 20' ' ' VAL . . . . . . . . . . . . . 27.3 m -75.44 -18.09 15.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 121.235 0.54 . . . . 10.0 110.676 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -70.91 -56.35 6.43 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.534 -0.757 . . . . 10.0 110.794 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 22' ' ' LYS . . . . . 0.5 ' HD2' ' OE2' ' C' ' 24' ' ' GLU . 45.5 mttm -81.22 -2.01 47.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.399 -0.818 . . . . 10.0 111.735 -178.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 87.7 mttt 55.58 49.23 16.98 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.475 0.655 . . . . 10.0 110.571 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . 0.5 ' OE2' ' HD2' ' C' ' 22' ' ' LYS . 46.3 mt-10 -82.47 -15.36 52.79 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.546 -0.752 . . . . 10.0 110.096 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 17.1 tt -114.2 161.14 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 115.608 -0.724 . . . . 10.0 109.829 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.31 154.08 39.29 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 123.288 0.368 . . . . 10.0 110.11 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -52.25 -44.5 64.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.95 0.405 . . . . 10.0 111.46 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 28' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -59.03 -45.07 91.65 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.882 -0.599 . . . . 10.0 110.646 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 29' ' ' GLY . . . . . 0.643 ' O ' ' HG ' ' C' ' 33' ' ' LEU . . . -68.12 -38.11 87.82 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.639 -0.709 . . . . 10.0 112.183 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.55 -43.31 84.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.047 0.451 . . . . 10.0 110.402 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 31' ' ' ASP . . . . . 0.488 ' O ' ' HB3' ' C' ' 34' ' ' ASN . 31.1 t70 -69.41 -37.59 77.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.904 -0.589 . . . . 10.0 110.347 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 24.3 m -64.23 -36.11 83.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.676 -0.693 . . . . 10.0 110.39 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 33' ' ' LEU . . . . . 0.643 ' HG ' ' O ' ' C' ' 29' ' ' GLY . 46.5 mt -73.05 -26.86 61.44 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.849 -0.426 . . . . 10.0 109.849 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 34' ' ' ASN . . . . . 0.488 ' HB3' ' O ' ' C' ' 31' ' ' ASP . 24.8 t30 -61.83 -56.6 17.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.917 -0.583 . . . . 10.0 110.303 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 35' ' ' VAL . . . . . 0.411 HG23 ' H ' ' A' ' 123' ' ' GLY . 6.3 p -66.64 -38.23 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 115.672 -0.695 . . . . 10.0 110.639 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . 0.478 ' O ' HG13 ' C' ' 40' ' ' ILE . . . -64.28 -32.57 74.22 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.389 -0.369 . . . . 10.0 110.995 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 14.0 mtm -59.29 -52.8 64.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.636 -0.256 . . . . 10.0 111.024 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 38' ' ' ASP . . . . . 0.568 ' CB ' ' HA3' ' A' ' 123' ' ' GLY . 28.1 m-20 -63.99 -26.55 68.62 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.462 -0.335 . . . . 10.0 110.597 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 39' ' ' CYS . . . . . 0.476 ' HB2' ' O ' ' C' ' 36' ' ' ALA . 62.7 m -60.23 -43.41 96.06 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 109.351 -0.611 . . . . 10.0 109.351 178.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 40' ' ' ILE . . . . . 0.478 HG13 ' O ' ' C' ' 36' ' ' ALA . 14.8 mt -69.03 -47.75 73.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.554 -0.748 . . . . 10.0 110.551 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 41' ' ' SER . . . . . 0.472 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 17.8 m -59.78 -43.18 94.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.916 -0.583 . . . . 10.0 111.712 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -68.59 -43.23 76.93 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.281 -0.418 . . . . 10.0 111.238 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.9 -44.86 75.98 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.355 0.502 . . . . 10.0 112.355 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 44' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -86.36 -7.31 58.56 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.95 0.352 . . . . 10.0 111.95 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.16 55.38 21.83 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.893 -0.67 . . . . 10.0 113.326 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 46' ' ' PHE . . . . . 0.472 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 4.7 p90 -153.98 177.7 10.75 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.896 -0.779 . . . . 10.0 108.896 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -125.27 150.87 46.67 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.263 0.554 . . . . 10.0 111.576 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 48' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -71.83 -27.63 63.04 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.499 -0.773 . . . . 10.0 110.954 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -72.15 2.8 5.27 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.006 -0.543 . . . . 10.0 111.246 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -108.96 0.88 20.3 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.436 0.532 . . . . 10.0 112.436 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 10.5 m -50.24 -43.21 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 114.379 1.252 . . . . 10.0 114.379 -177.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 52' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.77 -30.06 67.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.868 0.365 . . . . 10.0 111.174 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.91 -38.16 10.7 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.957 -0.64 . . . . 10.0 112.786 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 54' ' ' ILE . . . . . . . . . . . . . 37.3 mt -73.84 -62.68 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.853 0.359 . . . . 10.0 111.035 -179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 55' ' ' LEU . . . . . 0.472 ' CD2' ' HG ' ' C' ' 11' ' ' LEU . 68.9 mt -66.25 -54.97 18.66 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.628 -0.714 . . . . 10.0 110.71 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 52.67 -99.5 0.04 OUTLIER Glycine 0 CA--C 1.518 0.279 0 O-C-N 123.931 0.769 . . . . 10.0 112.457 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -138.89 21.09 2.65 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.187 -0.672 . . . . 10.0 109.187 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 18.4 m -78.69 -59.67 2.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.27 -0.877 . . . . 10.0 111.399 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 . . . . . 0 C--N 1.321 -0.636 0 N-CA-C 109.956 -0.387 . . . . 10.0 109.956 -179.901 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.8 p . . . . . 0 N--CA 1.453 -0.322 0 CA-C-O 120.807 0.336 . . . . 10.0 110.121 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -89.16 132.1 34.99 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.411 -0.359 . . . . 10.0 110.981 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -120.73 122.48 40.49 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.466 -0.938 . . . . 10.0 108.466 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.7 m -92.17 109.74 21.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.921 0.391 . . . . 10.0 110.346 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.542 ' O ' ' HA ' ' A' ' 87' ' ' SER . 2.3 mm? -81.67 110.65 17.21 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.239 -0.652 . . . . 10.0 109.239 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -120.52 107.11 12.47 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.316 -0.402 . . . . 10.0 111.059 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 46.5 tttm -96.74 120.57 37.31 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.587 -0.523 . . . . 10.0 109.587 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.488 HG23 ' OD2' ' C' ' 28' ' ' ASP . 18.1 mt -83.87 -36.21 11.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 O-C-N 123.863 0.727 . . . . 10.0 111.087 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.456 ' OE1' ' HA ' ' A' ' 147' ' ' MET . 19.7 mt-30 -65.42 149.17 50.46 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.993 -0.283 . . . . 10.0 110.394 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.91 134.05 78.49 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 116.437 -0.347 . . . . 10.0 111.041 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -80.07 142.14 60.91 Favored 'Cis proline' 0 C--O 1.236 0.4 0 C-N-CA 124.23 -1.154 . . . . 10.0 111.836 -1.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -80.36 158.13 26.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.029 -0.532 . . . . 10.0 111.585 -178.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -165.87 157.07 13.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.694 -0.685 . . . . 10.0 110.524 177.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.542 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 70.4 m -149.81 99.88 2.9 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.552 -0.536 . . . . 10.0 109.552 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.3 pt -121.03 155.32 24.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.039 -0.528 . . . . 10.0 110.761 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -114.91 119.33 36.18 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.554 -0.293 . . . . 10.0 110.546 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -118.11 156.05 29.34 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 110.059 -0.349 . . . . 10.0 110.059 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -107.89 110.99 22.89 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.098 -0.705 . . . . 10.0 109.098 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -117.56 151.55 36.92 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.788 0.328 . . . . 10.0 110.922 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.507 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 0.6 OUTLIER -66.93 134.01 93.95 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.072 -0.513 . . . . 10.0 110.626 179.682 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -52.46 -32.26 51.94 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.549 2.166 . . . . 10.0 112.853 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.4 m -97.52 20.27 12.03 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.042 -0.526 . . . . 10.0 111.529 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.507 ' HB2' ' O ' ' A' ' 93' ' ' SER . 0.6 OUTLIER -83.45 171.35 13.52 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.88 0.371 . . . . 10.0 110.896 -179.546 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.467 HG22 ' H ' ' A' ' 99' ' ' LEU . 4.9 m -105.99 146.41 30.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.963 -0.562 . . . . 10.0 111.006 -179.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.439 HG12 ' O ' ' A' ' 130' ' ' LEU . 39.2 mm -61.76 -29.52 46.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 121.31 0.576 . . . . 10.0 110.392 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.467 ' H ' HG22 ' A' ' 97' ' ' THR . 0.6 OUTLIER -56.32 -42.78 78.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.591 -0.732 . . . . 10.0 110.942 179.723 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -64.6 -36.38 84.06 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 120.695 0.283 . . . . 10.0 110.981 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 59.2 mt -65.8 -48.27 82.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.267 -0.424 . . . . 10.0 109.886 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.459 ' HE2' HG13 ' A' ' 114' ' ' ILE . 23.5 mtpt -60.15 -44.06 95.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.786 -0.643 . . . . 10.0 110.331 178.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -64.21 -33.46 75.85 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.776 -0.647 . . . . 10.0 110.227 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.414 ' O ' ' HG3' ' A' ' 108' ' ' GLU . 61.2 t60 -69.89 -37.7 76.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.822 -0.627 . . . . 10.0 110.398 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 60.8 mt -60.55 -39.97 89.85 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.115 0.483 . . . . 10.0 110.165 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 102' ' ' LYS . 12.2 mt -70.14 -38.5 75.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.996 -0.547 . . . . 10.0 109.905 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 48.9 m -66.02 -23.73 66.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.741 -0.663 . . . . 10.0 110.965 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 104' ' ' HIS . 47.2 mt-10 -96.75 7.05 47.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.154 -0.475 . . . . 10.0 110.202 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 58.13 32.09 21.56 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.452 -0.795 . . . . 10.0 111.683 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 6.3 mmpp? -100.39 -8.01 23.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.633 -0.712 . . . . 10.0 109.455 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -130.55 167.23 19.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.297 -0.865 . . . . 10.0 111.258 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.8 t -101.1 -61.36 1.38 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.876 -0.602 . . . . 10.0 110.138 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.495 ' O ' HG13 ' A' ' 117' ' ' ILE . 20.2 m170 -139.59 143.76 37.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.351 -0.386 . . . . 10.0 110.335 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.498 ' HA ' HD12 ' A' ' 117' ' ' ILE . 3.9 tt -59.5 -42.91 89.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 121.317 0.58 . . . . 10.0 110.811 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.49 -15.03 33.87 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.084 -0.962 . . . . 10.0 112.304 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -110.94 14.95 22.0 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.493 0.553 . . . . 10.0 112.493 -178.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.498 HD12 ' HA ' ' A' ' 114' ' ' ILE . 71.1 mt -105.79 120.96 57.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-O 120.973 0.416 . . . . 10.0 110.725 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -121.9 114.07 20.5 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.961 -0.755 . . . . 10.0 108.961 178.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 126' ' ' LEU . 69.8 mt -100.37 131.37 46.33 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.746 0.784 . . . . 10.0 110.988 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.548 HD11 ' SG ' ' C' ' 39' ' ' CYS . 0.4 OUTLIER -118.06 144.29 45.73 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.914 -1.039 . . . . 10.0 108.753 179.187 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.541 HD23 ' HD2' ' A' ' 124' ' ' LYS . 27.6 tp -128.87 93.34 3.58 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 107.45 -1.315 . . . . 10.0 107.45 178.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.532 ' HG2' ' ND2' ' A' ' 141' ' ' ASN . 0.2 OUTLIER 35.29 69.33 0.17 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 113.903 -1.499 . . . . 10.0 112.498 -179.473 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.514 ' HA3' ' HB3' ' C' ' 38' ' ' ASP . . . 86.51 -45.28 3.43 Favored Glycine 0 CA--C 1.51 -0.256 0 C-N-CA 121.071 -0.585 . . . . 10.0 112.399 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.541 ' HD2' HD23 ' A' ' 121' ' ' LEU . 39.7 ttmt -63.33 121.7 14.38 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.556 -0.535 . . . . 10.0 109.556 178.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.9 t -85.8 128.42 39.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 111.79 0.293 . . . . 10.0 111.79 -178.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' A' ' 119' ' ' LEU . 5.3 mp -96.88 144.71 26.56 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.149 -0.315 . . . . 10.0 110.149 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.734 ' HB2' HD13 ' A' ' 130' ' ' LEU . 88.2 m-70 -122.7 161.1 24.51 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.598 -0.441 . . . . 10.0 110.259 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.09 -34.19 68.06 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.224 0.824 . . . . 10.0 113.224 -178.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -96.93 8.35 44.63 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.985 0.365 . . . . 10.0 111.985 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.734 HD13 ' HB2' ' A' ' 127' ' ' HIS . 1.1 mp -80.54 144.92 32.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.985 0.421 . . . . 10.0 110.65 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -107.68 148.67 29.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.769 -0.65 . . . . 10.0 109.362 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 51.0 mt -57.12 -39.18 74.61 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.106 0.409 . . . . 10.0 112.106 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.87 -18.52 58.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.749 0.309 . . . . 10.0 110.746 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -78.62 -49.33 13.42 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.811 -0.632 . . . . 10.0 110.623 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.437 HD22 ' HG ' ' A' ' 126' ' ' LEU . 1.2 pp -76.4 -26.49 55.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.283 -0.417 . . . . 10.0 111.159 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 10.8 mttp 60.84 100.52 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 O-C-N 123.634 0.584 . . . . 10.0 111.409 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.9 p -88.14 128.93 40.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.986 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.88 128.64 89.16 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.982 -0.554 . . . . 10.0 111.435 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -69.25 -9.69 26.97 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.479 2.119 . . . . 10.0 111.924 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -92.02 8.67 36.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.457 0.646 . . . . 10.0 109.484 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.532 ' ND2' ' HG2' ' A' ' 122' ' ' LYS . 5.9 t-20 -134.61 -74.52 0.47 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.229 -0.896 . . . . 10.0 109.737 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.3 m 55.87 26.5 9.77 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.881 0.697 . . . . 10.0 112.881 178.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 19.4 m -121.0 124.24 44.38 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.009 0.433 . . . . 10.0 111.12 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.445 HD13 HD13 ' A' ' 121' ' ' LEU . 24.5 mm -103.19 125.77 57.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.82 -0.627 . . . . 10.0 110.115 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.19 106.44 14.09 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.355 -0.98 . . . . 10.0 108.355 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 30.0 t -89.35 122.27 40.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.668 -0.696 . . . . 10.0 111.816 -177.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' MET . . . . . 0.456 ' HA ' ' OE1' ' A' ' 82' ' ' GLN . 26.1 mmt -122.67 117.73 26.46 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.434 -0.803 . . . . 10.0 109.486 178.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 23.1 mt -135.45 138.26 48.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.798 -0.637 . . . . 10.0 110.233 -178.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 9.0 mtpt -103.83 115.02 64.1 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.928 -0.578 . . . . 10.0 110.903 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo . . . . . 0 N--CA 1.462 -0.34 0 C-N-CA 122.053 1.835 . . . . 10.0 111.503 179.248 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.449 -0.511 0 N-CA-C 110.09 -0.337 . . . . 10.0 110.09 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 7.1 ptpp? -57.2 -34.95 69.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.38 -0.373 . . . . 10.0 111.341 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -61.65 -44.17 97.47 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.239 -0.437 . . . . 10.0 110.64 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -56.99 -48.09 79.25 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.467 0.651 . . . . 10.0 109.571 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.607 ' O ' HG12 ' B' ' 12' ' ' ILE . 42.8 mm -63.4 -47.8 90.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.145 -0.934 . . . . 10.0 110.911 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.87 -41.26 70.62 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.983 0.421 . . . . 10.0 110.824 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.8 -31.4 70.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.904 -0.589 . . . . 10.0 110.554 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.36 -33.22 67.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.181 0.515 . . . . 10.0 109.676 179.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.715 HD12 HG12 ' C' ' 12' ' ' ILE . 18.6 mm -66.08 -50.33 69.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.572 -0.74 . . . . 10.0 111.2 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 28.8 m -65.19 -32.18 57.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.804 0.335 . . . . 10.0 110.608 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' ASN . . . . . 0.415 ' HB2' HG11 ' B' ' 51' ' ' VAL . 41.8 t30 -68.73 -48.92 62.59 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.244 -0.435 . . . . 10.0 109.954 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' TYR . . . . . 0.589 ' O ' HG12 ' B' ' 19' ' ' ILE . 5.5 t80 -59.54 -43.2 93.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.235 -0.439 . . . . 10.0 110.708 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 11.4 m-30 -56.82 -45.5 82.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.773 0.32 . . . . 10.0 110.315 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 74.2 m -58.54 -42.45 87.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.903 -0.59 . . . . 10.0 111.2 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 1.5 m -70.14 -21.72 63.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.377 -0.374 . . . . 10.0 111.501 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.589 HG12 ' O ' ' B' ' 15' ' ' TYR . 34.2 mm -87.27 -39.3 12.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.873 -0.331 . . . . 10.0 110.944 -178.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 30.3 m -73.33 -32.2 36.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.61 0.243 . . . . 10.0 110.469 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -65.1 -51.43 61.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.293 -0.412 . . . . 10.0 111.109 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -84.11 -4.6 58.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.329 -0.396 . . . . 10.0 111.492 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 53.0 mttm 57.03 47.44 17.51 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.49 0.662 . . . . 10.0 111.088 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.507 ' O ' ' HE2' ' C' ' 5' ' ' LYS . 80.9 mt-10 -89.31 30.01 1.03 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.702 -0.681 . . . . 10.0 110.348 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 13.3 tt -158.78 171.38 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.764 -0.828 . . . . 10.0 108.764 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.91 155.87 39.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.753 0.311 . . . . 10.0 110.368 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -59.96 -48.0 83.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.234 -0.439 . . . . 10.0 111.072 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.59 -39.17 93.7 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.197 -0.456 . . . . 10.0 109.875 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.503 ' O ' ' HG ' ' B' ' 33' ' ' LEU . . . -66.71 -31.78 79.42 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.756 -0.656 . . . . 10.0 111.514 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.74 -38.07 89.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.648 0.261 . . . . 10.0 110.546 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -66.53 -36.52 82.88 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 108.713 -0.847 . . . . 10.0 108.713 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . 0.64 ' HB3' ' SG ' ' C' ' 39' ' ' CYS . 2.4 m -64.79 -33.36 75.81 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.18 -0.918 . . . . 10.0 110.095 178.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' B' ' 29' ' ' GLY . 25.2 mt -73.35 -40.53 64.33 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.192 -0.458 . . . . 10.0 110.099 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 55.9 m-20 -62.75 -44.86 95.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.818 -0.628 . . . . 10.0 110.986 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.452 ' CG2' ' HG3' ' A' ' 147' ' ' MET . 11.9 p -72.22 -37.53 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 116.331 -0.395 . . . . 10.0 110.564 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.7 -35.04 79.6 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 109.621 -0.511 . . . . 10.0 109.621 178.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' MET . . . . . . . . . . . . . 25.0 ttm -56.18 -51.62 67.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.388 -0.824 . . . . 10.0 110.028 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . 0.528 ' OD1' ' HD3' ' B' ' 48' ' ' ARG . 0.7 OUTLIER -69.09 -40.11 78.62 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.45 -0.795 . . . . 10.0 110.054 -179.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 4.5 t -52.64 -45.45 66.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.268 -0.878 . . . . 10.0 110.6 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 75.8 mt -74.42 -44.34 48.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.51 -0.768 . . . . 10.0 111.196 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.699 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 34.6 m -57.75 -43.74 85.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.85 0.357 . . . . 10.0 110.893 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -68.67 -41.73 78.85 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.955 -0.566 . . . . 10.0 110.849 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.29 -27.96 69.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.262 -0.426 . . . . 10.0 111.807 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -104.15 0.61 29.79 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.81 0.338 . . . . 10.0 111.479 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.08 46.68 84.47 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 116.052 -0.522 . . . . 10.0 113.718 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.699 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 9.2 p90 -135.51 154.91 51.24 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 117.176 0.488 . . . . 10.0 109.953 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -71.61 141.66 49.98 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.267 0.556 . . . . 10.0 112.044 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.528 ' HD3' ' OD1' ' B' ' 38' ' ' ASP . 0.1 OUTLIER -59.31 -42.47 91.47 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.066 -0.97 . . . . 10.0 110.257 179.409 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -88.69 5.23 44.18 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.084 0.772 . . . . 10.0 113.084 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.54 3.39 11.48 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.282 0.475 . . . . 10.0 112.282 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.428 HG23 ' H ' ' B' ' 52' ' ' SER . 13.0 m -43.91 -54.38 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 113.02 0.748 . . . . 10.0 113.02 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' SER . . . . . 0.428 ' H ' HG23 ' B' ' 51' ' ' VAL . 18.3 m -52.88 -35.94 58.49 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 113.213 0.82 . . . . 10.0 113.213 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.28 -33.79 55.99 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.128 -1.034 . . . . 10.0 112.349 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 22.7 mt -89.5 -59.5 2.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 113.759 1.022 . . . . 10.0 113.759 -178.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 60.2 mt -66.07 -67.89 0.41 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.402 0.89 . . . . 10.0 113.402 -177.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.52 -152.51 39.52 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.456 -0.878 . . . . 10.0 111.04 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.75 23.65 3.64 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.564 0.697 . . . . 10.0 109.674 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 1.4 m -86.94 40.42 0.91 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.972 -1.013 . . . . 10.0 111.416 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 . . . . . 0 CA--C 1.531 0.218 0 CA-C-N 115.955 -0.566 . . . . 10.0 111.586 179.919 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.231 0 N-CA-C 109.69 -0.485 . . . . 10.0 109.69 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -101.56 142.82 32.36 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.934 -0.395 . . . . 10.0 109.934 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 5' ' ' LYS . . . . . 0.507 ' HE2' ' O ' ' B' ' 24' ' ' GLU . 7.2 ptpp? -62.87 -37.08 85.45 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.32 0.489 . . . . 10.0 112.32 -178.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 6' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -62.08 -43.4 98.92 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.654 0.264 . . . . 10.0 110.29 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . 0.487 ' O ' HD21 ' C' ' 55' ' ' LEU . 69.9 mt-10 -64.02 -49.9 70.59 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.767 -0.651 . . . . 10.0 110.249 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 8' ' ' ILE . . . . . 0.603 ' O ' HG13 ' C' ' 12' ' ' ILE . 50.0 mm -61.64 -43.72 97.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.813 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.43 -45.36 76.77 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.249 -0.432 . . . . 10.0 111.121 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.84 -34.88 79.41 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.781 -0.645 . . . . 10.0 110.867 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 1.3 mt -65.36 -32.45 74.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.573 -0.285 . . . . 10.0 110.651 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 12' ' ' ILE . . . . . 0.715 HG12 HD12 ' B' ' 12' ' ' ILE . 7.5 mt -67.71 -55.13 18.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.341 -0.391 . . . . 10.0 110.748 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 17.9 m -64.37 -30.86 51.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.812 -0.631 . . . . 10.0 111.311 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 14' ' ' ASN . . . . . 0.523 ' HB2' HG11 ' C' ' 51' ' ' VAL . 45.9 t30 -70.39 -45.72 65.41 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.126 0.488 . . . . 10.0 109.716 178.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 15' ' ' TYR . . . . . 0.6 ' CE2' HG13 ' B' ' 8' ' ' ILE . 4.7 t80 -62.84 -46.99 85.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.863 -0.608 . . . . 10.0 110.454 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -56.11 -47.58 77.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.07 -0.514 . . . . 10.0 111.356 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 37.0 m -58.92 -41.25 86.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 10.0 111.584 -179.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 3.4 p -75.21 -20.84 59.06 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.297 0.481 . . . . 10.0 112.297 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 19' ' ' ILE . . . . . 0.502 HG12 ' O ' ' C' ' 15' ' ' TYR . 20.4 mm -84.06 -35.33 10.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.771 0.32 . . . . 10.0 110.666 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 20' ' ' VAL . . . . . . . . . . . . . 29.4 m -78.7 -28.12 14.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.866 -0.333 . . . . 10.0 110.385 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.1 -50.83 62.69 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.966 0.413 . . . . 10.0 110.221 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -85.8 1.69 48.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.241 -0.436 . . . . 10.0 110.064 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 63.7 mttm 48.03 53.54 11.45 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.105 -0.952 . . . . 10.0 111.989 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -85.09 13.73 5.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.468 . . . . 10.0 110.197 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 13.5 tt -138.82 167.6 20.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.744 -0.662 . . . . 10.0 109.823 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 8.2 p -66.22 160.42 24.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.524 0.202 . . . . 10.0 110.589 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -59.69 -41.99 91.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.919 0.39 . . . . 10.0 110.53 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 28' ' ' ASP . . . . . 0.488 ' OD2' HG23 ' A' ' 81' ' ' ILE . 31.0 t70 -68.84 -39.86 79.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.971 -0.558 . . . . 10.0 109.865 179.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 29' ' ' GLY . . . . . 0.537 ' O ' ' HG ' ' C' ' 33' ' ' LEU . . . -64.57 -35.66 92.2 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.927 -0.654 . . . . 10.0 111.627 178.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.4 -45.92 91.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.345 0.593 . . . . 10.0 110.113 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -60.9 -38.22 84.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.415 -0.811 . . . . 10.0 110.025 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 3.0 t -62.09 -34.37 76.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.358 -0.837 . . . . 10.0 110.593 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 33' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' C' ' 29' ' ' GLY . 50.1 mt -74.94 -29.58 60.98 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.17 -0.468 . . . . 10.0 110.475 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -71.61 -47.57 53.82 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.428 -0.351 . . . . 10.0 110.965 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 35' ' ' VAL . . . . . 0.492 HG23 ' H ' ' A' ' 123' ' ' GLY . 2.5 p -64.16 -40.73 90.08 Favored 'Isoleucine or valine' 0 C--N 1.343 0.304 0 CA-C-O 120.684 0.278 . . . . 10.0 110.449 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.6 -35.61 79.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.847 0.356 . . . . 10.0 110.32 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 40.5 ttm -53.34 -59.89 3.99 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.585 -0.734 . . . . 10.0 111.769 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 38' ' ' ASP . . . . . 0.514 ' HB3' ' HA3' ' A' ' 123' ' ' GLY . 4.1 m-20 -65.89 -33.77 76.59 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 121.028 -0.269 . . . . 10.0 111.504 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 39' ' ' CYS . . . . . 0.64 ' SG ' ' HB3' ' B' ' 32' ' ' SER . 0.5 OUTLIER -60.86 -47.89 84.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.107 0.48 . . . . 10.0 110.064 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 40' ' ' ILE . . . . . . . . . . . . . 59.8 mt -68.34 -44.52 83.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.526 -0.761 . . . . 10.0 110.956 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 41' ' ' SER . . . . . 0.57 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 40.4 m -59.52 -45.75 90.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.063 -0.517 . . . . 10.0 111.432 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 -69.32 -40.12 77.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.312 -0.404 . . . . 10.0 110.839 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.52 -44.43 93.15 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.989 -0.55 . . . . 10.0 112.256 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 44' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -89.1 -6.82 56.77 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.633 0.254 . . . . 10.0 111.521 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.9 58.0 7.26 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 114.397 0.519 . . . . 10.0 114.397 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 46' ' ' PHE . . . . . 0.57 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 13.2 p90 -153.24 154.02 33.83 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.46 -0.57 . . . . 10.0 109.46 178.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 47' ' ' GLU . . . . . 0.432 ' HA ' ' OE1' ' C' ' 47' ' ' GLU . 0.0 OUTLIER -80.54 144.18 32.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.861 0.362 . . . . 10.0 111.155 -179.805 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 48' ' ' ARG . . . . . 0.452 ' HD3' ' OD1' ' C' ' 38' ' ' ASP . 0.0 OUTLIER -61.03 -34.94 75.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.978 -0.555 . . . . 10.0 111.001 -179.42 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.42 3.16 37.38 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.079 0.4 . . . . 10.0 112.079 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.4 1.79 47.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.805 0.336 . . . . 10.0 111.242 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 51' ' ' VAL . . . . . 0.523 HG11 ' HB2' ' C' ' 14' ' ' ASN . 5.9 m -49.72 -44.43 20.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 112.651 0.611 . . . . 10.0 112.651 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.7 -35.28 70.41 Favored 'General case' 0 C--O 1.225 -0.199 0 N-CA-C 112.461 0.541 . . . . 10.0 112.461 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.21 -28.22 58.56 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 119.712 -1.232 . . . . 10.0 112.642 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 54' ' ' ILE . . . . . . . . . . . . . 61.3 mt -89.05 -62.98 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 113.241 0.83 . . . . 10.0 113.241 -178.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 55' ' ' LEU . . . . . 0.487 HD21 ' O ' ' C' ' 7' ' ' GLU . 20.7 mt -74.81 -62.6 1.49 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.529 0.937 . . . . 10.0 113.529 -177.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.16 -119.79 6.89 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.216 -0.754 . . . . 10.0 111.216 -178.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -160.03 22.12 0.17 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.35 0.595 . . . . 10.0 110.086 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.52 44.87 1.14 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.587 -0.733 . . . . 10.0 111.617 -178.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 . . . . . 0 N--CA 1.463 0.204 0 CA-C-O 120.958 0.408 . . . . 10.0 110.785 -179.647 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.453 -0.308 0 CA-C-O 120.445 0.164 . . . . 10.0 110.68 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -91.16 124.78 35.64 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.957 -0.386 . . . . 10.0 109.957 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.6 mp -126.39 133.49 51.29 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.014 0.435 . . . . 10.0 110.861 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.419 HG23 ' HG2' ' A' ' 89' ' ' GLU . 8.8 m -102.97 117.08 33.8 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.246 -0.434 . . . . 10.0 110.701 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -85.68 107.78 17.72 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.12 0.486 . . . . 10.0 110.025 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.3 tptm -106.41 98.93 8.54 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.536 -0.756 . . . . 10.0 110.457 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -99.27 114.09 26.73 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.404 -0.362 . . . . 10.0 110.308 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 57.5 mt -84.05 -57.86 4.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.823 -0.626 . . . . 10.0 111.124 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -61.96 158.94 15.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.883 -0.598 . . . . 10.0 112.066 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -77.94 138.76 61.35 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.924 -0.58 . . . . 10.0 112.318 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -76.33 130.66 21.97 Favored 'Cis proline' 0 C--O 1.235 0.334 0 C-N-CA 123.247 -1.564 . . . . 10.0 110.619 -1.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.49 153.26 22.58 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.253 0.549 . . . . 10.0 111.459 -178.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.453 ' CE1' ' HB3' ' A' ' 110' ' ' LYS . 47.6 p90 -168.15 160.01 11.42 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.173 -0.921 . . . . 10.0 109.416 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.0 m -143.09 98.77 3.33 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.863 -0.791 . . . . 10.0 108.863 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 24.1 pt -119.75 153.44 22.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.18 -0.464 . . . . 10.0 111.048 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.419 ' HG2' HG23 ' A' ' 77' ' ' THR . 43.3 mt-10 -115.62 127.6 55.33 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 109.246 -0.649 . . . . 10.0 109.246 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.54 157.0 44.77 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.065 0.46 . . . . 10.0 110.402 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -114.54 137.79 51.44 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.126 -0.488 . . . . 10.0 109.911 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -129.75 165.09 22.6 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.251 -0.431 . . . . 10.0 110.416 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.537 ' O ' HD12 ' A' ' 132' ' ' LEU . 7.3 m -75.78 147.37 81.04 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.119 -0.492 . . . . 10.0 110.568 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.47 -22.57 59.75 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.864 2.376 . . . . 10.0 113.322 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.59 18.12 22.35 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.962 0.411 . . . . 10.0 110.791 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.47 ' HB2' ' O ' ' A' ' 93' ' ' SER . 0.3 OUTLIER -80.34 162.82 24.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.98 0.419 . . . . 10.0 110.83 179.872 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.6 m -109.38 150.77 27.56 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.976 -0.556 . . . . 10.0 111.506 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 37.8 mm -61.86 -22.05 27.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.272 0.558 . . . . 10.0 110.379 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.13 -38.45 68.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.281 -0.872 . . . . 10.0 110.418 178.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 73.3 mm-40 -62.09 -44.38 96.78 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.136 -0.484 . . . . 10.0 111.137 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.554 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 35.6 mt -63.7 -50.09 79.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.839 -0.619 . . . . 10.0 109.875 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -55.37 -44.55 76.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.626 -0.716 . . . . 10.0 110.854 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -63.73 -39.19 93.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 10.0 110.905 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -63.57 -39.81 95.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.131 -0.486 . . . . 10.0 110.918 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 101' ' ' ILE . 40.9 mt -62.13 -42.19 99.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.867 0.365 . . . . 10.0 110.478 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 48.8 mt -68.81 -44.24 82.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.439 -0.346 . . . . 10.0 110.563 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.5 m -61.07 -27.45 68.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.848 -0.615 . . . . 10.0 111.82 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -95.8 12.86 28.55 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 120.797 0.332 . . . . 10.0 111.145 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 59.76 34.43 21.96 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.696 -0.684 . . . . 10.0 111.925 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.453 ' HB3' ' CE1' ' A' ' 86' ' ' PHE . 17.5 mmtp -107.2 -7.17 16.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.324 0.583 . . . . 10.0 110.472 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.487 ' HB2' HD13 ' A' ' 148' ' ' ILE . . . -141.67 142.02 33.36 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.439 -0.8 . . . . 10.0 109.81 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.33 -41.84 17.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.728 0.299 . . . . 10.0 111.387 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.404 ' O ' HG13 ' A' ' 117' ' ' ILE . 2.6 t-80 -151.69 141.59 22.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.613 -0.267 . . . . 10.0 110.845 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.489 ' HA ' HD12 ' A' ' 117' ' ' ILE . 4.1 tt -62.21 -41.92 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 116.279 -0.419 . . . . 10.0 111.876 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.508 ' HB2' ' OE2' ' A' ' 116' ' ' GLU . 11.2 m -53.67 -17.93 2.61 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.922 0.712 . . . . 10.0 112.922 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.508 ' OE2' ' HB2' ' A' ' 115' ' ' SER . 0.9 OUTLIER -109.74 7.27 24.19 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 122.102 -0.374 . . . . 10.0 111.341 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.489 HD12 ' HA ' ' A' ' 114' ' ' ILE . 66.1 mt -93.48 120.68 43.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.635 -0.505 . . . . 10.0 109.635 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.9 mmmt -124.24 118.57 27.11 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.297 -0.41 . . . . 10.0 110.377 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.448 ' O ' ' HB2' ' A' ' 126' ' ' LEU . 3.9 mm? -95.52 110.73 22.76 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.397 -0.365 . . . . 10.0 110.757 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.647 HD21 HG11 ' B' ' 35' ' ' VAL . 2.7 mm? -101.26 107.36 18.71 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.491 -0.929 . . . . 10.0 108.491 177.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.402 HD13 HD13 ' A' ' 144' ' ' ILE . 5.0 tp -90.94 101.22 13.99 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.713 0.768 . . . . 10.0 109.278 178.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.431 ' HD2' ' HA ' ' A' ' 122' ' ' LYS . 13.5 tptp 52.33 56.34 7.85 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 113.957 -1.474 . . . . 10.0 109.142 -177.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.758 ' HA2' ' SG ' ' C' ' 39' ' ' CYS . . . 79.05 -43.56 2.48 Favored Glycine 0 C--O 1.228 -0.245 0 CA-C-N 114.581 -1.191 . . . . 10.0 112.509 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 22.0 tttp -58.07 119.65 7.17 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.001 -0.6 . . . . 10.0 111.351 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.4 p -72.34 136.38 25.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 113.562 0.949 . . . . 10.0 113.562 -177.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' A' ' 119' ' ' LEU . 1.5 mp -102.31 156.83 17.33 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 114.901 -1.045 . . . . 10.0 109.332 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 62.6 m-70 -116.65 152.73 33.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.061 0.458 . . . . 10.0 110.822 -178.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -52.77 -52.23 57.47 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.575 0.954 . . . . 10.0 113.575 -178.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -89.42 11.05 20.37 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.002 0.371 . . . . 10.0 112.002 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.1 tp -74.03 146.58 43.63 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.905 0.383 . . . . 10.0 111.022 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -106.54 150.56 26.01 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.927 -0.578 . . . . 10.0 110.003 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.537 HD12 ' O ' ' A' ' 93' ' ' SER . 81.4 mt -58.22 -31.73 67.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.015 0.436 . . . . 10.0 111.282 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.1 -33.08 67.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.892 -0.595 . . . . 10.0 111.218 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -77.39 -44.9 27.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.277 -0.42 . . . . 10.0 111.29 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.5 pp -74.08 -25.76 59.99 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.8 -0.36 . . . . 10.0 111.1 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt 65.1 93.01 0.07 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.238 0.542 . . . . 10.0 111.758 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.8 t -71.68 112.24 6.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.975 -0.557 . . . . 10.0 110.06 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.12 125.05 84.29 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.515 -0.311 . . . . 10.0 110.916 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.1 -12.67 36.95 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.068 2.512 . . . . 10.0 112.633 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -82.8 -0.86 49.85 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.241 0.543 . . . . 10.0 110.367 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 55.1 m-20 -131.7 -71.32 0.56 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.629 -0.714 . . . . 10.0 109.271 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 31.9 m 58.16 17.75 4.79 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.491 -0.777 . . . . 10.0 111.649 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.22 124.22 47.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.22 -0.445 . . . . 10.0 110.689 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.402 HD13 HD13 ' A' ' 121' ' ' LEU . 4.5 mm -110.96 124.4 67.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.324 -0.621 . . . . 10.0 109.324 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.54 129.99 34.99 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.684 -0.488 . . . . 10.0 109.684 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 2.2 t -107.65 131.14 58.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.349 0.595 . . . . 10.0 111.252 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' MET . . . . . 0.41 ' SD ' HD23 ' A' ' 120' ' ' LEU . 1.8 mpt? -129.72 125.31 35.63 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.201 -1.037 . . . . 10.0 108.201 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.487 HD13 ' HB2' ' A' ' 111' ' ' ALA . 47.6 mt -135.84 139.4 46.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 116.562 -0.29 . . . . 10.0 110.326 -178.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -101.69 113.72 65.78 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 109.053 -0.721 . . . . 10.0 109.053 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo . . . . . 0 C--O 1.233 0.249 0 C-N-CA 122.387 2.058 . . . . 10.0 112.863 -178.812 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 51.8 p . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 109.898 -0.408 . . . . 10.0 109.898 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . 0.455 ' HB2' ' CE1' ' B' ' 44' ' ' PHE . 7.8 ptpp? -57.81 -41.17 81.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.368 -0.378 . . . . 10.0 110.859 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -59.87 -50.46 73.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 10.0 111.811 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -59.1 -42.37 90.32 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.705 0.288 . . . . 10.0 110.852 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.607 ' O ' HG13 ' B' ' 12' ' ' ILE . 47.8 mm -62.02 -47.5 92.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.77 -0.455 . . . . 10.0 109.77 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.521 ' HA ' HD12 ' B' ' 12' ' ' ILE . . . -57.43 -41.99 81.5 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.75 -0.659 . . . . 10.0 111.053 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.03 -36.9 85.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.108 -0.496 . . . . 10.0 110.597 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 23.9 mt -69.64 -33.52 72.74 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.789 -0.448 . . . . 10.0 109.789 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.607 HG13 ' O ' ' B' ' 8' ' ' ILE . 86.1 mt -64.07 -57.0 13.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.984 -0.553 . . . . 10.0 111.025 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 29.4 m -59.41 -32.84 49.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.21 -0.45 . . . . 10.0 111.274 -178.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -72.19 -46.18 57.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.244 -0.434 . . . . 10.0 110.835 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' TYR . . . . . 0.545 ' O ' HG12 ' B' ' 19' ' ' ILE . 2.1 m-85 -68.89 -46.82 67.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.453 -0.34 . . . . 10.0 111.459 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -55.26 -52.15 64.34 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.683 0.278 . . . . 10.0 111.179 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . 0.506 ' O ' ' HB2' ' B' ' 21' ' ' GLU . 18.8 p -59.53 -38.06 80.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.408 -0.36 . . . . 10.0 111.369 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 76.6 p -74.89 -20.72 59.6 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.073 0.397 . . . . 10.0 112.073 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.545 HG12 ' O ' ' B' ' 15' ' ' TYR . 25.9 mm -80.39 -42.48 21.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.165 0.507 . . . . 10.0 109.808 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 19.5 m -75.92 -27.78 18.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.775 -0.648 . . . . 10.0 110.433 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . 0.506 ' HB2' ' O ' ' B' ' 17' ' ' SER . 2.4 tp10 -70.06 -42.51 72.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.124 -0.489 . . . . 10.0 110.33 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 30.9 mtmt -78.36 -1.68 34.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 10.0 110.755 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 66.6 mmtt 55.73 38.84 30.61 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.745 -0.662 . . . . 10.0 110.847 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.563 ' O ' ' HE2' ' C' ' 5' ' ' LYS . 25.1 mt-10 -90.55 24.31 2.69 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.27 -0.423 . . . . 10.0 111.497 -178.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 17.6 tt -155.31 161.16 2.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.401 -0.363 . . . . 10.0 110.128 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.62 160.42 32.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.471 -0.332 . . . . 10.0 110.524 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -57.89 -46.25 85.2 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 111.738 0.273 . . . . 10.0 111.738 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -56.52 -42.08 77.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.846 0.355 . . . . 10.0 110.301 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.67 -42.67 61.9 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.021 -0.609 . . . . 10.0 111.912 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.85 -36.66 77.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.93 0.395 . . . . 10.0 110.526 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -71.82 -43.01 66.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.791 -0.64 . . . . 10.0 110.139 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 38.5 m -63.12 -38.64 91.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.69 -0.687 . . . . 10.0 110.282 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 92.7 mt -72.79 -39.27 66.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.255 -0.43 . . . . 10.0 110.316 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -61.33 -46.19 91.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.125 -0.489 . . . . 10.0 111.242 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.647 HG11 HD21 ' A' ' 120' ' ' LEU . 13.1 p -71.18 -34.62 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 116.516 -0.311 . . . . 10.0 110.342 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.12 -38.06 87.25 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.458 -0.571 . . . . 10.0 109.458 178.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' MET . . . . . . . . . . . . . 18.0 ttm -57.43 -44.46 84.69 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.688 -0.687 . . . . 10.0 110.01 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -60.88 -45.8 93.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.676 -0.693 . . . . 10.0 110.58 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 76.0 m -62.85 -40.99 99.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.0 -0.546 . . . . 10.0 110.384 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' ILE . . . . . 0.515 HD13 HG21 ' B' ' 12' ' ' ILE . 89.3 mt -65.32 -47.01 88.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.033 -0.53 . . . . 10.0 111.001 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.647 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 48.9 m -59.07 -42.3 90.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.86 0.362 . . . . 10.0 111.064 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -72.48 -39.46 67.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.247 -0.433 . . . . 10.0 111.232 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.59 -43.14 93.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.32 -0.4 . . . . 10.0 111.997 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' PHE . . . . . 0.455 ' CE1' ' HB2' ' B' ' 5' ' ' LYS . 58.0 m-85 -87.08 -4.28 59.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.679 -0.237 . . . . 10.0 111.377 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 62.46 52.22 50.66 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.238 -0.506 . . . . 10.0 113.023 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.647 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 4.7 p90 -146.58 164.46 32.55 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.241 -0.281 . . . . 10.0 110.241 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.99 148.87 21.86 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.436 -0.347 . . . . 10.0 110.496 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.411 ' HG3' ' H ' ' B' ' 48' ' ' ARG . 6.6 mtm180 -65.83 -32.92 74.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.317 0.579 . . . . 10.0 110.611 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -78.75 4.2 14.48 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.416 -0.811 . . . . 10.0 112.269 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.41 3.1 29.42 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.771 0.319 . . . . 10.0 110.386 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.537 HG23 ' H ' ' B' ' 52' ' ' SER . 0.8 OUTLIER -44.97 -64.01 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 115.54 -0.754 . . . . 10.0 112.804 -179.142 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' SER . . . . . 0.537 ' H ' HG23 ' B' ' 51' ' ' VAL . 0.2 OUTLIER -53.49 -30.01 39.05 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.688 0.625 . . . . 10.0 112.688 -179.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.14 -44.61 22.62 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.562 -0.828 . . . . 10.0 112.793 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 48.4 mt -82.58 -46.33 19.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 112.233 0.457 . . . . 10.0 112.233 -178.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 67.3 mt -73.16 -57.31 4.11 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.837 0.351 . . . . 10.0 111.071 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.72 -143.31 45.14 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.591 -0.814 . . . . 10.0 111.468 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 48.7 tttt -109.83 14.03 23.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.187 0.518 . . . . 10.0 110.213 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 5.1 m -79.34 138.54 37.74 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.842 -0.617 . . . . 10.0 110.408 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.323 -0.563 0 CA-C-O 121.049 0.452 . . . . 10.0 110.574 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.256 0 CA-C-O 120.835 0.35 . . . . 10.0 110.652 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 4' ' ' SER . . . . . . . . . . . . . 21.6 p -108.99 167.96 9.71 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.265 -0.425 . . . . 10.0 110.047 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 5' ' ' LYS . . . . . 0.563 ' HE2' ' O ' ' B' ' 24' ' ' GLU . 6.6 ptpp? -55.27 -42.28 73.33 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.445 0.535 . . . . 10.0 112.445 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 6' ' ' GLU . . . . . 0.448 ' H ' ' HG2' ' C' ' 6' ' ' GLU . 5.7 pt-20 -62.64 -38.79 91.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.497 -0.319 . . . . 10.0 111.788 -178.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -76.22 -40.64 51.62 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.619 0.247 . . . . 10.0 110.866 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 8' ' ' ILE . . . . . 0.409 HG13 ' CE1' ' B' ' 15' ' ' TYR . 17.0 mm -60.93 -46.34 96.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.33 -0.395 . . . . 10.0 110.361 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.18 -41.67 97.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.108 -0.496 . . . . 10.0 110.072 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.84 -44.61 95.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.633 -0.712 . . . . 10.0 110.811 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.35 -37.95 89.24 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.041 -0.527 . . . . 10.0 110.934 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 12' ' ' ILE . . . . . 0.405 HD13 ' O ' ' C' ' 8' ' ' ILE . 1.3 mp -68.23 -47.73 76.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.179 -0.464 . . . . 10.0 111.606 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 35.9 m -65.91 -25.16 35.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-O 121.136 0.493 . . . . 10.0 110.175 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.91 -41.91 50.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.925 -0.579 . . . . 10.0 109.778 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 15' ' ' TYR . . . . . 0.527 ' O ' HG12 ' C' ' 19' ' ' ILE . 0.5 OUTLIER -72.59 -37.44 68.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.567 -179.637 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -59.77 -47.84 84.06 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.373 -0.376 . . . . 10.0 110.787 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 17' ' ' SER . . . . . 0.491 ' O ' ' HB2' ' C' ' 21' ' ' GLU . 2.6 p -61.48 -42.42 98.75 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.645 -0.252 . . . . 10.0 110.945 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 2.0 p -68.22 -25.51 65.24 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 111.865 0.32 . . . . 10.0 111.865 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 19' ' ' ILE . . . . . 0.527 HG12 ' O ' ' C' ' 15' ' ' TYR . 20.8 mm -78.65 -42.99 25.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 121.057 0.456 . . . . 10.0 110.448 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 20' ' ' VAL . . . . . . . . . . . . . 16.1 m -77.11 -23.69 14.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.869 0.366 . . . . 10.0 110.267 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' C' ' 17' ' ' SER . 5.0 tp10 -63.51 -51.2 66.53 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.341 -0.614 . . . . 10.0 109.341 178.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -77.01 -5.24 47.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.04 -0.982 . . . . 10.0 111.483 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm 58.03 42.93 21.82 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.317 0.579 . . . . 10.0 109.708 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . 0.445 ' O ' ' HE2' ' B' ' 5' ' ' LYS . 9.0 mt-10 -81.48 3.14 25.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.547 -0.751 . . . . 10.0 110.922 -178.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 18.2 tt -141.88 152.33 18.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 109.415 -0.587 . . . . 10.0 109.415 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.33 161.41 5.61 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 123.426 0.454 . . . . 10.0 111.844 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -54.27 -42.51 70.06 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.376 -0.374 . . . . 10.0 111.113 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.37 -49.9 71.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.774 -0.648 . . . . 10.0 110.493 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 29' ' ' GLY . . . . . 0.669 ' O ' ' HG ' ' C' ' 33' ' ' LEU . . . -68.64 -44.29 72.03 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.696 -0.684 . . . . 10.0 111.979 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.54 -45.67 81.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.87 0.367 . . . . 10.0 111.163 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -62.92 -44.81 95.08 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.969 -0.559 . . . . 10.0 110.076 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 53.5 m -60.59 -40.41 91.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.634 -0.712 . . . . 10.0 110.944 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 33' ' ' LEU . . . . . 0.669 ' HG ' ' O ' ' C' ' 29' ' ' GLY . 34.9 mt -67.16 -36.66 82.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.636 -0.256 . . . . 10.0 110.538 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -58.74 -57.76 11.59 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.083 -0.508 . . . . 10.0 111.013 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 35' ' ' VAL . . . . . . . . . . . . . 3.0 p -65.39 -38.53 82.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.394 -0.366 . . . . 10.0 111.194 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.48 -32.49 70.31 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.636 0.255 . . . . 10.0 110.918 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 49.1 mtm -60.92 -44.04 97.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.244 -0.435 . . . . 10.0 110.702 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 38' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -69.68 -30.96 68.74 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 109.819 -0.438 . . . . 10.0 109.819 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 39' ' ' CYS . . . . . 0.758 ' SG ' ' HA2' ' A' ' 123' ' ' GLY . 32.0 m -63.18 -48.22 79.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.28 0.562 . . . . 10.0 109.642 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 40' ' ' ILE . . . . . . . . . . . . . 66.4 mt -66.76 -45.68 87.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.21 -0.905 . . . . 10.0 110.776 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 41' ' ' SER . . . . . 0.519 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 27.9 m -62.31 -42.12 99.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.83 -0.623 . . . . 10.0 111.7 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -68.04 -39.99 82.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.869 0.366 . . . . 10.0 110.47 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.88 -49.21 78.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.777 -0.647 . . . . 10.0 111.967 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 44' ' ' PHE . . . . . 0.506 ' CE1' ' HB2' ' C' ' 5' ' ' LYS . 86.4 m-85 -88.17 -3.2 58.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.791 0.329 . . . . 10.0 111.477 -179.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.75 64.31 4.42 Favored Glycine 0 C--N 1.331 0.253 0 CA-C-N 116.116 -0.493 . . . . 10.0 113.781 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 46' ' ' PHE . . . . . 0.519 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 13.8 p90 -153.29 157.57 40.32 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.18 -0.304 . . . . 10.0 110.18 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 19.3 mp0 -83.98 137.92 33.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.4 -0.364 . . . . 10.0 110.614 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 48' ' ' ARG . . . . . 0.404 ' H ' ' HG3' ' C' ' 48' ' ' ARG . 7.8 mtm180 -65.78 -36.24 82.96 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.503 0.668 . . . . 10.0 110.229 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -79.95 15.0 1.57 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.114 -0.948 . . . . 10.0 111.782 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -104.15 1.05 30.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.968 0.413 . . . . 10.0 110.596 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 4.1 m -45.72 -42.06 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 113.053 0.76 . . . . 10.0 113.053 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 52' ' ' SER . . . . . . . . . . . . . 1.5 m -58.16 -28.53 64.81 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.325 0.491 . . . . 10.0 112.325 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.41 -28.25 27.95 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.66 -0.781 . . . . 10.0 112.408 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 54' ' ' ILE . . . . . . . . . . . . . 35.3 mt -85.21 -62.13 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.726 0.298 . . . . 10.0 110.913 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 47.5 mt -63.2 -44.31 95.71 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.777 -0.647 . . . . 10.0 110.854 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.34 -132.71 52.09 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.942 -0.647 . . . . 10.0 112.752 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 22.1 tttt -116.96 11.41 14.32 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.931 0.396 . . . . 10.0 110.237 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 2.0 m -78.19 136.81 37.89 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.798 -0.637 . . . . 10.0 110.984 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 59' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' C' ' 59' ' ' GLU . 1.1 pm0 . . . . . 0 N--CA 1.449 -0.51 0 CA-C-O 121.049 0.452 . . . . 10.0 109.879 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.9 t . . . . . 0 N--CA 1.45 -0.462 0 N-CA-C 109.609 -0.515 . . . . 10.0 109.609 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -87.41 125.31 34.19 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.836 0.35 . . . . 10.0 110.181 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 mp -120.94 122.29 39.86 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.679 -0.489 . . . . 10.0 109.679 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.7 m -101.01 113.93 27.39 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 110.089 -0.337 . . . . 10.0 110.089 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.463 ' O ' ' HA ' ' A' ' 87' ' ' SER . 2.8 mm? -88.41 117.73 27.54 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.183 -0.303 . . . . 10.0 110.183 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -114.63 99.19 7.35 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.923 -0.58 . . . . 10.0 109.714 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 85' ' ' LYS . 19.4 tptm -88.39 113.67 24.22 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.827 -0.624 . . . . 10.0 109.963 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 96.0 mt -81.46 -54.73 9.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.65 -0.704 . . . . 10.0 111.215 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -66.67 162.98 19.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.15 -0.477 . . . . 10.0 111.722 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.91 139.09 40.0 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.123 -0.49 . . . . 10.0 111.437 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.404 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 7.9 Cg_exo -75.37 132.11 26.48 Favored 'Cis proline' 0 C--O 1.236 0.382 0 C-N-CA 123.047 -1.647 . . . . 10.0 110.378 -1.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -91.7 159.05 16.04 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.823 0.344 . . . . 10.0 111.458 -178.413 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -176.27 169.42 2.74 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.71 -0.677 . . . . 10.0 109.985 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 70.0 m -146.81 110.25 4.85 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.15 0.5 . . . . 10.0 110.184 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 33.8 pt -122.54 147.63 26.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.862 -0.608 . . . . 10.0 110.915 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -119.23 122.53 42.16 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.969 -0.56 . . . . 10.0 110.044 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -142.52 164.86 28.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.567 -0.288 . . . . 10.0 110.399 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.98 136.31 51.48 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.091 0.472 . . . . 10.0 110.565 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -126.81 170.2 12.43 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.741 -0.663 . . . . 10.0 109.684 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.568 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 5.3 m -92.31 148.27 36.2 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 109.862 -0.422 . . . . 10.0 109.862 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -51.8 -31.01 40.36 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.738 2.292 . . . . 10.0 112.683 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.75 10.84 19.45 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 112.295 0.48 . . . . 10.0 112.295 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.568 ' HB2' ' O ' ' A' ' 93' ' ' SER . 0.5 OUTLIER -81.03 152.72 27.78 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.746 -0.464 . . . . 10.0 109.746 179.111 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.17 154.39 21.26 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.156 -0.474 . . . . 10.0 110.068 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 39.3 mm -63.28 -21.87 29.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.53 0.681 . . . . 10.0 109.364 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.27 -44.04 75.24 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 114.756 -1.111 . . . . 10.0 110.474 178.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -62.79 -41.93 99.48 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.7 -0.682 . . . . 10.0 110.733 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.512 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 49.3 mt -60.64 -48.59 88.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.673 -0.694 . . . . 10.0 109.932 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.407 ' HA ' HD12 ' A' ' 105' ' ' LEU . 84.6 mttt -54.06 -43.79 70.56 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.219 -0.9 . . . . 10.0 111.609 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -62.78 -35.56 80.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.011 0.434 . . . . 10.0 110.589 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.577 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 36.1 t60 -66.08 -37.78 86.64 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.088 -0.505 . . . . 10.0 110.627 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 101' ' ' ILE . 11.3 mt -63.9 -40.12 95.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.208 0.528 . . . . 10.0 110.179 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 32.8 mt -69.97 -38.04 74.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.911 -0.586 . . . . 10.0 109.558 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 32.4 t -66.72 -22.28 66.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.396 -0.82 . . . . 10.0 111.076 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.577 ' HG2' ' O ' ' A' ' 104' ' ' HIS . 19.9 mm-40 -94.08 11.65 29.14 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 121.071 -0.252 . . . . 10.0 110.399 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 58.58 30.09 19.35 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.014 -0.539 . . . . 10.0 111.235 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.5 mmpp? -106.57 -5.67 18.58 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.127 -0.488 . . . . 10.0 110.513 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.613 ' HB2' HD13 ' A' ' 148' ' ' ILE . . . -135.54 154.44 51.38 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.711 -0.677 . . . . 10.0 109.946 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.7 m -107.81 -30.39 8.55 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.914 -0.315 . . . . 10.0 111.624 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.423 ' O ' HG13 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -152.75 136.83 16.41 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.22 -0.289 . . . . 10.0 110.22 -178.694 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.419 ' HA ' HD12 ' A' ' 117' ' ' ILE . 15.8 tt -65.77 -36.24 77.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.567 0.699 . . . . 10.0 109.983 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.533 ' HB2' ' OE2' ' A' ' 116' ' ' GLU . 0.7 OUTLIER -50.23 -34.98 24.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.278 -1.328 . . . . 10.0 113.232 179.398 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.533 ' OE2' ' HB2' ' A' ' 115' ' ' SER . 1.0 OUTLIER -99.08 12.01 37.34 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.402 0.519 . . . . 10.0 112.402 -178.707 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 113' ' ' HIS . 57.0 mt -93.71 121.07 44.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.64 -0.424 . . . . 10.0 110.5 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.1 mmmt -121.79 114.4 21.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.297 -0.41 . . . . 10.0 110.464 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.406 ' HA ' HD13 ' A' ' 119' ' ' LEU . 2.9 mm? -91.4 128.23 37.15 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.976 0.417 . . . . 10.0 111.241 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.643 HD21 HG11 ' B' ' 35' ' ' VAL . 2.8 mm? -116.01 137.43 52.12 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.982 -0.748 . . . . 10.0 108.982 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 16.5 tp -121.06 95.68 4.79 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.26 -1.015 . . . . 10.0 108.26 178.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.436 ' HD2' ' HA ' ' A' ' 122' ' ' LYS . 4.1 tptp 42.36 60.32 2.38 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.11 -0.95 . . . . 10.0 110.584 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.594 ' HA2' ' SG ' ' C' ' 39' ' ' CYS . . . 86.69 -46.05 3.52 Favored Glycine 0 C--N 1.331 0.299 0 CA-C-N 115.792 -0.64 . . . . 10.0 113.238 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.9 tttp -60.46 121.23 11.58 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 120.631 0.253 . . . . 10.0 110.554 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.472 ' HA ' HD13 ' A' ' 120' ' ' LEU . 12.8 p -79.59 136.49 23.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.097 0.475 . . . . 10.0 111.458 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.2 mp -106.03 157.31 17.61 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.041 -0.527 . . . . 10.0 111.202 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.429 ' H ' HD22 ' A' ' 130' ' ' LEU . 85.5 m-70 -116.98 158.5 24.0 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 116.315 -0.402 . . . . 10.0 110.433 -178.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.64 -48.25 82.39 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.491 -0.777 . . . . 10.0 112.143 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -82.97 5.52 21.76 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.93 -0.577 . . . . 10.0 111.162 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.429 HD22 ' H ' ' A' ' 127' ' ' HIS . 4.0 tp -73.84 139.58 45.17 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.114 0.483 . . . . 10.0 111.447 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -102.82 148.8 25.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.382 -0.826 . . . . 10.0 109.641 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 60.4 mt -56.51 -39.11 72.75 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.991 0.367 . . . . 10.0 111.991 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.8 p -75.58 -19.19 59.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.821 0.343 . . . . 10.0 111.076 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -81.28 -42.5 20.55 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.253 -0.43 . . . . 10.0 111.255 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.2 pp -82.62 -22.51 34.71 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 121.084 -0.246 . . . . 10.0 110.876 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt 67.58 88.46 0.11 Allowed 'General case' 0 N--CA 1.463 0.218 0 O-C-N 123.723 0.639 . . . . 10.0 110.755 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 30.8 t -63.72 105.85 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.613 -0.721 . . . . 10.0 110.644 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.79 117.43 35.22 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.895 -0.593 . . . . 10.0 111.403 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -67.85 -11.75 33.11 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.822 2.348 . . . . 10.0 112.718 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -88.69 6.44 38.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.507 0.67 . . . . 10.0 110.014 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -134.97 -66.35 0.59 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.193 -0.912 . . . . 10.0 109.295 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.1 m 52.71 22.92 2.45 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.205 -0.907 . . . . 10.0 112.2 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 36.4 m -123.69 125.72 45.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.05 0.452 . . . . 10.0 110.188 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.27 117.59 55.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 108.292 -1.003 . . . . 10.0 108.292 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.37 126.6 31.38 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.318 -0.623 . . . . 10.0 109.318 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.2 t -99.7 130.75 48.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.89 -0.595 . . . . 10.0 112.095 -177.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -122.64 117.71 26.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.089 -0.96 . . . . 10.0 109.257 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.613 HD13 ' HB2' ' A' ' 111' ' ' ALA . 21.1 mt -138.3 143.73 32.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.503 -0.317 . . . . 10.0 111.175 -177.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -112.2 117.98 46.72 Favored Pre-proline 0 N--CA 1.452 -0.371 0 CA-C-N 116.339 -0.391 . . . . 10.0 110.093 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo . . . . . 0 C--O 1.236 0.39 0 C-N-CA 122.535 2.157 . . . . 10.0 112.653 179.771 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 48.9 p . . . . . 0 N--CA 1.448 -0.565 0 CA-C-O 120.919 0.39 . . . . 10.0 111.008 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -59.38 -44.07 92.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.977 -0.556 . . . . 10.0 111.106 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -61.21 -47.89 84.02 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.317 -0.401 . . . . 10.0 111.133 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -57.29 -41.16 79.25 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.34 -0.391 . . . . 10.0 110.694 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.715 ' O ' HG13 ' B' ' 12' ' ' ILE . 26.0 mm -61.49 -48.43 88.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.787 -0.449 . . . . 10.0 109.787 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.22 -43.37 82.76 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.965 -0.561 . . . . 10.0 111.264 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.8 -34.44 77.91 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.025 -0.534 . . . . 10.0 110.614 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 26.0 mt -71.78 -34.11 69.16 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.164 -0.471 . . . . 10.0 110.282 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.715 HG13 ' O ' ' B' ' 8' ' ' ILE . 21.4 mt -63.5 -52.48 57.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.229 -0.441 . . . . 10.0 110.571 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.529 HG12 ' HG3' ' B' ' 37' ' ' MET . 34.4 m -63.26 -30.51 49.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 116.358 -0.383 . . . . 10.0 111.06 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -68.85 -50.46 49.69 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.969 0.414 . . . . 10.0 110.793 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' TYR . . . . . 0.503 ' O ' HG12 ' B' ' 19' ' ' ILE . 1.7 m-85 -70.66 -36.22 73.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.885 -0.598 . . . . 10.0 111.669 -178.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -61.22 -54.63 41.77 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 121.191 -0.204 . . . . 10.0 111.547 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 12.4 p -60.37 -40.07 89.46 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.712 0.264 . . . . 10.0 111.712 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 4.8 p -70.69 -23.53 62.49 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 111.846 0.313 . . . . 10.0 111.846 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.503 HG12 ' O ' ' B' ' 15' ' ' TYR . 10.8 mm -79.95 -41.57 21.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 120.955 0.407 . . . . 10.0 109.934 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 10.6 m -77.77 -29.01 15.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.842 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . 0.477 ' HA ' ' OE1' ' B' ' 21' ' ' GLU . 3.8 tp10 -70.03 -43.88 70.39 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.616 -0.513 . . . . 10.0 109.616 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -71.32 -8.83 56.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.125 -0.488 . . . . 10.0 110.389 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm 60.36 46.35 10.1 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.692 -0.685 . . . . 10.0 110.131 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.475 ' O ' ' HE2' ' C' ' 5' ' ' LYS . 43.1 mt-10 -96.6 13.32 28.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.139 -0.937 . . . . 10.0 110.471 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 15.0 tt -148.64 154.44 10.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.659 -0.701 . . . . 10.0 109.759 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 1.8 p -67.86 162.73 23.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.485 -0.325 . . . . 10.0 110.926 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 41.5 mp0 -56.09 -46.79 78.92 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.422 -0.354 . . . . 10.0 111.945 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -57.54 -41.22 80.53 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.19 0.519 . . . . 10.0 110.255 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.47 ' O ' ' HG ' ' B' ' 33' ' ' LEU . . . -71.29 -42.43 57.29 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.707 -0.678 . . . . 10.0 111.585 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.25 -44.76 95.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.754 -0.223 . . . . 10.0 111.239 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -69.08 -33.26 73.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.833 0.349 . . . . 10.0 110.59 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 69.4 m -65.03 -42.04 94.69 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.593 -0.521 . . . . 10.0 109.593 178.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' B' ' 29' ' ' GLY . 79.1 mt -72.51 -31.18 65.14 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.438 -0.579 . . . . 10.0 109.438 178.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -62.38 -53.6 52.53 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.463 -0.789 . . . . 10.0 110.985 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.643 HG11 HD21 ' A' ' 120' ' ' LEU . 12.0 p -73.2 -33.73 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 116.363 -0.38 . . . . 10.0 110.654 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . 0.45 ' O ' HG13 ' B' ' 40' ' ' ILE . . . -62.53 -43.49 98.68 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.213 -0.662 . . . . 10.0 109.213 178.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' MET . . . . . 0.529 ' HG3' HG12 ' B' ' 13' ' ' VAL . 15.3 ttm -56.49 -41.6 76.91 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.089 -0.96 . . . . 10.0 110.316 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -62.15 -47.63 83.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.275 -0.875 . . . . 10.0 110.532 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 17.4 m -62.3 -46.89 86.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.937 -0.574 . . . . 10.0 110.82 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' ILE . . . . . 0.45 HG13 ' O ' ' B' ' 36' ' ' ALA . 58.3 mt -60.35 -38.44 77.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.171 -0.468 . . . . 10.0 110.757 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.615 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 0.1 OUTLIER -59.85 -47.37 86.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 10.0 110.99 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -77.69 -23.49 49.54 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.495 -0.321 . . . . 10.0 111.39 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.21 -39.35 92.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.443 -0.344 . . . . 10.0 111.124 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -100.92 2.57 40.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.197 -0.456 . . . . 10.0 111.093 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 62.2 55.67 26.51 Favored Glycine 0 CA--C 1.519 0.289 0 CA-C-N 115.859 -0.61 . . . . 10.0 113.599 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.615 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 6.6 p90 -149.37 160.78 43.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 117.079 0.44 . . . . 10.0 110.541 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.86 150.84 20.28 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.792 -0.448 . . . . 10.0 109.792 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 1.4 mtm180 -63.8 -28.63 69.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.226 0.536 . . . . 10.0 110.73 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -78.31 7.86 5.85 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.787 -0.642 . . . . 10.0 111.691 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.32 2.89 55.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.013 0.435 . . . . 10.0 110.502 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.545 HG23 ' H ' ' B' ' 52' ' ' SER . 1.5 m -47.29 -64.02 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.248 -0.887 . . . . 10.0 112.792 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' SER . . . . . 0.545 ' H ' HG23 ' B' ' 51' ' ' VAL . 0.8 OUTLIER -56.33 -36.38 68.67 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.675 0.62 . . . . 10.0 112.675 -179.201 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.79 -44.99 60.23 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.818 -0.706 . . . . 10.0 112.906 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 57.8 mt -78.3 -50.44 19.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.856 0.36 . . . . 10.0 111.618 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 41.4 mt -71.18 -51.74 23.13 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.233 -0.44 . . . . 10.0 111.504 -178.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.94 -145.74 50.14 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.582 -0.818 . . . . 10.0 111.292 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 38.7 tttt -97.98 -8.98 26.89 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.005 0.431 . . . . 10.0 110.287 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.54 123.74 18.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.402 -0.817 . . . . 10.0 111.718 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 . . . . . 0 C--N 1.323 -0.564 0 CA-C-N 115.708 -0.678 . . . . 10.0 110.378 179.197 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 120.551 0.215 . . . . 10.0 110.592 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 4' ' ' SER . . . . . 0.547 ' O ' HG12 ' C' ' 8' ' ' ILE . 33.3 p -102.78 166.28 10.57 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.355 -0.384 . . . . 10.0 110.729 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 5' ' ' LYS . . . . . 0.475 ' HE2' ' O ' ' B' ' 24' ' ' GLU . 10.1 ptpp? -59.5 -39.56 84.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.246 -0.433 . . . . 10.0 110.916 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 6' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -60.87 -45.25 95.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 10.0 110.719 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -65.6 -37.36 86.4 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.304 -0.407 . . . . 10.0 110.588 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 8' ' ' ILE . . . . . 0.547 HG12 ' O ' ' C' ' 4' ' ' SER . 38.6 mm -64.85 -45.69 94.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 10.0 110.084 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.89 -45.9 85.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.918 -0.583 . . . . 10.0 110.222 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.33 -37.56 87.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.603 -0.726 . . . . 10.0 111.264 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 2.2 mt -68.33 -44.77 74.62 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.836 0.35 . . . . 10.0 110.977 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 12' ' ' ILE . . . . . . . . . . . . . 1.4 mp -63.03 -45.9 97.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.76 -0.654 . . . . 10.0 111.521 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 28.8 m -66.61 -27.76 41.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-O 120.919 0.39 . . . . 10.0 110.612 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 14' ' ' ASN . . . . . 0.428 ' HB2' HG11 ' C' ' 51' ' ' VAL . 0.3 OUTLIER -74.18 -44.03 54.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.029 -0.532 . . . . 10.0 110.358 178.909 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 15' ' ' TYR . . . . . 0.549 ' O ' HG12 ' C' ' 19' ' ' ILE . 1.1 m-85 -68.04 -37.15 81.01 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.482 -0.326 . . . . 10.0 110.298 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 5.9 m-30 -58.31 -51.33 70.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.397 -0.365 . . . . 10.0 110.657 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 1.5 p -62.44 -38.5 89.98 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.865 -0.607 . . . . 10.0 111.542 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 11.7 p -71.11 -21.33 62.23 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.743 0.306 . . . . 10.0 111.419 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 19' ' ' ILE . . . . . 0.549 HG12 ' O ' ' C' ' 15' ' ' TYR . 25.2 mm -85.71 -44.56 17.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 CA-C-O 120.941 0.4 . . . . 10.0 111.143 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 20' ' ' VAL . . . . . . . . . . . . . 35.5 m -72.66 -32.64 41.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.202 -0.454 . . . . 10.0 111.721 -177.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . 0.483 ' HA ' ' OE1' ' C' ' 21' ' ' GLU . 1.1 tp10 -78.6 -18.81 54.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.864 0.364 . . . . 10.0 111.098 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -95.19 -6.26 42.06 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.718 -0.475 . . . . 10.0 109.718 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm 59.11 50.81 7.66 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.355 -0.839 . . . . 10.0 110.916 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -98.62 4.2 47.99 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.541 -0.754 . . . . 10.0 111.27 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 19.9 tt -143.73 153.66 16.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.936 -0.394 . . . . 10.0 109.936 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.82 162.41 13.61 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.415 -0.357 . . . . 10.0 111.386 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -56.23 -40.74 74.59 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.182 -0.463 . . . . 10.0 111.585 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.38 -48.07 77.61 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.385 0.612 . . . . 10.0 109.96 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 29' ' ' GLY . . . . . 0.595 ' O ' ' HG ' ' C' ' 33' ' ' LEU . . . -70.33 -38.31 70.85 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.314 -0.857 . . . . 10.0 112.224 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.17 -46.79 79.19 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.52 0.2 . . . . 10.0 111.273 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -66.7 -39.29 88.02 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.823 -0.436 . . . . 10.0 109.823 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 50.7 m -59.0 -39.17 81.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.7 -0.682 . . . . 10.0 110.218 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 33' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' C' ' 29' ' ' GLY . 52.1 mt -75.68 -27.78 58.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.013 -0.539 . . . . 10.0 110.179 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -71.08 -49.92 39.33 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 116.07 -0.513 . . . . 10.0 110.816 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 35' ' ' VAL . . . . . 0.462 HG23 ' H ' ' A' ' 123' ' ' GLY . 8.9 p -67.01 -43.32 89.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-N 116.573 -0.285 . . . . 10.0 111.272 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' C' ' 39' ' ' CYS . . . -63.82 -30.99 72.02 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.886 0.374 . . . . 10.0 111.246 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 37' ' ' MET . . . . . 0.437 ' HB2' ' O ' ' C' ' 33' ' ' LEU . 26.7 ttm -59.01 -49.79 76.54 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.091 -0.504 . . . . 10.0 110.545 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 38' ' ' ASP . . . . . 0.559 ' CB ' ' HA3' ' A' ' 123' ' ' GLY . 15.2 m-20 -68.61 -26.15 65.22 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.968 -0.56 . . . . 10.0 110.623 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 39' ' ' CYS . . . . . 0.594 ' SG ' ' HA2' ' A' ' 123' ' ' GLY . 84.9 m -58.49 -46.35 86.84 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.515 0.674 . . . . 10.0 109.534 178.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 40' ' ' ILE . . . . . . . . . . . . . 6.6 mt -73.06 -39.73 57.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.244 -0.889 . . . . 10.0 110.346 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 41' ' ' SER . . . . . 0.533 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 19.7 m -60.45 -44.39 95.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.618 -0.719 . . . . 10.0 111.863 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -71.79 -41.07 68.77 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.896 -0.322 . . . . 10.0 110.772 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.75 -40.22 91.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.328 -0.396 . . . . 10.0 111.679 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 44' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -90.98 -10.73 41.28 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.52 -0.309 . . . . 10.0 111.166 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 66.22 47.85 68.94 Favored Glycine 0 CA--C 1.517 0.188 0 C-N-CA 121.238 -0.506 . . . . 10.0 112.711 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 46' ' ' PHE . . . . . 0.533 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 3.3 p90 -142.62 156.75 45.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.795 0.331 . . . . 10.0 110.6 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -89.01 142.33 27.73 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.085 -0.507 . . . . 10.0 110.133 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 48' ' ' ARG . . . . . 0.511 ' O ' HG13 ' C' ' 51' ' ' VAL . 0.1 OUTLIER -61.41 -33.52 73.84 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.128 0.489 . . . . 10.0 111.202 -179.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 49' ' ' GLU . . . . . 0.401 ' H ' ' CD ' ' C' ' 49' ' ' GLU . 1.7 pm0 -76.95 8.58 3.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.726 -0.67 . . . . 10.0 112.169 -179.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.18 1.36 57.26 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.059 0.456 . . . . 10.0 110.684 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 51' ' ' VAL . . . . . 0.511 HG13 ' O ' ' C' ' 48' ' ' ARG . 5.9 m -46.53 -46.46 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 115.282 -0.872 . . . . 10.0 112.902 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.36 -35.12 64.91 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.499 0.555 . . . . 10.0 112.499 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.9 -34.79 23.52 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.547 -0.835 . . . . 10.0 113.248 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 54' ' ' ILE . . . . . . . . . . . . . 56.1 mt -80.84 -59.17 3.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.943 0.401 . . . . 10.0 111.175 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 36.1 mt -67.12 -49.51 64.64 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.246 -0.433 . . . . 10.0 111.078 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.13 -135.3 45.83 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.993 -0.622 . . . . 10.0 112.654 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 8.9 tttt -105.45 -5.67 20.12 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.122 0.487 . . . . 10.0 110.003 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.21 130.26 44.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.667 -0.697 . . . . 10.0 111.408 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 . . . . . 0 N--CA 1.449 -0.516 0 CA-C-O 120.992 0.425 . . . . 10.0 109.946 179.318 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.3 t . . . . . 0 N--CA 1.451 -0.408 0 N-CA-C 110.278 -0.267 . . . . 10.0 110.278 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -93.79 125.31 38.34 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.539 -0.464 . . . . 10.0 110.504 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.6 mp -127.93 139.85 52.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.812 -0.631 . . . . 10.0 110.744 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.2 m -102.43 115.36 30.41 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.136 -0.484 . . . . 10.0 110.146 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 87' ' ' SER . 2.2 mm? -85.91 110.45 19.44 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.795 -0.446 . . . . 10.0 109.795 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 51.4 tttt -108.9 102.56 11.56 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.215 -0.448 . . . . 10.0 111.267 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.549 ' HG2' ' O ' ' A' ' 84' ' ' PRO . 17.8 tptm -95.88 106.13 18.23 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.952 0.406 . . . . 10.0 110.097 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 91.9 mt -73.43 -55.94 11.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.512 -0.767 . . . . 10.0 111.548 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -70.19 164.54 24.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.405 -0.361 . . . . 10.0 110.88 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.496 ' HA ' ' C ' ' A' ' 84' ' ' PRO . . . -83.75 143.2 43.27 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 111.678 0.251 . . . . 10.0 111.678 -178.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.549 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 10.8 Cg_exo -69.14 128.37 11.81 Favored 'Cis proline' 0 C--N 1.347 0.495 0 C-N-CA 123.019 -1.659 . . . . 10.0 110.585 -1.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.459 ' N ' ' HA ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -86.77 148.08 25.57 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.418 -0.355 . . . . 10.0 111.204 -178.618 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -170.73 166.0 7.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.074 -0.512 . . . . 10.0 110.065 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.432 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 38.6 m -150.39 106.31 3.43 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.585 -0.524 . . . . 10.0 109.585 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 43.9 pt -126.86 158.88 37.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.314 -0.403 . . . . 10.0 111.058 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -121.39 139.82 52.94 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.506 -0.553 . . . . 10.0 109.506 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -149.61 165.01 33.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.883 0.373 . . . . 10.0 111.357 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -110.39 124.64 52.09 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.665 -0.698 . . . . 10.0 109.863 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -118.45 171.04 8.43 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.994 -0.548 . . . . 10.0 110.512 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.582 ' O ' HD12 ' A' ' 132' ' ' LEU . 1.5 m -80.15 144.87 59.39 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.424 -0.353 . . . . 10.0 110.368 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -59.04 -15.11 26.19 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.815 2.343 . . . . 10.0 112.332 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.0 t -119.21 19.98 12.72 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 116.244 -0.435 . . . . 10.0 110.434 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 93' ' ' SER . 0.3 OUTLIER -73.15 164.7 26.31 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.149 0.499 . . . . 10.0 111.182 -179.163 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.04 147.76 35.32 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.763 -0.653 . . . . 10.0 110.429 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 38.3 mm -58.83 -24.83 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 121.518 0.675 . . . . 10.0 110.49 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.39 -39.08 60.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.912 -1.04 . . . . 10.0 111.185 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 72.7 mm-40 -66.28 -39.9 89.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 10.0 110.978 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.652 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 18.0 mt -65.01 -51.05 71.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.171 -0.468 . . . . 10.0 109.956 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 9.0 mttm -54.97 -50.46 68.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.496 -0.774 . . . . 10.0 111.759 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -62.49 -32.01 72.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.653 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.41 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 15.9 t60 -67.66 -39.17 84.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.048 -0.524 . . . . 10.0 109.999 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 101' ' ' ILE . 28.2 mt -59.71 -39.58 85.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.056 -0.52 . . . . 10.0 110.293 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 16.6 mt -72.91 -34.37 46.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 116.022 -0.536 . . . . 10.0 110.159 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.8 t -64.78 -22.79 67.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.794 -0.639 . . . . 10.0 111.128 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 104' ' ' HIS . 16.3 mm-40 -100.09 7.28 44.76 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.828 -0.434 . . . . 10.0 109.828 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 60.21 31.62 20.56 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.687 -0.688 . . . . 10.0 111.172 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -101.56 -9.22 21.19 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.385 -0.598 . . . . 10.0 109.385 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.13 148.17 52.11 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.105 -0.952 . . . . 10.0 109.96 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.34 -55.74 3.19 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.806 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.569 ' O ' HG13 ' A' ' 117' ' ' ILE . 32.7 m170 -131.39 139.12 49.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.667 -0.242 . . . . 10.0 110.949 -179.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.476 ' HA ' HD12 ' A' ' 117' ' ' ILE . 4.5 tt -64.87 -44.34 96.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.362 0.601 . . . . 10.0 110.405 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 16.3 t -52.31 -33.34 41.92 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.903 -1.044 . . . . 10.0 111.73 178.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -93.27 16.01 14.2 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.32 0.489 . . . . 10.0 112.32 -177.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.569 HG13 ' O ' ' A' ' 113' ' ' HIS . 55.2 mt -106.66 123.52 61.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.346 -0.388 . . . . 10.0 110.188 178.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -120.11 116.59 25.99 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.659 -0.497 . . . . 10.0 109.659 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -94.34 123.48 37.77 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.739 0.304 . . . . 10.0 110.216 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.502 HD21 HG11 ' B' ' 35' ' ' VAL . 2.8 mm? -109.21 141.1 41.96 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.193 -0.669 . . . . 10.0 109.193 179.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 24.7 tp -126.1 98.33 5.45 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.145 -1.057 . . . . 10.0 108.145 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 11.1 tptp 46.49 51.62 11.65 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.497 0.665 . . . . 10.0 110.246 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.64 ' HA3' ' CB ' ' C' ' 38' ' ' ASP . . . 89.72 -44.14 3.01 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.231 -0.895 . . . . 10.0 113.384 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.405 ' HZ2' ' CD ' ' C' ' 42' ' ' GLU . 0.4 OUTLIER -59.09 129.77 43.77 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.489 0.185 . . . . 10.0 110.88 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.448 ' HA ' HD13 ' A' ' 120' ' ' LEU . 8.8 p -82.61 139.29 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.136 0.493 . . . . 10.0 112.102 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 4.4 mp -112.46 154.37 25.95 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 115.654 -0.703 . . . . 10.0 111.055 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -117.16 159.48 22.54 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 121.763 -0.586 . . . . 10.0 112.208 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.38 -51.69 67.38 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.212 1.005 . . . . 10.0 112.229 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -83.18 6.94 17.6 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.3 -0.863 . . . . 10.0 112.194 -177.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.2 tp -79.77 148.69 31.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.928 0.394 . . . . 10.0 111.308 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -109.62 151.77 26.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.803 -0.635 . . . . 10.0 110.33 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.582 HD12 ' O ' ' A' ' 93' ' ' SER . 79.5 mt -59.09 -37.13 76.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 10.0 111.96 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.72 -17.53 60.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.086 0.47 . . . . 10.0 111.221 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -88.98 -40.06 13.29 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.176 -0.465 . . . . 10.0 110.958 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.432 HD11 HG22 ' A' ' 137' ' ' VAL . 3.0 pp -82.41 -26.44 32.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.612 -0.267 . . . . 10.0 111.301 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 26.2 mtmt 64.7 96.1 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 O-C-N 123.887 0.742 . . . . 10.0 111.131 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.432 HG22 HD11 ' A' ' 135' ' ' LEU . 6.8 t -71.83 121.03 21.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.86 -0.609 . . . . 10.0 110.632 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.76 119.73 65.75 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 10.0 110.723 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -58.72 -34.5 98.99 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.924 2.416 . . . . 10.0 113.531 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -84.41 15.84 3.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.019 0.438 . . . . 10.0 111.47 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -128.26 -74.14 0.58 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.977 -0.556 . . . . 10.0 109.853 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.2 m 58.58 9.89 1.24 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.792 -0.64 . . . . 10.0 112.639 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.8 m -109.24 123.82 49.87 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.321 0.582 . . . . 10.0 111.326 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 14.7 mm -107.61 119.23 56.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.479 -0.782 . . . . 10.0 109.984 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.4 124.53 30.75 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.856 0.36 . . . . 10.0 110.359 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.6 t -99.48 124.63 52.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.935 -0.575 . . . . 10.0 111.282 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' MET . . . . . 0.431 ' SD ' HD23 ' A' ' 120' ' ' LEU . 2.0 mpt? -122.67 121.69 37.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.884 -0.598 . . . . 10.0 110.633 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 22.0 mt -137.74 142.23 36.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.609 -0.269 . . . . 10.0 111.027 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.486 ' HD3' ' HD2' ' A' ' 150' ' ' PRO . 0.4 OUTLIER -125.99 107.86 25.08 Favored Pre-proline 0 N--CA 1.454 -0.274 0 N-CA-C 109.943 -0.391 . . . . 10.0 109.943 178.282 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.486 ' HD2' ' HD3' ' A' ' 149' ' ' LYS . 19.4 Cg_endo . . . . . 0 C--N 1.349 0.554 0 C-N-CA 122.889 2.393 . . . . 10.0 113.067 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.45 -0.432 0 N-CA-C 109.44 -0.578 . . . . 10.0 109.44 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -56.52 -46.56 80.53 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.248 -0.433 . . . . 10.0 111.438 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -56.64 -53.33 58.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.515 . . . . 10.0 112.033 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -57.24 -46.17 83.25 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.252 0.345 . . . . 10.0 110.814 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.41 ' HA ' HD13 ' B' ' 8' ' ' ILE . 17.2 mm -59.22 -45.9 92.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 10.0 110.41 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.571 ' HA ' HD12 ' B' ' 12' ' ' ILE . . . -60.64 -43.62 97.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.996 -0.547 . . . . 10.0 111.027 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.25 -36.11 82.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.035 -0.53 . . . . 10.0 110.616 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 17.7 mt -64.95 -36.25 83.79 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.343 0.592 . . . . 10.0 109.566 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.571 HD12 ' HA ' ' B' ' 9' ' ' ALA . 14.5 mt -61.42 -57.68 11.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.057 -0.974 . . . . 10.0 110.965 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.471 HG21 ' HA ' ' B' ' 48' ' ' ARG . 16.5 m -62.33 -25.98 39.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.989 0.423 . . . . 10.0 110.61 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -69.61 -51.53 34.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.777 -0.647 . . . . 10.0 110.657 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' TYR . . . . . 0.491 ' O ' HG12 ' B' ' 19' ' ' ILE . 2.3 m-85 -72.99 -39.67 65.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 10.0 111.844 -178.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -56.03 -50.85 69.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.67 0.271 . . . . 10.0 110.353 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 4.6 p -59.04 -46.32 88.52 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.654 -0.248 . . . . 10.0 111.338 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 6.7 p -65.06 -20.5 66.51 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.148 0.425 . . . . 10.0 112.148 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.491 HG12 ' O ' ' B' ' 15' ' ' TYR . 29.3 mm -85.05 -43.46 16.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 121.074 0.464 . . . . 10.0 110.349 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 35.2 m -75.97 -29.04 19.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.201 -0.454 . . . . 10.0 110.532 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . 0.534 ' HA ' ' OE1' ' B' ' 21' ' ' GLU . 1.8 tp10 -75.67 -34.79 60.48 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.269 -0.423 . . . . 10.0 110.766 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -81.86 -5.12 57.97 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.825 0.345 . . . . 10.0 110.446 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 34.0 mmtt 59.3 52.65 5.83 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.529 -0.759 . . . . 10.0 111.046 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -108.13 16.34 23.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.807 -0.633 . . . . 10.0 111.802 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -147.19 151.77 13.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 116.199 -0.455 . . . . 10.0 110.14 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 10.5 p -60.82 161.94 7.43 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.277 -0.419 . . . . 10.0 111.435 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -60.0 -49.68 76.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.074 0.464 . . . . 10.0 110.887 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.55 -42.97 93.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.427 -0.806 . . . . 10.0 110.003 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.13 -39.51 92.66 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.767 -0.73 . . . . 10.0 111.975 178.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.0 -44.55 97.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.875 0.369 . . . . 10.0 110.357 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -65.24 -35.59 81.51 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.374 -0.602 . . . . 10.0 109.374 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 47.9 m -60.95 -44.18 97.65 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 115.824 -0.625 . . . . 10.0 109.747 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 69.7 mt -72.11 -36.51 69.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.075 0.464 . . . . 10.0 110.044 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 12.7 t30 -60.02 -48.69 80.65 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.745 -0.662 . . . . 10.0 111.531 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.502 HG11 HD21 ' A' ' 120' ' ' LEU . 8.4 p -72.86 -35.61 49.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 120.85 0.357 . . . . 10.0 110.755 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.53 -39.36 93.62 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.534 -0.543 . . . . 10.0 109.534 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' MET . . . . . . . . . . . . . 24.1 ttm -57.79 -45.55 85.88 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.352 -0.84 . . . . 10.0 110.15 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -61.91 -42.13 98.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.562 -0.744 . . . . 10.0 110.801 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' CYS . . . . . 0.411 ' SG ' ' HG2' ' A' ' 147' ' ' MET . 59.3 m -63.43 -40.91 98.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.068 -0.514 . . . . 10.0 110.857 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' ILE . . . . . 0.557 HD13 HG21 ' B' ' 12' ' ' ILE . 55.0 mt -67.3 -40.35 84.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 110.144 -0.317 . . . . 10.0 110.144 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.644 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 9.7 m -63.1 -39.13 93.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.105 0.479 . . . . 10.0 110.081 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -70.86 -45.36 64.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.627 -0.715 . . . . 10.0 110.491 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.56 -48.66 78.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.539 -0.755 . . . . 10.0 112.547 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -83.42 -2.47 55.92 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.902 -0.319 . . . . 10.0 111.496 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 57.69 58.89 12.23 Favored Glycine 0 CA--C 1.518 0.236 0 CA-C-N 116.125 -0.489 . . . . 10.0 113.54 178.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.644 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 9.1 p90 -148.78 170.94 17.1 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.968 -0.382 . . . . 10.0 109.968 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -105.7 146.21 30.08 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.147 -0.316 . . . . 10.0 110.147 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.471 ' HA ' HG21 ' B' ' 13' ' ' VAL . 1.3 mtm180 -71.55 -26.87 62.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.278 0.561 . . . . 10.0 110.507 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -82.92 14.95 2.95 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.655 -0.702 . . . . 10.0 111.306 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -104.51 4.13 32.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.64 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -41.12 -63.52 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 114.011 1.115 . . . . 10.0 114.011 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 1.9 m -53.9 -31.86 51.46 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.578 0.584 . . . . 10.0 112.578 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.33 -41.68 30.15 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.986 -0.626 . . . . 10.0 113.352 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 19.6 mt -83.01 -43.54 18.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.999 0.428 . . . . 10.0 111.45 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 57.1 mt -71.52 -56.71 5.38 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.052 -0.522 . . . . 10.0 111.017 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.97 -150.38 45.9 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.692 -0.766 . . . . 10.0 111.298 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 32.8 tttt -103.8 2.5 32.9 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.357 0.599 . . . . 10.0 109.734 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.69 131.89 47.43 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.102 -0.954 . . . . 10.0 111.747 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.983 -0.553 . . . . 10.0 109.946 179.155 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.313 0 CA-C-O 120.823 0.344 . . . . 10.0 111.551 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 4' ' ' SER . . . . . 0.52 ' O ' HG12 ' C' ' 8' ' ' ILE . 23.0 p -98.3 163.68 12.62 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.339 -0.391 . . . . 10.0 110.213 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -57.76 -35.39 70.69 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 110.521 -0.178 . . . . 10.0 110.521 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 6' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -60.25 -49.67 76.7 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.219 0.533 . . . . 10.0 109.651 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -62.71 -42.32 99.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.365 -0.834 . . . . 10.0 110.817 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 8' ' ' ILE . . . . . 0.52 HG12 ' O ' ' C' ' 4' ' ' SER . 39.4 mm -59.15 -46.1 92.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.99 -0.55 . . . . 10.0 110.171 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 9' ' ' ALA . . . . . 0.438 ' HB1' ' CE1' ' C' ' 46' ' ' PHE . . . -59.82 -43.66 94.4 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.086 -0.506 . . . . 10.0 110.554 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.91 -40.36 94.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.025 -0.534 . . . . 10.0 111.086 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 22.3 mt -65.15 -40.47 94.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.031 -0.531 . . . . 10.0 109.76 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 12' ' ' ILE . . . . . . . . . . . . . 1.2 mp -63.15 -47.86 90.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.187 -0.915 . . . . 10.0 111.869 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 34.1 m -71.09 -25.49 25.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.669 -0.412 . . . . 10.0 111.448 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -73.27 -40.59 64.46 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.063 0.459 . . . . 10.0 109.987 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 15' ' ' TYR . . . . . 0.544 ' O ' HG12 ' C' ' 19' ' ' ILE . 9.1 m-85 -71.74 -42.85 66.76 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.12 -0.491 . . . . 10.0 110.849 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -54.27 -49.48 69.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.737 0.304 . . . . 10.0 110.508 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 17' ' ' SER . . . . . 0.496 ' O ' ' HB2' ' C' ' 21' ' ' GLU . 2.2 p -61.97 -41.66 98.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.139 -0.482 . . . . 10.0 111.4 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 3.6 p -69.36 -22.51 63.73 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 120.617 -0.433 . . . . 10.0 111.843 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 19' ' ' ILE . . . . . 0.544 HG12 ' O ' ' C' ' 15' ' ' TYR . 37.7 mm -80.83 -41.1 19.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 109.8 -0.444 . . . . 10.0 109.8 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 20' ' ' VAL . . . . . . . . . . . . . 16.8 m -77.85 -18.65 13.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.171 -0.677 . . . . 10.0 109.171 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' C' ' 17' ' ' SER . 4.1 tp10 -73.47 -50.67 20.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.551 -0.749 . . . . 10.0 110.734 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -84.07 1.09 45.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.368 -0.378 . . . . 10.0 111.782 -178.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 34.3 mmtt 55.79 46.83 21.6 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.162 0.506 . . . . 10.0 110.234 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -83.41 1.13 43.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.962 -0.563 . . . . 10.0 111.376 -178.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 16.0 tt -142.96 161.2 17.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.36 -0.607 . . . . 10.0 109.36 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 5.3 p -59.95 156.29 14.9 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.182 0.301 . . . . 10.0 110.607 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -60.76 -23.6 65.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.02 0.438 . . . . 10.0 110.337 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 28' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -68.39 -54.09 19.5 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.066 -0.716 . . . . 10.0 109.066 178.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 29' ' ' GLY . . . . . 0.42 ' O ' ' HG ' ' C' ' 33' ' ' LEU . . . -65.82 -33.05 84.74 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.318 -0.855 . . . . 10.0 110.984 178.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.72 -42.84 94.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.968 0.413 . . . . 10.0 110.441 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -68.02 -38.03 82.11 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.264 -0.643 . . . . 10.0 109.264 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 6.0 m -61.0 -43.48 98.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.407 -0.815 . . . . 10.0 110.046 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 33' ' ' LEU . . . . . 0.438 ' O ' ' HB2' ' C' ' 37' ' ' MET . 87.6 mt -71.05 -25.38 62.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.051 0.453 . . . . 10.0 110.373 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -72.25 -52.97 13.97 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.056 -0.52 . . . . 10.0 111.004 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 35' ' ' VAL . . . . . 0.53 HG23 ' H ' ' A' ' 123' ' ' GLY . 7.6 p -69.21 -39.6 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 116.421 -0.354 . . . . 10.0 110.49 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . 0.56 ' O ' HD12 ' C' ' 40' ' ' ILE . . . -63.75 -32.25 73.69 Favored 'General case' 0 C--O 1.226 -0.163 0 CA-C-O 120.448 0.166 . . . . 10.0 110.661 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 37' ' ' MET . . . . . 0.438 ' HB2' ' O ' ' C' ' 33' ' ' LEU . 30.6 ttm -53.92 -52.44 60.59 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.178 0.513 . . . . 10.0 110.879 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 38' ' ' ASP . . . . . 0.64 ' CB ' ' HA3' ' A' ' 123' ' ' GLY . 1.7 m-20 -70.73 -26.44 63.39 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 116.176 -0.465 . . . . 10.0 111.124 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 39' ' ' CYS . . . . . 0.505 ' SG ' ' HA2' ' A' ' 123' ' ' GLY . 77.5 m -61.09 -42.24 98.15 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.773 -0.825 . . . . 10.0 108.773 177.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 40' ' ' ILE . . . . . 0.56 HD12 ' O ' ' C' ' 36' ' ' ALA . 1.4 mp -70.99 -40.74 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 115.097 -0.956 . . . . 10.0 109.891 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 41' ' ' SER . . . . . 0.638 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 13.4 m -60.18 -43.9 95.51 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.686 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 42' ' ' GLU . . . . . 0.405 ' CD ' ' HZ2' ' A' ' 124' ' ' LYS . 13.4 tt0 -72.2 -42.07 66.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.187 -0.461 . . . . 10.0 111.448 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.77 -48.46 75.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.286 -0.416 . . . . 10.0 111.626 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 44' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -88.96 -1.17 57.98 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.479 -0.328 . . . . 10.0 111.378 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 59.02 57.92 17.29 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.352 -0.451 . . . . 10.0 113.184 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 46' ' ' PHE . . . . . 0.638 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 4.3 p90 -145.65 156.36 43.6 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.989 0.395 . . . . 10.0 110.172 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 26.1 mp0 -81.84 128.04 33.62 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.488 -0.324 . . . . 10.0 110.302 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.5 -17.13 58.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.55 -0.295 . . . . 10.0 111.667 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -85.15 -2.53 58.13 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 122.321 0.249 . . . . 10.0 111.583 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.8 4.96 30.59 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.763 0.653 . . . . 10.0 112.763 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 51' ' ' VAL . . . . . 0.437 HG23 ' H ' ' C' ' 52' ' ' SER . 3.6 m -42.98 -57.36 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 114.427 1.269 . . . . 10.0 114.427 -178.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 52' ' ' SER . . . . . 0.437 ' H ' HG23 ' C' ' 51' ' ' VAL . 1.2 m -61.31 -18.92 60.91 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.874 0.694 . . . . 10.0 112.874 -178.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.39 -48.59 4.99 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.809 -0.71 . . . . 10.0 112.953 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 54' ' ' ILE . . . . . . . . . . . . . 64.3 mt -74.66 -45.73 43.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.936 0.398 . . . . 10.0 110.311 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 45.7 mt -71.84 -47.82 50.45 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.178 0.513 . . . . 10.0 109.979 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 56.57 -137.0 48.83 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.373 -0.83 . . . . 10.0 112.371 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -111.6 24.07 13.19 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.954 -0.758 . . . . 10.0 108.954 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 6.8 m -91.7 139.92 30.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.181 -0.918 . . . . 10.0 111.006 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.324 -0.539 0 CA-C-N 116.165 -0.471 . . . . 10.0 109.84 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.6 t . . . . . 0 N--CA 1.457 -0.122 0 CA-C-O 120.594 0.235 . . . . 10.0 110.684 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -86.2 127.46 34.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.58 -0.282 . . . . 10.0 110.381 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.2 mp -127.29 129.76 48.3 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.449 -0.341 . . . . 10.0 110.5 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 20.5 m -101.32 114.18 27.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.866 -0.606 . . . . 10.0 110.402 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.489 ' O ' ' HA ' ' A' ' 87' ' ' SER . 2.0 mm? -90.54 126.1 35.82 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.727 -0.472 . . . . 10.0 109.727 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.6 tttp -130.21 106.78 8.82 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.491 -0.322 . . . . 10.0 110.746 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 82' ' ' GLN . 47.0 tttm -93.71 110.39 22.02 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.959 -0.385 . . . . 10.0 109.959 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 63.5 mt -74.92 -34.33 32.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 115.381 -0.827 . . . . 10.0 111.312 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.413 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 71.6 mt-30 -83.24 156.13 23.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.344 -0.389 . . . . 10.0 110.418 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.431 ' HA ' ' C ' ' A' ' 84' ' ' PRO . . . -78.54 138.93 58.8 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.458 -0.337 . . . . 10.0 111.421 -178.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.431 ' C ' ' HA ' ' A' ' 83' ' ' ALA . 17.0 Cg_exo -70.29 131.63 20.5 Favored 'Cis proline' 0 C--N 1.347 0.488 0 C-N-CA 123.613 -1.411 . . . . 10.0 112.137 -1.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -83.64 148.2 27.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.275 -0.42 . . . . 10.0 110.813 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.413 ' HZ ' HD22 ' A' ' 105' ' ' LEU . 27.8 p90 -170.07 161.86 8.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.869 0.366 . . . . 10.0 110.915 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.489 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 39.8 m -146.8 108.09 4.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.715 -0.675 . . . . 10.0 109.72 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 41.7 pt -129.35 162.33 37.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.534 -0.303 . . . . 10.0 110.532 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -125.54 137.97 53.95 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.882 0.372 . . . . 10.0 110.563 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 46.1 t60 -149.72 151.25 33.34 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.771 -0.649 . . . . 10.0 109.491 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -99.49 132.03 45.1 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.047 0.451 . . . . 10.0 110.135 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -121.25 169.29 10.71 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.041 0.448 . . . . 10.0 111.283 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.518 ' O ' HD12 ' A' ' 132' ' ' LEU . 38.2 t -81.87 144.99 52.72 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.566 -0.743 . . . . 10.0 110.194 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.62 -14.52 31.6 Favored 'Trans proline' 0 CA--C 1.531 0.33 0 C-N-CA 122.55 2.167 . . . . 10.0 111.952 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -114.51 17.44 17.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.122 -0.49 . . . . 10.0 110.486 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.476 ' HB2' ' O ' ' A' ' 93' ' ' SER . 0.2 OUTLIER -77.04 161.19 28.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.36 -0.382 . . . . 10.0 110.591 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -111.41 151.29 28.68 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.032 -0.531 . . . . 10.0 111.129 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 19.0 mm -59.81 -29.48 43.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 120.973 0.416 . . . . 10.0 110.808 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.28 -35.86 65.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.788 -0.642 . . . . 10.0 110.638 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -62.46 -44.71 95.74 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.606 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.608 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 23.3 mt -65.12 -44.3 95.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.52 -0.548 . . . . 10.0 109.52 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.597 ' HD3' HG13 ' A' ' 114' ' ' ILE . 56.1 mttt -54.46 -50.06 68.6 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.283 -0.871 . . . . 10.0 111.292 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -58.33 -40.34 81.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.941 -0.572 . . . . 10.0 111.233 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -64.07 -36.71 84.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 10.0 110.588 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.608 ' HG ' ' O ' ' A' ' 101' ' ' ILE . 44.4 mt -63.61 -38.66 91.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.969 0.414 . . . . 10.0 110.528 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 22.3 mt -72.95 -43.26 59.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.205 -0.452 . . . . 10.0 110.135 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.5 t -63.39 -21.47 66.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.758 -0.655 . . . . 10.0 111.718 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -95.23 13.27 26.06 Favored 'General case' 0 C--N 1.331 -0.197 0 O-C-N 122.341 -0.224 . . . . 10.0 111.018 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 61.6 27.99 17.32 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 123.462 0.476 . . . . 10.0 111.366 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.74 -22.7 13.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.877 0.37 . . . . 10.0 111.167 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -113.38 150.53 32.53 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.116 -0.493 . . . . 10.0 110.153 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.5 m -106.29 -18.21 14.06 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.352 -0.385 . . . . 10.0 111.579 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.478 ' HB3' ' CD ' ' A' ' 116' ' ' GLU . 0.2 OUTLIER -169.49 136.58 1.7 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.461 -0.57 . . . . 10.0 109.461 -178.5 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.597 HG13 ' HD3' ' A' ' 102' ' ' LYS . 0.8 OUTLIER -66.03 -39.83 85.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 121.191 0.519 . . . . 10.0 111.074 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.43 ' HB2' ' OE1' ' A' ' 116' ' ' GLU . 14.8 m -48.35 -44.13 34.12 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.86 -1.064 . . . . 10.0 113.209 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.478 ' CD ' ' HB3' ' A' ' 113' ' ' HIS . 0.7 OUTLIER -89.69 14.47 11.66 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.263 0.838 . . . . 10.0 113.263 -178.234 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 113' ' ' HIS . 51.5 mt -91.77 121.34 42.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.371 -0.532 . . . . 10.0 110.249 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.5 mmmt -123.54 115.06 20.92 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.739 -0.467 . . . . 10.0 109.739 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -94.6 124.88 38.9 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.151 0.501 . . . . 10.0 110.856 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.433 ' HB3' HG21 ' C' ' 35' ' ' VAL . 0.0 OUTLIER -109.85 139.51 44.85 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.538 -0.755 . . . . 10.0 109.98 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.458 HD13 HD13 ' A' ' 144' ' ' ILE . 31.9 tp -128.65 94.74 3.93 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.133 -1.432 . . . . 10.0 107.133 178.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 48.2 tttp 33.88 65.3 0.3 Allowed 'General case' 0 N--CA 1.464 0.274 0 O-C-N 124.261 0.976 . . . . 10.0 111.495 -177.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.49 ' HA3' ' CB ' ' C' ' 38' ' ' ASP . . . 87.41 -46.0 3.44 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.668 -0.696 . . . . 10.0 113.559 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.429 ' HE2' ' O ' ' A' ' 135' ' ' LEU . 43.1 tttp -63.04 121.23 13.06 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.683 -0.488 . . . . 10.0 109.683 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.0 p -84.11 133.84 28.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.354 0.597 . . . . 10.0 112.075 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.6 mp -100.49 152.34 20.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.647 -0.706 . . . . 10.0 110.083 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -120.93 157.44 29.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.621 0.248 . . . . 10.0 110.733 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.81 -47.32 51.45 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.628 0.973 . . . . 10.0 113.628 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -92.29 12.96 20.7 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.412 0.523 . . . . 10.0 112.412 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 130' ' ' LEU . 3.2 tp -75.36 142.35 43.16 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.103 0.478 . . . . 10.0 111.37 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -104.7 149.27 25.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.562 -0.744 . . . . 10.0 109.614 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.518 HD12 ' O ' ' A' ' 93' ' ' SER . 35.2 mt -56.79 -33.07 66.29 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.787 0.292 . . . . 10.0 111.787 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.7 p -77.7 -14.27 59.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.051 0.453 . . . . 10.0 111.101 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -90.58 -40.71 11.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.267 -0.424 . . . . 10.0 110.841 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.429 ' O ' ' HE2' ' A' ' 124' ' ' LYS . 0.7 OUTLIER -83.86 -20.61 32.82 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 121.124 -0.23 . . . . 10.0 110.915 179.701 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 30.2 mtmt 64.41 91.55 0.08 Allowed 'General case' 0 C--O 1.234 0.266 0 O-C-N 123.756 0.66 . . . . 10.0 111.268 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 29.4 t -63.55 109.4 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.93 -0.577 . . . . 10.0 110.073 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.94 122.99 88.8 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.881 -0.6 . . . . 10.0 110.923 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -66.79 -17.9 52.52 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.652 2.234 . . . . 10.0 112.056 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -87.49 2.58 50.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.892 -0.594 . . . . 10.0 110.379 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -121.76 -73.08 0.66 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.572 -0.74 . . . . 10.0 109.593 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.2 m 59.78 8.52 1.37 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.506 -0.77 . . . . 10.0 112.75 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.7 m -122.56 131.47 53.85 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.879 0.371 . . . . 10.0 111.215 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.458 HD13 HD13 ' A' ' 121' ' ' LEU . 25.0 mm -112.97 122.61 67.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.772 -0.649 . . . . 10.0 109.923 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.18 121.01 26.51 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.411 -0.588 . . . . 10.0 109.411 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 12.6 t -97.62 127.22 50.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.177 0.513 . . . . 10.0 112.033 -178.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -122.94 116.89 24.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.376 -0.829 . . . . 10.0 109.357 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 49.3 mt -138.1 143.13 33.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 110.012 -0.366 . . . . 10.0 110.012 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 25.7 mmmt -97.81 110.07 53.83 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 108.834 -0.802 . . . . 10.0 108.834 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo . . . . . 0 N--CA 1.46 -0.471 0 C-N-CA 122.434 2.089 . . . . 10.0 113.063 -178.786 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.235 0.29 0 N-CA-C 109.429 -0.582 . . . . 10.0 109.429 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -59.94 -46.63 88.77 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.946 0.35 . . . . 10.0 111.946 -178.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -59.56 -46.27 89.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.673 0.273 . . . . 10.0 111.439 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -62.24 -46.62 88.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.34 -0.391 . . . . 10.0 111.167 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.723 ' O ' HG13 ' B' ' 12' ' ' ILE . 32.0 mm -62.94 -45.27 99.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 110.041 -0.355 . . . . 10.0 110.041 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.47 -45.2 73.1 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.388 -0.369 . . . . 10.0 110.752 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.09 -36.29 83.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.864 -0.607 . . . . 10.0 110.55 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.03 -38.02 87.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.275 -0.42 . . . . 10.0 110.653 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.723 HG13 ' O ' ' B' ' 8' ' ' ILE . 13.3 mt -63.35 -55.52 22.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.252 -0.431 . . . . 10.0 111.12 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 35.3 m -64.18 -32.35 57.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.034 -0.53 . . . . 10.0 111.253 -178.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -70.03 -40.91 74.9 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.586 -0.524 . . . . 10.0 109.586 178.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' TYR . . . . . 0.619 ' O ' HG12 ' B' ' 19' ' ' ILE . 21.3 t80 -64.91 -47.8 76.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.988 -0.551 . . . . 10.0 110.08 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 14.7 m-30 -58.04 -44.09 87.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 10.0 111.077 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 70.8 m -57.54 -40.82 79.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 10.0 110.609 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 10.9 m -74.41 -20.89 59.89 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.936 -0.575 . . . . 10.0 111.621 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.619 HG12 ' O ' ' B' ' 15' ' ' TYR . 29.4 mm -79.22 -42.26 23.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.608 0.242 . . . . 10.0 110.555 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 27.0 m -79.15 -21.27 12.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.144 0.497 . . . . 10.0 109.808 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -58.15 -42.61 86.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.172 -0.922 . . . . 10.0 110.67 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 4.4 mttp -109.59 0.56 19.18 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.755 -0.657 . . . . 10.0 109.962 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 33.2 mttt 54.7 52.13 12.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.214 -0.903 . . . . 10.0 110.706 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -82.94 35.16 0.47 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.299 -0.864 . . . . 10.0 110.44 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' ILE . . . . . 0.446 HG12 ' N ' ' B' ' 26' ' ' SER . 12.4 tt -163.68 164.8 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.592 -0.731 . . . . 10.0 109.374 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' SER . . . . . 0.446 ' N ' HG12 ' B' ' 25' ' ' ILE . 0.7 OUTLIER -62.73 160.2 14.77 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.728 0.411 . . . . 10.0 111.957 -179.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -55.94 -55.21 35.44 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.045 -0.525 . . . . 10.0 111.681 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.75 -42.64 89.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.006 0.431 . . . . 10.0 110.159 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.527 ' O ' ' HG ' ' B' ' 33' ' ' LEU . . . -61.15 -42.77 99.89 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.698 -0.683 . . . . 10.0 112.26 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.37 -38.76 88.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.024 0.44 . . . . 10.0 110.437 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -68.33 -35.84 78.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.707 -0.679 . . . . 10.0 109.875 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 14.6 m -65.85 -38.46 88.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.669 -0.696 . . . . 10.0 110.024 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' B' ' 29' ' ' GLY . 53.9 mt -70.63 -31.81 68.91 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.0 0.429 . . . . 10.0 109.903 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -61.38 -51.76 67.43 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.743 -0.662 . . . . 10.0 110.685 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 12.2 p -70.25 -32.77 51.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.902 -0.59 . . . . 10.0 110.831 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.6 -45.43 86.99 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 109.245 -0.65 . . . . 10.0 109.245 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' MET . . . . . . . . . . . . . 6.0 ttm -59.91 -37.98 80.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.707 -0.679 . . . . 10.0 109.636 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -66.78 -51.59 53.96 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.914 -1.039 . . . . 10.0 111.278 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.66 -33.41 75.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.49 -0.323 . . . . 10.0 111.642 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 50.6 mt -66.99 -46.27 85.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 110.133 -0.321 . . . . 10.0 110.133 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.526 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 28.7 m -59.4 -33.3 71.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.204 0.526 . . . . 10.0 109.982 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -74.38 -47.26 35.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.548 -0.751 . . . . 10.0 110.874 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.16 -37.5 85.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.088 -0.505 . . . . 10.0 112.258 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -94.0 -4.03 50.37 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 121.014 -0.274 . . . . 10.0 111.553 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.57 59.99 9.76 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 121.399 -0.429 . . . . 10.0 113.517 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.526 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 7.1 p90 -153.1 165.04 36.87 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.994 -0.372 . . . . 10.0 109.994 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -101.22 135.25 43.0 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.769 0.319 . . . . 10.0 111.382 -179.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.53 -20.45 64.66 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.101 -0.5 . . . . 10.0 111.623 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -83.17 -15.49 50.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.86 0.362 . . . . 10.0 111.303 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.6 3.54 47.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.365 -0.379 . . . . 10.0 111.748 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 2.6 m -47.24 -49.23 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 112.778 0.659 . . . . 10.0 112.778 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -50.61 -34.16 24.98 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 113.367 0.877 . . . . 10.0 113.367 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.63 -27.49 50.89 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.813 -0.708 . . . . 10.0 112.616 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 49.6 mt -87.02 -50.71 13.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.031 0.443 . . . . 10.0 111.976 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 69.1 mt -81.45 -67.4 0.78 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.106 -0.497 . . . . 10.0 112.228 -178.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.23 -129.06 8.81 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.567 -0.825 . . . . 10.0 111.044 -178.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -158.33 23.27 0.24 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.429 0.633 . . . . 10.0 110.012 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.1 32.88 0.89 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.507 -0.769 . . . . 10.0 111.466 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 . . . . . 0 N--CA 1.464 0.239 0 CA-C-N 115.713 -0.676 . . . . 10.0 111.978 179.856 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 110.021 -0.363 . . . . 10.0 110.021 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 4' ' ' SER . . . . . 0.535 ' O ' HG12 ' C' ' 8' ' ' ILE . 0.0 OUTLIER -89.42 137.79 32.02 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.386 -0.37 . . . . 10.0 110.719 -179.491 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 5' ' ' LYS . . . . . 0.519 ' HE3' HD12 ' B' ' 19' ' ' ILE . 49.5 mttp -63.77 -45.24 90.67 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.708 0.289 . . . . 10.0 110.486 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 6' ' ' GLU . . . . . 0.487 ' HB3' HG21 ' C' ' 54' ' ' ILE . 7.5 mt-10 -54.47 -57.19 12.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.577 -0.738 . . . . 10.0 111.299 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . 0.55 ' HG3' ' O ' ' C' ' 54' ' ' ILE . 1.5 mp0 -61.61 -39.38 91.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.76 -0.654 . . . . 10.0 112.272 -179.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 8' ' ' ILE . . . . . 0.535 HG12 ' O ' ' C' ' 4' ' ' SER . 27.2 mm -66.7 -47.93 81.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.89 0.376 . . . . 10.0 110.247 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.48 -42.05 95.47 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.088 -0.505 . . . . 10.0 110.1 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.68 -40.46 92.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.621 -0.718 . . . . 10.0 110.926 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.5 -33.82 76.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.931 0.396 . . . . 10.0 110.392 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 12' ' ' ILE . . . . . 0.468 HG13 HG12 ' B' ' 12' ' ' ILE . 1.2 mp -70.89 -48.3 57.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.064 -0.516 . . . . 10.0 111.064 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 26.8 m -65.69 -28.03 43.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-O 121.218 0.532 . . . . 10.0 110.05 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -73.25 -39.77 65.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.66 -0.7 . . . . 10.0 109.382 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 15' ' ' TYR . . . . . 0.471 ' O ' HG12 ' C' ' 19' ' ' ILE . 32.7 t80 -68.89 -43.49 75.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 10.0 110.308 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 10.1 m-30 -55.63 -46.88 77.36 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.171 -0.468 . . . . 10.0 110.412 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 19.9 m -60.84 -43.89 97.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.868 -0.605 . . . . 10.0 111.364 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 12.7 m -67.67 -22.67 65.29 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.982 0.364 . . . . 10.0 111.982 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 19' ' ' ILE . . . . . 0.471 HG12 ' O ' ' C' ' 15' ' ' TYR . 29.5 mm -82.62 -39.7 16.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.589 0.233 . . . . 10.0 111.052 -179.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 20' ' ' VAL . . . . . . . . . . . . . 13.6 m -77.5 -23.69 14.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.289 0.566 . . . . 10.0 109.814 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -66.86 -48.08 69.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.122 -0.944 . . . . 10.0 111.018 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 33.7 mttp -91.12 -5.49 55.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.676 -0.238 . . . . 10.0 110.911 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 64.6 mttm 63.72 49.33 2.99 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.82 -0.627 . . . . 10.0 110.825 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -81.94 -5.44 58.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.894 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 12.7 tt -131.62 162.34 39.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.545 -0.539 . . . . 10.0 109.545 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.09 153.62 11.25 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 122.59 0.356 . . . . 10.0 111.156 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -58.4 -40.2 81.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.852 0.358 . . . . 10.0 110.858 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 28' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -67.12 -40.81 86.87 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.183 0.516 . . . . 10.0 109.697 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 29' ' ' GLY . . . . . 0.517 ' O ' ' HG ' ' C' ' 33' ' ' LEU . . . -65.16 -33.18 86.26 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.514 -0.766 . . . . 10.0 111.23 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.32 -39.63 95.08 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.815 -0.439 . . . . 10.0 109.815 178.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -63.17 -35.76 81.38 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.89 -0.596 . . . . 10.0 109.666 178.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 1.2 t -65.66 -43.83 88.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.494 -0.775 . . . . 10.0 109.81 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 33' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' C' ' 29' ' ' GLY . 43.5 mt -66.93 -34.52 77.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.074 0.464 . . . . 10.0 109.765 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -60.89 -50.43 73.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.388 -0.823 . . . . 10.0 110.94 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 35' ' ' VAL . . . . . 0.433 HG21 ' HB3' ' A' ' 120' ' ' LEU . 12.2 p -71.86 -36.29 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 116.425 -0.352 . . . . 10.0 111.416 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.13 -33.34 74.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.875 0.369 . . . . 10.0 110.462 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 34.7 ttm -53.83 -59.96 3.94 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.643 -0.708 . . . . 10.0 111.036 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 38' ' ' ASP . . . . . 0.578 ' OD2' ' HD3' ' C' ' 48' ' ' ARG . 3.3 m-20 -67.03 -27.19 67.2 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.243 -0.435 . . . . 10.0 111.139 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 39' ' ' CYS . . . . . 0.415 ' N ' ' HA2' ' A' ' 123' ' ' GLY . 1.1 t -65.04 -49.12 71.38 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.047 0.451 . . . . 10.0 110.48 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 40' ' ' ILE . . . . . . . . . . . . . 53.6 mt -66.94 -38.28 81.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.735 -0.666 . . . . 10.0 109.837 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 41' ' ' SER . . . . . 0.722 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 35.5 m -62.21 -47.22 85.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.546 -0.752 . . . . 10.0 110.716 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -65.1 -40.94 95.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.165 -0.471 . . . . 10.0 110.724 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.97 -43.92 91.42 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.519 0.562 . . . . 10.0 112.519 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 44' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -94.82 -2.47 50.8 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.969 0.359 . . . . 10.0 111.969 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.75 53.02 12.65 Favored Glycine 0 CA--C 1.52 0.387 0 N-CA-C 114.4 0.52 . . . . 10.0 114.4 178.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 46' ' ' PHE . . . . . 0.722 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 30.2 p90 -144.67 157.11 44.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 117.165 0.483 . . . . 10.0 110.473 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -83.18 146.15 28.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.528 -0.306 . . . . 10.0 110.298 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 48' ' ' ARG . . . . . 0.578 ' HD3' ' OD2' ' C' ' 38' ' ' ASP . 0.0 OUTLIER -61.91 -28.91 69.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.379 0.609 . . . . 10.0 110.578 179.619 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 49' ' ' GLU . . . . . 0.438 ' C ' ' H ' ' C' ' 51' ' ' VAL . 4.3 mp0 -84.91 18.88 2.28 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.437 -0.801 . . . . 10.0 112.393 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.1 8.26 0.22 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.941 0.896 . . . . 10.0 112.695 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 51' ' ' VAL . . . . . 0.438 ' H ' ' C ' ' C' ' 49' ' ' GLU . 3.5 m -34.67 -38.61 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 N-CA-C 117.708 2.484 . . . . 10.0 117.708 -176.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 52' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.17 -54.03 4.42 Favored 'General case' 0 C--O 1.217 -0.63 0 N-CA-C 118.653 2.834 . . . . 10.0 118.653 -175.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.11 -56.87 9.43 Favored Glycine 0 CA--C 1.494 -1.254 0 C-N-CA 119.869 -1.158 . . . . 10.0 115.799 -171.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 54' ' ' ILE . . . . . 0.55 ' O ' ' HG3' ' C' ' 7' ' ' GLU . 0.5 OUTLIER -82.0 -35.18 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 C-N-CA 119.847 -0.741 . . . . 10.0 110.561 -179.355 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.4 -75.38 0.33 Allowed 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 116.101 1.889 . . . . 10.0 116.101 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.36 -145.71 49.12 Favored Glycine 0 N--CA 1.471 1.014 0 C-N-CA 121.538 -0.363 . . . . 10.0 112.437 -177.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -150.44 22.46 0.82 Allowed 'General case' 0 C--O 1.233 0.186 0 N-CA-C 109.541 -0.541 . . . . 10.0 109.541 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.12 42.36 0.65 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.529 -0.76 . . . . 10.0 112.043 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 . . . . . 0 N--CA 1.467 0.38 0 CA-C-O 121.61 0.719 . . . . 10.0 111.613 -179.868 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 15.4 t . . . . . 0 N--CA 1.454 -0.227 0 N-CA-C 109.811 -0.44 . . . . 10.0 109.811 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -91.87 122.38 34.34 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.835 0.35 . . . . 10.0 110.569 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.1 mp -125.38 121.36 33.65 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.388 -0.369 . . . . 10.0 110.432 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.6 m -93.97 113.17 25.11 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 120.829 0.347 . . . . 10.0 110.202 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.562 ' O ' ' HA ' ' A' ' 87' ' ' SER . 2.6 mm? -84.94 119.33 25.25 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.948 -0.569 . . . . 10.0 109.771 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -121.16 100.89 7.31 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.131 0.491 . . . . 10.0 110.921 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 84' ' ' PRO . 20.5 tptm -87.13 114.86 24.1 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.579 -0.737 . . . . 10.0 110.757 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 16.0 mt -77.66 -66.41 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 O-C-N 123.915 0.759 . . . . 10.0 111.285 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -60.43 160.8 8.24 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.893 -0.594 . . . . 10.0 111.323 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.454 ' HA ' ' C ' ' A' ' 84' ' ' PRO . . . -86.02 143.13 36.95 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.225 -0.443 . . . . 10.0 111.134 -178.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.454 ' C ' ' HA ' ' A' ' 83' ' ' ALA . 43.7 Cg_endo -71.6 127.54 12.64 Favored 'Cis proline' 0 C--N 1.346 0.423 0 C-N-CA 123.068 -1.638 . . . . 10.0 111.202 -0.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.445 ' N ' ' HA ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -93.34 158.58 15.67 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.175 -0.466 . . . . 10.0 112.001 -178.627 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -178.96 172.4 1.3 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.318 -0.856 . . . . 10.0 109.316 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 66.4 m -152.95 110.34 3.53 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.899 0.381 . . . . 10.0 110.301 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.8 pt -119.15 158.82 20.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.875 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -114.81 113.9 24.84 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.085 -0.709 . . . . 10.0 109.085 179.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -129.51 147.88 51.36 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.175 0.512 . . . . 10.0 110.415 -178.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.91 130.65 53.82 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.862 -0.608 . . . . 10.0 109.368 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -121.39 171.6 8.65 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.09 0.472 . . . . 10.0 111.425 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.577 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 0.7 OUTLIER -80.02 151.2 72.92 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.732 -0.667 . . . . 10.0 110.977 -179.779 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -65.39 -16.73 55.59 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 122.311 2.007 . . . . 10.0 112.504 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.1 m -110.72 15.52 21.9 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.434 -0.58 . . . . 10.0 109.434 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.577 ' HB2' ' O ' ' A' ' 93' ' ' SER . 0.3 OUTLIER -75.38 161.81 28.93 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.699 -0.682 . . . . 10.0 110.806 -179.759 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.97 157.82 26.04 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.605 -0.725 . . . . 10.0 110.886 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.542 ' O ' ' HG3' ' A' ' 102' ' ' LYS . 41.2 mm -67.25 -22.29 28.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.343 -0.614 . . . . 10.0 109.343 178.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.42 -38.73 71.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.205 -0.907 . . . . 10.0 110.141 178.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -68.24 -40.61 81.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.035 -0.529 . . . . 10.0 110.996 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.531 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 51.7 mt -62.26 -47.26 93.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.796 -0.638 . . . . 10.0 109.588 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.542 ' HG3' ' O ' ' A' ' 98' ' ' ILE . 79.9 mttt -55.46 -44.4 76.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.927 -1.033 . . . . 10.0 111.436 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.487 ' OE1' ' HA ' ' A' ' 103' ' ' GLN . 10.0 mm-40 -62.26 -37.67 86.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.62 -0.264 . . . . 10.0 111.21 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -65.11 -39.77 93.61 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.906 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 101' ' ' ILE . 34.2 mt -63.03 -44.75 95.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.097 -0.501 . . . . 10.0 111.397 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 102' ' ' LYS . 12.6 mt -67.94 -42.21 85.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.121 -0.49 . . . . 10.0 111.404 -178.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 49.8 m -69.84 -9.89 56.44 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.013 0.375 . . . . 10.0 112.013 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -107.72 16.12 23.95 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 121.104 -0.238 . . . . 10.0 110.895 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 58.83 26.35 14.69 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.707 -0.679 . . . . 10.0 111.673 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.6 mmpp? -96.36 -16.48 21.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.369 0.604 . . . . 10.0 110.069 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.689 ' HB2' HD13 ' A' ' 148' ' ' ILE . . . -137.08 166.52 23.5 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.294 -0.866 . . . . 10.0 110.349 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.6 m -108.18 -49.46 3.19 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.766 0.317 . . . . 10.0 110.94 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.488 ' O ' HG13 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -136.87 139.01 41.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.138 -179.45 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.435 ' HB ' HD11 ' A' ' 106' ' ' ILE . 6.0 tt -64.07 -39.06 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.513 0.673 . . . . 10.0 109.865 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.0 m -52.39 -27.93 17.67 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.321 -1.309 . . . . 10.0 112.45 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.23 -4.56 38.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.71 0.291 . . . . 10.0 111.417 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 113' ' ' HIS . 59.1 mt -89.75 127.11 42.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.022 0.439 . . . . 10.0 110.945 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.62 128.83 20.99 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.544 -0.91 . . . . 10.0 108.544 177.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.433 HD12 HG22 ' A' ' 144' ' ' ILE . 4.2 mm? -91.24 136.69 32.92 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.387 0.613 . . . . 10.0 111.21 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.542 ' HG ' HG22 ' C' ' 35' ' ' VAL . 3.7 tp -110.46 126.45 54.35 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.78 -1.1 . . . . 10.0 108.633 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 47.3 tp -113.76 93.04 4.19 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 106.624 -1.621 . . . . 10.0 106.624 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.42 ' HD3' ' HA ' ' A' ' 122' ' ' LYS . 2.7 tppp? 38.68 60.98 1.27 Allowed 'General case' 0 CA--C 1.539 0.546 0 O-C-N 123.944 0.778 . . . . 10.0 110.587 -177.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.504 ' HA3' ' CB ' ' C' ' 38' ' ' ASP . . . 87.95 -45.87 3.36 Favored Glycine 0 C--N 1.332 0.349 0 CA-C-N 115.544 -0.753 . . . . 10.0 113.999 -178.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.2 tttp -59.76 118.65 6.4 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 110.189 -0.3 . . . . 10.0 110.189 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.4 p -78.99 137.18 22.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.62 0.724 . . . . 10.0 112.205 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.432 ' HG ' HD23 ' A' ' 130' ' ' LEU . 6.8 mp -104.34 156.91 17.52 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 114.824 -1.08 . . . . 10.0 110.624 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -116.26 164.17 14.9 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.004 0.43 . . . . 10.0 112.005 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -55.15 -56.04 24.43 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 114.071 1.137 . . . . 10.0 114.071 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -91.72 14.7 14.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.864 0.364 . . . . 10.0 111.322 -178.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.432 HD23 ' HG ' ' A' ' 126' ' ' LEU . 15.1 tp -68.22 139.84 56.05 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.718 0.294 . . . . 10.0 110.501 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -97.4 145.24 26.36 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.261 -0.427 . . . . 10.0 110.484 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.482 HD12 ' O ' ' A' ' 93' ' ' SER . 10.7 mt -54.03 -38.75 65.5 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.747 0.647 . . . . 10.0 112.747 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.35 -17.14 56.92 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.817 0.303 . . . . 10.0 111.817 -179.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -79.13 -45.8 19.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.833 0.349 . . . . 10.0 110.278 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.7 pp -77.01 -23.7 52.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.875 -0.602 . . . . 10.0 110.81 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.2 mtmt 65.89 90.57 0.09 Allowed 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.618 0.574 . . . . 10.0 111.767 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.5 t -68.2 103.63 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.812 -0.631 . . . . 10.0 109.923 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.39 135.38 86.54 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.975 -0.557 . . . . 10.0 111.007 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -68.8 -22.23 37.14 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.224 1.95 . . . . 10.0 110.973 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -78.53 -3.55 44.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.306 -0.861 . . . . 10.0 110.485 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -122.69 -83.65 0.66 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.934 -0.575 . . . . 10.0 110.093 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.2 m 61.01 3.14 0.63 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.715 -0.675 . . . . 10.0 112.198 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.5 m -102.32 114.54 28.79 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-O 120.96 0.41 . . . . 10.0 110.044 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.433 HG22 HD12 ' A' ' 119' ' ' LEU . 1.4 mm -104.92 109.03 26.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 108.287 -1.005 . . . . 10.0 108.287 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.441 ' OG1' HG21 ' C' ' 35' ' ' VAL . 0.0 OUTLIER -79.6 122.03 26.0 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.653 -0.869 . . . . 10.0 108.653 -179.172 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.0 t -91.43 121.83 42.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.414 -0.812 . . . . 10.0 111.431 -177.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 81.5 mmm -115.56 113.96 24.31 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.008 -0.996 . . . . 10.0 109.732 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.689 HD13 ' HB2' ' A' ' 111' ' ' ALA . 11.3 mt -139.35 144.38 29.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.579 -0.737 . . . . 10.0 111.465 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -107.96 120.9 45.57 Favored Pre-proline 0 C--N 1.321 -0.656 0 N-CA-C 108.134 -1.062 . . . . 10.0 108.134 178.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo . . . . . 0 N--CA 1.462 -0.353 0 C-N-CA 122.332 2.022 . . . . 10.0 112.434 -179.109 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 109.985 -0.376 . . . . 10.0 109.985 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . 0.406 ' HG2' ' H ' ' B' ' 5' ' ' LYS . 4.4 ptpp? -60.35 -40.88 92.27 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.456 -0.338 . . . . 10.0 111.577 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -58.3 -43.13 87.94 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.858 0.361 . . . . 10.0 110.534 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -66.91 -46.19 75.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.03 -0.532 . . . . 10.0 111.424 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.449 ' O ' HD13 ' B' ' 12' ' ' ILE . 32.5 mm -65.0 -46.09 92.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.747 0.308 . . . . 10.0 110.532 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.76 -43.72 81.05 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.015 0.436 . . . . 10.0 110.622 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.59 -34.82 77.8 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.687 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.57 -35.73 77.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.911 0.386 . . . . 10.0 110.282 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.516 HG12 HG23 ' C' ' 12' ' ' ILE . 1.6 mp -68.23 -50.55 56.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.775 -0.648 . . . . 10.0 111.138 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 31.4 m -63.92 -32.28 56.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 N-CA-C 109.694 -0.484 . . . . 10.0 109.694 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -64.18 -53.46 48.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.571 -0.741 . . . . 10.0 109.843 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' TYR . . . . . 0.603 ' O ' HG12 ' B' ' 19' ' ' ILE . 39.1 t80 -60.3 -48.16 82.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.766 -0.652 . . . . 10.0 111.217 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 10.1 m-30 -53.95 -47.74 70.97 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.813 0.34 . . . . 10.0 110.526 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 50.7 m -57.5 -36.45 71.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.18 -0.464 . . . . 10.0 111.247 178.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 1.2 m -74.84 -19.29 60.23 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.268 -0.423 . . . . 10.0 111.193 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.603 HG12 ' O ' ' B' ' 15' ' ' TYR . 35.8 mm -81.39 -43.01 20.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.392 -0.367 . . . . 10.0 111.549 -178.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 16.8 m -76.26 -25.89 16.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.232 0.539 . . . . 10.0 109.93 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -62.12 -43.92 97.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.264 -0.88 . . . . 10.0 111.344 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -102.61 4.33 38.24 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.894 -0.323 . . . . 10.0 110.433 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 54.0 mttm 52.07 54.85 10.11 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 115.454 -0.794 . . . . 10.0 110.675 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -88.82 25.54 1.75 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.34 -0.846 . . . . 10.0 110.8 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 15.9 tt -161.7 164.02 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.756 -0.656 . . . . 10.0 109.405 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 2.4 p -64.5 155.64 32.19 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.627 -0.26 . . . . 10.0 111.175 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -59.07 -42.31 90.06 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.927 0.394 . . . . 10.0 110.901 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -59.93 -41.37 91.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.789 -0.641 . . . . 10.0 109.948 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.426 ' O ' ' HG ' ' B' ' 33' ' ' LEU . . . -73.09 -34.7 58.16 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.805 -0.712 . . . . 10.0 111.583 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.37 -42.76 99.23 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-O 120.822 0.344 . . . . 10.0 110.542 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -63.6 -41.14 98.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.233 0.54 . . . . 10.0 109.597 178.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 42.4 m -61.8 -46.38 89.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.243 -0.89 . . . . 10.0 110.923 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' B' ' 29' ' ' GLY . 68.5 mt -68.52 -30.27 69.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.381 -0.372 . . . . 10.0 110.938 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -65.63 -51.93 55.81 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.35 -0.386 . . . . 10.0 111.048 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 14.6 p -67.09 -33.92 66.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.916 -0.584 . . . . 10.0 110.538 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.79 -42.1 91.14 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.647 -0.501 . . . . 10.0 109.647 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' MET . . . . . 0.586 ' SD ' ' HD2' ' B' ' 48' ' ' ARG . 11.0 ttm -56.5 -53.02 62.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.259 -0.882 . . . . 10.0 110.354 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.66 -46.41 88.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 10.0 111.42 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 50.2 t -58.08 -44.68 87.68 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.513 -0.312 . . . . 10.0 111.749 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 87.5 mt -64.66 -39.0 84.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.269 0.557 . . . . 10.0 109.92 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.424 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 24.3 m -64.75 -40.32 95.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.597 -0.729 . . . . 10.0 110.442 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -75.82 -24.78 55.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.468 -0.333 . . . . 10.0 110.847 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.86 -33.38 66.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.052 -0.522 . . . . 10.0 111.09 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -102.36 -3.23 27.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.879 0.371 . . . . 10.0 111.241 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 66.48 59.65 7.03 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 114.466 0.547 . . . . 10.0 114.466 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.424 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 22.0 p90 -154.16 159.83 41.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 117.271 0.536 . . . . 10.0 110.335 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -86.52 144.06 27.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.879 0.371 . . . . 10.0 110.766 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.586 ' HD2' ' SD ' ' B' ' 37' ' ' MET . 3.1 mtm180 -64.88 -25.9 68.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.053 -0.522 . . . . 10.0 110.685 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 55.7 mp0 -85.07 -8.47 58.66 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.15 -0.477 . . . . 10.0 112.118 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.11 2.68 17.16 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 111.937 0.347 . . . . 10.0 111.937 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 13.4 m -45.63 -53.16 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 113.06 0.763 . . . . 10.0 113.06 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 1.4 m -49.68 -41.59 43.5 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.321 0.86 . . . . 10.0 113.321 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.77 -29.55 65.15 Favored Glycine 0 C--O 1.23 -0.139 0 C-N-CA 120.686 -0.769 . . . . 10.0 112.456 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 25.5 mt -87.96 -51.0 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 112.902 0.705 . . . . 10.0 112.902 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 26.3 mt -82.29 -69.32 0.63 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.136 0.791 . . . . 10.0 113.136 -177.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.0 -132.91 11.44 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.618 -0.801 . . . . 10.0 111.701 -178.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -156.94 29.94 0.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.394 0.616 . . . . 10.0 109.942 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.03 30.48 1.61 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.39 -0.823 . . . . 10.0 111.361 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 . . . . . 0 C--O 1.235 0.324 0 CA-C-N 115.838 -0.619 . . . . 10.0 110.208 -178.903 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.427 0 N-CA-C 109.57 -0.53 . . . . 10.0 109.57 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 4' ' ' SER . . . . . 0.503 ' HB2' ' OE1' ' C' ' 7' ' ' GLU . 0.8 OUTLIER -96.98 154.2 17.45 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.727 0.298 . . . . 10.0 110.695 -178.016 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 5' ' ' LYS . . . . . 0.457 ' HB3' ' CE1' ' C' ' 44' ' ' PHE . 17.7 mttp -61.78 -40.99 97.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.083 -0.508 . . . . 10.0 111.757 -178.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 6' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -57.9 -57.94 10.56 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.459 0.474 . . . . 10.0 110.374 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . 0.503 ' OE1' ' HB2' ' C' ' 4' ' ' SER . 2.6 mp0 -55.79 -44.91 78.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.684 -0.689 . . . . 10.0 111.772 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 8' ' ' ILE . . . . . 0.65 ' O ' HG13 ' C' ' 12' ' ' ILE . 38.8 mm -62.58 -53.18 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 C-N-CA 121.233 -0.187 . . . . 10.0 110.604 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.99 -45.26 75.0 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.347 -0.388 . . . . 10.0 110.774 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.63 -35.0 79.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.797 -0.638 . . . . 10.0 110.942 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.6 -35.66 80.73 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.216 -0.447 . . . . 10.0 111.06 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 12' ' ' ILE . . . . . 0.65 HG13 ' O ' ' C' ' 8' ' ' ILE . 6.6 mt -69.87 -50.41 49.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.928 0.394 . . . . 10.0 111.265 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 13' ' ' VAL . . . . . 0.407 ' HA ' ' HG3' ' C' ' 37' ' ' MET . 16.4 m -68.11 -27.94 39.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 116.005 -0.543 . . . . 10.0 110.965 -178.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 14' ' ' ASN . . . . . 0.461 ' HB2' HG11 ' C' ' 51' ' ' VAL . 33.9 t30 -74.22 -43.06 58.62 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.256 -0.646 . . . . 10.0 109.256 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 15' ' ' TYR . . . . . 0.598 ' O ' HG12 ' C' ' 19' ' ' ILE . 13.1 t80 -64.28 -49.01 73.51 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.521 -0.763 . . . . 10.0 110.882 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 11.9 m-30 -55.75 -43.77 76.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.502 -0.317 . . . . 10.0 111.711 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 66.6 m -59.48 -40.61 87.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.569 -0.287 . . . . 10.0 111.522 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 1.3 m -76.25 -23.13 54.47 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.024 0.379 . . . . 10.0 112.024 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 19' ' ' ILE . . . . . 0.598 HG12 ' O ' ' C' ' 15' ' ' TYR . 29.2 mm -77.13 -38.48 27.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.067 0.461 . . . . 10.0 110.684 -178.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 20' ' ' VAL . . . . . . . . . . . . . 33.4 m -79.74 -20.12 12.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.377 0.608 . . . . 10.0 109.775 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -62.91 -51.63 66.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.973 -1.012 . . . . 10.0 110.838 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -92.7 -2.36 56.1 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.676 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 63.6 mttm 56.03 56.4 5.97 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.704 -0.68 . . . . 10.0 109.911 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -84.96 13.02 6.46 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.177 -0.92 . . . . 10.0 110.529 -179.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 15.9 tt -150.09 163.3 3.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.658 -0.867 . . . . 10.0 108.658 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 13.8 m -66.07 162.76 18.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.662 0.267 . . . . 10.0 110.639 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -60.82 -39.57 89.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.516 -0.311 . . . . 10.0 111.626 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 28' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -59.75 -47.84 84.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.018 0.437 . . . . 10.0 110.256 179.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 29' ' ' GLY . . . . . 0.535 ' O ' ' HG ' ' C' ' 33' ' ' LEU . . . -65.58 -41.36 96.14 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.855 -0.688 . . . . 10.0 111.587 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.5 -42.34 96.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.709 0.29 . . . . 10.0 111.36 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.9 -38.82 92.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.082 0.468 . . . . 10.0 110.319 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 6.3 m -62.46 -40.15 95.69 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.679 -0.691 . . . . 10.0 110.067 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 33' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' C' ' 29' ' ' GLY . 62.4 mt -72.2 -31.51 65.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.833 -0.621 . . . . 10.0 111.169 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -64.42 -53.77 43.18 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.256 -0.429 . . . . 10.0 111.717 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 35' ' ' VAL . . . . . 0.542 HG22 ' HG ' ' A' ' 120' ' ' LEU . 11.3 p -67.79 -35.06 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-O 120.888 0.375 . . . . 10.0 110.664 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.72 -29.2 66.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.794 0.331 . . . . 10.0 110.529 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 37' ' ' MET . . . . . 0.407 ' HG3' ' HA ' ' C' ' 13' ' ' VAL . 30.5 ttm -58.55 -50.94 71.97 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.006 -0.543 . . . . 10.0 110.514 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 38' ' ' ASP . . . . . 0.504 ' CB ' ' HA3' ' A' ' 123' ' ' GLY . 1.0 OUTLIER -69.71 -28.65 66.0 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 116.43 -0.35 . . . . 10.0 110.62 -179.721 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 39' ' ' CYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 123' ' ' GLY . 7.8 t -61.61 -50.25 73.33 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.423 -0.584 . . . . 10.0 109.423 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 40' ' ' ILE . . . . . . . . . . . . . 79.4 mt -60.57 -46.04 96.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.323 -0.853 . . . . 10.0 109.927 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 41' ' ' SER . . . . . 0.835 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 47.4 m -58.87 -38.18 78.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.55 -0.75 . . . . 10.0 111.366 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -70.71 -44.98 65.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.714 -0.675 . . . . 10.0 110.863 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.41 -37.44 72.74 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.819 0.674 . . . . 10.0 112.819 -178.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 44' ' ' PHE . . . . . 0.457 ' CE1' ' HB3' ' C' ' 5' ' ' LYS . 94.1 m-85 -97.9 2.35 49.08 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.179 -0.326 . . . . 10.0 111.633 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.74 57.93 16.39 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.314 -0.47 . . . . 10.0 113.518 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 46' ' ' PHE . . . . . 0.835 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 10.5 p90 -147.71 175.64 10.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 117.121 0.46 . . . . 10.0 110.404 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -100.97 136.19 41.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.642 -0.253 . . . . 10.0 110.355 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 48' ' ' ARG . . . . . 0.435 ' O ' HG13 ' C' ' 51' ' ' VAL . 5.1 ptm180 -58.98 -37.47 76.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 10.0 111.293 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.61 18.58 3.86 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.752 1.019 . . . . 10.0 113.752 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.92 1.66 37.08 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.989 0.424 . . . . 10.0 111.421 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 51' ' ' VAL . . . . . 0.461 HG11 ' HB2' ' C' ' 14' ' ' ASN . 27.2 m -45.22 -35.78 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 114.097 1.147 . . . . 10.0 114.097 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.98 -35.6 71.43 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.316 0.858 . . . . 10.0 113.316 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.55 -20.31 69.19 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 111.087 -0.805 . . . . 10.0 111.087 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 54' ' ' ILE . . . . . . . . . . . . . 50.5 mt -91.69 -65.38 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 114.35 1.241 . . . . 10.0 114.35 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 72.8 mt -78.43 -66.73 0.82 Allowed 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.222 -0.899 . . . . 10.0 112.984 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 75.39 -141.37 27.67 Favored Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 120.156 -1.021 . . . . 10.0 110.849 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 12.6 pttp -136.42 22.35 3.18 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.103 0.477 . . . . 10.0 110.546 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.44 19.09 1.31 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.747 -0.66 . . . . 10.0 111.337 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 . . . . . 0 N--CA 1.464 0.229 0 CA-C-N 115.623 -0.717 . . . . 10.0 111.039 -179.783 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 35.6 mtm . . . . . 0 N--CA 1.481 1.093 0 N-CA-C 109.826 -0.435 . . . . 10.0 109.826 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.2 t -101.54 133.38 45.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.99 -0.374 . . . . 10.0 109.99 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -86.25 120.13 27.28 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.268 -0.424 . . . . 10.0 110.858 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.1 mp -125.72 120.08 29.7 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.881 -0.599 . . . . 10.0 109.844 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.437 HG23 ' HG2' ' A' ' 89' ' ' GLU . 15.6 m -99.54 112.97 25.1 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.968 0.413 . . . . 10.0 109.943 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 87' ' ' SER . 3.0 mm? -84.57 114.65 22.12 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.873 -0.603 . . . . 10.0 109.645 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -117.93 103.83 10.31 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.079 -0.51 . . . . 10.0 110.232 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 84' ' ' PRO . 15.9 tptm -92.17 121.8 34.04 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.806 -0.633 . . . . 10.0 109.348 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.4 HD13 ' HB2' ' C' ' 32' ' ' SER . 75.6 mt -84.97 -57.78 4.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 O-C-N 123.631 0.582 . . . . 10.0 111.543 -179.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -66.15 158.51 28.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.856 -0.611 . . . . 10.0 111.023 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.28 139.71 56.22 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 120.877 0.37 . . . . 10.0 111.188 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.509 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 7.3 Cg_exo -75.17 129.44 18.67 Favored 'Cis proline' 0 C--O 1.235 0.335 0 C-N-CA 123.297 -1.543 . . . . 10.0 110.708 -1.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.444 ' HE3' ' HB2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -92.08 158.99 15.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.191 0.519 . . . . 10.0 110.953 -179.179 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -173.23 167.9 4.77 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.396 -0.82 . . . . 10.0 109.879 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.552 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 46.4 m -146.61 97.66 2.95 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.275 -0.639 . . . . 10.0 109.275 178.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 38.0 pt -110.45 146.01 16.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.804 -0.634 . . . . 10.0 110.657 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.437 ' HG2' HG23 ' A' ' 77' ' ' THR . 19.7 mt-10 -110.98 126.16 54.48 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.062 -0.718 . . . . 10.0 109.062 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 12.0 m80 -142.5 159.42 42.26 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.393 0.616 . . . . 10.0 111.976 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -105.75 126.76 52.54 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.044 -0.98 . . . . 10.0 109.922 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -117.89 167.65 11.22 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.935 -0.575 . . . . 10.0 110.587 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.574 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 1.7 m -89.72 153.73 47.81 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.144 -0.48 . . . . 10.0 110.463 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -60.52 -27.88 85.66 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.342 2.028 . . . . 10.0 112.329 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.6 m -103.97 17.93 23.07 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.002 -0.545 . . . . 10.0 110.678 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.574 ' HB2' ' O ' ' A' ' 93' ' ' SER . 0.3 OUTLIER -73.33 152.1 41.03 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.985 -0.552 . . . . 10.0 110.153 179.565 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.58 147.09 28.01 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.707 -0.679 . . . . 10.0 110.457 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 30.9 mm -62.3 -23.76 32.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.189 0.519 . . . . 10.0 110.511 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.447 HD22 ' HA ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -59.2 -37.94 78.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.61 -0.723 . . . . 10.0 110.509 179.187 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -61.77 -40.02 93.69 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.457 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.591 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 45.9 mt -63.15 -47.49 92.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.974 -0.557 . . . . 10.0 109.65 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -56.49 -47.36 79.43 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.448 -0.796 . . . . 10.0 110.962 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -61.35 -39.99 92.62 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.963 -0.562 . . . . 10.0 110.598 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 25.1 t60 -62.7 -38.54 90.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.476 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 101' ' ' ILE . 58.1 mt -65.43 -39.62 92.3 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.953 0.406 . . . . 10.0 110.671 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 43.2 mt -69.73 -39.7 78.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.103 0.478 . . . . 10.0 110.313 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.1 m -67.09 -20.33 65.79 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.893 -0.594 . . . . 10.0 111.305 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -98.8 14.6 28.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.633 -0.258 . . . . 10.0 111.242 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 58.11 35.12 24.86 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.121 -0.491 . . . . 10.0 111.166 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 8.6 mmtp -112.99 -13.34 13.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.547 -0.297 . . . . 10.0 111.335 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.466 ' HB2' HD13 ' A' ' 148' ' ' ILE . . . -135.06 155.81 50.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.394 -0.366 . . . . 10.0 110.762 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.1 m -94.46 -61.35 1.53 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.246 -0.434 . . . . 10.0 111.266 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -137.98 147.8 44.6 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.964 -0.384 . . . . 10.0 109.964 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.546 ' HA ' HD12 ' A' ' 117' ' ' ILE . 48.1 pt -60.43 -32.95 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.378 0.608 . . . . 10.0 110.843 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.4 m -58.59 -28.82 65.93 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.694 -1.139 . . . . 10.0 112.961 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.93 14.57 24.97 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.168 0.433 . . . . 10.0 112.168 -177.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.546 HD12 ' HA ' ' A' ' 114' ' ' ILE . 32.6 mt -115.87 135.44 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 113.288 0.847 . . . . 10.0 113.288 -178.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 52.7 tttt -140.88 129.12 22.27 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 109.198 -0.667 . . . . 10.0 109.198 175.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -96.18 136.1 37.09 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.274 0.559 . . . . 10.0 111.342 -179.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.402 ' HB3' ' HB ' ' A' ' 145' ' ' THR . 0.0 OUTLIER -112.46 134.67 53.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.263 -0.88 . . . . 10.0 110.029 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.525 ' O ' ' HB3' ' A' ' 124' ' ' LYS . 43.0 tp -127.49 96.63 4.61 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 107.429 -1.322 . . . . 10.0 107.429 177.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.412 ' HA ' HG23 ' C' ' 35' ' ' VAL . 21.7 tptp 36.43 59.39 0.98 Allowed 'General case' 0 N--CA 1.467 0.387 0 O-C-N 124.059 0.849 . . . . 10.0 111.457 -177.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.27 -43.99 3.16 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 121.001 -0.619 . . . . 10.0 112.734 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.525 ' HB3' ' O ' ' A' ' 121' ' ' LEU . 26.9 tptt -59.73 126.87 29.3 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.916 -0.642 . . . . 10.0 109.765 178.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.0 m -94.15 140.72 16.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.688 0.625 . . . . 10.0 112.688 -178.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 7.2 mp -106.69 154.39 21.03 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.746 -0.661 . . . . 10.0 110.462 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -115.26 158.41 22.38 Favored 'General case' 0 C--O 1.226 -0.153 0 CA-C-O 120.677 0.275 . . . . 10.0 110.823 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.4 -55.01 20.93 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.827 1.047 . . . . 10.0 113.827 -178.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -94.02 19.35 9.23 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.756 0.312 . . . . 10.0 111.57 -177.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 12.8 tp -78.3 149.58 33.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.91 0.386 . . . . 10.0 111.088 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -108.9 150.28 27.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.768 -0.651 . . . . 10.0 110.031 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.492 HD12 ' O ' ' A' ' 93' ' ' SER . 64.3 mt -59.1 -28.18 66.27 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.211 0.449 . . . . 10.0 112.211 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.14 -12.55 59.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.118 0.485 . . . . 10.0 111.024 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -92.08 -49.86 5.99 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.131 -0.486 . . . . 10.0 110.839 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.3 pp -75.1 -25.93 58.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.017 -0.538 . . . . 10.0 111.274 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt 67.94 99.38 0.05 Allowed 'General case' 0 N--CA 1.465 0.313 0 O-C-N 124.062 0.851 . . . . 10.0 111.578 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.8 t -72.97 107.68 3.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.755 -0.461 . . . . 10.0 109.755 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.422 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 2.2 p -66.62 123.53 86.02 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.315 -0.402 . . . . 10.0 110.964 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 138' ' ' THR . 16.7 Cg_exo -63.95 -24.0 67.66 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.731 2.288 . . . . 10.0 111.66 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -78.26 4.29 13.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.55 -0.75 . . . . 10.0 111.402 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -132.83 -72.61 0.51 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.758 -0.201 . . . . 10.0 110.991 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.0 m 60.33 14.94 5.02 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.321 0.581 . . . . 10.0 111.366 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.7 m -114.02 120.15 39.61 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.948 -0.569 . . . . 10.0 110.316 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.426 HD13 HD13 ' A' ' 121' ' ' LEU . 19.3 mm -110.22 119.71 59.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.964 -0.562 . . . . 10.0 109.737 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' A' ' 120' ' ' LEU . 1.6 m -83.19 123.91 30.02 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.345 -0.389 . . . . 10.0 110.32 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 13.4 t -97.52 124.95 50.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.135 -0.484 . . . . 10.0 111.942 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 13.7 mmt -117.94 118.37 31.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.53 -0.759 . . . . 10.0 109.494 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.466 HD13 ' HB2' ' A' ' 111' ' ' ALA . 35.4 mt -136.51 140.84 42.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 111.548 0.203 . . . . 10.0 111.548 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -106.68 120.13 49.31 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 108.264 -1.013 . . . . 10.0 108.264 178.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.87 126.19 12.95 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.39 2.06 . . . . 10.0 113.264 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -95.97 -13.17 24.04 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.731 -0.668 . . . . 10.0 110.197 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 68.8 mt -88.44 125.22 34.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.59 -0.732 . . . . 10.0 109.802 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.288 -0.863 . . . . 10.0 110.81 -179.235 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' -1' ' ' SER . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.477 0.878 0 CA-C-O 120.793 0.33 . . . . 10.0 111.668 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 0' ' ' VAL . . . . . . . . . . . . . 1.1 t -83.08 14.02 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 112.556 0.576 . . . . 10.0 112.556 -177.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -56.4 106.78 0.31 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.054 0.454 . . . . 10.0 111.594 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.16 13.23 31.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.505 -0.77 . . . . 10.0 111.288 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -81.12 126.08 31.02 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.398 -0.365 . . . . 10.0 110.559 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 1.3 m -84.82 142.54 29.69 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.764 -0.458 . . . . 10.0 109.764 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . 0.446 ' H ' ' HG2' ' B' ' 5' ' ' LYS . 1.6 ptpp? -60.14 -43.36 95.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.329 -0.396 . . . . 10.0 111.501 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -59.04 -36.27 74.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.574 0.226 . . . . 10.0 110.972 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -64.66 -50.96 65.0 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.073 0.464 . . . . 10.0 109.88 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.508 ' O ' HD13 ' B' ' 12' ' ' ILE . 44.3 mm -61.51 -46.79 95.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.567 -0.742 . . . . 10.0 110.961 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.36 -47.77 75.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.9 0.381 . . . . 10.0 110.971 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.94 -32.11 73.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.986 -0.552 . . . . 10.0 110.694 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.3 mt -69.48 -38.06 77.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.362 -0.381 . . . . 10.0 110.399 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.508 HD13 ' O ' ' B' ' 8' ' ' ILE . 1.4 mp -63.46 -50.94 76.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.027 -0.533 . . . . 10.0 110.622 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 12.3 m -67.83 -33.61 62.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.758 0.314 . . . . 10.0 110.722 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -67.38 -48.37 67.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.282 0.563 . . . . 10.0 110.074 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' TYR . . . . . 0.653 ' O ' HG12 ' B' ' 19' ' ' ILE . 15.9 t80 -60.56 -52.31 65.71 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.456 -0.793 . . . . 10.0 110.931 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -54.75 -46.76 74.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.27 -0.423 . . . . 10.0 111.64 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 27.3 m -59.55 -42.55 92.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.695 0.283 . . . . 10.0 111.279 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 23.6 p -72.44 -19.07 61.64 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 122.205 -0.309 . . . . 10.0 111.271 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.653 HG12 ' O ' ' B' ' 15' ' ' TYR . 31.5 mm -79.86 -39.8 20.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.996 0.427 . . . . 10.0 110.09 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 5.3 m -75.66 -22.79 16.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 121.503 0.668 . . . . 10.0 109.303 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -60.03 -48.99 79.44 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 114.616 -1.175 . . . . 10.0 110.862 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 3.5 mttp -102.08 6.73 41.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.809 -0.632 . . . . 10.0 110.797 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 26.9 mtpt 50.82 56.94 7.22 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.356 0.598 . . . . 10.0 110.589 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -90.6 33.68 0.91 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.425 -0.807 . . . . 10.0 110.973 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' ILE . . . . . 0.475 HG12 ' H ' ' B' ' 26' ' ' SER . 13.3 tt -168.44 168.63 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.218 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . 0.475 ' H ' HG12 ' B' ' 25' ' ' ILE . 1.9 m -58.21 154.8 12.47 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.926 0.491 . . . . 10.0 112.105 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -52.12 -58.22 7.25 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.911 0.708 . . . . 10.0 112.911 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -70.56 -23.59 62.63 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.244 0.545 . . . . 10.0 109.68 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.607 ' O ' ' HG ' ' B' ' 33' ' ' LEU . . . -63.96 -44.16 96.39 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 110.233 -1.147 . . . . 10.0 110.233 178.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.59 -40.69 95.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.168 0.509 . . . . 10.0 110.083 178.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -62.56 -43.22 99.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.465 -0.789 . . . . 10.0 110.051 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 50.9 m -62.64 -42.49 99.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.428 -0.806 . . . . 10.0 110.393 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 0.607 ' HG ' ' O ' ' B' ' 29' ' ' GLY . 82.2 mt -64.1 -38.91 92.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.35 -0.386 . . . . 10.0 110.341 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -65.77 -46.72 77.68 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.207 -0.451 . . . . 10.0 111.481 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.8 -38.33 80.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 116.451 -0.341 . . . . 10.0 111.091 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.55 -39.9 88.76 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.204 -0.665 . . . . 10.0 109.204 178.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' MET . . . . . 0.602 ' SD ' ' HD2' ' B' ' 48' ' ' ARG . 0.7 OUTLIER -59.23 -45.14 91.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.362 -0.836 . . . . 10.0 110.142 178.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -61.09 -46.2 91.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.427 -0.806 . . . . 10.0 110.691 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 7.8 t -67.58 -38.39 83.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 10.0 111.01 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' ILE . . . . . 0.484 HD13 HG21 ' B' ' 12' ' ' ILE . 55.9 mt -63.58 -39.02 83.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.878 0.37 . . . . 10.0 110.034 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.708 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 14.2 m -63.01 -38.49 91.38 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.52 -0.548 . . . . 10.0 109.52 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -69.78 -40.99 75.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.857 -0.61 . . . . 10.0 110.286 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.96 -39.45 81.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.48 -0.782 . . . . 10.0 111.975 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -94.89 -0.72 53.77 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.671 -0.24 . . . . 10.0 111.3 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.4 39.82 97.8 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-N 116.203 -0.453 . . . . 10.0 113.2 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.708 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 6.5 p90 -131.26 160.78 33.9 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.358 -0.608 . . . . 10.0 109.358 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -94.15 140.44 29.75 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.834 0.35 . . . . 10.0 110.61 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.602 ' HD2' ' SD ' ' B' ' 37' ' ' MET . 17.3 mtm180 -57.7 -29.68 64.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.899 -0.591 . . . . 10.0 111.664 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 30.4 mp0 -83.82 -0.42 51.05 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.594 -0.73 . . . . 10.0 112.894 -177.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.65 3.52 40.59 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 122.309 -0.245 . . . . 10.0 111.582 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.539 HG23 ' H ' ' B' ' 52' ' ' SER . 4.3 m -41.45 -59.75 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 113.215 0.82 . . . . 10.0 113.215 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' SER . . . . . 0.539 ' H ' HG23 ' B' ' 51' ' ' VAL . 0.1 OUTLIER -59.03 -20.96 58.04 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 113.103 0.779 . . . . 10.0 113.103 -179.527 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.88 -38.43 13.74 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.569 -0.824 . . . . 10.0 112.027 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 32.5 mt -86.25 -51.72 12.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 112.266 0.469 . . . . 10.0 112.266 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 83.5 mt -83.56 -67.31 0.8 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.18 0.515 . . . . 10.0 111.998 -178.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . 0.49 ' HA2' ' HB3' ' C' ' 71' ' ' SER . . . 78.03 -114.78 4.06 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 110.993 -0.843 . . . . 10.0 110.993 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 45.1 pttt -157.72 23.63 0.28 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.21 0.528 . . . . 10.0 110.381 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.61 35.53 0.41 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.757 -0.656 . . . . 10.0 111.391 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 50.82 73.04 0.31 Allowed 'General case' 0 N--CA 1.46 0.072 0 CA-C-N 116.292 -0.413 . . . . 10.0 110.653 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.23 94.93 0.39 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.314 0.578 . . . . 10.0 111.119 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 7.5 mttt -95.31 90.37 5.81 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.677 -0.692 . . . . 10.0 109.77 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -71.42 78.32 0.58 Allowed Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.733 -0.667 . . . . 10.0 112.219 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -67.34 90.56 0.23 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.255 0.55 . . . . 10.0 110.906 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -139.73 91.77 2.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.686 -0.688 . . . . 10.0 109.849 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 81.1 mt -85.41 -23.53 27.88 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.952 -0.567 . . . . 10.0 110.589 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . 59.51 19.83 8.29 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.664 0.602 . . . . 10.0 110.876 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 59.43 41.34 19.57 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.262 -0.881 . . . . 10.0 111.156 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 59.3 mt -94.99 106.74 18.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.106 0.479 . . . . 10.0 110.972 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -112.78 10.49 19.2 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.768 -0.651 . . . . 10.0 109.529 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -100.74 41.67 1.16 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.387 -0.824 . . . . 10.0 109.399 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.52 -32.92 73.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.371 -0.831 . . . . 10.0 110.964 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.543 -0.741 . . . . 10.0 109.512 179.715 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' -1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.483 1.197 0 CA-C-O 120.593 0.235 . . . . 10.0 111.448 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 0' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -106.54 50.37 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-O 121.531 0.682 . . . . 10.0 109.595 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -68.96 96.32 0.77 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.975 -1.012 . . . . 10.0 110.632 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.42 61.2 5.52 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.481 -0.781 . . . . 10.0 110.996 -178.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -139.8 143.44 36.87 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.773 -0.455 . . . . 10.0 109.773 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -98.78 138.52 35.81 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.489 -0.56 . . . . 10.0 109.489 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . 0.545 ' HB2' ' CE1' ' C' ' 44' ' ' PHE . 0.2 OUTLIER -60.64 -32.73 71.88 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.387 -0.37 . . . . 10.0 111.199 -179.233 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 6' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -59.75 -52.33 65.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.198 0.523 . . . . 10.0 110.288 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -55.62 -51.45 67.13 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.767 -0.651 . . . . 10.0 110.986 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 8' ' ' ILE . . . . . 0.668 ' O ' HG13 ' C' ' 12' ' ' ILE . 48.6 mm -57.18 -48.86 81.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.707 -0.679 . . . . 10.0 110.99 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.31 -44.98 72.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.044 0.45 . . . . 10.0 110.808 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.68 -33.78 76.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.752 -0.658 . . . . 10.0 110.877 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.58 -37.42 79.84 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.123 -0.325 . . . . 10.0 110.123 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 12' ' ' ILE . . . . . 0.668 HG13 ' O ' ' C' ' 8' ' ' ILE . 21.6 mt -64.01 -57.09 13.08 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.517 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 13' ' ' VAL . . . . . 0.55 HG12 ' HG2' ' C' ' 37' ' ' MET . 33.0 m -63.61 -26.2 40.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.682 -0.69 . . . . 10.0 111.506 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -75.73 -46.76 29.19 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.323 0.582 . . . . 10.0 109.603 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 15' ' ' TYR . . . . . 0.508 ' O ' HG12 ' C' ' 19' ' ' ILE . 46.9 t80 -64.07 -43.73 94.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.671 -0.695 . . . . 10.0 110.002 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -57.15 -42.67 81.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.982 -0.553 . . . . 10.0 110.292 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 67.0 m -57.95 -42.9 85.92 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.972 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.55 -20.68 58.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.541 -0.299 . . . . 10.0 111.647 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 19' ' ' ILE . . . . . 0.508 HG12 ' O ' ' C' ' 15' ' ' TYR . 19.7 mm -74.59 -40.45 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.181 0.515 . . . . 10.0 109.764 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 20' ' ' VAL . . . . . . . . . . . . . 17.8 m -82.14 -17.2 11.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.787 -0.642 . . . . 10.0 109.728 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -64.47 -59.61 4.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.369 -0.832 . . . . 10.0 110.163 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -87.73 -3.31 58.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.371 -0.377 . . . . 10.0 110.493 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 64.4 mttm 59.49 58.22 3.03 Favored 'General case' 0 C--N 1.334 -0.066 0 CA-C-N 115.747 -0.661 . . . . 10.0 109.954 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -86.23 9.84 16.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.469 -0.787 . . . . 10.0 110.935 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 15.2 tt -144.36 165.53 13.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.361 -0.607 . . . . 10.0 109.361 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.04 154.67 22.16 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 122.524 0.329 . . . . 10.0 111.243 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -56.3 -46.99 79.56 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.386 -0.37 . . . . 10.0 111.151 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 28' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -64.34 -35.2 80.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.229 0.538 . . . . 10.0 109.736 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 29' ' ' GLY . . . . . 0.575 ' O ' ' HG ' ' C' ' 33' ' ' LEU . . . -66.3 -39.97 94.52 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 110.918 -0.873 . . . . 10.0 110.918 178.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.14 -39.15 93.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.923 0.392 . . . . 10.0 110.27 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -62.81 -42.06 99.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.591 -0.731 . . . . 10.0 109.812 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 32' ' ' SER . . . . . 0.4 ' HB2' HD13 ' A' ' 81' ' ' ILE . 19.4 t -64.96 -43.76 91.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.365 -0.834 . . . . 10.0 110.763 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 33' ' ' LEU . . . . . 0.575 ' HG ' ' O ' ' C' ' 29' ' ' GLY . 64.2 mt -67.96 -27.73 66.85 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.336 -0.393 . . . . 10.0 110.933 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -73.04 -39.25 66.09 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 116.477 -0.328 . . . . 10.0 111.561 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 35' ' ' VAL . . . . . 0.412 HG23 ' HA ' ' A' ' 122' ' ' LYS . 10.2 p -75.17 -36.05 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 N-CA-C 109.535 -0.543 . . . . 10.0 109.535 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.96 -34.58 78.07 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.702 -0.681 . . . . 10.0 110.097 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 37' ' ' MET . . . . . 0.55 ' HG2' HG12 ' C' ' 13' ' ' VAL . 2.9 ttm -54.3 -53.48 53.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.54 -0.755 . . . . 10.0 110.986 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 38' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -69.92 -25.97 63.92 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 121.096 -0.242 . . . . 10.0 110.905 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 39' ' ' CYS . . . . . . . . . . . . . 1.1 t -66.47 -47.62 72.5 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.587 -0.523 . . . . 10.0 109.587 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 40' ' ' ILE . . . . . . . . . . . . . 11.4 mt -67.99 -37.86 78.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.688 -0.687 . . . . 10.0 109.835 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 41' ' ' SER . . . . . 0.609 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 35.4 m -63.25 -43.51 97.79 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.916 -0.584 . . . . 10.0 110.274 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -66.67 -39.76 88.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.789 -0.641 . . . . 10.0 110.47 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.82 -39.06 80.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.921 -0.581 . . . . 10.0 112.027 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 44' ' ' PHE . . . . . 0.545 ' CE1' ' HB2' ' C' ' 5' ' ' LYS . 65.2 m-85 -96.98 -3.33 41.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.68 -0.236 . . . . 10.0 111.59 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.68 39.53 97.62 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.212 -0.518 . . . . 10.0 113.446 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 46' ' ' PHE . . . . . 0.609 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 4.8 p90 -131.88 154.7 48.94 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.397 -0.594 . . . . 10.0 109.397 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -94.24 145.27 24.84 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.644 -0.422 . . . . 10.0 110.656 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 48' ' ' ARG . . . . . 0.411 ' H ' ' HG3' ' C' ' 48' ' ' ARG . 10.8 mtm-85 -63.27 -15.74 58.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.301 0.572 . . . . 10.0 110.233 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -80.16 -11.08 59.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.57 -0.741 . . . . 10.0 112.406 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -93.53 2.41 56.43 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.254 0.465 . . . . 10.0 112.254 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 12.1 m -47.58 -44.92 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 113.39 0.885 . . . . 10.0 113.39 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.21 -44.7 92.26 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.821 0.674 . . . . 10.0 112.821 -179.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.2 -26.69 74.42 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.338 -0.934 . . . . 10.0 112.679 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 54' ' ' ILE . . . . . . . . . . . . . 67.3 mt -84.56 -63.44 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.947 0.403 . . . . 10.0 111.962 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 19.0 mt -70.82 -61.1 1.89 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.591 0.589 . . . . 10.0 112.591 -178.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 66.28 -130.0 31.94 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 111.04 -0.824 . . . . 10.0 111.04 -177.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 11.2 pttp -151.35 28.75 0.64 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.187 0.518 . . . . 10.0 110.35 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.55 30.82 0.78 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.013 -0.539 . . . . 10.0 111.121 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 61.05 86.33 0.1 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.747 -0.661 . . . . 10.0 111.022 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 60' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -72.58 81.32 1.09 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.364 0.602 . . . . 10.0 110.707 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -83.39 71.36 10.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.616 -0.72 . . . . 10.0 110.277 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.81 74.04 2.03 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.756 -0.656 . . . . 10.0 112.369 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 63' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -66.74 100.31 0.69 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.909 0.385 . . . . 10.0 110.298 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 64' ' ' HIS . . . . . . . . . . . . . 17.0 t60 -133.4 85.73 2.23 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.183 -0.462 . . . . 10.0 109.872 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 74.1 mt -67.57 -31.03 70.82 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.687 -0.688 . . . . 10.0 111.327 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . 60.86 23.22 13.26 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.485 0.491 . . . . 10.0 110.715 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 63.63 35.84 11.3 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.243 -0.89 . . . . 10.0 111.743 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 68' ' ' ILE . . . . . . . . . . . . . 96.5 mt -83.49 109.01 16.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.086 0.47 . . . . 10.0 111.417 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.86 -5.63 10.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.018 -0.537 . . . . 10.0 109.99 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 70' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -92.16 44.71 1.18 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.345 0.593 . . . . 10.0 110.135 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 71' ' ' SER . . . . . 0.49 ' HB3' ' HA2' ' B' ' 56' ' ' GLY . 1.9 p -94.21 31.58 1.67 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.945 -0.571 . . . . 10.0 110.598 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.887 0 CA-C-N 115.864 -0.607 . . . . 10.0 109.532 -179.737 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 84.4 mmm . . . . . 0 N--CA 1.478 0.974 0 CA-C-O 120.553 0.216 . . . . 10.0 110.754 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.0 p -114.74 121.75 67.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.191 0.52 . . . . 10.0 110.307 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -85.36 138.66 32.14 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.837 -0.62 . . . . 10.0 110.285 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.8 mp -127.97 125.22 39.06 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.964 -0.562 . . . . 10.0 109.929 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.45 HG23 ' HG2' ' A' ' 89' ' ' GLU . 3.0 m -93.45 106.84 18.77 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.015 -0.539 . . . . 10.0 110.417 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 87' ' ' SER . 3.4 mm? -80.73 110.53 16.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.958 -0.565 . . . . 10.0 110.089 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -121.42 108.63 13.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.654 -0.703 . . . . 10.0 110.626 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.1 tttm -106.15 125.69 51.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.245 -0.434 . . . . 10.0 110.959 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.46 HG21 ' OG ' ' C' ' 32' ' ' SER . 2.0 mp -83.91 -49.31 16.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 115.525 -0.761 . . . . 10.0 110.546 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -64.8 151.55 45.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.093 -0.503 . . . . 10.0 110.76 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.94 136.47 76.6 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.334 -0.393 . . . . 10.0 111.437 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -74.31 135.79 41.91 Favored 'Cis proline' 0 C--N 1.345 0.387 0 C-N-CA 123.73 -1.363 . . . . 10.0 111.682 -1.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -92.02 151.76 20.31 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.36 -0.382 . . . . 10.0 110.572 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.522 ' CZ ' ' HB3' ' A' ' 110' ' ' LYS . 33.8 p90 -171.18 165.73 7.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.124 -0.489 . . . . 10.0 111.193 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 51.1 m -148.41 103.57 3.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.547 -0.751 . . . . 10.0 109.591 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.5 pt -135.13 163.73 35.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.423 -0.353 . . . . 10.0 110.436 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.45 ' HG2' HG23 ' A' ' 77' ' ' THR . 5.2 mt-10 -114.8 148.72 38.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.712 0.291 . . . . 10.0 111.316 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 24.4 m80 -145.89 145.74 30.83 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.05 -0.722 . . . . 10.0 109.05 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -102.01 127.42 48.9 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.175 -0.676 . . . . 10.0 109.175 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -121.44 170.32 9.76 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.483 0.659 . . . . 10.0 111.618 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.0 145.76 33.74 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 115.172 -0.922 . . . . 10.0 109.16 178.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.12 -25.67 37.29 Favored 'Trans proline' 0 CA--C 1.527 0.156 0 C-N-CA 122.108 1.872 . . . . 10.0 112.523 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.89 17.06 8.28 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.823 0.344 . . . . 10.0 111.02 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -91.98 170.19 10.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.392 -0.367 . . . . 10.0 110.453 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.85 159.55 22.89 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.022 -0.536 . . . . 10.0 110.387 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.546 ' HB ' ' HA ' ' A' ' 128' ' ' ASP . 49.2 mm -66.8 -23.43 31.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.49 0.662 . . . . 10.0 109.835 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -57.96 -43.26 86.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.428 -0.806 . . . . 10.0 110.642 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -63.47 -33.9 76.59 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.16 -0.473 . . . . 10.0 111.275 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 47.7 mt -64.85 -44.75 96.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.3 -0.409 . . . . 10.0 110.184 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -54.76 -45.58 74.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.762 -0.653 . . . . 10.0 110.81 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -71.59 -33.09 68.74 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.701 -0.681 . . . . 10.0 110.425 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -64.62 -43.52 93.46 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.814 -0.63 . . . . 10.0 110.363 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 36.6 mt -60.53 -41.57 94.71 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.332 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 85.2 mt -62.35 -38.35 80.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.048 -0.523 . . . . 10.0 110.601 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.1 m -65.36 -26.82 68.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.074 -0.512 . . . . 10.0 111.547 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -98.83 12.92 34.24 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.936 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 59.94 24.5 13.62 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.69 -0.686 . . . . 10.0 111.558 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.522 ' HB3' ' CZ ' ' A' ' 86' ' ' PHE . 41.6 mmtm -91.02 -16.85 27.25 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.475 0.655 . . . . 10.0 109.339 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.415 ' CB ' HD13 ' A' ' 148' ' ' ILE . . . -137.86 151.2 47.81 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.89 -1.05 . . . . 10.0 109.837 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.4 m -101.86 -46.73 4.81 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.812 -0.355 . . . . 10.0 111.643 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.496 ' O ' HG13 ' A' ' 117' ' ' ILE . 1.7 t-160 -134.72 127.92 31.95 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.789 -0.364 . . . . 10.0 111.498 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.554 ' HA ' HD12 ' A' ' 117' ' ' ILE . 11.2 tt -56.47 -41.85 73.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 115.746 -0.661 . . . . 10.0 111.572 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.43 -14.19 26.32 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.291 -0.868 . . . . 10.0 113.274 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -114.22 13.6 17.97 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.076 -0.39 . . . . 10.0 111.797 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.554 HD12 ' HA ' ' A' ' 114' ' ' ILE . 62.0 mt -99.61 121.31 50.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.751 0.31 . . . . 10.0 111.038 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -126.11 117.96 24.26 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.473 -0.33 . . . . 10.0 110.248 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -94.4 138.27 32.55 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.235 0.541 . . . . 10.0 111.562 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -120.38 133.45 55.44 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.102 -1.073 . . . . 10.0 108.102 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 53.6 tp -115.96 96.53 5.63 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 106.009 -1.849 . . . . 10.0 106.009 178.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.9 tptm 43.8 64.9 1.13 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 114.648 -1.16 . . . . 10.0 110.628 -177.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.689 ' HA2' ' SG ' ' C' ' 39' ' ' CYS . . . 80.88 -47.87 3.62 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.556 -0.747 . . . . 10.0 113.859 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 39.5 tttp -67.38 120.76 14.41 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 109.419 -0.586 . . . . 10.0 109.419 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.1 p -66.06 139.42 21.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.356 0.598 . . . . 10.0 112.499 -178.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 126' ' ' LEU . 2.3 tp -105.69 103.1 12.54 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.645 -0.707 . . . . 10.0 110.253 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -69.98 143.46 52.6 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.074 -0.966 . . . . 10.0 111.876 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.546 ' HA ' ' HB ' ' A' ' 98' ' ' ILE . 0.3 OUTLIER -61.57 -39.87 92.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.718 -0.674 . . . . 10.0 112.223 -179.561 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -73.88 -9.35 58.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.331 -0.395 . . . . 10.0 111.553 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 17.1 tp -76.85 142.01 40.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.251 -0.432 . . . . 10.0 110.356 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.467 ' HB2' ' HB2' ' A' ' 134' ' ' ASP . 41.2 m-85 -93.8 149.74 20.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.057 -0.52 . . . . 10.0 110.659 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 34.3 mt -59.32 -38.52 80.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.93 0.395 . . . . 10.0 111.21 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.24 -19.73 61.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.257 -0.429 . . . . 10.0 111.01 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.467 ' HB2' ' HB2' ' A' ' 131' ' ' PHE . 13.3 t0 -81.56 -40.37 23.18 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.738 -0.664 . . . . 10.0 111.108 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.3 pp -83.87 -26.36 29.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.508 -0.315 . . . . 10.0 111.317 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 96.0 mttt 63.07 99.18 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 O-C-N 123.659 0.599 . . . . 10.0 112.202 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.0 t -79.92 114.23 20.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.073 -0.512 . . . . 10.0 110.298 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.85 137.76 76.59 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.34 -0.391 . . . . 10.0 111.289 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -62.78 -16.99 57.0 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.818 2.345 . . . . 10.0 112.692 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -106.03 6.32 31.08 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.067 0.461 . . . . 10.0 110.924 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -140.34 71.28 1.37 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.753 -0.658 . . . . 10.0 109.536 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.4 t -99.27 11.81 38.0 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.654 -0.703 . . . . 10.0 110.17 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.35 95.58 5.76 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.127 0.489 . . . . 10.0 110.672 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 24.9 mm -92.37 104.4 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 N-CA-C 107.527 -1.286 . . . . 10.0 107.527 177.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.93 121.45 26.5 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.203 -0.453 . . . . 10.0 110.234 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 10.4 t -105.62 136.95 37.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.777 -0.647 . . . . 10.0 111.775 -178.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 25.1 mmt -136.0 120.78 18.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.126 -0.943 . . . . 10.0 108.643 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.415 HD13 ' CB ' ' A' ' 111' ' ' ALA . 11.8 mt -139.68 94.05 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.723 -0.391 . . . . 10.0 111.119 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -94.35 107.09 27.03 Favored Pre-proline 0 C--N 1.32 -0.706 0 N-CA-C 109.213 -0.662 . . . . 10.0 109.213 175.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.96 147.23 43.23 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.508 2.139 . . . . 10.0 112.759 -178.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -83.9 101.98 12.06 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.536 -0.756 . . . . 10.0 110.174 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 46.3 mt -90.01 148.88 22.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.22 -0.446 . . . . 10.0 110.413 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.494 -0.765 . . . . 10.0 109.946 -179.72 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' -1' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.474 0.735 0 CA-C-O 120.47 0.176 . . . . 10.0 110.779 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 0' ' ' VAL . . . . . . . . . . . . . 3.6 m -135.86 -175.0 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.304 -0.628 . . . . 10.0 109.304 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -171.11 -79.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.002 0.429 . . . . 10.0 110.12 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 70.6 m -155.53 -31.72 0.1 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.144 -0.48 . . . . 10.0 110.382 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.39 134.51 57.07 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.222 -0.445 . . . . 10.0 110.588 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . 0.487 ' O ' HG12 ' B' ' 8' ' ' ILE . 64.6 p -94.68 178.86 5.45 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.062 -0.517 . . . . 10.0 110.717 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . 0.403 ' HE2' ' O ' ' C' ' 24' ' ' GLU . 7.8 ptpp? -54.34 -44.69 72.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.046 -0.525 . . . . 10.0 111.33 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -59.04 -47.19 86.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.408 -0.36 . . . . 10.0 111.487 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -59.86 -45.4 92.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.828 0.347 . . . . 10.0 110.511 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.487 HG12 ' O ' ' B' ' 4' ' ' SER . 37.2 mm -60.17 -49.62 83.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.739 -0.664 . . . . 10.0 110.505 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.4 -41.76 85.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.392 -0.367 . . . . 10.0 111.191 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.57 -38.09 89.81 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.207 0.527 . . . . 10.0 110.44 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 40.7 mt -66.1 -39.32 89.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.949 -0.569 . . . . 10.0 109.63 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.421 HD13 ' O ' ' B' ' 8' ' ' ILE . 1.3 mp -56.8 -46.85 83.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.311 -0.858 . . . . 10.0 111.406 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 12.9 m -71.72 -29.78 35.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.579 -0.448 . . . . 10.0 111.731 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -73.88 -41.62 61.91 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.749 0.309 . . . . 10.0 111.288 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -69.38 -43.6 73.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.379 -0.373 . . . . 10.0 111.199 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' PHE . . . . . 0.404 ' CE2' HG23 ' B' ' 12' ' ' ILE . 14.7 m-30 -61.43 -49.86 75.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.408 -0.36 . . . . 10.0 111.03 -179.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 6.0 p -57.65 -45.26 85.74 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.929 0.344 . . . . 10.0 111.929 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 5.0 p -69.02 -21.25 64.13 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.036 0.384 . . . . 10.0 112.036 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 22.5 mm -85.65 -43.58 16.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 120.689 -0.404 . . . . 10.0 110.676 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 26.9 m -73.54 -35.2 44.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.891 -0.324 . . . . 10.0 111.294 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -68.8 -38.28 79.82 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 120.487 -0.485 . . . . 10.0 110.235 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 33.2 mtmt -75.12 -7.15 52.97 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.132 -0.322 . . . . 10.0 110.132 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 29.8 mmtm 57.63 41.33 25.69 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.808 -0.633 . . . . 10.0 110.375 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.467 ' O ' ' HE2' ' C' ' 5' ' ' LYS . 38.4 mt-10 -91.61 9.83 30.61 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.529 -0.759 . . . . 10.0 110.338 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 9.0 tp -141.99 150.18 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 N-CA-C 108.834 -0.802 . . . . 10.0 108.834 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 1.2 p -62.65 154.95 27.62 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.287 -0.264 . . . . 10.0 110.287 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -57.21 -32.56 66.62 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.672 0.273 . . . . 10.0 110.712 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -63.2 -46.64 86.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.419 0.628 . . . . 10.0 109.716 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.539 ' O ' ' HG ' ' B' ' 33' ' ' LEU . . . -71.13 -40.72 61.37 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.542 -0.754 . . . . 10.0 111.384 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.73 -42.77 93.9 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.898 0.38 . . . . 10.0 111.069 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.415 ' O ' HG12 ' B' ' 35' ' ' VAL . 27.7 t0 -61.34 -44.19 97.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.619 -0.719 . . . . 10.0 110.214 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 13.4 m -65.52 -41.52 93.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.703 -0.68 . . . . 10.0 110.64 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' B' ' 29' ' ' GLY . 82.1 mt -66.08 -43.63 86.79 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.792 0.33 . . . . 10.0 111.296 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -60.3 -51.02 71.3 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 116.001 -0.545 . . . . 10.0 112.206 -178.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.415 HG12 ' O ' ' B' ' 31' ' ' ASP . 7.1 p -66.64 -42.06 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 120.797 -0.361 . . . . 10.0 111.063 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.43 -35.0 77.88 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.947 0.403 . . . . 10.0 110.419 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' MET . . . . . . . . . . . . . 22.7 ttm -56.24 -51.12 69.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.578 -0.737 . . . . 10.0 111.033 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.97 -33.63 76.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.073 -0.512 . . . . 10.0 111.508 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 39.9 m -65.28 -42.95 92.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.015 0.436 . . . . 10.0 110.284 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 46.7 mt -67.27 -34.52 69.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.844 -0.617 . . . . 10.0 110.321 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.665 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 50.9 m -65.23 -40.51 94.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.061 -0.518 . . . . 10.0 110.74 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -72.72 -27.47 62.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 10.0 111.284 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.45 -39.37 81.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.981 -0.554 . . . . 10.0 111.54 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -97.13 -0.84 46.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.333 -0.394 . . . . 10.0 111.869 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.23 60.62 7.29 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.351 -0.452 . . . . 10.0 114.168 178.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.665 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 13.6 p90 -154.11 167.78 28.7 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.028 -0.36 . . . . 10.0 110.028 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -98.93 151.62 20.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.013 0.435 . . . . 10.0 110.379 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 3.9 mtm180 -71.34 -28.21 63.91 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.129 0.49 . . . . 10.0 110.632 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -84.51 7.34 20.24 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.054 -0.521 . . . . 10.0 112.257 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.13 4.38 48.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.513 0.197 . . . . 10.0 111.523 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.453 HG23 ' H ' ' B' ' 52' ' ' SER . 4.8 m -41.37 -57.39 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 113.425 0.898 . . . . 10.0 113.425 -179.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' SER . . . . . 0.453 ' H ' HG23 ' B' ' 51' ' ' VAL . 0.6 OUTLIER -53.72 -36.54 62.37 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.824 0.675 . . . . 10.0 112.824 -179.28 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.72 -42.25 32.35 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.934 -0.651 . . . . 10.0 113.353 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 24.8 mt -83.69 -45.64 18.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 112.253 0.464 . . . . 10.0 112.253 -178.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 81.0 mt -73.17 -64.27 1.01 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.949 0.404 . . . . 10.0 111.378 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.25 -151.05 48.11 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.912 -0.661 . . . . 10.0 112.403 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 10.0 tttt -100.08 6.92 44.96 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.073 0.463 . . . . 10.0 110.466 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.47 134.89 55.42 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.565 -0.743 . . . . 10.0 110.289 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -87.59 122.97 31.97 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.178 0.513 . . . . 10.0 110.648 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -88.0 156.44 19.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.767 -0.651 . . . . 10.0 110.371 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -154.82 168.07 28.14 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.163 -0.472 . . . . 10.0 110.306 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -150.16 60.6 0.42 Allowed Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 111.455 -0.658 . . . . 10.0 111.455 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -79.52 127.89 32.7 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.769 -0.456 . . . . 10.0 109.769 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 46.0 p-80 -145.76 109.08 4.65 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.02 -0.537 . . . . 10.0 110.395 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -82.63 -13.05 57.16 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.453 0.644 . . . . 10.0 109.623 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -84.51 120.92 26.88 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.26 -0.882 . . . . 10.0 109.199 178.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.6 148.03 49.93 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.103 -0.499 . . . . 10.0 110.692 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . 0.406 HD12 ' HA ' ' C' ' 52' ' ' SER . 15.7 mt -81.57 83.69 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.294 -0.412 . . . . 10.0 109.901 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 97.4 mt 70.66 -67.8 0.23 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.142 -0.935 . . . . 10.0 111.039 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -148.88 -14.43 0.31 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.224 -0.444 . . . . 10.0 110.871 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 14.2 m 58.21 35.52 25.06 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 123.488 0.493 . . . . 10.0 111.013 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.696 -0.669 . . . . 10.0 110.667 -179.888 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' -1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.478 0.946 0 CA-C-O 120.901 0.381 . . . . 10.0 111.105 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 0' ' ' VAL . . . . . . . . . . . . . 13.5 m -128.54 168.31 22.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.978 -0.379 . . . . 10.0 109.978 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -135.39 -58.93 0.78 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.598 0.237 . . . . 10.0 111.289 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 48.2 m -157.01 -21.53 0.09 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.929 0.395 . . . . 10.0 110.785 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.31 145.8 55.43 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.972 -0.558 . . . . 10.0 111.336 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 4' ' ' SER . . . . . 0.553 ' O ' HG12 ' C' ' 8' ' ' ILE . 0.7 OUTLIER -109.89 166.32 11.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.246 -0.434 . . . . 10.0 110.106 179.857 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . 0.491 ' HB2' ' CE1' ' C' ' 44' ' ' PHE . 10.3 ptpp? -51.86 -38.67 56.9 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 123.515 0.51 . . . . 10.0 111.863 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 6' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 -59.39 -54.59 44.93 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.381 -0.372 . . . . 10.0 111.494 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -60.91 -40.3 92.62 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.688 0.28 . . . . 10.0 110.34 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 8' ' ' ILE . . . . . 0.553 HG12 ' O ' ' C' ' 4' ' ' SER . 48.4 mm -60.0 -47.73 90.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.88 -0.6 . . . . 10.0 109.658 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.39 -44.82 76.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.966 -0.561 . . . . 10.0 111.203 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . 0.41 ' HB2' HD12 ' C' ' 54' ' ' ILE . . . -65.82 -40.56 91.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.913 -0.585 . . . . 10.0 111.089 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 32.4 mt -61.36 -39.1 89.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.903 0.382 . . . . 10.0 110.26 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 12' ' ' ILE . . . . . 0.538 HD13 ' O ' ' C' ' 8' ' ' ILE . 1.6 mp -63.17 -54.87 27.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.656 -0.702 . . . . 10.0 111.75 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 28.5 m -66.56 -26.04 36.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.262 0.467 . . . . 10.0 112.262 -178.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 14' ' ' ASN . . . . . 0.549 ' HB2' HG11 ' C' ' 51' ' ' VAL . 0.7 OUTLIER -76.24 -40.09 52.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.981 0.419 . . . . 10.0 110.433 -179.668 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 15' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -72.6 -45.11 60.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.151 -0.477 . . . . 10.0 111.32 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -56.51 -49.67 74.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.371 -0.377 . . . . 10.0 110.846 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 10.0 p -58.48 -45.07 89.43 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.43 -0.35 . . . . 10.0 111.586 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 4.4 p -69.33 -22.24 63.78 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.805 -0.358 . . . . 10.0 111.845 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 19' ' ' ILE . . . . . . . . . . . . . 20.2 mm -79.34 -43.39 23.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 110.129 -0.322 . . . . 10.0 110.129 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 20' ' ' VAL . . . . . . . . . . . . . 4.2 m -73.99 -27.83 22.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.71 0.29 . . . . 10.0 110.385 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -69.84 -53.62 17.3 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.905 -0.406 . . . . 10.0 109.905 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 34.5 mtmt -70.67 -6.79 39.74 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.843 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm 61.48 47.03 6.96 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.251 0.548 . . . . 10.0 110.426 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . 0.403 ' O ' ' HE2' ' B' ' 5' ' ' LYS . 9.1 mt-10 -85.41 -3.93 59.0 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.827 -0.624 . . . . 10.0 110.422 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 11.2 tt -134.94 159.45 41.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.056 -0.52 . . . . 10.0 110.129 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -68.19 166.35 16.45 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.218 0.207 . . . . 10.0 111.272 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -53.74 -50.34 66.18 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.066 0.395 . . . . 10.0 112.066 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.76 -47.37 77.11 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.033 0.444 . . . . 10.0 110.48 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.09 -42.44 91.94 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.833 -0.699 . . . . 10.0 112.028 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.35 -41.68 80.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.881 0.372 . . . . 10.0 110.963 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -68.07 -38.47 82.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.952 -0.567 . . . . 10.0 110.163 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 32' ' ' SER . . . . . 0.46 ' OG ' HG21 ' A' ' 81' ' ' ILE . 48.7 m -61.74 -29.37 70.07 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.455 -0.793 . . . . 10.0 109.938 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 33' ' ' LEU . . . . . 0.464 ' O ' ' HG3' ' C' ' 37' ' ' MET . 48.4 mt -77.76 -37.11 49.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.341 -0.39 . . . . 10.0 110.359 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -58.36 -53.63 56.13 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.06 -0.518 . . . . 10.0 110.369 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 35' ' ' VAL . . . . . 0.4 HG23 ' H ' ' A' ' 123' ' ' GLY . 9.4 p -67.2 -38.58 81.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 115.361 -0.836 . . . . 10.0 110.681 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.94 -40.97 95.3 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 120.669 0.271 . . . . 10.0 111.257 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 37' ' ' MET . . . . . 0.464 ' HG3' ' O ' ' C' ' 33' ' ' LEU . 70.8 mtm -54.74 -47.14 74.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.426 -0.352 . . . . 10.0 110.593 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 38' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -69.41 -28.65 66.33 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 116.468 -0.333 . . . . 10.0 110.855 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 39' ' ' CYS . . . . . 0.689 ' SG ' ' HA2' ' A' ' 123' ' ' GLY . 91.8 m -61.25 -42.84 99.32 Favored 'General case' 0 CA--C 1.522 -0.115 0 N-CA-C 108.871 -0.789 . . . . 10.0 108.871 177.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 40' ' ' ILE . . . . . . . . . . . . . 1.4 mp -73.25 -46.11 51.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 114.84 -1.073 . . . . 10.0 110.704 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 41' ' ' SER . . . . . 0.621 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 9.2 m -60.98 -42.09 97.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.406 -0.361 . . . . 10.0 111.585 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -72.96 -29.28 62.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.412 -0.358 . . . . 10.0 110.506 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.6 -46.8 65.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.154 -0.476 . . . . 10.0 111.727 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 44' ' ' PHE . . . . . 0.491 ' CE1' ' HB2' ' C' ' 5' ' ' LYS . 93.4 m-85 -92.18 -7.03 49.49 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.089 0.403 . . . . 10.0 112.089 -178.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.36 60.86 5.18 Favored Glycine 0 C--O 1.227 -0.309 0 C-N-CA 121.244 -0.503 . . . . 10.0 113.889 178.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 46' ' ' PHE . . . . . 0.621 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 3.6 p90 -153.56 169.25 23.67 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 110.179 -0.304 . . . . 10.0 110.179 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 51.5 mp0 -99.23 144.08 28.76 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.803 0.335 . . . . 10.0 110.85 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.95 -28.36 69.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.214 0.53 . . . . 10.0 110.965 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -80.1 14.33 1.92 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.733 -0.667 . . . . 10.0 112.509 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -104.72 2.82 30.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.24 0.543 . . . . 10.0 110.753 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 51' ' ' VAL . . . . . 0.549 HG11 ' HB2' ' C' ' 14' ' ' ASN . 1.7 m -49.44 -45.78 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 113.546 0.943 . . . . 10.0 113.546 -179.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 52' ' ' SER . . . . . 0.406 ' HA ' HD12 ' B' ' 68' ' ' ILE . 0.4 OUTLIER -60.63 -27.22 67.61 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.785 0.291 . . . . 10.0 111.785 -179.338 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.91 -37.78 12.54 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.845 -0.693 . . . . 10.0 112.667 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 54' ' ' ILE . . . . . 0.41 HD12 ' HB2' ' C' ' 10' ' ' ALA . 40.0 mt -81.14 -56.35 6.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 O-C-N 122.697 -0.296 . . . . 10.0 111.253 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 26.5 mt -67.01 -41.24 87.0 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.229 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 58.08 -139.41 47.61 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.621 -0.718 . . . . 10.0 112.077 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 66.2 tttt -108.76 -6.34 15.93 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.074 0.464 . . . . 10.0 110.32 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 3.1 m -65.34 148.21 52.09 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.622 -0.717 . . . . 10.0 111.27 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -97.01 134.39 40.44 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.068 0.461 . . . . 10.0 110.146 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 60' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -98.87 153.33 18.88 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.373 -0.376 . . . . 10.0 110.465 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 7.8 ptmm? -134.64 162.03 33.47 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.424 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -138.78 39.22 1.59 Allowed Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 111.381 -0.687 . . . . 10.0 111.381 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 63' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -60.98 145.03 52.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.784 0.326 . . . . 10.0 110.42 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 64' ' ' HIS . . . . . . . . . . . . . 42.2 p-80 -161.67 113.16 1.72 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.064 -0.516 . . . . 10.0 109.958 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . 0.402 HD22 ' N ' ' C' ' 65' ' ' LEU . 3.2 mm? -89.34 -20.64 23.79 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.927 -0.579 . . . . 10.0 109.825 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -76.92 147.57 36.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.47 -0.786 . . . . 10.0 110.056 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -79.33 149.03 31.87 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.994 0.426 . . . . 10.0 110.96 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 68' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -91.53 82.34 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.89 -0.596 . . . . 10.0 110.324 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 93.4 mt 69.53 -73.95 0.09 Allowed 'General case' 0 N--CA 1.465 0.279 0 O-C-N 124.068 0.855 . . . . 10.0 110.696 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 70' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -132.27 -21.95 2.28 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.818 -0.628 . . . . 10.0 110.95 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 71' ' ' SER . . . . . . . . . . . . . 15.2 m 60.42 30.59 19.91 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.954 -0.566 . . . . 10.0 111.335 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.869 0 CA-C-O 118.522 -0.751 . . . . 10.0 109.868 179.961 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.4 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 33.7 mtm . . . . . 0 N--CA 1.481 1.084 0 N-CA-C 110.321 -0.251 . . . . 10.0 110.321 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.4 t -95.58 139.36 19.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.845 0.355 . . . . 10.0 111.475 -178.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.448 ' CD2' ' HB3' ' A' ' 91' ' ' ASP . 4.8 m170 -91.53 126.3 36.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.075 -0.511 . . . . 10.0 110.629 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.6 mp -126.9 120.03 28.18 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.01 -0.541 . . . . 10.0 109.923 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.1 m -94.07 114.75 26.97 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.452 -0.573 . . . . 10.0 109.452 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.426 ' O ' ' HA ' ' A' ' 87' ' ' SER . 2.5 mm? -88.3 122.67 32.08 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.283 -0.417 . . . . 10.0 110.679 -178.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -122.95 104.58 9.33 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.969 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -92.11 120.57 32.84 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.909 -0.404 . . . . 10.0 109.909 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 20.8 mt -86.83 -59.46 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.573 -0.285 . . . . 10.0 111.649 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -57.0 158.12 5.21 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.75 0.309 . . . . 10.0 111.397 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.28 138.6 55.92 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.42 -0.355 . . . . 10.0 111.059 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -74.2 130.73 21.54 Favored 'Cis proline' 0 C--O 1.237 0.435 0 C-N-CA 123.039 -1.65 . . . . 10.0 111.87 -1.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.4 ' HG3' ' H ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -87.8 152.62 21.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.422 -0.353 . . . . 10.0 111.271 -179.277 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -177.52 170.75 2.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.736 -0.665 . . . . 10.0 110.03 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 15.2 m -151.17 133.42 15.32 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.123 -0.49 . . . . 10.0 109.696 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.411 HG13 ' HB2' ' A' ' 78' ' ' LEU . 9.1 pt -138.16 150.31 24.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.932 0.396 . . . . 10.0 111.383 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -113.58 120.4 40.82 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.359 -0.608 . . . . 10.0 109.359 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.39 167.39 23.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.014 0.435 . . . . 10.0 111.433 -178.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.448 ' HB3' ' CD2' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -121.4 131.57 54.25 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.848 -0.614 . . . . 10.0 110.905 179.101 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.4 ' O ' ' HB3' ' A' ' 73' ' ' MET . 86.0 m-85 -118.74 168.8 10.39 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.727 -0.669 . . . . 10.0 109.85 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.608 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 7.4 t -80.89 146.95 60.74 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 116.545 -0.298 . . . . 10.0 110.398 -179.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.1 -22.62 70.47 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.245 1.963 . . . . 10.0 111.747 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 43.3 m -100.08 13.32 34.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.978 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.608 ' HB2' ' O ' ' A' ' 93' ' ' SER . 1.0 OUTLIER -80.52 163.11 23.97 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.528 -179.889 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.4 p -115.49 160.66 19.63 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.583 -0.735 . . . . 10.0 110.576 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 47.7 mm -65.28 -21.31 29.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.368 0.604 . . . . 10.0 109.438 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.28 -39.29 82.46 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.41 -0.814 . . . . 10.0 110.235 178.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -63.84 -40.24 96.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.103 -0.498 . . . . 10.0 110.316 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.526 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 54.1 mt -65.93 -48.6 81.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.841 -0.618 . . . . 10.0 109.499 178.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.418 ' CD ' HG13 ' A' ' 114' ' ' ILE . 53.2 mttt -53.64 -48.01 69.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.322 -0.854 . . . . 10.0 111.151 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.481 ' OE1' ' HA ' ' A' ' 103' ' ' GLN . 11.4 mm-40 -59.8 -41.16 90.6 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.883 -0.599 . . . . 10.0 111.102 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.538 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 19.1 t60 -68.46 -33.75 74.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.29 -0.414 . . . . 10.0 110.539 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 101' ' ' ILE . 90.8 mt -62.55 -46.04 90.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.79 0.329 . . . . 10.0 110.989 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.6 mt -67.41 -32.35 56.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.124 0.488 . . . . 10.0 110.05 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.1 m -68.02 -15.49 63.62 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.511 -0.768 . . . . 10.0 112.159 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.538 ' HG2' ' O ' ' A' ' 104' ' ' HIS . 17.5 mm-40 -95.1 6.88 47.83 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.628 -0.508 . . . . 10.0 109.628 178.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.459 ' HA ' ' OE1' ' A' ' 109' ' ' GLU . 3.4 mm-40 60.35 32.1 20.58 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.486 -0.779 . . . . 10.0 111.039 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -110.98 -5.64 14.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.111 -0.495 . . . . 10.0 110.795 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.62 ' HB2' HD13 ' A' ' 148' ' ' ILE . . . -135.57 148.69 49.17 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.81 -0.632 . . . . 10.0 109.952 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.533 ' OG ' ' HA ' ' A' ' 150' ' ' PRO . 0.6 OUTLIER -87.71 -59.18 2.32 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.948 0.404 . . . . 10.0 110.901 -179.81 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.501 ' O ' HG13 ' A' ' 117' ' ' ILE . 40.8 m80 -138.26 154.02 49.07 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.345 -0.389 . . . . 10.0 110.919 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.418 HG13 ' CD ' ' A' ' 102' ' ' LYS . 0.3 OUTLIER -63.34 -36.75 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 115.502 -0.772 . . . . 10.0 110.386 179.562 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.87 -24.0 34.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.821 -1.081 . . . . 10.0 112.463 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.439 ' HG3' ' OD1' ' A' ' 151' ' ' ASN . 0.3 OUTLIER -103.19 0.16 31.32 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 121.182 -0.207 . . . . 10.0 111.397 -179.117 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 113' ' ' HIS . 28.2 mt -90.75 119.91 38.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 120.266 -0.574 . . . . 10.0 109.534 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.4 mmmt -118.1 112.15 19.82 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.114 0.483 . . . . 10.0 110.174 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.434 ' O ' ' HB2' ' A' ' 126' ' ' LEU . 3.2 mm? -92.99 113.7 26.06 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.653 0.74 . . . . 10.0 110.995 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.534 HD13 ' HA ' ' A' ' 125' ' ' VAL . 4.5 mm? -110.75 140.43 45.16 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 107.406 -1.331 . . . . 10.0 107.406 178.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.582 HD13 HD13 ' A' ' 144' ' ' ILE . 17.9 tp -121.98 97.91 5.7 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.821 -0.807 . . . . 10.0 108.821 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? 46.82 58.27 4.86 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.612 0.72 . . . . 10.0 109.972 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.686 ' HA2' ' SG ' ' C' ' 39' ' ' CYS . . . 83.87 -44.41 3.31 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 114.6 -1.182 . . . . 10.0 114.154 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 22.9 tttp -59.64 140.03 56.73 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 120.696 0.284 . . . . 10.0 111.006 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.534 ' HA ' HD13 ' A' ' 120' ' ' LEU . 7.2 p -90.35 136.16 24.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 112.942 0.719 . . . . 10.0 112.942 -178.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.434 ' HB2' ' O ' ' A' ' 119' ' ' LEU . 6.0 mp -110.83 156.29 21.34 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 114.983 -1.008 . . . . 10.0 110.001 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -116.0 158.38 23.19 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.452 0.538 . . . . 10.0 112.452 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -52.81 -55.1 25.41 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 113.377 0.88 . . . . 10.0 113.377 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -91.26 14.13 15.28 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.242 0.46 . . . . 10.0 112.242 -178.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 9.4 tp -70.24 143.87 52.02 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.708 0.289 . . . . 10.0 110.428 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -98.85 146.84 25.54 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.72 -0.673 . . . . 10.0 110.18 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.497 HD12 ' O ' ' A' ' 93' ' ' SER . 13.0 mt -57.53 -39.09 75.84 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.414 -0.357 . . . . 10.0 111.183 178.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.4 p -73.17 -21.96 60.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.123 0.487 . . . . 10.0 111.198 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -82.25 -45.56 14.86 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 120.812 0.339 . . . . 10.0 110.519 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.2 pp -74.1 -21.97 59.68 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.352 -0.385 . . . . 10.0 110.846 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.6 mtmt 63.43 92.2 0.07 Allowed 'General case' 0 C--O 1.236 0.352 0 O-C-N 123.691 0.619 . . . . 10.0 110.785 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.0 t -66.07 101.5 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.6 -0.727 . . . . 10.0 110.38 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.52 119.66 48.88 Favored Pre-proline 0 N--CA 1.451 -0.415 0 CA-C-N 116.098 -0.501 . . . . 10.0 110.652 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -65.57 -11.46 30.59 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.773 2.315 . . . . 10.0 112.727 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -93.04 7.3 44.7 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.965 -0.561 . . . . 10.0 110.19 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -128.63 -75.02 0.56 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.518 -0.765 . . . . 10.0 110.14 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 38.6 m 57.66 13.27 1.89 Allowed 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.486 0.55 . . . . 10.0 112.486 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.9 m -121.46 121.75 38.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.619 0.247 . . . . 10.0 110.882 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.582 HD13 HD13 ' A' ' 121' ' ' LEU . 10.7 mm -102.85 126.12 57.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.714 -0.675 . . . . 10.0 109.666 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.425 HG21 HG11 ' C' ' 35' ' ' VAL . 0.2 OUTLIER -86.43 107.15 17.92 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.887 -0.783 . . . . 10.0 108.887 179.302 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 21.7 t -87.34 126.08 41.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.663 -0.699 . . . . 10.0 110.209 -178.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 62.7 mtt -125.35 115.0 19.63 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.706 -1.134 . . . . 10.0 109.866 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.62 HD13 ' HB2' ' A' ' 111' ' ' ALA . 9.9 mt -138.96 146.11 26.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.35 -0.841 . . . . 10.0 110.674 -178.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.514 ' HD3' ' OD2' ' B' ' 38' ' ' ASP . 2.0 mmmm -125.94 115.51 24.24 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 109.37 -0.604 . . . . 10.0 109.37 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.533 ' HA ' ' OG ' ' A' ' 112' ' ' SER . 19.5 Cg_endo -61.82 117.47 4.3 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.425 2.084 . . . . 10.0 112.65 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.439 ' OD1' ' HG3' ' A' ' 116' ' ' GLU . 11.0 m120 -74.99 -38.23 61.67 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 108.954 -0.758 . . . . 10.0 108.954 178.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 69.3 mt -87.5 165.79 15.25 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.072 -0.967 . . . . 10.0 111.244 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.416 ' HG3' ' H ' ' A' ' 153' ' ' GLU . 11.8 mt-10 . . . . . 0 C--O 1.251 1.178 0 CA-C-N 115.606 -0.725 . . . . 10.0 110.698 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' -1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.482 1.175 0 CA-C-O 120.85 0.357 . . . . 10.0 110.709 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 0' ' ' VAL . . . . . . . . . . . . . 34.0 m -118.31 -162.57 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.975 -0.557 . . . . 10.0 109.968 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -156.96 -84.67 0.05 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.108 -0.33 . . . . 10.0 110.108 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 70.8 m -162.94 12.91 0.07 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 122.724 0.409 . . . . 10.0 110.378 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -97.87 151.28 20.4 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 122.292 -0.255 . . . . 10.0 110.599 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 80.1 p -86.82 157.11 19.64 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.376 -0.601 . . . . 10.0 109.376 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -53.1 -40.54 64.22 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.85 0.315 . . . . 10.0 111.85 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -60.91 -47.25 87.27 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.668 -0.242 . . . . 10.0 110.838 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -58.84 -39.83 82.43 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.114 0.483 . . . . 10.0 110.075 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.443 ' O ' HD12 ' B' ' 12' ' ' ILE . 50.1 mm -64.52 -49.3 81.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.726 -0.67 . . . . 10.0 110.084 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.27 -36.65 78.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.193 0.52 . . . . 10.0 110.335 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.99 -32.77 74.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.534 -0.757 . . . . 10.0 110.221 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 28.1 mt -70.98 -34.96 71.91 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.421 -0.585 . . . . 10.0 109.421 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.658 HG21 HD13 ' B' ' 40' ' ' ILE . 0.7 OUTLIER -59.37 -54.74 30.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.974 -0.557 . . . . 10.0 110.442 179.117 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 28.4 m -62.27 -33.51 59.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.33 -0.396 . . . . 10.0 111.117 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -68.72 -48.77 62.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.093 -0.503 . . . . 10.0 110.897 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' TYR . . . . . 0.484 ' O ' HG12 ' B' ' 19' ' ' ILE . 8.3 m-85 -70.94 -41.9 70.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.156 -0.474 . . . . 10.0 112.04 -178.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -55.92 -52.94 62.35 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 122.982 0.176 . . . . 10.0 111.45 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . 0.5 ' O ' ' HB2' ' B' ' 21' ' ' GLU . 4.9 p -58.74 -46.85 86.48 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.448 -0.342 . . . . 10.0 111.357 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 28.8 p -65.45 -20.59 66.43 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.225 0.454 . . . . 10.0 112.225 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.484 HG12 ' O ' ' B' ' 15' ' ' TYR . 22.9 mm -84.93 -42.12 16.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.798 0.332 . . . . 10.0 111.221 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 34.5 m -77.43 -31.6 17.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.006 0.431 . . . . 10.0 111.311 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' B' ' 17' ' ' SER . 0.4 OUTLIER -71.64 -25.69 62.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.075 -0.511 . . . . 10.0 111.188 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -94.59 1.13 55.62 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.397 0.618 . . . . 10.0 109.578 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 14.7 mmtt 55.33 45.56 25.28 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 114.805 -1.089 . . . . 10.0 111.573 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -93.66 24.32 4.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.946 0.403 . . . . 10.0 111.223 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 16.8 tt -160.87 161.39 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 116.173 -0.467 . . . . 10.0 110.41 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.84 159.86 29.53 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.817 -0.629 . . . . 10.0 111.443 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -56.97 -41.86 79.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.65 -0.705 . . . . 10.0 111.412 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.33 -50.67 72.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.998 -0.547 . . . . 10.0 109.845 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.501 ' O ' ' HG ' ' B' ' 33' ' ' LEU . . . -60.39 -41.08 98.37 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.622 -0.717 . . . . 10.0 111.677 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.25 -31.87 73.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.883 -0.158 . . . . 10.0 110.913 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -71.5 -43.3 66.79 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.43 -0.582 . . . . 10.0 109.43 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 4.1 m -62.54 -51.14 68.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.313 -0.858 . . . . 10.0 110.288 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' B' ' 29' ' ' GLY . 89.6 mt -59.12 -41.92 89.35 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.127 -0.488 . . . . 10.0 110.173 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -57.83 -49.61 76.09 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.752 -0.658 . . . . 10.0 111.106 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.439 HG11 HD21 ' A' ' 120' ' ' LEU . 2.6 p -70.93 -33.81 53.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.738 -0.385 . . . . 10.0 111.691 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.23 -39.25 89.43 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 109.625 -0.509 . . . . 10.0 109.625 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' MET . . . . . . . . . . . . . 32.8 ttm -54.65 -45.6 73.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.305 -0.861 . . . . 10.0 109.574 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . 0.514 ' OD2' ' HD3' ' A' ' 149' ' ' LYS . 18.4 t70 -62.6 -53.73 50.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.118 -0.947 . . . . 10.0 110.886 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 59.8 m -52.09 -47.76 65.07 Favored 'General case' 0 N--CA 1.462 0.137 0 O-C-N 123.581 0.551 . . . . 10.0 111.529 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' ILE . . . . . 0.658 HD13 HG21 ' B' ' 12' ' ' ILE . 59.7 mt -62.6 -44.83 99.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.02 -0.536 . . . . 10.0 110.69 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.556 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 49.0 m -61.28 -43.32 99.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.026 -0.534 . . . . 10.0 110.876 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -67.52 -42.39 82.87 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.679 -0.691 . . . . 10.0 111.243 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.2 -33.61 74.74 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.28 0.474 . . . . 10.0 112.28 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -90.38 -7.2 53.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.671 0.272 . . . . 10.0 111.062 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.84 46.74 90.96 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.201 -0.523 . . . . 10.0 112.864 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.556 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 3.7 p90 -144.34 154.71 43.31 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 122.569 -0.371 . . . . 10.0 110.474 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -92.93 147.08 23.14 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.404 -0.362 . . . . 10.0 110.408 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.415 ' H ' ' NE ' ' B' ' 48' ' ' ARG . 0.0 OUTLIER -64.98 -27.34 68.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.548 -0.296 . . . . 10.0 111.483 -179.134 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -72.68 -10.32 59.65 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.404 -0.362 . . . . 10.0 111.839 -179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.28 4.38 27.3 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.592 -0.276 . . . . 10.0 111.351 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.422 HG23 ' H ' ' B' ' 52' ' ' SER . 0.1 OUTLIER -42.77 -59.94 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 112.653 0.612 . . . . 10.0 112.653 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' SER . . . . . 0.422 ' H ' HG23 ' B' ' 51' ' ' VAL . 0.9 OUTLIER -60.89 -19.56 60.56 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.229 0.826 . . . . 10.0 113.229 -179.421 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.46 -38.5 12.35 Favored Glycine 0 C--O 1.235 0.203 0 C-N-CA 120.879 -0.677 . . . . 10.0 112.382 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 6.2 mt -86.63 -47.34 16.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.816 0.341 . . . . 10.0 111.23 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 53.4 mt -73.08 -57.88 3.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.306 0.574 . . . . 10.0 110.424 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.83 -144.7 48.56 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.327 -0.851 . . . . 10.0 112.569 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -91.67 -11.03 38.13 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.465 -0.367 . . . . 10.0 110.918 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.56 131.79 52.02 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.798 0.666 . . . . 10.0 112.798 -178.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -81.22 155.13 26.28 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.814 -0.81 . . . . 10.0 108.814 177.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -120.92 165.1 15.69 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 109.731 -0.47 . . . . 10.0 109.731 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? -157.03 160.95 39.47 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.046 0.45 . . . . 10.0 110.564 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -136.58 57.88 0.66 Allowed Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 115.54 -0.755 . . . . 10.0 111.631 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -78.28 130.38 36.15 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.765 -0.457 . . . . 10.0 109.765 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 48.7 p-80 -150.06 111.23 4.39 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.786 -0.643 . . . . 10.0 109.649 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.06 -8.51 58.65 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.447 -0.797 . . . . 10.0 110.487 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -86.24 126.86 34.59 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.527 -0.76 . . . . 10.0 110.306 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.83 126.16 27.61 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.834 -0.621 . . . . 10.0 110.367 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 19.9 mt -68.7 97.26 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.527 -0.306 . . . . 10.0 110.206 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 55.6 mt 63.8 -96.37 0.05 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.764 -0.653 . . . . 10.0 110.269 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -126.95 -1.45 6.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.627 0.251 . . . . 10.0 110.423 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 60.7 m 57.4 26.71 12.85 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.796 -0.638 . . . . 10.0 111.962 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.944 0 CA-C-O 118.422 -0.799 . . . . 10.0 111.206 179.952 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' -1' ' ' SER . . . . . . . . . . . . . 2.2 m . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 120.581 0.229 . . . . 10.0 110.465 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 0' ' ' VAL . . . . . . . . . . . . . 18.8 m -135.37 -179.97 3.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.2 -0.455 . . . . 10.0 110.631 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 1' ' ' ASP . . . . . 0.465 ' OD1' ' HG3' ' C' ' 61' ' ' LYS . 6.6 t70 -150.09 -77.63 0.14 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.713 -0.847 . . . . 10.0 108.713 178.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 35.4 m -170.35 9.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.628 -0.715 . . . . 10.0 110.418 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -90.25 153.86 20.16 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.644 -0.253 . . . . 10.0 111.047 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 4' ' ' SER . . . . . 0.532 ' O ' HG12 ' C' ' 8' ' ' ILE . 31.4 p -102.16 161.88 13.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.383 -0.371 . . . . 10.0 110.984 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -56.08 -39.34 71.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.294 -0.412 . . . . 10.0 111.498 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 6' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -61.2 -48.58 80.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.011 0.434 . . . . 10.0 110.911 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -63.49 -39.07 93.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.857 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 8' ' ' ILE . . . . . 0.532 HG12 ' O ' ' C' ' 4' ' ' SER . 43.6 mm -60.89 -46.83 95.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.564 -0.532 . . . . 10.0 109.564 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 9' ' ' ALA . . . . . 0.498 ' HB1' ' CE1' ' C' ' 46' ' ' PHE . . . -60.04 -44.09 94.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.692 -0.686 . . . . 10.0 110.825 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.99 -41.93 98.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.94 -0.573 . . . . 10.0 111.224 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 16.6 mt -62.44 -41.72 98.93 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.463 0.649 . . . . 10.0 110.006 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 12' ' ' ILE . . . . . 0.716 HG21 HD13 ' C' ' 40' ' ' ILE . 1.3 mp -59.22 -51.42 72.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.749 -1.114 . . . . 10.0 111.876 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 30.0 m -67.93 -24.95 31.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.028 0.442 . . . . 10.0 111.758 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -76.45 -42.56 43.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.749 0.309 . . . . 10.0 110.227 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 15' ' ' TYR . . . . . 0.469 ' O ' HG12 ' C' ' 19' ' ' ILE . 3.1 m-85 -73.32 -40.28 64.61 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.7 -0.4 . . . . 10.0 110.82 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -58.32 -49.48 77.03 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 109.998 -0.371 . . . . 10.0 109.998 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 35.4 p -62.05 -43.6 98.49 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.302 -0.408 . . . . 10.0 111.123 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 32.9 p -66.95 -24.45 66.07 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 111.69 0.256 . . . . 10.0 111.69 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 19' ' ' ILE . . . . . 0.469 HG12 ' O ' ' C' ' 15' ' ' TYR . 26.8 mm -80.6 -39.67 18.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 110.011 -0.366 . . . . 10.0 110.011 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 20' ' ' VAL . . . . . 0.402 HG12 ' HA ' ' C' ' 30' ' ' ALA . 19.5 m -77.43 -27.23 15.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.84 -0.344 . . . . 10.0 111.124 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . 0.402 ' HA ' ' OE1' ' C' ' 21' ' ' GLU . 2.5 tp10 -68.71 -50.33 51.66 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.846 -0.427 . . . . 10.0 109.846 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -71.92 -10.02 59.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.047 -0.524 . . . . 10.0 110.205 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm 58.95 42.31 19.66 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.506 0.67 . . . . 10.0 109.505 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -81.41 -6.28 58.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.232 -0.894 . . . . 10.0 110.729 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 18.1 tt -125.61 160.08 32.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.101 -0.5 . . . . 10.0 109.761 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -58.94 152.51 19.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.463 -0.335 . . . . 10.0 110.482 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -57.4 -34.49 68.94 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.81 0.338 . . . . 10.0 110.41 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 28' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -61.8 -50.77 71.0 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.51 -0.768 . . . . 10.0 109.983 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 29' ' ' GLY . . . . . 0.532 ' O ' ' HG ' ' C' ' 33' ' ' LEU . . . -67.33 -31.13 76.3 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.144 -0.934 . . . . 10.0 112.643 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . 0.402 ' HA ' HG12 ' C' ' 20' ' ' VAL . . . -59.96 -46.66 88.7 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.557 0.218 . . . . 10.0 110.461 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 31' ' ' ASP . . . . . 0.402 ' O ' HG12 ' C' ' 35' ' ' VAL . 14.5 t70 -63.64 -37.81 88.74 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.529 -0.545 . . . . 10.0 109.529 179.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 14.0 m -57.61 -44.91 85.82 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.449 -0.796 . . . . 10.0 109.784 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 33' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' C' ' 29' ' ' GLY . 51.6 mt -70.25 -37.37 74.93 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.026 -0.534 . . . . 10.0 110.501 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -59.17 -55.83 29.96 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.048 -0.524 . . . . 10.0 111.429 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 35' ' ' VAL . . . . . 0.425 HG11 HG21 ' A' ' 145' ' ' THR . 8.4 p -66.07 -41.77 90.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 115.961 -0.563 . . . . 10.0 111.117 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.55 -28.47 69.96 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.676 0.274 . . . . 10.0 111.032 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 9.0 mtm -59.98 -51.33 70.14 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.262 -0.426 . . . . 10.0 110.45 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 38' ' ' ASP . . . . . 0.629 ' CB ' ' HA3' ' A' ' 123' ' ' GLY . 1.2 m-20 -69.94 -27.47 64.78 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 109.639 -0.504 . . . . 10.0 109.639 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 39' ' ' CYS . . . . . 0.686 ' SG ' ' HA2' ' A' ' 123' ' ' GLY . 62.6 m -61.49 -50.25 73.46 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 109.297 -0.631 . . . . 10.0 109.297 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 40' ' ' ILE . . . . . 0.716 HD13 HG21 ' C' ' 12' ' ' ILE . 54.6 mt -67.2 -35.76 74.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.993 -1.003 . . . . 10.0 109.957 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 41' ' ' SER . . . . . 0.691 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 53.1 m -61.36 -51.81 67.27 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.713 -0.676 . . . . 10.0 110.536 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.82 -35.67 80.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.793 0.33 . . . . 10.0 110.867 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.66 -42.69 93.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.099 -0.5 . . . . 10.0 111.808 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 44' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -96.3 -2.48 45.79 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.869 0.366 . . . . 10.0 111.634 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.4 51.22 38.78 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.103 -0.57 . . . . 10.0 112.945 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 46' ' ' PHE . . . . . 0.691 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 4.3 p90 -144.48 157.58 44.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.055 0.455 . . . . 10.0 110.327 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -96.4 136.75 36.46 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.111 -0.495 . . . . 10.0 109.685 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 48' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -60.88 -13.97 19.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.757 -0.656 . . . . 10.0 112.111 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -84.03 -6.56 59.43 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.745 0.646 . . . . 10.0 112.745 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.53 4.55 27.57 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.134 0.42 . . . . 10.0 112.134 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 51' ' ' VAL . . . . . 0.4 HG23 ' H ' ' C' ' 52' ' ' SER . 4.9 m -45.03 -54.4 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 113.548 0.944 . . . . 10.0 113.548 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 52' ' ' SER . . . . . 0.4 ' H ' HG23 ' C' ' 51' ' ' VAL . 0.0 OUTLIER -58.93 -30.88 68.19 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.775 0.658 . . . . 10.0 112.775 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.13 -49.81 5.77 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.426 -0.892 . . . . 10.0 112.912 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 54' ' ' ILE . . . . . . . . . . . . . 80.0 mt -69.67 -54.6 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-O 120.642 0.258 . . . . 10.0 111.328 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 70.0 mt -68.77 -52.76 26.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.433 -0.349 . . . . 10.0 111.009 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.38 -136.66 47.57 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.261 -0.495 . . . . 10.0 112.837 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 30.9 tttt -108.3 3.43 23.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.222 0.534 . . . . 10.0 110.094 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 9.1 t -73.62 138.15 44.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.966 -0.561 . . . . 10.0 110.555 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -87.86 143.41 27.14 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.585 -0.734 . . . . 10.0 109.721 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 60' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -108.02 160.74 15.55 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.294 -0.632 . . . . 10.0 109.294 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 61' ' ' LYS . . . . . 0.465 ' HG3' ' OD1' ' C' ' 1' ' ' ASP . 10.2 ptmm? -140.97 170.45 15.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.917 0.389 . . . . 10.0 111.34 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -151.18 54.98 0.47 Allowed Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.284 -0.871 . . . . 10.0 111.081 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 63' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -82.2 133.05 35.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.147 0.498 . . . . 10.0 110.68 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 64' ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -153.33 112.43 3.77 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.118 0.485 . . . . 10.0 110.366 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -76.21 -28.51 57.24 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.775 -0.648 . . . . 10.0 109.475 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.17 137.46 35.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.3 -0.864 . . . . 10.0 109.646 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.44 155.53 36.2 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.178 -0.465 . . . . 10.0 110.365 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 68' ' ' ILE . . . . . . . . . . . . . 34.3 mt -83.85 100.08 6.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.453 -0.573 . . . . 10.0 109.453 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 33.6 mt 68.36 -74.62 0.07 Allowed 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.75 0.656 . . . . 10.0 110.508 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 70' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -150.26 -26.48 0.24 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.818 -0.628 . . . . 10.0 110.054 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 71' ' ' SER . . . . . 0.419 ' HA ' ' HB2' ' B' ' 52' ' ' SER . 16.8 m 56.45 47.34 19.04 Favored 'General case' 0 C--N 1.335 -0.044 0 CA-C-N 115.439 -0.8 . . . . 10.0 110.922 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.133 0 CA-C-N 115.384 -0.825 . . . . 10.0 110.321 -179.613 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 74.4 mmm . . . . . 0 N--CA 1.485 1.317 0 N-CA-C 110.079 -0.341 . . . . 10.0 110.079 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.1 t -104.45 135.78 40.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.927 -0.579 . . . . 10.0 110.352 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -87.57 129.29 35.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.57 0.224 . . . . 10.0 110.729 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.5 mp -127.87 129.17 46.46 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.126 0.489 . . . . 10.0 110.149 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.3 m -94.69 109.12 21.09 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.653 -0.703 . . . . 10.0 110.389 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -85.16 118.77 24.92 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.876 -0.787 . . . . 10.0 108.876 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -119.47 108.42 14.51 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.284 -0.416 . . . . 10.0 111.28 -178.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.521 ' HG2' ' O ' ' A' ' 84' ' ' PRO . 19.1 tptm -94.91 113.28 24.98 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 116.484 -0.326 . . . . 10.0 110.922 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.582 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 52.4 mt -80.49 -59.86 2.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 O-C-N 124.168 0.917 . . . . 10.0 111.542 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -63.13 160.31 15.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.787 0.327 . . . . 10.0 110.983 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.4 140.4 72.34 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 120.695 0.283 . . . . 10.0 111.401 -179.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.521 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 59.6 Cg_endo -76.9 140.61 66.02 Favored 'Cis proline' 0 C--N 1.343 0.266 0 C-N-CA 122.992 -1.67 . . . . 10.0 111.392 -1.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.582 ' HG2' ' O ' ' A' ' 81' ' ' ILE . 27.7 mtpp -82.91 145.1 29.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.436 -0.347 . . . . 10.0 110.965 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.424 ' CE2' ' HB3' ' A' ' 110' ' ' LYS . 34.1 p90 -165.73 156.08 13.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.714 0.292 . . . . 10.0 111.055 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.9 m -140.82 114.21 8.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.724 -0.671 . . . . 10.0 110.371 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 10.6 pt -134.87 149.02 29.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.558 -0.292 . . . . 10.0 110.816 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -117.16 116.62 27.65 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.384 -0.598 . . . . 10.0 109.384 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 25.7 t60 -130.3 146.31 51.88 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.412 -0.588 . . . . 10.0 109.412 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -99.11 139.66 34.43 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.201 0.524 . . . . 10.0 110.22 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -129.75 170.46 13.81 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.816 -0.629 . . . . 10.0 110.664 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.559 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 19.3 t -81.34 146.98 59.1 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 115.914 -0.585 . . . . 10.0 109.683 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -62.4 -18.02 60.73 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.126 1.884 . . . . 10.0 111.094 178.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.4 m -102.73 15.17 30.07 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.616 -0.72 . . . . 10.0 110.589 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.559 ' HB2' ' O ' ' A' ' 93' ' ' SER . 0.4 OUTLIER -83.5 167.88 17.0 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.043 0.449 . . . . 10.0 110.833 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.81 156.43 29.43 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.787 -0.642 . . . . 10.0 110.638 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 43.1 mm -63.3 -23.4 33.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.969 -0.559 . . . . 10.0 110.254 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.39 -40.58 65.14 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.355 -0.839 . . . . 10.0 110.873 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -64.02 -43.68 94.86 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 120.937 0.399 . . . . 10.0 110.864 -179.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.54 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 44.6 mt -62.12 -47.57 92.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.87 -0.605 . . . . 10.0 109.568 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -54.44 -46.41 73.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.341 -0.845 . . . . 10.0 111.237 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.437 ' OE1' ' HA ' ' A' ' 103' ' ' GLN . 16.0 mm-40 -65.04 -34.47 78.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.161 -0.472 . . . . 10.0 110.881 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 48.0 t60 -62.91 -39.56 94.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.342 -0.39 . . . . 10.0 110.326 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 101' ' ' ILE . 17.3 mt -63.14 -41.11 99.24 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.187 -0.46 . . . . 10.0 110.139 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 14.6 mt -68.53 -39.42 80.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.302 -0.408 . . . . 10.0 109.929 178.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.4 m -65.05 -26.07 68.09 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.214 0.531 . . . . 10.0 111.285 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -88.06 2.76 51.14 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.315 -0.402 . . . . 10.0 110.806 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 62.95 25.36 15.02 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.336 0.588 . . . . 10.0 109.997 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.424 ' HB3' ' CE2' ' A' ' 86' ' ' PHE . 22.5 mmtp -99.18 -8.16 25.51 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.565 -0.743 . . . . 10.0 109.89 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -130.6 154.46 47.84 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.397 -0.819 . . . . 10.0 110.371 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.1 m -107.77 -33.28 7.31 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.021 -0.536 . . . . 10.0 111.516 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.442 ' O ' HG13 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -154.57 129.89 9.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.582 -0.281 . . . . 10.0 110.777 -178.306 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.526 ' HA ' HD12 ' A' ' 117' ' ' ILE . 9.3 tt -61.77 -38.84 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-O 120.937 0.398 . . . . 10.0 111.451 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.565 ' HB3' ' OE2' ' A' ' 116' ' ' GLU . 8.1 t -49.48 -38.27 29.38 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.12 -0.946 . . . . 10.0 112.461 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.565 ' OE2' ' HB3' ' A' ' 115' ' ' SER . 1.3 pm0 -94.73 11.6 30.79 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.176 0.436 . . . . 10.0 112.176 -178.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' A' ' 114' ' ' ILE . 65.9 mt -95.6 119.98 44.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.992 -0.744 . . . . 10.0 108.992 178.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.8 mmmt -126.22 120.37 29.86 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.777 -0.453 . . . . 10.0 109.777 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -95.79 127.24 41.65 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.132 0.491 . . . . 10.0 111.248 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.59 HD21 HG11 ' B' ' 35' ' ' VAL . 3.0 mm? -110.33 138.46 46.69 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.493 -0.776 . . . . 10.0 108.98 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 25.3 tp -124.0 99.71 6.38 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.36 -0.607 . . . . 10.0 109.36 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 23.2 tptp 46.34 57.14 5.6 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 123.903 0.752 . . . . 10.0 110.416 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.568 ' HA3' ' CB ' ' C' ' 38' ' ' ASP . . . 81.48 -45.01 3.17 Favored Glycine 0 C--N 1.332 0.35 0 CA-C-N 115.567 -0.742 . . . . 10.0 113.097 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 40.1 tttp -62.61 133.16 54.49 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.807 -0.442 . . . . 10.0 109.807 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.3 p -83.03 141.03 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 113.341 0.867 . . . . 10.0 113.341 -177.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.5 mp -107.71 154.58 21.28 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.421 -0.808 . . . . 10.0 110.489 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 56.7 m-70 -111.9 154.61 24.95 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.781 0.324 . . . . 10.0 110.708 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -50.17 -54.04 23.54 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.727 1.01 . . . . 10.0 113.727 -178.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -96.51 18.69 13.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.921 0.391 . . . . 10.0 111.919 -177.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 130' ' ' LEU . 12.0 tp -68.81 146.77 52.59 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.029 0.442 . . . . 10.0 111.048 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -99.7 143.62 29.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.779 -0.646 . . . . 10.0 110.082 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.402 HD12 ' O ' ' A' ' 93' ' ' SER . 49.7 mt -56.8 -28.99 62.25 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.255 0.347 . . . . 10.0 111.692 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.69 -22.37 56.73 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.988 0.423 . . . . 10.0 111.687 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -83.11 -49.13 9.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.532 -0.304 . . . . 10.0 110.588 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.6 pp -72.72 -25.24 61.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 10.0 111.06 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt 65.85 91.96 0.08 Allowed 'General case' 0 N--CA 1.463 0.216 0 O-C-N 123.884 0.74 . . . . 10.0 112.064 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.2 t -66.99 110.08 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.415 -0.587 . . . . 10.0 109.415 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -81.51 124.69 79.92 Favored Pre-proline 0 N--CA 1.447 -0.584 0 CA-C-N 115.95 -0.568 . . . . 10.0 111.156 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -64.92 -17.07 58.38 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.819 2.346 . . . . 10.0 111.967 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -79.72 0.12 31.85 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.914 -0.585 . . . . 10.0 110.789 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -136.48 -63.88 0.61 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.119 -0.492 . . . . 10.0 109.787 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 30.5 m 51.6 24.48 2.34 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.634 -0.712 . . . . 10.0 112.543 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 32.4 m -124.71 126.32 45.51 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.142 0.496 . . . . 10.0 111.094 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 24.3 mm -106.73 120.51 58.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.567 -0.742 . . . . 10.0 109.584 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.24 117.85 23.23 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.242 -0.435 . . . . 10.0 109.83 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 29.1 t -93.46 127.73 45.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.689 -0.687 . . . . 10.0 111.221 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -124.65 117.26 23.88 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.47 -0.786 . . . . 10.0 109.247 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 10.2 mt -138.72 143.56 31.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.197 -0.456 . . . . 10.0 111.165 -177.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -109.8 114.56 56.45 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 108.846 -0.798 . . . . 10.0 108.846 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -61.54 124.97 15.67 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.447 2.098 . . . . 10.0 113.215 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -95.05 -0.06 53.99 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.535 -0.543 . . . . 10.0 109.535 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 26.8 mt -79.94 110.21 15.1 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.409 -0.814 . . . . 10.0 110.63 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.49 -0.767 . . . . 10.0 110.152 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' -1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.477 0 N-CA-C 110.082 -0.34 . . . . 10.0 110.082 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 0' ' ' VAL . . . . . . . . . . . . . 16.6 m -139.36 150.14 22.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.337 -0.392 . . . . 10.0 110.077 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -156.99 -86.92 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.878 -0.601 . . . . 10.0 109.513 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . 0.402 ' HB2' ' OE1' ' B' ' 59' ' ' GLU . 2.0 p -86.59 -43.14 12.91 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 121.078 0.466 . . . . 10.0 110.091 178.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -115.18 168.62 9.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.804 -0.634 . . . . 10.0 110.46 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . 0.484 ' O ' HG12 ' B' ' 8' ' ' ILE . 26.0 t -87.25 168.36 13.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.387 -0.37 . . . . 10.0 110.515 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 5.2 ptpp? -57.88 -44.17 86.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.284 -0.416 . . . . 10.0 110.664 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -58.11 -46.25 85.88 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.004 0.43 . . . . 10.0 110.549 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -62.29 -38.94 91.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.932 -0.577 . . . . 10.0 110.458 179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.494 HG13 ' CE2' ' C' ' 15' ' ' TYR . 38.7 mm -63.63 -45.8 96.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.992 -0.549 . . . . 10.0 109.99 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.41 -36.72 83.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.736 -0.665 . . . . 10.0 110.994 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.36 -34.03 77.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.984 -0.553 . . . . 10.0 110.48 179.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 22.9 mt -67.02 -35.63 80.32 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.57 -0.53 . . . . 10.0 109.57 178.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.479 HG23 HD13 ' C' ' 12' ' ' ILE . 53.4 mt -59.91 -56.96 13.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.515 -0.766 . . . . 10.0 111.396 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.468 ' HB ' ' HG2' ' B' ' 48' ' ' ARG . 24.4 m -65.44 -31.95 56.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.432 -0.349 . . . . 10.0 111.613 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -65.26 -51.38 61.2 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.215 0.531 . . . . 10.0 110.179 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' TYR . . . . . 0.48 ' O ' HG12 ' B' ' 19' ' ' ILE . 16.5 m-85 -64.28 -44.97 90.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.974 -0.557 . . . . 10.0 111.338 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 9.3 m-30 -58.32 -50.37 73.87 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.559 0.207 . . . . 10.0 111.559 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 24.2 m -56.97 -38.5 73.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.933 0.397 . . . . 10.0 111.456 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 2.7 p -79.03 -20.11 49.79 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.293 -0.255 . . . . 10.0 111.256 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.48 HG12 ' O ' ' B' ' 15' ' ' TYR . 13.6 mm -76.72 -41.2 33.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 109.487 -0.56 . . . . 10.0 109.487 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 26.6 m -76.04 -27.78 18.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.937 -0.574 . . . . 10.0 110.369 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 tm-20 -65.22 -52.08 56.91 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.531 -0.544 . . . . 10.0 109.531 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 21.4 mmtm -79.89 -8.75 59.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.642 -0.708 . . . . 10.0 110.545 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 52.1 mttt 55.36 52.78 10.82 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.486 -0.779 . . . . 10.0 110.843 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.482 ' O ' ' HE2' ' C' ' 5' ' ' LYS . 87.7 mt-10 -89.35 26.64 1.61 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.249 -0.887 . . . . 10.0 110.105 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 13.7 tt -162.25 160.77 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.598 -0.728 . . . . 10.0 109.848 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.48 153.22 36.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.597 -0.274 . . . . 10.0 110.847 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -59.15 -44.44 92.09 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.379 0.511 . . . . 10.0 112.379 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.79 -47.48 82.45 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.089 0.471 . . . . 10.0 110.228 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.445 ' O ' ' HG ' ' B' ' 33' ' ' LEU . . . -67.36 -34.54 85.41 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.791 -0.64 . . . . 10.0 111.901 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.9 -39.3 94.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.698 0.285 . . . . 10.0 111.02 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -70.55 -30.43 67.15 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.751 -0.463 . . . . 10.0 109.751 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 2.0 m -62.23 -43.14 99.5 Favored 'General case' 0 C--N 1.334 -0.097 0 N-CA-C 109.126 -0.694 . . . . 10.0 109.126 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' B' ' 29' ' ' GLY . 26.7 mt -70.23 -36.4 74.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.751 -0.659 . . . . 10.0 109.851 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -54.82 -56.2 21.95 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.227 -0.897 . . . . 10.0 110.853 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.59 HG11 HD21 ' A' ' 120' ' ' LEU . 7.1 p -73.17 -34.32 44.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 115.947 -0.57 . . . . 10.0 111.397 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.09 -32.68 74.11 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.991 -0.374 . . . . 10.0 109.991 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' MET . . . . . . . . . . . . . 22.7 mtm -60.05 -44.12 94.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.414 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.27 -47.65 85.11 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.234 -0.439 . . . . 10.0 110.006 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 15.8 m -58.18 -43.44 87.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.789 -0.641 . . . . 10.0 110.817 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' ILE . . . . . 0.445 HD13 HG21 ' B' ' 12' ' ' ILE . 96.5 mt -67.21 -48.65 77.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-O 120.742 0.305 . . . . 10.0 111.555 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.54 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 10.6 m -60.06 -46.4 89.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.361 -0.381 . . . . 10.0 110.895 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -67.41 -37.99 83.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.384 -0.371 . . . . 10.0 111.209 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.26 -42.36 99.13 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.877 0.325 . . . . 10.0 111.877 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -87.6 -7.87 56.96 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.889 0.329 . . . . 10.0 111.889 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.62 49.82 17.27 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.986 -0.626 . . . . 10.0 113.54 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.54 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 8.2 p90 -151.98 166.75 30.57 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.433 -0.58 . . . . 10.0 109.433 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -117.09 157.82 25.25 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.199 0.523 . . . . 10.0 110.554 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.468 ' HG2' ' HB ' ' B' ' 13' ' ' VAL . 0.6 OUTLIER -68.99 -22.94 64.06 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.473 -0.785 . . . . 10.0 111.597 -178.554 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -69.07 -8.57 46.39 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.179 0.807 . . . . 10.0 113.179 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -103.34 5.62 37.39 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.813 0.671 . . . . 10.0 112.813 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.548 HG23 ' H ' ' B' ' 52' ' ' SER . 2.6 m -40.69 -61.61 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 113.638 0.977 . . . . 10.0 113.638 -178.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' SER . . . . . 0.548 ' H ' HG23 ' B' ' 51' ' ' VAL . 1.0 OUTLIER -62.01 -23.14 66.25 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.991 0.737 . . . . 10.0 112.991 -178.696 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.66 -40.81 30.88 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.646 -0.788 . . . . 10.0 112.43 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 72.8 mt -81.34 -47.37 19.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.711 0.291 . . . . 10.0 111.226 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 67.0 mt -74.99 -67.99 0.59 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.742 0.306 . . . . 10.0 110.573 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . 0.555 ' HA2' ' HB3' ' C' ' 71' ' ' SER . . . 55.06 -106.13 0.49 Allowed Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.777 -0.647 . . . . 10.0 113.381 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 16.0 pttt -126.96 18.81 7.16 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.205 0.526 . . . . 10.0 110.211 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 13.1 m -76.68 -59.13 2.9 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.707 -0.678 . . . . 10.0 110.406 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . 0.402 ' OE1' ' HB2' ' B' ' 2' ' ' SER . 8.5 tt0 -152.61 146.8 25.49 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.359 -0.382 . . . . 10.0 110.051 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -166.54 -41.09 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.211 -0.45 . . . . 10.0 110.553 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -129.96 147.64 51.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.077 -0.51 . . . . 10.0 109.892 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . 0.505 ' CA ' ' HA2' ' C' ' 62' ' ' GLY . . . -127.14 -156.13 9.05 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.577 -0.82 . . . . 10.0 113.09 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -143.16 170.4 15.8 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.832 0.348 . . . . 10.0 110.646 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . 0.464 ' CD2' ' HA ' ' C' ' 58' ' ' SER . 6.7 m80 -71.31 101.64 2.4 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.631 -0.713 . . . . 10.0 110.297 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -121.85 131.01 53.81 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.935 -0.575 . . . . 10.0 110.303 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -89.38 54.16 2.85 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.356 0.598 . . . . 10.0 110.907 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.1 -24.29 35.25 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.813 -0.631 . . . . 10.0 110.726 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 5.3 mt -92.28 121.7 43.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.806 -0.634 . . . . 10.0 110.212 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 41.1 mt -97.22 -5.24 37.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.362 -0.381 . . . . 10.0 110.834 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -80.12 -22.31 42.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.156 0.503 . . . . 10.0 110.436 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.14 82.8 3.23 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.041 -0.527 . . . . 10.0 111.177 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.442 -0.79 . . . . 10.0 111.445 179.252 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' -1' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.475 0.797 0 CA-C-O 120.817 0.341 . . . . 10.0 110.858 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 0' ' ' VAL . . . . . 0.546 HG12 ' HA ' ' C' ' 4' ' ' SER . 2.2 m -137.68 70.26 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.391 0.615 . . . . 10.0 110.682 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.15 -90.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.527 -0.761 . . . . 10.0 111.343 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 3.3 p -83.84 -45.46 13.25 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.242 0.544 . . . . 10.0 110.604 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -104.66 172.88 6.56 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.388 -0.824 . . . . 10.0 110.27 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 4' ' ' SER . . . . . 0.546 ' HA ' HG12 ' C' ' 0' ' ' VAL . 8.6 t -97.8 171.77 8.1 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.347 -0.612 . . . . 10.0 109.347 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . 0.482 ' HE2' ' O ' ' B' ' 24' ' ' GLU . 3.4 ptpp? -59.23 -37.97 78.85 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 121.407 -0.117 . . . . 10.0 110.903 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 6' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -58.27 -45.55 87.66 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.055 0.455 . . . . 10.0 110.725 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -69.99 -41.44 74.38 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.19 -0.459 . . . . 10.0 110.735 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 8' ' ' ILE . . . . . 0.474 HG12 ' O ' ' C' ' 4' ' ' SER . 40.1 mm -59.19 -44.89 92.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.825 -0.435 . . . . 10.0 109.825 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.41 -39.93 92.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.824 -0.625 . . . . 10.0 110.442 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.42 -43.03 99.58 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.816 -0.629 . . . . 10.0 110.41 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . 0.472 ' HG ' ' CD2' ' C' ' 55' ' ' LEU . 7.0 mt -61.04 -40.43 93.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.457 -0.338 . . . . 10.0 110.743 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 12' ' ' ILE . . . . . 0.479 HD13 HG23 ' B' ' 12' ' ' ILE . 73.1 mt -65.2 -54.13 32.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.038 -0.528 . . . . 10.0 111.668 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 18.1 m -64.86 -27.47 42.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.899 0.38 . . . . 10.0 110.952 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -71.67 -47.08 56.65 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 120.986 0.422 . . . . 10.0 110.186 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 15' ' ' TYR . . . . . 0.494 ' CE2' HG13 ' B' ' 8' ' ' ILE . 3.2 m-85 -62.59 -42.66 99.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.829 -0.623 . . . . 10.0 110.598 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -59.18 -45.05 92.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.192 -0.458 . . . . 10.0 111.027 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 35.8 m -58.6 -39.7 81.15 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.119 -0.491 . . . . 10.0 111.692 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.71 -19.29 45.4 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.973 0.416 . . . . 10.0 111.139 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 19' ' ' ILE . . . . . . . . . . . . . 4.2 mm -75.87 -45.12 38.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.006 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 20' ' ' VAL . . . . . . . . . . . . . 27.3 m -75.44 -18.09 15.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 121.235 0.54 . . . . 10.0 110.676 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -70.91 -56.35 6.43 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.534 -0.757 . . . . 10.0 110.794 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 22' ' ' LYS . . . . . 0.5 ' HD2' ' OE2' ' C' ' 24' ' ' GLU . 45.5 mttm -81.22 -2.01 47.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.399 -0.818 . . . . 10.0 111.735 -178.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 87.7 mttt 55.58 49.23 16.98 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.475 0.655 . . . . 10.0 110.571 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . 0.5 ' OE2' ' HD2' ' C' ' 22' ' ' LYS . 46.3 mt-10 -82.47 -15.36 52.79 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.546 -0.752 . . . . 10.0 110.096 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 17.1 tt -114.2 161.14 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 115.608 -0.724 . . . . 10.0 109.829 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.31 154.08 39.29 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 123.288 0.368 . . . . 10.0 110.11 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -52.25 -44.5 64.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.95 0.405 . . . . 10.0 111.46 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 28' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -59.03 -45.07 91.65 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.882 -0.599 . . . . 10.0 110.646 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 29' ' ' GLY . . . . . 0.643 ' O ' ' HG ' ' C' ' 33' ' ' LEU . . . -68.12 -38.11 87.82 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.639 -0.709 . . . . 10.0 112.183 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.55 -43.31 84.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.047 0.451 . . . . 10.0 110.402 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 31' ' ' ASP . . . . . 0.488 ' O ' ' HB3' ' C' ' 34' ' ' ASN . 31.1 t70 -69.41 -37.59 77.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.904 -0.589 . . . . 10.0 110.347 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 24.3 m -64.23 -36.11 83.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.676 -0.693 . . . . 10.0 110.39 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 33' ' ' LEU . . . . . 0.643 ' HG ' ' O ' ' C' ' 29' ' ' GLY . 46.5 mt -73.05 -26.86 61.44 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.849 -0.426 . . . . 10.0 109.849 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 34' ' ' ASN . . . . . 0.488 ' HB3' ' O ' ' C' ' 31' ' ' ASP . 24.8 t30 -61.83 -56.6 17.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.917 -0.583 . . . . 10.0 110.303 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 35' ' ' VAL . . . . . 0.411 HG23 ' H ' ' A' ' 123' ' ' GLY . 6.3 p -66.64 -38.23 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 115.672 -0.695 . . . . 10.0 110.639 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . 0.478 ' O ' HG13 ' C' ' 40' ' ' ILE . . . -64.28 -32.57 74.22 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.389 -0.369 . . . . 10.0 110.995 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 14.0 mtm -59.29 -52.8 64.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.636 -0.256 . . . . 10.0 111.024 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 38' ' ' ASP . . . . . 0.568 ' CB ' ' HA3' ' A' ' 123' ' ' GLY . 28.1 m-20 -63.99 -26.55 68.62 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.462 -0.335 . . . . 10.0 110.597 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 39' ' ' CYS . . . . . 0.476 ' HB2' ' O ' ' C' ' 36' ' ' ALA . 62.7 m -60.23 -43.41 96.06 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 109.351 -0.611 . . . . 10.0 109.351 178.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 40' ' ' ILE . . . . . 0.478 HG13 ' O ' ' C' ' 36' ' ' ALA . 14.8 mt -69.03 -47.75 73.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.554 -0.748 . . . . 10.0 110.551 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 41' ' ' SER . . . . . 0.472 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 17.8 m -59.78 -43.18 94.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.916 -0.583 . . . . 10.0 111.712 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -68.59 -43.23 76.93 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.281 -0.418 . . . . 10.0 111.238 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.9 -44.86 75.98 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.355 0.502 . . . . 10.0 112.355 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 44' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -86.36 -7.31 58.56 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.95 0.352 . . . . 10.0 111.95 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.16 55.38 21.83 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.893 -0.67 . . . . 10.0 113.326 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 46' ' ' PHE . . . . . 0.472 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 4.7 p90 -153.98 177.7 10.75 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.896 -0.779 . . . . 10.0 108.896 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -125.27 150.87 46.67 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.263 0.554 . . . . 10.0 111.576 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 48' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -71.83 -27.63 63.04 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.499 -0.773 . . . . 10.0 110.954 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -72.15 2.8 5.27 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.006 -0.543 . . . . 10.0 111.246 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -108.96 0.88 20.3 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.436 0.532 . . . . 10.0 112.436 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 10.5 m -50.24 -43.21 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 114.379 1.252 . . . . 10.0 114.379 -177.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 52' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.77 -30.06 67.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.868 0.365 . . . . 10.0 111.174 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.91 -38.16 10.7 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.957 -0.64 . . . . 10.0 112.786 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 54' ' ' ILE . . . . . . . . . . . . . 37.3 mt -73.84 -62.68 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.853 0.359 . . . . 10.0 111.035 -179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 55' ' ' LEU . . . . . 0.472 ' CD2' ' HG ' ' C' ' 11' ' ' LEU . 68.9 mt -66.25 -54.97 18.66 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.628 -0.714 . . . . 10.0 110.71 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 52.67 -99.5 0.04 OUTLIER Glycine 0 CA--C 1.518 0.279 0 O-C-N 123.931 0.769 . . . . 10.0 112.457 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -138.89 21.09 2.65 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.187 -0.672 . . . . 10.0 109.187 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 58' ' ' SER . . . . . 0.464 ' HA ' ' CD2' ' B' ' 64' ' ' HIS . 18.4 m -78.69 -59.67 2.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.27 -0.877 . . . . 10.0 111.399 -179.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -139.28 136.74 35.22 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.956 -0.387 . . . . 10.0 109.956 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 60' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -168.72 -62.63 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.952 -0.567 . . . . 10.0 110.133 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp -87.74 119.89 28.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.915 -0.584 . . . . 10.0 109.86 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 62' ' ' GLY . . . . . 0.505 ' HA2' ' CA ' ' B' ' 62' ' ' GLY . . . -91.8 165.95 29.82 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.682 -0.771 . . . . 10.0 112.446 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 63' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -119.46 171.3 8.44 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.216 -0.661 . . . . 10.0 109.216 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 64' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -86.35 105.34 16.62 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.046 0.45 . . . . 10.0 110.519 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -107.84 -176.96 3.2 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.899 -0.591 . . . . 10.0 110.397 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.4 28.72 0.56 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.194 0.521 . . . . 10.0 109.953 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -67.91 -34.74 77.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.596 -0.729 . . . . 10.0 110.267 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 68' ' ' ILE . . . . . . . . . . . . . 25.7 mt -81.19 104.3 9.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.987 -0.551 . . . . 10.0 110.063 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 95.6 mt -94.97 -0.78 53.55 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.146 -0.479 . . . . 10.0 110.746 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 70' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -87.79 6.15 36.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.245 0.545 . . . . 10.0 110.532 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 71' ' ' SER . . . . . 0.555 ' HB3' ' HA2' ' B' ' 56' ' ' GLY . 36.3 m -108.87 47.49 0.91 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.12 -0.491 . . . . 10.0 111.022 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.003 0 CA-C-N 115.936 -0.574 . . . . 10.0 110.891 -179.87 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.413 ' HB2' ' OD2' ' A' ' 91' ' ' ASP . 29.8 mtt . . . . . 0 N--CA 1.479 0.994 0 N-CA-C 109.565 -0.531 . . . . 10.0 109.565 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.8 p -95.35 135.8 28.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.647 -0.421 . . . . 10.0 110.121 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -89.16 132.1 34.99 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.411 -0.359 . . . . 10.0 110.981 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -120.73 122.48 40.49 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.466 -0.938 . . . . 10.0 108.466 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.7 m -92.17 109.74 21.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.921 0.391 . . . . 10.0 110.346 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.542 ' O ' ' HA ' ' A' ' 87' ' ' SER . 2.3 mm? -81.67 110.65 17.21 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.239 -0.652 . . . . 10.0 109.239 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -120.52 107.11 12.47 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.316 -0.402 . . . . 10.0 111.059 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 46.5 tttm -96.74 120.57 37.31 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.587 -0.523 . . . . 10.0 109.587 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.488 HG23 ' OD2' ' C' ' 28' ' ' ASP . 18.1 mt -83.87 -36.21 11.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 O-C-N 123.863 0.727 . . . . 10.0 111.087 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.456 ' OE1' ' HA ' ' A' ' 147' ' ' MET . 19.7 mt-30 -65.42 149.17 50.46 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.993 -0.283 . . . . 10.0 110.394 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.91 134.05 78.49 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 116.437 -0.347 . . . . 10.0 111.041 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -80.07 142.14 60.91 Favored 'Cis proline' 0 C--O 1.236 0.4 0 C-N-CA 124.23 -1.154 . . . . 10.0 111.836 -1.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -80.36 158.13 26.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.029 -0.532 . . . . 10.0 111.585 -178.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -165.87 157.07 13.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.694 -0.685 . . . . 10.0 110.524 177.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.542 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 70.4 m -149.81 99.88 2.9 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.552 -0.536 . . . . 10.0 109.552 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.3 pt -121.03 155.32 24.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.039 -0.528 . . . . 10.0 110.761 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -114.91 119.33 36.18 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.554 -0.293 . . . . 10.0 110.546 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -118.11 156.05 29.34 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 110.059 -0.349 . . . . 10.0 110.059 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.413 ' OD2' ' HB2' ' A' ' 73' ' ' MET . 2.0 t70 -107.89 110.99 22.89 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.098 -0.705 . . . . 10.0 109.098 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -117.56 151.55 36.92 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.788 0.328 . . . . 10.0 110.922 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.507 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 0.6 OUTLIER -66.93 134.01 93.95 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.072 -0.513 . . . . 10.0 110.626 179.682 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -52.46 -32.26 51.94 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.549 2.166 . . . . 10.0 112.853 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.4 m -97.52 20.27 12.03 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.042 -0.526 . . . . 10.0 111.529 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.507 ' HB2' ' O ' ' A' ' 93' ' ' SER . 0.6 OUTLIER -83.45 171.35 13.52 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.88 0.371 . . . . 10.0 110.896 -179.546 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.467 HG22 ' H ' ' A' ' 99' ' ' LEU . 4.9 m -105.99 146.41 30.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.963 -0.562 . . . . 10.0 111.006 -179.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.439 HG12 ' O ' ' A' ' 130' ' ' LEU . 39.2 mm -61.76 -29.52 46.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 121.31 0.576 . . . . 10.0 110.392 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.467 ' H ' HG22 ' A' ' 97' ' ' THR . 0.6 OUTLIER -56.32 -42.78 78.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.591 -0.732 . . . . 10.0 110.942 179.723 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -64.6 -36.38 84.06 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 120.695 0.283 . . . . 10.0 110.981 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 59.2 mt -65.8 -48.27 82.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.267 -0.424 . . . . 10.0 109.886 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.459 ' HE2' HG13 ' A' ' 114' ' ' ILE . 23.5 mtpt -60.15 -44.06 95.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.786 -0.643 . . . . 10.0 110.331 178.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -64.21 -33.46 75.85 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.776 -0.647 . . . . 10.0 110.227 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.414 ' O ' ' HG3' ' A' ' 108' ' ' GLU . 61.2 t60 -69.89 -37.7 76.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.822 -0.627 . . . . 10.0 110.398 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 60.8 mt -60.55 -39.97 89.85 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.115 0.483 . . . . 10.0 110.165 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 102' ' ' LYS . 12.2 mt -70.14 -38.5 75.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.996 -0.547 . . . . 10.0 109.905 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 48.9 m -66.02 -23.73 66.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.741 -0.663 . . . . 10.0 110.965 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 104' ' ' HIS . 47.2 mt-10 -96.75 7.05 47.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.154 -0.475 . . . . 10.0 110.202 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 58.13 32.09 21.56 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.452 -0.795 . . . . 10.0 111.683 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 6.3 mmpp? -100.39 -8.01 23.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.633 -0.712 . . . . 10.0 109.455 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -130.55 167.23 19.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.297 -0.865 . . . . 10.0 111.258 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.8 t -101.1 -61.36 1.38 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.876 -0.602 . . . . 10.0 110.138 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.495 ' O ' HG13 ' A' ' 117' ' ' ILE . 20.2 m170 -139.59 143.76 37.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.351 -0.386 . . . . 10.0 110.335 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.498 ' HA ' HD12 ' A' ' 117' ' ' ILE . 3.9 tt -59.5 -42.91 89.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 121.317 0.58 . . . . 10.0 110.811 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.49 -15.03 33.87 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.084 -0.962 . . . . 10.0 112.304 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -110.94 14.95 22.0 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.493 0.553 . . . . 10.0 112.493 -178.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.498 HD12 ' HA ' ' A' ' 114' ' ' ILE . 71.1 mt -105.79 120.96 57.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-O 120.973 0.416 . . . . 10.0 110.725 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -121.9 114.07 20.5 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.961 -0.755 . . . . 10.0 108.961 178.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 126' ' ' LEU . 69.8 mt -100.37 131.37 46.33 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.746 0.784 . . . . 10.0 110.988 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.548 HD11 ' SG ' ' C' ' 39' ' ' CYS . 0.4 OUTLIER -118.06 144.29 45.73 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.914 -1.039 . . . . 10.0 108.753 179.187 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.541 HD23 ' HD2' ' A' ' 124' ' ' LYS . 27.6 tp -128.87 93.34 3.58 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 107.45 -1.315 . . . . 10.0 107.45 178.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.532 ' HG2' ' ND2' ' A' ' 141' ' ' ASN . 0.2 OUTLIER 35.29 69.33 0.17 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 113.903 -1.499 . . . . 10.0 112.498 -179.473 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.514 ' HA3' ' HB3' ' C' ' 38' ' ' ASP . . . 86.51 -45.28 3.43 Favored Glycine 0 CA--C 1.51 -0.256 0 C-N-CA 121.071 -0.585 . . . . 10.0 112.399 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.541 ' HD2' HD23 ' A' ' 121' ' ' LEU . 39.7 ttmt -63.33 121.7 14.38 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.556 -0.535 . . . . 10.0 109.556 178.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.9 t -85.8 128.42 39.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 111.79 0.293 . . . . 10.0 111.79 -178.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' A' ' 119' ' ' LEU . 5.3 mp -96.88 144.71 26.56 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.149 -0.315 . . . . 10.0 110.149 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.734 ' HB2' HD13 ' A' ' 130' ' ' LEU . 88.2 m-70 -122.7 161.1 24.51 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.598 -0.441 . . . . 10.0 110.259 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.09 -34.19 68.06 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.224 0.824 . . . . 10.0 113.224 -178.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -96.93 8.35 44.63 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.985 0.365 . . . . 10.0 111.985 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.734 HD13 ' HB2' ' A' ' 127' ' ' HIS . 1.1 mp -80.54 144.92 32.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.985 0.421 . . . . 10.0 110.65 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -107.68 148.67 29.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.769 -0.65 . . . . 10.0 109.362 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 51.0 mt -57.12 -39.18 74.61 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.106 0.409 . . . . 10.0 112.106 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.87 -18.52 58.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.749 0.309 . . . . 10.0 110.746 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -78.62 -49.33 13.42 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.811 -0.632 . . . . 10.0 110.623 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.437 HD22 ' HG ' ' A' ' 126' ' ' LEU . 1.2 pp -76.4 -26.49 55.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.283 -0.417 . . . . 10.0 111.159 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 10.8 mttp 60.84 100.52 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 O-C-N 123.634 0.584 . . . . 10.0 111.409 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.9 p -88.14 128.93 40.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.986 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.88 128.64 89.16 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.982 -0.554 . . . . 10.0 111.435 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -69.25 -9.69 26.97 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.479 2.119 . . . . 10.0 111.924 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -92.02 8.67 36.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.457 0.646 . . . . 10.0 109.484 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.532 ' ND2' ' HG2' ' A' ' 122' ' ' LYS . 5.9 t-20 -134.61 -74.52 0.47 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.229 -0.896 . . . . 10.0 109.737 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.3 m 55.87 26.5 9.77 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.881 0.697 . . . . 10.0 112.881 178.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 19.4 m -121.0 124.24 44.38 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.009 0.433 . . . . 10.0 111.12 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.445 HD13 HD13 ' A' ' 121' ' ' LEU . 24.5 mm -103.19 125.77 57.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.82 -0.627 . . . . 10.0 110.115 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.19 106.44 14.09 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.355 -0.98 . . . . 10.0 108.355 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 30.0 t -89.35 122.27 40.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.668 -0.696 . . . . 10.0 111.816 -177.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . 0.456 ' HA ' ' OE1' ' A' ' 82' ' ' GLN . 26.1 mmt -122.67 117.73 26.46 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.434 -0.803 . . . . 10.0 109.486 178.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 23.1 mt -135.45 138.26 48.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.798 -0.637 . . . . 10.0 110.233 -178.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 9.0 mtpt -103.83 115.02 64.1 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.928 -0.578 . . . . 10.0 110.903 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.43 108.59 1.62 Allowed 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.053 1.835 . . . . 10.0 111.503 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -78.57 61.51 2.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.235 0.54 . . . . 10.0 111.174 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 89.1 mt -94.31 -22.57 18.27 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.031 -0.532 . . . . 10.0 110.529 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.207 -0.901 . . . . 10.0 109.696 179.12 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' -1' ' ' SER . . . . . . . . . . . . . 6.7 p . . . . . 0 N--CA 1.478 0.936 0 CA-C-O 121.006 0.431 . . . . 10.0 110.827 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 0' ' ' VAL . . . . . . . . . . . . . 2.5 t -96.81 -0.01 10.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.0 0.429 . . . . 10.0 109.977 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -54.04 94.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.402 -0.817 . . . . 10.0 111.315 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.31 69.17 0.78 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.563 -0.744 . . . . 10.0 110.539 -178.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -144.92 148.53 33.97 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.039 -0.726 . . . . 10.0 109.039 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.34 134.38 34.36 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.594 -0.442 . . . . 10.0 110.09 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 7.1 ptpp? -57.2 -34.95 69.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.38 -0.373 . . . . 10.0 111.341 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -61.65 -44.17 97.47 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.239 -0.437 . . . . 10.0 110.64 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -56.99 -48.09 79.25 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.467 0.651 . . . . 10.0 109.571 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.607 ' O ' HG12 ' B' ' 12' ' ' ILE . 42.8 mm -63.4 -47.8 90.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.145 -0.934 . . . . 10.0 110.911 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.87 -41.26 70.62 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.983 0.421 . . . . 10.0 110.824 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.8 -31.4 70.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.904 -0.589 . . . . 10.0 110.554 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.36 -33.22 67.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.181 0.515 . . . . 10.0 109.676 179.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.715 HD12 HG12 ' C' ' 12' ' ' ILE . 18.6 mm -66.08 -50.33 69.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.572 -0.74 . . . . 10.0 111.2 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 28.8 m -65.19 -32.18 57.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.804 0.335 . . . . 10.0 110.608 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' ASN . . . . . 0.415 ' HB2' HG11 ' B' ' 51' ' ' VAL . 41.8 t30 -68.73 -48.92 62.59 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.244 -0.435 . . . . 10.0 109.954 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' TYR . . . . . 0.589 ' O ' HG12 ' B' ' 19' ' ' ILE . 5.5 t80 -59.54 -43.2 93.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.235 -0.439 . . . . 10.0 110.708 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 11.4 m-30 -56.82 -45.5 82.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.773 0.32 . . . . 10.0 110.315 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 74.2 m -58.54 -42.45 87.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.903 -0.59 . . . . 10.0 111.2 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 1.5 m -70.14 -21.72 63.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.377 -0.374 . . . . 10.0 111.501 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.589 HG12 ' O ' ' B' ' 15' ' ' TYR . 34.2 mm -87.27 -39.3 12.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.873 -0.331 . . . . 10.0 110.944 -178.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 30.3 m -73.33 -32.2 36.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.61 0.243 . . . . 10.0 110.469 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -65.1 -51.43 61.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.293 -0.412 . . . . 10.0 111.109 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -84.11 -4.6 58.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.329 -0.396 . . . . 10.0 111.492 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 53.0 mttm 57.03 47.44 17.51 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.49 0.662 . . . . 10.0 111.088 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.507 ' O ' ' HE2' ' C' ' 5' ' ' LYS . 80.9 mt-10 -89.31 30.01 1.03 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.702 -0.681 . . . . 10.0 110.348 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 13.3 tt -158.78 171.38 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.764 -0.828 . . . . 10.0 108.764 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.91 155.87 39.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.753 0.311 . . . . 10.0 110.368 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -59.96 -48.0 83.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.234 -0.439 . . . . 10.0 111.072 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.59 -39.17 93.7 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.197 -0.456 . . . . 10.0 109.875 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.503 ' O ' ' HG ' ' B' ' 33' ' ' LEU . . . -66.71 -31.78 79.42 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.756 -0.656 . . . . 10.0 111.514 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.74 -38.07 89.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.648 0.261 . . . . 10.0 110.546 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -66.53 -36.52 82.88 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 108.713 -0.847 . . . . 10.0 108.713 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . 0.64 ' HB3' ' SG ' ' C' ' 39' ' ' CYS . 2.4 m -64.79 -33.36 75.81 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.18 -0.918 . . . . 10.0 110.095 178.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' B' ' 29' ' ' GLY . 25.2 mt -73.35 -40.53 64.33 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.192 -0.458 . . . . 10.0 110.099 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 55.9 m-20 -62.75 -44.86 95.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.818 -0.628 . . . . 10.0 110.986 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.452 ' CG2' ' HG3' ' A' ' 147' ' ' MET . 11.9 p -72.22 -37.53 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 116.331 -0.395 . . . . 10.0 110.564 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.7 -35.04 79.6 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 109.621 -0.511 . . . . 10.0 109.621 178.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' MET . . . . . . . . . . . . . 25.0 ttm -56.18 -51.62 67.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.388 -0.824 . . . . 10.0 110.028 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . 0.528 ' OD1' ' HD3' ' B' ' 48' ' ' ARG . 0.7 OUTLIER -69.09 -40.11 78.62 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.45 -0.795 . . . . 10.0 110.054 -179.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 4.5 t -52.64 -45.45 66.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.268 -0.878 . . . . 10.0 110.6 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 75.8 mt -74.42 -44.34 48.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.51 -0.768 . . . . 10.0 111.196 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.699 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 34.6 m -57.75 -43.74 85.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.85 0.357 . . . . 10.0 110.893 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -68.67 -41.73 78.85 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.955 -0.566 . . . . 10.0 110.849 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.29 -27.96 69.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.262 -0.426 . . . . 10.0 111.807 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -104.15 0.61 29.79 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.81 0.338 . . . . 10.0 111.479 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.08 46.68 84.47 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 116.052 -0.522 . . . . 10.0 113.718 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.699 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 9.2 p90 -135.51 154.91 51.24 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 117.176 0.488 . . . . 10.0 109.953 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -71.61 141.66 49.98 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.267 0.556 . . . . 10.0 112.044 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.528 ' HD3' ' OD1' ' B' ' 38' ' ' ASP . 0.1 OUTLIER -59.31 -42.47 91.47 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.066 -0.97 . . . . 10.0 110.257 179.409 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -88.69 5.23 44.18 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.084 0.772 . . . . 10.0 113.084 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.54 3.39 11.48 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.282 0.475 . . . . 10.0 112.282 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.428 HG23 ' H ' ' B' ' 52' ' ' SER . 13.0 m -43.91 -54.38 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 113.02 0.748 . . . . 10.0 113.02 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' SER . . . . . 0.428 ' H ' HG23 ' B' ' 51' ' ' VAL . 18.3 m -52.88 -35.94 58.49 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 113.213 0.82 . . . . 10.0 113.213 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.28 -33.79 55.99 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.128 -1.034 . . . . 10.0 112.349 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 22.7 mt -89.5 -59.5 2.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 113.759 1.022 . . . . 10.0 113.759 -178.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 60.2 mt -66.07 -67.89 0.41 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.402 0.89 . . . . 10.0 113.402 -177.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . 0.609 ' HA2' ' OG ' ' C' ' 71' ' ' SER . . . 77.52 -152.51 39.52 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.456 -0.878 . . . . 10.0 111.04 -177.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.75 23.65 3.64 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.564 0.697 . . . . 10.0 109.674 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 1.4 m -86.94 40.42 0.91 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.972 -1.013 . . . . 10.0 111.416 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 54.51 82.51 0.09 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.955 -0.566 . . . . 10.0 111.586 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -73.96 78.69 1.67 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.123 0.487 . . . . 10.0 110.609 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -85.3 90.4 7.9 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.074 -0.512 . . . . 10.0 110.109 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -78.0 78.43 1.55 Allowed Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.477 -0.649 . . . . 10.0 111.477 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -69.3 93.62 0.65 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.314 0.578 . . . . 10.0 110.86 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 44.8 t60 -134.11 87.29 2.35 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.643 -0.708 . . . . 10.0 109.373 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 7.3 mt -78.15 -24.77 47.19 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.467 -0.788 . . . . 10.0 110.838 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . 57.33 19.26 4.91 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.156 -0.474 . . . . 10.0 111.004 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 57.07 37.93 28.89 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.478 -0.783 . . . . 10.0 111.391 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 93.7 mt -80.99 97.05 3.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.179 0.514 . . . . 10.0 110.341 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -104.4 26.41 8.98 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.041 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -126.83 54.95 1.58 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.951 -0.568 . . . . 10.0 109.902 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.87 0.41 35.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.748 -0.66 . . . . 10.0 111.247 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.553 -0.737 . . . . 10.0 110.987 -179.486 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' -1' ' ' SER . . . . . . . . . . . . . 9.2 p . . . . . 0 N--CA 1.478 0.958 0 CA-C-O 120.924 0.392 . . . . 10.0 110.197 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 0' ' ' VAL . . . . . . . . . . . . . 3.0 t -106.65 49.27 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.434 0.635 . . . . 10.0 109.573 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -71.65 96.29 1.56 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.722 -0.672 . . . . 10.0 109.273 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.35 62.45 7.43 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.744 -0.662 . . . . 10.0 111.987 -178.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -140.95 141.95 34.41 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.1 -0.5 . . . . 10.0 109.69 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -101.56 142.82 32.36 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.934 -0.395 . . . . 10.0 109.934 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . 0.507 ' HE2' ' O ' ' B' ' 24' ' ' GLU . 7.2 ptpp? -62.87 -37.08 85.45 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.32 0.489 . . . . 10.0 112.32 -178.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 6' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -62.08 -43.4 98.92 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.654 0.264 . . . . 10.0 110.29 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . 0.487 ' O ' HD21 ' C' ' 55' ' ' LEU . 69.9 mt-10 -64.02 -49.9 70.59 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.767 -0.651 . . . . 10.0 110.249 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 8' ' ' ILE . . . . . 0.603 ' O ' HG13 ' C' ' 12' ' ' ILE . 50.0 mm -61.64 -43.72 97.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.813 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.43 -45.36 76.77 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.249 -0.432 . . . . 10.0 111.121 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.84 -34.88 79.41 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.781 -0.645 . . . . 10.0 110.867 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 1.3 mt -65.36 -32.45 74.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.573 -0.285 . . . . 10.0 110.651 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 12' ' ' ILE . . . . . 0.715 HG12 HD12 ' B' ' 12' ' ' ILE . 7.5 mt -67.71 -55.13 18.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.341 -0.391 . . . . 10.0 110.748 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 17.9 m -64.37 -30.86 51.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.812 -0.631 . . . . 10.0 111.311 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 14' ' ' ASN . . . . . 0.523 ' HB2' HG11 ' C' ' 51' ' ' VAL . 45.9 t30 -70.39 -45.72 65.41 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.126 0.488 . . . . 10.0 109.716 178.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 15' ' ' TYR . . . . . 0.6 ' CE2' HG13 ' B' ' 8' ' ' ILE . 4.7 t80 -62.84 -46.99 85.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.863 -0.608 . . . . 10.0 110.454 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -56.11 -47.58 77.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.07 -0.514 . . . . 10.0 111.356 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 37.0 m -58.92 -41.25 86.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 10.0 111.584 -179.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 3.4 p -75.21 -20.84 59.06 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.297 0.481 . . . . 10.0 112.297 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 19' ' ' ILE . . . . . 0.502 HG12 ' O ' ' C' ' 15' ' ' TYR . 20.4 mm -84.06 -35.33 10.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.771 0.32 . . . . 10.0 110.666 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 20' ' ' VAL . . . . . . . . . . . . . 29.4 m -78.7 -28.12 14.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.866 -0.333 . . . . 10.0 110.385 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.1 -50.83 62.69 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.966 0.413 . . . . 10.0 110.221 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -85.8 1.69 48.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.241 -0.436 . . . . 10.0 110.064 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 63.7 mttm 48.03 53.54 11.45 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.105 -0.952 . . . . 10.0 111.989 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -85.09 13.73 5.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.468 . . . . 10.0 110.197 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 13.5 tt -138.82 167.6 20.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.744 -0.662 . . . . 10.0 109.823 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 8.2 p -66.22 160.42 24.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.524 0.202 . . . . 10.0 110.589 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -59.69 -41.99 91.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.919 0.39 . . . . 10.0 110.53 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 28' ' ' ASP . . . . . 0.488 ' OD2' HG23 ' A' ' 81' ' ' ILE . 31.0 t70 -68.84 -39.86 79.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.971 -0.558 . . . . 10.0 109.865 179.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 29' ' ' GLY . . . . . 0.537 ' O ' ' HG ' ' C' ' 33' ' ' LEU . . . -64.57 -35.66 92.2 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.927 -0.654 . . . . 10.0 111.627 178.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.4 -45.92 91.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.345 0.593 . . . . 10.0 110.113 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -60.9 -38.22 84.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.415 -0.811 . . . . 10.0 110.025 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 3.0 t -62.09 -34.37 76.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.358 -0.837 . . . . 10.0 110.593 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 33' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' C' ' 29' ' ' GLY . 50.1 mt -74.94 -29.58 60.98 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.17 -0.468 . . . . 10.0 110.475 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -71.61 -47.57 53.82 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.428 -0.351 . . . . 10.0 110.965 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 35' ' ' VAL . . . . . 0.492 HG23 ' H ' ' A' ' 123' ' ' GLY . 2.5 p -64.16 -40.73 90.08 Favored 'Isoleucine or valine' 0 C--N 1.343 0.304 0 CA-C-O 120.684 0.278 . . . . 10.0 110.449 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.6 -35.61 79.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.847 0.356 . . . . 10.0 110.32 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 40.5 ttm -53.34 -59.89 3.99 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.585 -0.734 . . . . 10.0 111.769 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 38' ' ' ASP . . . . . 0.514 ' HB3' ' HA3' ' A' ' 123' ' ' GLY . 4.1 m-20 -65.89 -33.77 76.59 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 121.028 -0.269 . . . . 10.0 111.504 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 39' ' ' CYS . . . . . 0.64 ' SG ' ' HB3' ' B' ' 32' ' ' SER . 0.5 OUTLIER -60.86 -47.89 84.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.107 0.48 . . . . 10.0 110.064 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 40' ' ' ILE . . . . . . . . . . . . . 59.8 mt -68.34 -44.52 83.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.526 -0.761 . . . . 10.0 110.956 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 41' ' ' SER . . . . . 0.57 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 40.4 m -59.52 -45.75 90.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.063 -0.517 . . . . 10.0 111.432 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 -69.32 -40.12 77.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.312 -0.404 . . . . 10.0 110.839 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.52 -44.43 93.15 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.989 -0.55 . . . . 10.0 112.256 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 44' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -89.1 -6.82 56.77 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.633 0.254 . . . . 10.0 111.521 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.9 58.0 7.26 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 114.397 0.519 . . . . 10.0 114.397 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 46' ' ' PHE . . . . . 0.57 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 13.2 p90 -153.24 154.02 33.83 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.46 -0.57 . . . . 10.0 109.46 178.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 47' ' ' GLU . . . . . 0.432 ' HA ' ' OE1' ' C' ' 47' ' ' GLU . 0.0 OUTLIER -80.54 144.18 32.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.861 0.362 . . . . 10.0 111.155 -179.805 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 48' ' ' ARG . . . . . 0.452 ' HD3' ' OD1' ' C' ' 38' ' ' ASP . 0.0 OUTLIER -61.03 -34.94 75.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.978 -0.555 . . . . 10.0 111.001 -179.42 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.42 3.16 37.38 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.079 0.4 . . . . 10.0 112.079 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.4 1.79 47.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.805 0.336 . . . . 10.0 111.242 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 51' ' ' VAL . . . . . 0.523 HG11 ' HB2' ' C' ' 14' ' ' ASN . 5.9 m -49.72 -44.43 20.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 112.651 0.611 . . . . 10.0 112.651 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.7 -35.28 70.41 Favored 'General case' 0 C--O 1.225 -0.199 0 N-CA-C 112.461 0.541 . . . . 10.0 112.461 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.21 -28.22 58.56 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 119.712 -1.232 . . . . 10.0 112.642 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 54' ' ' ILE . . . . . . . . . . . . . 61.3 mt -89.05 -62.98 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 113.241 0.83 . . . . 10.0 113.241 -178.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 55' ' ' LEU . . . . . 0.487 HD21 ' O ' ' C' ' 7' ' ' GLU . 20.7 mt -74.81 -62.6 1.49 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.529 0.937 . . . . 10.0 113.529 -177.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.16 -119.79 6.89 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.216 -0.754 . . . . 10.0 111.216 -178.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -160.03 22.12 0.17 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.35 0.595 . . . . 10.0 110.086 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.52 44.87 1.14 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.587 -0.733 . . . . 10.0 111.617 -178.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 57.21 71.71 0.56 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.958 0.408 . . . . 10.0 110.785 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 60' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -74.66 80.44 2.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.237 0.541 . . . . 10.0 109.9 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -94.52 94.88 8.46 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.71 -0.677 . . . . 10.0 111.004 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.58 83.78 1.42 Allowed Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.127 -0.789 . . . . 10.0 111.127 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 63' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -72.67 81.98 1.13 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.229 0.538 . . . . 10.0 111.471 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 64' ' ' HIS . . . . . . . . . . . . . 65.5 t60 -115.78 73.51 0.85 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.812 -0.81 . . . . 10.0 108.812 178.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 2.2 mt -59.76 -33.43 71.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.442 -0.799 . . . . 10.0 111.439 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . 62.21 10.28 3.7 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 123.422 0.451 . . . . 10.0 110.846 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 59.59 37.02 22.78 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.636 -0.711 . . . . 10.0 110.486 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 68' ' ' ILE . . . . . . . . . . . . . 75.7 mt -76.2 106.97 6.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.977 -0.556 . . . . 10.0 110.994 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . 0.442 HD13 ' HA ' ' C' ' 69' ' ' LEU . 3.6 mm? -114.32 11.4 17.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.862 -0.608 . . . . 10.0 109.789 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 70' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -95.04 23.04 5.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.494 -0.775 . . . . 10.0 111.231 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 71' ' ' SER . . . . . 0.609 ' OG ' ' HA2' ' B' ' 56' ' ' GLY . 6.8 m -107.34 31.83 5.11 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.109 -0.496 . . . . 10.0 110.756 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.442 -0.79 . . . . 10.0 110.853 -179.714 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 29.9 mtm . . . . . 0 N--CA 1.48 1.068 0 N-CA-C 109.702 -0.481 . . . . 10.0 109.702 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.7 t -90.18 124.75 42.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 121.089 -0.244 . . . . 10.0 110.68 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -91.16 124.78 35.64 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.957 -0.386 . . . . 10.0 109.957 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.6 mp -126.39 133.49 51.29 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.014 0.435 . . . . 10.0 110.861 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.419 HG23 ' HG2' ' A' ' 89' ' ' GLU . 8.8 m -102.97 117.08 33.8 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.246 -0.434 . . . . 10.0 110.701 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -85.68 107.78 17.72 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.12 0.486 . . . . 10.0 110.025 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.3 tptm -106.41 98.93 8.54 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.536 -0.756 . . . . 10.0 110.457 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -99.27 114.09 26.73 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.404 -0.362 . . . . 10.0 110.308 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 57.5 mt -84.05 -57.86 4.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.823 -0.626 . . . . 10.0 111.124 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -61.96 158.94 15.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.883 -0.598 . . . . 10.0 112.066 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -77.94 138.76 61.35 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.924 -0.58 . . . . 10.0 112.318 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -76.33 130.66 21.97 Favored 'Cis proline' 0 C--O 1.235 0.334 0 C-N-CA 123.247 -1.564 . . . . 10.0 110.619 -1.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.49 153.26 22.58 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.253 0.549 . . . . 10.0 111.459 -178.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.453 ' CE1' ' HB3' ' A' ' 110' ' ' LYS . 47.6 p90 -168.15 160.01 11.42 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.173 -0.921 . . . . 10.0 109.416 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.0 m -143.09 98.77 3.33 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.863 -0.791 . . . . 10.0 108.863 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 24.1 pt -119.75 153.44 22.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.18 -0.464 . . . . 10.0 111.048 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.419 ' HG2' HG23 ' A' ' 77' ' ' THR . 43.3 mt-10 -115.62 127.6 55.33 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 109.246 -0.649 . . . . 10.0 109.246 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.54 157.0 44.77 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.065 0.46 . . . . 10.0 110.402 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -114.54 137.79 51.44 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.126 -0.488 . . . . 10.0 109.911 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -129.75 165.09 22.6 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.251 -0.431 . . . . 10.0 110.416 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.537 ' O ' HD12 ' A' ' 132' ' ' LEU . 7.3 m -75.78 147.37 81.04 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.119 -0.492 . . . . 10.0 110.568 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.47 -22.57 59.75 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.864 2.376 . . . . 10.0 113.322 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.59 18.12 22.35 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.962 0.411 . . . . 10.0 110.791 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.47 ' HB2' ' O ' ' A' ' 93' ' ' SER . 0.3 OUTLIER -80.34 162.82 24.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.98 0.419 . . . . 10.0 110.83 179.872 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.6 m -109.38 150.77 27.56 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.976 -0.556 . . . . 10.0 111.506 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 37.8 mm -61.86 -22.05 27.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.272 0.558 . . . . 10.0 110.379 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.13 -38.45 68.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.281 -0.872 . . . . 10.0 110.418 178.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 73.3 mm-40 -62.09 -44.38 96.78 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.136 -0.484 . . . . 10.0 111.137 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.554 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 35.6 mt -63.7 -50.09 79.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.839 -0.619 . . . . 10.0 109.875 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -55.37 -44.55 76.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.626 -0.716 . . . . 10.0 110.854 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -63.73 -39.19 93.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 10.0 110.905 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -63.57 -39.81 95.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.131 -0.486 . . . . 10.0 110.918 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 101' ' ' ILE . 40.9 mt -62.13 -42.19 99.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.867 0.365 . . . . 10.0 110.478 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 48.8 mt -68.81 -44.24 82.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.439 -0.346 . . . . 10.0 110.563 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.5 m -61.07 -27.45 68.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.848 -0.615 . . . . 10.0 111.82 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -95.8 12.86 28.55 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 120.797 0.332 . . . . 10.0 111.145 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 59.76 34.43 21.96 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.696 -0.684 . . . . 10.0 111.925 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.453 ' HB3' ' CE1' ' A' ' 86' ' ' PHE . 17.5 mmtp -107.2 -7.17 16.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.324 0.583 . . . . 10.0 110.472 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.487 ' HB2' HD13 ' A' ' 148' ' ' ILE . . . -141.67 142.02 33.36 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.439 -0.8 . . . . 10.0 109.81 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.33 -41.84 17.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.728 0.299 . . . . 10.0 111.387 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.404 ' O ' HG13 ' A' ' 117' ' ' ILE . 2.6 t-80 -151.69 141.59 22.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.613 -0.267 . . . . 10.0 110.845 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.489 ' HA ' HD12 ' A' ' 117' ' ' ILE . 4.1 tt -62.21 -41.92 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 116.279 -0.419 . . . . 10.0 111.876 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.508 ' HB2' ' OE2' ' A' ' 116' ' ' GLU . 11.2 m -53.67 -17.93 2.61 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.922 0.712 . . . . 10.0 112.922 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.508 ' OE2' ' HB2' ' A' ' 115' ' ' SER . 0.9 OUTLIER -109.74 7.27 24.19 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 122.102 -0.374 . . . . 10.0 111.341 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.489 HD12 ' HA ' ' A' ' 114' ' ' ILE . 66.1 mt -93.48 120.68 43.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.635 -0.505 . . . . 10.0 109.635 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.9 mmmt -124.24 118.57 27.11 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.297 -0.41 . . . . 10.0 110.377 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.448 ' O ' ' HB2' ' A' ' 126' ' ' LEU . 3.9 mm? -95.52 110.73 22.76 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.397 -0.365 . . . . 10.0 110.757 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.647 HD21 HG11 ' B' ' 35' ' ' VAL . 2.7 mm? -101.26 107.36 18.71 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.491 -0.929 . . . . 10.0 108.491 177.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.402 HD13 HD13 ' A' ' 144' ' ' ILE . 5.0 tp -90.94 101.22 13.99 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.713 0.768 . . . . 10.0 109.278 178.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.431 ' HD2' ' HA ' ' A' ' 122' ' ' LYS . 13.5 tptp 52.33 56.34 7.85 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 113.957 -1.474 . . . . 10.0 109.142 -177.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.758 ' HA2' ' SG ' ' C' ' 39' ' ' CYS . . . 79.05 -43.56 2.48 Favored Glycine 0 C--O 1.228 -0.245 0 CA-C-N 114.581 -1.191 . . . . 10.0 112.509 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 22.0 tttp -58.07 119.65 7.17 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.001 -0.6 . . . . 10.0 111.351 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.4 p -72.34 136.38 25.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 113.562 0.949 . . . . 10.0 113.562 -177.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' A' ' 119' ' ' LEU . 1.5 mp -102.31 156.83 17.33 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 114.901 -1.045 . . . . 10.0 109.332 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 62.6 m-70 -116.65 152.73 33.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.061 0.458 . . . . 10.0 110.822 -178.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -52.77 -52.23 57.47 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.575 0.954 . . . . 10.0 113.575 -178.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -89.42 11.05 20.37 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.002 0.371 . . . . 10.0 112.002 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.1 tp -74.03 146.58 43.63 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.905 0.383 . . . . 10.0 111.022 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -106.54 150.56 26.01 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.927 -0.578 . . . . 10.0 110.003 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.537 HD12 ' O ' ' A' ' 93' ' ' SER . 81.4 mt -58.22 -31.73 67.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.015 0.436 . . . . 10.0 111.282 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.1 -33.08 67.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.892 -0.595 . . . . 10.0 111.218 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -77.39 -44.9 27.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.277 -0.42 . . . . 10.0 111.29 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.5 pp -74.08 -25.76 59.99 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.8 -0.36 . . . . 10.0 111.1 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt 65.1 93.01 0.07 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.238 0.542 . . . . 10.0 111.758 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.8 t -71.68 112.24 6.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.975 -0.557 . . . . 10.0 110.06 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.12 125.05 84.29 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.515 -0.311 . . . . 10.0 110.916 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.1 -12.67 36.95 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.068 2.512 . . . . 10.0 112.633 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -82.8 -0.86 49.85 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.241 0.543 . . . . 10.0 110.367 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 55.1 m-20 -131.7 -71.32 0.56 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.629 -0.714 . . . . 10.0 109.271 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 31.9 m 58.16 17.75 4.79 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.491 -0.777 . . . . 10.0 111.649 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.22 124.22 47.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.22 -0.445 . . . . 10.0 110.689 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.402 HD13 HD13 ' A' ' 121' ' ' LEU . 4.5 mm -110.96 124.4 67.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.324 -0.621 . . . . 10.0 109.324 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.54 129.99 34.99 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.684 -0.488 . . . . 10.0 109.684 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 2.2 t -107.65 131.14 58.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.349 0.595 . . . . 10.0 111.252 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . 0.41 ' SD ' HD23 ' A' ' 120' ' ' LEU . 1.8 mpt? -129.72 125.31 35.63 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.201 -1.037 . . . . 10.0 108.201 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.487 HD13 ' HB2' ' A' ' 111' ' ' ALA . 47.6 mt -135.84 139.4 46.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 116.562 -0.29 . . . . 10.0 110.326 -178.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -101.69 113.72 65.78 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 109.053 -0.721 . . . . 10.0 109.053 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.44 118.28 5.47 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.387 2.058 . . . . 10.0 112.863 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -92.54 -3.17 55.51 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.723 -0.671 . . . . 10.0 109.469 178.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 98.1 mt -102.32 128.22 48.97 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.581 -0.736 . . . . 10.0 110.329 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.476 -0.773 . . . . 10.0 110.345 179.984 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' -1' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.476 0.87 0 CA-C-O 120.787 0.327 . . . . 10.0 110.895 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 0' ' ' VAL . . . . . . . . . . . . . 29.9 m -117.01 -168.15 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.054 -0.521 . . . . 10.0 110.491 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . 0.452 ' OD2' ' HG3' ' B' ' 61' ' ' LYS . 32.4 t70 -159.92 -81.45 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.651 -0.25 . . . . 10.0 110.505 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 15.6 t -161.59 26.36 0.12 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.375 0.607 . . . . 10.0 110.343 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -116.35 144.69 43.94 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.856 -0.611 . . . . 10.0 109.859 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 51.8 p -97.75 177.2 5.55 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.612 -0.435 . . . . 10.0 109.898 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . 0.455 ' HB2' ' CE1' ' B' ' 44' ' ' PHE . 7.8 ptpp? -57.81 -41.17 81.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.368 -0.378 . . . . 10.0 110.859 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -59.87 -50.46 73.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 10.0 111.811 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -59.1 -42.37 90.32 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.705 0.288 . . . . 10.0 110.852 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.607 ' O ' HG13 ' B' ' 12' ' ' ILE . 47.8 mm -62.02 -47.5 92.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.77 -0.455 . . . . 10.0 109.77 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.521 ' HA ' HD12 ' B' ' 12' ' ' ILE . . . -57.43 -41.99 81.5 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.75 -0.659 . . . . 10.0 111.053 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.03 -36.9 85.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.108 -0.496 . . . . 10.0 110.597 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 23.9 mt -69.64 -33.52 72.74 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.789 -0.448 . . . . 10.0 109.789 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.607 HG13 ' O ' ' B' ' 8' ' ' ILE . 86.1 mt -64.07 -57.0 13.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.984 -0.553 . . . . 10.0 111.025 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 29.4 m -59.41 -32.84 49.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.21 -0.45 . . . . 10.0 111.274 -178.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -72.19 -46.18 57.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.244 -0.434 . . . . 10.0 110.835 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' TYR . . . . . 0.545 ' O ' HG12 ' B' ' 19' ' ' ILE . 2.1 m-85 -68.89 -46.82 67.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.453 -0.34 . . . . 10.0 111.459 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -55.26 -52.15 64.34 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.683 0.278 . . . . 10.0 111.179 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . 0.506 ' O ' ' HB2' ' B' ' 21' ' ' GLU . 18.8 p -59.53 -38.06 80.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.408 -0.36 . . . . 10.0 111.369 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 76.6 p -74.89 -20.72 59.6 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.073 0.397 . . . . 10.0 112.073 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.545 HG12 ' O ' ' B' ' 15' ' ' TYR . 25.9 mm -80.39 -42.48 21.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.165 0.507 . . . . 10.0 109.808 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 19.5 m -75.92 -27.78 18.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.775 -0.648 . . . . 10.0 110.433 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . 0.506 ' HB2' ' O ' ' B' ' 17' ' ' SER . 2.4 tp10 -70.06 -42.51 72.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.124 -0.489 . . . . 10.0 110.33 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 30.9 mtmt -78.36 -1.68 34.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 10.0 110.755 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 66.6 mmtt 55.73 38.84 30.61 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.745 -0.662 . . . . 10.0 110.847 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.563 ' O ' ' HE2' ' C' ' 5' ' ' LYS . 25.1 mt-10 -90.55 24.31 2.69 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.27 -0.423 . . . . 10.0 111.497 -178.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 17.6 tt -155.31 161.16 2.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.401 -0.363 . . . . 10.0 110.128 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.62 160.42 32.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.471 -0.332 . . . . 10.0 110.524 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -57.89 -46.25 85.2 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 111.738 0.273 . . . . 10.0 111.738 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -56.52 -42.08 77.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.846 0.355 . . . . 10.0 110.301 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.67 -42.67 61.9 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.021 -0.609 . . . . 10.0 111.912 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.85 -36.66 77.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.93 0.395 . . . . 10.0 110.526 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -71.82 -43.01 66.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.791 -0.64 . . . . 10.0 110.139 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 38.5 m -63.12 -38.64 91.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.69 -0.687 . . . . 10.0 110.282 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 92.7 mt -72.79 -39.27 66.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.255 -0.43 . . . . 10.0 110.316 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -61.33 -46.19 91.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.125 -0.489 . . . . 10.0 111.242 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.647 HG11 HD21 ' A' ' 120' ' ' LEU . 13.1 p -71.18 -34.62 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 116.516 -0.311 . . . . 10.0 110.342 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.12 -38.06 87.25 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.458 -0.571 . . . . 10.0 109.458 178.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' MET . . . . . . . . . . . . . 18.0 ttm -57.43 -44.46 84.69 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.688 -0.687 . . . . 10.0 110.01 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -60.88 -45.8 93.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.676 -0.693 . . . . 10.0 110.58 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 76.0 m -62.85 -40.99 99.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.0 -0.546 . . . . 10.0 110.384 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' ILE . . . . . 0.515 HD13 HG21 ' B' ' 12' ' ' ILE . 89.3 mt -65.32 -47.01 88.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.033 -0.53 . . . . 10.0 111.001 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.647 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 48.9 m -59.07 -42.3 90.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.86 0.362 . . . . 10.0 111.064 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -72.48 -39.46 67.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.247 -0.433 . . . . 10.0 111.232 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.59 -43.14 93.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.32 -0.4 . . . . 10.0 111.997 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' PHE . . . . . 0.455 ' CE1' ' HB2' ' B' ' 5' ' ' LYS . 58.0 m-85 -87.08 -4.28 59.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.679 -0.237 . . . . 10.0 111.377 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 62.46 52.22 50.66 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.238 -0.506 . . . . 10.0 113.023 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.647 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 4.7 p90 -146.58 164.46 32.55 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.241 -0.281 . . . . 10.0 110.241 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.99 148.87 21.86 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.436 -0.347 . . . . 10.0 110.496 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.411 ' HG3' ' H ' ' B' ' 48' ' ' ARG . 6.6 mtm180 -65.83 -32.92 74.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.317 0.579 . . . . 10.0 110.611 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -78.75 4.2 14.48 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.416 -0.811 . . . . 10.0 112.269 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.41 3.1 29.42 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.771 0.319 . . . . 10.0 110.386 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.537 HG23 ' H ' ' B' ' 52' ' ' SER . 0.8 OUTLIER -44.97 -64.01 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 115.54 -0.754 . . . . 10.0 112.804 -179.142 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' SER . . . . . 0.537 ' H ' HG23 ' B' ' 51' ' ' VAL . 0.2 OUTLIER -53.49 -30.01 39.05 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.688 0.625 . . . . 10.0 112.688 -179.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.14 -44.61 22.62 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.562 -0.828 . . . . 10.0 112.793 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 48.4 mt -82.58 -46.33 19.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 112.233 0.457 . . . . 10.0 112.233 -178.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 67.3 mt -73.16 -57.31 4.11 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.837 0.351 . . . . 10.0 111.071 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.72 -143.31 45.14 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.591 -0.814 . . . . 10.0 111.468 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . 0.427 ' HA ' ' HE2' ' C' ' 64' ' ' HIS . 48.7 tttt -109.83 14.03 23.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.187 0.518 . . . . 10.0 110.213 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 5.1 m -79.34 138.54 37.74 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.842 -0.617 . . . . 10.0 110.408 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.51 145.3 26.85 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.049 0.452 . . . . 10.0 110.574 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -106.69 172.09 7.0 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.029 -0.532 . . . . 10.0 109.957 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . 0.456 ' HA ' ' HA ' ' C' ' 61' ' ' LYS . 6.3 ptmm? -163.47 172.68 14.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.85 0.357 . . . . 10.0 110.882 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -146.01 52.99 0.56 Allowed Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 110.86 -0.896 . . . . 10.0 110.86 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -73.25 125.81 28.65 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.097 0.475 . . . . 10.0 110.571 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 50.4 p-80 -148.04 113.2 5.53 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.78 -0.645 . . . . 10.0 110.456 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -82.58 -12.52 57.65 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.135 -0.691 . . . . 10.0 109.135 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -86.38 135.9 33.33 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.087 -0.96 . . . . 10.0 110.594 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.86 149.88 46.34 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.86 -0.609 . . . . 10.0 110.306 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 10.7 mt -91.21 88.42 2.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.234 -0.654 . . . . 10.0 109.234 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 31.6 mt 72.26 -85.1 0.03 OUTLIER 'General case' 0 C--O 1.233 0.193 0 CA-C-N 114.987 -1.006 . . . . 10.0 110.022 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -131.45 -10.89 3.61 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.724 0.297 . . . . 10.0 110.237 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 30.7 m 61.48 25.93 15.77 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.853 -0.612 . . . . 10.0 112.043 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.152 0 CA-C-O 119.013 -0.518 . . . . 10.0 110.571 179.423 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' -1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.477 0.889 0 CA-C-O 120.515 0.198 . . . . 10.0 110.671 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 0' ' ' VAL . . . . . . . . . . . . . 27.7 m -110.66 -164.99 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.398 -0.364 . . . . 10.0 110.53 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 1' ' ' ASP . . . . . 0.542 ' OD1' ' HG3' ' C' ' 61' ' ' LYS . 6.5 t70 -156.76 -72.43 0.1 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.21 0.528 . . . . 10.0 109.804 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 43.9 t -165.12 16.35 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.406 -0.815 . . . . 10.0 109.738 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -103.23 150.94 23.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.253 -0.431 . . . . 10.0 110.652 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 4' ' ' SER . . . . . . . . . . . . . 21.6 p -108.99 167.96 9.71 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.265 -0.425 . . . . 10.0 110.047 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . 0.563 ' HE2' ' O ' ' B' ' 24' ' ' GLU . 6.6 ptpp? -55.27 -42.28 73.33 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.445 0.535 . . . . 10.0 112.445 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 6' ' ' GLU . . . . . 0.448 ' H ' ' HG2' ' C' ' 6' ' ' GLU . 5.7 pt-20 -62.64 -38.79 91.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.497 -0.319 . . . . 10.0 111.788 -178.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -76.22 -40.64 51.62 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.619 0.247 . . . . 10.0 110.866 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 8' ' ' ILE . . . . . 0.409 HG13 ' CE1' ' B' ' 15' ' ' TYR . 17.0 mm -60.93 -46.34 96.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.33 -0.395 . . . . 10.0 110.361 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.18 -41.67 97.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.108 -0.496 . . . . 10.0 110.072 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.84 -44.61 95.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.633 -0.712 . . . . 10.0 110.811 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.35 -37.95 89.24 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.041 -0.527 . . . . 10.0 110.934 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 12' ' ' ILE . . . . . 0.405 HD13 ' O ' ' C' ' 8' ' ' ILE . 1.3 mp -68.23 -47.73 76.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.179 -0.464 . . . . 10.0 111.606 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 35.9 m -65.91 -25.16 35.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-O 121.136 0.493 . . . . 10.0 110.175 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.91 -41.91 50.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.925 -0.579 . . . . 10.0 109.778 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 15' ' ' TYR . . . . . 0.527 ' O ' HG12 ' C' ' 19' ' ' ILE . 0.5 OUTLIER -72.59 -37.44 68.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.567 -179.637 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -59.77 -47.84 84.06 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.373 -0.376 . . . . 10.0 110.787 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 17' ' ' SER . . . . . 0.491 ' O ' ' HB2' ' C' ' 21' ' ' GLU . 2.6 p -61.48 -42.42 98.75 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.645 -0.252 . . . . 10.0 110.945 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 2.0 p -68.22 -25.51 65.24 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 111.865 0.32 . . . . 10.0 111.865 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 19' ' ' ILE . . . . . 0.527 HG12 ' O ' ' C' ' 15' ' ' TYR . 20.8 mm -78.65 -42.99 25.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 121.057 0.456 . . . . 10.0 110.448 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 20' ' ' VAL . . . . . . . . . . . . . 16.1 m -77.11 -23.69 14.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.869 0.366 . . . . 10.0 110.267 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' C' ' 17' ' ' SER . 5.0 tp10 -63.51 -51.2 66.53 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.341 -0.614 . . . . 10.0 109.341 178.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -77.01 -5.24 47.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.04 -0.982 . . . . 10.0 111.483 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm 58.03 42.93 21.82 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.317 0.579 . . . . 10.0 109.708 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . 0.445 ' O ' ' HE2' ' B' ' 5' ' ' LYS . 9.0 mt-10 -81.48 3.14 25.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.547 -0.751 . . . . 10.0 110.922 -178.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 18.2 tt -141.88 152.33 18.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 109.415 -0.587 . . . . 10.0 109.415 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.33 161.41 5.61 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 123.426 0.454 . . . . 10.0 111.844 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -54.27 -42.51 70.06 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.376 -0.374 . . . . 10.0 111.113 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.37 -49.9 71.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.774 -0.648 . . . . 10.0 110.493 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 29' ' ' GLY . . . . . 0.669 ' O ' ' HG ' ' C' ' 33' ' ' LEU . . . -68.64 -44.29 72.03 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.696 -0.684 . . . . 10.0 111.979 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.54 -45.67 81.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.87 0.367 . . . . 10.0 111.163 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -62.92 -44.81 95.08 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.969 -0.559 . . . . 10.0 110.076 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 53.5 m -60.59 -40.41 91.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.634 -0.712 . . . . 10.0 110.944 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 33' ' ' LEU . . . . . 0.669 ' HG ' ' O ' ' C' ' 29' ' ' GLY . 34.9 mt -67.16 -36.66 82.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.636 -0.256 . . . . 10.0 110.538 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -58.74 -57.76 11.59 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.083 -0.508 . . . . 10.0 111.013 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 35' ' ' VAL . . . . . . . . . . . . . 3.0 p -65.39 -38.53 82.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.394 -0.366 . . . . 10.0 111.194 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.48 -32.49 70.31 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.636 0.255 . . . . 10.0 110.918 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 49.1 mtm -60.92 -44.04 97.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.244 -0.435 . . . . 10.0 110.702 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 38' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -69.68 -30.96 68.74 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 109.819 -0.438 . . . . 10.0 109.819 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 39' ' ' CYS . . . . . 0.758 ' SG ' ' HA2' ' A' ' 123' ' ' GLY . 32.0 m -63.18 -48.22 79.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.28 0.562 . . . . 10.0 109.642 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 40' ' ' ILE . . . . . . . . . . . . . 66.4 mt -66.76 -45.68 87.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.21 -0.905 . . . . 10.0 110.776 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 41' ' ' SER . . . . . 0.519 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 27.9 m -62.31 -42.12 99.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.83 -0.623 . . . . 10.0 111.7 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -68.04 -39.99 82.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.869 0.366 . . . . 10.0 110.47 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.88 -49.21 78.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.777 -0.647 . . . . 10.0 111.967 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 44' ' ' PHE . . . . . 0.506 ' CE1' ' HB2' ' C' ' 5' ' ' LYS . 86.4 m-85 -88.17 -3.2 58.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.791 0.329 . . . . 10.0 111.477 -179.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.75 64.31 4.42 Favored Glycine 0 C--N 1.331 0.253 0 CA-C-N 116.116 -0.493 . . . . 10.0 113.781 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 46' ' ' PHE . . . . . 0.519 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 13.8 p90 -153.29 157.57 40.32 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.18 -0.304 . . . . 10.0 110.18 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 19.3 mp0 -83.98 137.92 33.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.4 -0.364 . . . . 10.0 110.614 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 48' ' ' ARG . . . . . 0.404 ' H ' ' HG3' ' C' ' 48' ' ' ARG . 7.8 mtm180 -65.78 -36.24 82.96 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.503 0.668 . . . . 10.0 110.229 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -79.95 15.0 1.57 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.114 -0.948 . . . . 10.0 111.782 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -104.15 1.05 30.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.968 0.413 . . . . 10.0 110.596 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 4.1 m -45.72 -42.06 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 113.053 0.76 . . . . 10.0 113.053 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 52' ' ' SER . . . . . . . . . . . . . 1.5 m -58.16 -28.53 64.81 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.325 0.491 . . . . 10.0 112.325 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.41 -28.25 27.95 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.66 -0.781 . . . . 10.0 112.408 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 54' ' ' ILE . . . . . . . . . . . . . 35.3 mt -85.21 -62.13 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.726 0.298 . . . . 10.0 110.913 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 47.5 mt -63.2 -44.31 95.71 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.777 -0.647 . . . . 10.0 110.854 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.34 -132.71 52.09 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.942 -0.647 . . . . 10.0 112.752 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 22.1 tttt -116.96 11.41 14.32 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.931 0.396 . . . . 10.0 110.237 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 2.0 m -78.19 136.81 37.89 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.798 -0.637 . . . . 10.0 110.984 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 59' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' C' ' 59' ' ' GLU . 1.1 pm0 -87.68 116.59 25.92 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.049 0.452 . . . . 10.0 109.879 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 60' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -78.02 167.99 20.58 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.231 -0.441 . . . . 10.0 110.619 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 61' ' ' LYS . . . . . 0.542 ' HG3' ' OD1' ' C' ' 1' ' ' ASP . 4.9 ptmm? -148.86 164.42 34.51 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.346 -0.388 . . . . 10.0 110.894 -179.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -147.74 55.79 0.51 Allowed Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.229 -0.749 . . . . 10.0 111.229 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 63' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -84.21 144.18 29.12 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.801 0.334 . . . . 10.0 110.391 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 64' ' ' HIS . . . . . 0.427 ' HE2' ' HA ' ' B' ' 57' ' ' LYS . 27.0 p-80 -153.99 107.52 2.95 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.001 0.429 . . . . 10.0 110.349 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -76.59 -13.49 60.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.768 -0.651 . . . . 10.0 109.979 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -89.57 151.36 21.98 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.651 -0.704 . . . . 10.0 109.896 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -83.71 148.2 27.21 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.114 -0.328 . . . . 10.0 110.114 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 68' ' ' ILE . . . . . . . . . . . . . 49.3 mt -84.68 83.17 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.028 0.442 . . . . 10.0 109.972 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 61.8 mt 63.53 -87.02 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.008 -0.996 . . . . 10.0 111.071 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 70' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -118.93 -11.53 9.69 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.207 -0.451 . . . . 10.0 111.308 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 71' ' ' SER . . . . . . . . . . . . . 11.4 m 58.1 30.0 18.67 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 123.566 0.541 . . . . 10.0 110.456 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.149 0 CA-C-O 118.196 -0.907 . . . . 10.0 110.095 -179.207 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 33.6 mtm . . . . . 0 N--CA 1.477 0.92 0 N-CA-C 110.277 -0.268 . . . . 10.0 110.277 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.9 t -115.4 130.94 69.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.609 -0.515 . . . . 10.0 109.609 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -87.41 125.31 34.19 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.836 0.35 . . . . 10.0 110.181 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 mp -120.94 122.29 39.86 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.679 -0.489 . . . . 10.0 109.679 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.7 m -101.01 113.93 27.39 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 110.089 -0.337 . . . . 10.0 110.089 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.463 ' O ' ' HA ' ' A' ' 87' ' ' SER . 2.8 mm? -88.41 117.73 27.54 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.183 -0.303 . . . . 10.0 110.183 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -114.63 99.19 7.35 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.923 -0.58 . . . . 10.0 109.714 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 85' ' ' LYS . 19.4 tptm -88.39 113.67 24.22 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.827 -0.624 . . . . 10.0 109.963 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 96.0 mt -81.46 -54.73 9.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.65 -0.704 . . . . 10.0 111.215 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -66.67 162.98 19.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.15 -0.477 . . . . 10.0 111.722 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.91 139.09 40.0 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.123 -0.49 . . . . 10.0 111.437 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.404 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 7.9 Cg_exo -75.37 132.11 26.48 Favored 'Cis proline' 0 C--O 1.236 0.382 0 C-N-CA 123.047 -1.647 . . . . 10.0 110.378 -1.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -91.7 159.05 16.04 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.823 0.344 . . . . 10.0 111.458 -178.413 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -176.27 169.42 2.74 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.71 -0.677 . . . . 10.0 109.985 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 70.0 m -146.81 110.25 4.85 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.15 0.5 . . . . 10.0 110.184 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 33.8 pt -122.54 147.63 26.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.862 -0.608 . . . . 10.0 110.915 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -119.23 122.53 42.16 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.969 -0.56 . . . . 10.0 110.044 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -142.52 164.86 28.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.567 -0.288 . . . . 10.0 110.399 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.98 136.31 51.48 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.091 0.472 . . . . 10.0 110.565 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -126.81 170.2 12.43 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.741 -0.663 . . . . 10.0 109.684 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.568 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 5.3 m -92.31 148.27 36.2 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 109.862 -0.422 . . . . 10.0 109.862 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -51.8 -31.01 40.36 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.738 2.292 . . . . 10.0 112.683 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.75 10.84 19.45 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 112.295 0.48 . . . . 10.0 112.295 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.568 ' HB2' ' O ' ' A' ' 93' ' ' SER . 0.5 OUTLIER -81.03 152.72 27.78 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.746 -0.464 . . . . 10.0 109.746 179.111 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.17 154.39 21.26 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.156 -0.474 . . . . 10.0 110.068 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 39.3 mm -63.28 -21.87 29.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.53 0.681 . . . . 10.0 109.364 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.27 -44.04 75.24 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 114.756 -1.111 . . . . 10.0 110.474 178.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -62.79 -41.93 99.48 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.7 -0.682 . . . . 10.0 110.733 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.512 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 49.3 mt -60.64 -48.59 88.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.673 -0.694 . . . . 10.0 109.932 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.407 ' HA ' HD12 ' A' ' 105' ' ' LEU . 84.6 mttt -54.06 -43.79 70.56 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.219 -0.9 . . . . 10.0 111.609 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -62.78 -35.56 80.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.011 0.434 . . . . 10.0 110.589 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.577 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 36.1 t60 -66.08 -37.78 86.64 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.088 -0.505 . . . . 10.0 110.627 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 101' ' ' ILE . 11.3 mt -63.9 -40.12 95.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.208 0.528 . . . . 10.0 110.179 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 32.8 mt -69.97 -38.04 74.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.911 -0.586 . . . . 10.0 109.558 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 32.4 t -66.72 -22.28 66.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.396 -0.82 . . . . 10.0 111.076 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.577 ' HG2' ' O ' ' A' ' 104' ' ' HIS . 19.9 mm-40 -94.08 11.65 29.14 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 121.071 -0.252 . . . . 10.0 110.399 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 58.58 30.09 19.35 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.014 -0.539 . . . . 10.0 111.235 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.5 mmpp? -106.57 -5.67 18.58 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.127 -0.488 . . . . 10.0 110.513 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.613 ' HB2' HD13 ' A' ' 148' ' ' ILE . . . -135.54 154.44 51.38 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.711 -0.677 . . . . 10.0 109.946 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.7 m -107.81 -30.39 8.55 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.914 -0.315 . . . . 10.0 111.624 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.423 ' O ' HG13 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -152.75 136.83 16.41 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.22 -0.289 . . . . 10.0 110.22 -178.694 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.419 ' HA ' HD12 ' A' ' 117' ' ' ILE . 15.8 tt -65.77 -36.24 77.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.567 0.699 . . . . 10.0 109.983 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.533 ' HB2' ' OE2' ' A' ' 116' ' ' GLU . 0.7 OUTLIER -50.23 -34.98 24.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.278 -1.328 . . . . 10.0 113.232 179.398 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.533 ' OE2' ' HB2' ' A' ' 115' ' ' SER . 1.0 OUTLIER -99.08 12.01 37.34 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.402 0.519 . . . . 10.0 112.402 -178.707 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 113' ' ' HIS . 57.0 mt -93.71 121.07 44.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.64 -0.424 . . . . 10.0 110.5 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.1 mmmt -121.79 114.4 21.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.297 -0.41 . . . . 10.0 110.464 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.406 ' HA ' HD13 ' A' ' 119' ' ' LEU . 2.9 mm? -91.4 128.23 37.15 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.976 0.417 . . . . 10.0 111.241 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.643 HD21 HG11 ' B' ' 35' ' ' VAL . 2.8 mm? -116.01 137.43 52.12 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.982 -0.748 . . . . 10.0 108.982 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 16.5 tp -121.06 95.68 4.79 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.26 -1.015 . . . . 10.0 108.26 178.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.436 ' HD2' ' HA ' ' A' ' 122' ' ' LYS . 4.1 tptp 42.36 60.32 2.38 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.11 -0.95 . . . . 10.0 110.584 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.594 ' HA2' ' SG ' ' C' ' 39' ' ' CYS . . . 86.69 -46.05 3.52 Favored Glycine 0 C--N 1.331 0.299 0 CA-C-N 115.792 -0.64 . . . . 10.0 113.238 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.9 tttp -60.46 121.23 11.58 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 120.631 0.253 . . . . 10.0 110.554 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.472 ' HA ' HD13 ' A' ' 120' ' ' LEU . 12.8 p -79.59 136.49 23.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.097 0.475 . . . . 10.0 111.458 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.2 mp -106.03 157.31 17.61 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.041 -0.527 . . . . 10.0 111.202 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.429 ' H ' HD22 ' A' ' 130' ' ' LEU . 85.5 m-70 -116.98 158.5 24.0 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 116.315 -0.402 . . . . 10.0 110.433 -178.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.64 -48.25 82.39 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.491 -0.777 . . . . 10.0 112.143 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -82.97 5.52 21.76 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.93 -0.577 . . . . 10.0 111.162 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.429 HD22 ' H ' ' A' ' 127' ' ' HIS . 4.0 tp -73.84 139.58 45.17 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.114 0.483 . . . . 10.0 111.447 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -102.82 148.8 25.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.382 -0.826 . . . . 10.0 109.641 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 60.4 mt -56.51 -39.11 72.75 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.991 0.367 . . . . 10.0 111.991 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.8 p -75.58 -19.19 59.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.821 0.343 . . . . 10.0 111.076 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -81.28 -42.5 20.55 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.253 -0.43 . . . . 10.0 111.255 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.2 pp -82.62 -22.51 34.71 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 121.084 -0.246 . . . . 10.0 110.876 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt 67.58 88.46 0.11 Allowed 'General case' 0 N--CA 1.463 0.218 0 O-C-N 123.723 0.639 . . . . 10.0 110.755 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 30.8 t -63.72 105.85 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.613 -0.721 . . . . 10.0 110.644 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.79 117.43 35.22 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.895 -0.593 . . . . 10.0 111.403 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -67.85 -11.75 33.11 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.822 2.348 . . . . 10.0 112.718 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -88.69 6.44 38.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.507 0.67 . . . . 10.0 110.014 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -134.97 -66.35 0.59 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.193 -0.912 . . . . 10.0 109.295 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.1 m 52.71 22.92 2.45 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.205 -0.907 . . . . 10.0 112.2 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 36.4 m -123.69 125.72 45.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.05 0.452 . . . . 10.0 110.188 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.27 117.59 55.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 108.292 -1.003 . . . . 10.0 108.292 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.37 126.6 31.38 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.318 -0.623 . . . . 10.0 109.318 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.2 t -99.7 130.75 48.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.89 -0.595 . . . . 10.0 112.095 -177.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -122.64 117.71 26.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.089 -0.96 . . . . 10.0 109.257 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.613 HD13 ' HB2' ' A' ' 111' ' ' ALA . 21.1 mt -138.3 143.73 32.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.503 -0.317 . . . . 10.0 111.175 -177.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -112.2 117.98 46.72 Favored Pre-proline 0 N--CA 1.452 -0.371 0 CA-C-N 116.339 -0.391 . . . . 10.0 110.093 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -67.07 112.83 2.62 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.535 2.157 . . . . 10.0 112.653 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -85.46 -22.16 28.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.058 0.456 . . . . 10.0 110.34 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 90.3 mt -71.71 130.6 41.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.59 -0.732 . . . . 10.0 110.488 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.95 0 CA-C-O 118.399 -0.81 . . . . 10.0 110.253 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' -1' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.476 0.839 0 N-CA-C 110.434 -0.21 . . . . 10.0 110.434 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 0' ' ' VAL . . . . . . . . . . . . . 16.2 m -123.47 -165.87 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.223 -0.444 . . . . 10.0 110.852 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -161.34 -80.93 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.075 0.464 . . . . 10.0 109.955 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 37.2 m -163.48 7.08 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.488 -0.778 . . . . 10.0 110.087 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.97 147.24 24.41 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.904 -0.589 . . . . 10.0 109.891 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 48.9 p -91.43 169.27 10.92 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.919 0.39 . . . . 10.0 111.008 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -59.38 -44.07 92.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.977 -0.556 . . . . 10.0 111.106 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -61.21 -47.89 84.02 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.317 -0.401 . . . . 10.0 111.133 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -57.29 -41.16 79.25 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.34 -0.391 . . . . 10.0 110.694 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.715 ' O ' HG13 ' B' ' 12' ' ' ILE . 26.0 mm -61.49 -48.43 88.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.787 -0.449 . . . . 10.0 109.787 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.22 -43.37 82.76 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.965 -0.561 . . . . 10.0 111.264 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.8 -34.44 77.91 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.025 -0.534 . . . . 10.0 110.614 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 26.0 mt -71.78 -34.11 69.16 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.164 -0.471 . . . . 10.0 110.282 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.715 HG13 ' O ' ' B' ' 8' ' ' ILE . 21.4 mt -63.5 -52.48 57.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.229 -0.441 . . . . 10.0 110.571 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.529 HG12 ' HG3' ' B' ' 37' ' ' MET . 34.4 m -63.26 -30.51 49.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 116.358 -0.383 . . . . 10.0 111.06 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -68.85 -50.46 49.69 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.969 0.414 . . . . 10.0 110.793 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' TYR . . . . . 0.503 ' O ' HG12 ' B' ' 19' ' ' ILE . 1.7 m-85 -70.66 -36.22 73.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.885 -0.598 . . . . 10.0 111.669 -178.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -61.22 -54.63 41.77 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 121.191 -0.204 . . . . 10.0 111.547 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 12.4 p -60.37 -40.07 89.46 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.712 0.264 . . . . 10.0 111.712 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 4.8 p -70.69 -23.53 62.49 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 111.846 0.313 . . . . 10.0 111.846 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.503 HG12 ' O ' ' B' ' 15' ' ' TYR . 10.8 mm -79.95 -41.57 21.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 120.955 0.407 . . . . 10.0 109.934 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 10.6 m -77.77 -29.01 15.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.842 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . 0.477 ' HA ' ' OE1' ' B' ' 21' ' ' GLU . 3.8 tp10 -70.03 -43.88 70.39 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.616 -0.513 . . . . 10.0 109.616 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -71.32 -8.83 56.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.125 -0.488 . . . . 10.0 110.389 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm 60.36 46.35 10.1 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.692 -0.685 . . . . 10.0 110.131 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.475 ' O ' ' HE2' ' C' ' 5' ' ' LYS . 43.1 mt-10 -96.6 13.32 28.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.139 -0.937 . . . . 10.0 110.471 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 15.0 tt -148.64 154.44 10.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.659 -0.701 . . . . 10.0 109.759 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 1.8 p -67.86 162.73 23.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.485 -0.325 . . . . 10.0 110.926 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 41.5 mp0 -56.09 -46.79 78.92 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.422 -0.354 . . . . 10.0 111.945 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -57.54 -41.22 80.53 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.19 0.519 . . . . 10.0 110.255 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.47 ' O ' ' HG ' ' B' ' 33' ' ' LEU . . . -71.29 -42.43 57.29 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.707 -0.678 . . . . 10.0 111.585 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.25 -44.76 95.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.754 -0.223 . . . . 10.0 111.239 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -69.08 -33.26 73.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.833 0.349 . . . . 10.0 110.59 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 69.4 m -65.03 -42.04 94.69 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.593 -0.521 . . . . 10.0 109.593 178.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' B' ' 29' ' ' GLY . 79.1 mt -72.51 -31.18 65.14 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.438 -0.579 . . . . 10.0 109.438 178.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -62.38 -53.6 52.53 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.463 -0.789 . . . . 10.0 110.985 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.643 HG11 HD21 ' A' ' 120' ' ' LEU . 12.0 p -73.2 -33.73 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 116.363 -0.38 . . . . 10.0 110.654 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . 0.45 ' O ' HG13 ' B' ' 40' ' ' ILE . . . -62.53 -43.49 98.68 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.213 -0.662 . . . . 10.0 109.213 178.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' MET . . . . . 0.529 ' HG3' HG12 ' B' ' 13' ' ' VAL . 15.3 ttm -56.49 -41.6 76.91 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.089 -0.96 . . . . 10.0 110.316 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -62.15 -47.63 83.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.275 -0.875 . . . . 10.0 110.532 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 17.4 m -62.3 -46.89 86.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.937 -0.574 . . . . 10.0 110.82 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' ILE . . . . . 0.45 HG13 ' O ' ' B' ' 36' ' ' ALA . 58.3 mt -60.35 -38.44 77.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.171 -0.468 . . . . 10.0 110.757 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.615 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 0.1 OUTLIER -59.85 -47.37 86.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 10.0 110.99 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -77.69 -23.49 49.54 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.495 -0.321 . . . . 10.0 111.39 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.21 -39.35 92.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.443 -0.344 . . . . 10.0 111.124 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -100.92 2.57 40.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.197 -0.456 . . . . 10.0 111.093 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 62.2 55.67 26.51 Favored Glycine 0 CA--C 1.519 0.289 0 CA-C-N 115.859 -0.61 . . . . 10.0 113.599 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.615 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 6.6 p90 -149.37 160.78 43.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 117.079 0.44 . . . . 10.0 110.541 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.86 150.84 20.28 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.792 -0.448 . . . . 10.0 109.792 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 1.4 mtm180 -63.8 -28.63 69.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.226 0.536 . . . . 10.0 110.73 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -78.31 7.86 5.85 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.787 -0.642 . . . . 10.0 111.691 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.32 2.89 55.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.013 0.435 . . . . 10.0 110.502 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.545 HG23 ' H ' ' B' ' 52' ' ' SER . 1.5 m -47.29 -64.02 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.248 -0.887 . . . . 10.0 112.792 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' SER . . . . . 0.545 ' H ' HG23 ' B' ' 51' ' ' VAL . 0.8 OUTLIER -56.33 -36.38 68.67 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.675 0.62 . . . . 10.0 112.675 -179.201 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.79 -44.99 60.23 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.818 -0.706 . . . . 10.0 112.906 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 57.8 mt -78.3 -50.44 19.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.856 0.36 . . . . 10.0 111.618 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 41.4 mt -71.18 -51.74 23.13 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.233 -0.44 . . . . 10.0 111.504 -178.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.94 -145.74 50.14 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.582 -0.818 . . . . 10.0 111.292 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 38.7 tttt -97.98 -8.98 26.89 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.005 0.431 . . . . 10.0 110.287 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.54 123.74 18.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.402 -0.817 . . . . 10.0 111.718 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -76.63 151.72 36.1 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.708 -0.678 . . . . 10.0 110.378 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -111.45 169.73 8.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.292 -0.413 . . . . 10.0 110.155 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 5.7 ptmm? -155.97 165.47 36.36 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.002 0.429 . . . . 10.0 110.883 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -141.42 55.98 0.6 Allowed Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.091 -0.959 . . . . 10.0 110.765 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -79.51 133.68 36.49 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.225 0.536 . . . . 10.0 110.682 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 44.5 p-80 -154.15 112.16 3.53 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.694 -0.685 . . . . 10.0 110.14 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -78.84 -10.43 59.79 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.425 0.631 . . . . 10.0 109.49 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.47 142.65 27.52 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.2 -0.909 . . . . 10.0 110.411 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -84.63 138.07 32.91 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.263 -0.426 . . . . 10.0 110.337 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 44.4 mt -71.95 97.55 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.996 -0.742 . . . . 10.0 108.996 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 76.6 mt 66.22 -87.06 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.279 -0.873 . . . . 10.0 109.792 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 20.7 p-10 -138.69 1.92 2.15 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.558 0.218 . . . . 10.0 110.599 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 75.3 m 59.08 21.93 9.95 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.992 -0.549 . . . . 10.0 112.187 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.924 0 CA-C-O 118.911 -0.566 . . . . 10.0 110.378 179.664 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' -1' ' ' SER . . . . . . . . . . . . . 49.3 m . . . . . 0 N--CA 1.48 1.051 0 CA-C-O 120.928 0.394 . . . . 10.0 110.927 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 0' ' ' VAL . . . . . . . . . . . . . 6.1 m -121.9 -166.91 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.153 -0.476 . . . . 10.0 109.776 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -151.66 -79.7 0.11 Allowed 'General case' 0 C--N 1.327 -0.404 0 O-C-N 123.583 0.552 . . . . 10.0 110.374 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 1.5 m -158.89 1.4 0.09 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.731 -0.668 . . . . 10.0 109.596 -178.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -87.53 157.98 19.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.973 -0.558 . . . . 10.0 110.592 -179.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 4' ' ' SER . . . . . 0.547 ' O ' HG12 ' C' ' 8' ' ' ILE . 33.3 p -102.78 166.28 10.57 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.355 -0.384 . . . . 10.0 110.729 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . 0.475 ' HE2' ' O ' ' B' ' 24' ' ' GLU . 10.1 ptpp? -59.5 -39.56 84.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.246 -0.433 . . . . 10.0 110.916 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 6' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -60.87 -45.25 95.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 10.0 110.719 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -65.6 -37.36 86.4 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.304 -0.407 . . . . 10.0 110.588 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 8' ' ' ILE . . . . . 0.547 HG12 ' O ' ' C' ' 4' ' ' SER . 38.6 mm -64.85 -45.69 94.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 10.0 110.084 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.89 -45.9 85.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.918 -0.583 . . . . 10.0 110.222 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.33 -37.56 87.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.603 -0.726 . . . . 10.0 111.264 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 2.2 mt -68.33 -44.77 74.62 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.836 0.35 . . . . 10.0 110.977 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 12' ' ' ILE . . . . . . . . . . . . . 1.4 mp -63.03 -45.9 97.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.76 -0.654 . . . . 10.0 111.521 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 28.8 m -66.61 -27.76 41.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-O 120.919 0.39 . . . . 10.0 110.612 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 14' ' ' ASN . . . . . 0.428 ' HB2' HG11 ' C' ' 51' ' ' VAL . 0.3 OUTLIER -74.18 -44.03 54.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.029 -0.532 . . . . 10.0 110.358 178.909 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 15' ' ' TYR . . . . . 0.549 ' O ' HG12 ' C' ' 19' ' ' ILE . 1.1 m-85 -68.04 -37.15 81.01 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.482 -0.326 . . . . 10.0 110.298 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 5.9 m-30 -58.31 -51.33 70.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.397 -0.365 . . . . 10.0 110.657 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 1.5 p -62.44 -38.5 89.98 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.865 -0.607 . . . . 10.0 111.542 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 11.7 p -71.11 -21.33 62.23 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.743 0.306 . . . . 10.0 111.419 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 19' ' ' ILE . . . . . 0.549 HG12 ' O ' ' C' ' 15' ' ' TYR . 25.2 mm -85.71 -44.56 17.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 CA-C-O 120.941 0.4 . . . . 10.0 111.143 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 20' ' ' VAL . . . . . . . . . . . . . 35.5 m -72.66 -32.64 41.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.202 -0.454 . . . . 10.0 111.721 -177.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . 0.483 ' HA ' ' OE1' ' C' ' 21' ' ' GLU . 1.1 tp10 -78.6 -18.81 54.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.864 0.364 . . . . 10.0 111.098 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -95.19 -6.26 42.06 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.718 -0.475 . . . . 10.0 109.718 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm 59.11 50.81 7.66 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.355 -0.839 . . . . 10.0 110.916 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -98.62 4.2 47.99 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.541 -0.754 . . . . 10.0 111.27 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 19.9 tt -143.73 153.66 16.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.936 -0.394 . . . . 10.0 109.936 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.82 162.41 13.61 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.415 -0.357 . . . . 10.0 111.386 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -56.23 -40.74 74.59 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.182 -0.463 . . . . 10.0 111.585 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.38 -48.07 77.61 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.385 0.612 . . . . 10.0 109.96 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 29' ' ' GLY . . . . . 0.595 ' O ' ' HG ' ' C' ' 33' ' ' LEU . . . -70.33 -38.31 70.85 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.314 -0.857 . . . . 10.0 112.224 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.17 -46.79 79.19 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.52 0.2 . . . . 10.0 111.273 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -66.7 -39.29 88.02 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.823 -0.436 . . . . 10.0 109.823 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 50.7 m -59.0 -39.17 81.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.7 -0.682 . . . . 10.0 110.218 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 33' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' C' ' 29' ' ' GLY . 52.1 mt -75.68 -27.78 58.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.013 -0.539 . . . . 10.0 110.179 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -71.08 -49.92 39.33 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 116.07 -0.513 . . . . 10.0 110.816 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 35' ' ' VAL . . . . . 0.462 HG23 ' H ' ' A' ' 123' ' ' GLY . 8.9 p -67.01 -43.32 89.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-N 116.573 -0.285 . . . . 10.0 111.272 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' C' ' 39' ' ' CYS . . . -63.82 -30.99 72.02 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.886 0.374 . . . . 10.0 111.246 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 37' ' ' MET . . . . . 0.437 ' HB2' ' O ' ' C' ' 33' ' ' LEU . 26.7 ttm -59.01 -49.79 76.54 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.091 -0.504 . . . . 10.0 110.545 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 38' ' ' ASP . . . . . 0.559 ' CB ' ' HA3' ' A' ' 123' ' ' GLY . 15.2 m-20 -68.61 -26.15 65.22 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.968 -0.56 . . . . 10.0 110.623 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 39' ' ' CYS . . . . . 0.594 ' SG ' ' HA2' ' A' ' 123' ' ' GLY . 84.9 m -58.49 -46.35 86.84 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.515 0.674 . . . . 10.0 109.534 178.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 40' ' ' ILE . . . . . . . . . . . . . 6.6 mt -73.06 -39.73 57.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.244 -0.889 . . . . 10.0 110.346 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 41' ' ' SER . . . . . 0.533 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 19.7 m -60.45 -44.39 95.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.618 -0.719 . . . . 10.0 111.863 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -71.79 -41.07 68.77 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.896 -0.322 . . . . 10.0 110.772 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.75 -40.22 91.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.328 -0.396 . . . . 10.0 111.679 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 44' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -90.98 -10.73 41.28 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.52 -0.309 . . . . 10.0 111.166 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 66.22 47.85 68.94 Favored Glycine 0 CA--C 1.517 0.188 0 C-N-CA 121.238 -0.506 . . . . 10.0 112.711 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 46' ' ' PHE . . . . . 0.533 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 3.3 p90 -142.62 156.75 45.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.795 0.331 . . . . 10.0 110.6 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -89.01 142.33 27.73 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.085 -0.507 . . . . 10.0 110.133 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 48' ' ' ARG . . . . . 0.511 ' O ' HG13 ' C' ' 51' ' ' VAL . 0.1 OUTLIER -61.41 -33.52 73.84 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.128 0.489 . . . . 10.0 111.202 -179.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 49' ' ' GLU . . . . . 0.401 ' H ' ' CD ' ' C' ' 49' ' ' GLU . 1.7 pm0 -76.95 8.58 3.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.726 -0.67 . . . . 10.0 112.169 -179.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.18 1.36 57.26 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.059 0.456 . . . . 10.0 110.684 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 51' ' ' VAL . . . . . 0.511 HG13 ' O ' ' C' ' 48' ' ' ARG . 5.9 m -46.53 -46.46 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 115.282 -0.872 . . . . 10.0 112.902 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.36 -35.12 64.91 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.499 0.555 . . . . 10.0 112.499 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.9 -34.79 23.52 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.547 -0.835 . . . . 10.0 113.248 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 54' ' ' ILE . . . . . . . . . . . . . 56.1 mt -80.84 -59.17 3.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.943 0.401 . . . . 10.0 111.175 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 36.1 mt -67.12 -49.51 64.64 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.246 -0.433 . . . . 10.0 111.078 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.13 -135.3 45.83 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.993 -0.622 . . . . 10.0 112.654 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 8.9 tttt -105.45 -5.67 20.12 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.122 0.487 . . . . 10.0 110.003 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.21 130.26 44.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.667 -0.697 . . . . 10.0 111.408 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -90.11 134.54 34.2 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 120.992 0.425 . . . . 10.0 109.946 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 60' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -94.89 168.87 10.53 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.538 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 12.1 ptmm? -150.44 161.17 43.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.285 -0.416 . . . . 10.0 110.831 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -137.59 55.77 0.68 Allowed Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.741 -0.943 . . . . 10.0 110.741 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 63' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -78.59 134.74 37.18 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.429 -0.386 . . . . 10.0 110.066 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 64' ' ' HIS . . . . . . . . . . . . . 36.6 p-80 -154.98 107.83 2.78 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.643 -0.423 . . . . 10.0 111.216 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -76.25 -20.74 57.12 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.157 -0.683 . . . . 10.0 109.157 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.25 127.22 33.45 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.5 -0.773 . . . . 10.0 110.163 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.0 143.62 56.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.274 -0.421 . . . . 10.0 110.212 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 68' ' ' ILE . . . . . . . . . . . . . 38.8 mt -79.91 90.23 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.063 0.458 . . . . 10.0 110.873 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 68.9 mt 72.35 -65.31 0.36 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 114.99 -1.005 . . . . 10.0 111.14 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 70' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -162.25 -29.59 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.17 -0.468 . . . . 10.0 110.502 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 71' ' ' SER . . . . . . . . . . . . . 71.3 m 61.92 44.19 8.56 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.976 -0.556 . . . . 10.0 111.418 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.662 -0.685 . . . . 10.0 110.639 -179.978 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.525 ' SD ' ' HB2' ' A' ' 91' ' ' ASP . 5.2 mtm . . . . . 0 N--CA 1.479 1.008 0 CA-C-O 121.094 0.474 . . . . 10.0 110.642 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.3 t -81.43 123.84 38.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.922 -0.581 . . . . 10.0 110.278 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -93.79 125.31 38.34 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.539 -0.464 . . . . 10.0 110.504 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.6 mp -127.93 139.85 52.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.812 -0.631 . . . . 10.0 110.744 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.2 m -102.43 115.36 30.41 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.136 -0.484 . . . . 10.0 110.146 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 87' ' ' SER . 2.2 mm? -85.91 110.45 19.44 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.795 -0.446 . . . . 10.0 109.795 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 51.4 tttt -108.9 102.56 11.56 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.215 -0.448 . . . . 10.0 111.267 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.549 ' HG2' ' O ' ' A' ' 84' ' ' PRO . 17.8 tptm -95.88 106.13 18.23 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.952 0.406 . . . . 10.0 110.097 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 91.9 mt -73.43 -55.94 11.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.512 -0.767 . . . . 10.0 111.548 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -70.19 164.54 24.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.405 -0.361 . . . . 10.0 110.88 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.496 ' HA ' ' C ' ' A' ' 84' ' ' PRO . . . -83.75 143.2 43.27 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 111.678 0.251 . . . . 10.0 111.678 -178.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.549 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 10.8 Cg_exo -69.14 128.37 11.81 Favored 'Cis proline' 0 C--N 1.347 0.495 0 C-N-CA 123.019 -1.659 . . . . 10.0 110.585 -1.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.459 ' N ' ' HA ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -86.77 148.08 25.57 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.418 -0.355 . . . . 10.0 111.204 -178.618 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -170.73 166.0 7.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.074 -0.512 . . . . 10.0 110.065 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.432 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 38.6 m -150.39 106.31 3.43 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.585 -0.524 . . . . 10.0 109.585 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 43.9 pt -126.86 158.88 37.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.314 -0.403 . . . . 10.0 111.058 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -121.39 139.82 52.94 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.506 -0.553 . . . . 10.0 109.506 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -149.61 165.01 33.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.883 0.373 . . . . 10.0 111.357 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.525 ' HB2' ' SD ' ' A' ' 73' ' ' MET . 0.0 OUTLIER -110.39 124.64 52.09 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.665 -0.698 . . . . 10.0 109.863 179.38 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -118.45 171.04 8.43 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.994 -0.548 . . . . 10.0 110.512 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.582 ' O ' HD12 ' A' ' 132' ' ' LEU . 1.5 m -80.15 144.87 59.39 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.424 -0.353 . . . . 10.0 110.368 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -59.04 -15.11 26.19 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.815 2.343 . . . . 10.0 112.332 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.0 t -119.21 19.98 12.72 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 116.244 -0.435 . . . . 10.0 110.434 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 93' ' ' SER . 0.3 OUTLIER -73.15 164.7 26.31 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.149 0.499 . . . . 10.0 111.182 -179.163 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.04 147.76 35.32 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.763 -0.653 . . . . 10.0 110.429 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 38.3 mm -58.83 -24.83 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 121.518 0.675 . . . . 10.0 110.49 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.39 -39.08 60.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.912 -1.04 . . . . 10.0 111.185 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 72.7 mm-40 -66.28 -39.9 89.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 10.0 110.978 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.652 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 18.0 mt -65.01 -51.05 71.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.171 -0.468 . . . . 10.0 109.956 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 9.0 mttm -54.97 -50.46 68.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.496 -0.774 . . . . 10.0 111.759 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -62.49 -32.01 72.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.653 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.41 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 15.9 t60 -67.66 -39.17 84.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.048 -0.524 . . . . 10.0 109.999 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 101' ' ' ILE . 28.2 mt -59.71 -39.58 85.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.056 -0.52 . . . . 10.0 110.293 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 16.6 mt -72.91 -34.37 46.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 116.022 -0.536 . . . . 10.0 110.159 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.8 t -64.78 -22.79 67.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.794 -0.639 . . . . 10.0 111.128 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 104' ' ' HIS . 16.3 mm-40 -100.09 7.28 44.76 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.828 -0.434 . . . . 10.0 109.828 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 60.21 31.62 20.56 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.687 -0.688 . . . . 10.0 111.172 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -101.56 -9.22 21.19 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.385 -0.598 . . . . 10.0 109.385 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.13 148.17 52.11 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.105 -0.952 . . . . 10.0 109.96 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.34 -55.74 3.19 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.806 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.569 ' O ' HG13 ' A' ' 117' ' ' ILE . 32.7 m170 -131.39 139.12 49.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.667 -0.242 . . . . 10.0 110.949 -179.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.476 ' HA ' HD12 ' A' ' 117' ' ' ILE . 4.5 tt -64.87 -44.34 96.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.362 0.601 . . . . 10.0 110.405 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 16.3 t -52.31 -33.34 41.92 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.903 -1.044 . . . . 10.0 111.73 178.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.484 ' HG3' ' OD1' ' A' ' 151' ' ' ASN . 7.1 mm-40 -93.27 16.01 14.2 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.32 0.489 . . . . 10.0 112.32 -177.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.569 HG13 ' O ' ' A' ' 113' ' ' HIS . 55.2 mt -106.66 123.52 61.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.346 -0.388 . . . . 10.0 110.188 178.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -120.11 116.59 25.99 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.659 -0.497 . . . . 10.0 109.659 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -94.34 123.48 37.77 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.739 0.304 . . . . 10.0 110.216 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.502 HD21 HG11 ' B' ' 35' ' ' VAL . 2.8 mm? -109.21 141.1 41.96 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.193 -0.669 . . . . 10.0 109.193 179.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 24.7 tp -126.1 98.33 5.45 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.145 -1.057 . . . . 10.0 108.145 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 11.1 tptp 46.49 51.62 11.65 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.497 0.665 . . . . 10.0 110.246 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.64 ' HA3' ' CB ' ' C' ' 38' ' ' ASP . . . 89.72 -44.14 3.01 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.231 -0.895 . . . . 10.0 113.384 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.405 ' HZ2' ' CD ' ' C' ' 42' ' ' GLU . 0.4 OUTLIER -59.09 129.77 43.77 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.489 0.185 . . . . 10.0 110.88 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.448 ' HA ' HD13 ' A' ' 120' ' ' LEU . 8.8 p -82.61 139.29 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.136 0.493 . . . . 10.0 112.102 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 4.4 mp -112.46 154.37 25.95 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 115.654 -0.703 . . . . 10.0 111.055 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -117.16 159.48 22.54 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 121.763 -0.586 . . . . 10.0 112.208 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.38 -51.69 67.38 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.212 1.005 . . . . 10.0 112.229 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -83.18 6.94 17.6 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.3 -0.863 . . . . 10.0 112.194 -177.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.2 tp -79.77 148.69 31.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.928 0.394 . . . . 10.0 111.308 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -109.62 151.77 26.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.803 -0.635 . . . . 10.0 110.33 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.582 HD12 ' O ' ' A' ' 93' ' ' SER . 79.5 mt -59.09 -37.13 76.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 10.0 111.96 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.72 -17.53 60.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.086 0.47 . . . . 10.0 111.221 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -88.98 -40.06 13.29 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.176 -0.465 . . . . 10.0 110.958 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.432 HD11 HG22 ' A' ' 137' ' ' VAL . 3.0 pp -82.41 -26.44 32.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.612 -0.267 . . . . 10.0 111.301 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 26.2 mtmt 64.7 96.1 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 O-C-N 123.887 0.742 . . . . 10.0 111.131 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.432 HG22 HD11 ' A' ' 135' ' ' LEU . 6.8 t -71.83 121.03 21.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.86 -0.609 . . . . 10.0 110.632 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.76 119.73 65.75 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 10.0 110.723 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -58.72 -34.5 98.99 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.924 2.416 . . . . 10.0 113.531 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -84.41 15.84 3.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.019 0.438 . . . . 10.0 111.47 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -128.26 -74.14 0.58 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.977 -0.556 . . . . 10.0 109.853 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.2 m 58.58 9.89 1.24 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.792 -0.64 . . . . 10.0 112.639 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.8 m -109.24 123.82 49.87 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.321 0.582 . . . . 10.0 111.326 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 14.7 mm -107.61 119.23 56.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.479 -0.782 . . . . 10.0 109.984 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.4 124.53 30.75 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.856 0.36 . . . . 10.0 110.359 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.6 t -99.48 124.63 52.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.935 -0.575 . . . . 10.0 111.282 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . 0.431 ' SD ' HD23 ' A' ' 120' ' ' LEU . 2.0 mpt? -122.67 121.69 37.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.884 -0.598 . . . . 10.0 110.633 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 22.0 mt -137.74 142.23 36.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.609 -0.269 . . . . 10.0 111.027 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.486 ' HD3' ' HD2' ' A' ' 150' ' ' PRO . 0.4 OUTLIER -125.99 107.86 25.08 Favored Pre-proline 0 N--CA 1.454 -0.274 0 N-CA-C 109.943 -0.391 . . . . 10.0 109.943 178.282 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.486 ' HD2' ' HD3' ' A' ' 149' ' ' LYS . 19.4 Cg_endo -59.54 119.44 6.66 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.889 2.393 . . . . 10.0 113.067 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.484 ' OD1' ' HG3' ' A' ' 116' ' ' GLU . 27.0 m120 -73.07 -27.07 61.52 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.155 0.502 . . . . 10.0 109.964 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 79.7 mt -78.39 155.78 29.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.585 -0.734 . . . . 10.0 110.239 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 . . . . . 0 C--O 1.251 1.147 0 CA-C-O 117.941 -1.028 . . . . 10.0 109.901 178.916 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' -1' ' ' SER . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.476 0.86 0 CA-C-O 120.757 0.313 . . . . 10.0 111.216 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 0' ' ' VAL . . . . . 0.401 ' HB ' ' H ' ' B' ' 1' ' ' ASP . 27.3 m -117.96 -151.98 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 115.856 -0.611 . . . . 10.0 109.822 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . 0.401 ' H ' ' HB ' ' B' ' 0' ' ' VAL . 43.0 t0 -174.81 -75.9 0.01 OUTLIER 'General case' 0 C--N 1.339 0.14 0 CA-C-O 120.713 0.292 . . . . 10.0 111.533 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 15.2 m -147.29 13.0 1.08 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.536 0.208 . . . . 10.0 111.442 -177.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -109.24 143.61 38.45 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 121.197 -0.201 . . . . 10.0 110.86 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.26 176.35 5.94 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.44 -0.578 . . . . 10.0 109.44 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -56.52 -46.56 80.53 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.248 -0.433 . . . . 10.0 111.438 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -56.64 -53.33 58.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.515 . . . . 10.0 112.033 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -57.24 -46.17 83.25 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.252 0.345 . . . . 10.0 110.814 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.41 ' HA ' HD13 ' B' ' 8' ' ' ILE . 17.2 mm -59.22 -45.9 92.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 10.0 110.41 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.571 ' HA ' HD12 ' B' ' 12' ' ' ILE . . . -60.64 -43.62 97.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.996 -0.547 . . . . 10.0 111.027 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.25 -36.11 82.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.035 -0.53 . . . . 10.0 110.616 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.418 HD21 ' CE2' ' B' ' 60' ' ' PHE . 17.7 mt -64.95 -36.25 83.79 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.343 0.592 . . . . 10.0 109.566 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.571 HD12 ' HA ' ' B' ' 9' ' ' ALA . 14.5 mt -61.42 -57.68 11.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.057 -0.974 . . . . 10.0 110.965 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.471 HG21 ' HA ' ' B' ' 48' ' ' ARG . 16.5 m -62.33 -25.98 39.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.989 0.423 . . . . 10.0 110.61 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -69.61 -51.53 34.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.777 -0.647 . . . . 10.0 110.657 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' TYR . . . . . 0.491 ' O ' HG12 ' B' ' 19' ' ' ILE . 2.3 m-85 -72.99 -39.67 65.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 10.0 111.844 -178.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -56.03 -50.85 69.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.67 0.271 . . . . 10.0 110.353 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 4.6 p -59.04 -46.32 88.52 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.654 -0.248 . . . . 10.0 111.338 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 6.7 p -65.06 -20.5 66.51 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.148 0.425 . . . . 10.0 112.148 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.491 HG12 ' O ' ' B' ' 15' ' ' TYR . 29.3 mm -85.05 -43.46 16.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 121.074 0.464 . . . . 10.0 110.349 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 35.2 m -75.97 -29.04 19.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.201 -0.454 . . . . 10.0 110.532 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . 0.534 ' HA ' ' OE1' ' B' ' 21' ' ' GLU . 1.8 tp10 -75.67 -34.79 60.48 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.269 -0.423 . . . . 10.0 110.766 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -81.86 -5.12 57.97 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.825 0.345 . . . . 10.0 110.446 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 34.0 mmtt 59.3 52.65 5.83 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.529 -0.759 . . . . 10.0 111.046 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -108.13 16.34 23.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.807 -0.633 . . . . 10.0 111.802 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -147.19 151.77 13.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 116.199 -0.455 . . . . 10.0 110.14 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 10.5 p -60.82 161.94 7.43 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.277 -0.419 . . . . 10.0 111.435 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -60.0 -49.68 76.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.074 0.464 . . . . 10.0 110.887 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.55 -42.97 93.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.427 -0.806 . . . . 10.0 110.003 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.13 -39.51 92.66 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.767 -0.73 . . . . 10.0 111.975 178.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.0 -44.55 97.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.875 0.369 . . . . 10.0 110.357 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -65.24 -35.59 81.51 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.374 -0.602 . . . . 10.0 109.374 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 47.9 m -60.95 -44.18 97.65 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 115.824 -0.625 . . . . 10.0 109.747 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 69.7 mt -72.11 -36.51 69.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.075 0.464 . . . . 10.0 110.044 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 12.7 t30 -60.02 -48.69 80.65 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.745 -0.662 . . . . 10.0 111.531 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.502 HG11 HD21 ' A' ' 120' ' ' LEU . 8.4 p -72.86 -35.61 49.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 120.85 0.357 . . . . 10.0 110.755 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.53 -39.36 93.62 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.534 -0.543 . . . . 10.0 109.534 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' MET . . . . . . . . . . . . . 24.1 ttm -57.79 -45.55 85.88 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.352 -0.84 . . . . 10.0 110.15 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -61.91 -42.13 98.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.562 -0.744 . . . . 10.0 110.801 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' CYS . . . . . 0.411 ' SG ' ' HG2' ' A' ' 147' ' ' MET . 59.3 m -63.43 -40.91 98.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.068 -0.514 . . . . 10.0 110.857 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' ILE . . . . . 0.557 HD13 HG21 ' B' ' 12' ' ' ILE . 55.0 mt -67.3 -40.35 84.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 110.144 -0.317 . . . . 10.0 110.144 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.644 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 9.7 m -63.1 -39.13 93.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.105 0.479 . . . . 10.0 110.081 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -70.86 -45.36 64.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.627 -0.715 . . . . 10.0 110.491 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.56 -48.66 78.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.539 -0.755 . . . . 10.0 112.547 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -83.42 -2.47 55.92 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.902 -0.319 . . . . 10.0 111.496 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 57.69 58.89 12.23 Favored Glycine 0 CA--C 1.518 0.236 0 CA-C-N 116.125 -0.489 . . . . 10.0 113.54 178.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.644 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 9.1 p90 -148.78 170.94 17.1 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.968 -0.382 . . . . 10.0 109.968 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -105.7 146.21 30.08 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.147 -0.316 . . . . 10.0 110.147 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.471 ' HA ' HG21 ' B' ' 13' ' ' VAL . 1.3 mtm180 -71.55 -26.87 62.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.278 0.561 . . . . 10.0 110.507 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -82.92 14.95 2.95 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.655 -0.702 . . . . 10.0 111.306 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -104.51 4.13 32.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.64 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -41.12 -63.52 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 114.011 1.115 . . . . 10.0 114.011 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' SER . . . . . 0.483 ' HB3' ' HA ' ' C' ' 71' ' ' SER . 1.9 m -53.9 -31.86 51.46 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.578 0.584 . . . . 10.0 112.578 -178.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.33 -41.68 30.15 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.986 -0.626 . . . . 10.0 113.352 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 19.6 mt -83.01 -43.54 18.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.999 0.428 . . . . 10.0 111.45 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 57.1 mt -71.52 -56.71 5.38 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.052 -0.522 . . . . 10.0 111.017 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.97 -150.38 45.9 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.692 -0.766 . . . . 10.0 111.298 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 32.8 tttt -103.8 2.5 32.9 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.357 0.599 . . . . 10.0 109.734 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.69 131.89 47.43 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.102 -0.954 . . . . 10.0 111.747 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -78.39 134.65 37.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.983 -0.553 . . . . 10.0 109.946 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' C' ' 61' ' ' LYS . 78.3 m-85 -90.11 158.1 17.45 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.174 -0.466 . . . . 10.0 110.737 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' C' ' 60' ' ' PHE . 11.0 ptmm? -147.57 149.47 32.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.931 0.396 . . . . 10.0 111.289 -178.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -140.71 51.08 0.73 Allowed Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 111.387 -0.685 . . . . 10.0 111.387 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -77.72 143.47 38.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.784 0.326 . . . . 10.0 110.852 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 39.4 p-80 -159.06 114.62 2.55 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.025 0.44 . . . . 10.0 110.407 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.5 HD13 ' HA ' ' B' ' 65' ' ' LEU . 3.1 mm? -84.68 -15.39 45.44 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.04 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -82.7 145.4 29.63 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.34 -0.615 . . . . 10.0 109.34 178.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -83.34 133.3 34.96 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.911 0.386 . . . . 10.0 110.524 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . 0.416 ' O ' ' HB2' ' B' ' 69' ' ' LEU . 4.2 mt -71.57 92.83 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.976 -0.556 . . . . 10.0 110.683 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.416 ' HB2' ' O ' ' B' ' 68' ' ' ILE . 21.3 mt 73.71 -57.46 0.62 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.604 0.762 . . . . 10.0 111.031 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . 0.5 ' ND2' ' HB3' ' B' ' 72' ' ' ALA . 27.4 p-10 -171.75 -22.52 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.606 -0.724 . . . . 10.0 109.574 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' SER . . . . . 0.417 ' H ' ' H ' ' B' ' 70' ' ' ASN . 2.6 m 62.71 37.34 12.74 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.069 -0.969 . . . . 10.0 110.654 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . 0.5 ' HB3' ' ND2' ' B' ' 70' ' ' ASN . . . . . . . . 0 C--O 1.252 1.214 0 CA-C-O 118.648 -0.691 . . . . 10.0 110.442 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' -1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 120.683 0.278 . . . . 10.0 110.559 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 0' ' ' VAL . . . . . . . . . . . . . 21.6 m -122.08 -168.21 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.205 -0.452 . . . . 10.0 110.274 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -157.79 -71.2 0.09 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.881 0.372 . . . . 10.0 110.38 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 53.3 m -160.24 -42.04 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.476 -0.565 . . . . 10.0 109.476 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -40.59 144.78 0.22 Allowed 'General case' 0 CA--C 1.533 0.313 0 O-C-N 124.515 1.134 . . . . 10.0 111.551 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 4' ' ' SER . . . . . 0.52 ' O ' HG12 ' C' ' 8' ' ' ILE . 23.0 p -98.3 163.68 12.62 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.339 -0.391 . . . . 10.0 110.213 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -57.76 -35.39 70.69 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 110.521 -0.178 . . . . 10.0 110.521 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 6' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -60.25 -49.67 76.7 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.219 0.533 . . . . 10.0 109.651 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -62.71 -42.32 99.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.365 -0.834 . . . . 10.0 110.817 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 8' ' ' ILE . . . . . 0.52 HG12 ' O ' ' C' ' 4' ' ' SER . 39.4 mm -59.15 -46.1 92.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.99 -0.55 . . . . 10.0 110.171 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 9' ' ' ALA . . . . . 0.438 ' HB1' ' CE1' ' C' ' 46' ' ' PHE . . . -59.82 -43.66 94.4 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.086 -0.506 . . . . 10.0 110.554 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.91 -40.36 94.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.025 -0.534 . . . . 10.0 111.086 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 22.3 mt -65.15 -40.47 94.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.031 -0.531 . . . . 10.0 109.76 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 12' ' ' ILE . . . . . . . . . . . . . 1.2 mp -63.15 -47.86 90.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.187 -0.915 . . . . 10.0 111.869 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 34.1 m -71.09 -25.49 25.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.669 -0.412 . . . . 10.0 111.448 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -73.27 -40.59 64.46 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.063 0.459 . . . . 10.0 109.987 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 15' ' ' TYR . . . . . 0.544 ' O ' HG12 ' C' ' 19' ' ' ILE . 9.1 m-85 -71.74 -42.85 66.76 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.12 -0.491 . . . . 10.0 110.849 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -54.27 -49.48 69.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.737 0.304 . . . . 10.0 110.508 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 17' ' ' SER . . . . . 0.496 ' O ' ' HB2' ' C' ' 21' ' ' GLU . 2.2 p -61.97 -41.66 98.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.139 -0.482 . . . . 10.0 111.4 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 3.6 p -69.36 -22.51 63.73 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 120.617 -0.433 . . . . 10.0 111.843 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 19' ' ' ILE . . . . . 0.544 HG12 ' O ' ' C' ' 15' ' ' TYR . 37.7 mm -80.83 -41.1 19.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 109.8 -0.444 . . . . 10.0 109.8 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 20' ' ' VAL . . . . . . . . . . . . . 16.8 m -77.85 -18.65 13.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.171 -0.677 . . . . 10.0 109.171 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' C' ' 17' ' ' SER . 4.1 tp10 -73.47 -50.67 20.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.551 -0.749 . . . . 10.0 110.734 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -84.07 1.09 45.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.368 -0.378 . . . . 10.0 111.782 -178.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 34.3 mmtt 55.79 46.83 21.6 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.162 0.506 . . . . 10.0 110.234 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -83.41 1.13 43.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.962 -0.563 . . . . 10.0 111.376 -178.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 16.0 tt -142.96 161.2 17.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.36 -0.607 . . . . 10.0 109.36 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 5.3 p -59.95 156.29 14.9 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.182 0.301 . . . . 10.0 110.607 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -60.76 -23.6 65.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.02 0.438 . . . . 10.0 110.337 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 28' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -68.39 -54.09 19.5 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.066 -0.716 . . . . 10.0 109.066 178.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 29' ' ' GLY . . . . . 0.42 ' O ' ' HG ' ' C' ' 33' ' ' LEU . . . -65.82 -33.05 84.74 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.318 -0.855 . . . . 10.0 110.984 178.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.72 -42.84 94.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.968 0.413 . . . . 10.0 110.441 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -68.02 -38.03 82.11 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.264 -0.643 . . . . 10.0 109.264 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 6.0 m -61.0 -43.48 98.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.407 -0.815 . . . . 10.0 110.046 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 33' ' ' LEU . . . . . 0.438 ' O ' ' HB2' ' C' ' 37' ' ' MET . 87.6 mt -71.05 -25.38 62.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.051 0.453 . . . . 10.0 110.373 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -72.25 -52.97 13.97 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.056 -0.52 . . . . 10.0 111.004 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 35' ' ' VAL . . . . . 0.53 HG23 ' H ' ' A' ' 123' ' ' GLY . 7.6 p -69.21 -39.6 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 116.421 -0.354 . . . . 10.0 110.49 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . 0.56 ' O ' HD12 ' C' ' 40' ' ' ILE . . . -63.75 -32.25 73.69 Favored 'General case' 0 C--O 1.226 -0.163 0 CA-C-O 120.448 0.166 . . . . 10.0 110.661 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 37' ' ' MET . . . . . 0.438 ' HB2' ' O ' ' C' ' 33' ' ' LEU . 30.6 ttm -53.92 -52.44 60.59 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.178 0.513 . . . . 10.0 110.879 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 38' ' ' ASP . . . . . 0.64 ' CB ' ' HA3' ' A' ' 123' ' ' GLY . 1.7 m-20 -70.73 -26.44 63.39 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 116.176 -0.465 . . . . 10.0 111.124 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 39' ' ' CYS . . . . . 0.505 ' SG ' ' HA2' ' A' ' 123' ' ' GLY . 77.5 m -61.09 -42.24 98.15 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.773 -0.825 . . . . 10.0 108.773 177.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 40' ' ' ILE . . . . . 0.56 HD12 ' O ' ' C' ' 36' ' ' ALA . 1.4 mp -70.99 -40.74 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 115.097 -0.956 . . . . 10.0 109.891 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 41' ' ' SER . . . . . 0.638 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 13.4 m -60.18 -43.9 95.51 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.686 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . 0.405 ' CD ' ' HZ2' ' A' ' 124' ' ' LYS . 13.4 tt0 -72.2 -42.07 66.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.187 -0.461 . . . . 10.0 111.448 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.77 -48.46 75.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.286 -0.416 . . . . 10.0 111.626 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 44' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -88.96 -1.17 57.98 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.479 -0.328 . . . . 10.0 111.378 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 59.02 57.92 17.29 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.352 -0.451 . . . . 10.0 113.184 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 46' ' ' PHE . . . . . 0.638 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 4.3 p90 -145.65 156.36 43.6 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.989 0.395 . . . . 10.0 110.172 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 26.1 mp0 -81.84 128.04 33.62 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.488 -0.324 . . . . 10.0 110.302 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.5 -17.13 58.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.55 -0.295 . . . . 10.0 111.667 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -85.15 -2.53 58.13 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 122.321 0.249 . . . . 10.0 111.583 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.8 4.96 30.59 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.763 0.653 . . . . 10.0 112.763 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 51' ' ' VAL . . . . . 0.437 HG23 ' H ' ' C' ' 52' ' ' SER . 3.6 m -42.98 -57.36 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 114.427 1.269 . . . . 10.0 114.427 -178.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 52' ' ' SER . . . . . 0.437 ' H ' HG23 ' C' ' 51' ' ' VAL . 1.2 m -61.31 -18.92 60.91 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.874 0.694 . . . . 10.0 112.874 -178.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.39 -48.59 4.99 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.809 -0.71 . . . . 10.0 112.953 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 54' ' ' ILE . . . . . . . . . . . . . 64.3 mt -74.66 -45.73 43.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.936 0.398 . . . . 10.0 110.311 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 45.7 mt -71.84 -47.82 50.45 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.178 0.513 . . . . 10.0 109.979 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 56.57 -137.0 48.83 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.373 -0.83 . . . . 10.0 112.371 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -111.6 24.07 13.19 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.954 -0.758 . . . . 10.0 108.954 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 6.8 m -91.7 139.92 30.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.181 -0.918 . . . . 10.0 111.006 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.71 145.89 24.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.165 -0.471 . . . . 10.0 109.84 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 60' ' ' PHE . . . . . 0.472 ' O ' ' HA ' ' B' ' 61' ' ' LYS . 76.9 m-85 -109.1 155.61 20.78 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.278 -0.419 . . . . 10.0 110.428 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 61' ' ' LYS . . . . . 0.485 ' HA ' ' O ' ' B' ' 60' ' ' PHE . 8.5 ptmm? -144.45 154.82 43.34 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.158 -0.473 . . . . 10.0 111.1 -178.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -139.57 60.25 0.58 Allowed Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.132 -0.787 . . . . 10.0 111.132 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 63' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -82.03 136.62 35.21 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.912 0.387 . . . . 10.0 110.175 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 64' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -149.13 111.96 4.83 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.334 0.588 . . . . 10.0 110.865 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -81.2 -13.62 58.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.367 -0.833 . . . . 10.0 108.887 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.61 137.31 32.46 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.284 -0.871 . . . . 10.0 109.919 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -72.34 149.8 44.07 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.892 -0.595 . . . . 10.0 109.566 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 68' ' ' ILE . . . . . . . . . . . . . 55.7 mt -88.68 97.82 7.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.987 0.423 . . . . 10.0 110.728 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 29.8 mt 62.48 -94.34 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.096 -0.956 . . . . 10.0 111.063 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 70' ' ' ASN . . . . . 0.504 ' ND2' ' HB3' ' C' ' 72' ' ' ALA . 29.0 p-10 -118.02 -14.27 9.98 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.733 -0.212 . . . . 10.0 111.367 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 71' ' ' SER . . . . . 0.483 ' HA ' ' HB3' ' B' ' 52' ' ' SER . 1.2 m 54.59 35.67 24.11 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.182 0.515 . . . . 10.0 110.795 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 72' ' ' ALA . . . . . 0.504 ' HB3' ' ND2' ' C' ' 70' ' ' ASN . . . . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.338 -0.839 . . . . 10.0 110.337 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 2.9 ttm . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 109.784 -0.45 . . . . 10.0 109.784 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.6 t -101.67 126.78 55.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.594 0.235 . . . . 10.0 110.684 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -86.2 127.46 34.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.58 -0.282 . . . . 10.0 110.381 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.2 mp -127.29 129.76 48.3 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.449 -0.341 . . . . 10.0 110.5 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 20.5 m -101.32 114.18 27.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.866 -0.606 . . . . 10.0 110.402 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.489 ' O ' ' HA ' ' A' ' 87' ' ' SER . 2.0 mm? -90.54 126.1 35.82 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.727 -0.472 . . . . 10.0 109.727 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.6 tttp -130.21 106.78 8.82 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.491 -0.322 . . . . 10.0 110.746 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 82' ' ' GLN . 47.0 tttm -93.71 110.39 22.02 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.959 -0.385 . . . . 10.0 109.959 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 63.5 mt -74.92 -34.33 32.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 115.381 -0.827 . . . . 10.0 111.312 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.413 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 71.6 mt-30 -83.24 156.13 23.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.344 -0.389 . . . . 10.0 110.418 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.431 ' HA ' ' C ' ' A' ' 84' ' ' PRO . . . -78.54 138.93 58.8 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.458 -0.337 . . . . 10.0 111.421 -178.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.431 ' C ' ' HA ' ' A' ' 83' ' ' ALA . 17.0 Cg_exo -70.29 131.63 20.5 Favored 'Cis proline' 0 C--N 1.347 0.488 0 C-N-CA 123.613 -1.411 . . . . 10.0 112.137 -1.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -83.64 148.2 27.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.275 -0.42 . . . . 10.0 110.813 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.413 ' HZ ' HD22 ' A' ' 105' ' ' LEU . 27.8 p90 -170.07 161.86 8.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.869 0.366 . . . . 10.0 110.915 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.489 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 39.8 m -146.8 108.09 4.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.715 -0.675 . . . . 10.0 109.72 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 41.7 pt -129.35 162.33 37.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.534 -0.303 . . . . 10.0 110.532 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -125.54 137.97 53.95 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.882 0.372 . . . . 10.0 110.563 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 46.1 t60 -149.72 151.25 33.34 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.771 -0.649 . . . . 10.0 109.491 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -99.49 132.03 45.1 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.047 0.451 . . . . 10.0 110.135 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -121.25 169.29 10.71 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.041 0.448 . . . . 10.0 111.283 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.518 ' O ' HD12 ' A' ' 132' ' ' LEU . 38.2 t -81.87 144.99 52.72 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.566 -0.743 . . . . 10.0 110.194 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.62 -14.52 31.6 Favored 'Trans proline' 0 CA--C 1.531 0.33 0 C-N-CA 122.55 2.167 . . . . 10.0 111.952 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -114.51 17.44 17.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.122 -0.49 . . . . 10.0 110.486 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.476 ' HB2' ' O ' ' A' ' 93' ' ' SER . 0.2 OUTLIER -77.04 161.19 28.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.36 -0.382 . . . . 10.0 110.591 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -111.41 151.29 28.68 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.032 -0.531 . . . . 10.0 111.129 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 19.0 mm -59.81 -29.48 43.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 120.973 0.416 . . . . 10.0 110.808 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.28 -35.86 65.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.788 -0.642 . . . . 10.0 110.638 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -62.46 -44.71 95.74 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.606 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.608 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 23.3 mt -65.12 -44.3 95.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.52 -0.548 . . . . 10.0 109.52 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.597 ' HD3' HG13 ' A' ' 114' ' ' ILE . 56.1 mttt -54.46 -50.06 68.6 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.283 -0.871 . . . . 10.0 111.292 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -58.33 -40.34 81.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.941 -0.572 . . . . 10.0 111.233 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -64.07 -36.71 84.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 10.0 110.588 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.608 ' HG ' ' O ' ' A' ' 101' ' ' ILE . 44.4 mt -63.61 -38.66 91.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.969 0.414 . . . . 10.0 110.528 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 22.3 mt -72.95 -43.26 59.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.205 -0.452 . . . . 10.0 110.135 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.5 t -63.39 -21.47 66.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.758 -0.655 . . . . 10.0 111.718 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -95.23 13.27 26.06 Favored 'General case' 0 C--N 1.331 -0.197 0 O-C-N 122.341 -0.224 . . . . 10.0 111.018 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 61.6 27.99 17.32 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 123.462 0.476 . . . . 10.0 111.366 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.74 -22.7 13.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.877 0.37 . . . . 10.0 111.167 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -113.38 150.53 32.53 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.116 -0.493 . . . . 10.0 110.153 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.425 ' OG ' ' HG ' ' A' ' 152' ' ' LEU . 1.5 m -106.29 -18.21 14.06 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.352 -0.385 . . . . 10.0 111.579 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.478 ' HB3' ' CD ' ' A' ' 116' ' ' GLU . 0.2 OUTLIER -169.49 136.58 1.7 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.461 -0.57 . . . . 10.0 109.461 -178.5 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.597 HG13 ' HD3' ' A' ' 102' ' ' LYS . 0.8 OUTLIER -66.03 -39.83 85.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 121.191 0.519 . . . . 10.0 111.074 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.43 ' HB2' ' OE1' ' A' ' 116' ' ' GLU . 14.8 m -48.35 -44.13 34.12 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.86 -1.064 . . . . 10.0 113.209 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.478 ' CD ' ' HB3' ' A' ' 113' ' ' HIS . 0.7 OUTLIER -89.69 14.47 11.66 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.263 0.838 . . . . 10.0 113.263 -178.234 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 113' ' ' HIS . 51.5 mt -91.77 121.34 42.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.371 -0.532 . . . . 10.0 110.249 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.5 mmmt -123.54 115.06 20.92 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.739 -0.467 . . . . 10.0 109.739 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -94.6 124.88 38.9 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.151 0.501 . . . . 10.0 110.856 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.433 ' HB3' HG21 ' C' ' 35' ' ' VAL . 0.0 OUTLIER -109.85 139.51 44.85 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.538 -0.755 . . . . 10.0 109.98 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.458 HD13 HD13 ' A' ' 144' ' ' ILE . 31.9 tp -128.65 94.74 3.93 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.133 -1.432 . . . . 10.0 107.133 178.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 48.2 tttp 33.88 65.3 0.3 Allowed 'General case' 0 N--CA 1.464 0.274 0 O-C-N 124.261 0.976 . . . . 10.0 111.495 -177.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.49 ' HA3' ' CB ' ' C' ' 38' ' ' ASP . . . 87.41 -46.0 3.44 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.668 -0.696 . . . . 10.0 113.559 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.429 ' HE2' ' O ' ' A' ' 135' ' ' LEU . 43.1 tttp -63.04 121.23 13.06 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.683 -0.488 . . . . 10.0 109.683 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.0 p -84.11 133.84 28.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.354 0.597 . . . . 10.0 112.075 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.6 mp -100.49 152.34 20.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.647 -0.706 . . . . 10.0 110.083 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -120.93 157.44 29.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.621 0.248 . . . . 10.0 110.733 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.81 -47.32 51.45 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.628 0.973 . . . . 10.0 113.628 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -92.29 12.96 20.7 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.412 0.523 . . . . 10.0 112.412 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 130' ' ' LEU . 3.2 tp -75.36 142.35 43.16 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.103 0.478 . . . . 10.0 111.37 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -104.7 149.27 25.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.562 -0.744 . . . . 10.0 109.614 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.518 HD12 ' O ' ' A' ' 93' ' ' SER . 35.2 mt -56.79 -33.07 66.29 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.787 0.292 . . . . 10.0 111.787 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.7 p -77.7 -14.27 59.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.051 0.453 . . . . 10.0 111.101 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -90.58 -40.71 11.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.267 -0.424 . . . . 10.0 110.841 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.429 ' O ' ' HE2' ' A' ' 124' ' ' LYS . 0.7 OUTLIER -83.86 -20.61 32.82 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 121.124 -0.23 . . . . 10.0 110.915 179.701 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 30.2 mtmt 64.41 91.55 0.08 Allowed 'General case' 0 C--O 1.234 0.266 0 O-C-N 123.756 0.66 . . . . 10.0 111.268 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 29.4 t -63.55 109.4 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.93 -0.577 . . . . 10.0 110.073 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.94 122.99 88.8 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.881 -0.6 . . . . 10.0 110.923 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -66.79 -17.9 52.52 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.652 2.234 . . . . 10.0 112.056 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -87.49 2.58 50.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.892 -0.594 . . . . 10.0 110.379 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -121.76 -73.08 0.66 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.572 -0.74 . . . . 10.0 109.593 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.2 m 59.78 8.52 1.37 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.506 -0.77 . . . . 10.0 112.75 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.7 m -122.56 131.47 53.85 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.879 0.371 . . . . 10.0 111.215 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.458 HD13 HD13 ' A' ' 121' ' ' LEU . 25.0 mm -112.97 122.61 67.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.772 -0.649 . . . . 10.0 109.923 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.18 121.01 26.51 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.411 -0.588 . . . . 10.0 109.411 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 12.6 t -97.62 127.22 50.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.177 0.513 . . . . 10.0 112.033 -178.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -122.94 116.89 24.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.376 -0.829 . . . . 10.0 109.357 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 49.3 mt -138.1 143.13 33.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 110.012 -0.366 . . . . 10.0 110.012 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 25.7 mmmt -97.81 110.07 53.83 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 108.834 -0.802 . . . . 10.0 108.834 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.13 113.29 3.74 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.434 2.089 . . . . 10.0 113.063 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 28.0 p30 -108.03 7.55 27.84 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.867 -0.606 . . . . 10.0 109.784 178.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.425 ' HG ' ' OG ' ' A' ' 112' ' ' SER . 72.8 mt -78.74 118.28 20.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.477 -0.783 . . . . 10.0 109.843 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 . . . . . 0 C--O 1.251 1.173 0 CA-C-O 118.583 -0.722 . . . . 10.0 110.198 -179.866 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' -1' ' ' SER . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.48 1.036 0 CA-C-O 120.62 0.248 . . . . 10.0 110.527 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 0' ' ' VAL . . . . . . . . . . . . . 24.2 t -70.45 -67.59 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 109.136 -0.69 . . . . 10.0 109.136 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . 0.5 ' HA ' ' O ' ' B' ' 63' ' ' GLN . 18.8 m-20 43.42 78.72 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 O-C-N 124.303 1.002 . . . . 10.0 111.828 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.15 26.77 1.32 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.366 -0.834 . . . . 10.0 111.463 -178.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -97.44 122.02 40.01 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.68 0.276 . . . . 10.0 110.828 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.37 143.26 27.92 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.429 -0.582 . . . . 10.0 109.429 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -59.94 -46.63 88.77 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.946 0.35 . . . . 10.0 111.946 -178.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -59.56 -46.27 89.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.673 0.273 . . . . 10.0 111.439 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -62.24 -46.62 88.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.34 -0.391 . . . . 10.0 111.167 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.723 ' O ' HG13 ' B' ' 12' ' ' ILE . 32.0 mm -62.94 -45.27 99.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 110.041 -0.355 . . . . 10.0 110.041 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.47 -45.2 73.1 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.388 -0.369 . . . . 10.0 110.752 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.09 -36.29 83.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.864 -0.607 . . . . 10.0 110.55 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.03 -38.02 87.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.275 -0.42 . . . . 10.0 110.653 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.723 HG13 ' O ' ' B' ' 8' ' ' ILE . 13.3 mt -63.35 -55.52 22.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.252 -0.431 . . . . 10.0 111.12 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 35.3 m -64.18 -32.35 57.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.034 -0.53 . . . . 10.0 111.253 -178.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -70.03 -40.91 74.9 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.586 -0.524 . . . . 10.0 109.586 178.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' TYR . . . . . 0.619 ' O ' HG12 ' B' ' 19' ' ' ILE . 21.3 t80 -64.91 -47.8 76.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.988 -0.551 . . . . 10.0 110.08 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 14.7 m-30 -58.04 -44.09 87.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 10.0 111.077 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 70.8 m -57.54 -40.82 79.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 10.0 110.609 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 10.9 m -74.41 -20.89 59.89 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.936 -0.575 . . . . 10.0 111.621 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.619 HG12 ' O ' ' B' ' 15' ' ' TYR . 29.4 mm -79.22 -42.26 23.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.608 0.242 . . . . 10.0 110.555 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 27.0 m -79.15 -21.27 12.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.144 0.497 . . . . 10.0 109.808 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -58.15 -42.61 86.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.172 -0.922 . . . . 10.0 110.67 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 4.4 mttp -109.59 0.56 19.18 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.755 -0.657 . . . . 10.0 109.962 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 33.2 mttt 54.7 52.13 12.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.214 -0.903 . . . . 10.0 110.706 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -82.94 35.16 0.47 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.299 -0.864 . . . . 10.0 110.44 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' ILE . . . . . 0.446 HG12 ' N ' ' B' ' 26' ' ' SER . 12.4 tt -163.68 164.8 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.592 -0.731 . . . . 10.0 109.374 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . 0.446 ' N ' HG12 ' B' ' 25' ' ' ILE . 0.7 OUTLIER -62.73 160.2 14.77 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.728 0.411 . . . . 10.0 111.957 -179.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -55.94 -55.21 35.44 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.045 -0.525 . . . . 10.0 111.681 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.75 -42.64 89.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.006 0.431 . . . . 10.0 110.159 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.527 ' O ' ' HG ' ' B' ' 33' ' ' LEU . . . -61.15 -42.77 99.89 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.698 -0.683 . . . . 10.0 112.26 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.37 -38.76 88.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.024 0.44 . . . . 10.0 110.437 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -68.33 -35.84 78.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.707 -0.679 . . . . 10.0 109.875 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 14.6 m -65.85 -38.46 88.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.669 -0.696 . . . . 10.0 110.024 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' B' ' 29' ' ' GLY . 53.9 mt -70.63 -31.81 68.91 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.0 0.429 . . . . 10.0 109.903 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -61.38 -51.76 67.43 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.743 -0.662 . . . . 10.0 110.685 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 12.2 p -70.25 -32.77 51.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.902 -0.59 . . . . 10.0 110.831 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.6 -45.43 86.99 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 109.245 -0.65 . . . . 10.0 109.245 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' MET . . . . . . . . . . . . . 6.0 ttm -59.91 -37.98 80.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.707 -0.679 . . . . 10.0 109.636 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -66.78 -51.59 53.96 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.914 -1.039 . . . . 10.0 111.278 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.66 -33.41 75.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.49 -0.323 . . . . 10.0 111.642 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 50.6 mt -66.99 -46.27 85.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 110.133 -0.321 . . . . 10.0 110.133 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.526 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 28.7 m -59.4 -33.3 71.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.204 0.526 . . . . 10.0 109.982 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -74.38 -47.26 35.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.548 -0.751 . . . . 10.0 110.874 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.16 -37.5 85.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.088 -0.505 . . . . 10.0 112.258 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -94.0 -4.03 50.37 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 121.014 -0.274 . . . . 10.0 111.553 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.57 59.99 9.76 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 121.399 -0.429 . . . . 10.0 113.517 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.526 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 7.1 p90 -153.1 165.04 36.87 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.994 -0.372 . . . . 10.0 109.994 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -101.22 135.25 43.0 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.769 0.319 . . . . 10.0 111.382 -179.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.53 -20.45 64.66 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.101 -0.5 . . . . 10.0 111.623 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -83.17 -15.49 50.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.86 0.362 . . . . 10.0 111.303 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.6 3.54 47.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.365 -0.379 . . . . 10.0 111.748 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 2.6 m -47.24 -49.23 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 112.778 0.659 . . . . 10.0 112.778 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -50.61 -34.16 24.98 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 113.367 0.877 . . . . 10.0 113.367 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.63 -27.49 50.89 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.813 -0.708 . . . . 10.0 112.616 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 49.6 mt -87.02 -50.71 13.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.031 0.443 . . . . 10.0 111.976 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 69.1 mt -81.45 -67.4 0.78 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.106 -0.497 . . . . 10.0 112.228 -178.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.23 -129.06 8.81 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.567 -0.825 . . . . 10.0 111.044 -178.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -158.33 23.27 0.24 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.429 0.633 . . . . 10.0 110.012 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.1 32.88 0.89 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.507 -0.769 . . . . 10.0 111.466 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 64.44 104.78 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.713 -0.676 . . . . 10.0 111.978 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -80.1 82.4 6.17 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.638 -0.71 . . . . 10.0 109.885 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -80.68 57.66 3.03 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.954 -0.567 . . . . 10.0 111.513 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.6 70.83 2.94 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 111.145 -0.782 . . . . 10.0 111.145 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' GLN . . . . . 0.5 ' O ' ' HA ' ' B' ' 1' ' ' ASP . 0.6 OUTLIER -68.6 87.58 0.33 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.942 0.401 . . . . 10.0 111.785 -178.791 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 34.3 t60 -97.66 76.62 2.51 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.08 -0.711 . . . . 10.0 109.08 178.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 79.0 mt -57.84 -41.17 81.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.346 -0.843 . . . . 10.0 111.217 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . 58.45 16.7 4.33 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 123.692 0.62 . . . . 10.0 111.111 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 50.29 49.39 20.65 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-N 115.199 -0.909 . . . . 10.0 111.63 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 72.6 mt -85.3 84.46 2.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.268 0.556 . . . . 10.0 110.202 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -78.96 -24.99 43.51 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.995 -0.743 . . . . 10.0 108.995 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . 0.549 ' O ' ' HB3' ' C' ' 52' ' ' SER . 58.3 t30 -81.91 55.2 2.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.58 -0.736 . . . . 10.0 109.54 178.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.71 -32.79 16.03 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.794 -0.639 . . . . 10.0 110.144 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.167 0 CA-C-O 117.939 -1.029 . . . . 10.0 109.624 179.707 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' -1' ' ' SER . . . . . . . . . . . . . 5.5 p . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 120.908 0.385 . . . . 10.0 111.795 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 0' ' ' VAL . . . . . . . . . . . . . 35.6 m -91.72 37.06 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-O 121.254 0.55 . . . . 10.0 111.532 -178.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -68.82 96.29 0.74 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.74 -0.663 . . . . 10.0 110.702 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.47 65.86 2.32 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.432 -0.804 . . . . 10.0 110.655 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -132.51 139.54 47.96 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.082 -0.508 . . . . 10.0 110.021 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 4' ' ' SER . . . . . 0.535 ' O ' HG12 ' C' ' 8' ' ' ILE . 0.0 OUTLIER -89.42 137.79 32.02 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.386 -0.37 . . . . 10.0 110.719 -179.491 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . 0.519 ' HE3' HD12 ' B' ' 19' ' ' ILE . 49.5 mttp -63.77 -45.24 90.67 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.708 0.289 . . . . 10.0 110.486 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 6' ' ' GLU . . . . . 0.487 ' HB3' HG21 ' C' ' 54' ' ' ILE . 7.5 mt-10 -54.47 -57.19 12.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.577 -0.738 . . . . 10.0 111.299 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . 0.55 ' HG3' ' O ' ' C' ' 54' ' ' ILE . 1.5 mp0 -61.61 -39.38 91.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.76 -0.654 . . . . 10.0 112.272 -179.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 8' ' ' ILE . . . . . 0.535 HG12 ' O ' ' C' ' 4' ' ' SER . 27.2 mm -66.7 -47.93 81.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.89 0.376 . . . . 10.0 110.247 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.48 -42.05 95.47 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.088 -0.505 . . . . 10.0 110.1 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.68 -40.46 92.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.621 -0.718 . . . . 10.0 110.926 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.5 -33.82 76.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.931 0.396 . . . . 10.0 110.392 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 12' ' ' ILE . . . . . 0.468 HG13 HG12 ' B' ' 12' ' ' ILE . 1.2 mp -70.89 -48.3 57.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.064 -0.516 . . . . 10.0 111.064 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 26.8 m -65.69 -28.03 43.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-O 121.218 0.532 . . . . 10.0 110.05 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 14' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -73.25 -39.77 65.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.66 -0.7 . . . . 10.0 109.382 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 15' ' ' TYR . . . . . 0.471 ' O ' HG12 ' C' ' 19' ' ' ILE . 32.7 t80 -68.89 -43.49 75.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 10.0 110.308 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 10.1 m-30 -55.63 -46.88 77.36 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.171 -0.468 . . . . 10.0 110.412 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 19.9 m -60.84 -43.89 97.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.868 -0.605 . . . . 10.0 111.364 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 12.7 m -67.67 -22.67 65.29 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.982 0.364 . . . . 10.0 111.982 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 19' ' ' ILE . . . . . 0.471 HG12 ' O ' ' C' ' 15' ' ' TYR . 29.5 mm -82.62 -39.7 16.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.589 0.233 . . . . 10.0 111.052 -179.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 20' ' ' VAL . . . . . . . . . . . . . 13.6 m -77.5 -23.69 14.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.289 0.566 . . . . 10.0 109.814 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -66.86 -48.08 69.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.122 -0.944 . . . . 10.0 111.018 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 33.7 mttp -91.12 -5.49 55.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.676 -0.238 . . . . 10.0 110.911 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 64.6 mttm 63.72 49.33 2.99 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.82 -0.627 . . . . 10.0 110.825 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -81.94 -5.44 58.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.894 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 12.7 tt -131.62 162.34 39.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.545 -0.539 . . . . 10.0 109.545 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.09 153.62 11.25 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 122.59 0.356 . . . . 10.0 111.156 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -58.4 -40.2 81.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.852 0.358 . . . . 10.0 110.858 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 28' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -67.12 -40.81 86.87 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.183 0.516 . . . . 10.0 109.697 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 29' ' ' GLY . . . . . 0.517 ' O ' ' HG ' ' C' ' 33' ' ' LEU . . . -65.16 -33.18 86.26 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.514 -0.766 . . . . 10.0 111.23 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.32 -39.63 95.08 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.815 -0.439 . . . . 10.0 109.815 178.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -63.17 -35.76 81.38 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.89 -0.596 . . . . 10.0 109.666 178.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 1.2 t -65.66 -43.83 88.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.494 -0.775 . . . . 10.0 109.81 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 33' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' C' ' 29' ' ' GLY . 43.5 mt -66.93 -34.52 77.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.074 0.464 . . . . 10.0 109.765 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -60.89 -50.43 73.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.388 -0.823 . . . . 10.0 110.94 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 35' ' ' VAL . . . . . 0.433 HG21 ' HB3' ' A' ' 120' ' ' LEU . 12.2 p -71.86 -36.29 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 116.425 -0.352 . . . . 10.0 111.416 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.13 -33.34 74.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.875 0.369 . . . . 10.0 110.462 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 34.7 ttm -53.83 -59.96 3.94 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.643 -0.708 . . . . 10.0 111.036 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 38' ' ' ASP . . . . . 0.578 ' OD2' ' HD3' ' C' ' 48' ' ' ARG . 3.3 m-20 -67.03 -27.19 67.2 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.243 -0.435 . . . . 10.0 111.139 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 39' ' ' CYS . . . . . 0.415 ' N ' ' HA2' ' A' ' 123' ' ' GLY . 1.1 t -65.04 -49.12 71.38 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.047 0.451 . . . . 10.0 110.48 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 40' ' ' ILE . . . . . . . . . . . . . 53.6 mt -66.94 -38.28 81.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.735 -0.666 . . . . 10.0 109.837 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 41' ' ' SER . . . . . 0.722 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 35.5 m -62.21 -47.22 85.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.546 -0.752 . . . . 10.0 110.716 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -65.1 -40.94 95.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.165 -0.471 . . . . 10.0 110.724 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.97 -43.92 91.42 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.519 0.562 . . . . 10.0 112.519 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 44' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -94.82 -2.47 50.8 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.969 0.359 . . . . 10.0 111.969 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.75 53.02 12.65 Favored Glycine 0 CA--C 1.52 0.387 0 N-CA-C 114.4 0.52 . . . . 10.0 114.4 178.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 46' ' ' PHE . . . . . 0.722 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 30.2 p90 -144.67 157.11 44.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 117.165 0.483 . . . . 10.0 110.473 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -83.18 146.15 28.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.528 -0.306 . . . . 10.0 110.298 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 48' ' ' ARG . . . . . 0.578 ' HD3' ' OD2' ' C' ' 38' ' ' ASP . 0.0 OUTLIER -61.91 -28.91 69.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.379 0.609 . . . . 10.0 110.578 179.619 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 49' ' ' GLU . . . . . 0.438 ' C ' ' H ' ' C' ' 51' ' ' VAL . 4.3 mp0 -84.91 18.88 2.28 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.437 -0.801 . . . . 10.0 112.393 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.1 8.26 0.22 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.941 0.896 . . . . 10.0 112.695 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 51' ' ' VAL . . . . . 0.438 ' H ' ' C ' ' C' ' 49' ' ' GLU . 3.5 m -34.67 -38.61 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 N-CA-C 117.708 2.484 . . . . 10.0 117.708 -176.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 52' ' ' SER . . . . . 0.549 ' HB3' ' O ' ' B' ' 70' ' ' ASN . 0.0 OUTLIER -88.17 -54.03 4.42 Favored 'General case' 0 C--O 1.217 -0.63 0 N-CA-C 118.653 2.834 . . . . 10.0 118.653 -175.794 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.11 -56.87 9.43 Favored Glycine 0 CA--C 1.494 -1.254 0 C-N-CA 119.869 -1.158 . . . . 10.0 115.799 -171.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 54' ' ' ILE . . . . . 0.55 ' O ' ' HG3' ' C' ' 7' ' ' GLU . 0.5 OUTLIER -82.0 -35.18 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 C-N-CA 119.847 -0.741 . . . . 10.0 110.561 -179.355 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.4 -75.38 0.33 Allowed 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 116.101 1.889 . . . . 10.0 116.101 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.36 -145.71 49.12 Favored Glycine 0 N--CA 1.471 1.014 0 C-N-CA 121.538 -0.363 . . . . 10.0 112.437 -177.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -150.44 22.46 0.82 Allowed 'General case' 0 C--O 1.233 0.186 0 N-CA-C 109.541 -0.541 . . . . 10.0 109.541 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.12 42.36 0.65 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.529 -0.76 . . . . 10.0 112.043 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 65.1 107.77 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.61 0.719 . . . . 10.0 111.613 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 60' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -82.8 78.97 9.32 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.684 -0.689 . . . . 10.0 110.497 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 35.4 mttp -83.98 64.96 8.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.941 -0.572 . . . . 10.0 111.395 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.8 86.36 1.42 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.704 -0.76 . . . . 10.0 111.374 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 63' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -80.28 75.99 7.08 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.467 0.543 . . . . 10.0 112.467 -178.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 64' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -103.05 81.68 2.0 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.089 -0.708 . . . . 10.0 109.089 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 50.7 mt -69.92 -37.14 75.82 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.703 -0.68 . . . . 10.0 111.139 -179.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . 59.62 20.59 9.19 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 123.555 0.534 . . . . 10.0 111.109 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 56.42 45.58 22.39 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.555 -0.748 . . . . 10.0 111.337 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 68' ' ' ILE . . . . . . . . . . . . . 97.1 mt -84.42 99.52 6.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.318 0.58 . . . . 10.0 110.978 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . 0.42 HD13 ' HA ' ' C' ' 69' ' ' LEU . 3.8 mm? -106.87 -11.8 15.64 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.65 0.738 . . . . 10.0 109.044 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 70' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -89.37 42.49 1.09 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.753 -1.112 . . . . 10.0 110.906 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -78.57 -18.3 54.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.897 -0.592 . . . . 10.0 110.289 179.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.033 0 CA-C-N 115.747 -0.66 . . . . 10.0 110.077 -179.999 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 49.1 mtm . . . . . 0 N--CA 1.483 1.191 0 N-CA-C 110.076 -0.342 . . . . 10.0 110.076 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 15.4 t -94.51 133.81 34.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.811 -0.44 . . . . 10.0 109.811 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -91.87 122.38 34.34 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.835 0.35 . . . . 10.0 110.569 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.1 mp -125.38 121.36 33.65 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.388 -0.369 . . . . 10.0 110.432 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.6 m -93.97 113.17 25.11 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 120.829 0.347 . . . . 10.0 110.202 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.562 ' O ' ' HA ' ' A' ' 87' ' ' SER . 2.6 mm? -84.94 119.33 25.25 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.948 -0.569 . . . . 10.0 109.771 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -121.16 100.89 7.31 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.131 0.491 . . . . 10.0 110.921 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 84' ' ' PRO . 20.5 tptm -87.13 114.86 24.1 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.579 -0.737 . . . . 10.0 110.757 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 16.0 mt -77.66 -66.41 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 O-C-N 123.915 0.759 . . . . 10.0 111.285 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -60.43 160.8 8.24 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.893 -0.594 . . . . 10.0 111.323 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.454 ' HA ' ' C ' ' A' ' 84' ' ' PRO . . . -86.02 143.13 36.95 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.225 -0.443 . . . . 10.0 111.134 -178.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.454 ' C ' ' HA ' ' A' ' 83' ' ' ALA . 43.7 Cg_endo -71.6 127.54 12.64 Favored 'Cis proline' 0 C--N 1.346 0.423 0 C-N-CA 123.068 -1.638 . . . . 10.0 111.202 -0.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.445 ' N ' ' HA ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -93.34 158.58 15.67 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.175 -0.466 . . . . 10.0 112.001 -178.627 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -178.96 172.4 1.3 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.318 -0.856 . . . . 10.0 109.316 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 66.4 m -152.95 110.34 3.53 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.899 0.381 . . . . 10.0 110.301 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.8 pt -119.15 158.82 20.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.875 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -114.81 113.9 24.84 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.085 -0.709 . . . . 10.0 109.085 179.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -129.51 147.88 51.36 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.175 0.512 . . . . 10.0 110.415 -178.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.91 130.65 53.82 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.862 -0.608 . . . . 10.0 109.368 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -121.39 171.6 8.65 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.09 0.472 . . . . 10.0 111.425 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.577 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 0.7 OUTLIER -80.02 151.2 72.92 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.732 -0.667 . . . . 10.0 110.977 -179.779 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -65.39 -16.73 55.59 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 122.311 2.007 . . . . 10.0 112.504 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.1 m -110.72 15.52 21.9 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.434 -0.58 . . . . 10.0 109.434 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.577 ' HB2' ' O ' ' A' ' 93' ' ' SER . 0.3 OUTLIER -75.38 161.81 28.93 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.699 -0.682 . . . . 10.0 110.806 -179.759 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.97 157.82 26.04 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.605 -0.725 . . . . 10.0 110.886 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.542 ' O ' ' HG3' ' A' ' 102' ' ' LYS . 41.2 mm -67.25 -22.29 28.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.343 -0.614 . . . . 10.0 109.343 178.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.42 -38.73 71.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.205 -0.907 . . . . 10.0 110.141 178.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -68.24 -40.61 81.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.035 -0.529 . . . . 10.0 110.996 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.531 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 51.7 mt -62.26 -47.26 93.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.796 -0.638 . . . . 10.0 109.588 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.542 ' HG3' ' O ' ' A' ' 98' ' ' ILE . 79.9 mttt -55.46 -44.4 76.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.927 -1.033 . . . . 10.0 111.436 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.487 ' OE1' ' HA ' ' A' ' 103' ' ' GLN . 10.0 mm-40 -62.26 -37.67 86.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.62 -0.264 . . . . 10.0 111.21 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -65.11 -39.77 93.61 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.906 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 101' ' ' ILE . 34.2 mt -63.03 -44.75 95.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.097 -0.501 . . . . 10.0 111.397 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 102' ' ' LYS . 12.6 mt -67.94 -42.21 85.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.121 -0.49 . . . . 10.0 111.404 -178.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 49.8 m -69.84 -9.89 56.44 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.013 0.375 . . . . 10.0 112.013 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -107.72 16.12 23.95 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 121.104 -0.238 . . . . 10.0 110.895 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 58.83 26.35 14.69 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.707 -0.679 . . . . 10.0 111.673 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.6 mmpp? -96.36 -16.48 21.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.369 0.604 . . . . 10.0 110.069 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.689 ' HB2' HD13 ' A' ' 148' ' ' ILE . . . -137.08 166.52 23.5 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.294 -0.866 . . . . 10.0 110.349 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.497 ' HB2' ' OD1' ' A' ' 151' ' ' ASN . 4.6 m -108.18 -49.46 3.19 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.766 0.317 . . . . 10.0 110.94 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.488 ' O ' HG13 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -136.87 139.01 41.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.138 -179.45 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.435 ' HB ' HD11 ' A' ' 106' ' ' ILE . 6.0 tt -64.07 -39.06 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.513 0.673 . . . . 10.0 109.865 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.0 m -52.39 -27.93 17.67 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.321 -1.309 . . . . 10.0 112.45 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.23 -4.56 38.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.71 0.291 . . . . 10.0 111.417 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 113' ' ' HIS . 59.1 mt -89.75 127.11 42.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.022 0.439 . . . . 10.0 110.945 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.62 128.83 20.99 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.544 -0.91 . . . . 10.0 108.544 177.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.433 HD12 HG22 ' A' ' 144' ' ' ILE . 4.2 mm? -91.24 136.69 32.92 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.387 0.613 . . . . 10.0 111.21 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.542 ' HG ' HG22 ' C' ' 35' ' ' VAL . 3.7 tp -110.46 126.45 54.35 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.78 -1.1 . . . . 10.0 108.633 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 47.3 tp -113.76 93.04 4.19 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 106.624 -1.621 . . . . 10.0 106.624 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.42 ' HD3' ' HA ' ' A' ' 122' ' ' LYS . 2.7 tppp? 38.68 60.98 1.27 Allowed 'General case' 0 CA--C 1.539 0.546 0 O-C-N 123.944 0.778 . . . . 10.0 110.587 -177.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.504 ' HA3' ' CB ' ' C' ' 38' ' ' ASP . . . 87.95 -45.87 3.36 Favored Glycine 0 C--N 1.332 0.349 0 CA-C-N 115.544 -0.753 . . . . 10.0 113.999 -178.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.2 tttp -59.76 118.65 6.4 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 110.189 -0.3 . . . . 10.0 110.189 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.4 p -78.99 137.18 22.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.62 0.724 . . . . 10.0 112.205 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.432 ' HG ' HD23 ' A' ' 130' ' ' LEU . 6.8 mp -104.34 156.91 17.52 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 114.824 -1.08 . . . . 10.0 110.624 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -116.26 164.17 14.9 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.004 0.43 . . . . 10.0 112.005 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -55.15 -56.04 24.43 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 114.071 1.137 . . . . 10.0 114.071 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -91.72 14.7 14.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.864 0.364 . . . . 10.0 111.322 -178.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.432 HD23 ' HG ' ' A' ' 126' ' ' LEU . 15.1 tp -68.22 139.84 56.05 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.718 0.294 . . . . 10.0 110.501 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -97.4 145.24 26.36 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.261 -0.427 . . . . 10.0 110.484 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.482 HD12 ' O ' ' A' ' 93' ' ' SER . 10.7 mt -54.03 -38.75 65.5 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.747 0.647 . . . . 10.0 112.747 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.35 -17.14 56.92 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.817 0.303 . . . . 10.0 111.817 -179.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -79.13 -45.8 19.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.833 0.349 . . . . 10.0 110.278 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.7 pp -77.01 -23.7 52.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.875 -0.602 . . . . 10.0 110.81 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.2 mtmt 65.89 90.57 0.09 Allowed 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.618 0.574 . . . . 10.0 111.767 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.5 t -68.2 103.63 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.812 -0.631 . . . . 10.0 109.923 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.39 135.38 86.54 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.975 -0.557 . . . . 10.0 111.007 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -68.8 -22.23 37.14 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.224 1.95 . . . . 10.0 110.973 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -78.53 -3.55 44.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.306 -0.861 . . . . 10.0 110.485 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -122.69 -83.65 0.66 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.934 -0.575 . . . . 10.0 110.093 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.2 m 61.01 3.14 0.63 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.715 -0.675 . . . . 10.0 112.198 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.5 m -102.32 114.54 28.79 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-O 120.96 0.41 . . . . 10.0 110.044 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.433 HG22 HD12 ' A' ' 119' ' ' LEU . 1.4 mm -104.92 109.03 26.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 108.287 -1.005 . . . . 10.0 108.287 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.441 ' OG1' HG21 ' C' ' 35' ' ' VAL . 0.0 OUTLIER -79.6 122.03 26.0 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.653 -0.869 . . . . 10.0 108.653 -179.172 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.0 t -91.43 121.83 42.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.414 -0.812 . . . . 10.0 111.431 -177.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 81.5 mmm -115.56 113.96 24.31 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.008 -0.996 . . . . 10.0 109.732 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.689 HD13 ' HB2' ' A' ' 111' ' ' ALA . 11.3 mt -139.35 144.38 29.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.579 -0.737 . . . . 10.0 111.465 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -107.96 120.9 45.57 Favored Pre-proline 0 C--N 1.321 -0.656 0 N-CA-C 108.134 -1.062 . . . . 10.0 108.134 178.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -70.11 111.3 2.84 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.332 2.022 . . . . 10.0 112.434 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.497 ' OD1' ' HB2' ' A' ' 112' ' ' SER . 3.3 m120 -87.67 18.08 4.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.934 -0.575 . . . . 10.0 109.989 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.6 mt -75.31 91.27 2.67 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.757 -0.656 . . . . 10.0 109.929 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.245 0.846 0 CA-C-O 118.007 -0.997 . . . . 10.0 110.097 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' -1' ' ' SER . . . . . . . . . . . . . 7.0 p . . . . . 0 N--CA 1.474 0.747 0 CA-C-O 120.656 0.265 . . . . 10.0 111.207 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 0' ' ' VAL . . . . . . . . . . . . . 1.9 t -91.44 13.11 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 116.29 -0.414 . . . . 10.0 112.089 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -58.82 102.55 0.12 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.063 0.459 . . . . 10.0 111.08 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.33 12.37 31.38 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.236 -0.438 . . . . 10.0 111.782 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.6 129.56 34.96 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 121.117 -0.233 . . . . 10.0 110.654 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.01 142.86 27.28 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.985 -0.376 . . . . 10.0 109.985 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . 0.406 ' HG2' ' H ' ' B' ' 5' ' ' LYS . 4.4 ptpp? -60.35 -40.88 92.27 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.456 -0.338 . . . . 10.0 111.577 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -58.3 -43.13 87.94 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.858 0.361 . . . . 10.0 110.534 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -66.91 -46.19 75.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.03 -0.532 . . . . 10.0 111.424 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.449 ' O ' HD13 ' B' ' 12' ' ' ILE . 32.5 mm -65.0 -46.09 92.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.747 0.308 . . . . 10.0 110.532 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.76 -43.72 81.05 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.015 0.436 . . . . 10.0 110.622 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.59 -34.82 77.8 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.687 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.57 -35.73 77.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.911 0.386 . . . . 10.0 110.282 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.516 HG12 HG23 ' C' ' 12' ' ' ILE . 1.6 mp -68.23 -50.55 56.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.775 -0.648 . . . . 10.0 111.138 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 31.4 m -63.92 -32.28 56.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 N-CA-C 109.694 -0.484 . . . . 10.0 109.694 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -64.18 -53.46 48.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.571 -0.741 . . . . 10.0 109.843 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' TYR . . . . . 0.603 ' O ' HG12 ' B' ' 19' ' ' ILE . 39.1 t80 -60.3 -48.16 82.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.766 -0.652 . . . . 10.0 111.217 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' PHE . . . . . . . . . . . . . 10.1 m-30 -53.95 -47.74 70.97 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.813 0.34 . . . . 10.0 110.526 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 50.7 m -57.5 -36.45 71.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.18 -0.464 . . . . 10.0 111.247 178.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 1.2 m -74.84 -19.29 60.23 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.268 -0.423 . . . . 10.0 111.193 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.603 HG12 ' O ' ' B' ' 15' ' ' TYR . 35.8 mm -81.39 -43.01 20.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.392 -0.367 . . . . 10.0 111.549 -178.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 16.8 m -76.26 -25.89 16.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.232 0.539 . . . . 10.0 109.93 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -62.12 -43.92 97.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.264 -0.88 . . . . 10.0 111.344 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -102.61 4.33 38.24 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.894 -0.323 . . . . 10.0 110.433 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 54.0 mttm 52.07 54.85 10.11 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 115.454 -0.794 . . . . 10.0 110.675 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -88.82 25.54 1.75 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.34 -0.846 . . . . 10.0 110.8 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 15.9 tt -161.7 164.02 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.756 -0.656 . . . . 10.0 109.405 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 2.4 p -64.5 155.64 32.19 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.627 -0.26 . . . . 10.0 111.175 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -59.07 -42.31 90.06 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.927 0.394 . . . . 10.0 110.901 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -59.93 -41.37 91.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.789 -0.641 . . . . 10.0 109.948 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.426 ' O ' ' HG ' ' B' ' 33' ' ' LEU . . . -73.09 -34.7 58.16 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.805 -0.712 . . . . 10.0 111.583 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.37 -42.76 99.23 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-O 120.822 0.344 . . . . 10.0 110.542 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -63.6 -41.14 98.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.233 0.54 . . . . 10.0 109.597 178.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 42.4 m -61.8 -46.38 89.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.243 -0.89 . . . . 10.0 110.923 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' B' ' 29' ' ' GLY . 68.5 mt -68.52 -30.27 69.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.381 -0.372 . . . . 10.0 110.938 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -65.63 -51.93 55.81 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.35 -0.386 . . . . 10.0 111.048 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 14.6 p -67.09 -33.92 66.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.916 -0.584 . . . . 10.0 110.538 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.79 -42.1 91.14 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.647 -0.501 . . . . 10.0 109.647 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' MET . . . . . 0.586 ' SD ' ' HD2' ' B' ' 48' ' ' ARG . 11.0 ttm -56.5 -53.02 62.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.259 -0.882 . . . . 10.0 110.354 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.66 -46.41 88.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 10.0 111.42 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 50.2 t -58.08 -44.68 87.68 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.513 -0.312 . . . . 10.0 111.749 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 87.5 mt -64.66 -39.0 84.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.269 0.557 . . . . 10.0 109.92 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.424 ' HA ' ' CE1' ' B' ' 46' ' ' PHE . 24.3 m -64.75 -40.32 95.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.597 -0.729 . . . . 10.0 110.442 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -75.82 -24.78 55.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.468 -0.333 . . . . 10.0 110.847 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.86 -33.38 66.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.052 -0.522 . . . . 10.0 111.09 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -102.36 -3.23 27.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.879 0.371 . . . . 10.0 111.241 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 66.48 59.65 7.03 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 114.466 0.547 . . . . 10.0 114.466 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.424 ' CE1' ' HA ' ' B' ' 41' ' ' SER . 22.0 p90 -154.16 159.83 41.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 117.271 0.536 . . . . 10.0 110.335 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -86.52 144.06 27.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.879 0.371 . . . . 10.0 110.766 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.586 ' HD2' ' SD ' ' B' ' 37' ' ' MET . 3.1 mtm180 -64.88 -25.9 68.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.053 -0.522 . . . . 10.0 110.685 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 55.7 mp0 -85.07 -8.47 58.66 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.15 -0.477 . . . . 10.0 112.118 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.11 2.68 17.16 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 111.937 0.347 . . . . 10.0 111.937 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 13.4 m -45.63 -53.16 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 113.06 0.763 . . . . 10.0 113.06 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' SER . . . . . . . . . . . . . 1.4 m -49.68 -41.59 43.5 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.321 0.86 . . . . 10.0 113.321 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.77 -29.55 65.15 Favored Glycine 0 C--O 1.23 -0.139 0 C-N-CA 120.686 -0.769 . . . . 10.0 112.456 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 25.5 mt -87.96 -51.0 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 112.902 0.705 . . . . 10.0 112.902 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 26.3 mt -82.29 -69.32 0.63 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.136 0.791 . . . . 10.0 113.136 -177.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.0 -132.91 11.44 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.618 -0.801 . . . . 10.0 111.701 -178.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -156.94 29.94 0.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.394 0.616 . . . . 10.0 109.942 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.03 30.48 1.61 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.39 -0.823 . . . . 10.0 111.361 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 60.94 75.08 0.42 Allowed 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.838 -0.619 . . . . 10.0 110.208 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -70.03 101.67 1.85 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.224 -0.898 . . . . 10.0 110.653 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 16.8 mttp -95.51 93.45 7.2 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.765 -0.652 . . . . 10.0 110.903 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.87 68.15 2.58 Favored Glycine 0 N--CA 1.451 -0.356 0 N-CA-C 111.115 -0.794 . . . . 10.0 111.115 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -63.36 100.16 0.23 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.287 0.565 . . . . 10.0 111.513 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 69.2 t60 -142.1 90.29 2.24 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.237 -0.892 . . . . 10.0 109.025 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 73.7 mt -80.6 -26.03 38.1 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.614 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . 58.41 18.69 5.79 Favored 'General case' 0 N--CA 1.462 0.158 0 O-C-N 123.672 0.607 . . . . 10.0 111.277 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 61.56 34.34 17.88 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.918 -0.583 . . . . 10.0 111.39 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . 0.428 HG21 ' HA ' ' C' ' 52' ' ' SER . 73.2 mt -78.77 95.89 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.145 0.498 . . . . 10.0 110.207 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -86.12 -38.72 17.46 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.585 -0.734 . . . . 10.0 111.087 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -81.49 75.3 8.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.367 0.603 . . . . 10.0 110.954 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.86 5.67 35.99 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.767 -0.651 . . . . 10.0 110.29 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.399 -0.81 . . . . 10.0 110.625 -179.3 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' -1' ' ' SER . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.475 0.777 0 CA-C-O 120.947 0.403 . . . . 10.0 110.55 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 0' ' ' VAL . . . . . . . . . . . . . 1.9 t -85.22 39.42 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.919 -0.582 . . . . 10.0 111.378 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 1' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -73.33 105.18 4.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.542 0.687 . . . . 10.0 111.023 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.7 48.56 1.07 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.802 -1.09 . . . . 10.0 111.25 -178.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -126.7 132.26 51.19 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.57 -0.53 . . . . 10.0 109.57 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 4' ' ' SER . . . . . 0.503 ' HB2' ' OE1' ' C' ' 7' ' ' GLU . 0.8 OUTLIER -96.98 154.2 17.45 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.727 0.298 . . . . 10.0 110.695 -178.016 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . 0.457 ' HB3' ' CE1' ' C' ' 44' ' ' PHE . 17.7 mttp -61.78 -40.99 97.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.083 -0.508 . . . . 10.0 111.757 -178.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 6' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -57.9 -57.94 10.56 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.459 0.474 . . . . 10.0 110.374 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . 0.503 ' OE1' ' HB2' ' C' ' 4' ' ' SER . 2.6 mp0 -55.79 -44.91 78.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.684 -0.689 . . . . 10.0 111.772 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 8' ' ' ILE . . . . . 0.65 ' O ' HG13 ' C' ' 12' ' ' ILE . 38.8 mm -62.58 -53.18 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 C-N-CA 121.233 -0.187 . . . . 10.0 110.604 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.99 -45.26 75.0 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.347 -0.388 . . . . 10.0 110.774 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.63 -35.0 79.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.797 -0.638 . . . . 10.0 110.942 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.6 -35.66 80.73 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.216 -0.447 . . . . 10.0 111.06 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 12' ' ' ILE . . . . . 0.65 HG13 ' O ' ' C' ' 8' ' ' ILE . 6.6 mt -69.87 -50.41 49.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.928 0.394 . . . . 10.0 111.265 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 13' ' ' VAL . . . . . 0.407 ' HA ' ' HG3' ' C' ' 37' ' ' MET . 16.4 m -68.11 -27.94 39.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 116.005 -0.543 . . . . 10.0 110.965 -178.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 14' ' ' ASN . . . . . 0.461 ' HB2' HG11 ' C' ' 51' ' ' VAL . 33.9 t30 -74.22 -43.06 58.62 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.256 -0.646 . . . . 10.0 109.256 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 15' ' ' TYR . . . . . 0.598 ' O ' HG12 ' C' ' 19' ' ' ILE . 13.1 t80 -64.28 -49.01 73.51 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.521 -0.763 . . . . 10.0 110.882 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 11.9 m-30 -55.75 -43.77 76.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.502 -0.317 . . . . 10.0 111.711 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 66.6 m -59.48 -40.61 87.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.569 -0.287 . . . . 10.0 111.522 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 1.3 m -76.25 -23.13 54.47 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.024 0.379 . . . . 10.0 112.024 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 19' ' ' ILE . . . . . 0.598 HG12 ' O ' ' C' ' 15' ' ' TYR . 29.2 mm -77.13 -38.48 27.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.067 0.461 . . . . 10.0 110.684 -178.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 20' ' ' VAL . . . . . . . . . . . . . 33.4 m -79.74 -20.12 12.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.377 0.608 . . . . 10.0 109.775 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -62.91 -51.63 66.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.973 -1.012 . . . . 10.0 110.838 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 22' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -92.7 -2.36 56.1 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.676 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 63.6 mttm 56.03 56.4 5.97 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.704 -0.68 . . . . 10.0 109.911 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -84.96 13.02 6.46 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.177 -0.92 . . . . 10.0 110.529 -179.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 15.9 tt -150.09 163.3 3.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.658 -0.867 . . . . 10.0 108.658 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 13.8 m -66.07 162.76 18.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.662 0.267 . . . . 10.0 110.639 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -60.82 -39.57 89.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.516 -0.311 . . . . 10.0 111.626 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 28' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -59.75 -47.84 84.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.018 0.437 . . . . 10.0 110.256 179.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 29' ' ' GLY . . . . . 0.535 ' O ' ' HG ' ' C' ' 33' ' ' LEU . . . -65.58 -41.36 96.14 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.855 -0.688 . . . . 10.0 111.587 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.5 -42.34 96.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.709 0.29 . . . . 10.0 111.36 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.9 -38.82 92.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.082 0.468 . . . . 10.0 110.319 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 32' ' ' SER . . . . . . . . . . . . . 6.3 m -62.46 -40.15 95.69 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.679 -0.691 . . . . 10.0 110.067 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 33' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' C' ' 29' ' ' GLY . 62.4 mt -72.2 -31.51 65.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.833 -0.621 . . . . 10.0 111.169 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 34' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -64.42 -53.77 43.18 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.256 -0.429 . . . . 10.0 111.717 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 35' ' ' VAL . . . . . 0.542 HG22 ' HG ' ' A' ' 120' ' ' LEU . 11.3 p -67.79 -35.06 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-O 120.888 0.375 . . . . 10.0 110.664 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.72 -29.2 66.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.794 0.331 . . . . 10.0 110.529 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 37' ' ' MET . . . . . 0.407 ' HG3' ' HA ' ' C' ' 13' ' ' VAL . 30.5 ttm -58.55 -50.94 71.97 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.006 -0.543 . . . . 10.0 110.514 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 38' ' ' ASP . . . . . 0.504 ' CB ' ' HA3' ' A' ' 123' ' ' GLY . 1.0 OUTLIER -69.71 -28.65 66.0 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 116.43 -0.35 . . . . 10.0 110.62 -179.721 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 39' ' ' CYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 123' ' ' GLY . 7.8 t -61.61 -50.25 73.33 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.423 -0.584 . . . . 10.0 109.423 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 40' ' ' ILE . . . . . . . . . . . . . 79.4 mt -60.57 -46.04 96.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.323 -0.853 . . . . 10.0 109.927 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 41' ' ' SER . . . . . 0.835 ' HA ' ' CE1' ' C' ' 46' ' ' PHE . 47.4 m -58.87 -38.18 78.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.55 -0.75 . . . . 10.0 111.366 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -70.71 -44.98 65.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.714 -0.675 . . . . 10.0 110.863 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.41 -37.44 72.74 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.819 0.674 . . . . 10.0 112.819 -178.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 44' ' ' PHE . . . . . 0.457 ' CE1' ' HB3' ' C' ' 5' ' ' LYS . 94.1 m-85 -97.9 2.35 49.08 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.179 -0.326 . . . . 10.0 111.633 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.74 57.93 16.39 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.314 -0.47 . . . . 10.0 113.518 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 46' ' ' PHE . . . . . 0.835 ' CE1' ' HA ' ' C' ' 41' ' ' SER . 10.5 p90 -147.71 175.64 10.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 117.121 0.46 . . . . 10.0 110.404 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 47' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -100.97 136.19 41.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.642 -0.253 . . . . 10.0 110.355 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 48' ' ' ARG . . . . . 0.435 ' O ' HG13 ' C' ' 51' ' ' VAL . 5.1 ptm180 -58.98 -37.47 76.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 10.0 111.293 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.61 18.58 3.86 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.752 1.019 . . . . 10.0 113.752 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.92 1.66 37.08 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.989 0.424 . . . . 10.0 111.421 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 51' ' ' VAL . . . . . 0.461 HG11 ' HB2' ' C' ' 14' ' ' ASN . 27.2 m -45.22 -35.78 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 114.097 1.147 . . . . 10.0 114.097 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 52' ' ' SER . . . . . 0.428 ' HA ' HG21 ' B' ' 68' ' ' ILE . 0.7 OUTLIER -57.98 -35.6 71.43 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.316 0.858 . . . . 10.0 113.316 -179.164 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.55 -20.31 69.19 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 111.087 -0.805 . . . . 10.0 111.087 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 54' ' ' ILE . . . . . . . . . . . . . 50.5 mt -91.69 -65.38 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 114.35 1.241 . . . . 10.0 114.35 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 72.8 mt -78.43 -66.73 0.82 Allowed 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.222 -0.899 . . . . 10.0 112.984 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 75.39 -141.37 27.67 Favored Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 120.156 -1.021 . . . . 10.0 110.849 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 12.6 pttp -136.42 22.35 3.18 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.103 0.477 . . . . 10.0 110.546 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.44 19.09 1.31 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.747 -0.66 . . . . 10.0 111.337 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 60.2 88.15 0.08 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.623 -0.717 . . . . 10.0 111.039 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 60' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -69.68 104.98 2.55 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.666 -0.697 . . . . 10.0 111.254 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -86.48 72.78 10.22 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.077 -0.51 . . . . 10.0 110.427 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.98 78.72 1.93 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 121.158 -0.544 . . . . 10.0 111.944 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 63' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -78.21 86.97 4.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.953 0.406 . . . . 10.0 111.741 -178.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 64' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -110.01 88.33 2.73 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.221 -0.659 . . . . 10.0 109.221 177.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 46.2 mt -75.13 -30.06 60.7 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.919 -0.582 . . . . 10.0 110.896 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . 59.12 13.73 3.11 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.695 -0.684 . . . . 10.0 111.89 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 69.54 29.93 4.17 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 123.688 0.618 . . . . 10.0 111.556 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 68' ' ' ILE . . . . . . . . . . . . . 83.3 mt -85.65 107.52 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.223 0.535 . . . . 10.0 111.068 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -108.59 -16.19 14.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.737 -0.665 . . . . 10.0 110.079 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 70' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -83.16 54.2 2.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.791 -0.641 . . . . 10.0 111.912 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.31 -10.54 57.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.067 0.46 . . . . 10.0 110.862 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.244 0 CA-C-O 118.508 -0.758 . . . . 10.0 110.519 -179.489 . . . . . . . . 0 0 . 1 stop_ save_